id,pmid,year,seq,MAP,name,cter,nter,lyn_cyc,ldmix,non_nat,len,nature,activity,source,origin,exp_str,non_hem,dssp,smiles
1038,10924341,2000,ILPWKWPWWPWRR,ILPWKWPWWPWRR{ct:Amid},Indolicidin,Amidation,Free,Linear,L,None,13,Antibacterial,100% Hemolysis at 100 μg/ml,Rat,Indolicidin of bovine neutrophil,NA,NA,CCCCCCSSCSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1039,10924341,2000,ILPWKLPLLPLRR,ILPWKLPLLPLRR{ct:Amid},IL4,Amidation,Free,Linear,L,None,13,Antibacterial,0% Hemolysis at 100 μg/ml,Rat,Indolicidin analog of bovine neutrophil,NA,Non-hemolytic,CCSBTTTBGGGTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1040,10924341,2000,ILPLKLPWLPLRR,ILPLKLPWLPLRR{ct:Amid},IL8,Amidation,Free,Linear,L,None,13,Antibacterial,0% Hemolysis at 100 μg/ml,Rat,Indolicidin analog of bovine neutrophil,NA,Non-hemolytic,CCCSTTTSCGGGC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1041,10924341,2000,ILPLKLPLLPWRR,ILPLKLPLLPWRR{ct:Amid},IL11,Amidation,Free,Linear,L,None,13,Antibacterial,0% Hemolysis at 100 μg/ml,Rat,Indolicidin analog of bovine neutrophil,NA,Non-hemolytic,CCCCCSSCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1075,20969885,2011,GIWSSIKNLASKAWNSDIGQSLRNKAAGAINKFVADKIGVTPSQAAS,GIWSSIKNLASKAWNSDIGQSLRNKAAGAINKFVADKIGVTPSQAAS,Vejovine,Free,Free,Linear,L,None,47,Antibacterial,HC50 = 100 µM,Human,Vejovine (scorpion venom of Vaejovis mexicanus),NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
1091,17212422,2007,APC-L-ACPC-K-ACPC-L-APC-L-ACPC-K-ACPC-L-APC-L-ACPC,{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}{cyc:N-C}{ct:Amid},Peptide 1,Amidation,Free,Cyclic,L,"APC = APC, ACPC = ACPC",15,Antibacterial,>10% Hemolysis at 3.1 μg/ml,Human,Synthetic peptide,NA,NA,NA,NA
1092,17212422,2007,APC-L-ACPC-L-APC-L-ACPC-K-ACPC-L-ACPC-K-ACPC-L-APC,{nnr:APC}-L-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:APC}{cyc:N-C}{ct:Amid},Peptide 2,Amidation,Free,Cyclic,L,"APC = APC, ACPC = ACPC",15,Antibacterial,>10% Hemolysis at 1.6 μg/ml,Human,Synthetic peptide,NA,NA,NA,NA
1093,17212422,2007,ACPC-L-APC-K-APC-L-ACPC-K-APC-L-ACPC-L-ACPC-L-ACPC,{nnr:ACPC}-L-{nnr:APC}-K-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:APC}-L-{nnr:ACPC}-L-{nnr:ACPC}-L-{nnr:ACPC}{cyc:N-C}{ct:Amid},Peptide 3,Amidation,Free,Cyclic,L,"APC = APC, ACPC = ACPC",15,Antibacterial,>10% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,NA,NA
1094,17212422,2007,APC-L-APC-L-ACPC-K-ACPC-L-ACPC-L-APC-L-ACPC-K-ACPC,{nnr:APC}-L-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}{cyc:N-C}{ct:Amid},Peptide 4,Amidation,Free,Cyclic,L,"APC = APC, ACPC = ACPC",15,Antibacterial,>10% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,NA,NA
1095,17212422,2007,APC-L-ACPC-L-APC-L-ACPC-L-APC-L-ACPC-K-ACPC-L-APC,{nnr:APC}-L-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:APC}{cyc:N-C}{ct:Amid},Peptide 5,Amidation,Free,Cyclic,L,"APC = APC, ACPC = ACPC",15,Antibacterial,>10% Hemolysis at 1.6 μg/ml,Human,Synthetic peptide,NA,NA,NA,NA
1096,17212422,2007,APC-F-ACPC-L-APC-L-ACPC-F-APC-F-ACPC-K-ACPC-L-APC,{nnr:APC}-F-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-F-{nnr:APC}-F-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:APC}{cyc:N-C}{ct:Amid},Peptide 6,Amidation,Free,Cyclic,L,"APC = APC, ACPC = ACPC",15,Antibacterial,>10% Hemolysis at 1.6 μg/ml,Human,Synthetic peptide,NA,NA,NA,NA
1097,17212422,2007,APC-L-ACPC-K-ACPC-A-APC-A-ACPC-K-ACPC-A-APC-L-ACPC,{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-A-{nnr:APC}-A-{nnr:ACPC}-K-{nnr:ACPC}-A-{nnr:APC}-L-{nnr:ACPC}{cyc:N-C}{ct:Amid},Peptide 7,Amidation,Free,Cyclic,L,"APC = APC, ACPC = ACPC",15,Antibacterial,>10% Hemolysis at >400 μg/ml,Human,Synthetic peptide,NA,NA,NA,NA
1098,17212422,2007,APC-L-ACPC-A-APC-A-ACPC-K-ACPC-L-ACPC-K-ACPC-A-APC,{nnr:APC}-L-{nnr:ACPC}-A-{nnr:APC}-A-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:ACPC}-K-{nnr:ACPC}-A-{nnr:APC}{cyc:N-C}{ct:Amid},Peptide 8,Amidation,Free,Cyclic,L,"APC = APC, ACPC = ACPC",15,Antibacterial,>10% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,NA,NA
1099,17212422,2007,ACPC-A-APC-K-APC-L-ACPC-K-APC-A-ACPC-A-ACPC-L-ACPC,{nnr:ACPC}-A-{nnr:APC}-K-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:APC}-A-{nnr:ACPC}-A-{nnr:ACPC}-L-{nnr:ACPC}{cyc:N-C}{ct:Amid},Peptide 9,Amidation,Free,Cyclic,L,"APC = APC, ACPC = ACPC",15,Antibacterial,>10% Hemolysis at >400 μg/ml,Human,Synthetic peptide,NA,NA,NA,NA
1243,18779649,2008,GWGSFFKKAAHVGKHVGKAALTHYL,GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid},L-Pleurocidin,Amidation,Free,Linear,L,None,25,Antibacterial,77% Hemolysis at 100 µM,Human,Skin mucous of the winter flounder (Pleuronectes americanus ),α-helix,NA,CCHHHHTTTCCCSSSSGGGSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
1244,18779649,2008,GWGSFFKKAAHVGKHVGKAALTHYL,GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid},L-Pleurocidin,Amidation,Free,Linear,L,None,25,Antibacterial,29% Hemolysis at 50 µM,Human,Skin mucous of the winter flounder (Pleuronectes americanus ),α-helix,NA,CCHHHHTTTCCCSSSSGGGSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
1245,18779649,2008,GWGSFFKKAAHVGKHVGKAALTHYL,GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid},L-Pleurocidin,Amidation,Free,Linear,L,None,25,Antibacterial,0% Hemolysis at 3.13-25 µM,Human,Skin mucous of the winter flounder (Pleuronectes americanus ),α-helix,NA,CCHHHHTTTCCCSSSSGGGSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
1246,18779649,2008,gwgsffkkaahvgkhvgkaalthyl,G{d}W{d}G{d}S{d}F{d}F{d}K{d}K{d}A{d}A{d}H{d}V{d}G{d}K{d}H{d}V{d}G{d}K{d}A{d}A{d}L{d}T{d}H{d}Y{d}L{d}{ct:Amid},D-Pleurocidin,Amidation,Free,Linear,D,None,25,Antibacterial,19% Hemolysis at 100 µM,Human,Skin mucous of the winter flounder (Pleuronectes americanus ),α-helix,NA,NA,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
1247,18779649,2008,gwgsffkkaahvgkhvgkaalthyl,G{d}W{d}G{d}S{d}F{d}F{d}K{d}K{d}A{d}A{d}H{d}V{d}G{d}K{d}H{d}V{d}G{d}K{d}A{d}A{d}L{d}T{d}H{d}Y{d}L{d}{ct:Amid},D-Pleurocidin,Amidation,Free,Linear,D,None,25,Antibacterial,0% Hemolysis at 3.13-50 µM,Human,Skin mucous of the winter flounder (Pleuronectes americanus ),α-helix,NA,NA,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
1292,19399781,2009,Aib-GL-Aib-GGL-Aib-GI-LOL,{nnr:Aib}GL{nnr:Aib}GGL{nnr:Aib}GILOL{nt:Acet}{ct:leucinol},Trichogin GA IV,"1,2-aminoalcohol, Lol (leucinol)",Acetylated by lipol (n-octanoyl),Linear,L,Aib = α-aminoisobutyric acid,11,Antifungal and Antibacterial,2% Hemolysis at 15 µM,Human,Trichogin GA IV (Trichoderma longibrachiatum),mixed 310/α-helical,NA,NA,NA
1293,19399781,2009,Aib-GL-Aib-GGL-Aib-GIL,{nnr:Aib}GL{nnr:Aib}GGL{nnr:Aib}GIL{nt:Acet}{ct:Methoxy(Ome)},Tric-OMe,Methoxy (Ome),Acetylated by lipol (n-octanoyl),Linear,L,Aib = α-aminoisobutyric acid,11,Antifungal and Antibacterial,2% Hemolysis at 15 µM,Human,Trichogin GA IV analogue (Trichoderma longibrachiatum),mixed 310/α-helical,NA,NA,NA
1294,19399781,2009,Aib-GGL-Aib-GIL,{nnr:Aib}GGL{nnr:Aib}GIL{nt:Acet}{ct:Methoxy(Ome)},Tric-8,Methoxy (Ome),Acetylated by lipol (n-octanoyl),Linear,L,Aib = α-aminoisobutyric acid,8,Antifungal and Antibacterial,0% Hemolysis at 15 µM (non-hemolytic),Human,Trichogin GA IV analogue (Trichoderma longibrachiatum),mixed 310/α-helical,Non-hemolytic,NA,NA
1295,19399781,2009,Aib-GIL,{nnr:Aib}GIL{nt:Acet}{ct:Methoxy(Ome)},Tric-4,Methoxy (Ome),Acetylated by lipol (n-octanoyl),Linear,L,Aib = α-aminoisobutyric acid,4,Antifungal and Antibacterial,0% Hemolysis at 15 µM (non-hemolytic),Human,Trichogin GA IV analogue (Trichoderma longibrachiatum),mixed 310/α-helical,Non-hemolytic,NA,NA
1455,19703772,2009,KLLLKLWLKLLK,KLLLKLWLKLLK{nt:Acet}{ct:Amid},KL1,Amidation,Acetylation,Linear,L,None,12,Antibacterial,100% Hemolysis at >50 μg/ml,Human,Synthetic peptide,α-helix,NA,CTTHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
1456,19703772,2009,K-Ψ[CH2NH]-LLLKLWLKLLK,K{nnr:Ψ[CH2NH]}LLLKLWLKLLK{nt:Acet}{ct:Amid},KL2,Amidation,Acetylation,Linear,L,nnr:Ψ[CH2NH],12,Antibacterial,100% Hemolysis at 150 μg/ml,Human,Synthetic peptide,α-helix,NA,NA,NA
1457,19703772,2009,KLLLKLWL-Ψ[CH2NH]-KLLK,KLLLKLWL{Ψ[CH2NH]}KLLK{nt:Acet}{ct:Amid},KL3,Amidation,Acetylation,Linear,L,nnr:Ψ[CH2NH],12,Antibacterial,Low Hemolysis upto 200 μg/ml,Human,Synthetic peptide,α-helix,NA,NA,NA
1464,20176897,2010,G-ΔF-RK-ΔF-HK-ΔF-WA,G-{nnr:ΔF}-RK-{nnr:ΔF}-HK-{nnr:ΔF}-WA{nt:Acet}{ct:Amid},ΔFm,Amidation,Acetylation,Linear,L,"ΔF = α,β-didehydrophenylalanine",10,Antibacterial,0% Hemolysis upto 1358 μg/ml (non-hemolytic),Human,Synthetic peptide,Helical,Non-hemolytic,NA,NA
1465,20176897,2010,G-ΔF-RK-ΔF-KA-ΔF-WH,G-{nnr:ΔF}-RK-{nnr:ΔF}-KA-{nnr:ΔF}-WH{nt:Acet}{ct:Amid},ΔFmscr,Amidation,Acetylation,Linear,L,"ΔF = α,β-didehydrophenylalanine",10,Antibacterial,0% Hemolysis upto 679 μg/ml (non-hemolytic),Human,Synthetic peptide,helical,Non-hemolytic,NA,NA
1466,20195659,2011,IDWLKLGKMVMDVL,IDWLKLGKMVMDVL{ct:Amid},Polybia MP3,Amidation,Free,Linear,L,None,14,Antibacterial,EC50 = 50 µM,Rabbit,Venom sac of the Polybia paulista,helical,NA,CCTTTSSSSSSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
1467,20195659,2011,INWLKLGKMVIDAL,INWLKLGKMVIDAL{ct:Amid},Polybia MP2,Amidation,Free,Linear,L,None,14,Antibacterial,EC50 = 50 µM,Rabbit,Venom sac of the Polybia paulista,helical,NA,CCSSCCSCCSSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C
1468,20195659,2011,IDWKKLLDAAKQIL,IDWKKLLDAAKQIL{ct:Amid},Polybia MP1,Amidation,Free,Linear,L,None,14,Antibacterial,Non-hemolytic,Rabbit,Venom sac of the Polybia paulista,helical,NA,CCHHHHHHHHTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
1469,20195659,2011,INWKKLLDAAKQIL,INWKKLLDAAKQIL{ct:Amid},Polybia N2-MP1,Amidation,Free,Linear,L,None,14,Antibacterial,EC50 = 26 µM,Rabbit,Venom sac of the Polybia paulista,helical,NA,CCHHHHHHHHTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
1470,20196123,2010,ILPWKWPWWPWRR,ILPWKWPWWPWRR{ct:Amid},Ind,Amidation,Free,Linear,L,None,13,Antibacterial,100% Hemolysis at 50 µM,Human,Indolicidin (bovine),Random-coil,NA,CCCCCCSSCSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1471,20196123,2010,ILPLKWPWWPWRR,ILPLKWPWWPWRR{ct:Amid},[L4]Ind,Amidation,Free,Linear,L,None,13,Antibacterial,73% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,CCSSCCSCCSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1472,20196123,2010,ILPWKLPWWPWRR,ILPWKLPWWPWRR{ct:Amid},[L6]Ind,Amidation,Free,Linear,L,None,13,Antibacterial,88% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,CTTTTSSCCSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1473,20196123,2010,ILPWKWPLWPWRR,ILPWKWPLWPWRR{ct:Amid},[L8]Ind,Amidation,Free,Linear,L,None,13,Antibacterial,63% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,NA,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1474,20196123,2010,ILPWKWPWLPWRR,ILPWKWPWLPWRR{ct:Amid},[L9]Ind,Amidation,Free,Linear,L,None,13,Antibacterial,6% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,CCSSCCSSSCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1475,20196123,2010,ILPWKWPWWPLRR,ILPWKWPWWPLRR{ct:Amid},[L11]Ind,Amidation,Free,Linear,L,None,13,Antibacterial,13% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,CCTTCCSCCSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1476,20196123,2010,ILPLKLPLLPLRR,ILPLKLPLLPLRR{ct:Amid},"[L4,6,8,9,11]Ind",Amidation,Free,Linear,L,None,13,Antibacterial,100% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,CCTTTTTHHHHCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1477,20196123,2010,ILPFKFPFFPFRR,ILPFKFPFFPFRR{ct:Amid},"[F4,6,8,9,11]Ind",Amidation,Free,Linear,L,None,13,Antibacterial,6% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,CCCCCCSCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1478,20196123,2010,ILPYKYPYYPYRR,ILPYKYPYYPYRR{ct:Amid},"[Y4,6,8,9,11]Ind",Amidation,Free,Linear,L,None,13,Antibacterial,4% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,CCSSCCSCCSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1479,20196123,2010,ILPLKLPWWPWRR,ILPLKLPWWPWRR{ct:Amid},"[L4,6]Ind",Amidation,Free,Linear,L,None,13,Antibacterial,8% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,CCTTSSSCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1480,20196123,2010,ILPKKKPWWPWRR,ILPKKKPWWPWRR{ct:Amid},"[K4,6]Ind",Amidation,Free,Linear,L,None,13,Antibacterial,8% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,CCCSSCSCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1481,20196123,2010,ILPWKWPLLPWRR,ILPWKWPLLPWRR{ct:Amid},"[L8,9]Ind",Amidation,Free,Linear,L,None,13,Antibacterial,18% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,CCSCCCSCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1482,20196123,2010,ILPWKWPYLPWRR,ILPWKWPYLPWRR{ct:Amid},"[Y8,L9]Ind",Amidation,Free,Linear,L,None,13,Antibacterial,60% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,NA,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1483,20196123,2010,ILPWKWPKLPWRR,ILPWKWPKLPWRR{ct:Amid},"[K8,L9]Ind",Amidation,Free,Linear,L,None,13,Antibacterial,0% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,Non-hemolytic,CCCSSSSCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1484,20196123,2010,ILPWKWPWLPLRR,ILPWKWPWLPLRR{ct:Amid},"[L9,11]Ind",Amidation,Free,Linear,L,None,13,Antibacterial,3% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,CCSSCCSSCGGGC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1485,20196123,2010,ILPWKWPWLPYRR,ILPWKWPWLPYRR{ct:Amid},"[L9,Y11]Ind",Amidation,Free,Linear,L,None,13,Antibacterial,12% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,CCCCCCSSCSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1486,20196123,2010,ILPWKWPWLPKRR,ILPWKWPWLPKRR{ct:Amid},"[L9,K11]Ind",Amidation,Free,Linear,L,None,13,Antibacterial,3% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,CCSSCCSCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1487,20196123,2010,ILPKKWPKLPWRR,ILPKKWPKLPWRR{ct:Amid},"[K4,8,L9]Ind",Amidation,Free,Linear,L,None,13,Antibacterial,7% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,CCSSCCCCCCTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1488,20196123,2010,ILPWKKPKLPWRR,ILPWKKPKLPWRR{ct:Amid},"[K6,8,L9]Ind",Amidation,Free,Linear,L,None,13,Antibacterial,11% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,CCSSCTTSSSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1489,20196123,2010,ILPWKWPWLPWKK,ILPWKWPWLPWKK{ct:Amid},"[L9,K12,13]Ind",Amidation,Free,Linear,L,None,13,Antibacterial,8% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,CCSSCCSSCSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
1490,20196123,2010,RRWPWWPWKWPLI,RRWPWWPWKWPLI{ct:Amid},Retro-Ind,Amidation,Free,Linear,L,None,13,Antibacterial,36% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,CCCSSCCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
1491,20196123,2010,RRWPLLPWKWPLI,RRWPLLPWKWPLI{ct:Amid},"Retro-[L8,9]Indb",Amidation,Free,Linear,L,None,13,Antibacterial,11% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,CCCSSCSSCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
1492,20196123,2010,RRWPLKPWKKPLI,RRWPLKPWKKPLI{ct:Amid},"Retro-[K4,8,L9]Indb",Amidation,Free,Linear,L,None,13,Antibacterial,9% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,CCSSSSSSCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
1493,20196123,2010,RRWPLKPKKWPLI,RRWPLKPKKWPLI{ct:Amid},"Retro-[K6,8,L9]Indb",Amidation,Free,Linear,L,None,13,Antibacterial,7% Hemolysis at 50 µM,Human,Indolicidin analog (synthetic peptide),Random-coil,NA,CCCCCSSSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
1540,20927512,2011,MSVSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK,MSVSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK,Tmp1,Free,Free,Linear,L,None,34,Antibacterial,0% Hemolysis at 50 µM (non-hemolytic),Sheep,Tmp1 (goat skin surface metagenome),α Helix,Non-hemolytic,CCTTTTHHHHHHHHHHHHHHHHHHTTTTTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
1541,20927512,2011,LGFGTFVLMLLGLVVELIK,LGFGTFVLMLLGLVVELIK,TMDSP,Free,Free,Linear,L,None,19,Antibacterial,Mild hemolytic activity at 50 µM,Sheep,Tmp1 (goat skin surface metagenome),α Helix,NA,CCSTTSHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
1542,20927512,2011,MLSVSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK,MLSVSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK,T1RM1,Free,Free,Linear,L,None,35,Antibacterial,0% Hemolysis at 50 µM (non-hemolytic),Sheep,Tmp1 (goat skin surface metagenome),α Helix,Non-hemolytic,CCSTTTCHHHHHHHHHHHHHHHHHHHHHTTCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
1543,20927512,2011,MVSVSVAVQLMLGFGTFVLMLLGLVVELIKNSNKK,MVSVSVAVQLMLGFGTFVLMLLGLVVELIKNSNKK,T1RM2,Free,Free,Linear,L,None,35,Antibacterial,0% Hemolysis at 50 µM (non-hemolytic),Sheep,Tmp1 (goat skin surface metagenome),α Helix,Non-hemolytic,CCCCTHHHHHHHHHHHHHHHHHHHHHHHTTCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
1544,20927512,2011,MESVSVAVQLMLGFGTFVLMLLGLVVELIKNSNKK,MESVSVAVQLMLGFGTFVLMLLGLVVELIKNSNKK,T1RM3,Free,Free,Linear,L,None,35,Antibacterial,0% Hemolysis at 50 µM (non-hemolytic),Sheep,Tmp1 (goat skin surface metagenome),α Helix,Non-hemolytic,CCSSHHHHHHHHHHHHHHHHHHHHHHHHTTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
1545,20927512,2011,MLSLSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK,MLSLSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK,T1RM4,Free,Free,Linear,L,None,35,Antibacterial,0% Hemolysis at 50 µM (non-hemolytic),Sheep,Tmp1 (goat skin surface metagenome),α Helix,Non-hemolytic,CCSHHHHHHHHHHHHHHHHHHHHHHHHHHHHSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
1546,20927512,2011,MESVSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK,MESVSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK,T1SDM1,Free,Free,Linear,L,None,35,Antibacterial,0% Hemolysis at 50 µM (non-hemolytic),Sheep,Tmp1 (goat skin surface metagenome),α Helix,Non-hemolytic,CCSSSSHHHHHHHHHHHHHHHHHHHHHHHHHSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
1547,20927512,2011,MESQSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK,MESQSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK,T1SDM2,Free,Free,Linear,L,None,35,Antibacterial,0% Hemolysis at 50 µM (non-hemolytic),Sheep,Tmp1 (goat skin surface metagenome),α Helix,Non-hemolytic,CCCTTTHHHHHHHHHHHHHHHHHHHHHIIIIISCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
1548,20927512,2011,MESQSNAVQLMLGFGTFVLMLLGLVVELIKNSNKK,MESQSNAVQLMLGFGTFVLMLLGLVVELIKNSNKK,T1SDM3,Free,Free,Linear,L,None,35,Antibacterial,0% Hemolysis at 50 µM (non-hemolytic),Sheep,Tmp1 (goat skin surface metagenome),α Helix,Non-hemolytic,CCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
1561,21184776,2011,NGVQPKY,NGVQPKY,Leucrocin I,Free,Free,Linear,L,None,7,Antibacterial,15.88% Hemolysis upto 48.0μg,Human,Leucrocin (serum and plasma of Crocodylus siamensis),28.57% Extended strand 71.43% Random coil,NA,CCSSCCC,CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
1562,21184776,2011,NAGSLLSGWG,NAGSLLSGWG,Leucrocin II,Free,Free,Linear,L,None,10,Antibacterial,91.73% Hemolysis at 10μg,Human,Leucrocin (serum and plasma of Crocodylus siamensis),44.44% Extended strand 55.56% Random coil,NA,CCCCCCCTTC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O
1563,21184776,2011,NAGSLLSGWG,NAGSLLSGWG,Leucrocin II,Free,Free,Linear,L,None,10,Antibacterial,11.63% Hemolysis at 6.0μg,Human,Leucrocin (serum and plasma of Crocodylus siamensis),45.44% Extended strand 55.56% Random coil,NA,CCCCCCCTTC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O
1564,14709550,2004,kGGGkWGGkGGk,K{d}GGGK{d}WGGK{d}GGK{d}{nt:Palmitoylation}{ct:Amid},PA-D-G,Amidation,Palmitoylation,Linear,Mix,nter = Palmitoylation,12,Antifungal and Antibacterial,>75% Hemolysis at 100 µM,Human,Synthetic peptide,Random coils,NA,NA,NCCCC[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCCN)C(=O)O
1565,14709550,2004,KAaaKWAaKaAK,KAA{d}A{d}KWAA{d}KA{d}AK{nt:Palmitoylation}{ct:Amid},PA-D-A,Amidation,Palmitoylation,Linear,Mix,nter = Palmitoylation,12,Antifungal and Antibacterial,<25% Hemolysis at 100 µM,Human,Synthetic peptide,Random coils,NA,NA,C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
1566,14709550,2004,KVvvKWVvKvVK,KVV{d}V{d}KWVV{d}KV{d}VK{nt:Palmitoylation}{ct:Amid},PA-D-V,Amidation,Palmitoylation,Linear,Mix,nter = Palmitoylation,12,Antifungal and Antibacterial,100% Hemolysis at 100 µM,Human,Synthetic peptide,β-aggregates,NA,NA,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
1567,14709550,2004,KLllKWLlKlLK,KLL{d}L{d}KWLL{d}KL{d}LK{nt:Palmitoylation}{ct:Amid},PA-D-L,Amidation,Palmitoylation,Linear,Mix,nter = Palmitoylation,12,Antifungal and Antibacterial,>75% Hemolysis at 100 µM,Human,Synthetic peptide,α-helical,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
1608,15298176,2004,GLFGVLAKVAAHVVPAIAEHF,GLFGVLAKVAAHVVPAIAEHF{ct:Amid},Mac,Amidation,Free,Linear,L,None,21,Antibacterial,100% Hemolysis at 100 µM,Rabbit,Maculatin 1.1 from dorsal glands of the tree frog Litoria genimaculata,α-helical,NA,CCTTTTTSTTSSSGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
1609,15298176,2004,GLFGVLAKVAAHVVPAIAKHF,GLFGVLAKVAAHVVPAIAKHF{ct:Amid},[K19]Mac,Amidation,Free,Linear,L,None,21,Antibacterial,100% Hemolysis at 100 µM,Rabbit,Analog of Maculatin 1.1 (dorsal glands of the tree frog Litoria genimaculata),α-helical,NA,CCCCHHHHHHSCIIIIICC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
1610,15298176,2004,GLFGVLAKVAAKVVPAIAKHF,GLFGVLAKVAAKVVPAIAKHF{ct:Amid},"[K12,19]Mac",Amidation,Free,Linear,L,None,21,Antibacterial,100% Hemolysis at 100 µM,Rabbit,Analog of Maculatin 1.1 (dorsal glands of the tree frog Litoria genimaculata),α-helical,NA,CCTTHHHHHHHTTIIIIICC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
1611,15298176,2004,GLFGVLAKVAAHVVAAIAEHF,GLFGVLAKVAAHVVAAIAEHF{ct:Amid},[A15]Mac,Amidation,Free,Linear,L,None,21,Antibacterial,100% Hemolysis at 100 µM,Rabbit,Analog of Maculatin 1.1 (dorsal glands of the tree frog Litoria genimaculata),α-helical,NA,CCTTTHHHHTSCSSCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
1612,15298176,2004,LFGVLAKVAAHVVPAIAEHF,LFGVLAKVAAHVVPAIAEHF{ct:Amid},[∆1]Mac,Amidation,Free,Linear,L,None,20,Antibacterial,~10% Hemolysis at 100 µM,Rabbit,Analog of Maculatin 1.1 (dorsal glands of the tree frog Litoria genimaculata),α-helical,NA,CTTHHHHHHCSCCTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
1637,15752569,2005,FLSLIPHAINAVSAIAKHN,FLSLIPHAINAVSAIAKHN{ct:Amid},PS-1,Amidation,Free,Linear,L,None,19,Antibacterial and Antiprotozoan,1.98% Hemolysis at 64 µM,Human,"Skin secretion of the Brazilian tree-frogs, Phyllomedusa hypochondrialis and Phyllomedusa oreades",α-helical,NA,CCSCSCTHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)O
1638,15752569,2005,FLSLIPHAINAVSTLVHHF,FLSLIPHAINAVSTLVHHF{ct:Amid},PS-2,Amidation,Free,Linear,L,None,19,Antibacterial and Antiprotozoan,2.05% Hemolysis at 64 µM,Human,"Skin secretion of the Brazilian tree-frogs, Phyllomedusa hypochondrialis and Phyllomedusa oreades",α-helical,NA,CTTSCCTHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
1685,16730857,2006,KLKFKLKQ,KLKFKLKQ{cyc:N-C},BPC8L,Free,Free,Cyclic,L,None,8,Antibacterial,68±7.5% Hemolysis at 360 µM,Human,Synthetic peptide,NA,NA,CCCSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
1686,16730857,2006,KLKLKFKLKQ,KLKLKFKLKQ{cyc:N-C},BPC10L,Free,Free,Cyclic,L,None,10,Antibacterial,81 ± 5.3% Hemolysis at 360 µM,Human,Synthetic peptide,NA,NA,CCTTSCSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
1709,16940084,2006,QRLFQVKGRR,QRLFQVKGRR,PBP 10,Free,Free,Linear,L,None,10,Antibacterial,>40% Hemolysis at 40 µM,Human,Derived from the polyphosphoinositide binding site of gelsolin,NA,NA,CCCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
1724,17067722,2006,MKLGLLVVLAVAVLVPSLSEGQNVPSCQLKDPNQTPVEAGNMRNKREADDSSEESDLAEI,MKLGLLVVLAVAVLVPSLSEGQNVPSCQLKDPNQTPVEAGNMRNKREADDSSEESDLAEI,Pp B,Free,Free,Linear,L,None,60,Antibacterial,3.2 HU/mg,Horse,Grammistins (Pogonoperca punctata),NA,NA,CCSSCCBTHHHHTTSCCCCCCSSSSTTCCCSSCCCGGGTCCCCCCSSSCCCCCCCCCCBC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)O
1725,17067722,2006,IGGIISFFKRLF,IGGIISFFKRLF,Gs B,Free,Free,Linear,L,None,12,Antibacterial,<10 HU/mg,Horse,Grammistins (Pogonoperca punctata),NA,NA,CCCSSSTTTTTC,CC[C@H](C)[C@H](N)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
1726,17067722,2006,MKLGLLVVLAVAVLVPSLSEQDFPSCQLKEPNQTPVEAGNMRNKREADESSEEFDLAEM,MKLGLLVVLAVAVLVPSLSEQDFPSCQLKEPNQTPVEAGNMRNKREADESSEEFDLAEM,Pp l,Free,Free,Linear,L,None,60,Antibacterial,79 HU/mg,Horse,Grammistins (Pogonoperca punctata),NA,NA,NA,CSCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)O
1727,17067722,2006,VKRALSALKPKNKRFIGGIISFFKRLFG,VKRALSALKPKNKRFIGGIISFFKRLFG,Pp 2b,Free,Free,Linear,L,None,28,Antibacterial,63 HU/mg,Horse,Grammistins (Pogonoperca punctata),NA,NA,CTTTTSSCCCSSCCCCCTHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O)[C@@H](C)CC
1861,17688900,2007,FLSLALAALPKFLCLVFKKC,FLSLALAALPKFLCLVFKKC,Brevinin-1DYa,Free,Free,Linear,L,None,20,Antibacterial,LC50 <5 µM,Human,brevinin family (Rana dybowskii),NA,NA,CHHHHHHHSTTTTCCGGGCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)C(C)C
1862,17688900,2007,FLSLALAALPKLFCLIFKKC,FLSLALAALPKLFCLIFKKC,Brevinin-1DYb,Free,Free,Linear,L,None,20,Antibacterial,LC50 <5 µM,Human,brevinin family (Rana dybowskii),NA,NA,CHHHHHTTTTTTTSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
1863,17688900,2007,FLPLLLAGLPKLLCLFFKKC,FLPLLLAGLPKLLCLFFKKC,Brevinin-1DYc,Free,Free,Linear,L,None,20,Antibacterial,LC50 <5 µM,Human,brevinin family (Rana dybowskii),NA,NA,CHHHHHSSSCTTTSSSSCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
1868,15055772,2004,KWKLFKKIPKFLHLAKKF,KWKLFKKIPKFLHLAKKF{ct:Amid},P18,Amidation,Free,Linear,L,None,18,Antibacterial,Non-hemolytic,Human,cecropin A-magainin 2 hybrid,NA,Non-hemolytic,CCCSCSCCTTTSCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
1880,15298176,2004,FGVLAKVAAHVVPAIAEHF,FGVLAKVAAHVVPAIAEHF{ct:Amid},"[∆1,2]Mac",Amidation,Free,Linear,L,None,19,Antibacterial,0%Hemolysis at 100 µM (non-hemolytic),Rabbit,Analog of Maculatin 1.1 (Mac),NA,Non-hemolytic,CCCGGGGGGTTTGGGTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
1906,16730857,2006,KFKQ,KFKQ{cyc:N-C},BPC4L,Free,Free,Cyclic,L,None,4,Antibacterial,0% Hemolysis at 360 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCCC,NCCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
1907,16730857,2006,KfKQ,KF{d}KQ{cyc:N-C},BPC4D,Free,Free,Cyclic,Mix,None,4,Antibacterial,0% Hemolysis at 360 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCCC,NCCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
1908,16730857,2006,KfKLKQ,KF{d}KLKQ{cyc:N-C},BPC6D,Free,Free,Cyclic,Mix,None,6,Antibacterial,0% Hemolysis at 360 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
1909,16730857,2006,KLKLKLKE,KLKLKLKE{cyc:N-C},BPC8S2,Free,Free,Cyclic,L,None,8,Antibacterial,0% Hemolysis at 360 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O
1910,16730859,2006,VTLASHLPSDFTPAVHASLDKFLANVSTVLTSKYR,VTLASHLPSDFTPAVHASLDKFLANVSTVLTSKYR,α107–141,Free,Free,Linear,L,None,35,Antibacterial,Non-hemolytic,Bovine,Bovine hemoglobin,NA,Non-hemolytic,CCCCCCSSCCSTTSCTTTTTHHHHHHHHSSCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
1911,16730859,2006,TSKYR,TSKYR,α137–141,Free,Free,Linear,L,None,5,Antibacterial,Non-hemolytic,Bovine,Bovine hemoglobin,NA,Non-hemolytic,CCSCC,C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1912,16730859,2006,STVLTSKYR,STVLTSKYR,α133–141,Free,Free,Linear,L,None,9,Antibacterial,Non-hemolytic,Bovine,Bovine hemoglobin,NA,Non-hemolytic,CCSSSCSCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
1913,16730859,2006,VTLASHLPSDFTPAVHASLDKFLANVSTVL,VTLASHLPSDFTPAVHASLDKFLANVSTVL,a107–136,Free,Free,Linear,L,None,30,Antibacterial,Non-hemolytic,Bovine,Bovine hemoglobin,NA,Non-hemolytic,CCCSSCSSCCSTTCSSTHHHHTTTCSCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)O
1914,16730859,2006,QADFQKVVAGVANALAHRYH,QADFQKVVAGVANALAHRYH,β126-145,Free,Free,Linear,L,None,20,Antibacterial,Non-hemolytic,Bovine,Bovine hemoglobin,NA,Non-hemolytic,CCSHHHHHHHHHHHHSCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
2031,10819172,2000,KLLLKLLLKLLK,KLLLKLLLKLLK{ct:Amid},S1,Amidation,Free,Linear,L,None,12,Antibacterial,100% Hemolysis at 200 μg/ml,Mouse,Synthetic peptide,NA,NA,CTTHHHHTTTCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2032,10819172,2000,KLLΨ[CH2OCONH]LKLLLKLLK,KLL{conj:Ψ[CH2OCONH]}LKLLLKLLK{ct:Amid},SC1,Amidation,Free,Linear,L,conj = Ψ[CH2OCONH],12,Antibacterial,100% Hemolysis at 200 μg/ml,Mouse,Synthetic peptide,NA,NA,NA,NA
2033,10819172,2000,KLLΨ[CH2OCONH]LKLLLΨ[CH2OCONH]KLLK,KLL{conj:Ψ[CH2OCONH]}LKLLL{conj:Ψ[CH2OCONH]}KLLK{ct:Amid},SC2,Amidation,Free,Linear,L,conj = Ψ[CH2OCONH],12,Antibacterial,~90% Hemolysis at 200 μg/ml,Mouse,Synthetic peptide,NA,NA,NA,NA
2068,23430306,2013,LRRLWLRANRL,LRRLWLRANRL,LRR-1,Free,Free,Linear,L,None,11,Antibacterial,0% Hemolysis at 128 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCCCCCSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)O
2069,23430306,2013,LRRLWLRANRLLRRLWLRANRL,LRRLWLRANRLLRRLWLRANRL,LRR-2,Free,Free,Linear,L,None,22,Antibacterial,~70% Hemolysis at 128 µM,Human,Synthetic peptide,NA,NA,CCTTHHHHHHHHHHHHHHHSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)O
2073,21168461,2011,AMNSQLTLIVTIVLIFSSSRCERILDLRKTKKSCKNGEVLGCVSGHGPPGCSENECGGPRPKACFFDCHYGCCMCTGKLYRRKRDRKCVPKHECLL,AMNSQLTLIVTIVLIFSSSRCERILDLRKTKKSCKNGEVLGCVSGHGPPGCSENECGGPRPKACFFDCHYGCCMCTGKLYRRKRDRKCVPKHECLL,Rhamp,Free,Free,Linear,L,None,96,Antibacterial,Very little Hemolysis at 10 µM,Rabbit,Rhamp from the salivary glands of female tick Rhipicephalus haemaphysaloides,NA,NA,CCCCCCCCCCSCCCSSCCSSSTHHHHHHHGGGCCCCSSSCCCSSSCCCCCCCCCCCSSSCCCCCBSSSSBCSCCSTTTTTTCSSCCCSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O
2100,11168895,2000,GWGSFFKKAAHVGKHVGKAALTHYL,GWGSFFKKAAHVGKHVGKAALTHYL,Pleurocidin,Free,Free,Linear,L,None,25,Antibacterial,6% Hemolysis at 100 µM,Rabbit,Pleurocidin isolated from the skin mucous secretions of the winter flounder(Pleuronectes americanus),NA,NA,CCHHHHTTTCCCSSSSGGGSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
2101,11168895,2000,GWGSFFKKAAHVGKHVGKAALTHYL,GWGSFFKKAAHVGKHVGKAALTHYL,Pleurocidin,Free,Free,Linear,L,None,25,Antibacterial,15% Hemolysis at 100 µM,Human,Pleurocidin isolated from the skin mucous secretions of the winter flounder(Pleuronectes americanus),NA,NA,CCHHHHTTTCCCSSSSGGGSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
2102,11168895,2000,AWASFFKKAAHVGKHVGKAALTHYL,AWASFFKKAAHVGKHVGKAALTHYL,"[A1,3]Ple",Free,Free,Linear,L,None,25,Antibacterial,4% Hemolysis at 100 µM,Rabbit,Pleurocidin analogs (Pleuronectes americanus),NA,NA,CHHHHHHHHSSCCSSTTSSSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
2103,11168895,2000,AWASFFKKAAHVGKHVGKAALTHYL,AWASFFKKAAHVGKHVGKAALTHYL,"[A1,3]Ple",Free,Free,Linear,L,None,25,Antibacterial,8% Hemolysis at 100 µM,Human,Pleurocidin analogs (Pleuronectes americanus),NA,NA,CHHHHHHHHSSCCSSTTSSSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
2104,11168895,2000,GWGSFFKKAAHVAKHVAKAALTHYL,GWGSFFKKAAHVAKHVAKAALTHYL,"[A13,17]Ple",Free,Free,Linear,L,None,25,Antibacterial,50% Hemolysis at 100 µM,Rabbit,Pleurocidin analogs (Pleuronectes americanus),NA,NA,CTTTTGGGTSSCSCTTSSCSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
2105,11168895,2000,GWGSFFKKAAHVAKHVAKAALTHYL,GWGSFFKKAAHVAKHVAKAALTHYL,"[A13,17]Ple",Free,Free,Linear,L,None,25,Antibacterial,93% Hemolysis at 100 µM,Human,Pleurocidin analogs (Pleuronectes americanus),NA,NA,CTTTTGGGTSSCSCTTSSCSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
2106,11168895,2000,AWASFFKKAAHVAKHVAKAALTHYL,AWASFFKKAAHVAKHVAKAALTHYL,"[A1,3,13,17]Ple",Free,Free,Linear,L,None,25,Antibacterial,45% Hemolysis at 100 µM,Rabbit,Pleurocidin analogs (Pleuronectes americanus),NA,NA,CHHHHGGGTSSCSSHHHHHSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
2107,11168895,2000,AWASFFKKAAHVAKHVAKAALTHYL,AWASFFKKAAHVAKHVAKAALTHYL,"[A1,3,13,17]Ple",Free,Free,Linear,L,None,25,Antibacterial,90% Hemolysis at 100 µM,Human,Pleurocidin analogs (Pleuronectes americanus),NA,NA,CHHHHGGGTSSCSSHHHHHSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
2108,11168895,2000,GWGSFFKKAAAVGKAVGKAALTAYL,GWGSFFKKAAAVGKAVGKAALTAYL,"[A11,15,23]Ple",Free,Free,Linear,L,None,25,Antibacterial,15% Hemolysis at 100 µM,Rabbit,Pleurocidin analogs (Pleuronectes americanus),NA,NA,CTTHHHHTTHHHHHHHHHHHTTTCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
2109,11168895,2000,GWGSFFKKAAAVGKAVGKAALTAYL,GWGSFFKKAAAVGKAVGKAALTAYL,"[A11,15,23]Ple",Free,Free,Linear,L,None,25,Antibacterial,45% Hemolysis at 100 µM,Human,Pleurocidin analogs (Pleuronectes americanus),NA,NA,CTTHHHHTTHHHHHHHHHHHTTTCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
2110,11226440,2001,VLSAADKGNVKAAWGKVGGHAAE,VLSAADKGNVKAAWGKVGGHAAE,α 1-23 peptide,Free,Free,Linear,L,None,23,Antibacterial,0% Hemolysis upto 2.013 mM (non-hemolytic),Bovine,Peptic bovine hemoglobin hydrolysate,NA,Non-hemolytic,CCCSSCCCBTTBTSSSSSSSCC,CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C
2131,11557475,2001,GFKLKGMARISCLPNGQWSNFPPKCIRECAMVSS,GFKLKGMARISCLPNGQWSNFPPKCIRECAMVSS,S1,Free,Free,Linear,L,None,34,Antibacterial,0% Hemolysis at 100 μg/ml (non-hemolytic),Human,Synthetic peptide (Factor C Sushi Peptides),NA,Non-hemolytic,CCCCCCCCCCCCCSCSSSSCCCTTTHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)CC
2132,11557475,2001,GFKLKGKAKISCLPNGQWSNFPPKCIRECAMVSS,GFKLKGKAKISCLPNGQWSNFPPKCIRECAMVSS,S1Δ,Free,Free,Linear,L,None,34,Antibacterial,0% Hemolysis at 100 μg/ml (non-hemolytic),Human,Synthetic peptide (Factor C Sushi Peptides),NA,Non-hemolytic,CCCCCCCCCCCSSCCSSCCCCCGGGHHHHTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)CC
2133,11557475,2001,HAEHKVKIGVEQKYGQFPQGTEVTYTCSGNYFLM,HAEHKVKIGVEQKYGQFPQGTEVTYTCSGNYFLM,S3,Free,Free,Linear,L,None,34,Antibacterial,8% Hemolysis at 100 μg/ml,Human,Synthetic peptide (Factor C Sushi Peptides),NA,NA,CCCCSCSCSCCSCSSSCSSCSSCCCSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
2134,11557475,2001,HAEHKVKIKVKQKYGQFPQGTEVTYTCSGNYFLM,HAEHKVKIKVKQKYGQFPQGTEVTYTCSGNYFLM,S3Δ,Free,Free,Linear,L,None,34,Antibacterial,37% Hemolysis at 100 μg/ml,Human,Synthetic peptide (Factor C Sushi Peptides),NA,NA,CCSSCCCCBCSSSSSBCCCCTTTTCSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
2147,11892852,2001,FLPLLAGLAANFLPKIFCKITRKC,FLPLLAGLAANFLPKIFCKITRKC{cyc:N-C},Brevinin 1E (B),Free,Free,Cyclic,L,None,24,Antibacterial,100% Hemolysis at 0.7 µM,Rat,Brevinin 1E from the skin secretions of Rana esculenta,NA,NA,CCHHHHHHHHHHHHHHHHHHCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC
2148,11892852,2001,FLPLLAGLAANFLPKIFC-Acm-KITRKC-Acm,FLPLLAGLAANFLPKIFC-{nnr:Acm}-KITRKC-{nnr:Acm},Brevinin1E linear (BL),Free,Free,Linear,L,Acm = acetamidomethyl,26,Antibacterial,100% Hemolysis at 5 µM,Rat,Synthetic brevinin 1E variants (Rana esculenta),NA,NA,NA,NA
2149,11892852,2001,FLPLLAGLCKITRKCAANFLPKIF,FLPLLAGLCKITRKCAANFLPKIF{cyc:N-C},Analog of brevinin 1E (BA),Free,Free,Cyclic,L,None,24,Antibacterial,100% Hemolysis at 7 µM,Rat,Synthetic brevinin 1E variants (Rana esculenta),NA,NA,CCTTTSHHHHHHHHHTTCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2150,11892852,2001,FLPLLAGLC-Acm-KITRKC-Acm-AANFLPKIF,FLPLLAGLC-{nnr:Acm}-KITRKC-{nnr:Acm}-AANFLPKIF,Linear analog of brevinin 1E (BAL),Free,Free,Linear,L,Acm = acetamidomethyl,26,Antibacterial,Non-hemolytic,Rat,Synthetic brevinin 1E variants (Rana esculenta),NA,Non-hemolytic,NA,NA
2155,12005420,2001,KWKFKKIPKFLHLAKKF,KWKFKKIPKFLHLAKKF{ct:Amid},P18,Amidation,Free,Linear,L,None,17,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2156,12005420,2001,KWKLFKKILKFLHLAKKF,KWKLFKKILKFLHLAKKF{ct:Amid},[L9]-P18,Amidation,Free,Linear,L,None,18,Antibacterial,88.6% Hemolysis at 100 µM,Human,Synthetic peptide,NA,NA,CCTTHHHHTTTSSTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2157,12005420,2001,KWKLFKKISKFLHLAKKF,KWKLFKKISKFLHLAKKF{ct:Amid},[S9]-P18,Amidation,Free,Linear,L,None,18,Antibacterial,50.4% Hemolysis at 100 µM,Human,Synthetic peptide,NA,NA,CCTTHHHHTTTSCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2158,12005420,2001,WKLFKKIPKFLHLAKKF,WKLFKKIPKFLHLAKKF{ct:Amid},N-1,Amidation,Free,Linear,L,None,17,Antibacterial,10.1% Hemolysis at 100 µM,Human,Synthetic peptide,NA,NA,CCSSSCCTTTCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2159,12005420,2001,FKLFKKIPKFLHLAKKF,FKLFKKIPKFLHLAKKF{ct:Amid},N-2,Amidation,Free,Linear,L,None,17,Antibacterial,0.6% Hemolysis at 100 µM,Human,Synthetic peptide,NA,NA,CCCCCCCTTTCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2160,12005420,2001,KWFKKIPKFLHLAKKF,KWFKKIPKFLHLAKKF{ct:Amid},N-3,Amidation,Free,Linear,L,None,16,Antibacterial,1.8% Hemolysis at 100 µM,Human,Synthetic peptide,NA,NA,CCTTHHHHHCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2161,12005420,2001,WFKKIPKFLHLAKKF,WFKKIPKFLHLAKKF{ct:Amid},N-4,Amidation,Free,Linear,L,None,15,Antibacterial,1.5% Hemolysis at 100 µM,Human,Synthetic peptide,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2162,12005420,2001,WKKIPKFLHLAKKF,WKKIPKFLHLAKKF{ct:Amid},N-5,Amidation,Free,Linear,L,None,14,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCCCCTTCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2163,12005420,2001,KWFKKIPKFLHLLKKF,KWFKKIPKFLHLLKKF{ct:Amid},N-3L,Amidation,Free,Linear,L,None,16,Antibacterial,27.3% Hemolysis at 100 µM,Human,Synthetic peptide,NA,NA,CCTTSTTTTCSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2164,12005420,2001,WFKKIPKFLHLLKKF,WFKKIPKFLHLLKKF{ct:Amid},N-4L,Amidation,Free,Linear,L,None,15,Antibacterial,28.8% Hemolysis at 100 µM,Human,Synthetic peptide,NA,NA,CCCCCGGGCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2165,12005420,2001,WKKIPKFLHLLKKF,WKKIPKFLHLLKKF{ct:Amid},N-5L,Amidation,Free,Linear,L,None,14,Antibacterial,9.4% Hemolysis at 100 µM,Human,Synthetic peptide,NA,NA,CCCCGGGCSTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2166,12005420,2001,KWKLFKKIPFLHLAKKF,KWKLFKKIPFLHLAKKF{ct:Amid},C-1,Amidation,Free,Linear,L,None,17,Antibacterial,30.3% Hemolysis at 100 µM,Human,Synthetic peptide,NA,NA,CCCCTTSCCSSCSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2167,12005420,2001,KWKLFKKIPKFLHLAKK,KWKLFKKIPKFLHLAKK{ct:Amid},C-2,Amidation,Free,Linear,L,None,17,Antibacterial,19.8% Hemolysis at 100 µM,Human,Synthetic peptide,NA,NA,CCCCCCCCGGGSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2168,12005420,2001,KWKLFKKIPLHLAKKF,KWKLFKKIPLHLAKKF{ct:Amid},C-3,Amidation,Free,Linear,L,None,16,Antibacterial,4.7% Hemolysis at 100 µM,Human,Synthetic peptide,NA,NA,CCCCSSCCSCSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2169,12005420,2001,KWKLFKKIPKFLHLAK,KWKLFKKIPKFLHLAK{ct:Amid},C-4,Amidation,Free,Linear,L,None,16,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CTTHHHHTTCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
2170,12005420,2001,KWKLFKKIPHLAKKF,KWKLFKKIPHLAKKF{ct:Amid},C-5,Amidation,Free,Linear,L,None,15,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCCCCCCSCSTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2171,12005420,2001,KWKLFKKIPKFLHLA,KWKLFKKIPKFLHLA{ct:Amid},C-6,Amidation,Free,Linear,L,None,15,Antibacterial,6.7% Hemolysis at 100 µM,Human,Synthetic peptide,NA,NA,CCSSCCCTTSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
2172,12005420,2001,KWKLFKKIPLAKKF,KWKLFKKIPLAKKF{ct:Amid},C-7,Amidation,Free,Linear,L,None,14,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCCCCCSSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2173,12005420,2001,KWKLFKKIPKFLHL,KWKLFKKIPKFLHL{ct:Amid},C-8,Amidation,Free,Linear,L,None,14,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCCCCCCTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O
2174,12005420,2001,KWKLFKKIPLKKF,KWKLFKKIPLKKF{ct:Amid},C-9,Amidation,Free,Linear,L,None,13,Antibacterial,6.2% Hemolysis at 100 µM,Human,Synthetic peptide,NA,NA,CCSCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2175,12005420,2001,KWKLFKKIPKFLH,KWKLFKKIPKFLH{ct:Amid},C-10,Amidation,Free,Linear,L,None,13,Antibacterial,7.6% Hemolysis at 100 µM,Human,Synthetic peptide,NA,NA,CCSSCCCGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
2194,12054688,2002,ILGKIWEGIKSLF,ILGKIWEGIKSLF{ct:Amid},IsCT,Amidation,Free,Linear,L,None,13,Antibacterial and Antifungal,~30% Hemolysis at 200 µM,Sheep,IsCT (Isolated from the venom of scorpion Opisthacanthus madagascariensis),NA,NA,CCSTHHHHTTCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
2195,12054688,2002,ILGKIWEGIKS,ILGKIWEGIKS,IsCTf,Free,Free,Linear,L,None,11,Antibacterial and Antifungal,~0% Hemolysis at 200 µM (non-hemolytic),Sheep,IsCT analogs (Isolated from the venom of scorpion Opisthacanthus madagascariensis),NA,Non-hemolytic,CGGGGCCSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
2196,12054688,2002,IFGAIWNGIKSLF,IFGAIWNGIKSLF{ct:Amid},IsCT2,Amidation,Free,Linear,L,None,13,Antibacterial and Antifungal,<20% Hemolysis at 200 µM,Sheep,IsCT analogs (Isolated from the venom of scorpion Opisthacanthus madagascariensis),NA,NA,CTTHHHHHHTTCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
2197,12054688,2002,IFGAIWNGIKS,IFGAIWNGIKS,IsCT2f,Free,Free,Linear,L,None,11,Antibacterial and Antifungal,~0% Hemolysis at 200 µM (non-hemolytic),Sheep,IsCT analogs (Isolated from the venom of scorpion Opisthacanthus madagascariensis),NA,Non-hemolytic,CCSSSCCSTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
2198,12110678,2002,LKLLKKLLKKLLKLL,LKLLKKLLKKLLKLL{ct:Amid},Amphipathic-1L,Amidation,Free,Linear,L,None,13,Antibacterial,100% Hemolysis at 100 µM,Human,Synthetic peptide,NA,NA,CTTHHHHHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)O
2199,12110678,2002,KLKLLKLLKLLKLLK,KLKLLKLLKLLKLLK{ct:Amid},Scrambled-4L,Amidation,Free,Linear,L,None,15,Antibacterial,82% Hemolysis at 100 µM,Human,Synthetic peptide,NA,NA,CCCTHHHHHHTGGGC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2200,12110678,2002,KKKLLLLLLLLLKKK,KKKLLLLLLLLLKKK{ct:Amid},Segregated-5L,Amidation,Free,Linear,L,None,15,Antibacterial,66% Hemolysis at 100 µM,Human,Synthetic peptide,NA,NA,CCCCTHHHHHHHCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2201,12110678,2002,LKlLKkLlkKLLkLL,LKL{d}LKK{d}LL{d}K{d}KLLK{d}LL{ct:Amid},Amphipathic-1D,Amidation,Free,Linear,Mix,None,15,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CTTHHHHHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)O
2202,12110678,2002,LLkKLlKllLKLlKK,LLK{d}KLL{d}KL{d}L{d}LKLL{d}KK{ct:Amid},Amphipathic-2D,Amidation,Free,Linear,Mix,None,15,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CHHHHHHHHHHHCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2203,12110678,2002,LLkLLkKllKKLlKL,LLK{d}LLK{d}KL{d}L{d}KKLL{d}KL{ct:Amid},Amphipathic-3D,Amidation,Free,Linear,Mix,None,15,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CTTTHHHHHTTCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)O
2204,12110678,2002,KLkLLkLlkLLKlLK,KLK{d}LLK{d}LL{d}K{d}LLKL{d}LK{ct:Amid},Scrambled-4D,Amidation,Free,Linear,Mix,None,15,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCCTHHHHHHTGGGC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2205,12110678,2002,KKkLLlLllLLLkKK,KKK{d}LLL{d}LL{d}L{d}LLLK{d}KK{ct:Amid},Scrambled-5D,Amidation,Free,Linear,Mix,None,15,Antibacterial,3% Hemolysis at 100 µM,Human,Synthetic peptide,NA,NA,CCCCTHHHHHHHCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2206,12110678,2002,LLlLLkKkkKKLlLL,LLL{d}LLK{d}KK{d}K{d}KKLL{d}LL{ct:Amid},Scrambled-6D,Amidation,Free,Linear,Mix,None,15,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCSSCGGGTCGGGCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)O
2207,12207877,2002,VRRFPWWWPFLRR,VRRFPWWWPFLRR,Tritrpticin,Free,Free,Linear,L,None,13,Antibacterial and Antifungal,>80% Hemolysis at 200 μg/ml,Human,Tritrpticin,NA,NA,CCCCSSCSCGGGC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
2208,12207877,2002,VRRFGWWWGFLRR,VRRFGWWWGFLRR,TPG,Free,Free,Linear,L,None,13,Antibacterial and Antifungal,>60% Hemolysis at 200 μg/ml,Human,Tritrpticin analogs,NA,NA,CTTSCCCTTTSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
2209,12207877,2002,VRRFAWWWAFLRR,VRRFAWWWAFLRR,TPA,Free,Free,Linear,L,None,13,Antibacterial and Antifungal,~ 90% Hemolysis at 200 μg/ml,Human,Tritrpticin analogs,NA,NA,CCSCHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
2210,12207877,2002,VRRFPFFFPFLRR,VRRFPFFFPFLRR,TWF,Free,Free,Linear,L,None,13,Antibacterial and Antifungal,0% Hemolysis at 200 μg/ml (non-hemolytic),Human,Tritrpticin analogs,NA,Non-hemolytic,CCTTTTCCCCTTC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
2211,12207877,2002,VRRFPAAAPFLRR,VRRFPAAAPFLRR,TWA,Free,Free,Linear,L,None,13,Antibacterial and Antifungal,0% Hemolysis at 200 μg/ml (non-hemolytic),Human,Tritrpticin analogs,NA,Non-hemolytic,CCCSCCCCGGGGC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
2212,12207877,2002,ILPWKWPWWPWRR,ILPWKWPWWPWRR{ct:Amid},Indolicidin,Amidation,Free,Linear,L,None,13,Antibacterial and Antifungal,~ 80% Hemolysis at 200 μg/ml,Human,Indolicidin,NA,NA,CCCCCCSSCSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
2213,12297012,2002,GSKKPVPIIYCNRRTGKCQRM,GSKKPVPIIYCNRRTGKCQRM,Thanatin,Free,Free,Linear,L,None,21,Antibacterial,0% Hemolysis at 20.8 µM (non-hemolytic),Human,Thanatin (Podisus maculiventris),NA,Non-hemolytic,CBCCSSCBCCCCCCCSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)CN)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O
2214,12297012,2002,GSKKPVPIIYCNRRGKCQRM,GSKKPVPIIYCNRRGKCQRM,Th1,Free,Free,Linear,L,None,20,Antibacterial,0% Hemolysis at 20.8 µM (non-hemolytic),Human,Thanatin analogs (Podisus maculiventris),NA,Non-hemolytic,CCCCSSCTTSCSCCSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)CN)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)O
2215,12297012,2002,GSKKPVPIIYCNRRTKCQRM,GSKKPVPIIYCNRRTKCQRM,Th2,Free,Free,Linear,L,None,20,Antibacterial,0% Hemolysis at 20.8 µM (non-hemolytic),Human,Thanatin analogs (Podisus maculiventris),NA,Non-hemolytic,CCCSCCCBCCSSSSSTTBCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)CN)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O
2216,12297012,2002,GSKKPVPIIYCNRRKCQRM,GSKKPVPIIYCNRRKCQRM,Th3,Free,Free,Linear,L,None,19,Antibacterial,0% Hemolysis at 20.8 µM (non-hemolytic),Human,Thanatin analogs (Podisus maculiventris),NA,Non-hemolytic,CCCSCCCCSCCSTTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)CN)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)O
2217,12297012,2002,GSKKPVPIIYCNRRATGKCQRM,GSKKPVPIIYCNRRATGKCQRM,Th4,Free,Free,Linear,L,None,22,Antibacterial,0% Hemolysis at 20.8 µM (non-hemolytic),Human,Thanatin analogs (Podisus maculiventris),NA,Non-hemolytic,CBCSSSCBSCCSSCCCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)CN)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O
2218,12297012,2002,GSKKPVPIIYCNRRAATGKCQRM,GSKKPVPIIYCNRRAATGKCQRM,Th5,Free,Free,Linear,L,None,23,Antibacterial,0% Hemolysis at 20.8 µM (non-hemolytic),Human,Thanatin analogs (Podisus maculiventris),NA,Non-hemolytic,CTTCSSCCCSSCCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)CN)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O
2219,12297012,2002,GSKKPVPIIYANRRTGKAQRM,GSKKPVPIIYANRRTGKAQRM,Th6,Free,Free,Linear,L,None,21,Antibacterial,0% Hemolysis at 20.8 µM (non-hemolytic),Human,Thanatin analogs (Podisus maculiventris),NA,Non-hemolytic,CCCCCCCSEECCCSSSCCEEC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)CN)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O
2220,12354111,2002,GKVWDWIKSTAKKLWNSEPVKELKNTALNAAKNLVAEKIGAATPS,GKVWDWIKSTAKKLWNSEPVKELKNTALNAAKNLVAEKIGAATPS,Opistoporin 1,Free,Free,Linear,L,None,45,Antibacterial and Antifungal,~30% Hemolysis at 100 µM,Human,Opistoporin 1(Isolated from venom of Opistophtalmus carinatus),NA,NA,CCCCCHHHHTHHHHTCCCCTTTHHHHHHHHHHHHHHHHTTCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
2221,12354111,2002,FKLGSFLKKAWKSKLAKKLRAKGKEMLKDYAKGLLEGGSEEVPGQ,FKLGSFLKKAWKSKLAKKLRAKGKEMLKDYAKGLLEGGSEEVPGQ,Parabutoporin,Free,Free,Linear,L,None,45,Antibacterial and Antifungal,~60% Hemolysis at 100 µM,Human,Parabutoporin (Isolated from venom of Parabuthus schlechteri),NA,NA,CCSSHHHHHHHHHHTGGGGGTHHHHTTTGGGGGTCSSCCCCCSCC,CSCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
2271,12404639,2002,LRLKYRRFKYRV,LRLKYRRFKYRV{cyc:N-C},Mimetic 1,Free,Free,Cyclic,L,None,12,Antibacterial,27% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCCCCCCCSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C
2272,12404639,2002,LRLQYRRFQYRV,LRLQYRRFQYRV{cyc:N-C},Mimetic 2,Free,Free,Cyclic,L,None,12,Antibacterial,27% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCCCCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C
2273,12404639,2002,LRLEYRRFEYRV,LRLEYRRFEYRV{cyc:N-C},Mimetic 3,Free,Free,Cyclic,L,None,12,Antibacterial,14% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCCCCTTCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C
2274,12404639,2002,LRLKKRRWKYRV,LRLKKRRWKYRV{cyc:N-C},Mimetic 4,Free,Free,Cyclic,L,None,12,Antibacterial,1% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCSCCSSCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C
2275,12404639,2002,LRLKKRRWKYRV,LRLKKRRWKYRV{cyc:N-C},Mimetic 5,Free,Free,Cyclic,L,None,12,Antibacterial,13% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCSCCSSCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C
2276,12404639,2002,LCLKKRRWKYCV,LCLKKRRWKYCV{cyc:N-C},Mimetic 6,Free,Free,Cyclic,L,None,12,Antibacterial,3% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCCCCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C
2277,12404639,2002,LRCKKRRWKCRV,LRCKKRRWKCRV{cyc:N-C},Mimetic 7,Free,Free,Cyclic,L,None,12,Antibacterial,1% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCBTTBCCSSCC,CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C
2278,12581207,2003,FFGWLIKGAIHAGKAIHGLIHRRRH,FFGWLIKGAIHAGKAIHGLIHRRRH{ct:Amid},Chrysophsin-1,Amidation,Free,Linear,L,None,25,Antibacterial,100% Hemolysis at 1 µM,Human,Synthetic peptide,NA,NA,CCGGGSTTSSSSCCCSSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)CC
2279,12581207,2003,FFGWLIRGAIHAGKAIHGLIHRRRH,FFGWLIRGAIHAGKAIHGLIHRRRH{ct:Amid},Chrysophsin-2,Amidation,Free,Linear,L,None,25,Antibacterial,100% Hemolysis at 1 µM,Human,Synthetic peptide,NA,NA,CTTTTCGGGSSSCCSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)CC
2280,12581207,2003,FIGLLISAGKAIHDLIRRRH,FIGLLISAGKAIHDLIRRRH{ct:Amid},Chrysophsin-3,Amidation,Free,Linear,L,None,20,Antibacterial,100% Hemolysis at 5 µM,Human,Synthetic peptide,NA,NA,CCSCCCCSGGGCSCTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)CC
2281,12569105,2003,FFHLHFH-dcΔDOPA,FFHLHFH-{nnr:dcΔDOPA}{cyc:N-C},Plicatamide,Free,Free,Cyclic,L,"dcΔDOPA = decarboxy-(E)α,β-dehydro3,4-dihydroxyphenylalanine",8,Antibacterial,100% Hemolysis at ~40 µM,Human,Plicatamide (Styela plicata),NA,NA,NA,NA
2282,12569105,2003,FFHLHFH-dcΔDOPA,FFHLHFH-{nnr:dcΔDOPA}{cyc:N-C},Plicatamide,Free,Free,Cyclic,L,"dcΔDOPA = decarboxy-(E)α,β-dehydro3,4-dihydroxyphenylalanine",8,Antibacterial,~10% Hemolysis at 80 µM,Sheep,Plicatamide (Styela plicata),NA,NA,NA,NA
2286,12712499,2003,VOLfPVOLfP,V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C},GS,Free,Free,Cyclic,Mix,O = L-Ornithine,10,Antibacterial and Antifungal,100% Hemolysis at 15-50 μg/ml,Human,Gramicidin S analogs,NA,NA,NA,NA
2287,12712499,2003,yPyP,Y{d}PY{d}P{cyc:N-C},GS4,Free,Free,Cyclic,Mix,None,4,Antibacterial and Antifungal,100% Hemolysis at >150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCCC,N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2288,12712499,2003,KyPKyP,KY{d}PKY{d}P{cyc:N-C},GS6,Free,Free,Cyclic,Mix,None,6,Antibacterial and Antifungal,100% Hemolysis at >150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCCCCC,NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2289,12712499,2003,VKyPKLyP,VKY{d}PKLY{d}P{cyc:N-C},GS8,Free,Free,Cyclic,Mix,None,8,Antibacterial and Antifungal,100% Hemolysis at >150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCSSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2290,12712499,2003,VKLyPVKLyP,VKLY{d}PVKLY{d}P{cyc:N-C},GS10,Free,Free,Cyclic,Mix,None,10,Antibacterial and Antifungal,100% Hemolysis at 51–100 μg/ml,Human,Gramicidin S analogs,NA,NA,CCSSCCSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2291,12712499,2003,VKLKyPKVKLyP,VKLKY{d}PKVKLY{d}P{cyc:N-C},GS12,Free,Free,Cyclic,Mix,None,12,Antibacterial and Antifungal,100% Hemolysis at >150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCTTCSSSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C
2292,12712499,2003,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at <15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2293,12712499,2003,vKLKVyPLKVKLyP,V{d}KLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14V1,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50µg/m,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2294,12712499,2003,VkLKVyPLKVKLyP,VK{d}LKVY{d}PLKVKLY{d}P{cyc:N-C},GS14K2,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50µg/m,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2295,12712499,2003,VKlKVyPLKVKLyP,VKL{d}KVY{d}PLKVKLY{d}P{cyc:N-C},GS14L3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at <15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2296,12712499,2003,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at >150 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2297,12712499,2003,VKLKvyPLKVKLyP,VKLKV{d}Y{d}PLKVKLY{d}P{cyc:N-C},GS14V5,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 100–150 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2298,12712499,2003,VKLKVYPLKVKLyP,VKLKVYPLKVKLY{d}P{cyc:N-C},GS14Y6,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50µg/m,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2299,12712499,2003,VKLKVyplKVKLyP,VKLKVY{d}P{d}L{d}KVKLY{d}P{cyc:N-C},GS14P7,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at <15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2300,12712499,2003,VKLKVyPlKVKLyP,VKLKVY{d}PL{d}KVKLY{d}P{cyc:N-C},GS14L8,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2301,12712499,2003,VKLKVyPLkVKLyP,VKLKVY{d}PLK{d}VKLY{d}P{cyc:N-C},GS14K9,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 51–100 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2302,12712499,2003,VKLKVyPLKvKLyP,VKLKVY{d}PLKV{d}KLY{d}P{cyc:N-C},GS14V10,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at <15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2303,12712499,2003,VKLKVyPLKVkLyP,VKLKVY{d}PLKVK{d}LY{d}P{cyc:N-C},GS14K11,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 100–150 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2304,12712499,2003,VKLKVyPLKVKlyP,VKLKVY{d}PLKVKL{d}Y{d}P{cyc:N-C},GS14L12,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2305,12712499,2003,VKLKVyPLKVKLYP,VKLKVY{d}PLKVKLYP{cyc:N-C},GS14Y13,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at < 15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2306,12712499,2003,VKLKVyPLKVKLyp,VKLKVY{d}PLKVKLY{d}P{d}{cyc:N-C},GS14P14,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at < 15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2307,12712499,2003,VKKLVyPLKVKLyP,VKKLVY{d}PLKVKLY{d}P{cyc:N-C},GS14 K3L4,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 100–150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCCSSCCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2308,12712499,2003,LKLkLfPLKLKLfP,LKLK{d}LF{d}PLKLKLF{d}P{cyc:N-C},"GS14K4 Y2/F2, V3/L3",Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at < 15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCCCCTTSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O
2309,12712499,2003,LKLkLyPLKLKLyP,LKLK{d}LY{d}PLKLKLY{d}P{cyc:N-C},GS14K4 V3/L3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50 μg/ml,Human,Gramicidin S analogs,NA,NA,CCBTTBSSCSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2310,12712499,2003,VKLkVfPLKVKLfP,VKLK{d}VF{d}PLKVKLF{d}P{cyc:N-C},GS14K4 Y2/F2,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50 μg/ml,Human,Gramicidin S analogs,NA,NA,CBCTTTTCCBCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2311,12712499,2003,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at > 150 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2312,12712499,2003,AKLkAyPLKAKLyP,AKLK{d}AY{d}PLKAKLY{d}P{cyc:N-C},GS14K4 V3/A3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at > 150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCCCCCCSSSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2313,12712499,2003,VKAkVyPAKVKAyP,VKAK{d}VY{d}PAKVKAY{d}P{cyc:N-C},GS14K4 L3/A3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at > 150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCSSSCSSCCCCCC,CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2314,12712499,2003,AKAkAyPAKAKAyP,AKAK{d}AY{d}PAKAKAY{d}P{cyc:N-C},GS14K4 V3L3/A6,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at > 150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCCCCCCTTCCCCC,C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2315,12963031,2003,HVDKKVADKVLLLKQLRIMRLLTRL,HVDKKVADKVLLLKQLRIMRLLTRL,Spinigerin,Free,Free,Linear,L,None,25,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Human,Spinigerin isolated from the fungus-growing termite Pseudacanthotermes spiniger,NA,Non-hemolytic,CCSSSSGGGGHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
2316,12963031,2003,KKVADKVLLLKQLRIMRL,KKVADKVLLLKQLRIMRL,Spinigerin (4–21),Free,Free,Linear,L,None,18,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Human,Spinigerin truncate isolated from the fungus-growing termite Pseudacanthotermes spiniger,NA,Non-hemolytic,CCSCCHHHHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O
2317,14514057,2003,KWKLFKKIGIGKFLHSAKKF,KWKLFKKIGIGKFLHSAKKF{ct:Amid},CA-MA,Amidation,Free,Linear,L,None,20,Antibacterial and Antitumor,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCCCCCCCSSGGGSSSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2318,14514057,2003,KWKKLLKKPLLKKLLKKL,KWKKLLKKPLLKKLLKKL{ct:Amid},CA-MA analogue P5,Amidation,Free,Linear,L,None,18,Antibacterial and Antitumor,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CHHHHTHHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)O
2319,14514057,2003,KWKLKPLLKKLLKKL,KWKLKPLLKKLLKKL{ct:Amid},P6,Amidation,Free,Linear,L,None,15,Antibacterial and Antitumor,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCCCGGGHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)O
2320,14514057,2003,KWKKLLKKPLKLKL,KWKKLLKKPLKLKL{ct:Amid},P7,Amidation,Free,Linear,L,None,14,Antibacterial and Antitumor,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CTHHHHTSCSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)O
2321,14514057,2003,KPLLKKLLKKL,KPLLKKLLKKL{ct:Amid},P8,Amidation,Free,Linear,L,None,11,Antibacterial and Antitumor,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CTTHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN)C(=O)O
2322,14514057,2003,KLLKKPLKLKL,KLLKKPLKLKL{ct:Amid},P9,Amidation,Free,Linear,L,None,11,Antibacterial and Antitumor,0% Hemolysis at 100 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CGGGTGGGCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
2323,14531844,2003,FLPILASLAAKFGPKLFCLVTKKC,FLPILASLAAKFGPKLFCLVTKKC,Brevinin-1BYa,Free,Free,Linear,L,None,24,Antibacterial,HC50 = 4 µM,Human,Brevinin-1B analog,NA,NA,CCHHHHHHHHHHTTCCCCCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C
2324,14531844,2003,FLPILASLAAKLGPKLFCLVTKKC,FLPILASLAAKLGPKLFCLVTKKC,Brevinin-1BYb,Free,Free,Linear,L,None,24,Antibacterial,HC50 = 4 µM,Human,Brevinin-1B analog,NA,NA,CCHHHHHHHHHHSSSCCCCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C
2325,14531844,2003,FLPILASLAATLGPKLLCLITKKC,FLPILASLAATLGPKLLCLITKKC,Brevinin-1BYc,Free,Free,Linear,L,None,24,Antibacterial,Non-hemolytic,Human,Brevinin-1B analog(Rana boylii),α-helix,Non-hemolytic,CCHHHHHHHHHHTTTTCCGGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
2326,14531844,2003,GILSTFKGLAKGVAKDLAGNLLDKFKCKITGC,GILSTFKGLAKGVAKDLAGNLLDKFKCKITGC,Ranatuerin-2BYa,Free,Free,Linear,L,None,32,Antibacterial,HC50 = 120 µM,Human,Ranatuerin-2B analog,NA,NA,CCSSSCHHHHHHHTTTCSSCSTTSCCCCCCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C)[C@@H](C)O
2327,14531844,2003,GIMDSVKGLAKNLAGKLLDSLKCKITGC,GIMDSVKGLAKNLAGKLLDSLKCKITGC,Ranatuerin-2BYb,Free,Free,Linear,L,None,28,Antibacterial,HC50 >200 µM,Human,Ranatuerin-2B analog,NA,NA,CCSTHIIIIIHHHTTGGGSSSCSCCSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C
2328,14531844,2003,FLPIIAKVLSGLL,FLPIIAKVLSGLL{ct:Amid},Temporin-1BYa,Amidation,Free,Linear,L,None,13,Antibacterial,Non-hemolytic,Human,Temporin-1B analog(Rana boylii),NA,Non-hemolytic,CCTHHHHHHTCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
2329,15019213,2003,AKKVFKRLEKLFSKIQNDK,AKKVFKRLEKLFSKIQNDK,HP (2–20),Free,Free,Linear,L,None,19,Antibacterial and Antifungal,<20% Hemolysis at 2.15 to 215 µM,Human,"N-terminus of Helicobacter pylori ribosomal protein 1, HpRpL1",NA,NA,CHHHHTTTHHHHSGGGSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
2330,14642822,2003,GYGCPFNQYQCHSHCSGIRGYKGGYCKGTFKQTCKCY,GYGCPFNQYQCHSHCSGIRGYKGGYCKGTFKQTCKCY,Ornithodoros defensin A,Free,Free,Linear,L,None,37,Antibacterial,EC50 >100 (μg/ml),Human,Synthetic peptide,NA,NA,CCSSSSCCCSCSSSSCCCCCCCCCCCSSSCCCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)O
2331,14642822,2003,GYGCPFNQYQCHSHCSGIRGYKGGYCKGTFKQTCKCY,GYGCPFNQYQCHSHCSGIRGYKGGYCKGTFKQTCKCY,Ornithodoros defensin A,Free,Free,Linear,L,None,37,Antibacterial,EC50 >100 (μg/ml),Rabbit,Synthetic peptide,NA,NA,CCSSSSCCCSCSSSSCCCCCCCCCCCSSSCCCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)O
2332,14642822,2003,LTCDLLSFEAKGFAANHSLCAAHCLAIGRKGGACQNGVCVCRR,LTCDLLSFEAKGFAANHSLCAAHCLAIGRKGGACQNGVCVCRR,Oryctes defensin,Free,Free,Linear,L,None,43,Antibacterial,EC50 >100 (μg/ml),Human,Synthetic peptide,NA,NA,CCCCSSSCSSCCCCCCSTTTCSTTTTSCCSBCSSSCBTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
2333,14642822,2003,LTCDLLSFEAKGFAANHSLCAAHCLAIGRKGGACQNGVCVCRR,LTCDLLSFEAKGFAANHSLCAAHCLAIGRKGGACQNGVCVCRR,Oryctes defensin,Free,Free,Linear,L,None,43,Antibacterial,EC50 >100 (μg/ml),Rabbit,Synthetic peptide,NA,NA,CCCCSSSCSSCCCCCCSTTTCSTTTTSCCSBCSSSCBTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
2354,14596922,2003,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid},Melittin,Amidation,Free,Linear,L,None,26,Antibacterial,HC10 = 1.78 μg/ml,Human,Melittin,NA,NA,CCCSSHHHHHHSCHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
2355,14596922,2003,GLPALISWIKRKRQQ,GLPALISWIKRKRQQ{ct:Amid},Mel(12-26),Amidation,Free,Linear,L,None,15,Antibacterial,HC10 = 4500 μg/ml,Human,Melittin analogs,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC
2356,14596922,2003,LLPALISWIKRKRQQ,LLPALISWIKRKRQQ{ct:Amid},"Mel(12-26,L1)",Amidation,Free,Linear,L,None,15,Antibacterial,HC10 = 192 μg/ml,Human,Melittin analogs,NA,NA,CCHHHHHHTGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC
2357,14596922,2003,GSPALISWIKRKRQQ,GSPALISWIKRKRQQ{ct:Amid},"Mel(12-26,S2)",Amidation,Free,Linear,L,None,15,Antibacterial,HC10 = 1588 μg/ml,Human,Melittin analogs,NA,NA,CCSSHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC
2358,14596922,2003,GLLALISWIKRKRQQ,GLLALISWIKRKRQQ{ct:Amid},"Mel(12-26,L3)",Amidation,Free,Linear,L,None,15,Antibacterial,HC10 = 35.2 μg/ml,Human,Melittin analogs,NA,NA,CGGGHIIIIIHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC
2359,14596922,2003,GLSALISWIKRKRQQ,GLSALISWIKRKRQQ{ct:Amid},"Mel(12-26,S3)",Amidation,Free,Linear,L,None,15,Antibacterial,HC10 = 44 μg/ml,Human,Melittin analogs,NA,NA,CHHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC
2360,14596922,2003,GLPLLISWIKRKRQQ,GLPLLISWIKRKRQQ{ct:Amid},"Mel(12-26,L4)",Amidation,Free,Linear,L,None,15,Antibacterial,HC10 = 203 μg/ml,Human,Melittin analogs,NA,NA,CCSCCCHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
2361,14596922,2003,GLPASISWIKRKRQQ,GLPASISWIKRKRQQ{ct:Amid},"Mel(12-26,S5)",Amidation,Free,Linear,L,None,15,Antibacterial,HC10 = 3840 μg/ml,Human,Melittin analogs,NA,NA,CCSSSCHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC
2362,14596922,2003,GLPALSSWIKRKRQQ,GLPALSSWIKRKRQQ{ct:Amid},"Mel(12-26,S6)",Amidation,Free,Linear,L,None,15,Antibacterial,HC10 = 650 μg/ml,Human,Melittin analogs,NA,NA,CCTTSTHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
2363,14596922,2003,GLPALILWIKRKRQQ,GLPALILWIKRKRQQ{ct:Amid},"Mel(12-26,L7)",Amidation,Free,Linear,L,None,15,Antibacterial,HC10 = 15.4 μg/ml,Human,Melittin analogs,NA,NA,CCTTCCCHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC
2364,14596922,2003,GLPALISLIKRKRQQ,GLPALISLIKRKRQQ{ct:Amid},"Mel(12-26,L8)",Amidation,Free,Linear,L,None,15,Antibacterial,HC10 = 9350 μg/ml,Human,Melittin analogs,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC
2365,14596922,2003,GLPALISSIKRKRQQ,GLPALISSIKRKRQQ{ct:Amid},"Mel(12-26,S8)",Amidation,Free,Linear,L,None,15,Antibacterial,HC10 = 13800 μg/ml,Human,Melittin analogs,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC
2366,14596922,2003,GLPALISWSKRKRQQ,GLPALISWSKRKRQQ{ct:Amid},"Mel(12-26,S9)",Amidation,Free,Linear,L,None,15,Antibacterial,HC10 = 6140 μg/ml,Human,Melittin analogs,NA,NA,CCCTTCSTTGGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
2367,15752569,2005,FLSLIPHAINAVSAIAKHN,FLSLIPHAINAVSAIAKHN{ct:Amid},PS-1,Amidation,Free,Linear,L,None,19,Antibacterial and Antiprotozoa,1.98% Hemolysis at 64 µM,Human,"Phylloseptin analogs isolated from the skin secretion of the Brazilian tree-frogs, Phyllomedusa hypochondrialis and Phyllomedusa oreades",NA,NA,CCSCCCSHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)O
2368,15752569,2005,FLSLIPHAINAVSTLVHHF,FLSLIPHAINAVSTLVHHF{ct:Amid},PS-2,Amidation,Free,Linear,L,None,19,Antibacterial and Antiprotozoa,2.05% Hemolysis at 64 µM,Human,"Phylloseptin analogs isolated from the skin secretion of the Brazilian tree-frogs, Phyllomedusa hypochondrialis and Phyllomedusa oreades",NA,NA,CCSSCCSHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
2369,15581850,2004,SIGSALKKALPVAKKIGKIALPIAKAALPVAAGLVG,SIGSALKKALPVAKKIGKIALPIAKAALPVAAGLVG,CtxA,Free,Free,Linear,L,None,36,Antibacterial,Hemolytic at 110 µM,Human,Ceratotoxins are α-helical cationic peptides isolated from the medfly Ceratitis capitata,NA,NA,CCHHHHHHHCCHHHHHCSCCCCGGGCCCSSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC
2370,15581850,2004,SLGGVISGAKKVAKVAIPIGKAVLPVVAKLVG,SLGGVISGAKKVAKVAIPIGKAVLPVVAKLVG,CtxC,Free,Free,Linear,L,None,32,Antibacterial,Hemolytic 645 µM,Human,Ceratotoxins are α-helical cationic peptides isolated from the medfly Ceratitis capitata,NA,NA,CTTSCCSGGGGTSCCCCTTCSTTHHHHBTTBC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C
2371,15581850,2004,SIGTAVKKAVPIAKKVGKVAIPIAKAVLSVVGQLVG,SIGTAVKKAVPIAKKVGKVAIPIAKAVLSVVGQLVG,CtxD,Free,Free,Linear,L,None,36,Antibacterial,Hemolytic at 84 µM,Human,Ceratotoxins are α-helical cationic peptides isolated from the medfly Ceratitis capitata,NA,NA,CHHHHHHHHSCHHHHHCCCCCCHHHHHHHTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)O
2372,15581850,2004,SIGSALKKALPVAKKIGKIALPIAKAALP,SIGSALKKALPVAKKIGKIALPIAKAALP,CtxA1–29,Free,Free,Linear,L,None,29,Antibacterial,Hemolytic at 960 µM,Human,Ceratotoxins are α-helical cationic peptides isolated from the medfly Ceratitis capitata,NA,NA,CTHHHHTTTCHHHHTTSBCCSSHHHHCBC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC)[C@@H](C)CC
2373,15328096,2004,CVKVKVKVGSGVKVKVKVC,CVKVKVKVGSGVKVKVKVC{cyc:N-C}{nt:Acet}{ct:Amid},V1,Amidation,Acetylation,Cyclic,L,None,19,Antibacterial,EC50 = 880000 nM,Human,Synthetic peptide,NA,NA,CCCCSSCCSSSSCCCCCCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C)C(C)C
2374,15328096,2004,CVKVSVKVGSGVKVSVKVC,CVKVSVKVGSGVKVSVKVC{cyc:N-C}{nt:Acet}{ct:Amid},V2,Amidation,Acetylation,Cyclic,L,None,19,Antibacterial,"EC50 = 5,89,000 nM",Human,Synthetic peptide,NA,NA,CCCCCEECSSSEECCCSCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C)C(C)C
2375,15328096,2004,CVKVRVKVGSGVKVRVKVC,CVKVRVKVGSGVKVRVKVC{cyc:N-C}{nt:Acet}{ct:Amid},V3,Amidation,Acetylation,Cyclic,L,None,19,Antibacterial,EC50 = 590000 nM,Human,Synthetic peptide,NA,NA,CCCCSSCCSSSSCCCCCCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C)C(C)C
2376,15328096,2004,CVKVQVKVGSGVKVQVKVC,CVKVQVKVGSGVKVQVKVC{cyc:N-C}{nt:Acet}{ct:Amid},V4,Amidation,Acetylation,Cyclic,L,None,19,Antibacterial,EC50 = 3226000 nM,Human,Synthetic peptide,NA,NA,CCCCSSSSSCCSCCCCCCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C)C(C)C
2377,15328096,2004,CAKAKAKAGSGAKAKAKAC,CAKAKAKAGSGAKAKAKAC{cyc:N-C}{nt:Acet}{ct:Amid},V5,Amidation,Acetylation,Cyclic,L,None,19,Antibacterial,EC50 = 1055000 nM,Human,Synthetic peptide,NA,NA,CBTTBCCCCSSCCCTTSCC,C[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O
2378,15328096,2004,CFKFKFKFGSGFKFKFKFC,CFKFKFKFGSGFKFKFKFC{cyc:N-C}{nt:Acet}{ct:Amid},V6,Amidation,Acetylation,Cyclic,L,None,19,Antibacterial,EC50 = 35000 nM,Human,Synthetic peptide,NA,NA,CCCTTSSSSSSSCCCCSCC,NCCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)O
2379,15328096,2004,CWKWKWKWGSGWKWKWKWC,CWKWKWKWGSGWKWKWKWC{cyc:N-C}{nt:Acet}{ct:Amid},V7,Amidation,Acetylation,Cyclic,L,None,19,Antibacterial,EC50 = 45000 nM,Human,Synthetic peptide,NA,NA,CCCCGGGCCSSSSSCSSCC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
2380,12081622,2002,ISRLAGLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPE,ISRLAGLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPE,CRAMP,Free,Free,Linear,L,None,38,Antibacterial,0% Hemolysis at 50 µM (non-hemolytic),Human,CRAMP (Mouse femoral marrow cells),NA,Non-hemolytic,CCHHHHHTTTSTTHHHHHHHHHHTTGGGTHHHHSCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
2382,12147359,2002,AKKVFKRLEKLFSKIQNWK,AKKVFKRLEKLFSKIQNWK,Anal 1,Free,Free,Linear,L,None,19,Antibacterial and Antifungal and Anticancer,0% Hemolysis at 100 µM (non-hemolytic),Human,HP (2 – 20) analogs (Helicobacter pylori),NA,Non-hemolytic,CGGGGGGTGGGSCTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
2383,12147359,2002,AKKVFKRLEKLFSKIWNDK,AKKVFKRLEKLFSKIWNDK,Anal 2,Free,Free,Linear,L,None,19,Antibacterial and Antifungal and Anticancer,0% Hemolysis at 100 µM (non-hemolytic),Human,HP (2 – 20) analogs (Helicobacter pylori),NA,Non-hemolytic,CTTTTHHHHHHHCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
2384,12147359,2002,AKKVFKRLEKLFSKIWNWK,AKKVFKRLEKLFSKIWNWK,Anal 3,Free,Free,Linear,L,None,19,Antibacterial and Antifungal and Anticancer,0% Hemolysis at 100 µM (non-hemolytic),Human,HP (2 – 20) analogs (Helicobacter pylori),NA,Non-hemolytic,CGGGGHHHHHHHHHHSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
2385,12147359,2002,AKKVFKRLEKSFSKIQNDK,AKKVFKRLEKSFSKIQNDK,Anal 4,Free,Free,Linear,L,None,19,Antibacterial and Antifungal and Anticancer,0% Hemolysis at 100 µM (non-hemolytic),Human,HP (2 – 20) analogs (Helicobacter pylori),NA,Non-hemolytic,CHHHHTTGGGTTCTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
2386,12147359,2002,AKKVSKRLEKLFSKIQNDK,AKKVSKRLEKLFSKIQNDK,Anal 5,Free,Free,Linear,L,None,19,Antibacterial and Antifungal and Anticancer,0% Hemolysis at 100 µM (non-hemolytic),Human,HP (2 – 20) analogs (Helicobacter pylori),NA,Non-hemolytic,CHHHHHHHHTTTCTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
2387,15572194,2004,SADLVKKIWDNPAL,SADLVKKIWDNPAL{nt:Acet}{ct:Amid},Polybine-I,Amidation,Acetylation,Linear,L,None,14,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Rat,Polybine-I (From venom of Polybia paulista),NA,Non-hemolytic,CHHHHHTTTCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O
2388,15572194,2004,SVDMVMKGLKIWPL,SVDMVMKGLKIWPL{nt:Acet}{ct:Amid},Polybine-II,Amidation,Acetylation,Linear,L,None,14,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Rat,Polybine-II (From venom of Polybia paulista),NA,Non-hemolytic,CHHHIIIIISCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O
2389,15546886,2005,GCRFCCNCCPNMSGCGVCCRF,GCRFCCNCCPNMSGCGVCCRF,Bass Hepcidin,Free,Free,Linear,L,None,21,Antibacterial and Antifungal,0% Hemolysis at 100 μg/ml (non-hemolytic),Rat,Bass hepcidin (Morone chrysops x Morone saxatilis),NA,Non-hemolytic,CCCCCSSSSSCCSCCSSSSCC,CSCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
2394,15358153,2004,AKKVFKRLEKLFSKIQNDK,AKKVFKRLEKLFSKIQNDK{ct:Amid},HP (2–20),Amidation,Free,Linear,L,None,19,Antibacterial,0% Hemolysis at 140 μg/ml (non-hemolytic),Human,HP (2–20) (Helicobacter pylori),NA,Non-hemolytic,CHHHHTTTHHHHSGGGSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
2395,15369808,2004,ILGKIWEGIKSLF,ILGKIWEGIKSLF{ct:Amid},IsCT,Amidation,Free,Linear,L,None,13,Antibacterial and Antifungal,80% Hemolysis at 100 µM,Human,IsCT,NA,NA,CCSTHHHHTTCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
2396,15369808,2004,ILGKIAEGIKSLF,ILGKIAEGIKSLF{ct:Amid},[A6]-IsCT,Amidation,Free,Linear,L,None,13,Antibacterial and Antifungal,0% Hemolysis at 100 µM (non-hemolytic),Human,IsCT analogs (Opisthacanthus madagascariensis),NA,Non-hemolytic,CHHHHHHGGGTCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
2397,15369808,2004,ILGKILEGIKSLF,ILGKILEGIKSLF{ct:Amid},[L6]-IsCT,Amidation,Free,Linear,L,None,13,Antibacterial and Antifungal,~20% Hemolysis at 100 µM,Human,IsCT analogs (Opisthacanthus madagascariensis),NA,NA,CTTHHHHHHHTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
2398,15369808,2004,ILGKIWKGIKSLF,ILGKIWKGIKSLF{ct:Amid},[K7]-IsCT,Amidation,Free,Linear,L,None,13,Antibacterial and Antifungal,~50% Hemolysis at 100 µM,Human,IsCT analogs (Opisthacanthus madagascariensis),NA,NA,CHHHHHTTTTSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
2399,15369808,2004,ILGKILKGIKKLF,ILGKILKGIKKLF{ct:Amid},"[L6, K11]-IsCT",Amidation,Free,Linear,L,None,13,Antibacterial and Antifungal,~20% Hemolysis at 100 µM,Human,IsCT analogs (Opisthacanthus madagascariensis),NA,NA,CHHHHHHHHTTCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
2400,15369808,2004,ILGKIWKIKKLF,ILGKIWKIKKLF{ct:Amid},"[K7, P8, K11]-IsCT",Amidation,Free,Linear,L,None,12,Antibacterial and Antifungal,0% Hemolysis at 100 µM (non-hemolytic),Human,IsCT analogs (Opisthacanthus madagascariensis),NA,Non-hemolytic,CTTSSSCCCSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
2401,12878508,2003,WLNALLHHGLNCAKGVLA,WLNALLHHGLNCAKGVLA{ct:Amid},18Hc,Amidation,Free,Linear,L,None,18,Antibacterial,~20% Hemolysis at 100 μg/ml,Human,Synthetic Analogs of Halocidin (Tunicate Halocynthia aurantium),NA,NA,CHHHHSSTTSSCCCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)C(C)C
2402,12878508,2003,WLNALLKKGLNCAKGVLA,WLNALLKKGLNCAKGVLA{ct:Amid},18HcKK,Amidation,Free,Linear,L,None,18,Antibacterial,<10% Hemolysis at 100 μg/ml,Human,Synthetic Analogs of Halocidin (Tunicate Halocynthia aurantium),NA,NA,CHHHHTTCCCCCTTSCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)C(C)C
2403,12878508,2003,KWLNALLHHGLNCAKGVLA,KWLNALLHHGLNCAKGVLA{ct:Amid},K19Hc,Amidation,Free,Linear,L,None,19,Antibacterial,~10% Hemolysis at 100 μg/ml,Human,Synthetic Analogs of Halocidin (Tunicate Halocynthia aurantium),NA,NA,CTHHHHSSSCCTTTTTC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)C(C)C
2404,12878508,2003,KWLNALLKKGLNCAKGVLA,KWLNALLKKGLNCAKGVLA{ct:Amid},K19HcKK,Amidation,Free,Linear,L,None,19,Antibacterial,<10% Hemolysis at 100 μg/ml,Human,Synthetic Analogs of Halocidin (Tunicate Halocynthia aurantium),NA,NA,CCHHHHTTSCCCCTTSTTC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)C(C)C
2405,12878508,2003,KWKLFKKIPKFLHLAKKF,KWKLFKKIPKFLHLAKKF{ct:Amid},P18,Amidation,Free,Linear,L,None,18,Antibacterial,<0% Hemolysis at 100 μg/ml,Human,P18 (Halocynthia aurantium),NA,Non-hemolytic,CCCSCSCCTTTSCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2406,11846794,2002,RLYR,RLYR,RLYR,Free,Free,Linear,L,None,4,Antibacterial and Antifungal,EC50 = 5200 µM,Human,Synthetic peptide,NA,NA,CCCC,CC(C)C[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
2407,11846794,2002,RLYRRLYR,RLYRRLYR,(RLYR)2,Free,Free,Linear,L,None,8,Antibacterial and Antifungal,EC50 = 1950 µM,Human,Synthetic peptide,NA,NA,CGGGGTCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
2408,11846794,2002,RLYRRLYRRLYRRLYR,RLYRRLYRRLYRRLYR,(RLYR)4,Free,Free,Linear,L,None,16,Antibacterial and Antifungal,EC50 = 338 µM,Human,Synthetic peptide,NA,NA,CTTHHHHHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
2409,11846794,2002,RLYRRLYRRLYRRLYRRLYRRLYRRLYRRLYR,RLYRRLYRRLYRRLYRRLYRRLYRRLYRRLYR,(RLYR)8,Free,Free,Linear,L,None,32,Antibacterial and Antifungal,EC50 = 48 µM,Human,Synthetic peptide,NA,NA,CTHHHHGGGTCHHHHHHHTHHHHHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
2410,11846794,2002,RLYRRLYRK,RLYRRLYRK,(RLYR)2-[K],Free,Free,Linear,L,None,19,Antibacterial and Antifungal,EC50 = 3700 µM,Human,Synthetic peptide,NA,NA,CTHHHHTTC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
2411,11846794,2002,RLYRRLYRRLYRRLYRKKK,RLYRRLYRRLYRRLYRKKK,(RLYR)4-[K2K],Free,Free,Linear,L,None,35,Antibacterial and Antifungal,EC50 = 1510 µM,Human,Synthetic peptide,NA,NA,CTTHHHHHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2412,11846794,2002,RLYRRLYRRLYRRLYRRLYRRLYRRLYRKKKKK,RLYRRLYRRLYRRLYRRLYRRLYRRLYRKKKKK,(RLYR)8-([K2K]2K),Free,Free,Linear,L,None,8,Antibacterial and Antifungal,EC50 = 1514 µM,Human,Synthetic peptide,NA,NA,CTHHHHHHHHTHHHHHHHHHHHHHHHHHHHGGGTCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2413,11846794,2002,RLYRKVYG,RLYRKVYG{cyc:N-C},RLYRKVYG,Free,Free,Cyclic,L,None,17,Antibacterial and Antifungal,EC50 = 3950 µM,Human,Synthetic peptide,NA,NA,CCCCSSCC,CC(C)C[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O)C(C)C
2414,11846794,2002,RLYRKVYGRLYRKVYGK,RLYRKVYGRLYRKVYGK{cyc:N-C},(RLYRKVYG)2-[K],Free,Free,Cyclic,L,None,17,Antibacterial and Antifungal,EC50 = 1420 µM,Human,Synthetic peptide,NA,NA,CTHHHHHHHHGGGGSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
2415,11846794,2002,RLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGKKK,RLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGKKK{cyc:N-C},(RLYRKVYG)4-[K2K],Free,Free,Cyclic,L,None,35,Antibacterial and Antifungal,EC50 = 610 µM,Human,Synthetic peptide,NA,NA,CTHHHHHHHHHHHHTHHHHHHHHIIIIITHHHHHC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
2416,11846794,2002,RLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGKKKKK,RLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGKKKKK{cyc:N-C},(RLYRKVYG)8 (K2K)2K,Free,Free,Cyclic,L,None,63,Antibacterial and Antifungal,EC50 = 112 µM,Human,Synthetic peptide,NA,NA,CGGGGTTHHHHHHHHHHHGGGGHHHHHHHHHHHHHGGGGHHHHHHHTHHHHHHHHHHHTHHHHCSSSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
2417,10819172,2000,KLLLKLLLKLLK,KLLLKLLLKLLK{cyc:N-C}{ct:Amid},S1,Amidation,Free,Cyclic,L,None,12,Antibacterial,100% Hemolysis at 200 μg/ml,Mouse,Synthetic peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2418,10819172,2000,KLLLKLLLKLLK,KLLLKLLLKLLK{cyc:N-C}{ct:Amid},SC1,Amidation,Free,Cyclic,L,None,12,Antibacterial,100% Hemolysis at 200 μg/ml,Mouse,Synthetic peptide,NA,NA,CCSCTTTHHHHC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2419,10819172,2000,KLLLKLLLKLLK,KLLLKLLLKLLK{cyc:N-C}{ct:Amid},SC2,Amidation,Free,Cyclic,L,None,12,Antibacterial,~90% Hemolysis at 200 μg/ml,Mouse,Synthetic peptide,NA,NA,CCSCTTTHHHHC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2425,11682479,2002,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 1.5 μg/ml,Human,Synthetic peptide,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2426,11682479,2002,LKLkLfPLKLKLfP,LKLK{d}LF{d}PLKLKLF{d}P{cyc:N-C},"Y2/F2, V3/L3",Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 12.5 μg/ml,Human,Synthetic peptide,NA,NA,CTTCCCCTTSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O
2427,11682479,2002,LKLkLyPLKLKLyP,LKLK{d}LY{d}PLKLKLY{d}P{cyc:N-C},V3/L3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 25 μg/ml,Human,Synthetic peptide,NA,NA,CCBTTBSSCSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2428,11682479,2002,VKLkVfPLKVKLfP,VKLK{d}VF{d}PLKVKLF{d}P{cyc:N-C},Y2/F2,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 40 μg/ml,Human,Synthetic peptide,NA,NA,CBCTTTTCCBCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2429,11682479,2002,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 200 μg/ml,Human,Synthetic peptide,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2430,11682479,2002,AKLkAyPLKAKLyP,AKLK{d}AY{d}PLKAKLY{d}P{cyc:N-C},V3/A3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at >800 μg/ml,Human,Synthetic peptide,NA,NA,CCCCCCCSSSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2431,11682479,2002,VKAkVyPAKVKAyP,VKAK{d}VY{d}PAKVKAY{d}P{cyc:N-C},L3/A3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at >800 μg/ml,Human,Synthetic peptide,NA,NA,CCSSSCSSCCCCCC,CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2432,11682479,2002,AKAkAyPAKAKAyP,AKAK{d}AY{d}PAKAKAY{d}P{cyc:N-C},V3L3/A6,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at >800 μg/ml,Human,Synthetic peptide,NA,NA,NA,C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2471,11779154,2002,RIIDLLWRVRRPQKPKFVTVWVR,RIIDLLWRVRRPQKPKFVTVWVR,PMAP-23,Free,Free,Linear,L,None,23,Antibacterial,0% Hemolysis at 100 µM (non-hemolytic),Human,Porcine myeloid antibacterial peptide,NA,Non-hemolytic,CCSSSTTTCCCCSSCSCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C
2472,12168695,2002,GIGAVLKVLTTGLpALISWIKRKRQQ,GIGAVLKVLTTGLP{d}ALISWIKRKRQQ{ct:Amid},Melittin-1,Amidation,Free,Linear,Mix,None,26,Antibacterial,50% Hemolysis at >200 μg/ml,Human,Melittin analogs,NA,NA,CCCCCTHHHHTCCHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
2473,12168695,2002,GIGAVLKVLTTGLpALISWIKFKRQQ,GIGAVLKVLTTGLP{d}ALISWIKFKRQQ{ct:Amid},Melittin-2,Amidation,Free,Linear,Mix,None,26,Antibacterial,50% Hemolysis at >80 μg/ml,Human,Melittin analogs,NA,NA,CCCCCSSCTTCCCHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
2474,12168695,2002,GIGAVLKVLTTGLpALISWIKXXKRQQ,GIGAVLKVLTTGLP{d}ALISWIKXXKRQQ{ct:Amid},Melittin-1P,Amidation,Free,Linear,Mix,None,27,Antibacterial,50% Hemolysis at >18 μg/ml,Human,Melittin analogs,NA,NA,NA,NA
2475,12168695,2002,GIGAVLKVLTTGLpALISWIKXKRQQ,GIGAVLKVLTTGLP{d}ALISWIKXKRQQ{nt:Acet}{ct:Amid},Melittin-A1P,Amidation,Acetylation,Linear,Mix,None,26,Antibacterial,50% Hemolysis at >200 μg/ml,Human,Melittin analogs,NA,NA,NA,NA
2476,12168695,2002,GIGAVLKVLTTGLpALISWIKRKRQQ,GIGAVLKVLTTGLP{d}ALISWIKRKRQQ{nt:Acet}{ct:Amid},Melittin-A1,Amidation,Acetylation,Linear,Mix,None,26,Antibacterial,50% Hemolysis at >200 μg/ml,Human,Melittin analogs,NA,NA,CCCCCTHHHHTCCHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
2477,12429503,2002,GIFPKIIGKGIVNGIKSLAKGVGMKVFKAGLNNIGNTGCNNRDEC,GIFPKIIGKGIVNGIKSLAKGVGMKVFKAGLNNIGNTGCNNRDEC,Palustrin-3AR,Free,Free,Linear,L,None,45,Antibacterial,HC50 = 200 µM,Human,Palustrin-3 analog (Rana areolata),NA,NA,CCSHHHHHHHHHHHHHHHCGGGTTHHHHHHHHCCCCCSCCCSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C
2478,12429503,2002,GIFSKINKKKAKTGLFNIIKTVGKEAGMDVIRAGIDTISCKIKGEC,GIFSKINKKKAKTGLFNIIKTVGKEAGMDVIRAGIDTISCKIKGEC,Esculentin-1ARa,Free,Free,Linear,L,None,46,Antibacterial,HC50 = 180 µM,Human,Esculentin-1 analog (Rana areolata),NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC
2479,12429503,2002,GLFPKFNKKKVKTGIFDIIKTVGKEAGMDVLRTGIDVIGCKIKGEC,GLFPKFNKKKVKTGIFDIIKTVGKEAGMDVLRTGIDVIGCKIKGEC,Esculentin-1ARb,Free,Free,Linear,L,None,46,Antibacterial,HC50 = 120 µM,Human,Esculentin-1 analog (Rana areolata),NA,NA,CCCCCCCTTCCSSSCCCSCTTTTHHHHCCSSCSSSCSSSCTTSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC
2480,12429503,2002,GLMDTVKNAAKNLAGQLLDTIKCKMTGC,GLMDTVKNAAKNLAGQLLDTIKCKMTGC,Ranatuerin-2ARa,Free,Free,Linear,L,None,28,Antibacterial,HC50 = 100 µM,Human,Ranatuerin-2 analog (Rana areolata),NA,NA,CTHHHHHHHHHHHTTTGGGGGGSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
2481,12429503,2002,GILDTIKNAAKTVAVGLLEKIKCKMTGC,GILDTIKNAAKTVAVGLLEKIKCKMTGC,Ranatuerin-2ARb,Free,Free,Linear,L,None,28,Antibacterial,HC50 = 150 µM,Human,Ranatuerin-2 analog (Rana areolata),NA,NA,CCTHIIIIIGGGSHHHHHGGGGSCCSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O
2482,12429503,2002,GFISTVKNLATNVAGTVIDTIKCKVTGGC,GFISTVKNLATNVAGTVIDTIKCKVTGGC,Palustrin-2AR,Free,Free,Linear,L,None,29,Antibacterial,HC50 > 300 µM,Human,Palustrin-2 analog (Rana areolata),NA,NA,CCSSCHHHHTTCCCCCCCCCSSSCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O
2483,12429503,2002,FLPIVGRLISGLL,FLPIVGRLISGLL{ct:Amid},Temporin-1AR,Amidation,Free,Linear,L,None,13,Antibacterial,HC50 = 210 µM,Human,Temporin-1 analog (Rana areolata),NA,NA,CCCCHHHHHTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
2692,22083756,2012,CLRIGMRGRELMGGIGKTM,CLRIGMRGRELMGGIGKTM,pCM19,Free,Free,Linear,L,None,19,Antibacterial,0.109% hemolytic at 100 μg/ml,Human,"Peptide of hGlyrichin,corresponding to amino acids 42 to 60 (Homo sapien)",NA,NA,CCCSCCEESSSSEECCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CS)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O
2693,22083756,2012,CLRIGMRGRELMGGIGKTM,CLRIGMRGRELMGGIGKTM,pCM19,Free,Free,Linear,L,None,19,Antibacterial,0.119% hemolytic at 3000 μg/ml,Human,"Peptide of hGlyrichin,corresponding to amino acids 42 to 60 (Homo sapien)",NA,NA,CCCSCCEESSSSEECCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CS)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O
3133,21664395,2011,GIGKFLHSAGKFGKAFIGEIMKS,GIGKFLHSAGKFGKAFIGEIMKS,Magainin-M1,Free,Free,Linear,L,None,23,Antibacterial,LC50 = 180 µM,Human,Derived from skin secretions of Xenopus muelleri,NA,NA,CCSSSSSSSCCSTTTTTTTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
3134,21664395,2011,WCPPMIPLCSRF,WCPPMIPLCSRF{cyc:N-C}{ct:Amid},Tigerinin-M1,Amidation,Free,Cyclic,L,None,12,Antibacterial,LC50 >500 µM,Human,Derived from skin secretions of Xenopus muelleri,NA,NA,CCCCCCSCSTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
3135,21664395,2011,GIGKFLHSAGKFGKAFLGEVMKS,GIGKFLHSAGKFGKAFLGEVMKS,Magainin-MW1,Free,Free,Linear,L,None,23,Antibacterial,LC50 >200 µM,Human,Derived from skin secretions of Xenopus muelleri West,NA,NA,CTTSCCSTTCSSGGGGGGGTCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)C(C)C
3136,21664395,2011,GMASKAGSVLGKITKIALGAL,GMASKAGSVLGKITKIALGAL{ct:Amid},PGLa-MW1,Amidation,Free,Linear,L,None,21,Antibacterial,LC50 >200 µM,Human,Derived from skin secretions of Xenopus muelleri West,NA,NA,CCEETTEEGGGGGGGTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)CN)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O
3137,21664395,2011,GLGSLLGKAFKFGLKTVGKMMGGAPREQ,GLGSLLGKAFKFGLKTVGKMMGGAPREQ,CPF-MW1,Free,Free,Linear,L,None,28,Antibacterial,LC50 = 70 µM,Human,Derived from skin secretions of Xenopus muelleri West,NA,NA,CHHHHHHHHHHHHGGGHHHHHTTSCCCC,CSCC[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
3138,21664395,2011,GLGSLLGKAFKFGLKTVGKMMGGAPREE,GLGSLLGKAFKFGLKTVGKMMGGAPREE,CPF-MW2,Free,Free,Linear,L,None,28,Antibacterial,LC50 = 105 µM,Human,Derived from skin secretions of Xenopus muelleri West,NA,NA,CHHHHHHHHHHHHHTTHHHHSCCSCCCC,CSCC[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O
3237,23026014,2013,WFRKQLKW,WFRKQLKW,L10,Free,Free,Linear,L,None,8,Antibacterial and Antifungal,No Hemolysis upto 800 μg/ml,Human,Derived from modified N-terminal domain of bovine lactoferrin,NA,Non-hemolytic,CTTSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
3305,1362637,1992,PKLLETFLSKWIG,PKLLETFLSKWIG,SPF,Free,Free,Linear,L,None,13,Antibacterial,10% Hemolysis at 9 µM,Rat,Seminalplasmin derivative,NA,NA,CCHHIIIIITTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)NCC(=O)O
3306,1362637,1992,PKLLKTFLSKWIG,PKLLKTFLSKWIG,SPFK,Free,Free,Linear,L,None,13,Antibacterial,10% Hemolysis at 9 µM,Rat,SPF analog,NA,NA,CCGGGTTSSTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)NCC(=O)O
3307,2253768,1990,gigkflhsakkfgkafvgeimns,G{d}I{d}G{d}K{d}F{d}L{d}H{d}S{d}A{d}K{d}K{d}F{d}G{d}K{d}A{d}F{d}V{d}G{d}E{d}I{d}M{d}N{d}S{d},All-D-Magainin-2,Free,Free,Linear,D,None,23,Antibacterial and Antifungal,0% Hemolysis upto 80 μg/ml,Human,Derived from skin of Xenopus laevis,NA,NA,CCSSSSSGGGTCSSGGGGTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3308,2253768,1990,gigkflhsakkfgkafvgeimns,G{d}I{d}G{d}K{d}F{d}L{d}H{d}S{d}A{d}K{d}K{d}F{d}G{d}K{d}A{d}F{d}V{d}G{d}E{d}I{d}M{d}N{d}S{d},All-D-Magainin-2,Free,Free,Linear,D,None,23,Antibacterial and Antifungal,1% Hemolysis at 100 μg/ml,Human,Derived from skin of Xenopus laevis,NA,NA,CCSSSSSGGGTCSSGGGGTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3309,2253768,1990,gigkflhsakkfgkafvgeimns,G{d}I{d}G{d}K{d}F{d}L{d}H{d}S{d}A{d}K{d}K{d}F{d}G{d}K{d}A{d}F{d}V{d}G{d}E{d}I{d}M{d}N{d}S{d},All-D-Magainin-2,Free,Free,Linear,D,None,23,Antibacterial and Antifungal,2% Hemolysis at 200 μg/ml,Human,Derived from skin of Xenopus laevis,NA,NA,CCSSSSSGGGTCSSGGGGTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3310,2253768,1990,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS,All-L-Magainin-2,Free,Free,Linear,L,None,23,Antibacterial and Antifungal,0% Hemolysis at 25 μg/ml (non hemolytic),Human,Derived from skin of Xenopus laevis,NA,Non-hemolytic,CCSSSSSGGGTCSSGGGGTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3311,2253768,1990,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS,All-L-Magainin-2,Free,Free,Linear,L,None,23,Antibacterial and Antifungal,1% Hemolysis at 80 μg/ml,Human,Derived from skin of Xenopus laevis,NA,NA,CCSSSSSGGGTCSSGGGGTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3312,2253768,1990,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS,All-L-Magainin-2,Free,Free,Linear,L,None,23,Antibacterial and Antifungal,2% Hemolysis at 200 μg/ml,Human,Derived from skin of Xenopus laevis,NA,NA,CCSSSSSGGGTCSSGGGGTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3378,9273892,1997,LALILRKIVTAL,LALILRKIVTAL{nt:Fmoc}{ct:Amid},FCR(3A),Amidation,Fmoc,Linear,L,None,13,Antibacterial,100% Hemolysis at 8μg,Rat,Crabrolin (Vespa crabro),NA,NA,CHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC
3379,9273892,1997,LALILRKIVTAL,LALILRKIVTAL{ct:Amid},CR(3A),Amidation,Free,Linear,L,None,13,Antibacterial,~90% Hemolysis at 80μg,Rat,Crabrolin (Vespa crabro),NA,NA,CHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC
3380,9273892,1997,LKLIPRKIVTAL,LKLIPRKIVTAL{nt:Fmoc}{ct:Amid},"FCR(3K,6P)",Amidation,Fmoc,Linear,L,None,13,Antibacterial,~60% Hemolysis at 80μg,Rat,Crabrolin (Vespa crabro),NA,NA,CCCCCTTGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(C)C
3381,9273892,1997,LKLIPRKIVTAL,LKLIPRKIVTAL{ct:Amid},"CR(3K,6P)",Amidation,Free,Linear,L,None,13,Antibacterial,Non-hemolytic,Rat,Crabrolin (Vespa crabro),NA,Non-hemolytic,CCCCCTTGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(C)C
3382,9273892,1997,LPLILRKIVTAL,LPLILRKIVTAL{nt:Fmoc}{ct:Amid},FCR,Amidation,Fmoc,Linear,L,None,13,Antibacterial,~80% Hemolysis at 8μg,Rat,Crabrolin (Vespa crabro),NA,NA,CCCHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC
3383,9273892,1997,LPLILRKIVTAL,LPLILRKIVTAL{ct:Amid},CR,Amidation,Free,Linear,L,None,13,Antibacterial,Non-hemolytic,Rat,Crabrolin (Vespa crabro),NA,Non-hemolytic,CCCHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC
3432,1605597,1992,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS,Peptide-1,Free,Free,Linear,L,None,23,Antibacterial,0% Hemolysis upto 100 μg/ml,Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,NA,CCSSSSSGGGTCSSGGGGTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3433,1605597,1992,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS,Peptide-1,Free,Free,Linear,L,None,23,Antibacterial,1% Hemolysis upto 200 μg/ml,Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,NA,CCSSSSSGGGTCSSGGGGTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3434,1605597,1992,KKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS,KKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS,Peptide-3,Free,Free,Linear,L,None,33,Antibacterial,0% Hemolysis upto 200 μg/ml (non hemolytic),Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3435,1605597,1992,AAAAAAAAAAGIGKFLHSAKKFGKAFVGEIMNS,AAAAAAAAAAGIGKFLHSAKKFGKAFVGEIMNS,Peptide-4,Free,Free,Linear,L,None,33,Antibacterial,2% Hemolysis upto 100 μg/ml,Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,NA,CTTSTTSHHHHHHHHSCSSSSTTSSTTTTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3436,1605597,1992,AAAAAAAAAAGIGKFLHSAKKFGKAFVGEIMNS,AAAAAAAAAAGIGKFLHSAKKFGKAFVGEIMNS,Peptide-4,Free,Free,Linear,L,None,33,Antibacterial,9% Hemolysis upto 200 μg/ml,Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,NA,CTTSTTSHHHHHHHHSCSSSSTTSSTTTTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3437,1605597,1992,RRRRRRRRRRGIGKFLHSAKKFGKAFVGEIMNS,RRRRRRRRRRGIGKFLHSAKKFGKAFVGEIMNS,Peptide-5,Free,Free,Linear,L,None,33,Antibacterial,0% Hemolysis at 25 μg/ml,Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,NA,CCCCGGGGGTTTGGGCCTTSSSSSSTTTGGGC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3438,1605597,1992,RRRRRRRRRRGIGKFLHSAKKFGKAFVGEIMNS,RRRRRRRRRRGIGKFLHSAKKFGKAFVGEIMNS,Peptide-5,Free,Free,Linear,L,None,33,Antibacterial,1% Hemolysis at 50 μg/ml,Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,NA,CCCCGGGGGTTTGGGCCTTSSSSSSTTTGGGC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3439,1605597,1992,RRRRRRRRRRGIGKFLHSAKKFGKAFVGEIMNS,RRRRRRRRRRGIGKFLHSAKKFGKAFVGEIMNS,Peptide-5,Free,Free,Linear,L,None,33,Antibacterial,2% Hemolysis at 100 μg/ml,Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,NA,CCCCGGGGGTTTGGGCCTTSSSSSSTTTGGGC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3440,1605597,1992,RRRRRRRRRRGIGKFLHSAKKFGKAFVGEIMNS,RRRRRRRRRRGIGKFLHSAKKFGKAFVGEIMNS,Peptide-5,Free,Free,Linear,L,None,33,Antibacterial,4% Hemolysis at 200 μg/ml,Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,NA,CCCCGGGGGTTTGGGCCTTSSSSSSTTTGGGC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3441,1605597,1992,KKKKKKKKKKKKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS,KKKKKKKKKKKKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS,Peptide-6,Free,Free,Linear,L,None,43,Antibacterial,1% Hemolysis at 25 μg/ml,Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3442,1605597,1992,KKKKKKKKKKKKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS,KKKKKKKKKKKKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS,Peptide-6,Free,Free,Linear,L,None,43,Antibacterial,2% Hemolysis at 50 μg/ml,Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3443,1605597,1992,KKKKKKKKKKKKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS,KKKKKKKKKKKKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS,Peptide-6,Free,Free,Linear,L,None,43,Antibacterial,6% Hemolysis at 100 μg/ml,Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3444,1605597,1992,KKKKKKKKKKKKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS,KKKKKKKKKKKKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS,Peptide-6,Free,Free,Linear,L,None,43,Antibacterial,14% Hemolysis at 200 μg/ml,Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3445,1605597,1992,GIGKFLHSAKKFGKAFVGEIMNSKKKKKKKKKK,GIGKFLHSAKKFGKAFVGEIMNSKKKKKKKKKK,Peptide-7,Free,Free,Linear,L,None,33,Antibacterial,0% Hemolysis upto 100 μg/ml,Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C
3446,1605597,1992,GIGKFLHSAKKFGKAFVGEIMNSKKKKKKKKKK,GIGKFLHSAKKFGKAFVGEIMNSKKKKKKKKKK,Peptide-7,Free,Free,Linear,L,None,33,Antibacterial,1% Hemolysis at 200 μg/ml,Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C
3447,1605597,1992,KKFLHSAKKWLKAFVKLKKNW,KKFLHSAKKWLKAFVKLKKNW,Peptide-8,Free,Free,Linear,L,None,21,Antibacterial,3% Hemolysis at 25 μg/ml,Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,NA,CCSSCTHHHHHHHHHTTSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
3448,1605597,1992,KKFLHSAKKWLKAFVKLKKNW,KKFLHSAKKWLKAFVKLKKNW,Peptide-8,Free,Free,Linear,L,None,21,Antibacterial,16% Hemolysis at 50 μg/ml,Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,NA,CCSSCTHHHHHHHHHTTSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
3449,1605597,1992,KKFLHSAKKWLKAFVKLKKNW,KKFLHSAKKWLKAFVKLKKNW,Peptide-8,Free,Free,Linear,L,None,21,Antibacterial,29% Hemolysis at 100 μg/ml,Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,NA,CCSSCTHHHHHHHHHTTSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
3450,1605597,1992,KKFLHSAKKWLKAFVKLKKNW,KKFLHSAKKWLKAFVKLKKNW,Peptide-8,Free,Free,Linear,L,None,21,Antibacterial,41% Hemolysis at 200 μg/ml,Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,NA,CCSSCTHHHHHHHHHTTSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
3451,1605597,1992,GIGKLFLHAAKKFAKAFVAEKMNS,GIGKLFLHAAKKFAKAFVAEKMNS,Peptide-9,Free,Free,Linear,L,None,24,Antibacterial,0% Hemolysis upto 200 μg/ml (non hemolytic),Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,Non-hemolytic,CTTTTSSCTHHHHGGGGTGGGTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C
3452,1605597,1992,KKKKKKKKKKGIGKLFLHAAKKFAKAFVAEKMNS,KKKKKKKKKKGIGKLFLHAAKKFAKAFVAEKMNS,Peptide-10,Free,Free,Linear,L,None,34,Antibacterial,0% Hemolysis at 100 μg/ml,Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,NA,CCGGGGCCCCCCCSSSSSHHHHHHHHTTTTSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C
3453,1605597,1992,KKKKKKKKKKGIGKLFLHAAKKFAKAFVAEKMNS,KKKKKKKKKKGIGKLFLHAAKKFAKAFVAEKMNS,Peptide-10,Free,Free,Linear,L,None,34,Antibacterial,2% Hemolysis at 200 μg/ml,Human,Magainin-2 analog (Skin secretion of the african frog Xenopus laevis),NA,NA,CCGGGGCCCCCCCSSSSSHHHHHHHHTTTTSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C
3454,10604598,1999,PKLLKTFLSKWIG,PKLLKTFLSKWIG,SPFK,Free,Free,Linear,L,None,13,Antibacterial,100% Hemolysis at 65 μg/ml,Rat,Synthetic peptide,NA,NA,CCGGGTTSSTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)NCC(=O)O
3455,10604598,1999,CKLLKTFLSKWIC,CKLLKTFLSKWIC{cyc:N-C},SC,Free,Free,Cyclic,L,None,13,Antibacterial,100% Hemolysis at 40 μg/ml,Rat,Synthetic peptide,NA,NA,CCHHHHTGGGTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)O
3456,10604598,1999,CKLLKTFLSKWIC,CKLLKTFLSKWIC{cyc:N-C}{ct:Amid},SAC,Amidation,Free,Cyclic,L,None,13,Antibacterial,100% Hemolysis at 5 μg/ml,Rat,Synthetic peptide,NA,NA,CCHHHHTGGGTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)O
3457,8823199,1996,KLALKLALKALKAALKLA,KLALKLALKALKAALKLA,KLAL,Free,Free,Linear,L,None,18,Antibacterial,EC50 = 10 µM,Human,Synthetic peptide,NA,NA,CGGGTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
3458,8823199,1996,klALKLALKALKAALKLA,K{d}L{d}ALKLALKALKAALKLA,k1/l2,Free,Free,Linear,Mix,None,18,Antibacterial,EC50 = 7 µM,Human,Synthetic peptide,NA,NA,CGGGTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
3459,8823199,1996,KLalKLALKALKAALKLA,KLA{d}L{d}KLALKALKAALKLA,a3/l4,Free,Free,Linear,Mix,None,18,Antibacterial,EC50 = 33 µM,Human,Synthetic peptide,NA,NA,CGGGTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
3460,8823199,1996,KLALklALKALKAALKLA,KLALK{d}L{d}ALKALKAALKLA,k5/l6,Free,Free,Linear,Mix,None,18,Antibacterial,EC50 = 160 µM,Human,Synthetic peptide,NA,NA,CGGGTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
3461,8823199,1996,KLALKLalKALKAALKLA,KLALKLA{d}L{d}KALKAALKLA,a7/l8,Free,Free,Linear,Mix,None,18,Antibacterial,EC50 = 180 µM,Human,Synthetic peptide,NA,NA,CGGGTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
3462,8823199,1996,KLALKLALkaLKAALKLA,KLALKLALK{d}A{d}LKAALKLA,k9/a10,Free,Free,Linear,Mix,None,18,Antibacterial,EC50 = 56 µM,Human,Synthetic peptide,NA,NA,CGGGTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
3463,8823199,1996,KLALKLALKAlkAALKLA,KLALKLALKAL{d}K{d}AALKLA,l11/k12,Free,Free,Linear,Mix,None,18,Antibacterial,EC50 = 540 µM,Human,Synthetic peptide,NA,NA,CGGGTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
3464,8823199,1996,KLALKLALKALKaaLKLA,KLALKLALKALKA{d}A{d}LKLA,a13/a14,Free,Free,Linear,Mix,None,18,Antibacterial,EC50 = 260 µM,Human,Synthetic peptide,NA,NA,CGGGTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
3465,8823199,1996,KLALKLALKALKAAlkLA,KLALKLALKALKAAL{d}K{d}LA,l15/k16,Free,Free,Linear,Mix,None,18,Antibacterial,EC50 = 210 µM,Human,Synthetic peptide,NA,NA,CGGGTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
3466,8823199,1996,KLALKLALKALKAALKla,KLALKLALKALKAALKL{d}A{d},l17/a18,Free,Free,Linear,Mix,None,18,Antibacterial,EC50 = 70 µM,Human,Synthetic peptide,NA,NA,CGGGTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
3495,19109988,2010,GFLSALKKYLPIVLKHV,GFLSALKKYLPIVLKHV,Osmin,Free,Free,Linear,L,None,17,Antibacterial and Antifungal,Weak hemolytic activity i.e. 5.0HU/mg,Human,Osmin (venom from the solitary bee Osmia rufa),NA,NA,CTHHHHTTTTTSSCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
3496,19109988,2010,GFLSALKKYLPIVLKHV,GFLSALKKYLPIVLKHV{ct:Amid},Osmin,Amidation,Free,Linear,L,None,17,Antibacterial and Antifungal,Hemolytic activity i.e. 16.6HU/mg,Human,Osmin (venom from the solitary bee Osmia rufa),NA,NA,CTHHHHTTTTTSSCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
3519,9166783,1997,GLGKFLHSAKRFGKAFVGEAMNS,GLGKFLHSAKRFGKAFVGEAMNS{ct:Amid},L2R11A20-M2a,Amidation,Free,Linear,L,None,23,Antibacterial,EC50 >1000 µM,Human,Maginin-2 analog ( skin of the African clawed frog Xenopus laevis),NA,NA,CCSCSSSHHHHHHHTTCTTCCC,CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O
3520,9166783,1997,GLGKFLHSAKRFGKAFVGEAMNS,GLGKFLHSAKRFGKAFVGEAMNS{ct:Amid},L2R11A20-M2a,Amidation,Free,Linear,L,None,23,Antibacterial,12% Hemolysis at 150 µM,Human,Maginin-2 analog ( skin of the African clawed frog Xenopus laevis),NA,NA,CCSCSSSHHHHHHHTTCTTCCC,CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O
3521,9166783,1997,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid},M2a,Amidation,Free,Linear,L,None,23,Antibacterial,EC50 = 430 µM,Human,Maginin-2 analog ( skin of the African clawed frog Xenopus laevis),NA,NA,CCSSSSSGGGTCSSGGGGTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3522,9166783,1997,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid},M2a,Amidation,Free,Linear,L,None,23,Antibacterial,30% Hemolysis at 150 µM,Human,Maginin-2 analog ( skin of the African clawed frog Xenopus laevis),NA,NA,CCSSSSSGGGTCSSGGGGTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3523,9166783,1997,GIGKFIHSAKKFGKLFVGEIMNS,GIGKFIHSAKKFGKLFVGEIMNS{ct:Amid},I6L15-M2a,Amidation,Free,Linear,L,None,23,Antibacterial,EC50 = 260 µM,Human,Maginin-2 analog ( skin of the African clawed frog Xenopus laevis),NA,NA,CCSSSSSCHHHHTCSSSSTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
3524,9166783,1997,GIGKFIHSAKKFGKLFVGEIMNS,GIGKFIHSAKKFGKLFVGEIMNS{ct:Amid},I6L15-M2a,Amidation,Free,Linear,L,None,23,Antibacterial,40% Hemolysis at 150 µM,Human,Maginin-2 analog ( skin of the African clawed frog Xenopus laevis),NA,NA,CCSSSSSCHHHHTCSSSSTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
3525,9166783,1997,GIGKFIHAAKKFGKLFIGEIMNS,GIGKFIHAAKKFGKLFIGEIMNS{ct:Amid},I6A8L15I17-M2a,Amidation,Free,Linear,L,None,23,Antibacterial,EC50 = 32 µM,Human,Maginin-2 analog ( skin of the African clawed frog Xenopus laevis),NA,NA,CCCCCCSGGGTSSCCCSCGGGC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
3526,9166783,1997,GIGKFIHAAKKFGKLFIGEIMNS,GIGKFIHAAKKFGKLFIGEIMNS{ct:Amid},I6A8L15I17-M2a,Amidation,Free,Linear,L,None,23,Antibacterial,98% Hemolysis at 150 µM,Human,Maginin-2 analog ( skin of the African clawed frog Xenopus laevis),NA,NA,CCCCCCSGGGTSSCCCSCGGGC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
3543,12581207,2003,FFGWLIKGAIHAGKAIHGLIHRRRH,FFGWLIKGAIHAGKAIHGLIHRRRH{ct:Amid},Chrysophsin-1,Amidation,Free,Linear,L,None,25,Antibacterial,~40% Hemolysis at 1 µM,Human,Chrysophsin (the gills of red sea bream Chrysophrys major),NA,NA,CCGGGSTTSSSSCCCSSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)CC
3544,12581207,2003,FFGWLIKGAIHAGKAIHGLIHRRRH,FFGWLIKGAIHAGKAIHGLIHRRRH{ct:Amid},Chrysophsin-1,Amidation,Free,Linear,L,None,25,Antibacterial,100% Hemolysis at 100 µM,Human,Chrysophsin (the gills of red sea bream Chrysophrys major),NA,NA,CCGGGSTTSSSSCCCSSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)CC
3545,12581207,2003,FFGWLIRGAIHAGKAIHGLIHRRRH,FFGWLIRGAIHAGKAIHGLIHRRRH{ct:Amid},Chrysophsin-2,Amidation,Free,Linear,L,None,25,Antibacterial,>40% Hemolysis at 1 µM,Human,Chrysophsin (the gills of red sea bream Chrysophrys major),NA,NA,CTTTTCGGGSSSCCSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)CC
3546,12581207,2003,FFGWLIRGAIHAGKAIHGLIHRRRH,FFGWLIRGAIHAGKAIHGLIHRRRH{ct:Amid},Chrysophsin-2,Amidation,Free,Linear,L,None,25,Antibacterial,100% Hemolysis at 100 µM,Human,Chrysophsin (the gills of red sea bream Chrysophrys major),NA,NA,CTTTTCGGGSSSCCSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)CC
3547,12581207,2003,FIGLLISAGKAIHDLIRRRH,FIGLLISAGKAIHDLIRRRH{ct:Amid},Chrysophsin-3,Amidation,Free,Linear,L,None,20,Antibacterial,0% Hemolysis at 1 µM,Human,Chrysophsin (the gills of red sea bream Chrysophrys major),NA,NA,CCSCCCCSGGGCSCTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)CC
3548,12581207,2003,FIGLLISAGKAIHDLIRRRH,FIGLLISAGKAIHDLIRRRH{ct:Amid},Chrysophsin-3,Amidation,Free,Linear,L,None,20,Antibacterial,100% Hemolysis at 100 µM,Human,Chrysophsin (the gills of red sea bream Chrysophrys major),NA,NA,CCSCCCCSGGGCSCTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)CC
3559,8223491,1993,IIGPVLGLVGSALGGLLKKI,IIGPVLGLVGSALGGLLKKI{ct:Amid},Peptide B,Amidation,Free,Linear,L,None,20,Antibacterial,Lethal concentration = 17.0 µM,Human,Synthetic peptide,NA,NA,CCSSCHHHHHHHTSSSCSCC,CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)CC
3560,2689223,1989,KWKLFKKIEKVGQNIRDGIIKAGPGIGAVLKVLTTGL,KWKLFKKIEKVGQNIRDGIIKAGPGIGAVLKVLTTGL{ct:Amid},CA(1-24)M(1-13),Amidation,Free,Linear,L,None,37,Antibacterial and Antiparasitic,Lethal concentration calculated from zone of inhibition >200 µM,Sheep,Cercropin-melittin hybrids,NA,NA,CBSCCTTGGGTCCTTSSTTSSSBCCSSCCGGGGGSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
3561,2689223,1989,KWKLFKKIEKVGQGIGAVLKVLTTGL,KWKLFKKIEKVGQGIGAVLKVLTTGL{ct:Amid},CA(1-13)M(1-13),Amidation,Free,Linear,L,None,26,Antibacterial and Antiparasitic,Lethal concentration calculated from zone of inhibition >200 µM,Sheep,Cercropin-melittin hybrids,NA,NA,CCTTGGGGTTTSCTHHHHHTGGGCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
3562,2689223,1989,AVAVVGQATQIAKKWKLFKKIEKVGQ,AVAVVGQATQIAKKWKLFKKIEKVGQ{ct:Amid},CA(25-37)CA(1-13),Amidation,Free,Linear,L,None,26,Antibacterial and Antiparasitic,Lethal concentration calculated from zone of inhibition >300 µM,Sheep,Cercropin-melittin hybrids,NA,NA,CCCCTTHHHHHHHHHHHHHHHTTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)CC
3563,2689223,1989,GIGAVLKVLTTGLKWKLFKKIEKVGQ,GIGAVLKVLTTGLKWKLFKKIEKVGQ{ct:Amid},M(1-13)CA(1-13),Amidation,Free,Linear,L,None,26,Antibacterial and Antiparasitic,Lethal concentration calculated from zone of inhibition 80 µM,Sheep,Cercropin-melittin hybrids,NA,NA,CGGGSHHHHHHHCCHHHHTTTTTTCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
3564,2689223,1989,LISWIKRKRQQGIGAVLKVLTTGL,LISWIKRKRQQGIGAVLKVLTTGL{ct:Amid},M(16-26)M(1-13),Amidation,Free,Linear,L,None,24,Antibacterial and Antiparasitic,Lethal concentration calculated from zone of inhibition >200 µM,Sheep,Cercropin-melittin hybrids,NA,NA,CCHHHHHHHTSCTTTCCCGGGCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
3581,9048567,1997,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid},Melittin,Amidation,Free,Linear,L,None,26,Antibacterial,100% Hemolysis at 50 µM,Human,Melittin ( venom of the honey bee Apis mellifera),NA,NA,CCCCCTHHHHTCCHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
3582,9048567,1997,GIGAvLKvLTTGLPALiSWIkRKRQQ,GIGAV{d}LKV{d}LTTGLPALI{d}SWIK{d}RKRQQ{ct:Amid},"[D]-V5,8,I17,K21-melittin",Amidation,Free,Linear,Mix,None,26,Antibacterial,0% Hemolysis at 50 µM,Human,Melittin diastereomers ( venom of the honey bee Apis mellifera),NA,Non-hemolytic,CCCCCTHHHHTCCHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
3583,9048567,1997,GIGAvLKvLTTGLPALiSWIkRKRQQ,GIGAV{d}LKV{d}LTTGLPALI{d}SWIK{d}RKRQQ,"[D]-V5,8,I17,K21-melittin",Free,Free,Linear,Mix,None,26,Antibacterial,~1-2% Hemolysis at 50 µM,Human,Melittin diastereomers (Apis mellifera),NA,NA,CCCCCTHHHHTCCHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
3584,9335545,1997,GVAKFGKAAAHFGKGWIKEMLNS,GVAKFGKAAAHFGKGWIKEMLNS{ct:Amid},80°M2a,Amidation,Free,Linear,L,None,23,Antibacterial,EC25 = 307 µM,Human,Synthetic peptide,NA,NA,CTTSCHHHHSSSCCHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O
3585,9335545,1997,GIAKFGKAAAHFGKKWVGELMNS,GIAKFGKAAAHFGKKWVGELMNS{ct:Amid},100°M2a,Amidation,Free,Linear,L,None,23,Antibacterial,EC25 = 159 µM,Human,Synthetic peptide,NA,NA,CCGGGCCTTSSHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C
3586,9335545,1997,GIGKFLHSAKKFGKAWVGEIMNS,GIGKFLHSAKKFGKAWVGEIMNS{ct:Amid},120°M2a,Amidation,Free,Linear,L,None,23,Antibacterial,EC25 = 271 µM,Human,Synthetic peptide,NA,NA,CCTTTSSCTTTGGGGGTTTTCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
3587,9335545,1997,GIGKFLHTLKTFGKKWVGEIMNS,GIGKFLHTLKTFGKKWVGEIMNS{ct:Amid},140°M2a,Amidation,Free,Linear,L,None,23,Antibacterial,EC25 = 15 µM,Human,Synthetic peptide,NA,NA,CTTTTSSIIIIITTHHHHGGGC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O
3588,9335545,1997,GIGKFLHKVKSFGKSWIGEIMNS,GIGKFLHKVKSFGKSWIGEIMNS{ct:Amid},160°M2a,Amidation,Free,Linear,L,None,23,Antibacterial,EC25 = 20 µM,Human,Synthetic peptide,NA,NA,CCCSSCCSSSSSSCTHHHHTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C
3589,9335545,1997,GIGKFLHKVGSFIKSWKGEIMNS,GIGKFLHKVGSFIKSWKGEIMNS{ct:Amid},180°M2a,Amidation,Free,Linear,L,None,23,Antibacterial,EC25 = 24 µM,Human,Synthetic peptide,NA,NA,CHHHHCCHHHHHHHGGGTSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C
3656,8849687,1996,ILPWKWPWWPWRR,ILPWKWPWWPWRR{ct:Amid},Indolicidin,Amidation,Free,Linear,L,None,13,Antibacterial,~90% Hemolysis at 20 µM,Rat,"Derived from cytoplasmic granules of bovine neutrophils,",NA,NA,CCCCCCSSCSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
3657,8849687,1996,ILPWKWPWWPWRR,ILPWKWPWWPWRR{ct:Amid},Indolicidin,Amidation,Free,Linear,L,None,13,Antibacterial,~100% Hemolysis at 30 µM,Rat,"Derived from cytoplasmic granules of bovine neutrophils,",NA,NA,CCCCCCSSCSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
3658,8849687,1996,ILAWKWAWWAWRR,ILAWKWAWWAWRR{ct:Amid},ILA,Amidation,Free,Linear,L,None,13,Antibacterial,~20% Hemolysis at 5 µM,Rat,Indolicidin analog,NA,NA,CGGGCHHHHTCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
3659,8849687,1996,ILAWKWAWWAWRR,ILAWKWAWWAWRR{ct:Amid},ILA,Amidation,Free,Linear,L,None,13,Antibacterial,100% Hemolysis at 20 μg/ml,Rat,Indolicidin analog,NA,NA,CGGGCHHHHTCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
3660,8849687,1996,ILPFKFPFFPFRR,ILPFKFPFFPFRR{ct:Amid},ILF,Amidation,Free,Linear,L,None,13,Antibacterial,~20% Hemolysis upto 80 μg/ml,Rat,Indolicidin analog,NA,NA,CCCCCCSCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
3661,8843284,1996,KFFKFFKFF,KFFKFFKFF,Synthetic peptide,Free,Free,Linear,L,None,9,Antibacterial,Strongly hemolytic at 40 μg/ml,Human,Synthetic peptide,NA,NA,CCCCCCCCC,NCCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
3662,8810288,1996,fPVOLfPVOL,F{d}PV{nnr:O}LF{d}PV{nnr:O}L{cyc:N-C},GS,Free,Free,Cyclic,Mix,O = L-Ornithine,10,Antibacterial,100% Hemolysis at 39 μg/ml,Human,Gramicidin S (Bacillus brevis),NA,NA,NA,NA
3663,8810288,1996,yPyP,Y{d}PY{d}P{cyc:N-C},GS4,Free,Free,Cyclic,Mix,None,4,Antibacterial,100% Hemolysis at >800 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCCC,N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
3664,8810288,1996,yPKyPK,Y{d}PKY{d}PK{cyc:N-C},GS6,Free,Free,Cyclic,Mix,None,6,Antibacterial,100% Hemolysis at >1600 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCCCCC,NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O
3665,8810288,1996,yPVKyPKL,Y{d}PVKY{d}PKL{cyc:N-C},GS8,Free,Free,Cyclic,Mix,None,8,Antibacterial,100% Hemolysis at >1600 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCSSCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)O
3666,8810288,1996,yPVKLyPVKL,Y{d}PVKLY{d}PVKL{cyc:N-C},GS10,Free,Free,Cyclic,Mix,None,10,Antibacterial,100% Hemolysis at 67 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCSSCCSTTC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(C)C)C(=O)O
3667,8810288,1996,yPVKLKyPKVKL,Y{d}PVKLKY{d}PKVKL{cyc:N-C},GS12,Free,Free,Cyclic,Mix,None,12,Antibacterial,100% Hemolysis at 250 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCCCCCCGGGCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(C)C)C(=O)O
3668,8810288,1996,yPVKLKVyPLKVKL,Y{d}PVKLKVY{d}PLKVKL{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antibacterial,100% Hemolysis at 6 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCCCCCCCGGGSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(C)C)C(C)C)C(=O)O
3669,8810288,1996,yPLKVKyPKLKV,Y{d}PLKVKY{d}PKLKV{cyc:N-C},GS12LV,Free,Free,Cyclic,Mix,None,12,Antibacterial,100% Hemolysis at 92 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCCCCCCSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C
3670,8810288,1996,fPVKLKfPKVKL,F{d}PVKLKF{d}PKVKL{cyc:N-C},GS12F,Free,Free,Cyclic,Mix,None,12,Antibacterial,100% Hemolysis at 400 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCCSSSCTTCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)O
3671,8810288,1996,fPVOLOfPOVOL,F{d}PV{nnr:O}L{nnr:O}F{d}P{nnr:O}V{nnr:O}L{cyc:N-C},GS12FO,Free,Free,Cyclic,Mix,O = L-Ornithine,12,Antibacterial,100% Hemolysis at 160 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,NA,NA
3672,8810288,1996,fPLOLOfPOLOL,F{d}PL{nnr:O}L{nnr:O}F{d}P{nnr:O}L{nnr:O}L{cyc:N-C},GS12FO/LL,Free,Free,Cyclic,Mix,O = L-Ornithine,12,Antibacterial,100% Hemolysis at 170 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,NA,NA
3673,8620888,1996,GFFALIPKIISSPLFKTLLSAVGSALSSSGG,GFFALIPKIISSPLFKTLLSAVGSALSSSGG,Pardaxin,Free,Free,Linear,L,None,31,Antibacterial,>20% Hemolysis at 25 µM,Human,Pardaxin (Pardachirus marmoratus),NA,NA,CCCSSCHHHHTSSTTHHHHHHHHHHHTTCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)CC
3674,8620888,1996,GFFALIPKIISSPLFKTLLSAVGSALSSSGG,GFFALIPKIISSPLFKTLLSAVGSALSSSGG,Pardaxin,Free,Free,Linear,L,None,31,Antibacterial,>50% Hemolysis at 50 µM,Human,Pardaxin (Pardachirus marmoratus),NA,NA,CCCSSCHHHHTSSTTHHHHHHHHHHHTTCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)CC
3675,8620888,1996,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE{ct:[NH(CH2)2NH2]2},Pardaxin- [NH(CH2)2NH2]2,[NH(CH2)2NH2]2,Free,Linear,L,None,33,Antibacterial,>100% Hemolysis at 12 µM,Human,Pardaxin analog (Pardachirus marmoratus),NA,NA,CCCSSCHHHHTSSTTHHHHHHHHHHHTTCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)CC
3676,8620888,1996,GFFALIPKIISSPLFKTLLSAV,GFFALIPKIISSPLFKTLLSAV,Des-(23-33)-pardaxin,Free,Free,Linear,L,None,22,Antibacterial,>100% Hemolysis at 10 µM,Human,Pardaxin analog (Pardachirus marmoratus),NA,NA,CCCCCCHHHHTSHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)CC
3677,8620888,1996,GFFALIPKIISSPLFKTLLSAV,GFFALIPKIISSPLFKTLLSAV{ct:[NH(CH2)2NH2]2},Des-(23-33)-pardaxin-[NH(CH2)2NH2]2,[NH(CH2)2NH2]2,Free,Linear,L,None,22,Antibacterial,<20% Hemolysis at 50 µM,Human,Pardaxin analog (Pardachirus marmoratus),NA,NA,CCCCCCHHHHTSHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)CC
3678,8620888,1996,KGFFALIPKIISSPLFKTLLSAV,KGFFALIPKIISSPLFKTLLSAV{ct:[NH(CH2)2NH2]2},Lys-des-(23- 33)-pardaxin-[NH(CH2)2NH2]2,[NH(CH2)2NH2]2,Free,Linear,L,[NH(CH2)2NH2]2,23,Antibacterial,No Hemolysis (Non hemolytic),Human,Pardaxin analog (Pardachirus marmoratus),NA,Non-hemolytic,CCSCCSCSSSCCCHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)CC
3679,8620888,1996,ISSPLFKTLLSAVGSALSSSGGQE,ISSPLFKTLLSAVGSALSSSGGQE,Des-(I -9)-pardaxin,Free,Free,Linear,L,None,24,Antibacterial,No Hemolysis (Non hemolytic),Human,Pardaxin analog (Pardachirus marmoratus),NA,Non-hemolytic,CCCHHHHHHHHHHHHHTSCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)[C@@H](C)O
3680,8620888,1996,ISSPLFKTLLSAVGSALSSSGGQE,ISSPLFKTLLSAVGSALSSSGGQE{ct:[NH(CH2)2NH2]2},Des-(I -9)-pardaxin-[NH(CH2)2NH2]2,[NH(CH2)2NH2]2,Free,Linear,L,[NH(CH2)2NH2]2,24,Antibacterial,No Hemolysis (Non hemolytic),Human,Pardaxin analog (Pardachirus marmoratus),NA,Non-hemolytic,CCCHHHHHHHHHHHHHTSCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)[C@@H](C)O
3681,8620888,1996,GFFALIPKIIS,GFFALIPKIIS,Des-(12-33)-pardaxin,Free,Free,Linear,L,None,11,Antibacterial,No Hemolysis (Non hemolytic),Human,Pardaxin analog (Pardachirus marmoratus),NA,Non-hemolytic,CCCCCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC
3682,8620888,1996,GFFALIPKIIS,GFFALIPKIIS{ct:[NH(CH2)2NH2]2},Des-(I 2-33)-pardaxin-[NH(CH2)2NH2]2,[NH(CH2)2NH2]2,Free,Linear,L,[NH(CH2)2NH2]2,11,Antibacterial,No Hemolysis (Non hemolytic),Human,Pardaxin analog (Pardachirus marmoratus),NA,Non-hemolytic,CCCCCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC
3695,19540868,2009,KDGYIIEHRGCKYSCFFGTNSWCNTECTLKKGSSGYCAWPACWCYGLPDNVKIFDSNNLKC,KDGYIIEHRGCKYSCFFGTNSWCNTECTLKKGSSGYCAWPACWCYGLPDNVKIFDSNNLKC{cyc:N-C},Bactridine 1,Free,Free,Cyclic,L,None,61,Antibacterial,0.2% Hemolysis at 90 µM,Human,Derived from venom of Tityus discrepans,NA,NA,CCSSSCCCCCCCCSCSTTSSCCSTTTTTTTTTTCSCCCTTTSCCSCCCCSSCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
3696,19540868,2009,KDGYIIEHRGCKYSCFFGTNSWCNTECTLKKGSSGYCAWPACWCYGLPDNVKIFDSNNLKC,KDGYIIEHRGCKYSCFFGTNSWCNTECTLKKGSSGYCAWPACWCYGLPDNVKIFDSNNLKC{cyc:N-C},Bactridine 1,Free,Free,Cyclic,L,None,61,Antibacterial,1.0% Hemolysis at 180 µM,Human,Derived from venom of Tityus discrepans,NA,NA,CCSSSCCCCCCCCSCSTTSSCCSTTTTTTTTTTCSCCCTTTSCCSCCCCSSCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
3697,19540868,2009,KDGYLVGNDGCKYSCFTRPGTYCANECSRVKGKDGYCYAWMACYCYSMPNWVKTWNRATNRCGR,KDGYLVGNDGCKYSCFTRPGTYCANECSRVKGKDGYCYAWMACYCYSMPNWVKTWNRATNRCGR{cyc:N-C},Bactridine 2,Free,Free,Cyclic,L,None,64,Antibacterial,7.6% Hemolysis at 90 µM,Human,Derived from venom of Tityus discrepans,NA,NA,CCSCCSSSCSSSCCSCSSSSCCCHHHHHHCCCCCSCCCSCGGGCCCCSCCTTSCCCCCCCCTTC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C
3698,19540868,2009,KDGYLVGNDGCKYSCFTRPGTYCANECSRVKGKDGYCYAWMACYCYSMPNWVKTWNRATNRCGR,KDGYLVGNDGCKYSCFTRPGTYCANECSRVKGKDGYCYAWMACYCYSMPNWVKTWNRATNRCGR{cyc:N-C},Bactridine 2,Free,Free,Cyclic,L,None,64,Antibacterial,21.0% Hemolysis at 180 µM,Human,Derived from venom of Tityus discrepans,NA,NA,CCSCCSSSCSSSCCSCSSSSCCCHHHHHHCCCCCSCCCSCGGGCCCCSCCTTSCCCCCCCCTTC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C
3705,8353519,1993,SIGSALKKALPVAKKIGKIALPIAKAALP,SIGSALKKALPVAKKIGKIALPIAKAALP,Ceratotoxin A,Free,Free,Linear,L,None,29,Antibacterial,Area of inhibition ~25mm2 at 5 nmol,Human,Derived from secretion of the female reproductive accessory glands of Ceratitis capitata,NA,NA,CTHHHHTTTCHHHHTTSBCCSSHHHHCBC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC)[C@@H](C)CC
3707,19056441,2009,IFGAILPLALGALKNLIK,IFGAILPLALGALKNLIK{ct:Amid},Hy-a1,Amidation,Free,Linear,L,None,18,Antibacterial,HC50 = 18 µM,Human,Derived from skin secretion of Hypsiboas albopunctatus,NA,NA,CTTTSHHHHHHHHHHHCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
3750,12354111,2002,GKVWDWIKSTAKKLWNSEPVKELKNTALNAAKNLVAEKIGATPS,GKVWDWIKSTAKKLWNSEPVKELKNTALNAAKNLVAEKIGATPS,Opistoporin 1,Free,Free,Linear,L,None,44,Antibacterial and Antifungal,30% Hemolysis at 100 µM,Human,Opistoporin (Opistophtalmus carinatus),NA,NA,CCCCHHHHTTGGGGGCCCHHHHIIIIIHHHHIIIIITGGGTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
3751,12354111,2002,FKLGSFLKKAWKSKLAKKLRAKGKEMLKDYAKGLLEGGSEEVPGQ,FKLGSFLKKAWKSKLAKKLRAKGKEMLKDYAKGLLEGGSEEVPGQ,Parabutoporin,Free,Free,Linear,L,None,45,Antibacterial and Antifungal,<10% Hemolysis upto 5 µM,Human,Parabutoporin (Opistophtalmus carinatus),NA,NA,CCSSHHHHHHHHHHTGGGGGTHHHHTTTGGGGGTCSSCCCCCSCC,CSCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
3752,12354111,2002,FKLGSFLKKAWKSKLAKKLRAKGKEMLKDYAKGLLEGGSEEVPGQ,FKLGSFLKKAWKSKLAKKLRAKGKEMLKDYAKGLLEGGSEEVPGQ,Parabutoporin,Free,Free,Linear,L,None,45,Antibacterial and Antifungal,50% Hemolysis at 38 µM,Human,Parabutoporin (Opistophtalmus carinatus),NA,NA,CCSSHHHHHHHHHHTGGGGGTHHHHTTTGGGGGTCSSCCCCCSCC,CSCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
3753,12354111,2002,INLKALAALAKKIL,INLKALAALAKKIL,Mastoparan,Free,Free,Linear,L,None,14,Antibacterial and Antifungal,~10% Hemolysis at 100 µM,Human,Mastoparan (wasp),NA,NA,CCHHHHHHHHHTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
3754,15639237,2005,GLGSVFGRLARILGRVIPKV,GLGSVFGRLARILGRVIPKV{ct:Amid},Peptide P1,Amidation,Free,Linear,L,None,20,Antibacterial,20% Hemolysis at 10 µM,Human,Pilosulin 1 analog(Myrmecia pilosula),NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)CC)C(C)C
3755,15639237,2005,GLGSVFGRLARILGRVIPKV,GLGSVFGRLARILGRVIPKV{ct:Amid},Peptide P1,Amidation,Free,Linear,L,None,20,Antibacterial,100% Hemolysis at 100 µM,Human,Pilosulin 1 analog(Myrmecia pilosula),NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)CC)C(C)C
3756,15639237,2005,GLLSKFGRLARKLARVIPKV,GLLSKFGRLARKLARVIPKV{ct:Amid},Peptide P2,Amidation,Free,Linear,L,None,20,Antibacterial,15% Hemolysis at 10 µM,Human,Pilosulin 1 analog(Myrmecia pilosula),NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C
3757,15639237,2005,GLLSKFGRLARKLARVIPKV,GLLSKFGRLARKLARVIPKV{ct:Amid},Peptide P2,Amidation,Free,Linear,L,None,20,Antibacterial,40% Hemolysis at 100 µM,Human,Pilosulin 1 analog(Myrmecia pilosula),NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C
3767,10632060,1999,KKVVFKVKFKK,KKVVFKVKFKK{ct:Amid},MP,Amidation,Free,Linear,L,None,11,Antifungal and Antibacterial,0% Hemolysis upto 500 μg/ml (Non hemolytic),Mouse,Synthetic peptide,NA,Non-hemolytic,CCTTCCCCCCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
3768,10632060,1999,kΨ[CH2NH]KVVFKVKFKk,K{d}{Ψ[CH2NH]}KVVFKVKFKK{d}{ct:Amid},MP1,Amidation,Free,Linear,Mix,None,11,Antifungal and Antibacterial,0% Hemolysis upto 500 μg/ml (Non hemolytic),Mouse,Synthetic peptide,NA,Non-hemolytic,NA,NA
3769,10632060,1999,KΨ[CH2OCONH]KVVFKVKFKk,K{Ψ[CH2OCONH]}KVVFKVKFKK{d}{ct:Amid},MP6,Amidation,Free,Linear,Mix,None,11,Antifungal and Antibacterial,0% Hemolysis upto 500 μg/ml (Non hemolytic),Mouse,Synthetic peptide,NA,Non-hemolytic,NA,NA
4185,12110678,2002,LKLLKKLLKKLLKLL,LKLLKKLLKKLLKLL{ct:Amid},Amphipathic-1L,Amidation,Free,Linear,L,None,15,Antibacterial,100% hemolytic at 100 µM,Human,Synthetic peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)O
4186,12110678,2002,KLKLLKLLKLLKLLK,KLKLLKLLKLLKLLK{ct:Amid},Scrambled-4L,Amidation,Free,Linear,L,None,15,Antibacterial,82% hemolytic at 100 µM,Human,Synthetic peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
4187,12110678,2002,KKKLLLLLLLLLKKK,KKKLLLLLLLLLKKK{ct:Amid},Segregated-5L,Amidation,Free,Linear,L,None,15,Antibacterial,66% hemolytic at 100 µM,Human,Synthetic peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
4191,15298176,2004,FGVLAKVAAHVVPAIAEHF,FGVLAKVAAHVVPAIAEHF{ct:Amid},"[∆1,2]Mac",Amidation,Free,Linear,L,None,19,Antibacterial,0% Hemolysis upto 100 µM,Rabbit,Analog of Maculatin 1.1 (dorsal glands of the tree frog Litoria genimaculata),α-helical,Non-hemolytic,CCCGGGGGSSSGGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
4246,23935838,2013,AKKVFKRLPKLFSKIWNWK,AKKVFKRLPKLFSKIWNWK{ct:Amid},Anal 3-Pro,Amidation,Free,Linear,L,None,19,Antibacterial/ Antifungal,0 % Hemolysis at ~100 µM,Human,Helicobacter Pylori,Helix-hinge-Helix,Non-hemolytic,CGGGGGGTHHHHSCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
4383,24307932,2013,KRIVQRIKDFLR,KRIVQRIKDFLR{ct:Amid},KR-12,Amidation,Free,Linear,L,None,12,Antibacterial,10.6 % Hemolysis at 100 µM,Human,Human Cathelicidin Ll-37,Helical,NA,CGGGTTCTTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
4443,23831136,2013,NGVQPKY,NGVQPKY,Luecrocin I,Free,Free,Linear,L,None,7,Antibacterial,0 % Hemolysis at 91 μg/ml,Human,White Blood Cells Of Crocodylus Siamensis,α-Helical,Non-hemolytic,CCCCCCC,CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
4444,23831136,2013,NGVQPKYKWWKWWKKWW,NGVQPKYKWWKWWKKWW{ct:Amid},KT2,Amidation,Free,Linear,L,None,17,Antibacterial,<20 % Hemolysis at 91 μg/ml,Human,Synthetic,α-Helical,NA,CCSSCIIIIIHHTTTCC,CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
4445,23831136,2013,NGVQPKYRWWRWWRRWW,NGVQPKYRWWRWWRRWW{ct:Amid},RT2,Amidation,Free,Linear,L,None,17,Antibacterial,10 % Hemolysis at 91 μg/ml,Human,Synthetic,α-Helical,NA,CCSSCCCGGGGTGGGCC,CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
4446,23831136,2013,NGVQPKYKWWKWWKKWWW,NGVQPKYKWWKWWKKWWW{ct:Amid},KT3,Amidation,Free,Linear,L,None,18,Antibacterial,<60 % Hemolysis at 91 μg/ml,Human,Synthetic,α-Helical,NA,CCSSCCCGGGGTGGGTCC,CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
4447,23831136,2013,NGVQPKYRWWRWWRRWW,NGVQPKYRWWRWWRRWW,CRT2,Free,Free,Linear,L,None,17,Antibacterial,20 % Hemolysis at 91 μg/ml,Human,Synthetic,α-Helical,NA,CCSSCCCGGGGTGGGCC,CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
4448,23831136,2013,NGVQPKYRWWRWWRRWWW,NGVQPKYRWWRWWRRWWW,CRT3,Free,Free,Linear,L,None,18,Antibacterial,<30 % Hemolysis at 91 μg/ml,Human,Synthetic,α-Helical,NA,CCSCCCCTTHHHHTTTCC,CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
4449,23831136,2013,NGVQPWYKWWKWWKKWW,NGVQPWYKWWKWWKKWW{ct:Amid},KWKT2,Amidation,Free,Linear,L,None,17,Antibacterial,60 % Hemolysis at 91 μg/ml,Human,Synthetic,α-Helical,NA,CCCCHHHHHHHHHTSCC,CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
4450,23831136,2013,NGVQPKYRWWRWWRRWWWW,NGVQPKYRWWRWWRRWWWW{ct:Amid},RT4,Amidation,Free,Linear,L,None,19,Antibacterial,<60 % Hemolysis at 91 μg/ml,Human,Synthetic,α-Helical,NA,CCSCCCCTTHHHHTSCCCC,CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
4451,23831136,2013,RWWRWWRRWW,RWWRWWRRWW{ct:Amid},RW2,Amidation,Free,Linear,L,None,10,Antibacterial,<70 % Hemolysis at 91 μg/ml,Human,Synthetic,α-Helical,NA,CCCTTCTTTC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
4452,23831136,2013,RWWRWWRRWWW,RWWRWWRRWWW{ct:Amid},RW3,Amidation,Free,Linear,L,None,11,Antibacterial,<90 % Hemolysis at 91 μg/ml,Human,Synthetic,α-Helical,NA,CCCTTCCSSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
4454,24147906,2013,allL,A{d}L{d}L{d}L,0,Free,Free,Linear,Mix,lowercase letters correspond to D-amino acids,4,Antibacterial,15.6 ± 3.2 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCC,NA
4455,24147906,2013,LLLLL,LLLLL,1,Free,Free,Linear,L,None,5,Antibacterial,6.9 ± 1.8 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)O
4456,24147906,2013,LLLLD,LLLLD,2,Free,Free,Linear,L,None,5,Antibacterial,6.0 ± 0.5 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O
4457,24147906,2013,LLLDL,LLLDL,3,Free,Free,Linear,L,None,5,Antibacterial,2.7 ± 0.1 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCSCC,CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)O
4458,24147906,2013,LLDLL,LLDLL,4,Free,Free,Linear,L,None,5,Antibacterial,2.7 ± 1.4 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)O
4459,24147906,2013,LDLLL,LDLLL,5,Free,Free,Linear,L,None,5,Antibacterial,4.2 ± 0.6 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCSCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)O
4460,24147906,2013,DLLLL,DLLLL,6,Free,Free,Linear,L,None,5,Antibacterial,4.2 ± 0.8 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCSCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)O)C(=O)O
4461,24147906,2013,LLLDD,LLLDD,7,Free,Free,Linear,L,None,5,Antibacterial,5.1 ± 2.3 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O
4462,24147906,2013,LLDLD,LLDLD,8,Free,Free,Linear,L,None,5,Antibacterial,1.3 ± 0.2 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O
4463,24147906,2013,LDLLD,LDLLD,9,Free,Free,Linear,L,None,5,Antibacterial,1.4 ± 1.5 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CTTCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O
4464,24147906,2013,DLLLD,DLLLD,10,Free,Free,Linear,L,None,5,Antibacterial,2.4 ± 0.8 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O
4465,24147906,2013,LLDDL,LLDDL,11,Free,Free,Linear,L,None,5,Antibacterial,3.7 ± 1.7 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)O
4466,24147906,2013,LDLDL,LDLDL,12,Free,Free,Linear,L,None,5,Antibacterial,1.9 ± 2.2 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)O
4467,24147906,2013,DLLDL,DLLDL,13,Free,Free,Linear,L,None,5,Antibacterial,3.7 ± 0.3 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)O)C(=O)O
4468,24147906,2013,LDDLL,LDDLL,14,Free,Free,Linear,L,None,5,Antibacterial,0.5 ± 0.5 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)O
4469,24147906,2013,DLDLL,DLDLL,15,Free,Free,Linear,L,None,5,Antibacterial,1.6 ± 0.6 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)O)C(=O)O
4470,24147906,2013,DDLLL,DDLLL,16,Free,Free,Linear,L,None,5,Antibacterial,4.1 ± 0.9 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCSCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(=O)O
4471,24147906,2013,LLDDD,LLDDD,17,Free,Free,Linear,L,None,5,Antibacterial,6.2 ± 0.4 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O
4472,24147906,2013,LDLDD,LDLDD,18,Free,Free,Linear,L,None,5,Antibacterial,0–0.9 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCSCC,CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O
4473,24147906,2013,DLLDD,DLLDD,19,Free,Free,Linear,L,None,5,Antibacterial,0.5 ± 0.5 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O
4474,24147906,2013,LDDLD,LDDLD,20,Free,Free,Linear,L,None,5,Antibacterial,0.8 ± 0.1 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O
4475,24147906,2013,DLDLD,DLDLD,21,Free,Free,Linear,L,None,5,Antibacterial,0–0.6 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O
4476,24147906,2013,DDLLD,DDLLD,22,Free,Free,Linear,L,None,5,Antibacterial,8 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCSCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O
4477,24147906,2013,LDDDL,LDDDL,23,Free,Free,Linear,L,None,5,Antibacterial,3.3 ± 0.3 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCSCC,CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)O
4478,24147906,2013,DLDDL,DLDDL,24,Free,Free,Linear,L,None,5,Antibacterial,1.0 ± 0.7 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)O)C(=O)O
4479,24147906,2013,DDLDL,DDLDL,25,Free,Free,Linear,L,None,5,Antibacterial,3.5 ± 1.2 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(=O)O
4480,24147906,2013,DDDLL,DDDLL,26,Free,Free,Linear,L,None,5,Antibacterial,5.3 ± 0.3 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(=O)O
4481,24147906,2013,LDDDD,LDDDD,27,Free,Free,Linear,L,None,5,Antibacterial,1.3 ± 0.2 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCSCC,CC(C)C[C@H](N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O
4482,24147906,2013,DLDDD,DLDDD,28,Free,Free,Linear,L,None,5,Antibacterial,0–1.4 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O
4483,24147906,2013,DDLDD,DDLDD,29,Free,Free,Linear,L,None,5,Antibacterial,3.1 ± 1.1 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O
4484,24147906,2013,DDDLD,DDDLD,30,Free,Free,Linear,L,None,5,Antibacterial,0–3.1 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O
4485,24147906,2013,DDDDL,DDDDL,31,Free,Free,Linear,L,None,5,Antibacterial,8.5 ± 3.8 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(=O)O
4486,24147906,2013,DDDDD,DDDDD,32,Free,Free,Linear,L,None,5,Antibacterial,15 ± 2.2 % Hemolysis at 142 µM,Human,Synthetic,α-Helical,NA,CCCCC,N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O
4727,23860860,2014,SGKLCCRRKK,SGKLCCRRKK{ct:Amid},D0,Amidation,Free,Linear,L,None,10,Antibacterial,2.2 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic,CCSCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](N)CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
4728,23860860,2014,SGKLYYRRKK,SGKLYYRRKK{ct:Amid},D1,Amidation,Free,Linear,L,None,10,Antibacterial,2 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic,CTTSSCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
4729,23860860,2014,SGKLWWRRKK,SGKLWWRRKK{ct:Amid},D2,Amidation,Free,Linear,L,None,10,Antibacterial,2.5 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic,CTTCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
4730,23860860,2014,SGKRWWRRKK,SGKRWWRRKK{ct:Amid},D3,Amidation,Free,Linear,L,None,10,Antibacterial,5 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHCGGGC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
4731,23860860,2014,RGKRWWRRKK,RGKRWWRRKK{ct:Amid},D4,Amidation,Free,Linear,L,None,10,Antibacterial,55 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic,CCTTCSTTCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
4732,23860860,2014,RWKRWWRRKK,RWKRWWRRKK{ct:Amid},D5,Amidation,Free,Linear,L,None,10,Antibacterial,6.5 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic,CCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
4733,23860860,2014,RKKRWWRRKK,RKKRWWRRKK{ct:Amid},D6,Amidation,Free,Linear,L,None,10,Antibacterial,6.5 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic,CCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
4747,24176194,2014,AKKVFKRLEKLFSKIWNWK,AKKVFKRLEKLFSKIWNWK{ct:Amid},HPA3,Amidation,Free,Linear,L,None,19,Antibacterial,10 % Hemolysis at 49.2 µM,Human,Helicobacter Pylori,α-Helix,NA,CCTTHHHHHHHHTTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
4748,24176194,2014,AKKVFKRLPKLFSKIWNWK,AKKVFKRLPKLFSKIWNWK{ct:Amid},HPA3P,Amidation,Free,Linear,L,None,19,Antibacterial,10 % Hemolysis at >800 µM,Human,Helicobacter Pylori,α-Helix,NA,CGGGGGGTHHHHSCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
4749,24176194,2014,AKKVFKRLPKLPSKIWNWK,AKKVFKRLPKLPSKIWNWK{ct:Amid},HPA3P2,Amidation,Free,Linear,L,None,19,Antibacterial,10 % Hemolysis at >800 µM,Human,Helicobacter Pylori,α-Helix,NA,CTTGGGTSCCCSSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
4750,24176194,2014,AKKVFKRLEKLFSKIWNWK,AKKVFKRLEKLFSKIWNWK{ct:Amid},HPA3,Amidation,Free,Linear,L,None,19,Antibacterial,50 % Hemolysis at 397.7 µM,Human,Helicobacter Pylori,α-Helix,NA,CCTTHHHHHHHHTTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
4751,24176194,2014,AKKVFKRLPKLFSKIWNWK,AKKVFKRLPKLFSKIWNWK{ct:Amid},HPA3P,Amidation,Free,Linear,L,None,19,Antibacterial,50 % Hemolysis at >800 µM,Human,Helicobacter Pylori,α-Helix,NA,CGGGGGGTHHHHSCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
4752,24176194,2014,AKKVFKRLPKLPSKIWNWK,AKKVFKRLPKLPSKIWNWK{ct:Amid},HPA3P2,Amidation,Free,Linear,L,None,19,Antibacterial,50 % Hemolysis at >800 µM,Human,Helicobacter Pylori,α-Helix,NA,CTTGGGTSCCCSSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
4817,24161537,2014,LIAGLAANFLPKLFCKITK,LIAGLAANFLPKLFCKITK{ct:Amid},B1CTcu1,Amidation,Free,Linear,L,None,19,Antibacterial,1 % Hemolysis at 10 μg/ml,Rabbit,Indian Ranid Frog Clinotarsus Curtipes,α-Helix,Non-hemolytic,CGGGSHHHHHHHHHTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
4818,24161537,2014,FLPLLAGLAANFLPKIFCKITRK,FLPLLAGLAANFLPKIFCKITRK{ct:Amid},B1CTcu2,Amidation,Free,Linear,L,None,23,Antibacterial,17.8 % Hemolysis at 10 μg/ml,Rabbit,Indian Ranid Frog Clinotarsus Curtipes,α-Helix,NA,CCTHHHHHHHTTHHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@@H](C)CC
4819,24161537,2014,LPLLAGLAANFLPKIFCKITRK,LPLLAGLAANFLPKIFCKITRK{ct:Amid},B1CTcu3,Amidation,Free,Linear,L,None,22,Antibacterial,45 % Hemolysis at 10 μg/ml,Rabbit,Indian Ranid Frog Clinotarsus Curtipes,α-Helix,NA,CCCHHHHHHHHHHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@@H](C)CC
4820,24161537,2014,FLPFIAGMAAKFLPKIFCAISKK,FLPFIAGMAAKFLPKIFCAISKK{ct:Amid},B1CTcu4,Amidation,Free,Linear,L,None,23,Antibacterial,54.8 % Hemolysis at 10 μg/ml,Rabbit,Indian Ranid Frog Clinotarsus Curtipes,α-Helix,NA,CCTHHHHTGGGTHHHHHHHSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
4821,24161537,2014,LIAGLAANFLPQILCKIARKC,LIAGLAANFLPQILCKIARKC{ct:Amid},B1CTcu5,Amidation,Free,Linear,L,None,21,Antibacterial,37.5 % Hemolysis at 10 μg/ml,Rabbit,Indian Ranid Frog Clinotarsus Curtipes,α-Helix,NA,CCTTHHHIIIIIIIHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
4853,24859674,2014,MGWLKKLGKKIERVGQHTRDATIQTIGVAQQAVNVAATLKGLADG KILHNQNVNSWGPITVTPTTDGGETRFDGQIIVQMENDPVVAKAAANL AGKHAESSVVVQLDSDGNYRVVYGDPSKLDGKLRWQLVGHGRDHSET NNTRLSGYSADELAVKLAKFQQSFNQAENINNKPDHISIVGCSLVSDDKQ KGFMGWLKKLGKKIERVGQHTRDATIQTIGVAQQAVNVAATLKGLADG KILHNQNVNSWGPITVTPT,MGWLKKLGKKIERVGQHTRDATIQTIGVAQQAVNVAATLKGLADG KILHNQNVNSWGPITVTPTTDGGETRFDGQIIVQMENDPVVAKAAANL AGKHAESSVVVQLDSDGNYRVVYGDPSKLDGKLRWQLVGHGRDHSET NNTRLSGYSADELAVKLAKFQQSFNQAENINNKPDHISIVGCSLVSDDKQ KGFMGWLKKLGKKIERVGQHTRDATIQTIGVAQQAVNVAATLKGLADG KILHNQNVNSWGPITVTPT,GWKL-LUCILIN-CPD-His8,Free,Free,Linear,L,None,257,Antibacterial,0 % Hemolysis at 56.4 µM,Human,Recombinant Protein,Random coils,Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)N)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C=O)[C@@H](C)O)C(C)C.CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)CC)C(C)C.CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C=O)CCC(N)=O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC.CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C=O)CC(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)CC.CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC=O)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C.CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC=O)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C
4877,24168384,2014,GFFLNALKNFAKTAGKRLKSLLNHASCKLSGQC,GFFLNALKNFAKTAGKRLKSLLNHASCKLSGQC,Cyanophlyctin b,Free,Free,Linear,L,None,33,Antibacterial,0.7 % Hemolysis at 500 μg/ml,Human,Skin Secretions Of Euphlyctis Cyanophlyctis,α-Helix,Non-hemolytic,CCTHHHHHHHHHHHHHHHHHHTSSCSSCSCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
4878,24168384,2014,VIPFVASVAAEMMQHIFCAASRKC,VIPFVASVAAEMMQHIFCAASRKC,Brevini-Eu,Free,Free,Linear,L,None,24,Antibacterial,1.9 % Hemolysis at 500 μg/ml,Human,Skin Secretions Of Euphlyctis Cyanophlyctis,α-Helix,Non-hemolytic,CCTHHHHHHHHTTSSHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
4947,24871991,2014,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,M(melittin),Free,Free,Linear,L,None,26,Antibacterial,50 % Hemolysis at 8 μg/ml,Sheep,Bee Venom,α-Helix,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
4967,24953028,2014,W-3ABA-R,W-{nnr:3-ABA}-R{ct:Amid},1a,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,3,Antibacterial,10 % Hemolysis at 400 μg/ml,Human,Synthetic,NA,NA,NA,NA
4968,24953028,2014,W-3ABA-R,W-{nnr:3-ABA}-R{ct:Amid},1a,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,3,Antibacterial,50 % Hemolysis at >500 μg/ml,Human,Synthetic,NA,NA,NA,NA
4969,24953028,2014,WW-3-ABA-R,WW-{nnr:3-ABA}-R{ct:Amid},2a,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,4,Antibacterial,10 % Hemolysis at 100 μg/ml,Human,Synthetic,NA,NA,NA,NA
4970,24953028,2014,WW-3-ABA-R,WW-{nnr:3-ABA}-R{ct:Amid},2a,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,4,Antibacterial,50 % Hemolysis at 240 μg/ml,Human,Synthetic,NA,NA,NA,NA
4971,24953028,2014,RW-3-ABA-R,RW-{nnr:3-ABA}-R{ct:Amid},2b,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,4,Antibacterial,10 % Hemolysis at 205 μg/ml,Human,Synthetic,NA,NA,NA,NA
4972,24953028,2014,RW-3-ABA-R,RW-{nnr:3-ABA}-R{ct:Amid},2b,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,4,Antibacterial,50 % Hemolysis at 500 μg/ml,Human,Synthetic,NA,NA,NA,NA
4973,24953028,2014,WR-3-ABA-R,WR-{nnr:3-ABA}-R{ct:Amid},2c,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,4,Antibacterial,10 % Hemolysis at 300 μg/ml,Human,Synthetic,NA,NA,NA,NA
4974,24953028,2014,WR-3-ABA-R,WR-{nnr:3-ABA}-R{ct:Amid},2c,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,4,Antibacterial,50 % Hemolysis at >500 μg/ml,Human,Synthetic,NA,NA,NA,NA
4975,24953028,2014,WW-3ABA-RR,WW-{nnr:3-ABA}-RR{ct:Amid},3a,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,5,Antibacterial,10 % Hemolysis at 150 μg/ml,Human,Synthetic,NA,NA,NA,NA
4976,24953028,2014,WW-3ABA-RR,WW-{nnr:3-ABA}-RR{ct:Amid},3a,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,5,Antibacterial,50 % Hemolysis at 400 μg/ml,Human,Synthetic,NA,NA,NA,NA
4977,24953028,2014,RW-3-ABA-RR,RW-{nnr:3-ABA}-RR{ct:Amid},3b,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,5,Antibacterial,10 % Hemolysis at 350 μg/ml,Human,Synthetic,NA,NA,NA,NA
4978,24953028,2014,RW-3-ABA-RR,RW-{nnr:3-ABA}-RR{ct:Amid},3b,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,5,Antibacterial,50 % Hemolysis at >500 μg/ml,Human,Synthetic,NA,NA,NA,NA
4979,24953028,2014,WR-3-ABA-RR,WR-{nnr:3-ABA}-RR{ct:Amid},3c,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,5,Antibacterial,10 % Hemolysis at 325 μg/ml,Human,Synthetic,NA,NA,NA,NA
4980,24953028,2014,WR-3-ABA-RR,WR-{nnr:3-ABA}-RR{ct:Amid},3c,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,5,Antibacterial,50 % Hemolysis at >500 μg/ml,Human,Synthetic,NA,NA,NA,NA
4981,24953028,2014,WR-3-ABA-WR,WR-{nnr:3-ABA}-WR{ct:Amid},3d,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,5,Antibacterial,10 % Hemolysis at 220 μg/ml,Human,Synthetic,NA,NA,NA,NA
4982,24953028,2014,WR-3-ABA-WR,WR-{nnr:3-ABA}-WR{ct:Amid},3d,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,5,Antibacterial,50 % Hemolysis at 400 μg/ml,Human,Synthetic,NA,NA,NA,NA
4983,24953028,2014,RW-3-ABA-WR,RW-{nnr:3-ABA}-WR{ct:Amid},3e,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,5,Antibacterial,10 % Hemolysis at 250 μg/ml,Human,Synthetic,NA,NA,NA,NA
4984,24953028,2014,RW-3-ABA-WR,RW-{nnr:3-ABA}-WR{ct:Amid},3e,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,5,Antibacterial,50 % Hemolysis at 410 μg/ml,Human,Synthetic,NA,NA,NA,NA
4985,24953028,2014,WWR-3-ABA-RR,WWR-{nnr:3-ABA}-RR{ct:Amid},4a,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,10 % Hemolysis at 200 μg/ml,Human,Synthetic,NA,NA,NA,NA
4986,24953028,2014,WWR-3-ABA-RR,WWR-{nnr:3-ABA}-RR{ct:Amid},4a,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,50 % Hemolysis at 380 μg/ml,Human,Synthetic,NA,NA,NA,NA
4987,24953028,2014,RWR-3-ABA-WR,RWR-{nnr:3-ABA}-WR{ct:Amid},4b,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,10 % Hemolysis at 210 μg/ml,Human,Synthetic,NA,NA,NA,NA
4988,24953028,2014,RWR-3-ABA-WR,RWR-{nnr:3-ABA}-WR{ct:Amid},4b,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,50 % Hemolysis at 400 μg/ml,Human,Synthetic,NA,NA,NA,NA
4989,24953028,2014,RWW-3-ABA-RR,RWW-{nnr:3-ABA}-RR{ct:Amid},4c,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,10 % Hemolysis at 255 μg/ml,Human,Synthetic,NA,NA,NA,NA
4990,24953028,2014,RWW-3-ABA-RR,RWW-{nnr:3-ABA}-RR{ct:Amid},4c,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,50 % Hemolysis at 420 μg/ml,Human,Synthetic,NA,NA,NA,NA
4991,24953028,2014,WRR-3-ABA-WR,WRR-{nnr:3-ABA}-WR{ct:Amid},4d,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,10 % Hemolysis at 190 μg/ml,Human,Synthetic,NA,NA,NA,NA
4992,24953028,2014,WRR-3-ABA-WR,WRR-{nnr:3-ABA}-WR{ct:Amid},4d,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,50 % Hemolysis at 380 μg/ml,Human,Synthetic,NA,NA,NA,NA
4993,24953028,2014,WRW-3-ABA-RR,WRW-{nnr:3-ABA}-RR{ct:Amid},4e,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,10 % Hemolysis at 140 μg/ml,Human,Synthetic,NA,NA,NA,NA
4994,24953028,2014,WRW-3-ABA-RR,WRW-{nnr:3-ABA}-RR{ct:Amid},4e,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,50 % Hemolysis at 370 μg/ml,Human,Synthetic,NA,NA,NA,NA
4995,24953028,2014,RRW-3-ABA-WR,RRW-{nnr:3-ABA}-WR{ct:Amid},4f,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,10 % Hemolysis at 100 μg/ml,Human,Synthetic,NA,NA,NA,NA
4996,24953028,2014,RRW-3-ABA-WR,RRW-{nnr:3-ABA}-WR{ct:Amid},4f,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,50 % Hemolysis at 355 μg/ml,Human,Synthetic,NA,NA,NA,NA
4997,24953028,2014,WRW-3-ABA-WR,WRW-{nnr:3-ABA}-WR{ct:Amid},4g,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,10 % Hemolysis at 80 μg/ml,Human,Synthetic,NA,NA,NA,NA
4998,24953028,2014,WRW-3-ABA-WR,WRW-{nnr:3-ABA}-WR{ct:Amid},4g,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,50 % Hemolysis at 310 μg/ml,Human,Synthetic,NA,NA,NA,NA
4999,24953028,2014,OW-3-ABA-WO,OW-{nnr:3-ABA}-WO{ct:Amid},3f,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,5,Antibacterial,10 % Hemolysis at 190 μg/ml,Human,Synthetic,NA,NA,NA,NA
5000,24953028,2014,OW-3-ABA-WO,OW-{nnr:3-ABA}-WO{ct:Amid},3f,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,5,Antibacterial,50 % Hemolysis at >500 μg/ml,Human,Synthetic,NA,NA,NA,NA
5001,24953028,2014,OWW-3-ABA-OO,OWW-{nnr:3-ABA}-OO{ct:Amid},4h,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,10 % Hemolysis at 150 μg/ml,Human,Synthetic,NA,NA,NA,NA
5002,24953028,2014,OWW-3-ABA-OO,OWW-{nnr:3-ABA}-OO{ct:Amid},4h,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,50 % Hemolysis at 440 μg/ml,Human,Synthetic,NA,NA,NA,NA
5003,24953028,2014,WOO-3-ABA-WO,WOO-{nnr:3-ABA}-WO{ct:Amid},4i,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,10 % Hemolysis at 170 μg/ml,Human,Synthetic,NA,NA,NA,NA
5004,24953028,2014,WOO-3-ABA-WO,WOO-{nnr:3-ABA}-WO{ct:Amid},4i,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,50 % Hemolysis at 500 μg/ml,Human,Synthetic,NA,NA,NA,NA
5005,24953028,2014,WOW-3-ABA-OO,WOW-{nnr:3-ABA}-OO{ct:Amid},4j,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,10 % Hemolysis at 175 μg/ml,Human,Synthetic,NA,NA,NA,NA
5006,24953028,2014,WOW-3-ABA-OO,WOW-{nnr:3-ABA}-OO{ct:Amid},4j,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,50 % Hemolysis at 450 μg/ml,Human,Synthetic,NA,NA,NA,NA
5007,24953028,2014,OOW-3-ABA-WO,OOW-{nnr:3-ABA}-WO{ct:Amid},4k,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,10 % Hemolysis at 120 μg/ml,Human,Synthetic,NA,NA,NA,NA
5008,24953028,2014,OOW-3-ABA-WO,OOW-{nnr:3-ABA}-WO{ct:Amid},4k,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,50 % Hemolysis at 450 μg/ml,Human,Synthetic,NA,NA,NA,NA
5009,24953028,2014,WOW-3-ABA-WO,WOW-{nnr:3-ABA}-WO{ct:Amid},4l,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,10 % Hemolysis at 100 μg/ml,Human,Synthetic,NA,NA,NA,NA
5010,24953028,2014,WOW-3-ABA-WO,WOW-{nnr:3-ABA}-WO{ct:Amid},4l,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,50 % Hemolysis at 390 μg/ml,Human,Synthetic,NA,NA,NA,NA
5011,24953028,2014,RRF-3-ABA-FR,RRF-{nnr:3-ABA}-FR{ct:Amid},4m,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,10 % Hemolysis at 130 μg/ml,Human,Synthetic,NA,NA,NA,NA
5012,24953028,2014,RRF-3-ABA-FR,RRF-{nnr:3-ABA}-FR{ct:Amid},4m,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,50 % Hemolysis at 375 μg/ml,Human,Synthetic,NA,NA,NA,NA
5013,24953028,2014,FRF-3-ABA-FR,FRF-{nnr:3-ABA}-FR{ct:Amid},4n,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,10 % Hemolysis at 125 μg/ml,Human,Synthetic,NA,NA,NA,NA
5014,24953028,2014,FRF-3-ABA-FR,FRF-{nnr:3-ABA}-FR{ct:Amid},4n,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,50 % Hemolysis at 310 μg/ml,Human,Synthetic,NA,NA,NA,NA
5015,24953028,2014,OOF-3-ABA-FO,OOF-{nnr:3-ABA}-FO{ct:Amid},4o,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,10 % Hemolysis at 210 μg/ml,Human,Synthetic,NA,NA,NA,NA
5016,24953028,2014,OOF-3-ABA-FO,OOF-{nnr:3-ABA}-FO{ct:Amid},4o,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,50 % Hemolysis at 490 μg/ml,Human,Synthetic,NA,NA,NA,NA
5017,24953028,2014,FOF-3-ABA-FO,FOF-{nnr:3-ABA}-FO{ct:Amid},4p,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,10 % Hemolysis at 180 μg/ml,Human,Synthetic,NA,NA,NA,NA
5018,24953028,2014,FOF-3-ABA-FO,FOF-{nnr:3-ABA}-FO{ct:Amid},4p,Amidation,Free,Linear,L,3-ABA = 3-amino benzoic acid,6,Antibacterial,50 % Hemolysis at 400 μg/ml,Human,Synthetic,NA,NA,NA,NA
5019,24953028,2014,RRWWR,RRWWR{ct:Amid},5a,Amidation,Free,Linear,L,None,5,Antibacterial,10 % Hemolysis at 90 μg/ml,Human,Synthetic,NA,NA,CCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
5020,24953028,2014,RRWWR,RRWWR{ct:Amid},5a,Amidation,Free,Linear,L,None,5,Antibacterial,50 % Hemolysis at 240 μg/ml,Human,Synthetic,NA,NA,CCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
5021,24953028,2014,WRWWR,WRWWR{ct:Amid},5b,Amidation,Free,Linear,L,None,5,Antibacterial,10 % Hemolysis at 60 μg/ml,Human,Synthetic,NA,NA,CCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
5022,24953028,2014,WRWWR,WRWWR{ct:Amid},5b,Amidation,Free,Linear,L,None,5,Antibacterial,50 % Hemolysis at 200 μg/ml,Human,Synthetic,NA,NA,CCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
5023,24953028,2014,OOWWO,OOWWO{ct:Amid},5c,Amidation,Free,Linear,L,O = Ornithine,5,Antibacterial,10 % Hemolysis at 100 μg/ml,Human,Synthetic,NA,NA,NA,NA
5024,24953028,2014,OOWWO,OOWWO{ct:Amid},5c,Amidation,Free,Linear,L,O = Ornithine,5,Antibacterial,50 % Hemolysis at 310 μg/ml,Human,Synthetic,NA,NA,NA,NA
5025,24953028,2014,WOWWO,WOWWO{ct:Amid},5d,Amidation,Free,Linear,L,O = Ornithine,5,Antibacterial,10 % Hemolysis at 65 μg/ml,Human,Synthetic,NA,NA,NA,NA
5026,24953028,2014,WOWWO,WOWWO{ct:Amid},5d,Amidation,Free,Linear,L,O = Ornithine,5,Antibacterial,50 % Hemolysis at 220 μg/ml,Human,Synthetic,NA,NA,NA,NA
5036,24842084,2014,FLSHIAGFLSNLF,FLSHIAGFLSNLF{ct:Amid},Temporin-SHc(Temp-SHc),Amidation,Free,Linear,L,None,13,"Antibacterial, Antifungal",50 % Hemolysis at >80 µM,Human,Skin Of Pelophylax Saharica,α-Helix,NA,CCSSHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5037,24842084,2014,FLSHLAGFLSNLF,FLSHLAGFLSNLF{ct:Amid},L5 temp-SHc,Amidation,Free,Linear,L,None,13,"Antibacterial, Antifungal",50 % Hemolysis at >80 µM,Human,"Analogue Of Temp-Shc, Skin Of Pelophylax Saharica",α-Helix,NA,CCSCHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5038,24842084,2014,HSLFLAGFLSNLF,HSLFLAGFLSNLF{ct:Amid},(4-1)L5temp-SHc,Amidation,Free,Linear,L,None,13,"Antibacterial, Antifungal",50 % Hemolysis at 2 µM,Human,"Analogue Of Temp-Shc, Skin Of Pelophylax Saharica",α-Helix,NA,CCSHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5039,24952979,2014,IRCRRRFCRI,IRCRRRFCRI{ct:Amid},IR1,Amidation,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at >128 µM,Human,"Synthetic Peptide, Porcine Leukocytes",β-Sheet,NA,CCCSSSSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)[C@@H](C)CC
5040,24952979,2014,IRIRCRRRFCRIRI,IRIRCRRRFCRIRI{ct:Amid},IR2,Amidation,Free,Linear,L,None,14,Antibacterial,10 % Hemolysis at 128 µM,Human,"Synthetic Peptide, Porcine Leukocytes",β-Sheet,NA,CTTSCTTCCCSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
5041,24952979,2014,FRCRRRFCRF,FRCRRRFCRF{ct:Amid},FR1,Amidation,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at >128 µM,Human,"Synthetic Peptide, Porcine Leukocytes",β-Sheet,NA,CCCCTTSCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5042,24952979,2014,FRFRCRRRFCRFRF,FRFRCRRRFCRFRF{ct:Amid},FR2,Amidation,Free,Linear,L,None,14,Antibacterial,10 % Hemolysis at 64 µM,Human,"Synthetic Peptide, Porcine Leukocytes",β-Sheet,NA,CCSCCGGGTTTSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5043,24952979,2014,WRCRRRFCRW,WRCRRRFCRW{ct:Amid},WR1,Amidation,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at >128 µM,Human,"Synthetic Peptide, Porcine Leukocytes",β-Sheet,NA,CCSCCSCSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
5044,24952979,2014,WRWRCRRRFCRWRW,WRWRCRRRFCRWRW{ct:Amid},WR2,Amidation,Free,Linear,L,None,14,Antibacterial,10 % Hemolysis at 64 µM,Human,"Synthetic Peptide, Porcine Leukocytes",β-Sheet,NA,CCCCCSCCSCSSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
5045,24952979,2014,PRCRRRFCRP,PRCRRRFCRP{ct:Amid},PR1,Amidation,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at >128 µM,Human,"Synthetic Peptide, Porcine Leukocytes",β-Sheet,NA,CCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O
5046,24952979,2014,PRPRCRRRFCRPRP,PRPRCRRRFCRPRP{ct:Amid},PR2,Amidation,Free,Linear,L,None,14,Antibacterial,10 % Hemolysis at >128 µM,Human,"Synthetic Peptide, Porcine Leukocytes",β-Sheet,NA,CCCCCCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O
5047,24952979,2014,RGGRLCYCRRRFCVCVGR,RGGRLCYCRRRFCVCVGR{ct:Amid},Protegrin-1(PG-1),Amidation,Free,Linear,L,None,18,Antibacterial,10 % Hemolysis at 2 µM,Human,Porcine Leukocytes,β-Sheet,NA,CCCCCSCCSSSSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
5066,24981062,2014,SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW,SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW,AvBD103b,Free,Free,Linear,L,None,38,Antibacterial,0 % Hemolysis at 0.75 µM,Human,King Penguin (Aptenodytes Patagonicus),α-Helix/β-Sheet,Non-hemolytic,CCTTCCTTTSCCCCCCCBTTTBCHHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(C)C
5067,24981062,2014,SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW,SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW,AvBD103b,Free,Free,Linear,L,None,38,Antibacterial,0.84 % Hemolysis at 1.5 µM,Human,King Penguin (Aptenodytes Patagonicus),α-Helix/β-Sheet,NA,CCTTCCTTTSCCCCCCCBTTTBCHHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(C)C
5068,24981062,2014,SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW,SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW,AvBD103b,Free,Free,Linear,L,None,38,Antibacterial,1.01 % Hemolysis at 3 µM,Human,King Penguin (Aptenodytes Patagonicus),α-Helix/β-Sheet,NA,CCTTCCTTTSCCCCCCCBTTTBCHHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(C)C
5069,24981062,2014,SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW,SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW,AvBD103b,Free,Free,Linear,L,None,38,Antibacterial,1.18 % Hemolysis at 6 µM,Human,King Penguin (Aptenodytes Patagonicus),α-Helix/β-Sheet,NA,CCTTCCTTTSCCCCCCCBTTTBCHHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(C)C
5070,24981062,2014,SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW,SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW,AvBD103b,Free,Free,Linear,L,None,38,Antibacterial,1.37 % Hemolysis at 12 µM,Human,King Penguin (Aptenodytes Patagonicus),α-Helix/β-Sheet,NA,CCTTCCTTTSCCCCCCCBTTTBCHHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(C)C
5071,24981062,2014,SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW,SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW,AvBD103b,Free,Free,Linear,L,None,38,Antibacterial,2.61 % Hemolysis at 48 µM,Human,King Penguin (Aptenodytes Patagonicus),α-Helix/β-Sheet,NA,CCTTCCTTTSCCCCCCCBTTTBCHHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(C)C
5099,25445609,2014,GRRRRSVQWCA,GRRRRSVQWCA{nt:NH3},human lactoferrin (1-11),Free,NH3,Linear,L,NH3,11,Antibacterial and Antifungal,0 % Hemolysis at 1 mM,Rabbit,Human Lactoferrins,NA,Non-hemolytic,CCCCCCCSSCC,CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)O
5100,25445609,2014,GRRRRSVQWCAVSQPEATKCFQWQRNMRKVRGPPVSCIKRDSPIQEIQA,GRRRRSVQWCAVSQPEATKCFQWQRNMRKVRGPPVSCIKRDSPIQEIQA{nt:NH3},human lactoferricin,Free,NH3,Linear,L,NH3,49,Antibacterial and Antifungal,0 % Hemolysis at 1 mM,Rabbit,Human Lactoferrins,NA,Non-hemolytic,CCCCCCCCCCCCCCTTHHHHHHHHHHHTTTTSSSSCSSSSCCCTTGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)O
5101,25445609,2014,WNLLRQAQEKFGKDKSPK,WNLLRQAQEKFGKDKSPK{nt:NH3},human lactoferrampin,Free,NH3,Linear,L,NH3,18,Antibacterial and Antifungal,0 % Hemolysis at 1 mM,Rabbit,Human Lactoferrins,NA,Non-hemolytic,CCHHHHHHTTSSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
5102,25445609,2014,APRKNVRWCTI,APRKNVRWCTI{nt:NH3},bovine lactoferrin (1-11),Free,NH3,Linear,L,NH3,11,Antibacterial and Antifungal,0 % Hemolysis at 1 mM,Rabbit,Bovine Lactoferrins,NA,Non-hemolytic,CTTSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)O
5103,25445609,2014,MFKCRRWQWRMKKLGAPSITCVRRAF,MFKCRRWQWRMKKLGAPSITCVRRAF{nt:NH3},bovine lactoferricin,Free,NH3,Linear,L,NH3,26,Antibacterial and Antifungal,0 % Hemolysis at 1 mM,Rabbit,Bovine Lactoferrins,NA,Non-hemolytic,CCCCSSTHHHHTTTSCCCTTSTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O
5104,25445609,2014,DLIWKLLSKAQEKFGKNKSR,DLIWKLLSKAQEKFGKNKSR{nt:NH3},bovine lactoferrampin,Free,NH3,Linear,L,NH3,20,Antibacterial and Antifungal,0 % Hemolysis at 1 mM,Rabbit,Bovine Lactoferrins,NA,Non-hemolytic,CCHHHHHHHHHHHHCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5105,25473836,2014,FFHHIFRGIVHVGKTIHRLVTG,FFHHIFRGIVHVGKTIHRLVTG,Pis-1,Free,Free,Linear,L,None,22,"Antimicrobial, Antibacterial",~100 % Hemolysis at 100 µM,Human,Mast Cells Of Aquacultured Hybrid Striped Bass,α-Helical,NA,CCCHHHHSSTTTCCSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
5106,25473836,2014,AFHHIFRGIVHVGKTIHRLVTG,AFHHIFRGIVHVGKTIHRLVTG,PisF1A,Free,Free,Linear,L,None,22,"Antimicrobial, Antibacterial",100 % Hemolysis at 100 µM,Human,Pis-1 Analog,α-Helical,NA,CCCHHHHSSTTTCCSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)N)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
5107,25473836,2014,FAHHIFRGIVHVGKTIHRLVTG,FAHHIFRGIVHVGKTIHRLVTG,PisF2A,Free,Free,Linear,L,None,22,"Antimicrobial, Antibacterial",>12 % Hemolysis at 100 µM,Human,Pis-1 Analog,α-Helical,NA,CCSHHHHSSTTTCCSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
5108,25473836,2014,FFHHIARGIVHVGKTIHRLVTG,FFHHIARGIVHVGKTIHRLVTG,PisF6A,Free,Free,Linear,L,None,22,"Antimicrobial, Antibacterial",29 % Hemolysis at 100 µM,Human,Pis-1 Analog,α-Helical,NA,CCCHHHHSSTTTCCSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
5109,25473836,2014,KFHHIFRGIVHVGKTIHRLVTG,KFHHIFRGIVHVGKTIHRLVTG,PisF1K,Free,Free,Linear,L,None,22,"Antimicrobial, Antibacterial",50 % Hemolysis at 100 µM,Human,Pis-1 Analog,α-Helical,NA,CCSHHHHSSTTTCCSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
5110,25473836,2014,FKHHIFRGIVHVGKTIHRLVTG,FKHHIFRGIVHVGKTIHRLVTG,PisF2K,Free,Free,Linear,L,None,22,"Antimicrobial, Antibacterial",0 % Hemolysis at 100 µM,Human,Pis-1 Analog,α-Helical,Non-hemolytic,CCSSSSSSSTTTCCSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
5111,25473836,2014,FFHHIKRGIVHVGKTIHRLVTG,FFHHIKRGIVHVGKTIHRLVTG,PisF6K,Free,Free,Linear,L,None,22,"Antimicrobial, Antibacterial",0 % Hemolysis at 100 µM,Human,Pis-1 Analog,α-Helical,Non-hemolytic,CCSHHHHCSTTTCCSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
5112,25473836,2014,FFHHIFRGIKHVGKTIHRLVTG,FFHHIFRGIKHVGKTIHRLVTG,PisV10K,Free,Free,Linear,L,None,22,"Antimicrobial, Antibacterial",0 % Hemolysis at 50 µM,Human,Pis-1 Analog,α-Helical,Non-hemolytic,CCCTTTTSSTTCCCSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C
5113,25473836,2014,FFHHIFRGIKHVGKTIHRLVTG,FFHHIFRGIKHVGKTIHRLVTG,PisV10K,Free,Free,Linear,L,None,22,"Antimicrobial, Antibacterial",20 % Hemolysis at 100 µM,Human,Pis-1 Analog,α-Helical,NA,CCCTTTTSSTTCCCSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C
5114,25473836,2014,KFHHIFRGIKHVGKTIHRLVTG,KFHHIFRGIKHVGKTIHRLVTG,Pis-F1K/V10K,Free,Free,Linear,L,None,22,"Antimicrobial, Antibacterial",0 % Hemolysis at 100 µM,Human,Pis-1 Analog,α-Helical,Non-hemolytic,CCSHHHHSSTTTSCSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C
5115,25473836,2014,FKHHIFRGIKHVGKTIHRLVTG,FKHHIFRGIKHVGKTIHRLVTG,Pis-F2K/V10K,Free,Free,Linear,L,None,22,"Antimicrobial, Antibacterial",0 % Hemolysis at 100 µM,Human,Pis-1 Analog,α-Helical,Non-hemolytic,CCSHHHHSSSCSCSSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C
5116,25473836,2014,FFHHIKRGIKHVGKTIHRLVTG,FFHHIKRGIKHVGKTIHRLVTG,Pis-F6K/V10K,Free,Free,Linear,L,None,22,"Antimicrobial, Antibacterial",0 % Hemolysis at 100 µM,Human,Pis-1 Analog,α-Helical,Non-hemolytic,CCSHHHHCCCCCSCSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C
5117,25473836,2014,KFHHIFRGIKHVGKTIHRLVTG,KFHHIFRGIKHVGKTIHRLVTG,Pis-F1K/V10K,Free,Free,Linear,L,None,22,"Antimicrobial, Antibacterial",<20 % Hemolysis at 200 µM,Human,Pis-1 Analog,α-Helical,NA,CCSHHHHSSTTTSCSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C
5118,25473836,2014,FFHHIKRGIKHVGKTIHRLVTG,FFHHIKRGIKHVGKTIHRLVTG,Pis-F6K/V10K,Free,Free,Linear,L,None,22,"Antimicrobial, Antibacterial",19 % Hemolysis at 400 µM,Human,Pis-1 Analog,α-Helical,NA,CCSHHHHCCCCCSCSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C
5119,25473836,2014,FFHHIKRGIKHVGKTIHRLVTG,FFHHIKRGIKHVGKTIHRLVTG,Pis-F2K/V10K,Free,Free,Linear,L,None,22,"Antimicrobial, Antibacterial",0 % Hemolysis at 400 µM,Human,Pis-1 Analog,α-Helical,Non-hemolytic,CCSHHHHCCCCCSCSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C
5132,25200682,2014,GIGAVLKVLTTGLCALISWIKRKRQQ,GIGAVLKVLTTGLCALISWIKRKRQQ,MLT-P14C,Free,Free,Linear,L,None,26,Antibacterial,50 % Hemolysis at 2.5 µM,Human,"Analog Of Melittin, Bee Venom",α-Helix,NA,CCGGGGGGGGGCHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
5133,25200682,2014,GIGAVLKVLTTGLCALISWIKRKRQQGIGAVLKVLTTGLCALISWIKRKRQQ,GIGAVLKVLTTGLCALISWIKRKRQQGIGAVLKVLTTGLCALISWIKRKRQQ,Dimer-MLT-P14C,Free,Free,Linear,L,None,52,Antibacterial,50 % Hemolysis at 1 µM,Human,"Analog Of Melittin, Bee Venom",α-Helix,NA,CCTTHHHHHTSCHHHHTTTTTTGGGSCGGGTGGGGGGHHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
5134,25209888,2014,MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA,MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA{ct:Amid},Scolopendin 1,Amidation,Free,Linear,L,None,48,"Antibacterial, Antifungal",0 % Hemolysis at 80 µM,Human,Centipede Scolopendra Subspinipes Mutilans,NA,Non-hemolytic,CCSSCSSSSSBCSSSSSCBCCCCSSTTCCCCSCCSSCTTCCCSSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O
5135,25209888,2014,MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA,MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA{ct:Amid},Scolopendin 1,Amidation,Free,Linear,L,None,48,"Antibacterial, Antifungal",0 % Hemolysis at 40 µM,Human,Centipede Scolopendra Subspinipes Mutilans,NA,Non-hemolytic,CCSSCSSSSSBCSSSSSCBCCCCSSTTCCCCSCCSSCTTCCCSSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O
5136,25209888,2014,MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA,MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA{ct:Amid},Scolopendin 1,Amidation,Free,Linear,L,None,48,"Antibacterial, Antifungal",0 % Hemolysis at 20 µM,Human,Centipede Scolopendra Subspinipes Mutilans,NA,Non-hemolytic,CCSSCSSSSSBCSSSSSCBCCCCSSTTCCCCSCCSSCTTCCCSSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O
5137,25209888,2014,MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA,MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA{ct:Amid},Scolopendin 1,Amidation,Free,Linear,L,None,48,"Antibacterial, Antifungal",0 % Hemolysis at 10 µM,Human,Centipede Scolopendra Subspinipes Mutilans,NA,Non-hemolytic,CCSSCSSSSSBCSSSSSCBCCCCSSTTCCCCSCCSSCTTCCCSSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O
5138,25209888,2014,MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA,MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA{ct:Amid},Scolopendin 1,Amidation,Free,Linear,L,None,48,"Antibacterial, Antifungal",0 % Hemolysis at 5 µM,Human,Centipede Scolopendra Subspinipes Mutilans,NA,Non-hemolytic,CCSSCSSSSSBCSSSSSCBCCCCSSTTCCCCSCCSSCTTCCCSSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O
5139,25209888,2014,MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA,MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA{ct:Amid},Scolopendin 1,Amidation,Free,Linear,L,None,48,"Antibacterial, Antifungal",0 % Hemolysis at 2.5 µM,Human,Centipede Scolopendra Subspinipes Mutilans,NA,Non-hemolytic,CCSSCSSSSSBCSSSSSCBCCCCSSTTCCCCSCCSSCTTCCCSSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O
5140,25209888,2014,MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA,MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA{ct:Amid},Scolopendin 1,Amidation,Free,Linear,L,None,48,"Antibacterial, Antifungal",0 % Hemolysis at 1.3 µM,Human,Centipede Scolopendra Subspinipes Mutilans,NA,Non-hemolytic,CCSSCSSSSSBCSSSSSCBCCCCSSTTCCCCSCCSSCTTCCCSSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O
5154,24952727,2014,APKAMKLLKKLLKLQKKGI,APKAMKLLKKLLKLQKKGI,SHAP1,Free,Free,Linear,L,None,19,"Wound healing, Antibacterial, Antifungal",0 % Hemolysis at 1 µM,Human,Synthetic Peptide,α-Helical,Non-hemolytic,CCCTHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(=O)O
5155,24952727,2014,APKAMKLLKKLLKLQKKGI,APKAMKLLKKLLKLQKKGI,SHAP1,Free,Free,Linear,L,None,19,"Wound healing, Antibacterial, Antifungal",0 % Hemolysis at 10 µM,Human,Synthetic Peptide,α-Helical,Non-hemolytic,CCCTHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(=O)O
5156,24952727,2014,APKAMKLLKKLLKLQKKGI,APKAMKLLKKLLKLQKKGI,SHAP1,Free,Free,Linear,L,None,19,"Wound healing, Antibacterial, Antifungal",0 % Hemolysis at 100 µM,Human,Synthetic Peptide,α-Helical,Non-hemolytic,CCCTHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(=O)O
5157,24952727,2014,APKAMKLLKKLLKLQKKGI,APKAMKLLKKLLKLQKKGI,SHAP1,Free,Free,Linear,L,None,19,"Wound healing, Antibacterial, Antifungal",<5 % Hemolysis at 200 µM,Human,Synthetic Peptide,α-Helical,Non-hemolytic,CCCTHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(=O)O
5162,25016054,2014,ENFFKEIERAGQRIRDAIISAAPAVETLAQAQKIIKGGD,ENFFKEIERAGQRIRDAIISAAPAVETLAQAQKIIKGGD,GM1,Free,Free,Linear,L,None,39,"Antibacterial, Anti-infective",0 % Hemolysis at 100 μg/ml,Human,Galleria Mellonella Native,NA,Non-hemolytic,CCGGGHHHHHHHHTTSTTTCCSTTHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)CC
5163,25016054,2014,ENFFKEKERKGQRIRDAIISRRPRVETLAQAQKIIKGGD,ENFFKEKERKGQRIRDAIISRRPRVETLAQAQKIIKGGD,ΔGm1,Free,Free,Linear,L,None,39,"Antibacterial, Anti-infective",0 % Hemolysis at 100 μg/ml,Human,Galleria Mellonella Native Analogue,NA,Non-hemolytic,CCTHHHHHTTCTGGGTTTTSCCHHHHHHHHHHHHSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)CC
5210,24101243,2014,VDNANDLLSKVKKDKSD,VDNANDLLSKVKKDKSD,A1,Free,Free,Linear,L,None,17,Antibacterial,0 % Hemolysis at 500 μg/ml,Human,Human C8Α Complement System Peptide,α-Helix,Non-hemolytic,CCCSSTTTTGGGGCSCC,CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C
5211,24101243,2014,TSFLNELNKYNEKKFI,TSFLNELNKYNEKKFI,A2,Free,Free,Linear,L,None,16,Antibacterial,0 % Hemolysis at 500 μg/ml,Human,Human C8Α Complement System Peptide,α-Helix,Non-hemolytic,CCTHHHHTSSSTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)O
5212,24101243,2014,VIDKAKMESLGITSRDTT,VIDKAKMESLGITSRDTT,A3,Free,Free,Linear,L,None,18,Antibacterial,0 % Hemolysis at 500 μg/ml,Human,Human C8Α Complement System Peptide,α-Helix,Non-hemolytic,CEETTEESSTTCCCCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
5213,24101243,2014,KKFGGGKTERARKAMAVE,KKFGGGKTERARKAMAVE,A4,Free,Free,Linear,L,None,18,Antibacterial,0 % Hemolysis at 500 μg/ml,Human,Human C8Α Complement System Peptide,α-Helix,Non-hemolytic,CCCSSSSCTTSSCTTSCC,CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C
5235,25421112,2015,LLSNVAGLLKQFAK,LLSNVAGLLKQFAK,XPF2,Free,Free,Linear,L,None,14,Antibacterial,10 % Hemolysis at 256 μg/ml,Human,Silurana Tropicalis,α-Helix,NA,CTTHHHHHHHHHTC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
5236,25421112,2015,LLRRVAGLLKQFAK,LLRRVAGLLKQFAK,XPF4,Free,Free,Linear,L,None,14,Antibacterial,10 % Hemolysis at 256 μg/ml,Human,Silurana Tropicalis,α-Helix,Low hemolytic,CGGGGHHHHTTTTC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
5237,25421112,2015,LLRRVARLLKRFAK,LLRRVARLLKRFAK,XPF6,Free,Free,Linear,L,None,14,Antibacterial,10 % Hemolysis at 128 μg/ml,Human,Silurana Tropicalis,α-Helix,Low hemolytic,CHHHHHHHHTTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
5238,25433327,2015,GIGKFLHSAGKFGKAFVGEIMKS,GIGKFLHSAGKFGKAFVGEIMKS,Magainin-G1,Free,Free,Linear,L,None,23,Antibacterial,50 % Hemolysis at >160 µM,Human,Skin Secretions Of X. Gilli From The Cape Peninsula,α-Helix,NA,CCGGGSCSTTTGGGTHHHHTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
5239,25433327,2015,GMASKAGAIAGKIAKVALKAV,GMASKAGAIAGKIAKVALKAV{ct:Amid},PGLa-G2,Amidation,Free,Linear,L,None,21,Antibacterial,50 % Hemolysis at >160 µM,Human,Skin Secretions Of X. Gilli From The Cape Peninsula,α-Helix,NA,CCCCCCSSBCCCCSSSCCBCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)CN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)CC
5240,25433327,2015,GWASKIGQTLGKMAKVGLQELIQPK,GWASKIGQTLGKMAKVGLQELIQPK,XPF-G1,Free,Free,Linear,L,None,25,Antibacterial,50 % Hemolysis at >160 µM,Human,Skin Secretions Of X. Gilli From The Cape Peninsula,α-Helix,NA,CCTTHHIIIIIHHHHHHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)O
5241,25433327,2015,GFGSFLGKALKAALKIGANALGGAPQQ,GFGSFLGKALKAALKIGANALGGAPQQ,CPF-G2,Free,Free,Linear,L,None,27,Antibacterial,50 % Hemolysis,Human,Skin Secretions Of X. Gilli From The Cape Peninsula,α-Helix,NA,CHHHHHHHHHHHHTTSSTTTSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
5242,25433327,2015,GFGSFLGKALKAALKIGANALGGAPEQ,GFGSFLGKALKAALKIGANALGGAPEQ,CPF-G3,Free,Free,Linear,L,None,27,Antibacterial,50 % Hemolysis at 85 µM,Human,Skin Secretions Of X. Gilli From The Cape Peninsula,α-Helix,NA,CTHHHHHHHHHHHHTTSSSSCCCSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
5243,25433327,2015,GFGSVLGKLFKTAVKIIPSLLPSKQE,GFGSVLGKLFKTAVKIIPSLLPSKQE,CPF-G4,Free,Free,Linear,L,None,26,Antibacterial,50 % Hemolysis at 35 µM,Human,Skin Secretions Of X. Gilli From The Cape Peninsula,α-Helix,NA,CHHHHHHHHHHHHTTSGGGTCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)CC
5244,25433327,2015,GLASFLGKALKAGLKIGANLLGGAPQQ,GLASFLGKALKAGLKIGANLLGGAPQQ,CPF-G5,Free,Free,Linear,L,None,27,Antibacterial,50 % Hemolysis,Human,Skin Secretions Of X. Gilli From The Cape Peninsula,α-Helix,NA,CHHHHHHHHHHHHHHHHHHHSCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
5245,25433327,2015,GFGSFLGKALKAALKVGANMLGGAPQQ,GFGSFLGKALKAALKVGANMLGGAPQQ,CPF-G6,Free,Free,Linear,L,None,27,Antibacterial,50 % Hemolysis at 60 µM,Human,Skin Secretions Of X. Gilli From The Cape Peninsula,α-Helix,NA,CTHHHHHHHHHHHHHHHHHHTTTTTCC,CSCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
5246,26688811,2015,KWKYPKLLKKLLK,KWKYPKLLKKLLK,KW-13,Free,Free,Linear,L,None,13,Antibacterial,<1 % Hemolysis at 10 μg/ml,Human,Synthetic Peptide,α-Helix,NA,CCCCHHHHTTSCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
5247,26688811,2015,KWKYPKLLKKLLK,KWKYPKLLKKLLK,KW-13,Free,Free,Linear,L,None,13,Antibacterial,<1 % Hemolysis at 40 μg/ml,Human,Synthetic Peptide,α-Helix,NA,CCCCHHHHTTSCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
5248,26688811,2015,KWKYPKLLKKLLK,KWKYPKLLKKLLK,KW-13,Free,Free,Linear,L,None,13,Antibacterial,<1 % Hemolysis at 160 μg/ml,Human,Synthetic Peptide,α-Helix,NA,CCCCHHHHTTSCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
5249,26688811,2015,KWKYPKLLKKLLK,KWKYPKLLKKLLK,KW-13,Free,Free,Linear,L,None,13,Antibacterial,<1 % Hemolysis at 640 μg/ml,Human,Synthetic Peptide,α-Helix,NA,CCCCHHHHTTSCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
5268,25172690,2015,GLSRLFTALK,GLSRLFTALK,ACWWP1,Free,Free,Linear,L,None,10,"Antimicrobial, Antibacterial",0 % Hemolysis at 512 μg/ml,Mouse,Boiled–Dried Anchovies Cooking Wastewater,α-Helix,Non-hemolytic,CHHHHHTSCC,CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
5308,25575476,2015,AWNTYDYMKREHSLVKPYQG,AWNTYDYMKREHSLVKPYQG,MrMBL-N20,Free,Free,Linear,L,None,20,Antibacterial,5.3 ± 0.8 % Hemolysis at 5 µM,Human,Freshwater Prawn Macrobrachium Rosenbergii,α-Helix/Random coil,NA,CCCCCTTTBSSSSSSBSCC,CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)O)C(C)C
5309,25575476,2015,AWNTYDYMKREHSLVKPYQG,AWNTYDYMKREHSLVKPYQG,MrMBL-N20,Free,Free,Linear,L,None,20,Antibacterial,8.9 ± 1.2 % Hemolysis at 10 µM,Human,Freshwater Prawn Macrobrachium Rosenbergii,α-Helix/Random coil,NA,CCCCCTTTBSSSSSSBSCC,CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)O)C(C)C
5310,25575476,2015,AWNTYDYMKREHSLVKPYQG,AWNTYDYMKREHSLVKPYQG,MrMBL-N20,Free,Free,Linear,L,None,20,Antibacterial,14.5 ± 2.1 % Hemolysis at 25 µM,Human,Freshwater Prawn Macrobrachium Rosenbergii,α-Helix/Random coil,NA,CCCCCTTTBSSSSSSBSCC,CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)O)C(C)C
5311,25575476,2015,AWNTYDYMKREHSLVKPYQG,AWNTYDYMKREHSLVKPYQG,MrMBL-N20,Free,Free,Linear,L,None,20,Antibacterial,19.7 ± 2.5 % Hemolysis at 50 µM,Human,Freshwater Prawn Macrobrachium Rosenbergii,α-Helix/Random coil,NA,CCCCCTTTBSSSSSSBSCC,CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)O)C(C)C
5312,25575476,2015,AWNTYDYMKREHSLVKPYQG,AWNTYDYMKREHSLVKPYQG,MrMBL-N20,Free,Free,Linear,L,None,20,Antibacterial,24.7 ± 1.9 % Hemolysis at 100 µM,Human,Freshwater Prawn Macrobrachium Rosenbergii,α-Helix/Random coil,NA,CCCCCTTTBSSSSSSBSCC,CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)O)C(C)C
5313,25575476,2015,AWNTYDYMKREHSLVKPYQG,AWNTYDYMKREHSLVKPYQG,MrMBL-N20,Free,Free,Linear,L,None,20,Antibacterial,28.5 ± 1.5 % Hemolysis at 150 µM,Human,Freshwater Prawn Macrobrachium Rosenbergii,α-Helix/Random coil,NA,CCCCCTTTBSSSSSSBSCC,CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)O)C(C)C
5314,25575476,2015,AWNTYDYMKREHSLVKPYQG,AWNTYDYMKREHSLVKPYQG,MrMBL-N20,Free,Free,Linear,L,None,20,Antibacterial,33.6 ± 2.4 % Hemolysis at 200 µM,Human,Freshwater Prawn Macrobrachium Rosenbergii,α-Helix/Random coil,NA,CCCCCTTTBSSSSSSBSCC,CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)O)C(C)C
5315,25575476,2015,AWNTYDYMKREHSLVKPYQG,AWNTYDYMKREHSLVKPYQG,MrMBL-N20,Free,Free,Linear,L,None,20,Antibacterial,37.4 ± 2.0 % Hemolysis at 250 µM,Human,Freshwater Prawn Macrobrachium Rosenbergii,α-Helix/Random coil,NA,CCCCCTTTBSSSSSSBSCC,CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)O)C(C)C
5316,25575476,2015,GGLFYVKHKEQQRKRF,GGLFYVKHKEQQRKRF,MrMBL-C16,Free,Free,Linear,L,None,16,Antibacterial,7.9 ± 1.4 % Hemolysis at 5 µM,Human,Freshwater Prawn Macrobrachium Rosenbergii,α-Helix/Random coil,NA,CTTCCCSSSTTTSCC,CC(C)C[C@H](NC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
5317,25575476,2015,GGLFYVKHKEQQRKRF,GGLFYVKHKEQQRKRF,MrMBL-C16,Free,Free,Linear,L,None,16,Antibacterial,11.5 ± 1.3 % Hemolysis at 10 µM,Human,Freshwater Prawn Macrobrachium Rosenbergii,α-Helix/Random coil,NA,CTTCCCSSSTTTSCC,CC(C)C[C@H](NC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
5318,25575476,2015,GGLFYVKHKEQQRKRF,GGLFYVKHKEQQRKRF,MrMBL-C16,Free,Free,Linear,L,None,16,Antibacterial,18.7 ± 2.5 % Hemolysis at 25 µM,Human,Freshwater Prawn Macrobrachium Rosenbergii,α-Helix/Random coil,NA,CTTCCCSSSTTTSCC,CC(C)C[C@H](NC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
5319,25575476,2015,GGLFYVKHKEQQRKRF,GGLFYVKHKEQQRKRF,MrMBL-C16,Free,Free,Linear,L,None,16,Antibacterial,25.4 ± 2.2 % Hemolysis at 50 µM,Human,Freshwater Prawn Macrobrachium Rosenbergii,α-Helix/Random coil,NA,CTTCCCSSSTTTSCC,CC(C)C[C@H](NC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
5320,25575476,2015,GGLFYVKHKEQQRKRF,GGLFYVKHKEQQRKRF,MrMBL-C16,Free,Free,Linear,L,None,16,Antibacterial,31.4 ± 3.5 % Hemolysis at 100 µM,Human,Freshwater Prawn Macrobrachium Rosenbergii,α-Helix/Random coil,NA,CTTCCCSSSTTTSCC,CC(C)C[C@H](NC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
5321,25575476,2015,GGLFYVKHKEQQRKRF,GGLFYVKHKEQQRKRF,MrMBL-C16,Free,Free,Linear,L,None,16,Antibacterial,36.8 ± 1.7 % Hemolysis at 150 µM,Human,Freshwater Prawn Macrobrachium Rosenbergii,α-Helix/Random coil,NA,CTTCCCSSSTTTSCC,CC(C)C[C@H](NC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
5322,25575476,2015,GGLFYVKHKEQQRKRF,GGLFYVKHKEQQRKRF,MrMBL-C16,Free,Free,Linear,L,None,16,Antibacterial,41.5 ± 2.5 % Hemolysis at 200 µM,Human,Freshwater Prawn Macrobrachium Rosenbergii,α-Helix/Random coil,NA,CTTCCCSSSTTTSCC,CC(C)C[C@H](NC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
5323,25575476,2015,GGLFYVKHKEQQRKRF,GGLFYVKHKEQQRKRF,MrMBL-C16,Free,Free,Linear,L,None,16,Antibacterial,46.5 ± 2.2 % Hemolysis at 250 µM,Human,Freshwater Prawn Macrobrachium Rosenbergii,α-Helix/Random coil,NA,CTTCCCSSSTTTSCC,CC(C)C[C@H](NC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
5332,25311453,2015,YSKSLPLSVLNP,YSKSLPLSVLNP,Synthesized AN5-1,Free,Free,Linear,L,None,12,Antibacterial,10 % Hemolysis at 256 μg/ml,Human,Fermentation Broth Of Paenibacillus Alvei,NA,Low hemolytic,CCCCCCCCCCCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)O
5333,25311453,2015,YSKSLPLSVLNP,YSKSLPLSVLNP,Biosynthesized AN5-1,Free,Free,Linear,L,None,12,Antibacterial,10 % Hemolysis at 256 μg/ml,Human,Fermentation Broth Of Paenibacillus Alvei,NA,Low hemolytic,CCCCCCCCCCCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)O
5334,25680229,2015,GIGKFLKKAKKFGKAFVKILKK,GIGKFLKKAKKFGKAFVKILKK{ct:Amid},MSI-78,Amidation,Free,Linear,L,None,22,"Antimicrobial, Antibacterial",53 % Hemolysis at 512 μg/ml,Human,Skin Of The African Clawed Frog,α-Helix,NA,CTHHHHHHHTTTHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C
5335,25680229,2015,GIGKFLKKAKKFGKAFVKILKK,GIGKFLKKAKKFGKAFVKILKK{ct:Amid},MSI-78,Amidation,Free,Linear,L,None,22,"Antimicrobial, Antibacterial",25 % Hemolysis at 256 μg/ml,Human,Skin Of The African Clawed Frog,α-Helix,NA,CTHHHHHHHTTTHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C
5336,25680229,2015,GIGKFLKKAKKFGKAFVKILKK,GIGKFLKKAKKFGKAFVKILKK{ct:Amid},MSI-78,Amidation,Free,Linear,L,None,22,"Antimicrobial, Antibacterial",13 % Hemolysis at 128 μg/ml,Human,Skin Of The African Clawed Frog,α-Helix,NA,CTHHHHHHHTTTHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C
5337,25680229,2015,GIGKFLKKAKKF,GIGKFLKKAKKF{ct:Amid},CEM1,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibacterial",0 % Hemolysis at 0-512 μg/ml,Human,"Pexiganan, Synthetic Peptide",α-Helix,Non-hemolytic,CTHHHHTTCCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5338,25680229,2015,IGKFLKKAKKFG,IGKFLKKAKKFG{ct:Amid},CEM2,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibacterial",0 % Hemolysis at 0-512 μg/ml,Human,"Pexiganan, Synthetic Peptide",α-Helix,Non-hemolytic,CHHHHHHHTSCC,CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O
5339,25735802,2015,RFRRLRWKTRWRLKKI,RFRRLRWKTRWRLKKI{ct:Amid},PRW4,Amidation,Free,Linear,L,None,16,"Antimicrobial, Antibacterial",5 % Hemolysis at >256 µM,Human,Synthetic Peptide,α-Helix,Low hemolytic,CCCCSCCSSSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)O
5340,25735802,2015,RFRRLRCKTRCRLKKI,RFRRLRCKTRCRLKKI{ct:Amid},4,Amidation,Free,Linear,L,None,16,"Antimicrobial, Antibacterial",5 % Hemolysis at >256 µM,Human,Synthetic Peptide,α-Helix,Low hemolytic,CTTTCTTBCSSSCBCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)O
5341,25735802,2015,RFRRLRDKTRDRLKKI,RFRRLRDKTRDRLKKI{ct:Amid},4,Amidation,Free,Linear,L,None,16,"Antimicrobial, Antibacterial",5 % Hemolysis at >256 µM,Human,Synthetic Peptide,α-Helix,Low hemolytic,CCSSSTTTTTTGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)O
5342,25735802,2015,RFRRLRIKTRIRLKKI,RFRRLRIKTRIRLKKI{ct:Amid},4,Amidation,Free,Linear,L,None,16,"Antimicrobial, Antibacterial",5 % Hemolysis at >256 µM,Human,Synthetic Peptide,α-Helix,Low hemolytic,CCCCCCCSSSSCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)O
5343,25735802,2015,RFRRLRPKTRPRLKKI,RFRRLRPKTRPRLKKI{ct:Amid},4,Amidation,Free,Linear,L,None,16,"Antimicrobial, Antibacterial",5 % Hemolysis at >256 µM,Human,Synthetic Peptide,α-Helix,Low hemolytic,CCTTCCCSSCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)O
5344,25735802,2015,RFRRLRwKTRwRLKKI,RFRRLRW{d}KTRW{d}RLKKI{ct:Amid},PRW4-d,Amidation,Free,Linear,Mix,w = Wd (D-Trp-substituted),16,"Antimicrobial, Antibacterial",5 % Hemolysis at >256 µM,Human,Synthetic Peptide,α-Helix,Low hemolytic,CCCCSCCSSSCCCCCC,NA
5345,25735802,2015,RFRRLRWRTRWRLRRI,RFRRLRWRTRWRLRRI{ct:Amid},PRW4-R,Amidation,Free,Linear,L,None,16,"Antimicrobial, Antibacterial",5 % Hemolysis at >256 µM,Human,Synthetic Peptide,α-Helix,Low hemolytic,CCCSSCCSSSSCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)O
5346,25735802,2015,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,16,"Antimicrobial, Antibacterial",5 % Hemolysis at 0.25 µM,Human,"Control,Bee Venom",α-Helix,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
5365,25997127,2015,LIAGLAANFLPQILCKIARKC,LIAGLAANFLPQILCKIARKC{ct:Amid},linear B1CTcu5,Amidation,Free,Linear,L,None,21,Antibacterial,37 % Hemolysis at 25 μg/ml,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,CCTTHHHIIIIIIIHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
5366,25997127,2015,LIAGLAANFLPQILCKIARKC,LIAGLAANFLPQILCKIARKC{cyc:N-C}{ct:Amid},Cyclic B1CTcu5,Amidation,Free,Cyclic,L,None,21,Antibacterial,40 % Hemolysis at 25 μg/ml,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,CCTTHHHIIIIIIIHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
5367,25997127,2015,IAGLAANFLPQILCKIARKC,IAGLAANFLPQILCKIARKC{ct:Amid},B1CTcu5-L,Amidation,Free,Linear,L,None,20,Antibacterial,30.5 % Hemolysis at 50 μg/ml,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,CHHHHHHHHHHHHHTTTTCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
5368,25997127,2015,AGLAANFLPQILCKIARKC,AGLAANFLPQILCKIARKC{ct:Amid},B1CTcu5-LI,Amidation,Free,Linear,L,None,19,Antibacterial,26 % Hemolysis at 50 μg/ml,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,CCCSTTTHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
5369,25997127,2015,GLAANFLPQILCKIARKC,GLAANFLPQILCKIARKC{ct:Amid},B1CTcu5-LIA,Amidation,Free,Linear,L,None,18,Antibacterial,26.5 % Hemolysis at 100 μg/ml,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,CCCTTHHIIIIIHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
5370,25997127,2015,LAANFLPQILCKIARKC,LAANFLPQILCKIARKC{ct:Amid},B1CTcu5-LIAG,Amidation,Free,Linear,L,None,17,"Antibacterial, Antibiofilm",30 % Hemolysis at 12.5 μg/ml,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,CCSSHHIIIIIHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
5371,25997127,2015,KIAGLAANFLPQILCKIARKC,KIAGLAANFLPQILCKIARKC{ct:Amid},B1CTcu5K,Amidation,Free,Linear,L,None,21,"Antibacterial, Antibiofilm",15 % Hemolysis at 25 μg/ml,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,CCCCCHHHHHHHHHHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
5372,25997127,2015,WIAGLAANFLPQILCKIARKC,WIAGLAANFLPQILCKIARKC{ct:Amid},B1CTcu5W,Amidation,Free,Linear,L,None,21,"Antibacterial, Antibiofilm",39.11 % Hemolysis at 100 μg/ml,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,CCTTTHHHHHHHHTTTSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
5373,25997127,2015,RIAGLAANFLPQILCKIARKC,RIAGLAANFLPQILCKIARKC{ct:Amid},B1CTcu5R,Amidation,Free,Linear,L,None,21,"Antibacterial, Antibiofilm",19.4 % Hemolysis at 25 μg/ml,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,CCCCGGGGHHIIIIIHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
5374,25997127,2015,HIAGLAANFLPQILCKIARKC,HIAGLAANFLPQILCKIARKC{ct:Amid},B1CTcu5H,Amidation,Free,Linear,L,None,21,"Antibacterial, Antibiofilm",30.4 % Hemolysis at 50 μg/ml,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,CCSCHHHHHIIIIIHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
5375,25997127,2015,LGGGLAANFLPQILCKIARKC,LGGGLAANFLPQILCKIARKC{ct:Amid},B1CTcu5LGG,Amidation,Free,Linear,L,None,21,Antibacterial,23.4 % Hemolysis,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,CTTGGGGGHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
5376,25997127,2015,LIAGLAANFLPQILCKIARK,LIAGLAANFLPQILCKIARK{ct:Amid},B1CTcu5-C,Amidation,Free,Linear,L,None,20,Antibacterial,13 % Hemolysis at 25 μg/ml,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,CTTTTHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
5377,25997127,2015,LIAGLAANFLPQILC(Acm)KIARKC,LIAGLAANFLPQILC{nnr:Acm}KIARKC{ct:Amid},B1CTcu5C (Acm),Amidation,Free,Linear,L,Acm,21,Antibacterial,25 % Hemolysis at 12.5 μg/ml,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,NA,NA
5378,25997127,2015,LIAGLAANFLPQILC,LIAGLAANFLPQILC{ct:Amid},B1CTcu5-Rana,Amidation,Free,Linear,L,None,15,Antibacterial,NA,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,Non-hemolytic,CCTTHHHHHSCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O
5379,25997127,2015,LIAGLAANFL,LIAGLAANFL{ct:Amid},B1CTcu5L1-L10,Amidation,Free,Linear,L,None,10,Antibacterial,NA,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,Non-hemolytic,CCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
5380,25997127,2015,PQILCKIARKC,PQILCKIARKC{ct:Amid},B1CTcu5P11-C21,Amidation,Free,Linear,L,None,11,Antibacterial,NA,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,Non-hemolytic,CCCHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
5381,25997127,2015,LIAGLAANFLPQILCKIARKC,LIAGLAANFLPQILCKIARKC{ct:Amid},DB1CTcu5,Amidation,Free,Linear,L,None,21,"Antibacterial, Antibiofilm",40.22 % Hemolysis at 25 μg/ml,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,CCTTHHHIIIIIIIHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
5383,25807936,2015,6#IK,{nnr:6#}IK{ct:Amid},P1,Amidation,Free,Linear,L,"6# = BDZ,benzodiazepine scaffold",2,Antibacterial,50 % Hemolysis at >1000 μg/ml,Human,Bdz Peptidomimetic Compounds,α-Helix,NA,NA,NA
5384,25807936,2015,K6#CK,K{nnr:6#}CK{ct:Amid},P2,Amidation,Free,Linear,L,"6# = BDZ,benzodiazepine scaffold",3,Antibacterial,50 % Hemolysis at >1000 μg/ml,Human,Bdz Peptidomimetic Compounds,α-Helix,NA,NA,NA
5385,25807936,2015,k6#k,K{d}{nnr:6#}K{d}{ct:Amid},P3,Amidation,Free,Linear,D,"6# = BDZ,benzodiazepine scaffold",2,Antibacterial,50 % Hemolysis at >1000 μg/ml,Human,Bdz Peptidomimetic Compounds,α-Helix,NA,NA,NA
5386,25807936,2015,K6#VH,K{nnr:6#}VH{ct:Amid},P4,Amidation,Free,Linear,L,"6# = BDZ,benzodiazepine scaffold",3,Antibacterial,50 % Hemolysis at >1000 μg/ml,Human,Bdz Peptidomimetic Compounds,α-Helix,NA,NA,NA
5387,25807936,2015,K6#K,K{nnr:6#}K{ct:Amid},P5,Amidation,Free,Linear,L,"6# = BDZ,benzodiazepine scaffold",2,Antibacterial,50 % Hemolysis at >1000 μg/ml,Human,Bdz Peptidomimetic Compounds,α-Helix,NA,NA,NA
5388,25807936,2015,K6#KC,K{nnr:6#}KC{ct:Amid},P6,Amidation,Free,Linear,L,"6# = BDZ,benzodiazepine scaffold",3,Antibacterial,50 % Hemolysis at >1000 μg/ml,Human,Bdz Peptidomimetic Compounds,α-Helix,NA,NA,NA
5389,25807936,2015,K6#FK,K{nnr:6#}FK{ct:Amid},P7,Amidation,Free,Linear,L,"6# = BDZ,benzodiazepine scaffold",3,Antibacterial,50 % Hemolysis at >1000 μg/ml,Human,Bdz Peptidomimetic Compounds,α-Helix,NA,NA,NA
5390,25807936,2015,k6#fk,K{d}{nnr:6#}F{d}K{d}{ct:Amid},P8,Amidation,Free,Linear,D,"6# = BDZ,benzodiazepine scaffold",3,Antibacterial,50 % Hemolysis at >1000 μg/ml,Human,Bdz Peptidomimetic Compounds,α-Helix,NA,NA,NA
5391,25807936,2015,K6#LK,K{nnr:6#}LK{ct:Amid},P9,Amidation,Free,Linear,L,"6# = BDZ,benzodiazepine scaffold",3,Antibacterial,50 % Hemolysis at >1000 μg/ml,Human,Bdz Peptidomimetic Compounds,α-Helix,NA,NA,NA
5392,25807936,2015,GIGKFLKKAKKFGKAFVKILKK,GIGKFLKKAKKFGKAFVKILKK{ct:Amid},MSI-78,Amidation,Free,Linear,L,None,22,Antibacterial,50 % Hemolysis at 120 μg/ml,Human,Magainin Analogue,α-Helix,Non-hemolytic,CTHHHHHHHTTTHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C
5393,26046345,2015,ILPWKWPWWPWRR,ILPWKWPWWPWRR{ct:Amid},Indolicidin,Amidation,Free,Linear,L,None,13,Antibacterial,56.98 % Hemolysis at 250 μg/ml,Human,Neutrophil Blood Cells Of Cows,α-Helix,NA,CCCCCCSCCCTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5394,26046345,2015,LLPWKWPWWKWRR,LLPWKWPWWKWRR{ct:Amid},IN1,Amidation,Free,Linear,L,None,13,Antibacterial,3.6 % Hemolysis at 250 μg/ml,Human,Indolicidin Analog,α-Helix,Low hemolytic,CCSSSSCCCCCCC,CC(C)C[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5395,26046345,2015,RRPWRWPWWPWRR,RRPWRWPWWPWRR{ct:Amid},IN2,Amidation,Free,Linear,L,None,13,Antibacterial,15.39 % Hemolysis at 250 μg/ml,Human,Indolicidin Analog,α-Helix,NA,CCSCCCSCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
5396,26046345,2015,RRPWRWPRWPWRR,RRPWRWPRWPWRR{ct:Amid},IN3,Amidation,Free,Linear,L,None,13,Antibacterial,2.39 % Hemolysis at 250 μg/ml,Human,Indolicidin Analog,α-Helix,Low hemolytic,CCSSSCSSSTTTC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
5397,26046345,2015,FLGGLIKIVPAMICAVTKKC,FLGGLIKIVPAMICAVTKKC{ct:OH},Ranalexin,OH,Free,Linear,L,None,20,Antibacterial,<15 % Hemolysis at 250 μg/ml,Human,Bullfrog (Rana Catesbeiana) Skin,α-Helix,NA,CCSCGGGTHHHHHHHHSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C
5398,26046345,2015,FLGGLIKWWPWRR,FLGGLIKWWPWRR{ct:Amid},RN7-IN6,Amidation,Free,Linear,L,None,13,"Antibacterial, Antipneumococcal",0 % Hemolysis at 15.62 μg/ml,Human,Indolicidin Ranalexin Hybrid Peptide,α-Helix,Non-hemolytic,CCSCTTSCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5399,26046345,2015,FLGGLIKPWWPWRR,FLGGLIKPWWPWRR{ct:Amid},RN7-IN7,Amidation,Free,Linear,L,None,14,Antibacterial,<10 % Hemolysis at 250 μg/ml,Human,Indolicidin Ranalexin Hybrid Peptide,α-Helix,Non-hemolytic,CTTTTTSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5400,26046345,2015,FLGGLIKWPWWPWRR,FLGGLIKWPWWPWRR{ct:Amid},RN7-IN8,Amidation,Free,Linear,L,None,15,"Antibacterial, Antipneumococcal",0 % Hemolysis at 15.62 μg/ml,Human,Indolicidin Ranalexin Hybrid Peptide,α-Helix,Non-hemolytic,CCSCCCCSSSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5401,26046345,2015,FLGGLIKKWPWWPWRR,FLGGLIKKWPWWPWRR{ct:Amid},RN7-IN9,Amidation,Free,Linear,L,None,16,"Antibacterial, Antipneumococcal",0 % Hemolysis at 15.62 μg/ml,Human,Indolicidin Ranalexin Hybrid Peptide,α-Helix,Non-hemolytic,CCSSSSSCCSCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5402,26046345,2015,FLGGLIKWKWPWWPWRR,FLGGLIKWKWPWWPWRR{ct:Amid},RN7-IN10,Amidation,Free,Linear,L,None,17,"Antibacterial, Antipneumococcal",5.9 % Hemolysis at 15.62 μg/ml,Human,Indolicidin Ranalexin Hybrid Peptide,α-Helix,NA,CCSSCCCBSSSSSBCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5403,25966444,2015,Q(L)R,QLR{nt:C18-aliphatic chain}{ct:Amid},LP1,Amidation,C18-aliphatic chain,Linear,L,C18 = aliphatic chain,3,Antibacterial,50 % Hemolysis at >100 µM,Human,Host Defence Peptides,α-Helix,NA,NA,NA
5404,25966444,2015,QLR,QLR{nt:C18-aliphatic chain}{ct:Amid},LP2,Amidation,C18-aliphatic chain,Linear,L,C18 = aliphatic chain,3,Antibacterial,50 % Hemolysis at >100 µM,Human,Host Defence Peptides,α-Helix,NA,CCC,NA
5405,25966444,2015,CGCQ(L)R,CGCQLR{nt:C18-aliphatic chain}{ct:Amid},LP3,Amidation,C18-aliphatic chain,Linear,L,C18 = aliphatic chain,6,Antibacterial,50 % Hemolysis at >100 µM,Human,Host Defence Peptides,α-Helix,NA,NA,NA
5406,25966444,2015,CGCQLR,CGCQLR{nt:C18-aliphatic chain}{ct:Amid},LP4,Amidation,C18-aliphatic chain,Linear,L,C18 = aliphatic chain,6,Antibacterial,50 % Hemolysis at >100 µM,Human,Host Defence Peptides,α-Helix,NA,CCSTTC,NA
5407,25966444,2015,βAβAKIAKLKAKIQKLKQKIAKLK,{nnr:βA}{nnr:βA}KIAKLKAKIQKLKQKIAKLK{nt:C12-aliphatic chain}{ct:Amid},LH,Amidation,"C12-aliphatic domain,βA- 2 spacer",Linear,L,"C12 = aliphatic domain, βA = 2 spacer",22,Antibacterial,50 % Hemolysis at >100 µM,Human,Host Defence Peptides,α-Helix,NA,NA,NA
5408,25966444,2015,Q(L)R,QLR{nt:C18-aliphatic chain}{ct:Amid},LP1,Amidation,C18-aliphatic chain,Linear,L,C18 = aliphatic chain,3,Antibacterial,50 % Hemolysis at >100 µM,Bovine,Host Defence Peptides,α-Helix,NA,NA,NA
5409,25966444,2015,QLR,QLR{nt:C18-aliphatic chain}{ct:Amid},LP2,Amidation,C18-aliphatic chain,Linear,L,C18 = aliphatic chain,3,Antibacterial,50 % Hemolysis at >100 µM,Bovine,Host Defence Peptides,α-Helix,NA,CCC,NA
5410,25966444,2015,CGCQ(L)R,CGCQLR{nt:C18-aliphatic chain}{ct:Amid},LP3,Amidation,C18-aliphatic chain,Linear,L,C18 = aliphatic chain,6,Antibacterial,50 % Hemolysis at >100 µM,Bovine,Host Defence Peptides,α-Helix,NA,NA,NA
5411,25966444,2015,CGCQLR,CGCQLR{nt:C18-aliphatic chain}{ct:Amid},LP4,Amidation,C18-aliphatic chain,Linear,L,C18 = aliphatic chain,6,Antibacterial,50 % Hemolysis at >100 µM,Bovine,Host Defence Peptides,α-Helix,NA,CCSTTC,NA
5412,25966444,2015,βAβAKIAKLKAKIQKLKQKIAKLK,{nnr:βA}{nnr:βA}KIAKLKAKIQKLKQKIAKLK{nt:C12-aliphatic chain}{ct:Amid},LH,Amidation,"C12-aliphatic domain,βA- 2 spacer",Linear,L,"C12 = aliphatic domain, βA = 2 spacer",22,Antibacterial,50 % Hemolysis at >100 µM,Bovine,Host Defence Peptides,α-Helix,NA,NA,NA
5413,25826179,2015,FKKLKKLFSKLWNWK,FKKLKKLFSKLWNWK{nt:Acet}{ct:Amid},HPRP-A1,Amidation,Acetylation,Linear,L,None,15,Antibacterial,MHC % Hemolysis at 32 µM,Human,N-Terminus Of Ribosomal Protein L1 Of Helicobacter Pylori,α-Helix,NA,CTTTHHHHTTTCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
5414,25826179,2015,FKKLKKLFSKLKNWW,FKKLKKLFSKLKNWW{nt:Acet}{ct:Amid},HPRP-A2,Amidation,Acetylation,Linear,L,None,15,Antibacterial,MHC % Hemolysis at 16 µM,Human,Analog Of Hprp-A1,α-Helix,NA,CTTHHHHHHHHTCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
5415,25826179,2015,KFLKLKWLKSWKNFK,KFLKLKWLKSWKNFK{nt:Acet}{ct:Amid},HPRP-A3,Amidation,Acetylation,Linear,L,None,15,Antibacterial,MHC % Hemolysis at 250 µM,Human,Analog Of Hprp-A1,α-Helix,NA,CCCCCTTHHHHTTCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
5416,25826179,2015,FKLKLKFSNKLKWKW,FKLKLKFSNKLKWKW{nt:Acet}{ct:Amid},HPRP-B,Amidation,Acetylation,Linear,L,None,15,Antibacterial,MHC % Hemolysis at 64 µM,Human,Analog Of Hprp-A1,β-Sheets,NA,CCCCBCGGGSCBCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
5417,25826179,2015,LFKKNKLWFKSKKWL,LFKKNKLWFKSKKWL{nt:Acet}{ct:Amid},HPRP-C,Amidation,Acetylation,Linear,L,None,15,Antibacterial,MHC % Hemolysis at 500 µM,Human,Analog Of Hprp-A1,Random coil,NA,CCCCCCCCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)O
5465,26028561,2015,FKRLKKLISWIKRKRQQ,FKRLKKLISWIKRKRQQ{ct:Amid},Hn-Mc,Amidation,Free,Linear,L,None,17,Antibacterial,1.1 % Hemolysis at 250 µM,Rat,Hybrid Peptide,α-Helix,Low hemolytic,CTTTTTHHHHHHTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC
5466,25620367,2015,GFGCNGPWNEDDLRCHNHCKSIKGYKGGYCAKGGFVCKCY,GFGCNGPWNEDDLRCHNHCKSIKGYKGGYCAKGGFVCKCY,NZ2114,Free,Free,Linear,L,None,40,Antibacterial,<0.05 % Hemolysis at 128 μg/ml,Human,Variant Of Nz2114,α-Helix,Low hemolytic,CCCBSCSSSCCBSSSSSSSSTTCCCSSBTTBSSCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
5467,25620367,2015,GFGCNGPWQEDDVKCHNHCKSIKGYKGGYCAKGGFVCKCY,GFGCNGPWQEDDVKCHNHCKSIKGYKGGYCAKGGFVCKCY,MP1102,Free,Free,Linear,L,None,40,Antibacterial,<0.05 % Hemolysis at 128 μg/ml,Human,Pseudoplectania Nigrella,α-Helix,Low hemolytic,CCSCCSSCCCCCSCSSSSSSCCCCCCTHHHHCSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
5468,26238108,2015,KWKSFLKTFKSAKKTVLHTLLKAISS,KWKSFLKTFKSAKKTVLHTLLKAISS,A20L,Free,Free,Linear,L,None,26,Antibacterial,MHC % Hemolysis at 213.33 μg/ml,Human,Derivative Of V13K,α-Helix,NA,CHHHHHHHHHHHTTSSSSHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
5469,26204061,2015,GIIKKIIKKIIKKI,GIIKKIIKKIIKKI{ct:Amid},FITC,Amidation,Free,Linear,L,None,14,Antibacterial and Anticancer,50 % Hemolysis at 256 µM,Human,Synthetic Amphiphiles,α-Helix,Low hemolytic,CGGGTSGGGTGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
5470,26204061,2015,IIKKIIKKIIKKI,IIKKIIKKIIKKI{ct:Amid},1,Amidation,Free,Linear,L,None,13,Antibacterial and Anticancer,50 % Hemolysis at 256 µM,Human,Synthetic Amphiphiles,α-Helix,Low hemolytic,CHHHHGGGTTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
5471,26204061,2015,GIIKKIIKKIIKK,GIIKKIIKKIIKK{ct:Amid},2,Amidation,Free,Linear,L,None,13,Antibacterial and Anticancer,50 % Hemolysis at 500 µM,Human,Synthetic Amphiphiles,α-Helix,Low hemolytic,CTHHHHTHHHHTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
5472,26204061,2015,IIKKIIKKIIKK,IIKKIIKKIIKK{ct:Amid},Rhodamine,Amidation,Free,Linear,L,None,12,Antibacterial and Anticancer,50 % Hemolysis at >1000 µM,Human,Synthetic Amphiphiles,α-Helix,Low hemolytic,CHHHHHHHHHHC,CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
5473,26041027,2015,RPHGAGEGIDRVPAGPSPSEVGLAIPSGK,RPHGAGEGIDRVPAGPSPSEVGLAIPSGK{ct:Amid},Pep-7,Amidation,Free,Linear,L,None,29,Antibacterial,0.1 ± 0.1 % Hemolysis at 1.7 µM,Human,Porphyromonas Gingivalis,NA,NA,CCSSCSSCCCCSCSCCTTSHHHHSSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
5474,26041027,2015,RPHGAGEGIDRVPAGPSPSEVGLAIPSGK,RPHGAGEGIDRVPAGPSPSEVGLAIPSGK{ct:Amid},Pep-7,Amidation,Free,Linear,L,None,29,Antibacterial,0.1 ± 0.1 % Hemolysis at 3.4 µM,Human,Porphyromonas Gingivalis,NA,NA,CCSSCSSCCCCSCSCCTTSHHHHSSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
5475,26041027,2015,RPHGAGEGIDRVPAGPSPSEVGLAIPSGK,RPHGAGEGIDRVPAGPSPSEVGLAIPSGK{ct:Amid},Pep-7,Amidation,Free,Linear,L,None,29,Antibacterial,0.3 ± 0.1 % Hemolysis at 6.8 µM,Human,Porphyromonas Gingivalis,NA,NA,CCSSCSSCCCCSCSCCTTSHHHHSSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
5480,26149664,2015,RWK(N3),RWK{nnr:N3}{nt:H}{ct:Amid},3 a,Amidation,H,Linear,L,"N3 = 1,2,3-triazol-4-methoxy",3,Antibacterial,<1 % Hemolysis at <100 µM,Human,Arg-Trp-Based Peptides,α-Helix,Non-hemolytic,NA,NA
5481,26149664,2015,RWK(N3),RWK{nnr:N3}{nt:H}{ct:Amid},3 b,Amidation,H,Linear,L,"N3 = 1,2,3-triazol-4-methoxy",3,Antibacterial,<1 % Hemolysis at <100 µM,Human,Arg-Trp-Based Peptides,α-Helix,Non-hemolytic,NA,NA
5482,26149664,2015,RWK(N3),RWK{nnr:N3}{nt:H}{ct:Amid},3 c,Amidation,H,Linear,L,"N3 = 1,2,3-triazol-4-methoxy",3,Antibacterial,<1 % Hemolysis at <100 µM,Human,Arg-Trp-Based Peptides,α-Helix,Non-hemolytic,NA,NA
5483,26149664,2015,WRK(N3),WRK{nnr:N3}{nt:H}{ct:Amid},4 a,Amidation,H,Linear,L,"N3 = 1,2,3-triazol-4-methoxy",3,Antibacterial,<1 % Hemolysis at <100 µM,Human,Arg-Trp-Based Peptides,α-Helix,Non-hemolytic,NA,NA
5484,26149664,2015,WRK(N3),WRK{nnr:N3}{nt:H}{ct:Amid},4b,Amidation,H,Linear,L,"N3 = 1,2,3-triazol-4-methoxy",3,Antibacterial,<1 % Hemolysis at <100 µM,Human,Arg-Trp-Based Peptides,α-Helix,Non-hemolytic,NA,NA
5485,26149664,2015,WRK(N3),WRK{nnr:N3}{nt:H}{ct:Amid},4c,Amidation,H,Linear,L,"N3 = 1,2,3-triazol-4-methoxy",3,Antibacterial,<1 % Hemolysis at <100 µM,Human,Arg-Trp-Based Peptides,α-Helix,Non-hemolytic,NA,NA
5486,26149664,2015,RWRK(N3),RWRK{nnr:N3}{nt:H}{ct:Amid},5a,Amidation,H,Linear,L,"N3 = 1,2,3-triazol-4-methoxy",4,Antibacterial,<1 % Hemolysis at <100 µM,Human,Arg-Trp-Based Peptides,α-Helix,Non-hemolytic,NA,NA
5487,26149664,2015,RWRK(N3),RWRK{nnr:N3}{nt:H}{ct:Amid},5b,Amidation,H,Linear,L,"N3 = 1,2,3-triazol-4-methoxy",4,Antibacterial,<1 % Hemolysis at <100 µM,Human,Arg-Trp-Based Peptides,α-Helix,Non-hemolytic,NA,NA
5488,26149664,2015,RWRK(N3),RWRK{nnr:N3}{nt:H}{ct:Amid},5c,Amidation,H,Linear,L,"N3 = 1,2,3-triazol-4-methoxy",4,Antibacterial,<1 % Hemolysis at <100 µM,Human,Arg-Trp-Based Peptides,α-Helix,Non-hemolytic,NA,NA
5489,26149664,2015,WRWK(N3),WRWK{nnr:N3}{nt:H}{ct:Amid},6a,Amidation,H,Linear,L,"N3 = 1,2,3-triazol-4-methoxy",4,Antibacterial,<1 % Hemolysis at <100 µM,Human,Arg-Trp-Based Peptides,α-Helix,Non-hemolytic,NA,NA
5490,26149664,2015,WRWK(N3),WRWK{nnr:N3}{nt:H}{ct:Amid},6b,Amidation,H,Linear,L,"N3 = 1,2,3-triazol-4-methoxy",4,Antibacterial,<1 % Hemolysis at <100 µM,Human,Arg-Trp-Based Peptides,α-Helix,Non-hemolytic,NA,NA
5491,26149664,2015,WRWK(N3),WRWK{nnr:N3}{nt:H}{ct:Amid},6c,Amidation,H,Linear,L,"N3 = 1,2,3-triazol-4-methoxy",4,Antibacterial,<1 % Hemolysis at <100 µM,Human,Arg-Trp-Based Peptides,α-Helix,Non-hemolytic,NA,NA
5492,26149664,2015,RWRWRWK(N3),RWRWRWK{nnr:N3}{nt:H}{ct:Amid},7a,Amidation,H,Linear,L,"N3 = 1,2,3-triazol-4-methoxy",7,Antibacterial,<1 % Hemolysis at <100 µM,Human,Arg-Trp-Based Peptides,α-Helix,Non-hemolytic,NA,NA
5493,26149664,2015,RWRWRWK(N3),RWRWRWK{nnr:N3}{nt:H}{ct:Amid},7b,Amidation,H,Linear,L,"N3 = 1,2,3-triazol-4-methoxy",7,Antibacterial,<1 % Hemolysis at <100 µM,Human,Arg-Trp-Based Peptides,α-Helix,Non-hemolytic,NA,NA
5494,26149664,2015,RWRWRWK(N3),RWRWRWK{nnr:N3}{nt:H}{ct:Amid},7c,Amidation,H,Linear,L,"N3 = 1,2,3-triazol-4-methoxy",7,Antibacterial,<1 % Hemolysis at <100 µM,Human,Arg-Trp-Based Peptides,α-Helix,Non-hemolytic,NA,NA
5495,26160494,2015,KKYRYHLKPFSKK,KKYRYHLKPFSKK{nt:NH3+}{ct:Carboxyl (COO-)},p-(Ser11)-BthTX-I(COO-),Carboxyl (COO-),NH3+,Linear,L,"Cter = COO-, Nter = NH3+",13,Antibacterial,50 % Hemolysis at >128 µmol/L,Human,Analogues Bothropstoxin-I (Bthtx-I),α-Helix,NA,CCCCCCSTTSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
5496,26160494,2015,KKYRYHLKPFSKK,KKYRYHLKPFSKK{nt:NH3+}{ct:Amid},[p-(Ser11)-BthTX-I(CONH2)],Amidation,NH3+,Linear,L,None,13,Antibacterial,50 % Hemolysis at >128 µmol/L,Human,Analogues Bothropstoxin-I (Bthtx-I),α-Helix,NA,CCCCCCSTTSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
5497,26160494,2015,KKYRYHLKPFCKK,KKYRYHLKPFCKK{nt:NH3+}{ct:Carboxyl (COO-)},p-BthTX-I,Carboxyl (COO-),NH3+,Linear,L,"Cter = COO-, Nter = NH3+",13,Antibacterial,50 % Hemolysis at >128 µmol/L,Human,Bothropstoxin-I (Bthtx-I),α-Helix,NA,CCCCCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
5498,26160494,2015,KKYRYHLKPFCKKKKYRYHLKPFCKK,KKYRYHLKPFCKKKKYRYHLKPFCKK{nt:NH3+}{ct:Carboxyl (COO-)},(p-BthTX-I)2,Carboxyl (COO-),NH3+,Linear,L,"Cter = COO-, Nter = NH3+",26,Antibacterial,50 % Hemolysis at >128 µmol/L,Human,Analogues Bothropstoxin-I (Bthtx-I),α-Helix,NA,CCCCSCCCTTTTCCCCCCCSSSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
5499,26461841,2015,MFTLKKSLFLVLILGMVSLSLCRPQSLADKETSDDPTEEENTAGDEESVEKRDLGKASYPIAYS,MFTLKKSLFLVLILGMVSLSLCRPQSLADKETSDDPTEEENTAGDEESVEKRDLGKASYPIAYS,Spinosan-A,Free,Free,Linear,L,None,64,"Antibacterial, Antioxidative",2.36±0.023 % Hemolysis at 80 μg/ml,Rabbit,Paa Spinosa,α-Helix,NA,CCSCCCCSSHHHHHTTTTCCCCBTTBCSCCCCCCCCCSTTCSSCGGGCSSTTTTCCCSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C
5500,26461841,2015,MFTLKKSLFLILILGMVSLSLCGQRSLADKETSNDPTGEENTAGDEEGGEEGNLEMRRDYCKPEECDYYFSFPI,MFTLKKSLFLILILGMVSLSLCGQRSLADKETSNDPTGEENTAGDEEGGEEGNLEMRRDYCKPEECDYYFSFPI,Spinosan-B,Free,Free,Linear,L,None,74,"Antibacterial, Antioxidative",2.11±0.023 % Hemolysis at 80 μg/ml,Rabbit,Paa Spinosa,α-Helix,NA,CCSCBCCSGGGGGTTTTCCSSBSSCCTTSCCSSSCSCCCCCCCSSCSTTSCCSGGGTCSSSCSSCSCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)O
5501,26461841,2015,MFTLKKSLFLVLILGMVSLSLCRGRSLADKETSNDPTGEENTAGDEESGEKRDLSMMRKAGSNIVCGLNGLC,MFTLKKSLFLVLILGMVSLSLCRGRSLADKETSNDPTGEENTAGDEESGEKRDLSMMRKAGSNIVCGLNGLC,Spinosan-C,Free,Free,Linear,L,None,72,"Antibacterial, Antioxidative",2.94±0.023 % Hemolysis at 80 μg/ml,Rabbit,Paa Spinosa,α-Helix,NA,CCSCCSSTTTTSGGGGTTTCCCCCCSSSCCCCCCCTTCCCCHHHHCCSSCCCCSGGGGSTTCCCSSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C
5502,26461841,2015,MFTLKKSLFLVLILGMVSLSLCQQESNADKETTKEVTGEANTAGNVEIVEVAEVEKEMEELYKEIDDCVNYGNCKTLKLM,MFTLKKSLFLVLILGMVSLSLCQQESNADKETTKEVTGEANTAGNVEIVEVAEVEKEMEELYKEIDDCVNYGNCKTLKLM,Spinosan-D,Free,Free,Linear,L,None,80,"Antibacterial, Antioxidative",3.94±0.023 % Hemolysis at 80 μg/ml,Rabbit,Paa Spinosa,α-Helix,NA,CCSSSCCSSSCCTTTTTSCGGGTSTTSCCCCSSSTTCSHHHHHCCTTTCCSHHHHHHHHHHHHHIIIIISHHHHTSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C
5503,26235946,2015,KAAKAAKKAAKAAWK,KAAKAAKKAAKAAWK{nt:Acet}{ct:Amid},Ac-UM-14W,Amidation,Acetylation,Linear,L,X = residues cross-linked by an oct-4-enyl staple,15,Antibacterial,<1 % Hemolysis at 25 µM,Human,Doubly-Stapled Alanine/Lysine-Based Peptides,α-Helix,NA,CBTTSSSSCCCBCCC,NA
5504,26235946,2015,KXAKAXKKAAKAAWK,K{nnr:X}AKA{nnr:X}KKAAKAAWK{nt:Acet}{ct:Amid},Ac-SS-14W,Amidation,Acetylation,Linear,L,X = residues cross-linked by an oct-4-enyl staple,15,Antibacterial,<1 % Hemolysis at 25 µM,Human,Doubly-Stapled Alanine/Lysine-Based Peptides,α-Helix,NA,NA,NA
5505,26235946,2015,KXAKAXKKXAKAXWK,K{nnr:X}AKA{nnr:X}KK{nnr:X}AKA{nnr:X}WK{nt:Acet}{ct:Amid},Ac-DS-14W,Amidation,Acetylation,Linear,L,X = residues cross-linked by an oct-4-enyl staple,15,Antibacterial,38.8 % Hemolysis at 25 µM,Human,Doubly-Stapled Alanine/Lysine-Based Peptides,α-Helix,NA,NA,NA
5506,26235946,2015,KXAKAXKKXAKWXAK,K{nnr:X}AKA{nnr:X}KK{nnr:X}AKW{nnr:X}AK{nt:Acet}{ct:Amid},Ac-DS-12W,Amidation,Acetylation,Linear,L,X = residues cross-linked by an oct-4-enyl staple,15,Antibacterial,42.5 % Hemolysis at 25 µM,Human,Doubly-Stapled Alanine/Lysine-Based Peptides,α-Helix,NA,NA,NA
5507,26235946,2015,KXAKWXKKXAKAXAK,K{nnr:X}AKW{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:Acet}{ct:Amid},Ac-DS-3W,Amidation,Acetylation,Linear,L,X = residues cross-linked by an oct-4-enyl staple,15,Antibacterial,42.5 % Hemolysis at 25 µM,Human,Doubly-Stapled Alanine/Lysine-Based Peptides,α-Helix,NA,NA,NA
5508,26235946,2015,KXWKAXKKXAKAXAK,K{nnr:X}WKA{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:Acet}{ct:Amid},Ac-DS-5W,Amidation,Acetylation,Linear,L,X = residues cross-linked by an oct-4-enyl staple,15,Antibacterial,38.5 % Hemolysis at 25 µM,Human,Doubly-Stapled Alanine/Lysine-Based Peptides,α-Helix,NA,NA,NA
5509,26235946,2015,KXAKWXKKXAKAXAK,K{nnr:X}AKW{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:Succinylated}{ct:Amid},Su-DS-5W,Amidation,Succinylated,Linear,L,X = residues cross-linked by an oct-4-enyl staple,15,Antibacterial,32.6 % Hemolysis at 25 µM,Human,Doubly-Stapled Alanine/Lysine-Based Peptides,α-Helix,NA,NA,NA
5510,26235946,2015,KXAKWXKKXAKAXAK,K{nnr:X}AKW{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:H}{ct:Amid},H-DS-5W,Amidation,H,Linear,L,X = residues cross-linked by an oct-4-enyl staple,15,Antibacterial,25.5 % Hemolysis at 25 µM,Human,Doubly-Stapled Alanine/Lysine-Based Peptides,α-Helix,NA,NA,NA
5511,26235946,2015,KAAKAAKKAAKAAWK,KAAKAAKKAAKAAWK{nt:Acet}{ct:Amid},Ac-UM-14W,Amidation,Acetylation,Linear,L,X = residues cross-linked by an oct-4-enyl staple,15,Antibacterial,<1 % Hemolysis at 12.5 µM,Human,Doubly-Stapled Alanine/Lysine-Based Peptides,α-Helix,NA,NA,NA
5512,26235946,2015,KXAKAXKKAAKAAWK,K{nnr:X}AKA{nnr:X}KKAAKAAWK{nt:Acet}{ct:Amid},Ac-SS-14W,Amidation,Acetylation,Linear,L,X = residues cross-linked by an oct-4-enyl staple,15,Antibacterial,<1 % Hemolysis at 12.5 µM,Human,Doubly-Stapled Alanine/Lysine-Based Peptides,α-Helix,NA,NA,NA
5513,26235946,2015,KXAKAXKKXAKAXWK,K{nnr:X}AKA{nnr:X}KK{nnr:X}AKA{nnr:X}WK{nt:Acet}{ct:Amid},Ac-DS-14W,Amidation,Acetylation,Linear,L,X = residues cross-linked by an oct-4-enyl staple,15,Antibacterial,22.1 % Hemolysis at 12.5 µM,Human,Doubly-Stapled Alanine/Lysine-Based Peptides,α-Helix,NA,NA,NA
5514,26235946,2015,KXAKAXKKXAKWXAK,K{nnr:X}AKA{nnr:X}KK{nnr:X}AKW{nnr:X}AK{nt:Acet}{ct:Amid},Ac-DS-12W,Amidation,Acetylation,Linear,L,X = residues cross-linked by an oct-4-enyl staple,15,Antibacterial,25.3 % Hemolysis at 12.5 µM,Human,Doubly-Stapled Alanine/Lysine-Based Peptides,α-Helix,NA,NA,NA
5515,26235946,2015,KXAKWXKKXAKAXAK,K{nnr:X}AKW{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:Acet}{ct:Amid},Ac-DS-3W,Amidation,Acetylation,Linear,L,X = residues cross-linked by an oct-4-enyl staple,15,Antibacterial,28.9 % Hemolysis at 12.5 µM,Human,Doubly-Stapled Alanine/Lysine-Based Peptides,α-Helix,NA,NA,NA
5516,26235946,2015,KXWKAXKKXAKAXAK,K{nnr:X}WKA{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:Acet}{ct:Amid},Ac-DS-5W,Amidation,Acetylation,Linear,L,X = residues cross-linked by an oct-4-enyl staple,15,Antibacterial,22 % Hemolysis at 12.5 µM,Human,Doubly-Stapled Alanine/Lysine-Based Peptides,α-Helix,NA,NA,NA
5517,26235946,2015,KXAKWXKKXAKAXAK,K{nnr:X}AKW{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:Succinylated}{ct:Amid},Su-DS-5W,Amidation,Succinylated,Linear,L,X = residues cross-linked by an oct-4-enyl staple,15,Antibacterial,19.5 % Hemolysis at 12.5 µM,Human,Doubly-Stapled Alanine/Lysine-Based Peptides,α-Helix,NA,NA,NA
5518,26235946,2015,KXAKWXKKXAKAXAK,K{nnr:X}AKW{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:H}{ct:Amid},H-DS-5W,Amidation,H,Linear,L,X = residues cross-linked by an oct-4-enyl staple,15,Antibacterial,13.5 % Hemolysis at 12.5 µM,Human,Doubly-Stapled Alanine/Lysine-Based Peptides,α-Helix,NA,NA,NA
5587,26152423,2015,MRLVKVSAAVILVLLAVSAS,MRLVKVSAAVILVLLAVSAS,Rhamp1- His,Free,Free,Linear,L,None,22,Antibacterial,Hemolysis at 10 µM,Rabbit,Rhipicephalus Haemaphysaloides,NA,NA,CCCCCCSTTTCCCCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(C)C
5588,26159095,2015,GIVFLDHVESFQVKPKLRKFQLYF,GIVFLDHVESFQVKPKLRKFQLYF{cyc:N-C},cMnALF24,Free,Free,Cyclic,L,None,24,Antibacterial,~10 % Hemolysis at 0.67 µM,Rabbit,Macrobrachium Nipponense,β-Sheets,Low hemolytic,CCSCCCSTTSSSCSSBTTBSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C
5589,26159095,2015,GIVFLDHVESFQVKPKLRKFQLYF,GIVFLDHVESFQVKPKLRKFQLYF{cyc:N-C},cMnALF24,Free,Free,Cyclic,L,None,24,Antibacterial,~10 % Hemolysis at 3.35 µM,Rabbit,Macrobrachium Nipponense,β-Sheets,Low hemolytic,CCSCCCSTTSSSCSSBTTBSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C
5590,26159095,2015,GIVFLDHVESFQVKPKLRKFQLYF,GIVFLDHVESFQVKPKLRKFQLYF{cyc:N-C},cMnALF24,Free,Free,Cyclic,L,None,24,Antibacterial,~10 % Hemolysis at 6.7 µM,Rabbit,Macrobrachium Nipponense,β-Sheets,Low hemolytic,CCSCCCSTTSSSCSSBTTBSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C
5591,26159095,2015,GIVFLDHVESFQVKPKLRKFQLYF,GIVFLDHVESFQVKPKLRKFQLYF{cyc:N-C},cMnALF24,Free,Free,Cyclic,L,None,24,Antibacterial,~10 % Hemolysis at 33.5 µM,Rabbit,Macrobrachium Nipponense,β-Sheets,Low hemolytic,CCSCCCSTTSSSCSSBTTBSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C
5592,26159095,2015,GIVFLDHVESFQVKPKLRKFQLYF,GIVFLDHVESFQVKPKLRKFQLYF{cyc:N-C},cMnALF24,Free,Free,Cyclic,L,None,24,Antibacterial,22 % Hemolysis at 67 µM,Rabbit,Macrobrachium Nipponense,β-Sheets,Low hemolytic,CCSCCCSTTSSSCSSBTTBSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C
5593,26311041,2015,FVQWFSKFLGRIL,FVQWFSKFLGRIL{ct:Amid},TL,Amidation,Free,Linear,L,None,13,Antibacterial,50 % Hemolysis at 15.4 µM,Human,Amphibian Skin Temporins,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
5594,26311041,2015,FVQWWSKWLGRIL,FVQWWSKWLGRIL{ct:Amid},TL-1,Amidation,Free,Linear,L,None,13,Antibacterial,50 % Hemolysis at 21.4 µM,Human,Analog Of Tl,α-Helix,NA,CCTTHHHHGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
5595,26311041,2015,FVRWWSKWLRRIL,FVRWWSKWLRRIL{ct:Amid},TL-2,Amidation,Free,Linear,L,None,13,Antibacterial,50 % Hemolysis at 8.5 µM,Human,Analog Of Tl,α-Helix,NA,CCTTHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
5596,26311041,2015,FVRWWSRWLRRIL,FVRWWSRWLRRIL{ct:Amid},TL-3,Amidation,Free,Linear,L,None,13,Antibacterial,50 % Hemolysis at 8 µM,Human,Analog Of Tl,α-Helix,NA,CCTTTHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
5597,26311041,2015,FVKWWSKWLKKIL,FVKWWSKWLKKIL{ct:Amid},TL-4,Amidation,Free,Linear,L,None,13,Antibacterial,50 % Hemolysis at 15.9 µM,Human,Analog Of Tl,α-Helix,NA,CCGGGHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
5669,26489599,2015,ILRWPWWPWRRK,ILRWPWWPWRRK{ct:Amid},Omiganan,Amidation,Free,Linear,L,None,12,Antibacterial,23 ± 1 % Hemolysis at 100 µM,Human,Derivative Of Indolicidin From Bovine Neutrophils,NA,NA,CCCCCCCSSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
5670,26489599,2015,BRBR,BRBR{ct:Amid},23,Amidation,Free,Linear,L,None,4,Antibacterial,<1 % Hemolysis at 100 µM,Human,Tetrapeptide,NA,Low hemolytic,NA,NA
5696,26656394,2015,GLRKKFRKTRKRIQKLGRKIGKTGRKVWKAWREYGQIPYPCRI,GLRKKFRKTRKRIQKLGRKIGKTGRKVWKAWREYGQIPYPCRI,Cap11,Free,Free,Linear,L,None,43,Antibacterial,4 ± 0 % Hemolysis at 64 μg/ml,Horse,"Mammalian, Guinea Pig, Neutrophils",α-Helical,NA,CBCSTTTTTGGGHHHHGGGSHHHHHHHHHHHHHCCCBCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(=O)O
5697,26656394,2015,KLRKLFRKLLKLIRKLLR,KLRKLFRKLLKLIRKLLR,Cap11-1-18m2,Free,Free,Linear,L,None,18,Antibacterial,52 ± 6 % Hemolysis at 64 μg/ml,Horse,Truncated Derivative Of Cap11,α-Helical,NA,CHHHHHHHHHHHGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5698,26656394,2015,GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY,Cap18,Free,Free,Linear,L,None,37,Antibacterial,1 ± 0 % Hemolysis at 64 μg/ml,Horse,"Mammalian, Rabbit, Neutrophils",α-Helical,NA,CHHHHHHHHTTHHHHHHHHHHHHHHHHSSCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
5699,26656394,2015,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,26,Antibacterial,110 ± 1 % Hemolysis at 128 μg/ml,Horse,"Insects, Honey Bee",α-Helical,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
5700,26656394,2015,ILPWKWPWWPWR,ILPWKWPWWPWR,Indolicidin,Free,Free,Linear,L,None,12,Antibacterial,12 ± 0 % Hemolysis at 128 μg/ml,Horse,"Mammalian, Bovine Neutrophils",Extended,NA,CCSCSSSSSTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5701,26656394,2015,SWLSKTAKKLENSAKKRISEGIAIAIQGGPR,SWLSKTAKKLENSAKKRISEGIAIAIQGGPR,Cecropin P1,Free,Free,Linear,L,None,31,Antibacterial,0 ± 0 % Hemolysis at 256 μg/ml,Horse,"Mammalian, Pig, Small Intestine",α-Helical,Non-hemolytic,CCTHHHHHHHHHHHHHHTTSSSCCCCCCSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
5702,26656394,2015,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKALG,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKALG{ct:Amid},Cecropin B,Amidation,Free,Linear,L,None,36,Antibacterial,0 ± 0 % Hemolysis at 256 μg/ml,Horse,"Insects, Giant Silk Moth, Pupae",α-Helical,Non-hemolytic,CHHHHHHHHHHHHHHTTCTTCCSSSSSSSSCHHHHC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)C(C)C
5703,26656394,2015,RLARIVVIRVAR,RLARIVVIRVAR,Bac2A,Free,Free,Linear,L,None,12,Antibacterial,0 ± 0 % Hemolysis at 256 μg/ml,Horse,Non-Amidated Version Of Bac2A-Nh2,α-Helical/β-Sheet,Non-hemolytic,CCCCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5704,26656394,2015,RLARIVVIRVAR,RLARIVVIRVAR{ct:Amid},Bac2A-NH2,Amidation,Free,Linear,L,None,12,Antibacterial,0 ± 0 % Hemolysis at 256 μg/ml,Horse,Linear Variant Of Bactenecin From Bovine Neutrophils,NA,Non-hemolytic,CCCCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5705,26656394,2015,RRWKIVVIRWRR,RRWKIVVIRWRR{ct:Amid},Sub5-NH2,Amidation,Free,Linear,L,None,12,Antibacterial,0 ± 0 % Hemolysis at 256 μg/ml,Horse,Synthetic Variant Of Bac2A-Nh2,NA,Non-hemolytic,CCCCCCHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
5706,26656394,2015,GIHDILKYGKPS,GIHDILKYGKPS,Myxinidin,Free,Free,Linear,L,None,12,Antibacterial,0 ± 0 % Hemolysis at 256 μg/ml,Horse,"Fish, Epidermal Mucus Of Hagfish",NA,Non-hemolytic,CCSGGGSSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC
5707,26656394,2015,GIHDILKYGKPS,GIHDILKYGKPS{ct:Amid},Myxinidin-NH2,Amidation,Free,Linear,L,None,12,Antibacterial,0 ± 0 % Hemolysis at 256 μg/ml,Horse,Amidated Form Of Myxinidin,NA,Non-hemolytic,CCSGGGSSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC
5708,26656394,2015,VDKGSYLPRPTPPRPIYNRN,VDKGSYLPRPTPPRPIYNRN,Pyrrhocoricin,Free,Free,Linear,L,None,20,Antibacterial,0 ± 0 % Hemolysis at 256 μg/ml,Horse,"Insects, Pyrrhocoris Apterus",NA,Non-hemolytic,CCSSSCCSSCCCSCSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O
5709,26656394,2015,GNNRPVYIPQPRPPHPRI,GNNRPVYIPQPRPPHPRI,Apidaecin IA,Free,Free,Linear,L,None,18,Antibacterial,0 ± 0 % Hemolysis at 256 μg/ml,Horse,"Insects, Honey Bee","Extended, proline rich",Non-hemolytic,CTTSSSCCSSSSSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CN)C(C)C)[C@@H](C)CC)C(=O)O
5710,26656394,2015,VDKPDYRPRPRPPNM,VDKPDYRPRPRPPNM,Metalnikowin I,Free,Free,Linear,L,None,15,Antibacterial,0 ± 0 % Hemolysis at 256 μg/ml,Horse,"Insects, Palomena Prasina",NA,Non-hemolytic,CCCSSSCCCCCCSCC,CSCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)O
5711,26680226,2015,NLCASLRARHTIPQCRKFGRR,NLCASLRARHTIPQCRKFGRR{ct:Amid},mBjAMP1,Amidation,Free,Linear,L,None,21,Antibacterial,little Hemolysis at 100 μg/ml,Human,Vaguely Eel Amphioxus Branchiostoma Japonicum,α-Helical,Low hemolytic,CCCSSCTTCCSTTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5712,26680226,2015,NLCASLRARHTIPQCRKFGRR,NLCASLRARHTIPQCRKFGRR{ct:Amid},mBjAMP1,Amidation,Free,Linear,L,None,21,Antibacterial,little Hemolysis at 50 μg/ml,Human,Vaguely Eel Amphioxus Branchiostoma Japonicum,α-Helical,Low hemolytic,CCCSSCTTCCSTTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5713,26680226,2015,NLCASLRARHTIPQCRKFGRR,NLCASLRARHTIPQCRKFGRR{ct:Amid},mBjAMP1,Amidation,Free,Linear,L,None,21,Antibacterial,little Hemolysis at 25 μg/ml,Human,Vaguely Eel Amphioxus Branchiostoma Japonicum,α-Helical,Low hemolytic,CCCSSCTTCCSTTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5714,26680226,2015,NLCASLRARHTIPQCRKFGRR,NLCASLRARHTIPQCRKFGRR{ct:Amid},mBjAMP1,Amidation,Free,Linear,L,None,21,Antibacterial,little Hemolysis at 12.5 μg/ml,Human,Vaguely Eel Amphioxus Branchiostoma Japonicum,α-Helical,Low hemolytic,CCCSSCTTCCSTTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5715,26606380,2015,IKIPSFFRNILKKVGKEAVSLIAGALKQS,IKIPSFFRNILKKVGKEAVSLIAGALKQS,pseudhymenochirin-1Pb,Free,Free,Linear,L,None,29,"Antibacterial, Cytotoxicity",30 ± 5 % Hemolysis at >100 µM,Mouse,"Merlin’S Clawed Frog, Pseudhymenochirus Merlini",α-Helical,NA,CCSHHHHHHHTTHHHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC
5716,26606380,2015,GIFPIFAKLLGKVIKVASSLISKGRTE,GIFPIFAKLLGKVIKVASSLISKGRTE,pseudhymenochirin-2Pa,Free,Free,Linear,L,None,27,"Antibacterial, Cytotoxicity",7 ± 2 % Hemolysis at >100 µM,Mouse,"Merlin’S Clawed Frog, Pseudhymenochirus Merlini",α-Helical,NA,CCCHHHHHHHHHHHHHHHHHHTTCCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
5717,26295533,2015,ILPWKWPWWPWRR,ILPWKWPWWPWRR{ct:Amid},Indolicidin,Amidation,Free,Linear,L,None,13,"Antibacterial, Antifungal",21 % Hemolysis at 0.25 mg/ml,Human,Bovine Cathelicidin,α-Helical,NA,CCCCCCSCCCTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5718,26295533,2015,ILPWKWPWWPWRR,ILPWKWPWWPWRR{ct:Amid},Indolicidin,Amidation,Free,Linear,L,None,13,"Antibacterial, Antifungal",~10 % Hemolysis at 0.1 mg/ml,Human,Bovine Cathelicidin,α-Helical,NA,CCCCCCSCCCTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5719,26295533,2015,ILPWKWPWWPWRR,ILPWKWPWWPWRR{ct:Amid},Indolicidin,Amidation,Free,Linear,L,None,13,"Antibacterial, Antifungal",5 % Hemolysis at 0.05 mg/ml,Human,Bovine Cathelicidin,α-Helical,NA,CCCCCCSCCCTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5720,26295533,2015,ILPWKWPWWPWRR,ILPWKWPWWPWRR{ct:Amid},Indolicidin,Amidation,Free,Linear,L,None,13,"Antibacterial, Antifungal",6 % Hemolysis at 0.025 mg/ml,Human,Bovine Cathelicidin,α-Helical,NA,CCCCCCSCCCTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5721,26295533,2015,RLARIVVIRVAR,RLARIVVIRVAR{cyc:N-C}{ct:Amid},Bac2A,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.25 mg/ml,Human,Bovine Host Defense Peptide Variant,α-Helical,NA,CCCCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5722,26295533,2015,RLARIVVIRVAR,RLARIVVIRVAR{cyc:N-C}{ct:Amid},Bac2A,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.1 mg/ml,Human,Bovine Host Defense Peptide Variant,α-Helical,NA,CCCCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5723,26295533,2015,RLARIVVIRVAR,RLARIVVIRVAR{cyc:N-C}{ct:Amid},Bac2A,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.05 mg/ml,Human,Bovine Host Defense Peptide Variant,α-Helical,NA,CCCCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5724,26295533,2015,RLARIVVIRVAR,RLARIVVIRVAR{cyc:N-C}{ct:Amid},Bac2A,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.025 mg/ml,Human,Bovine Host Defense Peptide Variant,α-Helical,NA,CCCCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5725,26295533,2015,RLRRIVVIRVAR,RLRRIVVIRVAR{cyc:N-C}{ct:Amid},R3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.25 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5726,26295533,2015,RLRRIVVIRVAR,RLRRIVVIRVAR{cyc:N-C}{ct:Amid},R3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.1 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5727,26295533,2015,RLRRIVVIRVAR,RLRRIVVIRVAR{cyc:N-C}{ct:Amid},R3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.05 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5728,26295533,2015,RLRRIVVIRVAR,RLRRIVVIRVAR{cyc:N-C}{ct:Amid},R3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.025 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5729,26295533,2015,RLARIVPIRVAR,RLARIVPIRVAR{cyc:N-C}{ct:Amid},P7,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.25 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCCCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C
5730,26295533,2015,RLARIVPIRVAR,RLARIVPIRVAR{cyc:N-C}{ct:Amid},P7,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.1 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCCCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C
5731,26295533,2015,RLARIVPIRVAR,RLARIVPIRVAR{cyc:N-C}{ct:Amid},P7,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.05 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCCCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C
5732,26295533,2015,RLARIVPIRVAR,RLARIVPIRVAR{cyc:N-C}{ct:Amid},P7,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.025 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCCCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C
5733,26295533,2015,VRWRIRVAVIRA,VRWRIRVAVIRA{cyc:N-C}{ct:Amid},W3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",10 % Hemolysis at 0.25 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCSSSCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
5734,26295533,2015,VRWRIRVAVIRA,VRWRIRVAVIRA{cyc:N-C}{ct:Amid},W3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",5 % Hemolysis at 0.1 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCSSSCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
5735,26295533,2015,VRWRIRVAVIRA,VRWRIRVAVIRA{cyc:N-C}{ct:Amid},W3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",>5 % Hemolysis at 0.05 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCSSSCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
5736,26295533,2015,VRWRIRVAVIRA,VRWRIRVAVIRA{cyc:N-C}{ct:Amid},W3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.025 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCSSSCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
5737,26295533,2015,RRWRIVVIRVRR,RRWRIVVIRVRR{cyc:N-C}{ct:Amid},Sub3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<10 % Hemolysis at 0.25 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5738,26295533,2015,RRWRIVVIRVRR,RRWRIVVIRVRR{cyc:N-C}{ct:Amid},Sub3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",10 % Hemolysis at 0.1 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5739,26295533,2015,RRWRIVVIRVRR,RRWRIVVIRVRR{cyc:N-C}{ct:Amid},Sub3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",5 % Hemolysis at 0.05 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5740,26295533,2015,RRWRIVVIRVRR,RRWRIVVIRVRR{cyc:N-C}{ct:Amid},Sub3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.025 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5741,26295533,2015,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES{ct:Amid},LL-37,Amidation,Free,Linear,L,None,37,"Antibacterial, Antifungal",<5 % Hemolysis at 0.25 mg/ml,Human,Human Cathelicidin,α-Helical,NA,CCHHHHHHHHHHHHHHHHHHHHHHHHHHTTTTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
5742,26295533,2015,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES{ct:Amid},LL-37,Amidation,Free,Linear,L,None,37,"Antibacterial, Antifungal",<5 % Hemolysis at 0.1 mg/ml,Human,Human Cathelicidin,α-Helical,NA,CCHHHHHHHHHHHHHHHHHHHHHHHHHHTTTTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
5743,26295533,2015,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES{ct:Amid},LL-37,Amidation,Free,Linear,L,None,37,"Antibacterial, Antifungal",<5 % Hemolysis at 0.05 mg/ml,Human,Human Cathelicidin,α-Helical,NA,CCHHHHHHHHHHHHHHHHHHHHHHHHHHTTTTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
5744,26295533,2015,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES{ct:Amid},LL-37,Amidation,Free,Linear,L,None,37,"Antibacterial, Antifungal",<5 % Hemolysis at 0.025 mg/ml,Human,Human Cathelicidin,α-Helical,NA,CCHHHHHHHHHHHHHHHHHHHHHHHHHHTTTTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
5745,26100634,2015,GLFGVLAKVAAHVVPAIAEHF,GLFGVLAKVAAHVVPAIAEHF{ct:Amid},Maculatin 1.1,Amidation,Free,Linear,L,None,21,"Anticancer, Antibacterial Gram-",50 % Hemolysis at 29.5 ± 1.0 µM,Human,Australian Tree Frog Litoria Genimaculata,α-Helical,NA,CHHHHHHHHHSSSCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5746,26100634,2015,GIGAVLKVTTGLPALISWIKRKRQQ,GIGAVLKVTTGLPALISWIKRKRQQ{ct:Amid},Melittin,Amidation,Free,Linear,L,None,26,"Anticancer, Antibacterial Gram-",50 % Hemolysis at 1.2± 0.1 µM,Human,Bee Venom,α-Helical,NA,CCCCCCCCCSSCHHHHHHHHTTCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
5784,25982541,2015,FIGAAARLASKIF,FIGAAARLASKIF{ct:Amid},BmKn2A1,Amidation,Free,Linear,L,None,13,Antibacterial,0 % Hemolysis at 0-100 μg/ml,Human,Analogs Of The Scorpion Venom Bmkn Peptides,α-Helical,Non-hemolytic,CCSSGGGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5785,25982541,2015,FIGAVARLVSKIF,FIGAVARLVSKIF{ct:Amid},BmKn2V1,Amidation,Free,Linear,L,None,13,Antibacterial,<100 % Hemolysis at 100 μg/ml,Human,Analogs Of The Scorpion Venom Bmkn Peptides,α-Helical,NA,CCSHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5786,25982541,2015,FIGALARLLSKIF,FIGALARLLSKIF{ct:Amid},BmKn2L1,Amidation,Free,Linear,L,None,13,Antibacterial,<100 % Hemolysis at 100 μg/ml,Human,Analogs Of The Scorpion Venom Bmkn Peptides,α-Helical,NA,CCHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5787,25982541,2015,FIGAIAKLLKKIF,FIGAIAKLLKKIF{ct:Amid},BmKn2K7,Amidation,Free,Linear,L,None,13,Antibacterial,<100 % Hemolysis at 100 μg/ml,Human,Analogs Of The Scorpion Venom Bmkn Peptides,α-Helical,NA,CCHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
5788,25982541,2015,FIGAVKGLLSKIF,FIGAVKGLLSKIF{ct:Amid},BmKn1-6Lys,Amidation,Free,Linear,L,None,13,Antibacterial,<60 % Hemolysis at 100 μg/ml,Human,Analogs Of The Scorpion Venom Bmkn Peptides,α-Helical,NA,CCGGGHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5789,25982541,2015,FKGALAGLLSKKF,FKGALAGLLSKKF{ct:Amid},BmKn1L2K2,Amidation,Free,Linear,L,None,13,Antibacterial,0 % Hemolysis at 0-100 μg/ml,Human,Analogs Of The Scorpion Venom Bmkn Peptides,α-Helical,Non-hemolytic,CCCHHHHHSCSCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5805,25891396,2015,AGYLLGKINLKALAALAKKIL,AGYLLGKINLKALAALAKKIL{ct:Amid},TP10,Amidation,Free,Linear,L,None,21,"Antibacterial, Anti-biofilm",80 % Hemolysis at 512 μg/ml,Human,Deletion Analogue Of The Cpp Transportan,α-Helical-50% TFE solution,NA,CTTTSCCCCHHHHHTGGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
5806,25891396,2015,AGYLLGKINLKPLAALAKKIL,AGYLLGKINLKPLAALAKKIL{ct:Amid},TP10-2,Amidation,Free,Linear,L,None,21,Antibacterial,0 % Hemolysis at 512 μg/ml,Human,Transportan 10 Analogues,α-Helical,Non-hemolytic,CCSCTTCSTTHHHHHTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
5807,25891396,2015,AAYLLAKINLKALAALAKKIL,AAYLLAKINLKALAALAKKIL{ct:Amid},TP10-3,Amidation,Free,Linear,L,None,21,Antibacterial,39.57 % Hemolysis at 512 μg/ml,Human,Transportan 10 Analogues,α-Helical,NA,CCSSSCCCCHHHIIIIIHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](C)N)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
5808,25891396,2015,AGYLLGKINLKKLAKL(Aib)KKIL,AGYLLGKINLKKLAKL{nnr:Aib}KKIL{ct:Amid},TP10-5,Amidation,Free,Linear,L,Aib = α-aminoisobutyric acid,21,"Antibacterial, Anti-biofilm",80 % Hemolysis at 512 μg/ml,Human,Transportan 10 Analogues,α-Helical,NA,NA,NA
5809,25891396,2015,AGYLLGKINLKPLAKL(Aib)KKIL,AGYLLGKINLKPLAKL{nnr:Aib}KKIL{ct:Amid},TP10-7,Amidation,Free,Linear,L,Aib = α-aminoisobutyric acid,21,"Antibacterial, Anti-biofilm",59.45 % Hemolysis at 512 μg/ml,Human,Transportan 10 Analogues,α-Helical,NA,NA,NA
5810,25891396,2015,AGYLLPKINLKPLAKLPKKIL,AGYLLPKINLKPLAKLPKKIL{ct:Amid},TP10-8,Amidation,Free,Linear,L,None,21,Antibacterial,0 % Hemolysis at 512 μg/ml,Human,Transportan 10 Analogues,α-Helical,Non-hemolytic,CCSCCTTSCCHHHHTSSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
5811,25839356,2015,FIHHIIGWISHGVRAIHRAIH,FIHHIIGWISHGVRAIHRAIH{ct:Amid},Gad-1,Amidation,Free,Linear,L,None,21,Antibacterial Gram-,50 % Hemolysis at 43 µM,Human,Atlantic Cod (Gadus Morhua),α-Helical,NA,CCSHHHHSCTTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
5812,25839356,2015,FIHHIIGWISHGVRAIHRAIH,FIHHIIGWISHGVRAIHRAIH{ct:Amid},Gad-1,Amidation,Free,Linear,L,None,21,"Antibacterial Gram-, Anti-cancer",100 % Hemolysis at 100 µM,Human,Atlantic Cod (Gadus Morhua),α-Helical,NA,CCSHHHHSCTTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
5813,25839356,2015,FIHHIIGWISHGVRAIHRAIH,FIHHIIGWISHGVRAIHRAIH{ct:Amid},Gad-1,Amidation,Free,Linear,L,None,21,"Antibacterial Gram-, Anti-cancer",100 % Hemolysis at 200 µM,Human,Atlantic Cod (Gadus Morhua),α-Helical,NA,CCSHHHHSCTTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
5814,25839356,2015,FIHHIIGWISHGVRAIHRAIH,FIHHIIGWISHGVRAIHRAIH{ct:Amid},Gad-1,Amidation,Free,Linear,L,None,21,"Antibacterial Gram-, Anti-cancer",100 % Hemolysis at 400 µM,Human,Atlantic Cod (Gadus Morhua),α-Helical,NA,CCSHHHHSCTTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
5815,25839356,2015,FLHHIVGLIHHGLSLFGDR,FLHHIVGLIHHGLSLFGDR{ct:Amid},Gad-2,Amidation,Free,Linear,L,None,21,"Antibacterial Gram-, Anti-cancer",50 % Hemolysis at 56 µM,Human,Atlantic Cod (Gadus Morhua),α-Helical,NA,CCCTTTCCTTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5816,25839356,2015,FLHHIVGLIHHGLSLFGDR,FLHHIVGLIHHGLSLFGDR{ct:Amid},Gad-2,Amidation,Free,Linear,L,None,21,"Antibacterial Gram-, Anti-cancer",<90 % Hemolysis at 100 µM,Human,Atlantic Cod (Gadus Morhua),α-Helical,NA,CCCTTTCCTTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5817,25839356,2015,FLHHIVGLIHHGLSLFGDR,FLHHIVGLIHHGLSLFGDR{ct:Amid},Gad-2,Amidation,Free,Linear,L,None,21,"Antibacterial Gram-, Anti-cancer",100 % Hemolysis at 200 µM,Human,Atlantic Cod (Gadus Morhua),α-Helical,NA,CCCTTTCCTTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5818,25839356,2015,FLHHIVGLIHHGLSLFGDR,FLHHIVGLIHHGLSLFGDR{ct:Amid},Gad-2,Amidation,Free,Linear,L,None,21,"Antibacterial Gram-, Anti-cancer",100 % Hemolysis at 400 µM,Human,Atlantic Cod (Gadus Morhua),α-Helical,NA,CCCTTTCCTTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5819,25451872,2015,FIGAVAGLLSKIF,FIGAVAGLLSKIF{ct:Amid},BmKn1OR,Amidation,Free,Linear,L,None,13,Antibacterial,100 % Hemolysis at 50 μg/ml,Human,Analogs Of Peptides From Buthus Martensii Scorpion Venom,α-Helical,NA,CGGGGHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5820,25451872,2015,FIGAVAGLLSKIF,FIGAVAGLLSKIF{ct:Amid},BmKn1OR,Amidation,Free,Linear,L,None,13,Antibacterial,100 % Hemolysis at 100 μg/ml,Human,Analogs Of Peptides From Buthus Martensii Scorpion Venom,α-Helical,NA,CGGGGHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5821,25451872,2015,FIGAIARLLSKIF,FIGAIARLLSKIF{ct:Amid},BmKn2OR,Amidation,Free,Linear,L,None,13,Antibacterial,100 % Hemolysis at 50 μg/ml,Human,Analogs Of Peptides From Buthus Martensii Scorpion Venom,α-Helical,NA,CCHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
5822,25451872,2015,FIGAIARLLSKIF,FIGAIARLLSKIF{ct:Amid},BmKn2OR,Amidation,Free,Linear,L,None,13,Antibacterial,100 % Hemolysis at 100 μg/ml,Human,Analogs Of Peptides From Buthus Martensii Scorpion Venom,α-Helical,NA,CCHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
5823,25451872,2015,FIGAAAGLASKIF,FIGAAAGLASKIF{ct:Amid},BmKn1A1,Amidation,Free,Linear,L,None,13,Antibacterial,<10 % Hemolysis at 50 μg/ml,Human,Analogs Of Peptides From Buthus Martensii Scorpion Venom,α-Helical,NA,CCSSCTTTSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5824,25451872,2015,FIGAAAGLASKIF,FIGAAAGLASKIF{ct:Amid},BmKn1A1,Amidation,Free,Linear,L,None,13,Antibacterial,<10 % Hemolysis at 100 μg/ml,Human,Analogs Of Peptides From Buthus Martensii Scorpion Venom,α-Helical,NA,CCSSCTTTSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5825,25451872,2015,FIGAVAGLVSKIF,FIGAVAGLVSKIF{ct:Amid},BmKn1V1,Amidation,Free,Linear,L,None,13,Antibacterial,<10 % Hemolysis at 50 μg/ml,Human,Analogs Of Peptides From Buthus Martensii Scorpion Venom,α-Helical,NA,CTTHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5826,25451872,2015,FIGAVAGLVSKIF,FIGAVAGLVSKIF{ct:Amid},BmKn1V1,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 100 μg/ml,Human,Analogs Of Peptides From Buthus Martensii Scorpion Venom,α-Helical,NA,CTTHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5827,25451872,2015,FIGALAGLLSKIF,FIGALAGLLSKIF{ct:Amid},BmKn1L1,Amidation,Free,Linear,L,None,13,Antibacterial,100 % Hemolysis at 50 μg/ml,Human,Analogs Of Peptides From Buthus Martensii Scorpion Venom,α-Helical,NA,CCHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5828,25451872,2015,FIGALAGLLSKIF,FIGALAGLLSKIF{ct:Amid},BmKn1L1,Amidation,Free,Linear,L,None,13,Antibacterial,100 % Hemolysis at 100 μg/ml,Human,Analogs Of Peptides From Buthus Martensii Scorpion Venom,α-Helical,NA,CCHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5829,25451872,2015,FIGAVAKLLKKIF,FIGAVAKLLKKIF{ct:Amid},BmKn1K7,Amidation,Free,Linear,L,None,13,Antibacterial,<100 % Hemolysis at 50 μg/ml,Human,Analogs Of Peptides From Buthus Martensii Scorpion Venom,α-Helical,NA,CCHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5830,25451872,2015,FIGAVAKLLKKIF,FIGAVAKLLKKIF{ct:Amid},BmKn1K7,Amidation,Free,Linear,L,None,13,Antibacterial,<100 % Hemolysis at 100 μg/ml,Human,Analogs Of Peptides From Buthus Martensii Scorpion Venom,α-Helical,NA,CCHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5831,25451872,2015,FIGAVAELLEKIF,FIGAVAELLEKIF{ct:Amid},BmKn1E7,Amidation,Free,Linear,L,None,13,Antibacterial,0 % Hemolysis at 50 μg/ml,Human,Analogs Of Peptides From Buthus Martensii Scorpion Venom,α-Helical,Non-hemolytic,CCCSSSGGGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5832,25451872,2015,FIGAVAELLEKIF,FIGAVAELLEKIF{ct:Amid},BmKn1E7,Amidation,Free,Linear,L,None,13,Antibacterial,0 % Hemolysis at 100 μg/ml,Human,Analogs Of Peptides From Buthus Martensii Scorpion Venom,α-Helical,Non-hemolytic,CCCSSSGGGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
5861,25640709,2015,ILGPVLGLVSDTLDDVLGIL,ILGPVLGLVSDTLDDVLGIL{ct:Amid},MH5N,Amidation,Free,Linear,L,None,20,Antibacterial,20 % Hemolysis at 90 µM,Human,Synthetic Homologue Of Maximin H5,α-Helical,NA,CTTGGGGGGGTSCCIIIIIC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(C)C
5862,25640709,2015,ILGPVLGLVSDTLDDVLGIL,ILGPVLGLVSDTLDDVLGIL{ct:Amid},MH5N,Amidation,Free,Linear,L,None,20,Antibacterial,<12 % Hemolysis at <25 µM,Human,Synthetic Homologue Of Maximin H6,α-Helical,NA,CTTGGGGGGGTSCCIIIIIC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(C)C
5863,25640709,2015,ILGPVLGLVSDTLDDVLGIL,ILGPVLGLVSDTLDDVLGIL{ct:Amid},MH5N,Amidation,Free,Linear,L,None,20,Antibacterial,15 % Hemolysis at >450 µM,Human,Synthetic Homologue Of Maximin H7,α-Helical,NA,CTTGGGGGGGTSCCIIIIIC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(C)C
5864,25640709,2015,ILGPVLGLVSDTLDDVLGIL,ILGPVLGLVSDTLDDVLGIL{ct:Amid},MH5C,Amidation,Free,Linear,L,None,20,Antibacterial,12 % Hemolysis at 180 µM,Human,Isoform Of Mh5N,α-Helical,NA,CTTGGGGGGGTSCCIIIIIC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(C)C
5865,25640709,2015,ILGPVLGLVSDTLDDVLGIL,ILGPVLGLVSDTLDDVLGIL{ct:Amid},MH5C,Amidation,Free,Linear,L,None,20,Antibacterial,<12 % Hemolysis at <25 µM,Human,Isoform Of Mh5N,α-Helical,NA,CTTGGGGGGGTSCCIIIIIC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(C)C
5866,25640709,2015,ILGPVLGLVSDTLDDVLGIL,ILGPVLGLVSDTLDDVLGIL{ct:Amid},MH5C,Amidation,Free,Linear,L,None,20,Antibacterial,25 % Hemolysis at >450 µM,Human,Isoform Of Mh5N,α-Helical,NA,CTTGGGGGGGTSCCIIIIIC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(C)C
5867,26144972,2015,VARGWKRKCPLFGKGG,VARGWKRKCPLFGKGG,VG16KRKP,Free,Free,Linear,L,None,16,"Antibacterial, Antifungal",0.12 % Hemolysis at 25 µM,Human,Analogue Of Vg16,Loop-type,Non-hemolytic,CTTTCCCCCSCCSCCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)O
5868,26144972,2015,VARGWKRKCPLFGKGG,VARGWKRKCPLFGKGG,VG16KRKP,Free,Free,Linear,L,None,16,"Antibacterial, Antifungal",<0.12 % Hemolysis at 50 µM,Human,Analogue Of Vg16,Loop-type,Non-hemolytic,CTTTCCCCCSCCSCCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)O
5869,26144972,2015,VARGWKRKCPLFGKGG,VARGWKRKCPLFGKGG,VG16KRKP,Free,Free,Linear,L,None,16,"Antibacterial, Antifungal",0.1 % Hemolysis at 100 µM,Human,Analogue Of Vg16,Loop-type,Non-hemolytic,CTTTCCCCCSCCSCCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)O
5870,26144972,2015,VARGWKRKCPLFGKGG,VARGWKRKCPLFGKGG,VG16KRKP,Free,Free,Linear,L,None,16,"Antibacterial, Antifungal",0.09 % Hemolysis at 150 µM,Human,Analogue Of Vg16,Loop-type,Non-hemolytic,CTTTCCCCCSCCSCCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)O
5871,26144972,2015,VARGWKRKCPLFGKGG,VARGWKRKCPLFGKGG,VG16KRKP,Free,Free,Linear,L,None,16,"Antibacterial, Antifungal",<0.12 % Hemolysis at 200 µM,Human,Analogue Of Vg16,Loop-type,Non-hemolytic,CTTTCCCCCSCCSCCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)O
5872,26144972,2015,VARGWKRKCPLFGKGG,VARGWKRKCPLFGKGG,VG16KRKP,Free,Free,Linear,L,None,16,"Antibacterial, Antifungal",0.1 % Hemolysis at 250 µM,Human,Analogue Of Vg16,Loop-type,Non-hemolytic,CTTTCCCCCSCCSCCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)O
5873,25530580,2015,GLLTRIKTLL,GLLTRIKTLL{ct:Amid},4T,Amidation,Free,Linear,L,None,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,CCGGGSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
5874,25530580,2015,GLLHserRIKTLL,GLL{nnr:Hser}RIKTLL{ct:Amid},4Hser,Amidation,Free,Linear,L,HSer = homoserine,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5875,25530580,2015,GLLSRIKTLL,GLLSRIKTLL{ct:Amid},4S,Amidation,Free,Linear,L,None,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,CHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
5876,25530580,2015,GLLKRIKTLL,GLLKRIKTLL{ct:Amid},Anoplin,Amidation,Free,Linear,L,None,10,Antibacterial,50 % Hemolysis at >500 µM,Human,"Solitary Spider Wasp, Anoplius Samariensis",α-Helical,NA,CTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
5877,25530580,2015,GLLOrnRIKTLL,GLL{nnr:O}RIKTLL{ct:Amid},4Orn,Amidation,Free,Linear,L,O = L-Ornithine,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5878,25530580,2015,GLLKRIKSLL,GLLKRIKSLL{ct:Amid},8S,Amidation,Free,Linear,L,None,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,CHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
5879,25530580,2015,GLLDabRIKTLL,GLL{nnr:Dab}RIKTLL{ct:Amid},4Dab,Amidation,Free,Linear,L,"Dab = 2,4-diaminobutanoic acid",10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5880,25530580,2015,GLLDapRIKTLL,GLL{nnr:Dap}RIKTLL{ct:Amid},4Dap,Amidation,Free,Linear,L,"Dap = 2,3-diaminopropanoic acid",10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5881,25530580,2015,GLLKKIKKLL,GLLKKIKKLL{ct:Amid},5K8K,Amidation,Free,Linear,L,None,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,CTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
5882,25530580,2015,GLLKRIKKLL,GLLKRIKKLL{ct:Amid},8K,Amidation,Free,Linear,L,None,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,CHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
5883,25530580,2015,GLLDabRIKDabLL,GLL{nnr:Dab}RIK{nnr:Dab}LL{ct:Amid},"4,8Dab",Amidation,Free,Linear,L,"Dab = 2,4-diaminobutanoic acid",10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5884,25530580,2015,G(O-Me-Ser)(O-Me-Ser)KRIKT(O-Me-Ser)(O-Me-Ser),G{nnr:O-Me-Ser}{nnr:O-Me-Ser}KRIKT{nnr:O-Me-Ser}{nnr:O-Me-Ser}{ct:Amid},"2,3,9,10(O-Me-Ser)",Amidation,Free,Linear,L,O-Me-Ser = O-methyl-serine,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5885,25530580,2015,G(O-Me-Ser)LKRIKTL(O-Me-Ser),G{nnr:O-Me-Ser}LKRIKTL{nnr:O-Me-Ser}{ct:Amid},"2,10(O-Me-Ser)",Amidation,Free,Linear,L,O-Me-Ser = O-methyl-serine,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5886,25530580,2015,GVVKRIKTVV,GVVKRIKTVV{ct:Amid},"2,3,9,10V",Amidation,Free,Linear,L,None,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,CGGGGGTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
5887,25530580,2015,GMMKRIKTMM,GMMKRIKTMM{ct:Amid},"2,3,9,10M",Amidation,Free,Linear,L,None,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,CGGGGGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCSC)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O
5888,25530580,2015,G(O-Me-Ser)LKRIKTLL,G{nnr:O-Me-Ser}LKRIKTLL{ct:Amid},2(O-Me-Ser),Amidation,Free,Linear,L,O-Me-Ser = O-methyl-serine,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5889,25530580,2015,GNvaNvaKRIKTNvaNva,GNV{d}A{d}NV{d}A{d}KRIKTNV{d}A{d}NV{d}A{d}{ct:Amid},"2,3,9,10Nva",Amidation,Free,Linear,L,None,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
5890,25530580,2015,GVLKRIKTLV,GVLKRIKTLV{ct:Amid},"2,10V",Amidation,Free,Linear,L,None,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,CHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O
5891,25530580,2015,GLMKRIKTML,GLMKRIKTML{ct:Amid},"3,9M",Amidation,Free,Linear,L,None,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,CHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
5892,25530580,2015,GMLKRIKTLM,GMLKRIKTLM{ct:Amid},"2,10M",Amidation,Free,Linear,L,None,10,Antibacterial,50 % Hemolysis at 500 µM,Human,Anoplin Analogues,α-Helical,NA,CTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O
5893,25530580,2015,GNvaLKRIKTLNva,G{nnr:Nva}LKRIKTL{nnr:Nva}{ct:Amid},"2,10Nva",Amidation,Free,Linear,L,Nva = Norvaline,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5894,25530580,2015,GMLKRIKTLL,GMLKRIKTLL{ct:Amid},2M,Amidation,Free,Linear,L,None,10,Antibacterial,50 % Hemolysis at 400 µM,Human,Anoplin Analogues,α-Helical,NA,CTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
5895,25530580,2015,GNleLKRIKTLNle,G{nnr:Nle}LKRIKTL{nnr:Nle}{ct:Amid},"2,10Nle",Amidation,Free,Linear,L,Nle = Norleucine,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5896,25530580,2015,GNleNleKRIKTNleNle,G{nnr:Nle}{nnr:Nle}KRIKT{nnr:Nle}{nnr:Nle}{ct:Amid},"2,3,9,10Nle",Amidation,Free,Linear,L,Nle = Norleucine,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5897,25530580,2015,GEpaLKRIKTLEpa,G{nnr:Epa}LKRIKTL{nnr:Epa}{ct:Amid},"2,10Epa",Amidation,Free,Linear,L,"Epa = 2-amino,3-ethylpentanoic acid",10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5898,25530580,2015,GHleLKRIKTLHle,G{nnr:Hle}LKRIKTL{nnr:Hle}{ct:Amid},"2,10Hle",Amidation,Free,Linear,L,Hle = homoleucine,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5899,25530580,2015,GChaLKRIKTLL,G{nnr:Cha}LKRIKTLL{ct:Amid},2Cha,Amidation,Free,Linear,L,Cha = 3- cyclohexylalanine,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5900,25530580,2015,GLLKRIKTLCha,GLLKRIKTL{nnr:Cha}{ct:Amid},10Cha,Amidation,Free,Linear,L,Cha = 3- cyclohexylalanine,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5901,25530580,2015,GβNalKRIKTLL,G{nnr:βNal}KRIKTLL{ct:Amid},2(βNal),Amidation,Free,Linear,L,βNal = 3(2-naphtyl)alanine,10,Antibacterial,50 % Hemolysis at >500 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5902,25530580,2015,GHleHleKRIKTHleHle,G{nnr:Hle}{nnr:Hle}KRIKT{nnr:Hle}{nnr:Hle}{ct:Amid},"2,3,9,10Hle",Amidation,Free,Linear,L,Hle = homoleucine,10,Antibacterial,50 % Hemolysis at 380 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5903,25530580,2015,GAocLKRIKTLAoc,G{nnr:Aoc}LKRIKTL{nnr:Aoc}{ct:Amid},"2,10Aoc",Amidation,Free,Linear,L,Aoc = 2-aminooctanoic acid,10,Antibacterial,50 % Hemolysis at 500 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5904,25530580,2015,GChaLKRIKTChaL,G{nnr:Cha}LKRIKT{nnr:Cha}L{ct:Amid},"2,9Cha",Amidation,Free,Linear,L,Cha = 3- cyclohexylalanine,10,Antibacterial,50 % Hemolysis at 350 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5905,25530580,2015,GChaLKRIKTLCha,G{nnr:Cha}LKRIKTL{nnr:Cha}{ct:Amid},"2,10Cha",Amidation,Free,Linear,L,Cha = 3- cyclohexylalanine,10,Antibacterial,50 % Hemolysis at 300 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5906,25530580,2015,GAocAocKRIKTAocAoc,G{nnr:Aoc}{nnr:Aoc}KRIKT{nnr:Aoc}{nnr:Aoc}{ct:Amid},"2,3,9,10Aoc",Amidation,Free,Linear,L,Aoc = 2-aminooctanoic acid,10,Antibacterial,50 % Hemolysis at 125 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5907,25530580,2015,GALKRβNalKTLA,GALKR{nnr:βNal}KTLA{ct:Amid},"2,10A6(βNal)",Amidation,Free,Linear,L,βNal = 3(2-naphtyl)alanine,10,Antibacterial,50 % Hemolysis at 71 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5908,25530580,2015,GNvaNvaKRβNalKTNvaNva,G{nnr:Nva}{nnr:Nva}KR{nnr:βNal}KT{nnr:Nva}{nnr:Nva}{ct:Amid},"2,3,9,10Nva6(βNal)",Amidation,Free,Linear,L,"Nva = Norvaline, βNal = 3(2-naphtyl)alanine",10,Antibacterial,50 % Hemolysis at 120 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5909,25530580,2015,GNvaLKRβNalKTLNva,G{nnr:Nva}LKR{nnr:βNal}KTL{nnr:Nva}{ct:Amid},"2,10Nva6(βNal)",Amidation,Free,Linear,L,"Nva = Norvaline, βNal = 3(2-naphtyl)alanine",10,Antibacterial,50 % Hemolysis at 100 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5910,25530580,2015,GLNvaKRβNalKTNvaL,GL{nnr:Nva}KR{nnr:βNal}KT{nnr:Nva}L{ct:Amid},"3,9Nva6(βNal)",Amidation,Free,Linear,L,"Nva = Norvaline, βNal = 3(2-naphtyl)alanine",10,Antibacterial,50 % Hemolysis at 20 µM,Human,Anoplin Analogues,α-Helical,NA,NA,NA
5911,25530580,2015,GLLKKIKWLL,GLLKKIKWLL{ct:Amid},5K8W,Amidation,Free,Linear,L,None,10,Antibacterial,50 % Hemolysis at 130 µM,Human,Anoplin Analogues,α-Helical,NA,CTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
5912,25530580,2015,GLLKKIKWLL,GLLKKIKWLL{ct:Amid},5W,Amidation,Free,Linear,L,None,10,Antibacterial,50 % Hemolysis at 20 µM,Human,Anoplin Analogues,α-Helical,NA,CTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
5913,25530580,2015,GLLKFIKWLL,GLLKFIKWLL{ct:Amid},5F8W,Amidation,Free,Linear,L,None,10,Antibacterial,50 % Hemolysis at 2 µM,Human,Anoplin Analogues,α-Helical,NA,CTHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
5919,25728268,2015,MLIFVHIIAPVISGCAIAFFSYWLSRRNTK,MLIFVHIIAPVISGCAIAFFSYWLSRRNTK{ct:Amid},PepA1,Amidation,Free,Linear,L,None,30,Antibacterial,50 % Hemolysis at 70 µM,Human,Bacteria S. Aureus,α-Helical,NA,CCCCCSSHHHHTTTCHHHHHHHHCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
5920,25728268,2015,MLIFVHIIAPVISGC,MLIFVHIIAPVISGC{ct:Amid},Pep N-ter,Amidation,Free,Linear,L,None,15,Antibacterial,50 % Hemolysis at 300-900 µM,Human,Derived From Pepa1,NA,NA,CCCCCSHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C
5921,25728268,2015,AIAFFSYWLSRRNTK,AIAFFSYWLSRRNTK{ct:Amid},Pep C-ter,Amidation,Free,Linear,L,None,15,Antibacterial,50 % Hemolysis at 420 µM,Human,Derived From Pepa2,NA,NA,CCCSSHHHHTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
5922,25728268,2015,FFSYWLSRRNTK,FFSYWLSRRNTK{ct:Amid},Pep1,Amidation,Free,Linear,L,None,12,Antibacterial,50 % Hemolysis at 300-900 µM,Human,Derived From Pepa3,NA,NA,CCSSCCSSCCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
5923,25728268,2015,FFSYWLSRRTK,FFSYWLSRRTK{ct:Amid},Pep2,Amidation,Free,Linear,L,None,11,Antibacterial,50 % Hemolysis at 300-900 µM,Human,Derived From Pepa4,NA,NA,CCTBTTBCSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
5924,25728268,2015,FFSWLSRRTK,FFSWLSRRTK{ct:Amid},Pep3,Amidation,Free,Linear,L,None,10,Antibacterial,50 % Hemolysis at 300-900 µM,Human,Derived From Pepa5,NA,NA,CCSSSSSCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
5925,25728268,2015,FFWLSRRTK,FFWLSRRTK{ct:Amid},Pep4,Amidation,Free,Linear,L,None,9,Antibacterial,50 % Hemolysis at 300-900 µM,Human,Derived From Pepa6,NA,NA,CCSSSSCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
5926,25728268,2015,FFWLSRTK,FFWLSRTK{ct:Amid},Pep5,Amidation,Free,Linear,L,None,8,Antibacterial,50 % Hemolysis at 300-900 µM,Human,Derived From Pepa7,NA,NA,CTTTTTTC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
5927,25728268,2015,FFWLSRRTK,FFWLSRRTK{cyc:N-C},Pep6,Free,Free,Cyclic,L,None,9,Antibacterial,50 % Hemolysis at 5 µM,Human,Derived From Pepa8,NA,NA,CCSSSSCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
5928,25728268,2015,FFWSRRTK,FFWSRRTK{cyc:N-C},Pep7,Free,Free,Cyclic,L,None,8,Antibacterial,50 % Hemolysis at 14 µM,Human,Derived From Pepa9,NA,NA,CCSCCCCC,C[C@@H](O)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
5929,25728268,2015,FFWRRTK,FFWRRTK{cyc:N-C},Pep8,Free,Free,Cyclic,L,None,7,Antibacterial,50 % Hemolysis at 160 µM,Human,Derived From Pepa10,NA,NA,CCCCCCC,C[C@@H](O)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
5930,25728268,2015,FFWLRR-aza-β3Hyt-K,FFWLRR{nnr:aza-β3Hyt}K{ct:Amid},Pep9,Amidation,Free,Linear,L,aza-β3Hyt = aza-b3 -homohydroxythreonine,8,Antibacterial,50 % Hemolysis at 300-900 µM,Human,Derived From Pepa11,NA,NA,NA,NA
5931,25728268,2015,FFWLRR-aza-β3Hyt-K,FFWLRR{nnr:aza-β3Hyt}K{cyc:N-C},Pep10,Free,Free,Cyclic,L,aza-b3 = homohydroxythreonine,8,Antibacterial,50 % Hemolysis at 150 µM,Human,Derived From Pepa12,NA,NA,NA,NA
5932,25728268,2015,FFWRR-aza-β3Hyt-K,FFWRR{nnr:aza-β3Hyt}K{cyc:N-C},Pep11,Free,Free,Cyclic,L,aza-b3 = homohydroxythreonine,7,Antibacterial,50 % Hemolysis at 840 µM,Human,Derived From Pepa13,NA,NA,NA,NA
5933,25683050,2015,RWTWRGSGRWTWR,RWTWRGSGRWTWR{nt:Acet}{ct:Amid},l-RW,Amidation,Acetylation,Linear,L,None,13,Antibacterial,0 % Hemolysis at 8-500 μg/ml,Rabbit,Synthetic,NA,Non-hemolytic,CCCCSSSSCCCCC,C[C@@H](O)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5934,25941665,2015,MKILCFFIVLLFVAVHGAVGFSRSPRYHM QCGYRGTFCTPGKCPHGNAYLGLCRPKYSCCRWL,MKILCFFIVLLFVAVHGAVGFSRSPRYHM QCGYRGTFCTPGKCPHGNAYLGLCRPKYSCCRWL{nt:Acet},AvBD-4,Free,Acetylation,Linear,L,None,64,"Antibacterial, Antifungal",1 % Hemolysis at 12.5 μg/ml,Chicken,Synthetic Chicken Β-Defensin,NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)[C@@H](C)O)C(=O)O.CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C=O)CCSC)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)CC
5935,25941665,2015,MKILCFFIVLLFVAVHGAVGFSRSPRYHM QCGYRGTFCTPGKCPHGNAYLGLCRPKYSCCRWL,MKILCFFIVLLFVAVHGAVGFSRSPRYHM QCGYRGTFCTPGKCPHGNAYLGLCRPKYSCCRWL{nt:Acet},AvBD-4,Free,Acetylation,Linear,L,None,64,"Antibacterial, Antifungal",<3 % Hemolysis at 25 μg/ml,Chicken,Synthetic Chicken Β-Defensin,NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)[C@@H](C)O)C(=O)O.CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C=O)CCSC)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)CC
5936,25941665,2015,MKILCFFIVLLFVAVHGAVGFSRSPRYHM QCGYRGTFCTPGKCPHGNAYLGLCRPKYSCCRWL,MKILCFFIVLLFVAVHGAVGFSRSPRYHM QCGYRGTFCTPGKCPHGNAYLGLCRPKYSCCRWL{nt:Acet},AvBD-4,Free,Acetylation,Linear,L,None,64,"Antibacterial, Antifungal",<4 % Hemolysis at 50 μg/ml,Chicken,Synthetic Chicken Β-Defensin,NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)[C@@H](C)O)C(=O)O.CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C=O)CCSC)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)CC
5937,25941665,2015,MKILCFFIVLLFVAVHGAVGFSRSPRYHM QCGYRGTFCTPGKCPHGNAYLGLCRPKYSCCRWL,MKILCFFIVLLFVAVHGAVGFSRSPRYHM QCGYRGTFCTPGKCPHGNAYLGLCRPKYSCCRWL{nt:Acet},AvBD-4,Free,Acetylation,Linear,L,None,64,"Antibacterial, Antifungal",6 % Hemolysis at 100 μg/ml,Chicken,Synthetic Chicken Β-Defensin,NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)[C@@H](C)O)C(=O)O.CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C=O)CCSC)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)CC
5938,25941665,2015,MKILCLLFAVLLFLFQAAPGSADPLFPDTVACRT QGNFCRAGACPPTFTISGQCHGGLLNCCAKIPAQ,MKILCLLFAVLLFLFQAAPGSADPLFPDTVACRT QGNFCRAGACPPTFTISGQCHGGLLNCCAKIPAQ{nt:Acet},AvBD-10,Free,Acetylation,Linear,L,None,69,"Antibacterial, Antifungal",1 % Hemolysis at 12.5 μg/ml,Chicken,Synthetic Chicken Β-Defensin,NA,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC.CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C=O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
5939,25941665,2015,MKILCLLFAVLLFLFQAAPGSADPLFPDTVACRT QGNFCRAGACPPTFTISGQCHGGLLNCCAKIPAQ,MKILCLLFAVLLFLFQAAPGSADPLFPDTVACRT QGNFCRAGACPPTFTISGQCHGGLLNCCAKIPAQ{nt:Acet},AvBD-10,Free,Acetylation,Linear,L,None,69,"Antibacterial, Antifungal",<3 % Hemolysis at 25 μg/ml,Chicken,Synthetic Chicken Β-Defensin,NA,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC.CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C=O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
5940,25941665,2015,MKILCLLFAVLLFLFQAAPGSADPLFPDTVACRT QGNFCRAGACPPTFTISGQCHGGLLNCCAKIPAQ,MKILCLLFAVLLFLFQAAPGSADPLFPDTVACRT QGNFCRAGACPPTFTISGQCHGGLLNCCAKIPAQ{nt:Acet},AvBD-10,Free,Acetylation,Linear,L,None,69,"Antibacterial, Antifungal",<3 % Hemolysis at 50 μg/ml,Chicken,Synthetic Chicken Β-Defensin,NA,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC.CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C=O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
5941,25941665,2015,MKILCLLFAVLLFLFQAAPGSADPLFPDTVACRT QGNFCRAGACPPTFTISGQCHGGLLNCCAKIPAQ,MKILCLLFAVLLFLFQAAPGSADPLFPDTVACRT QGNFCRAGACPPTFTISGQCHGGLLNCCAKIPAQ{nt:Acet},AvBD-10,Free,Acetylation,Linear,L,None,69,"Antibacterial, Antifungal",<6 % Hemolysis at 100 μg/ml,Chicken,Synthetic Chicken Β-Defensin,NA,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC.CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C=O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
5942,26574006,2015,MANNVFDLDVEVKSVNSVNQNIGLFTSTCFSSQCFSSKFTDTFSSNCFTGRHQCGYTHGSC,MANNVFDLDVEVKSVNSVNQNIGLFTSTCFSSQCFSSKFTDTFSSNCFTGRHQCGYTHGSC,penisin,Free,Free,Linear,L,None,61,Antibacterial,0 % Hemolysis at 5 µM,Rabbit,Paenibacillus Sp. Strain A3,Random coil,Non-hemolytic,CCCCSSCSCSSSSSTBCSSCBSSCCCCSSSSCSCCCCSCTTTSCCCCCCSSSSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
5943,26574006,2015,MANNVFDLDVEVKSVNSVNQNIGLFTSTCFSSQCFSSKFTDTFSSNCFTGRHQCGYTHGSC,MANNVFDLDVEVKSVNSVNQNIGLFTSTCFSSQCFSSKFTDTFSSNCFTGRHQCGYTHGSC,penisin,Free,Free,Linear,L,None,61,Antibacterial,0 % Hemolysis at 10 µM,Rabbit,Paenibacillus Sp. Strain A3,Random coil,Non-hemolytic,CCCCSSCSCSSSSSTBCSSCBSSCCCCSSSSCSCCCCSCTTTSCCCCCCSSSSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
5944,26574006,2015,MANNVFDLDVEVKSVNSVNQNIGLFTSTCFSSQCFSSKFTDTFSSNCFTGRHQCGYTHGSC,MANNVFDLDVEVKSVNSVNQNIGLFTSTCFSSQCFSSKFTDTFSSNCFTGRHQCGYTHGSC,penisin,Free,Free,Linear,L,None,61,Antibacterial,0 % Hemolysis at 20 µM,Rabbit,Paenibacillus Sp. Strain A3,Random coil,Non-hemolytic,CCCCSSCSCSSSSSTBCSSCBSSCCCCSSSSCSCCCCSCTTTSCCCCCCSSSSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
5945,26574006,2015,MANNVFDLDVEVKSVNSVNQNIGLFTSTCFSSQCFSSKFTDTFSSNCFTGRHQCGYTHGSC,MANNVFDLDVEVKSVNSVNQNIGLFTSTCFSSQCFSSKFTDTFSSNCFTGRHQCGYTHGSC,penisin,Free,Free,Linear,L,None,61,Antibacterial,2 % Hemolysis at 40 µM,Rabbit,Paenibacillus Sp. Strain A3,Random coil,NA,CCCCSSCSCSSSSSTBCSSCBSSCCCCSSSSCSCCCCSCTTTSCCCCCCSSSSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
5946,26574006,2015,MANNVFDLDVEVKSVNSVNQNIGLFTSTCFSSQCFSSKFTDTFSSNCFTGRHQCGYTHGSC,MANNVFDLDVEVKSVNSVNQNIGLFTSTCFSSQCFSSKFTDTFSSNCFTGRHQCGYTHGSC,penisin,Free,Free,Linear,L,None,61,Antibacterial,<4 % Hemolysis at 80 µM,Rabbit,Paenibacillus Sp. Strain A3,Random coil,NA,CCCCSSCSCSSSSSTBCSSCBSSCCCCSSSSCSCCCCSCTTTSCCCCCCSSSSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
5947,26574006,2015,MANNVFDLDVEVKSVNSVNQNIGLFTSTCFSSQCFSSKFTDTFSSNCFTGRHQCGYTHGSC,MANNVFDLDVEVKSVNSVNQNIGLFTSTCFSSQCFSSKFTDTFSSNCFTGRHQCGYTHGSC,penisin,Free,Free,Linear,L,None,61,Antibacterial,<4 % Hemolysis at 100 µM,Rabbit,Paenibacillus Sp. Strain A3,Random coil,NA,CCCCSSCSCSSSSSTBCSSCBSSCCCCSSSSCSCCCCSCTTTSCCCCCCSSSSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
5954,25581614,2015,HLNKRVQRELIGWLDWLK,HLNKRVQRELIGWLDWLK,AmyI-1-18,Free,Free,Linear,L,None,18,"Antibacterial, Antifungal",20 % Hemolysis at 1000 µM,Sheep,Α-Amylase (Amyi-1) Of Rice (Oryza Sativa L. Japonica),α-Helical,Non-hemolytic,CCTTHHHHTTTTTCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
5955,25773522,2015,ILGKIWEGIKSLF,ILGKIWEGIKSLF{ct:Amid},IsCT,Amidation,Free,Linear,L,None,13,Antibacterial,~86 % Hemolysis at 90 µM,Human,"Scorpion, Opisthacanthus Madagascariensis",α-Helical,NA,CHHHHHHHHTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
5956,25773522,2015,ILGKIWKGIKSLF,ILGKIWKGIKSLF{ct:Amid},E7K-IsCT,Amidation,Free,Linear,L,None,13,Antibacterial,48 % Hemolysis at 90 µM,Human,Isct Designed Analogs,α-Helical,NA,CCHHHHHHHHTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
5957,25773522,2015,ILGKIWEGKKSLF,ILGKIWEGKKSLF{ct:Amid},I9K-IsCT,Amidation,Free,Linear,L,None,13,Antibacterial,0.4 % Hemolysis at 90 µM,Human,Isct Designed Analogs,α-Helical,Non-hemolytic,CCSTTSCGGGCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
5958,25773522,2015,ILGKIWKGKKSLF,ILGKIWKGKKSLF{ct:Amid},"E7K,I9K-IsCT",Amidation,Free,Linear,L,None,13,Antibacterial,0.14 % Hemolysis at 90 µM,Human,Isct Designed Analogs,α-Helical,Non-hemolytic,CCSSCSSSCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
5959,25773522,2015,ILGKIWEGIKSLF,ILGKIWEGIKSLF{ct:Amid},IsCT,Amidation,Free,Linear,L,None,13,Antibacterial,50 % Hemolysis at 43.59 µM,Human,"Scorpion, Opisthacanthus Madagascariensis",α-Helical,NA,CHHHHHHHHTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
5960,25773522,2015,ILGKIWKGIKSLF,ILGKIWKGIKSLF{ct:Amid},E7K-IsCT,Amidation,Free,Linear,L,None,13,Antibacterial,50 % Hemolysis at 92.17 µM,Human,Isct Designed Analogs,α-Helical,NA,CCHHHHHHHHTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
5961,25773522,2015,ILGKIWEGKKSLF,ILGKIWEGKKSLF{ct:Amid},I9K-IsCT,Amidation,Free,Linear,L,None,13,Antibacterial,50 % Hemolysis at 500 µM,Human,Isct Designed Analogs,α-Helical,Non-hemolytic,CCSTTSCGGGCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
5962,25773522,2015,ILGKIWKGKKSLF,ILGKIWKGKKSLF{ct:Amid},"E7K,I9K-IsCT",Amidation,Free,Linear,L,None,13,Antibacterial,50 % Hemolysis at 500 µM,Human,Isct Designed Analogs,α-Helical,Non-hemolytic,CCSSCSSSCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
5963,25583073,2015,VDIHVWDGVVDIHVWDGV,VDIHVWDGVVDIHVWDGV,PIP-18[59–76],Free,Free,Linear,L,None,18,"Antibacterial, Wound healing activity",<20 % Hemolysis at 100 μg/ml,Human,Python Reticulatus Serum Protein,α-Helical,Low hemolytic,CCSCCCCCCSSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C
5964,25583073,2015,LGRVDIHVWDGVYIRGR,LGRVDIHVWDGVYIRGR,[D-Ala66]-PNT.II,Free,Free,Linear,L,None,17,Antibacterial,<30 % Hemolysis at 100 μg/ml,Human,Python Reticulatus Serum Protein,α-Helical,NA,CCSSCSCTTTCSSTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5965,25583073,2015,CVDIHVWDGVC,CVDIHVWDGVC{cyc:N-C},Cyclic C-PIP[57-67]C,Free,Free,Cyclic,L,None,11,Antibacterial,30 % Hemolysis at 100 μg/ml,Human,Python Reticulatus Serum Protein,β or Helical,NA,CCSSCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
5966,25583073,2015,VEIHVWEGV,VEIHVWEGV,"D60,65E-PIP[59-67]",Free,Free,Linear,L,None,9,Antibacterial,<30 % Hemolysis at 100 μg/ml,Human,Python Reticulatus Serum Protein,α-Helical,NA,CCSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)C(C)C
5967,25583073,2015,VDIHVWDGV,VDIHVWDGV,β-Asp65-PIP[59-67],Free,Free,Linear,L,None,9,"Antibacterial, Wound healing activity",<20 % Hemolysis at 100 μg/ml,Human,Python Reticulatus Serum Protein,α-Helical,Low hemolytic,CCCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)C(C)C
6053,26456194,2016,SPAIWGCDSFLGYCRLACFAHEA,SPAIWGCDSFLGYCRLACFAHEA,defensin-TK,Free,Free,Linear,L,None,23,"Antibacterial, Antifungal",1.5 % Hemolysis at 50 μg/ml,Human,Frog Theloderma Kwangsiensis,α-Helix/β-Sheet,NA,CTTCCCSSCHHHHHTTSCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O
6054,26456194,2016,SPAIWGCDSFLGYCRLACFAHEA,SPAIWGCDSFLGYCRLACFAHEA,defensin-TK,Free,Free,Linear,L,None,23,"Antibacterial, Antifungal",2.7 % Hemolysis at 100 μg/ml,Human,Frog Theloderma Kwangsiensis,α-Helix/β-Sheet,NA,CTTCCCSSCHHHHHTTSCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O
6055,26456194,2016,SPAIWGCDSFLGYCRLACFAHEA,SPAIWGCDSFLGYCRLACFAHEA,defensin-TK,Free,Free,Linear,L,None,23,"Antibacterial, Antifungal",6.2 % Hemolysis at 200 μg/ml,Human,Frog Theloderma Kwangsiensis,α-Helix/β-Sheet,NA,CTTCCCSSCHHHHHTTSCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O
6058,26385363,2016,AAKAAAKAAAKAA,AAKAAAKAAAKAA{ct:Amid},KL0A10,Amidation,Free,Linear,L,None,13,Antibacterial,5 % Hemolysis at >256 µM,Human,Mirror-Like Peptides,α-Helix,NA,CCSCSSSCCCCCC,C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
6059,26385363,2016,LLKAAAKAAAKLL,LLKAAAKAAAKLL{ct:Amid},KL4A6,Amidation,Free,Linear,L,None,13,Antibacterial,5 % Hemolysis at >256 µM,Human,Mirror-Like Peptides,α-Helix,NA,CCCCTTHHHHTCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)O
6060,26385363,2016,AAKLLLKLLLKAA,AAKLLLKLLLKAA{ct:Amid},KL6A4,Amidation,Free,Linear,L,None,13,Antibacterial,5 % Hemolysis at 8 µM,Human,Mirror-Like Peptides,α-Helix,NA,CHHHHHHHHTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
6061,26385363,2016,LLKLLLKLLLKLL,LLKLLLKLLLKLL{ct:Amid},KL10A0,Amidation,Free,Linear,L,None,13,Antibacterial,5 % Hemolysis at 2 µM,Human,Mirror-Like Peptides,α-Helix,NA,CHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)O
6120,26918268,2016,Fmoc-k(iPr)(Boc),{conj:Fmoc}-K{d}{nnr:iPr}{nnr:Boc}{ct:OH},gA3K(iPr),OH,Free,Linear,Mix,"K{d} = D-lysine, fmoc = 9-fluorenylmethoxycarbonyl, iPr = Isopropyl group, Boc = ε-amino group of the lysine side chain",15,Antibacterial,0 % Hemolysis at 10 µM,Human,Bacillus Brevis,β-Helix,Non-hemolytic,NA,NA
6121,26918268,2016,Fmoc-k(Cy)(Boc),{conj:Fmoc}-K{d}{nnr:Cy}{nnr:Boc}{ct:OH},gA3K(Cy),OH,Free,Linear,Mix,"fmoc = 9-fluorenylmethoxycarbonyl, Cy = Cyclohexyl group, Boc=ε-amino group of the lysine side chain, K{d} = D-Lys",15,Antibacterial,55 % Hemolysis at 20 µM,Human,Bacillus Brevis,β-Helix,NA,NA,NA
6122,26918268,2016,Fmoc-k(CyMe)(Boc),{conj:Fmoc}-K{d}{nnr:CyMe}{nnr:Boc}{ct:OH},gA3K(CyMe),OH,Free,Linear,Mix,"fmoc = 9-fluorenylmethoxycarbonyl, CyMe = Cyclohexylmethyl group, Boc=ε-amino group of the lysine side chain, K{d} = D-Lys",15,Antibacterial,<90 % Hemolysis at 10 µM,Human,Bacillus Brevis,β-Helix,NA,NA,NA
6123,26918268,2016,Fmoc-k(Bn)(Boc),{conj:Fmoc}-K{d}{nnr:Bn}{nnr:Boc}{ct:OH},gA3K(Bn),OH,Free,Linear,Mix,"fmoc = 9-fluorenylmethoxycarbonyl, Bn = Benzyl group, Boc=ε-amino group of the lysine side chain, K{d} = D-Lys",15,Antibacterial,<90 % Hemolysis at 10 µM,Human,Bacillus Brevis,β-Helix,NA,NA,NA
6124,26918268,2016,Fmoc-k(2pyr)(Boc),{conj:Fmoc}-K{d}{nnr:2pyr}{nnr:Boc}{ct:OH},gA3K(2pyr),OH,Free,Linear,Mix,"fmoc = 9-fluorenylmethoxycarbonyl, 2pyr = 2-Pyridyl group, Boc = ε-amino group of the lysine side chain, K{d} = D-Lys",15,Antibacterial,0 % Hemolysis at 10 µM,Human,Bacillus Brevis,β-Helix,Non-hemolytic,NA,NA
6125,26918268,2016,Fmoc-k(3pyr)(Boc),{conj:Fmoc}-K{d}{nnr:3pyr}{nnr:Boc}{ct:OH},gA3K(3pyr),OH,Free,Linear,Mix,"fmoc = 9-fluorenylmethoxycarbonyl, 3pyr = 3-Pyridyl group, Boc = ε-amino group of the lysine side chain, K{d} = D-Lys",15,Antibacterial,0 % Hemolysis at 10 µM,Human,Bacillus Brevis,β-Helix,Non-hemolytic,NA,NA
6126,26918268,2016,Fmoc-k(4pyr)(Boc),{conj:Fmoc}-K{d}{nnr:4pyr}{nnr:Boc}{ct:OH},gA3K(4pyr),OH,Free,Linear,Mix,"fmoc = 9-fluorenylmethoxycarbonyl, 4pyr = 4-Pyridyl group, Boc=ε-amino group of the lysine side chain, K{d} = D-Lys",15,Antibacterial,0 % Hemolysis at 10 µM,Human,Bacillus Brevis,β-Helix,Non-hemolytic,NA,NA
6127,26918268,2016,Fmoc-k(4AMBn)(Boc),{conj:Fmoc}-K{d}{nnr:4AMBn}{nnr:Boc}{ct:OH},gA3K(4AMBn),OH,Free,Linear,Mix,"fmoc = 9-fluorenylmethoxycarbonyl, 4AMBn = 4-Aminomethylbenzyl group, Boc=ε-amino group of the lysine side chain, K{d} = D-Lys",15,Antibacterial,<25 % Hemolysis at 75 µM,Human,Bacillus Brevis,β-Helix,NA,NA,NA
6128,26876358,2016,GEGFLGMLLHGVGHAIHGLIHGK,GEGFLGMLLHGVGHAIHGLIHGK,Rbpisc,Free,Free,Linear,L,None,15,Antibacterial,0 % Hemolysis at <63 µM,Fish,Oplegnathus Fasciatus,Helix-Loop-Helix,NA,CCCSHHHHSSCSCCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CN)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
6129,26876358,2016,GEGFLGMLLHGVGHAIHGLIHGK,GEGFLGMLLHGVGHAIHGLIHGK,Rbpisc,Free,Free,Linear,L,None,15,Antibacterial,13 % Hemolysis at 125 µM,Fish,Oplegnathus Fasciatus,Helix-Loop-Helix,NA,CCCSHHHHSSCSCCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CN)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
6130,26876358,2016,GEGFLGMLLHGVGHAIHGLIHGK,GEGFLGMLLHGVGHAIHGLIHGK,Rbpisc,Free,Free,Linear,L,None,15,Antibacterial,28.9 % Hemolysis at 250 µM,Fish,Oplegnathus Fasciatus,Helix-Loop-Helix,NA,CCCSHHHHSSCSCCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CN)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
6131,26876358,2016,GEGFLGMLLHGVGHAIHGLIHGK,GEGFLGMLLHGVGHAIHGLIHGK,Rbpisc,Free,Free,Linear,L,None,15,Antibacterial,70.13 % Hemolysis at 500 µM,Fish,Oplegnathus Fasciatus,Helix-Loop-Helix,NA,CCCSHHHHSSCSCCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CN)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
6132,27114317,2016,FLKGCWTKWYSLKPKCPF,FLKGCWTKWYSLKPKCPF{ct:Amid},Megin 1,Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal",2.3 % Hemolysis at 25 µM,Human,Skin Venoms Of Spadefoot Toad Megophrys Minor,NA,NA,CCCCCCSSSSCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6133,27114317,2016,FLKGCWTKWYSLKPKCPF,FLKGCWTKWYSLKPKCPF{ct:Amid},Megin 1,Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal",5.6 % Hemolysis at 50 µM,Human,Skin Venoms Of Spadefoot Toad Megophrys Minor,NA,NA,CCCCCCSSSSCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6134,27114317,2016,FLKGCWTKWYSLKPKCPF,FLKGCWTKWYSLKPKCPF{ct:Amid},Megin 1,Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal",18.7 % Hemolysis at 100 µM,Human,Skin Venoms Of Spadefoot Toad Megophrys Minor,NA,NA,CCCCCCSSSSCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6135,27114317,2016,FLKGCWTKWYSLKPKCPF,FLKGCWTKWYSLKPKCPF{ct:Amid},Megin 1,Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal",29.5 % Hemolysis at 200 µM,Human,Skin Venoms Of Spadefoot Toad Megophrys Minor,NA,NA,CCCCCCSSSSCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6136,27114317,2016,FFVLKFLLKWAGKVGLEHLACKFKNWC,FFVLKFLLKWAGKVGLEHLACKFKNWC,Megin 2,Free,Free,Linear,L,None,27,"Antibacterial, Antifungal",3.9 % Hemolysis at 25 µM,Human,Skin Venoms Of Spadefoot Toad Megophrys Minor,NA,NA,CCGGGTGGGTTTTSCSCSSSSSCCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
6137,27114317,2016,FFVLKFLLKWAGKVGLEHLACKFKNWC,FFVLKFLLKWAGKVGLEHLACKFKNWC,Megin 2,Free,Free,Linear,L,None,27,"Antibacterial, Antifungal",13.7 % Hemolysis at 50 µM,Human,Skin Venoms Of Spadefoot Toad Megophrys Minor,NA,NA,CCGGGTGGGTTTTSCSCSSSSSCCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
6138,27114317,2016,FFVLKFLLKWAGKVGLEHLACKFKNWC,FFVLKFLLKWAGKVGLEHLACKFKNWC,Megin 2,Free,Free,Linear,L,None,27,"Antibacterial, Antifungal",27.7 % Hemolysis at 100 µM,Human,Skin Venoms Of Spadefoot Toad Megophrys Minor,NA,NA,CCGGGTGGGTTTTSCSCSSSSSCCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
6139,27114317,2016,FFVLKFLLKWAGKVGLEHLACKFKNWC,FFVLKFLLKWAGKVGLEHLACKFKNWC,Megin 2,Free,Free,Linear,L,None,27,"Antibacterial, Antifungal",45.3 % Hemolysis at 200 µM,Human,Skin Venoms Of Spadefoot Toad Megophrys Minor,NA,NA,CCGGGTGGGTTTTSCSCSSSSSCCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
6140,27114317,2016,FLKGCWTKWYSLKPKCPF,FLKGCWTKWYSLKPKCPF{ct:Amid},Megin 1,Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal",3.1 % Hemolysis at 25 µM,Rabbit,Skin Venoms Of Spadefoot Toad Megophrys Minor,NA,NA,CCCCCCSSSSCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6141,27114317,2016,FLKGCWTKWYSLKPKCPF,FLKGCWTKWYSLKPKCPF{ct:Amid},Megin 1,Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal",7.3 % Hemolysis at 50 µM,Rabbit,Skin Venoms Of Spadefoot Toad Megophrys Minor,NA,NA,CCCCCCSSSSCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6142,27114317,2016,FLKGCWTKWYSLKPKCPF,FLKGCWTKWYSLKPKCPF{ct:Amid},Megin 1,Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal",20.5 % Hemolysis at 100 µM,Rabbit,Skin Venoms Of Spadefoot Toad Megophrys Minor,NA,NA,CCCCCCSSSSCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6143,27114317,2016,FLKGCWTKWYSLKPKCPF,FLKGCWTKWYSLKPKCPF{ct:Amid},Megin 1,Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal",32.9 % Hemolysis at 200 µM,Rabbit,Skin Venoms Of Spadefoot Toad Megophrys Minor,NA,NA,CCCCCCSSSSCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6144,27114317,2016,FFVLKFLLKWAGKVGLEHLACKFKNWC,FFVLKFLLKWAGKVGLEHLACKFKNWC,Megin 2,Free,Free,Linear,L,None,27,"Antibacterial, Antifungal",5.6 % Hemolysis at 25 µM,Rabbit,Skin Venoms Of Spadefoot Toad Megophrys Minor,NA,NA,CCGGGTGGGTTTTSCSCSSSSSCCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
6145,27114317,2016,FFVLKFLLKWAGKVGLEHLACKFKNWC,FFVLKFLLKWAGKVGLEHLACKFKNWC,Megin 2,Free,Free,Linear,L,None,27,"Antibacterial, Antifungal",15.2 % Hemolysis at 50 µM,Rabbit,Skin Venoms Of Spadefoot Toad Megophrys Minor,NA,NA,CCGGGTGGGTTTTSCSCSSSSSCCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
6146,27114317,2016,FFVLKFLLKWAGKVGLEHLACKFKNWC,FFVLKFLLKWAGKVGLEHLACKFKNWC,Megin 2,Free,Free,Linear,L,None,27,"Antibacterial, Antifungal",36.2 % Hemolysis at 100 µM,Rabbit,Skin Venoms Of Spadefoot Toad Megophrys Minor,NA,NA,CCGGGTGGGTTTTSCSCSSSSSCCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
6147,27114317,2016,FFVLKFLLKWAGKVGLEHLACKFKNWC,FFVLKFLLKWAGKVGLEHLACKFKNWC,Megin 2,Free,Free,Linear,L,None,27,"Antibacterial, Antifungal",50.3 % Hemolysis at 200 µM,Rabbit,Skin Venoms Of Spadefoot Toad Megophrys Minor,NA,NA,CCGGGTGGGTTTTSCSCSSSSSCCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
6148,26998557,2016,GIMSSLMKKLAAHIAK,GIMSSLMKKLAAHIAK{ct:Amid},HYL,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at >400 µM,Human,Hylaeus Signatus,α-Helix,NA,CHHHHHHHHHHSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
6149,26998557,2016,GIMSSLMKKLKAHIAK,GIMSSLMKKLKAHIAK{ct:Amid},HYL-1,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at >400 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHHSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
6150,26998557,2016,GIMSSLMKKLAKHIAK,GIMSSLMKKLAKHIAK{ct:Amid},HYL-2,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at >400 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHHSCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
6151,26998557,2016,GIMSSLMKKLAAHIKK,GIMSSLMKKLAAHIKK{ct:Amid},HYL-3,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at >400 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHTSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
6152,26998557,2016,GIMSSLMKKLKKHIAK,GIMSSLMKKLKKHIAK{ct:Amid},HYL-4,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at >400 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHHSCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
6153,26998557,2016,GIMISLMKKLAAHIAK,GIMISLMKKLAAHIAK{ct:Amid},HYL-5,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at 320 µM,Human,Analog Of Hyl,α-Helix,NA,CCHHHHHHHHHSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
6154,26998557,2016,GIMSSLMKKLAAIIAK,GIMSSLMKKLAAIIAK{ct:Amid},HYL-6,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at 93 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
6155,26998557,2016,GIMSSLMKKLAKIIAK,GIMSSLMKKLAKIIAK{ct:Amid},HYL-7,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at >400 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
6156,26998557,2016,GIMSSLMKKLKKIIAK,GIMSSLMKKLKKIIAK{ct:Amid},HYL-8,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at >400 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
6157,26998557,2016,gimsslmkklkkiiak,G{d}I{d}M{d}S{d}S{d}L{d}M{d}K{d}K{d}L{d}K{d}K{d}I{d}I{d}A{d}K{d}{ct:Amid},HYL-9,Amidation,Free,Linear,D,None,16,"Antibacterial, Antifungal",50 % Hemolysis at >400 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
6158,26998557,2016,GIMSSLMKKLAKIIKK,GIMSSLMKKLAKIIKK{ct:Amid},HYL-10,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at >400 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
6159,26998557,2016,GIMSSLMKKLKKIIKK,GIMSSLMKKLKKIIKK{ct:Amid},HYL-11,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at 284 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
6160,26998557,2016,GILSSLLKKLKKIIAK,GILSSLLKKLKKIIAK{ct:Amid},HYL-12,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at 333 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
6161,26998557,2016,gilssllkklkkiiak,G{d}I{d}L{d}S{d}S{d}L{d}L{d}K{d}K{d}L{d}K{d}K{d}I{d}I{d}A{d}K{d}{ct:Amid},HYL-13,Amidation,Free,Linear,D,None,16,"Antibacterial, Antifungal",50 % Hemolysis at 373 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
6162,26998557,2016,GIXSSLXKKLKKIIAK,GI{nnr:X}SSL{nnr:X}KKLKKIIAK{ct:Amid},HYL-14,Amidation,Free,Linear,L,X = norleucine,16,"Antibacterial, Antifungal",50 % Hemolysis at >400 µM,Human,Analog Of Hyl,α-Helix,NA,NA,NA
6163,26998557,2016,GILKSLLKKLKKIIAK,GILKSLLKKLKKIIAK{ct:Amid},HYL-15,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at >400 µM,Human,Analog Of Hyl,α-Helix,NA,CTHHHHHHHHGGGGCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
6164,26998557,2016,GILSKLLKKLKKIIAK,GILSKLLKKLKKIIAK{ct:Amid},HYL-16,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at 364 µM,Human,Analog Of Hyl,α-Helix,NA,CTTHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
6165,26998557,2016,KILSSLLKKLKKIIAK,KILSSLLKKLKKIIAK{ct:Amid},HYL-17,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at 165 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
6166,26998557,2016,GIWSSLLKKLKKIIAK,GIWSSLLKKLKKIIAK{ct:Amid},HYL-18,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at >400 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
6167,26998557,2016,GILSSWLKKLKKIIAK,GILSSWLKKLKKIIAK{ct:Amid},HYL-19,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at 197 µM,Human,Analog Of Hyl,α-Helix,NA,CCHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
6168,26998557,2016,GILSSLWKKLKKIIAK,GILSSLWKKLKKIIAK{ct:Amid},HYL-20,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at 191 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
6169,26998557,2016,gilsslwkklkkiiak,G{d}I{d}L{d}S{d}S{d}L{d}W{d}K{d}K{d}L{d}K{d}K{d}I{d}I{d}A{d}K{d}{ct:Amid},HYL-21,Amidation,Free,Linear,D,None,16,"Antibacterial, Antifungal",50 % Hemolysis at >400 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
6170,26998557,2016,GKLSSLWKKLKKIIAK,GKLSSLWKKLKKIIAK{ct:Amid},HYL-22,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at >400 µM,Human,Analog Of Hyl,α-Helix,NA,CTTHHHHTTGGGGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
6171,26998557,2016,GILSSLLKKWKKIIAK,GILSSLLKKWKKIIAK{ct:Amid},HYL-23,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at 115 µM,Human,Analog Of Hyl,α-Helix,NA,CTHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
6172,26998557,2016,GILSSLLKKLKKWIAK,GILSSLLKKLKKWIAK{ct:Amid},HYL-24,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at 57 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
6173,26998557,2016,GILSSLWKKLKKWIAK,GILSSLWKKLKKWIAK{ct:Amid},HYL-25,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at >400 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
6174,26998557,2016,GILSSLWKKPKKIIAK,GILSSLWKKPKKIIAK{ct:Amid},HYL-26,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at >400 µM,Human,Analog Of Hyl,α-Helix,NA,CHHHHHTTSGGGTTCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
6175,27128941,2016,VWLSALKFIGKHLAKHQLSKL,VWLSALKFIGKHLAKHQLSKL{ct:Amid},Lycosin-II,Amidation,Free,Linear,L,None,21,Antibacterial,<10 % Hemolysis at 6.25 µM,Human,Chinese Wolf Spider Lycosa Singoriensis,α-Helix,NA,CCHHHHHHHHCSCSSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
6176,27128941,2016,VWLSALKFIGKHLAKHQLSKL,VWLSALKFIGKHLAKHQLSKL{ct:Amid},Lycosin-II,Amidation,Free,Linear,L,None,21,Antibacterial,<10 % Hemolysis at 12.5 µM,Human,Chinese Wolf Spider Lycosa Singoriensis,α-Helix,NA,CCHHHHHHHHCSCSSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
6177,27128941,2016,VWLSALKFIGKHLAKHQLSKL,VWLSALKFIGKHLAKHQLSKL{ct:Amid},Lycosin-II,Amidation,Free,Linear,L,None,21,Antibacterial,<10 % Hemolysis at 25 µM,Human,Chinese Wolf Spider Lycosa Singoriensis,α-Helix,NA,CCHHHHHHHHCSCSSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
6178,27128941,2016,VWLSALKFIGKHLAKHQLSKL,VWLSALKFIGKHLAKHQLSKL{ct:Amid},Lycosin-II,Amidation,Free,Linear,L,None,21,Antibacterial,20 % Hemolysis at 50 µM,Human,Chinese Wolf Spider Lycosa Singoriensis,α-Helix,NA,CCHHHHHHHHCSCSSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
6179,27128941,2016,VWLSALKFIGKHLAKHQLSKL,VWLSALKFIGKHLAKHQLSKL{ct:Amid},Lycosin-II,Amidation,Free,Linear,L,None,21,Antibacterial,<20 % Hemolysis at 100 µM,Human,Chinese Wolf Spider Lycosa Singoriensis,α-Helix,NA,CCHHHHHHHHCSCSSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
6180,27038545,2016,GLPGPLGPAGPK,GLPGPLGPAGPK,Collagencin,Free,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 7 µM,Horse,Fish Collagen,β-Sheet and β-Turn,NA,CCSTTSGGGSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
6181,27038545,2016,GLPGPLGPAGPK,GLPGPLGPAGPK,Collagencin,Free,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 15 µM,Horse,Fish Collagen,β-Sheet and β-Turn,NA,CCSTTSGGGSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
6182,27038545,2016,GLPGPLGPAGPK,GLPGPLGPAGPK,Collagencin,Free,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 29 µM,Horse,Fish Collagen,β-Sheet and β-Turn,NA,CCSTTSGGGSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
6183,27038545,2016,GLPGPLGPAGPK,GLPGPLGPAGPK,Collagencin,Free,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 59 µM,Horse,Fish Collagen,β-Sheet and β-Turn,NA,CCSTTSGGGSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
6184,27038545,2016,GLPGPLGPAGPK,GLPGPLGPAGPK,Collagencin,Free,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 118 µM,Horse,Fish Collagen,β-Sheet and β-Turn,NA,CCSTTSGGGSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
6185,27038545,2016,GLPGPLGPAGPK,GLPGPLGPAGPK,Collagencin,Free,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 235 µM,Horse,Fish Collagen,β-Sheet and β-Turn,NA,CCSTTSGGGSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
6186,27038545,2016,GLPGPLGPAGPK,GLPGPLGPAGPK,Collagencin,Free,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 470 µM,Horse,Fish Collagen,β-Sheet and β-Turn,NA,CCSTTSGGGSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
6187,27038545,2016,GLPGPLGPAGPK,GLPGPLGPAGPK,Collagencin,Free,Free,Linear,L,None,12,Antibacterial,<30 % Hemolysis at 940 µM,Horse,Fish Collagen,β-Sheet and β-Turn,NA,CCSTTSGGGSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
6188,27038545,2016,GLPGPLGPAGPK,GLPGPLGPAGPK,Collagencin,Free,Free,Linear,L,None,12,Antibacterial,<50 % Hemolysis at 1880 µM,Horse,Fish Collagen,β-Sheet and β-Turn,NA,CCSTTSGGGSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
6197,26837216,2016,RRRQKRIVVRRRLIR,RRRQKRIVVRRRLIR,P3,Free,Free,Linear,L,None,15,Antibacterial,0 % Hemolysis at 50 µM,Human,Cell-Penetrating Peptides,α-Helix,Non-hemolytic,CCSTHHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
6198,26837216,2016,RRWRRWNRFNRRRCR,RRWRRWNRFNRRRCR,P8,Free,Free,Linear,L,None,15,Antibacterial,0 % Hemolysis at 50 µM,Human,Cell-Penetrating Peptides,α-Helix,Non-hemolytic,CCCCSSCSCCGGGCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
6199,26849911,2016,RRLIWLILRLLR,RRLIWLILRLLR{ct:Amid},RR12Wpolar,Amidation,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 5 µM,mouse,Analogs Of Rr12,α-Helix,NA,CCCCHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
6200,26849911,2016,RRLIWLILRLLR,RRLIWLILRLLR{ct:Amid},RR12Wpolar,Amidation,Free,Linear,L,None,12,Antibacterial,<20 % Hemolysis at 10 µM,mouse,Analogs Of Rr12,α-Helix,NA,CCCCHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
6201,26849911,2016,RRLIRLILRLLR,RRLIRLILRLLR{ct:Amid},RR12,Amidation,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 25 µM,mouse,Synthetic,α-Helix,NA,CCHHHHGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
6202,26849911,2016,RRLIWLILRLLR,RRLIWLILRLLR{ct:Amid},RR12Wpolar,Amidation,Free,Linear,L,None,12,Antibacterial,<40 % Hemolysis at 25 µM,mouse,Analogs Of Rr12,α-Helix,NA,CCCCHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
6203,26849911,2016,RRLIRLWLRLLR,RRLIRLWLRLLR{ct:Amid},RR12Whydro,Amidation,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 25 µM,mouse,Analogs Of Rr12,α-Helix,NA,CCCGGGTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
6204,26849911,2016,RRLIRLILRLLR,RRLIRLILRLLR{ct:Amid},RR12,Amidation,Free,Linear,L,None,12,Antibacterial,<20 % Hemolysis at 50 µM,mouse,Synthetic,α-Helix,NA,CCHHHHGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
6205,26849911,2016,RRLIWLILRLLR,RRLIWLILRLLR{ct:Amid},RR12Wpolar,Amidation,Free,Linear,L,None,12,Antibacterial,<60 % Hemolysis at 50 µM,mouse,Analogs Of Rr12,α-Helix,NA,CCCCHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
6206,26849911,2016,RRLIRLWLRLLR,RRLIRLWLRLLR{ct:Amid},RR12Whydro,Amidation,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 50 µM,mouse,Analogs Of Rr12,α-Helix,NA,CCCGGGTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
6207,26849911,2016,RRLIRLILRLLR,RRLIRLILRLLR{ct:Amid},RR12,Amidation,Free,Linear,L,None,12,Antibacterial,<40 % Hemolysis at 100 µM,mouse,Synthetic,α-Helix,NA,CCHHHHGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
6208,26849911,2016,RRLIWLILRLLR,RRLIWLILRLLR{ct:Amid},RR12Wpolar,Amidation,Free,Linear,L,None,12,Antibacterial,<80 % Hemolysis at 100 µM,mouse,Analogs Of Rr12,α-Helix,NA,CCCCHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
6209,26849911,2016,RRLIRLWLRLLR,RRLIRLWLRLLR{ct:Amid},RR12Whydro,Amidation,Free,Linear,L,None,12,Antibacterial,<20 % Hemolysis at 100 µM,mouse,Analogs Of Rr12,α-Helix,NA,CCCGGGTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
6210,26896660,2016,RIVQRIKKWLLKWKKLGY,RIVQRIKKWLLKWKKLGY{ct:Amid},peptide 5,Amidation,Free,Linear,L,None,18,Antibacterial,8 ± 2 % Hemolysis at 55 µM,Human,Cationic Amps,α-Helix,NA,CTHHHHHHHHHHHHHCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
6211,26896660,2016,RIVQRILKWLKKWYKLGK,RIVQRILKWLKKWYKLGK{ct:Amid},peptide 8,Amidation,Free,Linear,L,None,18,Antibacterial,85 ± 12 % Hemolysis at 55 µM,Human,Cationic Amps,α-Helix,NA,CCHHHHHHHHHHTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O
6212,26896660,2016,RIVQRIAKWAKKWYKAGK,RIVQRIAKWAKKWYKAGK{ct:Amid},peptide 8.1,Amidation,Free,Linear,L,None,18,Antibacterial,5 ± 1 % Hemolysis at 55 µM,Human,Cationic Amps,α-Helix,NA,CTHHHHHHHHHHHTTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O
6213,26902768,2016,KRFWPLVPVAINTVAAGINLYKAIRRK,KRFWPLVPVAINTVAAGINLYKAIRRK{ct:Amid},Fow-3,Amidation,Free,Linear,L,None,27,Antibacterial,88.1 % Hemolysis at 256 µM,Human,Chicken Cathelicidin,Random coil- sodium phosphate buffer/α-Helical structure-SDS and TFE buffer,Non-hemolytic,CCCCCSSCCSGGGGGGTHHHHGGGGGC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
6214,26902768,2016,KRFWPLVPVAINTVA,KRFWPLVPVAINTVA{ct:Amid},Fow-3(1-15),Amidation,Free,Linear,L,None,15,Antibacterial,<5 % Hemolysis at 256 µM,Human,Truncated Peptides Of Fowlicidin-3,α-Helix,NA,CCCCCSCCTTCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)O
6215,26902768,2016,KRFWPLVPVAINTVAA,KRFWPLVPVAINTVAA{ct:Amid},Fow-3(1-19),Amidation,Free,Linear,L,None,19,Antibacterial,38.9 % Hemolysis at 256 µM,Human,Truncated Peptides Of Fowlicidin-3,α-Helix,NA,CCSCCCSSCEETTEEC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)O
6216,26902768,2016,LYKAIRRK,LYKAIRRK{ct:Amid},Fow-3(20-27),Amidation,Free,Linear,L,None,8,Antibacterial,<5 % Hemolysis at 256 µM,Human,Truncated Peptides Of Fowlicidin-3,α-Helix,NA,CCTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
6217,26902768,2016,KRFWPLVPVAINTVAL,KRFWPLVPVAINTVAL{ct:Amid},Fow-3(1-15-20-27),Amidation,Free,Linear,L,None,23,Antibacterial,<5 % Hemolysis at 256 µM,Human,Truncated Peptides Of Fowlicidin-3,Random coil- sodium phosphate buffer/α-Helical structure-SDS and TFE buffer,Non-hemolytic,CCCCCCCSSCCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O
6218,27033467,2016,AATKPKKAGAEAAPKKPAKKQTKKKPAKKAGGKKKPKRAGAKKAKK,AATKPKKAGAEAAPKKPAKKQTKKKPAKKAGGKKKPKRAGAKKAKK{ct:Amid},hdMolluscidin,Amidation,Free,Linear,L,None,46,Antibacterial,0 % Hemolysis at 100 μg/ml,Human,Marine Snail Haliotis Discus,α-Helix,Non-hemolytic,CCSSCCCCSCSCCTTCCCGGGCCCCCCSSCCCSSGGGTSCCBTTBC,C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@@H](C)O
6219,27243004,2016,OWOWORPVYOPRPRPPHPRL,{nnr:O}W{nnr:O}W{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu},Api793,Free,gu,Linear,L,"gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine",20,Antibacterial Gram-,1.3 ± 0.4 % Hemolysis at 0.1 g/L,Human,Apidaecin Analog Api137,NA,Non-hemolytic,NA,NA
6220,27243004,2016,OWOWOWORPVYOPRPRPPHPRL,{nnr:O}W{nnr:O}W{nnr:O}W{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu},Api794,Free,gu,Linear,L,"gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine",22,Antibacterial Gram-,1.7 ± 0.2 % Hemolysis at 0.1 g/L,Human,Apidaecin Analog Api137,NA,Non-hemolytic,NA,NA
6221,27243004,2016,OIOIORPVYOPRPRPPHPRL,{nnr:O}I{nnr:O}I{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu},Api795,Free,gu,Linear,L,"gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine",20,Antibacterial Gram-,−0.8 ± 0.4 % Hemolysis at 0.1 g/L,Human,Apidaecin Analog Api137,NA,Non-hemolytic,NA,NA
6222,27243004,2016,OIOIOIORPVYOPRPRPPHPRL,{nnr:O}I{nnr:O}I{nnr:O}I{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu},Api796,Free,gu,Linear,L,"gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine",22,Antibacterial Gram-,−0.8 ± 0.2 % Hemolysis at 0.1 g/L,Human,Apidaecin Analog Api137,NA,Non-hemolytic,NA,NA
6223,27243004,2016,OWOWORPVYOPRPRPPHPRL,{nnr:O}W{nnr:O}W{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu},Api793,Free,gu,Linear,L,"gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine",20,Antibacterial Gram-,1.6 ± 0.5 % Hemolysis at 0.6 g/L,Human,Apidaecin Analog Api137,NA,Non-hemolytic,NA,NA
6224,27243004,2016,OWOWOWORPVYOPRPRPPHPRL,{nnr:O}W{nnr:O}W{nnr:O}W{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu},Api794,Free,gu,Linear,L,"gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine",22,Antibacterial Gram-,1.9 ± 0.3 % Hemolysis at 0.6 g/L,Human,Apidaecin Analog Api137,NA,Non-hemolytic,NA,NA
6225,27243004,2016,OIOIORPVYOPRPRPPHPRL,{nnr:O}I{nnr:O}I{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu},Api795,Free,gu,Linear,L,"gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine",20,Antibacterial Gram-,0.0 ± 0.7 % Hemolysis at 0.6 g/L,Human,Apidaecin Analog Api137,NA,Non-hemolytic,NA,NA
6226,27243004,2016,OIOIOIORPVYOPRPRPPHPRL,{nnr:O}I{nnr:O}I{nnr:O}I{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu},Api796,Free,gu,Linear,L,"gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine",22,Antibacterial Gram-,−0.1 ± 0.8 % Hemolysis at 0.6 g/L,Human,Apidaecin Analog Api137,NA,Non-hemolytic,NA,NA
6227,27187467,2016,GMWSKIKETAMAAAKEAAKAAGKTISDMIKQ,GMWSKIKETAMAAAKEAAKAAGKTISDMIKQ{ct:Amid},Dermaseptin-PD-1,Amidation,Free,Linear,L,None,30,"Antibacterial, Antifungal, Anticancer",100 % Hemolysis at >156.8 µM,Horse,Pachymedusa Dacnicolor,α-Helix,Low hemolytic,CHHHHHHHHTTTTCTHHHHTTCCGGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)CN)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6228,27187467,2016,GMWSKIKNAGKAAAKAAAKAAGKAALDAVSEAI,GMWSKIKNAGKAAAKAAAKAAGKAALDAVSEAI{ct:Amid},Dermaseptin-PD-2,Amidation,Free,Linear,L,None,32,"Antibacterial, Antifungal, Anticancer",100 % Hemolysis at >161.6 µM,Horse,Pachymedusa Dacnicolor,α-Helix,Low hemolytic,CCGGGTSCCCCBSSSSSCCCSSSTTTSSBSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)CN)[C@@H](C)CC)C(C)C)C(=O)O
6229,26802742,2016,FIGALLRPALKLLA,FIGALLRPALKLLA{ct:Amid},Pxt-2,Amidation,Free,Linear,L,None,15,Antibacterial,2 % Hemolysis at 50 µM,Rat,X. Tropicalis Skin,α-Helix,NA,CCTTTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
6230,26802742,2016,FIGALLGPLLNLLK,FIGALLGPLLNLLK{ct:Amid},Pxt-5,Amidation,Free,Linear,L,None,15,Antibacterial,69.8 % Hemolysis at 50 µM,Rat,X. Tropicalis Skin,α-Helix,NA,CCHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
6231,26802742,2016,NLLGSLLKTGLKVGSNLL,NLLGSLLKTGLKVGSNLL{ct:Amid},Pxt-12,Amidation,Free,Linear,L,None,18,Antibacterial,0 % Hemolysis at 50 µM,Rat,X. Tropicalis Skin,α-Helix,Non-hemolytic,CCHHHHHHHHHHHSCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)C(C)C)C(=O)O
6232,26802742,2016,ALLKLAPRLLAGIF,ALLKLAPRLLAGIF{ct:Amid},Reverse Pxt-2,Amidation,Free,Linear,L,None,14,Antibacterial,1.5 % Hemolysis at 50 µM,Rat,X. Tropicalis Skin,α-Helix,NA,CHHHHSGGGGGCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6233,26802742,2016,KLLNLLPGLLAGIF,KLLNLLPGLLAGIF{ct:Amid},Reverse Pxt-5,Amidation,Free,Linear,L,None,14,Antibacterial,5.2 % Hemolysis at 50 µM,Rat,X. Tropicalis Skin,α-Helix,NA,CCTTTCGGGGSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6235,26802742,2016,INLKALAALAKKIL,INLKALAALAKKIL{ct:Amid},Mastoparan,Amidation,Free,Linear,L,None,14,Antibacterial,13.5 % Hemolysis at 50 µM,Rat,Wasp Venom,α-Helix,NA,CCHHHHHHHHHHCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
6236,26802742,2016,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid},Melittin,Amidation,Free,Linear,L,None,26,Antibacterial,100 % Hemolysis at 10 µM,Rat,Bee Venom,α-Helix,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
6237,26854372,2016,GSNFCDSKCKLCSKAGLADRCLKYCGICCEECKCVPSGTYGNKHECPCYRDKKNSKGKSKCP,GSNFCDSKCKLCSKAGLADRCLKYCGICCEECKCVPSGTYGNKHECPCYRDKKNSKGKSKCP,Snakin-1(SN-1),Free,Free,Linear,L,None,63,Antibacterial,little Hemolysis % Hemolysis at 0-128 µM,Sheep,Potato Solanum Tuberosum,α-Helix,NA,CCSCCHHHHHHSCSSCCCCTTTHHHHTTTTTTTCCCCSSCCSCCCTTCCCCCCSTTCCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(C)C
6244,26920749,2016,IDGLKAIWKKVADLLKNT,IDGLKAIWKKVADLLKNT{ct:Amid},L1A,Amidation,Free,Linear,L,None,18,Antibacterial,4 % Hemolysis at 148 µM,Human,Synthetic Peptide,α-Helix,NA,CCGGGTHHHHHHHHHSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC
6245,26920749,2016,IDGLKAIWKKVADLLKNT,IDGLKAIWKKVADLLKNT{nt:Acet}{ct:Amid},Ac-L1A,Amidation,acetylation,Linear,L,None,18,Antibacterial,5 % Hemolysis at 145 µM,Human,Synthetic Peptide,α-Helix,Non-hemolytic,CCGGGTHHHHHHHHHSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC
6246,26920749,2016,IDGLKAIVKKVADLLKNT,IDGLKAIVKKVADLLKNT{nt:Abz = ortho-aminobenzoic acid}{ct:Amid},Abz-L1A-W8V,Amidation,Abz = ortho-aminobenzoic acid,Linear,L,None,18,Antibacterial,46 % Hemolysis at 140 µM,Human,Synthetic Peptide,α-Helix,Non-hemolytic,CCHHHHHHHHHHHHHTCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)CC
6247,26975251,2016,KKLFKKILKYL,KKLFKKILKYL{ct:Amid},BP100-PP,Amidation,Free,Linear,L,None,11,Antibacterial,7 % Hemolysis at 1.25 µM,Human,Parent Peptide,α-Helix,NA,CGGGGGSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
6248,26975251,2016,KKLFKKILKYL,KKLFKKILKYL{ct:Amid},BP100-PP,Amidation,Free,Linear,L,None,11,Antibacterial,9 % Hemolysis at 2.5 µM,Human,Parent Peptide,α-Helix,NA,CGGGGGSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
6249,26975251,2016,KKLFKKILKYL,KKLFKKILKYL{ct:Amid},BP100-PP,Amidation,Free,Linear,L,None,11,Antibacterial,13 % Hemolysis at 5 µM,Human,Parent Peptide,α-Helix,NA,CGGGGGSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
6250,26975251,2016,KKLFKKILKYL,KKLFKKILKYL{ct:Amid},BP100-PP,Amidation,Free,Linear,L,None,11,Antibacterial,18 % Hemolysis at 10 µM,Human,Parent Peptide,α-Helix,NA,CGGGGGSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
6251,26975251,2016,KKLFKKILKYL,KKLFKKILKYL{ct:Amid},BP100-PP,Amidation,Free,Linear,L,None,11,Antibacterial,36 % Hemolysis at 20 µM,Human,Parent Peptide,α-Helix,NA,CGGGGGSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
6252,26975251,2016,KKLFKKILKYL,KKLFKKILKYL{ct:Amid},BP100-PP,Amidation,Free,Linear,L,None,11,Antibacterial,59 % Hemolysis at 40 µM,Human,Parent Peptide,α-Helix,NA,CGGGGGSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
6253,26975251,2016,KKLFKKILKYL,KKLFKKILKYL{ct:Amid},BP100-PP,Amidation,Free,Linear,L,None,11,Antibacterial,80 % Hemolysis at 80 µM,Human,Parent Peptide,α-Helix,NA,CGGGGGSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
6254,26975251,2016,KKLFKKILKYL,KKLFKKILKYL{ct:Amid},BP100-PP,Amidation,Free,Linear,L,None,11,Antibacterial,92 % Hemolysis at 160 µM,Human,Parent Peptide,α-Helix,NA,CGGGGGSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
6255,26975251,2016,XKLFKKILKYL,{nnr:X}KLFKKILKYL{ct:Amid},BP100K1A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,7 % Hemolysis at 1.25 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6256,26975251,2016,XKLFKKILKYL,{nnr:X}KLFKKILKYL{ct:Amid},BP100K1A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,9 % Hemolysis at 2.5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6257,26975251,2016,XKLFKKILKYL,{nnr:X}KLFKKILKYL{ct:Amid},BP100K1A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,8 % Hemolysis at 5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6258,26975251,2016,XKLFKKILKYL,{nnr:X}KLFKKILKYL{ct:Amid},BP100K1A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,13 % Hemolysis at 10 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6259,26975251,2016,XKLFKKILKYL,{nnr:X}KLFKKILKYL{ct:Amid},BP100K1A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,26 % Hemolysis at 20 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6260,26975251,2016,XKLFKKILKYL,{nnr:X}KLFKKILKYL{ct:Amid},BP100K1A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,43 % Hemolysis at 40 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6261,26975251,2016,XKLFKKILKYL,{nnr:X}KLFKKILKYL{ct:Amid},BP100K1A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,65 % Hemolysis at 80 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6262,26975251,2016,XKLFKKILKYL,{nnr:X}KLFKKILKYL{ct:Amid},BP100K1A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,87 % Hemolysis at 160 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6263,26975251,2016,KXLFKKILKYL,K{nnr:X}LFKKILKYL{ct:Amid},BP100K2A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,7 % Hemolysis at 1.25 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6264,26975251,2016,KXLFKKILKYL,K{nnr:X}LFKKILKYL{ct:Amid},BP100K2A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,8 % Hemolysis at 2.5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6265,26975251,2016,KXLFKKILKYL,K{nnr:X}LFKKILKYL{ct:Amid},BP100K2A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,11 % Hemolysis at 5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6266,26975251,2016,KXLFKKILKYL,K{nnr:X}LFKKILKYL{ct:Amid},BP100K2A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,9 % Hemolysis at 10 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6267,26975251,2016,KXLFKKILKYL,K{nnr:X}LFKKILKYL{ct:Amid},BP100K2A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,15 % Hemolysis at 20 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6268,26975251,2016,KXLFKKILKYL,K{nnr:X}LFKKILKYL{ct:Amid},BP100K2A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,20 % Hemolysis at 40 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6269,26975251,2016,KXLFKKILKYL,K{nnr:X}LFKKILKYL{ct:Amid},BP100K2A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,31 % Hemolysis at 80 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6270,26975251,2016,KXLFKKILKYL,K{nnr:X}LFKKILKYL{ct:Amid},BP100K2A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,48 % Hemolysis at 160 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6271,26975251,2016,KKXFKKILKYL,KK{nnr:X}FKKILKYL{ct:Amid},BP100L3A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,8 % Hemolysis at 1.25 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6272,26975251,2016,KKXFKKILKYL,KK{nnr:X}FKKILKYL{ct:Amid},BP100L3A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,4 % Hemolysis at 2.5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6273,26975251,2016,KKXFKKILKYL,KK{nnr:X}FKKILKYL{ct:Amid},BP100L3A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,7 % Hemolysis at 5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6274,26975251,2016,KKXFKKILKYL,KK{nnr:X}FKKILKYL{ct:Amid},BP100L3A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,7 % Hemolysis at 10 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6275,26975251,2016,KKXFKKILKYL,KK{nnr:X}FKKILKYL{ct:Amid},BP100L3A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,8 % Hemolysis at 20 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6276,26975251,2016,KKXFKKILKYL,KK{nnr:X}FKKILKYL{ct:Amid},BP100L3A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,7 % Hemolysis at 40 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6277,26975251,2016,KKXFKKILKYL,KK{nnr:X}FKKILKYL{ct:Amid},BP100L3A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,7 % Hemolysis at 80 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6278,26975251,2016,KKXFKKILKYL,KK{nnr:X}FKKILKYL{ct:Amid},BP100L3A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,12 % Hemolysis at 160 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6279,26975251,2016,KKLXKKILKYL,KKL{nnr:X}KKILKYL{ct:Amid},BP100F4A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,4 % Hemolysis at 1.25 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6280,26975251,2016,KKLXKKILKYL,KKL{nnr:X}KKILKYL{ct:Amid},BP100F4A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,3 % Hemolysis at 2.5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6281,26975251,2016,KKLXKKILKYL,KKL{nnr:X}KKILKYL{ct:Amid},BP100F4A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,7 % Hemolysis at 5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6282,26975251,2016,KKLXKKILKYL,KKL{nnr:X}KKILKYL{ct:Amid},BP100F4A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,10 % Hemolysis at 10 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6283,26975251,2016,KKLXKKILKYL,KKL{nnr:X}KKILKYL{ct:Amid},BP100F4A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,10 % Hemolysis at 20 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6284,26975251,2016,KKLXKKILKYL,KKL{nnr:X}KKILKYL{ct:Amid},BP100F4A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,8 % Hemolysis at 40 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6285,26975251,2016,KKLXKKILKYL,KKL{nnr:X}KKILKYL{ct:Amid},BP100F4A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,4 % Hemolysis at 80 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6286,26975251,2016,KKLXKKILKYL,KKL{nnr:X}KKILKYL{ct:Amid},BP100F4A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,5 % Hemolysis at 160 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6287,26975251,2016,KKLFXKILKYL,KKLF{nnr:X}KILKYL{ct:Amid},BP100K5A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,4 % Hemolysis at 1.25 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6288,26975251,2016,KKLFXKILKYL,KKLF{nnr:X}KILKYL{ct:Amid},BP100K5A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,6 % Hemolysis at 2.5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6289,26975251,2016,KKLFXKILKYL,KKLF{nnr:X}KILKYL{ct:Amid},BP100K5A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,7 % Hemolysis at 5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6290,26975251,2016,KKLFXKILKYL,KKLF{nnr:X}KILKYL{ct:Amid},BP100K5A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,6 % Hemolysis at 10 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6291,26975251,2016,KKLFXKILKYL,KKLF{nnr:X}KILKYL{ct:Amid},BP100K5A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,18 % Hemolysis at 20 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6292,26975251,2016,KKLFXKILKYL,KKLF{nnr:X}KILKYL{ct:Amid},BP100K5A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,40 % Hemolysis at 40 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6293,26975251,2016,KKLFXKILKYL,KKLF{nnr:X}KILKYL{ct:Amid},BP100K5A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,69 % Hemolysis at 80 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6294,26975251,2016,KKLFXKILKYL,KKLF{nnr:X}KILKYL{ct:Amid},BP100K5A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,93 % Hemolysis at 160 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6295,26975251,2016,KKLFKXILKYL,KKLFK{nnr:X}ILKYL{ct:Amid},BP100K6A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,4 % Hemolysis at 1.25 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6296,26975251,2016,KKLFKXILKYL,KKLFK{nnr:X}ILKYL{ct:Amid},BP100K6A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,5 % Hemolysis at 2.5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6297,26975251,2016,KKLFKXILKYL,KKLFK{nnr:X}ILKYL{ct:Amid},BP100K6A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,7 % Hemolysis at 5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6298,26975251,2016,KKLFKXILKYL,KKLFK{nnr:X}ILKYL{ct:Amid},BP100K6A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,8 % Hemolysis at 10 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6299,26975251,2016,KKLFKXILKYL,KKLFK{nnr:X}ILKYL{ct:Amid},BP100K6A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,14 % Hemolysis at 20 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6300,26975251,2016,KKLFKXILKYL,KKLFK{nnr:X}ILKYL{ct:Amid},BP100K6A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,36 % Hemolysis at 40 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6301,26975251,2016,KKLFKXILKYL,KKLFK{nnr:X}ILKYL{ct:Amid},BP100K6A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,64 % Hemolysis at 80 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6302,26975251,2016,KKLFKXILKYL,KKLFK{nnr:X}ILKYL{ct:Amid},BP100K6A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,91 % Hemolysis at 160 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6303,26975251,2016,KKLFKKXLKYL,KKLFKK{nnr:X}LKYL{ct:Amid},BP100I7A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,1 % Hemolysis at 1.25 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6304,26975251,2016,KKLFKKXLKYL,KKLFKK{nnr:X}LKYL{ct:Amid},BP100I7A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,3 % Hemolysis at 2.5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6305,26975251,2016,KKLFKKXLKYL,KKLFKK{nnr:X}LKYL{ct:Amid},BP100I7A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,3 % Hemolysis at 5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6306,26975251,2016,KKLFKKXLKYL,KKLFKK{nnr:X}LKYL{ct:Amid},BP100I7A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,5 % Hemolysis at 10 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6307,26975251,2016,KKLFKKXLKYL,KKLFKK{nnr:X}LKYL{ct:Amid},BP100I7A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,6 % Hemolysis at 20 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6308,26975251,2016,KKLFKKXLKYL,KKLFKK{nnr:X}LKYL{ct:Amid},BP100I7A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,7 % Hemolysis at 40 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6309,26975251,2016,KKLFKKXLKYL,KKLFKK{nnr:X}LKYL{ct:Amid},BP100I7A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,6 % Hemolysis at 80 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6310,26975251,2016,KKLFKKXLKYL,KKLFKK{nnr:X}LKYL{ct:Amid},BP100I7A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,7 % Hemolysis at 160 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6311,26975251,2016,KKLFKKIXKYL,KKLFKKI{nnr:X}KYL{ct:Amid},BP100L8A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,3 % Hemolysis at 1.25 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6312,26975251,2016,KKLFKKIXKYL,KKLFKKI{nnr:X}KYL{ct:Amid},BP100L8A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,9 % Hemolysis at 2.5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6313,26975251,2016,KKLFKKIXKYL,KKLFKKI{nnr:X}KYL{ct:Amid},BP100L8A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,8 % Hemolysis at 5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6314,26975251,2016,KKLFKKIXKYL,KKLFKKI{nnr:X}KYL{ct:Amid},BP100L8A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,11 % Hemolysis at 10 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6315,26975251,2016,KKLFKKIXKYL,KKLFKKI{nnr:X}KYL{ct:Amid},BP100L8A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,11 % Hemolysis at 20 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6316,26975251,2016,KKLFKKIXKYL,KKLFKKI{nnr:X}KYL{ct:Amid},BP100L8A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,10 % Hemolysis at 40 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6317,26975251,2016,KKLFKKIXKYL,KKLFKKI{nnr:X}KYL{ct:Amid},BP100L8A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,11 % Hemolysis at 80 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6318,26975251,2016,KKLFKKIXKYL,KKLFKKI{nnr:X}KYL{ct:Amid},BP100L8A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,16 % Hemolysis at 160 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6319,26975251,2016,KKLFKKILXYL,KKLFKKIL{nnr:X}YL{ct:Amid},BP100K9A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,12 % Hemolysis at 1.25 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6320,26975251,2016,KKLFKKILXYL,KKLFKKIL{nnr:X}YL{ct:Amid},BP100K9A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,7 % Hemolysis at 2.5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6321,26975251,2016,KKLFKKILXYL,KKLFKKIL{nnr:X}YL{ct:Amid},BP100K9A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,6 % Hemolysis at 5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6322,26975251,2016,KKLFKKILXYL,KKLFKKIL{nnr:X}YL{ct:Amid},BP100K9A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,11 % Hemolysis at 10 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6323,26975251,2016,KKLFKKILXYL,KKLFKKIL{nnr:X}YL{ct:Amid},BP100K9A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,13 % Hemolysis at 20 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6324,26975251,2016,KKLFKKILXYL,KKLFKKIL{nnr:X}YL{ct:Amid},BP100K9A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,22 % Hemolysis at 40 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6325,26975251,2016,KKLFKKILXYL,KKLFKKIL{nnr:X}YL{ct:Amid},BP100K9A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,38 % Hemolysis at 80 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6326,26975251,2016,KKLFKKILXYL,KKLFKKIL{nnr:X}YL{ct:Amid},BP100K9A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,57 % Hemolysis at 160 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6327,26975251,2016,KKLFKKILKXL,KKLFKKILK{nnr:X}L{ct:Amid},BP100Y10A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,4 % Hemolysis at 1.25 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6328,26975251,2016,KKLFKKILKXL,KKLFKKILK{nnr:X}L{ct:Amid},BP100Y10A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,4 % Hemolysis at 2.5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6329,26975251,2016,KKLFKKILKXL,KKLFKKILK{nnr:X}L{ct:Amid},BP100Y10A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,5 % Hemolysis at 5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6330,26975251,2016,KKLFKKILKXL,KKLFKKILK{nnr:X}L{ct:Amid},BP100Y10A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,6 % Hemolysis at 10 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6331,26975251,2016,KKLFKKILKXL,KKLFKKILK{nnr:X}L{ct:Amid},BP100Y10A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,12 % Hemolysis at 20 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6332,26975251,2016,KKLFKKILKXL,KKLFKKILK{nnr:X}L{ct:Amid},BP100Y10A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,13 % Hemolysis at 40 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6333,26975251,2016,KKLFKKILKXL,KKLFKKILK{nnr:X}L{ct:Amid},BP100Y10A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,23 % Hemolysis at 80 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6334,26975251,2016,KKLFKKILKXL,KKLFKKILK{nnr:X}L{ct:Amid},BP100Y10A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,37 % Hemolysis at 160 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6335,26975251,2016,KKLFKKILKYX,KKLFKKILKY{nnr:X}{ct:Amid},BP100L11A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,1 % Hemolysis at 1.25 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6336,26975251,2016,KKLFKKILKYX,KKLFKKILKY{nnr:X}{ct:Amid},BP100L11A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,4 % Hemolysis at 2.5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6337,26975251,2016,KKLFKKILKYX,KKLFKKILKY{nnr:X}{ct:Amid},BP100L11A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,6 % Hemolysis at 5 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6338,26975251,2016,KKLFKKILKYX,KKLFKKILKY{nnr:X}{ct:Amid},BP100L11A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,7 % Hemolysis at 10 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6339,26975251,2016,KKLFKKILKYX,KKLFKKILKY{nnr:X}{ct:Amid},BP100L11A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,5 % Hemolysis at 20 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6340,26975251,2016,KKLFKKILKYX,KKLFKKILKY{nnr:X}{ct:Amid},BP100L11A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,5 % Hemolysis at 40 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6341,26975251,2016,KKLFKKILKYX,KKLFKKILKY{nnr:X}{ct:Amid},BP100L11A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,4 % Hemolysis at 80 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6342,26975251,2016,KKLFKKILKYX,KKLFKKILKY{nnr:X}{ct:Amid},BP100L11A,Amidation,Free,Linear,L,"X = Ala-d3(3,3,3-2H3-Ala)",11,Antibacterial,6 % Hemolysis at 160 µM,Human,Bp100 Analogues,α-Helix,NA,NA,NA
6343,27015761,2016,LLPIVGNLLKSLLGWKRKRFG,LLPIVGNLLKSLLGWKRKRFG{ct:Amid},LG21,Amidation,Free,Linear,L,None,20,Antibacterial,8.5 % Hemolysis at 100 µM,Mouse,Hybrid Amp Consisted Of Temporin B (Tb) And Lps Binding Motif.,α-Helix,NA,CCCCHHHHHHHHHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O)C(C)C
6344,27015761,2016,LLPIVGALLKSLLGWKRKRFG,LLPIVGALLKSLLGWKRKRFG{ct:Amid},LG21N7A,Amidation,Free,Linear,L,None,20,Antibacterial,10 % Hemolysis at 100 µM,Mouse,Lg21 Ala Variant Peptides,α-Helix,NA,CCHHHHHHHHHHHHHHTTCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O)C(C)C
6345,27015761,2016,LLPIVGNLLASLLGWKRKRFG,LLPIVGNLLASLLGWKRKRFG{ct:Amid},LG21K10A,Amidation,Free,Linear,L,None,20,Antibacterial,12 % Hemolysis at 100 µM,Mouse,Lg21 Ala Variant Peptides,α-Helix,NA,CCCCTHHHHHHHHTSTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O)C(C)C
6346,27015761,2016,LLPIVGNLLKALLGWKRKRFG,LLPIVGNLLKALLGWKRKRFG{ct:Amid},LG21S11A,Amidation,Free,Linear,L,None,20,Antibacterial,10 % Hemolysis at 100 µM,Mouse,Lg21 Ala Variant Peptides,α-Helix,NA,CCCCHHHHTTTTTTCCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O)C(C)C
6347,27015761,2016,LLPIVGNLLKSLLGWARKRFG,LLPIVGNLLKSLLGWARKRFG{ct:Amid},LG21K16A,Amidation,Free,Linear,L,None,20,Antibacterial,25 % Hemolysis at 100 µM,Mouse,Lg21 Ala Variant Peptides,α-Helix,NA,CCCCHHHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O)C(C)C
6348,27015761,2016,LLPIVGNLLKSLLGWKAKRFG,LLPIVGNLLKSLLGWKAKRFG{ct:Amid},LG21R17A,Amidation,Free,Linear,L,None,20,Antibacterial,38 % Hemolysis at 100 µM,Mouse,Lg21 Ala Variant Peptides,α-Helix,NA,CCCCHHHHHHTTTTCCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O)C(C)C
6349,27015761,2016,LLPIVGNLLKSLLGWKRARFG,LLPIVGNLLKSLLGWKRARFG{ct:Amid},LG21K18A,Amidation,Free,Linear,L,None,20,Antibacterial,28 % Hemolysis at 100 µM,Mouse,Lg21 Ala Variant Peptides,α-Helix,NA,CCCCHHHHHHHHTSCTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O)C(C)C
6350,27015761,2016,LLPIVGNLLKSLLGWKRKAFG,LLPIVGNLLKSLLGWKRKAFG{ct:Amid},LG21R19A,Amidation,Free,Linear,L,None,20,Antibacterial,25 % Hemolysis at 100 µM,Mouse,Lg21 Ala Variant Peptides,α-Helix,NA,CCCSTHHHHTHHHHSTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O)C(C)C
6351,27046192,2016,RWWRWWRRWWR,RWWRWWRRWWR,WR12,Free,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 20 µM,Human,Cationic Antibiotic Peptides (Ecaps),α-Helix,NA,CCCGGGGTTTC,N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
6352,27046192,2016,KWWKWWKKWWK,KWWKWWKKWWK,WK12,Free,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 20 µM,Human,Cationic Antibiotic Peptides (Ecaps),α-Helix,NA,CCHHHHHTTCC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)O
6353,27129462,2016,RGSALTHLP,RGSALTHLP,RP9,Free,Free,Linear,L,None,9,"Antibacterial, Anticancer",3.3 ± 0.5 % Hemolysis at 61.2 µM,Human,Crocodile Leukocyte Extract,α-Helix,NA,CCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O
6354,27129462,2016,RGSALTHLP,RGSALTHLP,RP9,Free,Free,Linear,L,None,9,"Antibacterial, Anticancer",5.7 ± 0.2 % Hemolysis at 122.4 µM,Human,Crocodile Leukocyte Extract,α-Helix,NA,CCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O
6355,27197902,2016,GLRRALLRLLRSLRRLLLRA,GLRRALLRLLRSLRRLLLRA,P7,Free,Free,Linear,L,None,20,"Antibacterial, Antitumor, Antifungal",0 % Hemolysis at 4-32 µM,Mouse,Cell-Penetrating Peptide Pptg20,α-Helix,Non-hemolytic,CHHHHHHHHHHHHHHHHSCC,CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O
6356,27251456,2016,GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGCG,GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGCG{ct:Amid},PMAP-36,Amidation,Free,Linear,L,None,36,"Antibacterial, Antifungal",5 % Hemolysis at 4 µM,Human,Cathelicidin-Related,α-Helix(50% TFE and 30 mM SDS),NA,CCSGGGGGGGGGTHHHHHHHTTTSCTTTSCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C
6357,27251456,2016,RRLRKKTRKRLKKIGKVLKWI,RRLRKKTRKRLKKIGKVLKWI{ct:Amid},RI21,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",5 % Hemolysis at 32 µM,Human,Pmap-36 Analogues,α-Helix(50% TFE and 30 mM SDS),NA,CCCGGGGGTTHHHHHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(=O)O
6358,27251456,2016,RKKTRKRLKKIGKVLKWI,RKKTRKRLKKIGKVLKWI{ct:Amid},RI18,Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal",5 % Hemolysis at 128 µM,Human,Pmap-36 Analogues,α-Helix(50% TFE and 30 mM SDS),NA,CCSSCTTCTTCHHHHCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(=O)O
6359,27251456,2016,TRKRLKKIGKVLKWI,TRKRLKKIGKVLKWI{ct:Amid},TI15,Amidation,Free,Linear,L,None,15,"Antibacterial, Antifungal",5 % Hemolysis at >128 µM,Human,Pmap-36 Analogues,α-Helix(50% TFE and 30 mM SDS),NA,CGGGGGGTGGGTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(=O)O
6360,27251456,2016,RLKKIGKVLKWI,RLKKIGKVLKWI{ct:Amid},RI12,Amidation,Free,Linear,L,None,12,"Antibacterial, Antifungal",5 % Hemolysis at >128 µM,Human,Pmap-36 Analogues,α-Helix(50% TFE and 30 mM SDS),NA,CCHHHHTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)O
6361,27271216,2016,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid},Melittin,Amidation,Free,Linear,L,None,26,Antibacterial,10 % Hemolysis at 0.78 µM,Human,Bee Venom,α-Helix,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
6362,27271216,2016,RIGVLLARLPKLFSLFKLMGKKV,RIGVLLARLPKLFSLFKLMGKKV{ct:Amid},RV-23,Amidation,Free,Linear,L,None,23,Antibacterial,10 % Hemolysis at 6.25 µM,Human,Rana Draytonii,α-Helix,NA,CCHHHHTHHHHHHHHHHHHTSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
6363,27271216,2016,AIGSILGALAKGLPTLISWIKNR,AIGSILGALAKGLPTLISWIKNR{ct:Amid},AR-23,Amidation,Free,Linear,L,None,23,Antibacterial,10 % Hemolysis at 3.12 µM,Human,Rana Tagoi,α-Helix,NA,CHHHIIIIIITCCHHHHHHHCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC
6364,27271216,2016,RIGSILGALAKGLPTLISWIKNR,RIGSILGALAKGLPTLISWIKNR{ct:Amid},A(A1R),Amidation,Free,Linear,L,None,23,Antibacterial,10 % Hemolysis at 3.12 µM,Human,Ar-23 Analogues,α-Helix,NA,CTHHHHHHHTTCCGGGGGGTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O
6365,27271216,2016,AIGSILGRLAKGLPTLISWIKNR,AIGSILGRLAKGLPTLISWIKNR{ct:Amid},A(A8R),Amidation,Free,Linear,L,None,23,Antibacterial,10 % Hemolysis at 3.12 µM,Human,Ar-23 Analogues,α-Helix,NA,CHHHHHHHHTTSCHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC
6366,27271216,2016,AIGSILGALAKGLPTLKSWIKNR,AIGSILGALAKGLPTLKSWIKNR{ct:Amid},A(I17K),Amidation,Free,Linear,L,None,23,Antibacterial,10 % Hemolysis at 50 µM,Human,Ar-23 Analogues,α-Helix,NA,CHHHHHHHHHHHCHHHHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC
6367,27271216,2016,AIGSILGALAKGLPTLRSWIKNR,AIGSILGALAKGLPTLRSWIKNR{ct:Amid},A(I17R),Amidation,Free,Linear,L,None,23,Antibacterial,10 % Hemolysis at 25 µM,Human,Ar-23 Analogues,α-Helix,NA,CHHHHIIIIITSSHHHHHHSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC
6368,27271216,2016,RIGSILGRLAKGLPTLISWIKNR,RIGSILGRLAKGLPTLISWIKNR{ct:Amid},"A(A1R, A8R)",Amidation,Free,Linear,L,None,23,Antibacterial,10 % Hemolysis at 6.25 µM,Human,Ar-23 Analogues,α-Helix,NA,CTHHHHTTTTTSSHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O
6369,27271216,2016,RIGSILGALAKGLPTLKSWIKNR,RIGSILGALAKGLPTLKSWIKNR{ct:Amid},"A(A1R, I17K)",Amidation,Free,Linear,L,None,23,Antibacterial,10 % Hemolysis at 100 µM,Human,Ar-23 Analogues,α-Helix,NA,CCGGGHHHHTTTCHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)O
6370,27271216,2016,AIGSILGRLAKGLPTLKSWIKNR,AIGSILGRLAKGLPTLKSWIKNR{ct:Amid},"A(A8R, I17K)",Amidation,Free,Linear,L,None,23,Antibacterial,10 % Hemolysis at 100 µM,Human,Ar-23 Analogues,α-Helix,NA,CHHHHHHHHTTTCHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC
6371,27271216,2016,RIGSILGRLAKGLPTLKSWIKNR,RIGSILGRLAKGLPTLKSWIKNR{ct:Amid},"A(A1R, A8R, I17K)",Amidation,Free,Linear,L,None,23,Antibacterial,10 % Hemolysis at 200 µM,Human,Ar-23 Analogues,α-Helix,NA,CTHHHHTTTTTCCHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)O
6372,27271216,2016,RIGSILGRLAKGLPTLRSWIKNR,RIGSILGRLAKGLPTLRSWIKNR{ct:Amid},"A(A1R, A8R, I17R)",Amidation,Free,Linear,L,None,23,Antibacterial,10 % Hemolysis at 100 µM,Human,Ar-23 Analogues,α-Helix,NA,CHIIIIIIITTSCHHHHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)O
6373,27331141,2016,GFCWYVCVYRNGVRVCYRRCN,GFCWYVCVYRNGVRVCYRRCN,arenicin-3,Free,Free,Linear,L,None,21,"Antibacterial, Antifungal",4.4 ± 1.1 % Hemolysis at 300 μg/ml,Human,Coelomocytes Of Marine Polychaeta Lugworm Arenicola Marina,β-Hairpin,NA,CCSSCCCCCCCSSCCCCCSCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
6374,27331141,2016,KWCFRVCYRGICYRRCR,KWCFRVCYRGICYRRCR{ct:Amid},tachyplesin-1,Amidation,Free,Linear,L,None,17,"Antibacterial, Antifungal",27.8 ± 3.9 % Hemolysis at 300 μg/ml,Human,Hemocyte Debris Of Tachypleus Tridentatus,β-Hairpin,NA,CCCHHHHTTCCCCTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
6375,27331141,2016,RRWCFRVCYRGFCYRKCR,RRWCFRVCYRGFCYRKCR{ct:Amid},polyphemusin-1,Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal",29.6 ± 2.4 % Hemolysis at 300 μg/ml,Human,Hemocyte Debris Of Limulus Polyphemus,β-Hairpin,NA,CCCCCHHHHCCCCCCCCC,CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
6376,27331141,2016,ZCRRLCYKQRCVTYCRGR,ZCRRLCYKQRCVTYCRGR{nt:Z= N- terminal pyroglutamic acid}{ct:Amid},gomesin,Amidation,Z= N- terminal pyroglutamic acid,Linear,L,Z= N- terminal pyroglutamic acid,18,"Antibacterial, Antifungal",4.4 ± 0.1 % Hemolysis at 300 μg/ml,Human,Hemocytes Of The Spider Acanthoscurria Gomesiana,β-Hairpin,NA,NA,NA
6377,27331141,2016,RGGRLCYCRRRFCVCVGR,RGGRLCYCRRRFCVCVGR{ct:Amid},protegrin-1,Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal",64.8 ± 3.5 % Hemolysis at 300 μg/ml,Human,Porcine Neutrophils,β-Hairpin,NA,CCCCCSCCSSSSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
6378,27331141,2016,GSKKPVPIIYCNRRTGKCQRM,GSKKPVPIIYCNRRTGKCQRM{ct:Amid},thanatin,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",1.3 ± 0.4 % Hemolysis at 300 μg/ml,Human,"Spined Soldier Bug, Podisus Maculiventris",β-Hairpin,NA,CCCCSCSCCCCCSSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)CN)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O
6379,27367675,2016,KWKLFKKIFKRIVQRIKDFLRN,KWKLFKKIFKRIVQRIKDFLRN,C-L,Free,Free,Linear,L,None,22,Antibacterial,50 % Hemolysis at 221 ± 3.27 μg/ml,Sheep,Hybrid Peptide,α-Helix,NA,CCTTHHHHHHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
6380,27367675,2016,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,L,Free,Free,Linear,L,None,37,Antibacterial,50 % Hemolysis at 32 ± 0.68 μg/ml,Sheep,Human Leukocytes And Epithelia,α-Helix,NA,CCHHHHHHHHHHHHHHHHHHHHHHHHHHTTTTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
6381,27367675,2016,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,C-L,Free,Free,Linear,L,None,37,Antibacterial,50 % Hemolysis at 169 ± 15.1 μg/ml,Sheep,Hyalophora Cecropia,α-Helix,NA,CCCCGGGTHHHHTCTTSTTTTSCCCCEETTEESSSBC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)CC
6390,26952034,2016,ASKAGAIAGKIAKVALKAL,ASKAGAIAGKIAKVALKAL,XLAsp-P1,Free,Free,Linear,L,None,19,"Antibacterial, Anticancer",0 % Hemolysis at 8 μg/ml,Rabbit,Skin Of Xenopus Laevis,α-Helix,Low hemolytic,CCCCSCCSCCCTTTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC
6391,26952034,2016,ASKAGAIAGKIAKVALKAL,ASKAGAIAGKIAKVALKAL,XLAsp-P2,Free,Free,Linear,L,None,19,"Antibacterial, Anticancer",0 % Hemolysis at 16 μg/ml,Rabbit,Skin Of Xenopus Laevis,α-Helix,Low hemolytic,CCCCSCCSCCCTTTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC
6392,26952034,2016,ASKAGAIAGKIAKVALKAL,ASKAGAIAGKIAKVALKAL,XLAsp-P3,Free,Free,Linear,L,None,19,"Antibacterial, Anticancer",0 % Hemolysis at 32 μg/ml,Rabbit,Skin Of Xenopus Laevis,α-Helix,Low hemolytic,CCCCSCCSCCCTTTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC
6393,26952034,2016,ASKAGAIAGKIAKVALKAL,ASKAGAIAGKIAKVALKAL,XLAsp-P4,Free,Free,Linear,L,None,19,"Antibacterial, Anticancer",6.4 % Hemolysis at 64 μg/ml,Rabbit,Skin Of Xenopus Laevis,α-Helix,Low hemolytic,CCCCSCCSCCCTTTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC
6394,26952034,2016,ASKAGAIAGKIAKVALKAL,ASKAGAIAGKIAKVALKAL,XLAsp-P5,Free,Free,Linear,L,None,19,"Antibacterial, Anticancer",<20 % Hemolysis at 128 μg/ml,Rabbit,Skin Of Xenopus Laevis,α-Helix,Low hemolytic,CCCCSCCSCCCTTTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC
6421,27311856,2016,AAKIILNPKFRCKAAFC,#ERROR!,Kunitzin-RE,Free,Free,Linear,L,None,17,Antibacterial,little Hemolysis % at 120 µM,Horse,"European Frog, Rana Esculenta",Loop,Low hemolytic,CCSCCSCCCCSSCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC
6422,27311856,2016,AVNIPFKVHLRCKAAFC,AVNIPFKVHLRCKAAFC,Kunitzin-OS,Free,Free,Linear,L,None,12,Antibacterial,little Hemolysis % at 120 µM,Horse,"Chinese Frog, Odorrana Schmackeri",Loop,Low hemolytic,CCCCSSCCCSSTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)O)C(C)C
6427,27617260,2016,RWRWRW,RWRWRW{ct:Amid},MP196,Amidation,Free,Linear,L,None,6,Antibacterial,14 % Hemolysis at 250 μg/ml,Mouse,Synthetic,α-Helix,NA,CCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
6428,27617260,2016,RWRWRW,RWRWRW{ct:Amid},MP196,Amidation,Free,Linear,L,None,6,Antibacterial,23 % Hemolysis at 500 μg/ml,Mouse,Synthetic,α-Helix,NA,CCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
6434,27321580,2016,GFLDIVKGVGKVALGAVSKLF,GFLDIVKGVGKVALGAVSKLF{ct:Amid},CZS-1,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",0 % Hemolysis at 2 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHHHHHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
6435,27321580,2016,GFLDIVKGVGKVALGAVSKLF,GFLDIVKGVGKVALGAVSKLF{ct:Amid},CZS-1,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",0 % Hemolysis at 4 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHHHHHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
6436,27321580,2016,GFLDIVKGVGKVALGAVSKLF,GFLDIVKGVGKVALGAVSKLF{ct:Amid},CZS-1,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",1 % Hemolysis at 8 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHHHHHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
6437,27321580,2016,GFLDIVKGVGKVALGAVSKLF,GFLDIVKGVGKVALGAVSKLF{ct:Amid},CZS-1,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",9 % Hemolysis at 16 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHHHHHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
6438,27321580,2016,GFLDIVKGVGKVALGAVSKLF,GFLDIVKGVGKVALGAVSKLF{ct:Amid},CZS-1,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",20 % Hemolysis at 32 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHHHHHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
6439,27321580,2016,GFLDIVKGVGKVALGAVSKLF,GFLDIVKGVGKVALGAVSKLF{ct:Amid},CZS-1,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",33 % Hemolysis at 64 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHHHHHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
6440,27321580,2016,GFLDIVKGVGKVALGAVSKLF,GFLDIVKGVGKVALGAVSKLF{ct:Amid},CZS-1,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",62 % Hemolysis at 128 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHHHHHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
6441,27321580,2016,GFLDIVKGVGKVALGAVSKLF,GFLDIVKGVGKVALGAVSKLF{ct:Amid},CZS-1,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",105 % Hemolysis at 256 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHHHHHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
6442,27321580,2016,GFLDIVKGVGKVALGAVSKLF,GFLDIVKGVGKVALGAVSKLF{ct:Amid},CZS-1,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",107 % Hemolysis at 512 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHHHHHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
6443,27321580,2016,GFLDVIKHVGKAALGVVTHLINQ,GFLDVIKHVGKAALGVVTHLINQ{ct:Amid},CZS-1,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",0 % Hemolysis at 2 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHTCCHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6444,27321580,2016,GFLDVIKHVGKAALGVVTHLINQ,GFLDVIKHVGKAALGVVTHLINQ{ct:Amid},CZS-2,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",1 % Hemolysis at 4 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHTCCHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6445,27321580,2016,GFLDVIKHVGKAALGVVTHLINQ,GFLDVIKHVGKAALGVVTHLINQ{ct:Amid},CZS-2,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",1 % Hemolysis at 8 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHTCCHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6446,27321580,2016,GFLDVIKHVGKAALGVVTHLINQ,GFLDVIKHVGKAALGVVTHLINQ{ct:Amid},CZS-2,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",6 % Hemolysis at 16 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHTCCHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6447,27321580,2016,GFLDVIKHVGKAALGVVTHLINQ,GFLDVIKHVGKAALGVVTHLINQ{ct:Amid},CZS-2,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",26 % Hemolysis at 32 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHTCCHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6448,27321580,2016,GFLDVIKHVGKAALGVVTHLINQ,GFLDVIKHVGKAALGVVTHLINQ{ct:Amid},CZS-2,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",54 % Hemolysis at 64 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHTCCHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6449,27321580,2016,GFLDVIKHVGKAALGVVTHLINQ,GFLDVIKHVGKAALGVVTHLINQ{ct:Amid},CZS-2,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",75 % Hemolysis at 128 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHTCCHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6450,27321580,2016,GFLDVIKHVGKAALGVVTHLINQ,GFLDVIKHVGKAALGVVTHLINQ{ct:Amid},CZS-2,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",93 % Hemolysis at 256 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHTCCHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6451,27321580,2016,GFLDVIKHVGKAALGVVTHLINQ,GFLDVIKHVGKAALGVVTHLINQ{ct:Amid},CZS-2,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",100 % Hemolysis at 512 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHTCCHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6452,27321580,2016,GFLDVVKHIGKAALGAVTHLINQ,GFLDVVKHIGKAALGAVTHLINQ{ct:Amid},CZS-2,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",0 % Hemolysis at 2 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHSSHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
6453,27321580,2016,GFLDVVKHIGKAALGAVTHLINQ,GFLDVVKHIGKAALGAVTHLINQ{ct:Amid},CZS-3,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",1 % Hemolysis at 4 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHSSHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
6454,27321580,2016,GFLDVVKHIGKAALGAVTHLINQ,GFLDVVKHIGKAALGAVTHLINQ{ct:Amid},CZS-3,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",1 % Hemolysis at 8 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHSSHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
6455,27321580,2016,GFLDVVKHIGKAALGAVTHLINQ,GFLDVVKHIGKAALGAVTHLINQ{ct:Amid},CZS-3,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",2 % Hemolysis at 16 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHSSHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
6456,27321580,2016,GFLDVVKHIGKAALGAVTHLINQ,GFLDVVKHIGKAALGAVTHLINQ{ct:Amid},CZS-3,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",6 % Hemolysis at 32 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHSSHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
6457,27321580,2016,GFLDVVKHIGKAALGAVTHLINQ,GFLDVVKHIGKAALGAVTHLINQ{ct:Amid},CZS-3,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",24 % Hemolysis at 64 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHSSHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
6458,27321580,2016,GFLDVVKHIGKAALGAVTHLINQ,GFLDVVKHIGKAALGAVTHLINQ{ct:Amid},CZS-3,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",59 % Hemolysis at 128 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHSSHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
6459,27321580,2016,GFLDVVKHIGKAALGAVTHLINQ,GFLDVVKHIGKAALGAVTHLINQ{ct:Amid},CZS-3,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",83 % Hemolysis at 256 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHSSHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
6460,27321580,2016,GFLDVVKHIGKAALGAVTHLINQ,GFLDVVKHIGKAALGAVTHLINQ{ct:Amid},CZS-3,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",96 % Hemolysis at 512 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHSSHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
6617,27606830,2016,C16-KGGK,{conj:CH3(CH2)14CO}KGGK{ct:Amid},C16-KGGK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<20 % Hemolysis at 5 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6618,27606830,2016,CH3(CH2)14CO-KGGK,{conj:CH3(CH2)14CO}KGGK{ct:Amid},C16-KGGK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<20 % Hemolysis at 10 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6619,27606830,2016,CH3(CH2)14CO-KGGK,{conj:CH3(CH2)14CO}KGGK{ct:Amid},C16-KGGK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,20 % Hemolysis at 20 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6620,27606830,2016,CH3(CH2)14CO-KGGK,{conj:CH3(CH2)14CO}KGGK{ct:Amid},C16-KGGK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,>40 % Hemolysis at 50 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6621,27606830,2016,CH3(CH2)14CO-KGGK,{conj:CH3(CH2)14CO}KGGK{ct:Amid},C16-KGGK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<80 % Hemolysis at 100 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6622,27606830,2016,CH3(CH2)14CO–KkK,{conj:CH3(CH2)14CO}KK{d}K{ct:Amid},C16-KKK,Amidation,16C- palmitate,Linear,L,16C = palmitate,3,Antibacterial and Antibiofilm,<20 % Hemolysis at 5 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6623,27606830,2016,CH3(CH2)14CO–KkK,{conj:CH3(CH2)14CO}KK{d}K{ct:Amid},C16-KKK,Amidation,16C- palmitate,Linear,L,16C = palmitate,3,Antibacterial and Antibiofilm,20 % Hemolysis at 10 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6624,27606830,2016,CH3(CH2)14CO–KkK,{conj:CH3(CH2)14CO}KK{d}K{ct:Amid},C16-KKK,Amidation,16C- palmitate,Linear,L,16C = palmitate,3,Antibacterial and Antibiofilm,>20 % Hemolysis at 20 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6625,27606830,2016,CH3(CH2)14CO–KkK,{conj:CH3(CH2)14CO}KK{d}K{ct:Amid},C16-KKK,Amidation,16C- palmitate,Linear,L,16C = palmitate,3,Antibacterial and Antibiofilm,40 % Hemolysis at 50 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6626,27606830,2016,CH3(CH2)14CO–KkK,{conj:CH3(CH2)14CO}KK{d}K{ct:Amid},C16-KKK,Amidation,16C- palmitate,Linear,L,16C = palmitate,3,Antibacterial and Antibiofilm,<60 % Hemolysis at 100 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6627,27606830,2016,CH3(CH2)14CO—KAaK,{conj:CH3(CH2)14CO}KAA{d}K{ct:Amid},C16-KAAK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<20 % Hemolysis at 5 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6628,27606830,2016,CH3(CH2)14CO—KAaK,{conj:CH3(CH2)14CO}KAA{d}K{ct:Amid},C16-KAAK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<20 % Hemolysis at 10 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6629,27606830,2016,CH3(CH2)14CO—KAaK,{conj:CH3(CH2)14CO}KAA{d}K{ct:Amid},C16-KAAK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<20 % Hemolysis at 20 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6630,27606830,2016,CH3(CH2)14CO—KAaK,{conj:CH3(CH2)14CO}KAA{d}K{ct:Amid},C16-KAAK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,20 % Hemolysis at 50 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6631,27606830,2016,CH3(CH2)14CO—KAaK,{conj:CH3(CH2)14CO}KAA{d}K{ct:Amid},C16-KAAK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<40 % Hemolysis at 100 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6632,27606830,2016,CH3(CH2)14CO–KLlK,{conj:CH3(CH2)14CO}KLL{d}K{ct:Amid},C16-KLLK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<20 % Hemolysis at 5 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6633,27606830,2016,CH3(CH2)14CO–KLlK,{conj:CH3(CH2)14CO}KLL{d}K{ct:Amid},C16-KLLK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<20 % Hemolysis at 10 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6634,27606830,2016,CH3(CH2)14CO–KLlK,{conj:CH3(CH2)14CO}KLL{d}K{ct:Amid},C16-KLLK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,20 % Hemolysis at 20 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6635,27606830,2016,CH3(CH2)14CO–KLlK,{conj:CH3(CH2)14CO}KLL{d}K{ct:Amid},C16-KLLK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<40 % Hemolysis at 50 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6636,27606830,2016,CH3(CH2)14CO–KLlK,{conj:CH3(CH2)14CO}KLL{d}K{ct:Amid},C16-KLLK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<50 % Hemolysis at 100 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6637,26952110,2016,GILGKLWEGVKSIF,GILGKLWEGVKSIF{ct:Amid},Hp1404,Amidation,Free,Linear,L,None,14,Antibacterial,<20 % Hemolysis at 100 μg/ml,Human,Scorpion Heterometrus Petersii,α-Helical,NA,CCCHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)C(C)C
6638,26952110,2016,GILGKLWKGVKSIF,GILGKLWKGVKSIF{ct:Amid},K8,Amidation,Free,Linear,L,None,14,Antibacterial,<20 % Hemolysis at 100 μg/ml,Human,Hp1404 Derivative,α-Helical,NA,CHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)C(C)C
6639,26952110,2016,LILGKLWKGVKSIF,LILGKLWKGVKSIF{ct:Amid},L1K8,Amidation,Free,Linear,L,None,14,Antibacterial,0 % Hemolysis at 100 μg/ml,Human,Hp1404 Derivative,α-Helical,Non-hemolytic,CTTHHHHTTGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6640,26952110,2016,SILGKLWKGVKSIF,SILGKLWKGVKSIF{ct:Amid},S1K8,Amidation,Free,Linear,L,None,14,Antibacterial,0 % Hemolysis at 100 μg/ml,Human,Hp1404 Derivative,α-Helical,Non-hemolytic,CHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6641,26952110,2016,FILGKLWKGVKSIF,FILGKLWKGVKSIF{ct:Amid},F1K8,Amidation,Free,Linear,L,None,14,Antibacterial,<5 % Hemolysis at 100 μg/ml,Human,Hp1404 Derivative,α-Helical,NA,CHHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6642,26952110,2016,KILGKLWKGVKSIF,KILGKLWKGVKSIF{ct:Amid},K1K8,Amidation,Free,Linear,L,None,14,Antibacterial,0 % Hemolysis at 100 μg/ml,Human,Hp1404 Derivative,α-Helical,Non-hemolytic,CTTHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6643,26952110,2016,GILGKLWEGVKSIF,GILGKLWEGVKSIF{ct:Amid},Hp1404,Amidation,Free,Linear,L,None,14,Antibacterial,<50 % Hemolysis at 200 μg/ml,Human,Scorpion Heterometrus Petersii,α-Helical,NA,CCCHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)C(C)C
6644,26952110,2016,GILGKLWKGVKSIF,GILGKLWKGVKSIF{ct:Amid},K8,Amidation,Free,Linear,L,None,14,Antibacterial,<50 % Hemolysis at 200 μg/ml,Human,Hp1404 Derivative,α-Helical,NA,CHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)C(C)C
6645,26952110,2016,LILGKLWKGVKSIF,LILGKLWKGVKSIF{ct:Amid},L1K8,Amidation,Free,Linear,L,None,14,Antibacterial,0 % Hemolysis at 200 μg/ml,Human,Hp1404 Derivative,α-Helical,Non-hemolytic,CTTHHHHTTGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6646,26952110,2016,SILGKLWKGVKSIF,SILGKLWKGVKSIF{ct:Amid},S1K8,Amidation,Free,Linear,L,None,14,Antibacterial,<20 % Hemolysis at 200 μg/ml,Human,Hp1404 Derivative,α-Helical,NA,CHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6647,26952110,2016,FILGKLWKGVKSIF,#ERROR!,F1K8,Amidation,Free,Linear,L,None,14,Antibacterial,<40 % Hemolysis at 200 μg/ml,Human,Hp1404 Derivative,α-Helical,NA,CHHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6648,26952110,2016,KILGKLWKGVKSIF,KILGKLWKGVKSIF{ct:Amid},K1K8,Amidation,Free,Linear,L,None,14,Antibacterial,0 % Hemolysis at 200 μg/ml,Human,Hp1404 Derivative,α-Helical,Non-hemolytic,CTTHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6649,26952110,2016,GILGKLWEGVKSIF,GILGKLWEGVKSIF{ct:Amid},Hp1404,Amidation,Free,Linear,L,None,14,Antibacterial,<100 % Hemolysis at 400 μg/ml,Human,Scorpion Heterometrus Petersii,α-Helical,NA,CCCHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)C(C)C
6650,26952110,2016,GILGKLWKGVKSIF,GILGKLWKGVKSIF{ct:Amid},K8,Amidation,Free,Linear,L,None,14,Antibacterial,<80 % Hemolysis at 400 μg/ml,Human,Hp1404 Derivative,α-Helical,NA,CHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)C(C)C
6651,26952110,2016,LILGKLWKGVKSIF,LILGKLWKGVKSIF{ct:Amid},L1K8,Amidation,Free,Linear,L,None,14,Antibacterial,<20 % Hemolysis at 400 μg/ml,Human,Hp1404 Derivative,α-Helical,NA,CTTHHHHTTGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6652,26952110,2016,SILGKLWKGVKSIF,SILGKLWKGVKSIF{ct:Amid},S1K8,Amidation,Free,Linear,L,None,14,Antibacterial,50 % Hemolysis at 400 μg/ml,Human,Hp1404 Derivative,α-Helical,NA,CHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6653,26952110,2016,FILGKLWKGVKSIF,FILGKLWKGVKSIF{ct:Amid},F1K8,Amidation,Free,Linear,L,None,14,Antibacterial,<80 % Hemolysis at 400 μg/ml,Human,Hp1404 Derivative,α-Helical,NA,CHHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
6654,26952110,2016,KILGKLWKGVKSIF,KILGKLWKGVKSIF{ct:Amid},K1K8,Amidation,Free,Linear,L,None,14,Antibacterial,11.5 % Hemolysis at 400 μg/ml,Human,Hp1404 Derivative,α-Helical,NA,CTTHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
7165,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 8 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7166,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 15.6 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7167,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 31.2 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7168,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 62.5 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7169,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 125 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7170,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 250 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7171,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 500 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7172,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",<10 % Hemolysis at 1000 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7174,28230992,2017,LRRLRRRWRRRLRRL,LRRLRRRWRRRLRRL{ct:Amid},1,Amidation,Free,Linear,L,None,15,Antibacterial,10 % Hemolysis at >256 mg/L,Human,Synthetic,α-Helix,NA,CTTTHHHHGGGSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)O
7175,28230992,2017,ARRARRRWRRRARRA,ARRARRRWRRRARRA{ct:Amid},2,Amidation,Free,Linear,L,None,15,Antibacterial,10 % Hemolysis at >256 mg/L,Human,Synthetic,α-Helix,NA,CCCCSSGGGGCCCCC,C[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O
7176,28230992,2017,FRRFRRRWRRRFRRF,FRRFRRRWRRRFRRF{ct:Amid},3,Amidation,Free,Linear,L,None,15,Antibacterial,10 % Hemolysis at >256 mg/L,Human,Synthetic,α-Helix,NA,CCTTHHHHTTTSSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
7177,28230992,2017,WRRWRRRWRRRWRRW,WRRWRRRWRRRWRRW{ct:Amid},4,Amidation,Free,Linear,L,None,15,Antibacterial,10 % Hemolysis at >256 mg/L,Human,Synthetic,α-Helix,NA,CCSSHHHHGGGSCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
7178,28230992,2017,LRRLRRRWLRRLRRR,LRRLRRRWLRRLRRR{ct:Amid},5,Amidation,Free,Linear,L,None,15,Antibacterial,10 % Hemolysis at >256 mg/L,Human,Synthetic,α-Helix,NA,CCTTHHHHGGGSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
7179,28230992,2017,LRRLRRRLRRLRRRWRRRLRRLRRRLRRL,LRRLRRRLRRLRRRWRRRLRRLRRRLRRL{ct:Amid},6,Amidation,Free,Branched,L,None,29,Antibacterial,10 % Hemolysis at 64 mg/L,Human,Synthetic,α-Helix,NA,CHHHHHHHHHHTTHHHHHHHHHGGGGGCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)O
7180,28230992,2017,LRRLRRRLRRLRRRLRRLRRRWRRRLRRLRRRLRRLRRRLRRL,LRRLRRRLRRLRRRLRRLRRRWRRRLRRLRRRLRRLRRRLRRL{ct:Amid},7,Amidation,Free,Branched,L,None,43,Antibacterial,10 % Hemolysis at 64 mg/L,Human,Synthetic,α-Helix,NA,CHHHHHHHHHHTTHHHHHGGGTTHHHHHHTHHHHHHHHHHHCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)O
7181,28230992,2017,LRRLRRRWWRRRLRRL,LRRLRRRWWRRRLRRL{ct:Amid},8,Amidation,Free,Linear,L,None,16,Antibacterial,10 % Hemolysis at 256 mg/L,Human,Synthetic,α-Helix,NA,CCTTHHHHGGGTTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)O
7182,28230992,2017,LRRLRRRWWWRRRLRR,LRRLRRRWWWRRRLRR{ct:Amid},9,Amidation,Free,Linear,L,None,16,Antibacterial,10 % Hemolysis at >256 mg/L,Human,Synthetic,α-Helix,NA,CCSCTHHHHTGGGCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
7186,28254375,2017,ASVVNKLTGGVAGLLK,ASVVNKLTGGVAGLLK,TP,Free,Free,Linear,L,None,16,Antibacterial,<10 % Hemolysis at 1.25-160 µM,Mouse,Tibetan Swine,α-Helix,NA,CCTHHHHSCTTTTTCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
7187,28254375,2017,ASVVNKLTGGVAGLLK,ASVVNKLTGGVAGLLK,TP,Free,Free,Linear,L,None,16,Antibacterial,9.4 ± 1.01 % Hemolysis at 320 µM,Mouse,Tibetan Swine,α-Helix,NA,CCTHHHHSCTTTTTCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
7220,28299865,2017,ASKAGAIAG,ASKAGAIAG,XLAsp-P2,Free,Free,Linear,L,None,9,Antibacterial,0 % Hemolysis at 8 μg/ml,Rabbit,Xenopus Laevis Skin,Double Helix,Non-hemolytic,CCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)NCC(=O)O
7221,28299865,2017,ASKAGAIAG,ASKAGAIAG,XLAsp-P2,Free,Free,Linear,L,None,9,Antibacterial,<10 % Hemolysis at 16 μg/ml,Rabbit,Xenopus Laevis Skin,Double Helix,NA,CCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)NCC(=O)O
7222,28299865,2017,ASKAGAIAG,ASKAGAIAG,XLAsp-P2,Free,Free,Linear,L,None,9,Antibacterial,<10 % Hemolysis at 32 μg/ml,Rabbit,Xenopus Laevis Skin,Double Helix,NA,CCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)NCC(=O)O
7223,28299865,2017,ASKAGAIAG,ASKAGAIAG,XLAsp-P2,Free,Free,Linear,L,None,9,Antibacterial,<10 % Hemolysis at 64 μg/ml,Rabbit,Xenopus Laevis Skin,Double Helix,NA,CCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)NCC(=O)O
7224,28299865,2017,ASKAGAIAG,ASKAGAIAG,XLAsp-P2,Free,Free,Linear,L,None,9,Antibacterial,<40 % Hemolysis at 128 μg/ml,Rabbit,Xenopus Laevis Skin,Double Helix,NA,CCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)NCC(=O)O
7231,28347740,2017,RWKIFKKIERVGQNVRDGIIKAGPAIQVLGTAKALGK,RWKIFKKIERVGQNVRDGIIKAGPAIQVLGTAKALGK,ABP-dHC-Cecropin A,Free,Free,Linear,L,None,37,Antibacterial,0 % Hemolysis at 1-800 µM,Human,Drury (Hyphantria Cunea) (Dhc),α-Helix,Non-hemolytic,CCTTGGGTHHHHTTTTTTTCCCSSSTTSGGGCSSTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC
7232,28347740,2017,RWKIFKKIERVGQNVRDGIIKAGKAIQVLGTAKALGK,RWKIFKKIERVGQNVRDGIIKAGKAIQVLGTAKALGK,ABP-dHC-Cecropin A-K(24),Free,Free,Linear,L,None,37,Antibacterial,0 % Hemolysis at 1-800 µM,Human,Abp-Dhc-Cecropin A Analog,α-Helix,Non-hemolytic,CTTTTHHHHTHHHHTTSTTTTCCCTTCCTTTSTTSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC
7278,28657596,2017,ILGKIWEGIKSLF,ILGKIWEGIKSLF{ct:Amid},IsCT1,Amidation,Free,Linear,L,None,13,Antibacterial,~100 % Hemolysis at 50 μg/ml,Human,Scorpion Opithancatus Madagascariensis,α-Helix,NA,CHHHHHHHHTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
7279,28657596,2017,ILGKIWEGIKSLF,ILGKIWEGIKSLF{ct:Amid},IsCT1,Amidation,Free,Linear,L,None,13,Antibacterial,~100 % Hemolysis at 100 μg/ml,Human,Scorpion Opithancatus Madagascariensis,α-Helix,NA,CHHHHHHHHTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
7280,28657596,2017,IFGAIWNGIKSLF,IFGAIWNGIKSLF{ct:Amid},IsCT2,Amidation,Free,Linear,L,None,13,Antibacterial,~100 % Hemolysis at 50 μg/ml,Human,Scorpion Opithancatus Madagascariensis,α-Helix,NA,CCHHHHHHHHHHC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
7281,28657596,2017,IFGAIWNGIKSLF,IFGAIWNGIKSLF{ct:Amid},IsCT2,Amidation,Free,Linear,L,None,13,Antibacterial,~100 % Hemolysis at 100 μg/ml,Human,Scorpion Opithancatus Madagascariensis,α-Helix,NA,CCHHHHHHHHHHC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
7282,28657596,2017,ILGKAWEGAKSLF,ILGKAWEGAKSLF{ct:Amid},IsCT1A1,Amidation,Free,Linear,L,None,13,Antibacterial,10 % Hemolysis at 100 μg/ml,Human,Analogs Of Scorpion Venom Isct Peptides,α-Helix,NA,CTTSCCCCSSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
7283,28657596,2017,ILGKVWEGVKSLF,ILGKVWEGVKSLF{ct:Amid},IsCT1V1,Amidation,Free,Linear,L,None,13,Antibacterial,<10 % Hemolysis at 100 μg/ml,Human,Analogs Of Scorpion Venom Isct Peptides,α-Helix,NA,CTTHHHHHHTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
7284,28657596,2017,ILGKLWEGLKSLF,ILGKLWEGLKSLF{ct:Amid},IsCT1L1,Amidation,Free,Linear,L,None,13,Antibacterial,80 % Hemolysis at 50 μg/ml,Human,Analogs Of Scorpion Venom Isct Peptides,α-Helix,NA,CCHHHHHHHTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
7285,28657596,2017,ILGKLWEGLKSLF,ILGKLWEGLKSLF{ct:Amid},IsCT1L1,Amidation,Free,Linear,L,None,13,Antibacterial,<100 % Hemolysis at 100 μg/ml,Human,Analogs Of Scorpion Venom Isct Peptides,α-Helix,NA,CCHHHHHHHTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
7286,28657596,2017,ILGKIWKGIKSLF,ILGKIWKGIKSLF{ct:Amid},IsCT1K7,Amidation,Free,Linear,L,None,13,Antibacterial,50 % Hemolysis at 50 μg/ml,Human,Analogs Of Scorpion Venom Isct Peptides,α-Helix,NA,CCHHHHHHHHTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
7287,28657596,2017,ILGKIWKGIKSLF,ILGKIWKGIKSLF{ct:Amid},IsCT1K7,Amidation,Free,Linear,L,None,13,Antibacterial,<70 % Hemolysis at 100 μg/ml,Human,Analogs Of Scorpion Venom Isct Peptides,α-Helix,NA,CCHHHHHHHHTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
7288,28657596,2017,ILGKIWEGIESLF,ILGKIWEGIESLF{ct:Amid},IsCT1E7,Amidation,Free,Linear,L,None,13,Antibacterial,0 % Hemolysis at 100 μg/ml,Human,Analogs Of Scorpion Venom Isct Peptides,α-Helix,Non-hemolytic,CTTHHHHHHHTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
7289,28657596,2017,ILGAAWNGAKSLF,ILGAAWNGAKSLF{ct:Amid},IsCT2A1,Amidation,Free,Linear,L,None,13,Antibacterial,0 % Hemolysis at 100 μg/ml,Human,Analogs Of Scorpion Venom Isct Peptides,α-Helix,Non-hemolytic,CCCCSCCSSCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
7290,28657596,2017,ILGAVWNGVKSLF,ILGAVWNGVKSLF{ct:Amid},IsCT2V1,Amidation,Free,Linear,L,None,13,Antibacterial,20 % Hemolysis at 100 μg/ml,Human,Analogs Of Scorpion Venom Isct Peptides,α-Helix,NA,CCHHHHHHHHHHC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
7291,28661457,2017,DLRDSWKVIGSDKK,DLRDSWKVIGSDKK,AI-Hemocidin 2,Free,Free,Linear,L,None,14,Antibacterial,10 % Hemolysis at >500 μg/ml,Human,Arca Inflata,α-Helix,NA,CTTTTSSCSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
7292,28661457,2017,DLRDSWKVIGSDKK,DLRDSWKVIGSDKK,AI-Hemocidin 2,Free,Free,Linear,L,None,14,Antibacterial,10.27 ± 0.42 % Hemolysis at 500 μg/ml,Human,Arca Inflata,α-Helix,NA,CTTTTSSCSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
7322,28731688,2017,WWWLRRIW,WWWLRRIW{ct:Amid},WT,Amidation,Free,Linear,L,None,8,Antibacterial,50 % Hemolysis at 35 µM,Human,Motif Of A Short Trp-Rich,α-Helix,NA,CCCTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
7323,28731688,2017,RWWLRRIW,RWWLRRIW{ct:Amid},W1R,Amidation,Free,Linear,L,None,8,Antibacterial,50 % Hemolysis at >200 µM,Human,Motif Of A Short Trp-Rich,α-Helix,NA,CCSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
7324,28731688,2017,WRWLRRIW,WRWLRRIW{ct:Amid},W2R,Amidation,Free,Linear,L,None,8,Antibacterial,50 % Hemolysis at 100 µM,Human,Motif Of A Short Trp-Rich,α-Helix,NA,CCGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
7325,28731688,2017,WWRLRRIW,WWRLRRIW{ct:Amid},W3R,Amidation,Free,Linear,L,None,8,Antibacterial,50 % Hemolysis at >200 µM,Human,Motif Of A Short Trp-Rich,α-Helix,NA,CCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
7326,28731688,2017,WWWRRRIW,WWWRRRIW{ct:Amid},L4R,Amidation,Free,Linear,L,None,8,Antibacterial,50 % Hemolysis at >200 µM,Human,Motif Of A Short Trp-Rich,α-Helix,NA,CCCTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
7327,28731688,2017,WWWLRRRW,WWWLRRRW{ct:Amid},I7R,Amidation,Free,Linear,L,None,8,Antibacterial,50 % Hemolysis at 150 µM,Human,Motif Of A Short Trp-Rich,α-Helix,NA,CCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
7328,28731688,2017,WWWLRRIR,WWWLRRIR{ct:Amid},W8R,Amidation,Free,Linear,L,None,8,Antibacterial,50 % Hemolysis at >200 µM,Human,Motif Of A Short Trp-Rich,α-Helix,NA,CCSCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
7409,28894233,2017,IFGAILPLALGALKNLIK,IFGAILPLALGALKNLIK,RGD-Hylin a1,Free,Free,Linear,L,None,18,Antibacterial,30 % Hemolysis at 12.5 μg/ml,Human,Skin Of South American Tree Frogs,NA,NA,CCTTHHHHHHHHHHHHTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
7410,28894233,2017,IFGAILPLALGALKNLIK,IFGAILPLALGALKNLIK,RGD-Hylin a1,Free,Free,Linear,L,None,18,Antibacterial,76 % Hemolysis at 25 μg/ml,Human,Skin Of South American Tree Frogs,NA,NA,CCTTHHHHHHHHHHHHTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
7411,28894233,2017,IFGAILPLALGALKNLIK,IFGAILPLALGALKNLIK,RGD-Hylin a1,Free,Free,Linear,L,None,18,Antibacterial,82 % Hemolysis at 37 μg/ml,Human,Skin Of South American Tree Frogs,NA,NA,CCTTHHHHHHHHHHHHTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
7412,28894233,2017,IFGAILPLALGALKNLIK,IFGAILPLALGALKNLIK,RGD-Hylin a1,Free,Free,Linear,L,None,18,Antibacterial,99 % Hemolysis at 50 μg/ml,Human,Skin Of South American Tree Frogs,NA,NA,CCTTHHHHHHHHHHHHTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
7421,28656506,2017,GKPRPYSPRPTSHPRPIRV,GKPRPYSPRPTSHPRPIRV,n-drosocin,Free,Free,Linear,L,None,19,Antibacterial,<10 % Hemolysis at 200 µM,Rat,Drosophila Melanogaster,Random coil,NA,CCCCCCCCSSSSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C
7422,28656506,2017,GKPRPYSPRPTSHPRPIRV,GKPRPYSPRPTSHPRPIRV,M-drosocin,Free,Free,Linear,L,None,19,Antibacterial,<10 % Hemolysis at 200 µM,Rat,Drosophila Melanogaster,Random coil,NA,CCCCCCCCSSSSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C
7423,28656506,2017,GKPRPYSPRPTSHPRPIRV,GKPRPYSPRPTSHPRPIRV,Di-drosocin,Free,Free,Linear,L,None,19,Antibacterial,<10 % Hemolysis at 200 µM,Rat,Drosophila Melanogaster,Random coil,NA,CCCCCCCCSSSSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C
7436,28863356,2017,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},1,Amidation,Free,Linear,Mix,l = D-Leucine,13,Antibacterial,21(±4) % Hemolysis at 50 µM,Human,Amphibian Temporins,α-Helix,NA,CCCCHHHHHTTTC,NA
7437,28863356,2017,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},1,Amidation,Free,Linear,Mix,l = D-Leucine,13,Antibacterial,7(±3) % Hemolysis at 25 µM,Human,Amphibian Temporins,α-Helix,NA,CCCCHHHHHTTTC,NA
7438,28863356,2017,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},1,Amidation,Free,Linear,Mix,l = D-Leucine,13,Antibacterial,6(±3) % Hemolysis at 12.5 µM,Human,Amphibian Temporins,α-Helix,NA,CCCCHHHHHTTTC,NA
7439,28863356,2017,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},1,Amidation,Free,Linear,Mix,l = D-Leucine,13,Antibacterial,3(±2) % Hemolysis at 6.25 µM,Human,Amphibian Temporins,α-Helix,NA,CCCCHHHHHTTTC,NA
7440,28863356,2017,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},1,Amidation,Free,Linear,Mix,l = D-Leucine,13,Antibacterial,1(±1) % Hemolysis at 3.125 µM,Human,Amphibian Temporins,α-Helix,NA,CCCCHHHHHTTTC,NA
7441,28863356,2017,FVPWFSKFlkRIL,FVPWFSKFL{d}K{d}RIL{ct:Amid},9,Amidation,Free,Linear,Mix,"l = D-Leucine, k = D-Lys",13,Antibacterial,7(±4) % Hemolysis at 50 µM,Human,Tl Analogue,α-Helix,NA,CCCHHHHHHHTTC,NA
7442,28863356,2017,FVPWFSKFlkRIL,FVPWFSKFL{d}K{d}RIL{ct:Amid},9,Amidation,Free,Linear,Mix,"l = D-Leucine, k = D-Lys",13,Antibacterial,5(±3) % Hemolysis at 25 µM,Human,Tl Analogue,α-Helix,NA,CCCHHHHHHHTTC,NA
7443,28863356,2017,FVPWFSKFlkRIL,FVPWFSKFL{d}K{d}RIL{ct:Amid},9,Amidation,Free,Linear,Mix,"l = D-Leucine, k = D-Lys",13,Antibacterial,5(±2) % Hemolysis at 12.5 µM,Human,Tl Analogue,α-Helix,NA,CCCHHHHHHHTTC,NA
7444,28863356,2017,FVPWFSKFlkRIL,FVPWFSKFL{d}K{d}RIL{ct:Amid},9,Amidation,Free,Linear,Mix,"l = D-Leucine, k = D-Lys",13,Antibacterial,1(±2) % Hemolysis at 6.25 µM,Human,Tl Analogue,α-Helix,NA,CCCHHHHHHHTTC,NA
7445,28863356,2017,FVPWFSKFlkRIL,FVPWFSKFL{d}K{d}RIL{ct:Amid},9,Amidation,Free,Linear,Mix,"l = D-Leucine, k = D-Lys",13,Antibacterial,0(±1) % Hemolysis at 3.125 µM,Human,Tl Analogue,α-Helix,NA,CCCHHHHHHHTTC,NA
7446,28863356,2017,FVPWFSKFlWRIL,FVPWFSKFL{d}WRIL{ct:Amid},10,Amidation,Free,Linear,Mix,l = D-Leucine,13,Antibacterial,37(±1) % Hemolysis at 50 µM,Human,Tl Analogue,α-Helix,NA,CCCCHHHHHTTTC,NA
7447,28863356,2017,FVPWFSKFlWRIL,FVPWFSKFL{d}WRIL{ct:Amid},10,Amidation,Free,Linear,Mix,l = D-Leucine,13,Antibacterial,20(±3) % Hemolysis at 25 µM,Human,Tl Analogue,α-Helix,NA,CCCCHHHHHTTTC,NA
7448,28863356,2017,FVPWFSKFlWRIL,FVPWFSKFL{d}WRIL{ct:Amid},10,Amidation,Free,Linear,Mix,l = D-Leucine,13,Antibacterial,7(±1) % Hemolysis at 12.5 µM,Human,Tl Analogue,α-Helix,NA,CCCCHHHHHTTTC,NA
7449,28863356,2017,FVPWFSKFlWRIL,FVPWFSKFL{d}WRIL{ct:Amid},10,Amidation,Free,Linear,Mix,l = D-Leucine,13,Antibacterial,4(±2) % Hemolysis at 6.25 µM,Human,Tl Analogue,α-Helix,NA,CCCCHHHHHTTTC,NA
7450,28863356,2017,FVPWFSKFlWRIL,FVPWFSKFL{d}WRIL{ct:Amid},10,Amidation,Free,Linear,Mix,l = D-Leucine,13,Antibacterial,2(±1) % Hemolysis at 3.125 µM,Human,Tl Analogue,α-Helix,NA,CCCCHHHHHTTTC,NA
7465,29185466,2017,GFGMALKLLKKVL,GFGMALKLLKKVL{ct:Amid},Macropin,Amidation,Free,Linear,L,None,13,"Anti-bioflm, Antibacterial",5 % Hemolysis at 25 µM,Human,Macropis Fulvipes Venom,α-Helical,NA,CTTHHHHHHTTTC,CSCC[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
7514,28904355,2017,NPEKALEPLIAIQIAIKGMLNGWFTGVGFRRKR,NPEKALEPLIAIQIAIKGMLNGWFTGVGFRRKR,LysAB2 P0,Free,Free,Linear,L,None,33,Antibacterial,63.2 % Hemolysis at 64 µM,Human,Acinetobacter Baumannii Phage Endolysin Lysab2,α-Helix,NA,CGGGSSCSGGGSTHHHHHHSTTTSSCTTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O
7515,28904355,2017,NPEKALEPLIAIQIAIKGMLNGWFTGVGFRRKR,NPEKALEPLIAIQIAIKGMLNGWFTGVGFRRKR,LysAB2 P0,Free,Free,Linear,L,None,33,Antibacterial,100 % Hemolysis at 128 µM,Human,Acinetobacter Baumannii Phage Endolysin Lysab3,α-Helix,NA,CGGGSSCSGGGSTHHHHHHSTTTSSCTTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O
7516,28904355,2017,EKALEKLIAIQKAIKGMLNGWFTGVGFRRKR,EKALEKLIAIQKAIKGMLNGWFTGVGFRRKR,LysAB2 P1,Free,Free,Linear,L,None,31,Antibacterial,50 % Hemolysis at 32 µM,Human,Acinetobacter Baumannii Phage Endolysin Lysab4,α-Helix,NA,CCHHHHHHHHHHHHHHHHHHHHHCGGGGCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O
7517,28904355,2017,EKALEKLIAIQKAIKGMLNGWFTGVGFRRKR,EKALEKLIAIQKAIKGMLNGWFTGVGFRRKR,LysAB2 P1,Free,Free,Linear,L,None,31,Antibacterial,60 % Hemolysis at 64 µM,Human,Acinetobacter Baumannii Phage Endolysin Lysab5,α-Helix,NA,CCHHHHHHHHHHHHHHHHHHHHHCGGGGCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O
7518,28904355,2017,EKALEKLIAIQKAIKGMLNGWFTGVGFRRKR,EKALEKLIAIQKAIKGMLNGWFTGVGFRRKR,LysAB2 P1,Free,Free,Linear,L,None,31,Antibacterial,80 % Hemolysis at 128 µM,Human,Acinetobacter Baumannii Phage Endolysin Lysab6,α-Helix,NA,CCHHHHHHHHHHHHHHHHHHHHHCGGGGCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O
7519,28904355,2017,EKALEKLIAIQKAIKGMLAGWFTGVGARRKR,EKALEKLIAIQKAIKGMLAGWFTGVGARRKR,LysAB2 P2,Free,Free,Linear,L,None,31,Antibacterial,90 % Hemolysis at 128 µM,Human,Acinetobacter Baumannii Phage Endolysin Lysab7,α-Helix,NA,CCHHHHHHHHHHHHHHHHTTGGGSTTCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O
7520,28904355,2017,NPEKALEKLIAIQKAIKGMLNGWFTGVGFRRKR,NPEKALEKLIAIQKAIKGMLNGWFTGVGFRRKR,LysAB2 P3,Free,Free,Linear,L,None,33,Antibacterial,1.97 % Hemolysis at 4 µM,Human,Acinetobacter Baumannii Phage Endolysin Lysab8,α-Helix,NA,CCTHHHHHHHHHHHHHHHHHHHTTSTHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O
7521,28904355,2017,NPEKALEKLIAIQKAIKGMLNGWFTGVGFRRKR,NPEKALEKLIAIQKAIKGMLNGWFTGVGFRRKR,LysAB2 P3,Free,Free,Linear,L,None,33,Antibacterial,<10 % Hemolysis at 256 µM,Human,Acinetobacter Baumannii Phage Endolysin Lysab9,α-Helix,NA,CCTHHHHHHHHHHHHHHHHHHHTTSTHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O
8402,38802469,2024,AFCGGRCRGFRRRLFCTKAC,AFCGGRCRGFRRRLFCTKAC,AMP,Free,Free,Linear,L,None,20,Antibacterial and Antibioflm,<1 % Hemolysis at 1.5625-100 μg/ml,Human,Synthetic,expanded conformation,Non-hemolytic,CCSSCCCCCCCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
8403,38287360,2024,RWCVYAYVRVRGVLVRYRRCW,RWCVYAYVRVRGVLVRYRRCW,Ar-1,Free,Free,Linear,L,None,21,Antibacterial,50 % Hemolysis at >100 µM,Human,Arenicin Derivatives,anti-parallel β-Sheets,NA,NA,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
8404,38287360,2024,RWCVYAYVRVRGVLVRYRRCW,RWCVYAYVRVRGVLVRYRRCW,Ar-1,Free,Free,Linear,L,None,21,Antibacterial,10 % Hemolysis at 20.2±1.8 µM,Human,Arenicin Derivatives,anti-parallel β-Sheets,NA,NA,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
8405,38287360,2024,RW-Abu-VYAYVRVRGVLVRYRR-Abu-W,RW-{nnr:Abu}-VYAYVRVRGVLVRYRR-{nnr:Abu}-W,Ar-1-Abu,Free,Free,Linear,L,Abu = alpha-amino-n-butyric acid,21,Antibacterial,50 % Hemolysis at >100 µM,Human,Arenicin Derivatives,anti-parallel β-Sheets,NA,NA,NA
8406,38287360,2024,RW-Abu-VYAYVRVRGVLVRYRR-Abu-W,RW-{nnr:Abu}-VYAYVRVRGVLVRYRR-{nnr:Abu}-W,Ar-1-Abu,Free,Free,Linear,L,Abu = alpha-amino-n-butyric acid,21,Antibacterial,10 % Hemolysis at >100 µM,Human,Arenicin Derivatives,anti-parallel β-Sheets,NA,NA,NA
8407,38287360,2024,RWCVYAYVRIRGVLVRYRRCW,RWCVYAYVRIRGVLVRYRRCW,Ar-2,Free,Free,Linear,L,None,21,Antibacterial,50 % Hemolysis at 29.2±2.4 µM,Human,Arenicin Derivatives,anti-parallel β-Sheets,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(C)C
8408,38287360,2024,RWCVYAYVRIRGVLVRYRRCW,RWCVYAYVRIRGVLVRYRRCW,Ar-2,Free,Free,Linear,L,None,21,Antibacterial,10 % Hemolysis at 4.9±0.7 µM,Human,Arenicin Derivatives,anti-parallel β-Sheets,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(C)C
8409,38287360,2024,RW-Abu-VYAYVRIRGVLVRYRR-Abu-W,RW-{nnr:Abu}-VYAYVRIRGVLVRYRR-{nnr:Abu}-W,Ar-2-Abu,Free,Free,Linear,L,Abu = alpha-amino-n-butyric acid,21,Antibacterial,50 % Hemolysis at >100 µM,Human,Arenicin Derivatives,anti-parallel β-Sheets,NA,NA,NA
8410,38287360,2024,RW-Abu-VYAYVRIRGVLVRYRR-Abu-W,RW-{nnr:Abu}-VYAYVRIRGVLVRYRR-{nnr:Abu}-W,Ar-2-Abu,Free,Free,Linear,L,Abu = alpha-amino-n-butyric acid,21,Antibacterial,10 % Hemolysis at 15.4±1.0 µM,Human,Arenicin Derivatives,anti-parallel β-Sheets,NA,NA,NA
8411,38287360,2024,GFCWYVCVYRNGVRVCYRRCN,GFCWYVCVYRNGVRVCYRRCN,Ar-3,Free,Free,Linear,L,None,21,Antibacterial,50 % Hemolysis at >100 µM,Human,Arenicin Derivatives,anti-parallel β-Sheets,NA,NA,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
8412,38287360,2024,GFCWYVCVYRNGVRVCYRRCN,GFCWYVCVYRNGVRVCYRRCN,Ar-3,Free,Free,Linear,L,None,21,Antibacterial,10 % Hemolysis at 30.3±2.5 µM,Human,Arenicin Derivatives,anti-parallel β-Sheets,NA,NA,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
8413,38287360,2024,GF-Abu-WYV-Abu-VYRNGVRV-Abu-YRR-Abu-N,GF-{nnr:Abu}-WYV-{nnr:Abu}-VYRNGVRV-{nnr:Abu}-YRR-{nnr:Abu}-N,Ar-3-Abu,Free,Free,Linear,L,Abu = alpha-amino-n-butyric acid,21,Antibacterial,50 % Hemolysis at >100 µM,Human,Arenicin Derivatives,anti-parallel β-Sheets,NA,NA,NA
8414,38287360,2024,GF-Abu-WYV-Abu-VYRNGVRV-Abu-YRR-Abu-N,GF-{nnr:Abu}-WYV-{nnr:Abu}-VYRNGVRV-{nnr:Abu}-YRR-{nnr:Abu}-N,Ar-3-Abu,Free,Free,Linear,L,Abu = alpha-amino-n-butyric acid,21,Antibacterial,10 % Hemolysis at 39.3±3.2 µM,Human,Arenicin Derivatives,anti-parallel β-Sheets,NA,NA,NA
8415,38287360,2024,GFCWYV-Abu-VYRNGVRV-Abu-YRRCN,GFCWYV-{nnr:Abu}-VYRNGVRV-{nnr:Abu}-YRRCN,Ar-3(3–20),Free,Free,Linear,L,Abu = alpha-amino-n-butyric acid,21,Antibacterial,50 % Hemolysis at >100 µM,Human,Arenicin Derivatives,anti-parallel β-Sheets,NA,NA,NA
8416,38287360,2024,GFCWYV-Abu-VYRNGVRV-Abu-YRRCN,GFCWYV-{nnr:Abu}-VYRNGVRV-{nnr:Abu}-YRRCN,Ar-3(3–20),Free,Free,Linear,L,Abu = alpha-amino-n-butyric acid,21,Antibacterial,10 % Hemolysis at >100 µM,Human,Arenicin Derivatives,anti-parallel β-Sheets,NA,NA,NA
8417,38287360,2024,GF-Abu-WYVCVYRNGVRVCYRR-Abu-N,GF-{nnr:Abu}-WYVCVYRNGVRVCYRR-{nnr:Abu}-N,Ar-3(7–16),Free,Free,Linear,L,Abu = alpha-amino-n-butyric acid,21,Antibacterial,50 % Hemolysis at >100 µM,Human,Arenicin Derivatives,anti-parallel β-Sheets,NA,NA,NA
8418,38287360,2024,GF-Abu-WYVCVYRNGVRVCYRR-Abu-N,GF-{nnr:Abu}-WYVCVYRNGVRVCYRR-{nnr:Abu}-N,Ar-3(7–16),Free,Free,Linear,L,Abu = alpha-amino-n-butyric acid,21,Antibacterial,10 % Hemolysis at 41.1±4.3 µM,Human,Arenicin Derivatives,anti-parallel β-Sheets,NA,NA,NA
8446,38328670,2024,MAKRRKKAKKKAKKAKKRRRRR,MAKRRKKAKKKAKKAKKRRRRR,MR-22,Free,Free,Linear,L,None,21,Antibacterial,0 % Hemolysis at 2-256 μg/ml,Human,Synthetic,Helix/coil,Non-hemolytic,CCCCCCCTTCCSCC,CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
8491,38578302,2024,KYWKKYWKKYWK,KYWKKYWKKYWK{ct:Amid},KK12YW,Amidation,Free,Linear,L,None,11,Antibacterial,0 % Hemolysis at 0.44-229.27 μg/ml,Fish,Synthetic,α-Helical,Non-hemolytic,CHHHHHHHHSSSCSSGGGHHHHHHHC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCCN)C(=O)O
8492,38578302,2024,KYWKKYWKKYWK,KYWKKYWKKYWK{ct:Amid},KK12YW,Amidation,Free,Linear,L,None,11,Antibacterial,25 % Hemolysis at 458.55 μg/ml,Fish,Synthetic,α-Helical,NA,CHHHHHHHHHHHHHHHHHHHHHHTTC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCCN)C(=O)O
8493,38578302,2024,KYWKKYWKKYWK,KYWKKYWKKYWK{ct:Amid},KK12YW,Amidation,Free,Linear,L,None,11,Antibacterial,<50 % Hemolysis at 917.1 μg/ml,Fish,Synthetic,α-Helical,NA,CHHHHHHHHHHHHHHHHHHHHHHTTC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCCN)C(=O)O
8494,38578302,2024,KYWKKYWKKYWK,KYWKKYWKKYWK{ct:Amid},KK12YW,Amidation,Free,Linear,L,None,11,Antibacterial,<50 % Hemolysis at 1834.21 μg/ml,Fish,Synthetic,α-Helical,NA,CHHHHHHHHSSSCSSGGGHHHHHHHC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCCN)C(=O)O
8495,38578302,2024,KYWKKYWKKYWK,KYWKKYWKKYWK{ct:Amid},KK12YW,Amidation,Free,Linear,L,None,11,Antibacterial,<50 % Hemolysis at 3668.42 μg/ml,Fish,Synthetic,α-Helical,NA,CHHHHHHHHHHHHHHHHHHHHHHTTC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCCN)C(=O)O
8496,38578302,2024,KYWKKYWKKYWK,KYWKKYWKKYWK{ct:Amid},KK12YW,Amidation,Free,Linear,L,None,11,Antibacterial,51.2 % Hemolysis at 7336.84 μg/ml,Fish,Synthetic,α-Helical,NA,CHHHHHHHHHHHHHHHHHHHHHHTTC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCCN)C(=O)O
8533,38673786,2024,KKPKPKPKPWWWW,KKPKPKPKPWWWW{ct:Amid},K9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<10 % Hemolysis at 2 µM,Horse,Synthetic,α-Helical,NA,CCCCCSSSSCSCC,NCCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8534,38673786,2024,KKPKPKPKPWWWW,KKPKPKPKPWWWW{ct:Amid},K9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<10 % Hemolysis at 4 µM,Horse,Synthetic,α-Helical,NA,CCCCCSSSSCSCC,NCCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8535,38673786,2024,KKPKPKPKPWWWW,KKPKPKPKPWWWW{ct:Amid},K9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 8 µM,Horse,Synthetic,α-Helical,NA,CCCCCSSSSCSCC,NCCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8536,38673786,2024,KKPKPKPKPWWWW,KKPKPKPKPWWWW{ct:Amid},K9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 16 µM,Horse,Synthetic,α-Helical,NA,CCCCCSSSSCSCC,NCCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8537,38673786,2024,KKPKPKPKPWWWW,KKPKPKPKPWWWW{ct:Amid},K9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 32 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSCCCC,NCCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8538,38673786,2024,KKPKPKPKPWWWW,KKPKPKPKPWWWW{ct:Amid},K9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 64 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSCCCC,NCCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8539,38673786,2024,KKPKPKPKPWWWW,KKPKPKPKPWWWW{ct:Amid},K9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 128 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSCCCC,NCCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8540,38673786,2024,KKPRPRPRPWWWW,KKPRPRPRPWWWW{ct:Amid},KR9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 2 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8541,38673786,2024,KKPRPRPRPWWWW,KKPRPRPRPWWWW{ct:Amid},KR9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 4 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8542,38673786,2024,KKPRPRPRPWWWW,KKPRPRPRPWWWW{ct:Amid},KR9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 8 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8543,38673786,2024,KKPRPRPRPWWWW,KKPRPRPRPWWWW{ct:Amid},KR9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 16 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8544,38673786,2024,KKPRPRPRPWWWW,KKPRPRPRPWWWW{ct:Amid},KR9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 32 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8545,38673786,2024,KKPRPRPRPWWWW,KKPRPRPRPWWWW{ct:Amid},KR9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 64 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8546,38673786,2024,KKPRPRPRPWWWW,KKPRPRPRPWWWW{ct:Amid},KR9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<40 % Hemolysis at 128 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8547,38673786,2024,RRPRPRPRPWWWW,RRPRPRPRPWWWW{ct:Amid},R9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 2 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8548,38673786,2024,RRPRPRPRPWWWW,RRPRPRPRPWWWW{ct:Amid},R9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 4 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8549,38673786,2024,RRPRPRPRPWWWW,RRPRPRPRPWWWW{ct:Amid},R9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 8 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8550,38673786,2024,RRPRPRPRPWWWW,RRPRPRPRPWWWW{ct:Amid},R9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 16 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8551,38673786,2024,RRPRPRPRPWWWW,RRPRPRPRPWWWW{ct:Amid},R9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<30 % Hemolysis at 32 µM,Horse,Synthetic,α-Helical,NA,CCCCCCCSSSCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8552,38673786,2024,RRPRPRPRPWWWW,RRPRPRPRPWWWW{ct:Amid},R9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<50 % Hemolysis at 64 µM,Horse,Synthetic,α-Helical,NA,CCCCCCCSSSCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8553,38673786,2024,RRPRPRPRPWWWW,RRPRPRPRPWWWW{ct:Amid},R9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<80 % Hemolysis at 128 µM,Horse,Synthetic,α-Helical,NA,CCCCCCCSSSCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8554,38673786,2024,RRPRPRPRPWWWWW,RRPRPRPRPWWWWW{ct:Amid},R9W5,Amidation,Free,Linear,L,None,14,Antibacterial,<20 % Hemolysis at 2 µM,Horse,Synthetic,α-Helical,NA,CCCCCCCSSSCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8555,38673786,2024,RRPRPRPRPWWWWW,RRPRPRPRPWWWWW{ct:Amid},R9W5,Amidation,Free,Linear,L,None,14,Antibacterial,<20 % Hemolysis at 4 µM,Horse,Synthetic,α-Helical,NA,CCCCCCCSSSCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8556,38673786,2024,RRPRPRPRPWWWWW,RRPRPRPRPWWWWW{ct:Amid},R9W5,Amidation,Free,Linear,L,None,14,Antibacterial,<40 % Hemolysis at 8 µM,Horse,Synthetic,α-Helical,NA,CCCCCCCSSSCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8557,38673786,2024,RRPRPRPRPWWWWW,RRPRPRPRPWWWWW{ct:Amid},R9W5,Amidation,Free,Linear,L,None,14,Antibacterial,<70 % Hemolysis at 16 µM,Horse,Synthetic,α-Helical,NA,CCCCCCCSSSCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8558,38673786,2024,RRPRPRPRPWWWWW,RRPRPRPRPWWWWW{ct:Amid},R9W5,Amidation,Free,Linear,L,None,14,Antibacterial,<120 % Hemolysis at 32 µM,Horse,Synthetic,α-Helical,NA,CCCHHHHSSTTTCCSCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8559,38673786,2024,RRPRPRPRPWWWWW,RRPRPRPRPWWWWW{ct:Amid},R9W5,Amidation,Free,Linear,L,None,14,Antibacterial,<120 % Hemolysis at 64 µM,Horse,Synthetic,α-Helical,NA,CCCHHHHSSTTTCCSCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8560,38673786,2024,RRPRPRPRPWWWWW,RRPRPRPRPWWWWW{ct:Amid},R9W5,Amidation,Free,Linear,L,None,14,Antibacterial,<120 % Hemolysis at 128 µM,Horse,Synthetic,α-Helical,NA,CCCHHHHSSTTTCCSCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8561,38673786,2024,ILRWPWWPWRRK,ILRWPWWPWRRK{ct:Amid},Omiganan,Amidation,Free,Linear,L,None,12,Antibacterial,<20 % Hemolysis at 2 µM,Horse,Synthetic Analog To Indolicidin,α-Helical,NA,CCCHHHHSSTTTCCSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
8562,38673786,2024,ILRWPWWPWRRK,ILRWPWWPWRRK{ct:Amid},Omiganan,Amidation,Free,Linear,L,None,12,Antibacterial,<20 % Hemolysis at 4 µM,Horse,Synthetic Analog To Indolicidin,α-Helical,NA,CCCHHHHSSTTTCCSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
8563,38673786,2024,ILRWPWWPWRRK,ILRWPWWPWRRK{ct:Amid},Omiganan,Amidation,Free,Linear,L,None,12,Antibacterial,<20 % Hemolysis at 8 µM,Horse,Synthetic Analog To Indolicidin,α-Helical,NA,CCCHHHHSSTTTCCSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
8564,38673786,2024,ILRWPWWPWRRK,ILRWPWWPWRRK{ct:Amid},Omiganan,Amidation,Free,Linear,L,None,12,Antibacterial,<20 % Hemolysis at 16 µM,Horse,Synthetic Analog To Indolicidin,α-Helical,NA,CCCHHHHSSTTTCCSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
8565,38673786,2024,ILRWPWWPWRRK,ILRWPWWPWRRK{ct:Amid},Omiganan,Amidation,Free,Linear,L,None,12,Antibacterial,<40 % Hemolysis at 32 µM,Horse,Synthetic Analog To Indolicidin,α-Helical,NA,CBCCTTCCSSCCCSSSSSTTBSCSGGGSSSSCSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
8566,38673786,2024,ILRWPWWPWRRK,ILRWPWWPWRRK{ct:Amid},Omiganan,Amidation,Free,Linear,L,None,12,Antibacterial,<40 % Hemolysis at 64 µM,Horse,Synthetic Analog To Indolicidin,α-Helical,NA,CCSSCCSCSSSSSCCCCCCSCIIIIISSSSBSSSSBCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
8567,38673786,2024,ILRWPWWPWRRK,ILRWPWWPWRRK{ct:Amid},Omiganan,Amidation,Free,Linear,L,None,12,Antibacterial,<40 % Hemolysis at 128 µM,Horse,Synthetic Analog To Indolicidin,α-Helical,NA,CHHHHHGGGTTCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
8568,38673786,2024,FFHHIFRGIVHVGKTIHRLVTG,FFHHIFRGIVHVGKTIHRLVTG{ct:Amid},Piscidin 1,Amidation,Free,Linear,L,None,22,Antibacterial,<20 % Hemolysis at 2 µM,Horse,Mast Cells Of Fish,α-Helical,NA,CHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
8569,38673786,2024,FFHHIFRGIVHVGKTIHRLVTG,FFHHIFRGIVHVGKTIHRLVTG{ct:Amid},Piscidin 1,Amidation,Free,Linear,L,None,22,Antibacterial,<40 % Hemolysis at 4 µM,Horse,Mast Cells Of Fish,α-Helical,NA,CTHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
8570,38673786,2024,FFHHIFRGIVHVGKTIHRLVTG,FFHHIFRGIVHVGKTIHRLVTG{ct:Amid},Piscidin 1,Amidation,Free,Linear,L,None,22,Antibacterial,<70 % Hemolysis at 8 µM,Horse,Mast Cells Of Fish,α-Helical,NA,CHHHHHGGGTTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
8571,38673786,2024,FFHHIFRGIVHVGKTIHRLVTG,FFHHIFRGIVHVGKTIHRLVTG{ct:Amid},Piscidin 1,Amidation,Free,Linear,L,None,22,Antibacterial,<120 % Hemolysis at 16 µM,Horse,Mast Cells Of Fish,α-Helical,NA,CHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
8572,38673786,2024,FFHHIFRGIVHVGKTIHRLVTG,FFHHIFRGIVHVGKTIHRLVTG{ct:Amid},Piscidin 1,Amidation,Free,Linear,L,None,22,Antibacterial,<120 % Hemolysis at 32 µM,Horse,Mast Cells Of Fish,α-Helical,NA,CTHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
8573,38673786,2024,FFHHIFRGIVHVGKTIHRLVTG,FFHHIFRGIVHVGKTIHRLVTG{ct:Amid},Piscidin 1,Amidation,Free,Linear,L,None,22,Antibacterial,<120 % Hemolysis at 64 µM,Horse,Mast Cells Of Fish,α-Helical,NA,CHHHHHGGGTTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
8574,38673786,2024,FFHHIFRGIVHVGKTIHRLVTG,FFHHIFRGIVHVGKTIHRLVTG{ct:Amid},Piscidin 1,Amidation,Free,Linear,L,None,22,Antibacterial,<120 % Hemolysis at 128 µM,Horse,Mast Cells Of Fish,α-Helical,NA,CHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
8611,37992185,2024,YGKAAAAK‐Aic‐AAAKAAAAK,YGKAAAAK‐{nnr:Aic}‐AAAKAAAAK,peptideA,Free,Free,Linear,L,Aic = 2−aminoindane‐2‐carboxylicacid,18,Antibacterial,0 % Hemolysis at <at150 µM,Human,Synthetic,NA,Non-hemolytic,NA,NA
8618,37734650,2024,KLKSKLMVVCNKIGLLKSLCRKFVKSH,KLKSKLMVVCNKIGLLKSLCRKFVKSH,NKL-WT,Free,Free,Linear,L,None,27,Antibacterial and Anticancer,16.3 % Hemolysis at 40 µM,Rabbit,Antarctic Teleost Trematomus Bernacchii,α-Helical,NA,CCCCCSGGGSTHHHHHHHHSSSCCCCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C
8619,37734650,2024,KLKSKLMVVCNKIGLLKSLCRKFVKSH,KLKSKLMVVCNKIGLLKSLCRKFVKSH,NKL-WT,Free,Free,Linear,L,None,27,Antibacterial and Anticancer,40.5 % Hemolysis at 80 µM,Rabbit,Antarctic Teleost Trematomus Bernacchii,α-Helical,NA,CCCCCCGGGSTHHHHHHHHSSSCCSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C
8620,37734650,2024,KLKSKLMVVANKIGLLKSLARKFVKSH,KLKSKLMVVANKIGLLKSLARKFVKSH,NKL-MUT,Free,Free,Linear,L,None,27,Antibacterial and Anticancer,0.9 % Hemolysis at 5 µM,Rabbit,Antarctic Teleost Trematomus Bernacchii,α-Helical,NA,CCCCCCGGGSTHHHHHHHHSSSCCSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C
8621,37734650,2024,KLKSKLMVVANKIGLLKSLARKFVKSH,KLKSKLMVVANKIGLLKSLARKFVKSH,NKL-MUT,Free,Free,Linear,L,None,27,Antibacterial and Anticancer,2.6 % Hemolysis at 80 µM,Rabbit,Antarctic Teleost Trematomus Bernacchii,α-Helical,NA,CCSSSCCHHHHHHHHHHHHHHHSSSCCSTTGGGTHHHHHHHHHHHGGGSHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C
8651,37760693,2024,FLWRISKFLGKKL,FLWRISKFLGKKL{ct:Amid},HRZN-13,Amidation,Free,Linear,L,None,13,Antibacterial/ Antibiofilm,0.7 % Hemolysis at 100 μg/ml,Human,Sythesized,α-Helical,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
8652,37760693,2024,FLWRISKFLGRKL,FLWRISKFLGRKL{ct:Amid},HRZN-14,Amidation,Free,Linear,L,None,13,Antibacterial/ Antibiofilm,5.6 % Hemolysis at 100 μg/ml,Human,Sythesized,α-Helical,Non-hemolytic,CCSSSHHHHHHHHHHHHHHHHHCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
8653,37760693,2024,FLPWISKFLGKIL,FLPWISKFLGKIL{ct:Amid},HRZN-15,Amidation,Free,Linear,L,None,13,Antibacterial/ Antibiofilm,100 % Hemolysis at 100 μg/ml,Human,Sythesized,α-Helical,NA,CCCCHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
8654,37760693,2024,FLPWISKFLGKIL,FLPWISKFLGKIL{ct:Amid},HRZN-15,Amidation,Free,Linear,L,None,13,Antibacterial/ Antibiofilm,8.6 % Hemolysis at 10 μg/ml,Human,Sythesized,α-Helical,NA,CCHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
8655,37760693,2024,FLKKIWKLLGKLL,FLKKIWKLLGKLL{ct:Amid},HRZN-16,Amidation,Free,Linear,L,None,13,Antibacterial/ Antibiofilm,100 % Hemolysis at 100 μg/ml,Human,Sythesized,α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
8656,37760693,2024,FLKKIWKLLGKLL,FLKKIWKLLGKLL{ct:Amid},HRZN-16,Amidation,Free,Linear,L,None,13,Antibacterial/ Antibiofilm,67 % Hemolysis at 10 μg/ml,Human,Sythesized,α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
8657,37760693,2024,KLWKLLKKLGRLL,KLWKLLKKLGRLL{ct:Amid},HRZN-17,Amidation,Free,Linear,L,None,13,Antibacterial/ Antibiofilm,18 % Hemolysis at 10 μg/ml,Human,Sythesized,α-Helical,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
8658,37760693,2024,KLWKLLKKLGRLL,KLWKLLKKLGRLL{ct:Amid},HRZN-17,Amidation,Free,Linear,L,None,13,Antibacterial/ Antibiofilm,74 % Hemolysis at 100 μg/ml,Human,Sythesized,α-Helical,NA,CCHHHHHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
8659,37760693,2024,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL-37,Free,Free,Linear,L,None,39,Antibacterial/ Antibiofilm,5.4 % Hemolysis at 10 μg/ml,Human,Sythesized,α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
8660,37760693,2024,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL-37,Free,Free,Linear,L,None,39,Antibacterial/ Antibiofilm,22 % Hemolysis at 100 μg/ml,Human,Sythesized,α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
8712,29568446,2017,ACLLQSLLCPYSTHRCG,ACLLQSLLCPYSTHRCG{cyc:N-C},P8-d-C10,Free,Free,Bicyclic,L,None,17,Antibacterial,6 % Hemolysis at 32 μg/ml,Sheep,Peptide Phage,NA,Low hemolytic,CGGGGTGGGTCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C)O
8713,29568446,2017,ACLLQSLLCPYSTHACG,ACLLQSLLCPYSTHACG{cyc:N-C},P8-d-(R15A)-C10,Free,Free,Bicyclic,L,None,17,Antibacterial,0 % Hemolysis at 32 μg/ml,Sheep,Peptide Phage,NA,Non-hemolytic,CCCCCCGGGTTCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C)O
8714,29568446,2017,ACLLQSLLCPYSTARCG,ACLLQSLLCPYSTARCG{cyc:N-C},"P8-d-(H14R, R15A)-C10",Free,Free,Bicyclic,L,None,17,Antibacterial,2 % Hemolysis at 32 μg/ml,Sheep,Peptide Phage,NA,Low hemolytic,CCTTCCHHHHSCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C)O
8715,29568446,2017,ACLLQSLLCAYSTHRCG,ACLLQSLLCAYSTHRCG{cyc:N-C},"P8-d-(P10R, R15A)-C10",Free,Free,Bicyclic,L,None,17,Antibacterial,0 % Hemolysis at 32 μg/ml,Sheep,Peptide Phage,NA,Non-hemolytic,CCCHHHHTTSCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C)O
8716,29568446,2017,ACLLQALLCPYSTHRCG,ACLLQALLCPYSTHRCG{cyc:N-C},"P8-d-(S6R, R15A)-C10",Free,Free,Bicyclic,L,None,17,Antibacterial,0 % Hemolysis at 32 μg/ml,Sheep,Peptide Phage,NA,Non-hemolytic,CCTHHHHHHHTTTCCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C)O
8717,29568446,2017,ACLLQALLCPYSTHRCG,ACLLQALLCPYSTHRCG{cyc:N-C},"P8-L-(S6R, R15A)-C10",Free,Free,Bicyclic,L,None,17,Antibacterial,0 % Hemolysis at 32 μg/ml,Sheep,Peptide Phage,NA,Non-hemolytic,CCSCCSCSSSSSCCCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C)O
8753,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R1}{ct:Amid},C6-Pat,Amidation,R1 = hexanoyl,Linear,Mix,"R1 = hexanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.61 ± 0.25 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8755,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2}{ct:Amid},C7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,1.77 ± 0.81 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8757,29136469,2017,DabIDabfLDablLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2}{ct:Amid},C7DLeu7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,26.5 ± 4.45 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8758,29136469,2017,DabFDabfLDablLS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2}{ct:Amid},C7Phe2DLeu7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,8.34 ± 1.80 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8759,29136469,2017,DabFDabfLDablFS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}FS{nt:R2}{ct:Amid},C7Phe2DLeu7Phe8-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,64.2 ± 3.28 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8760,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R3}{ct:Amid},C8-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,25.3 ± 4.15 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8764,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R4}{ct:Amid},C10-Pat,Amidation,R4 = decanoyl,Linear,Mix,"R4 = decanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,93.9 ± 7.57 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8770,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R1 = hexanoyl}{ct:{nt:R4}{ct:Amid}},C6-Pat,Amidation,R1 = hexanoyl,Linear,Mix,"R1 = hexanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.08 ± 0.85 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8772,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,1.18 ± 0.68 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8774,29136469,2017,DabIDabfLDablLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7DLeu7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,4.86 ± 1.05 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8775,29136469,2017,DabFDabfLDablLS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7Phe2DLeu7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,2.03 ± 0.44 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8776,29136469,2017,DabFDabfLDablFS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}FS{nt:R2 = heptanoyl}{ct:Amid},C7Phe2DLeu7Phe8-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,18.8 ± 2.44 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8777,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R3 = octanoyl}{ct:Amid},C8-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,6.18 ± 2.48 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8781,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R4 = decanoyl}{ct:Amid},C10-Pat,Amidation,R4 = decanoyl,Linear,Mix,"R4 = decanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,73.4 ± 7.59 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8787,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R1 = hexanoyl}{ct:Amid},C6-Pat,Amidation,R1 = hexanoyl,Linear,Mix,"R1 = hexanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.41 ± 0.58 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8789,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.78 ± 0.30 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8791,29136469,2017,DabIDabfLDablLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7DLeu7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,1.39 ± 0.55 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8792,29136469,2017,DabFDabfLDablLS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7Phe2DLeu7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.39 ± 0.30 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8793,29136469,2017,DabFDabfLDablFS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}FS{nt:R2 = heptanoyl}{ct:Amid},C7Phe2DLeu7Phe8-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,5.10 ± 1.26 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8794,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R3 = octanoyl}{ct:Amid},C8-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,1.91 ± 0.25 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8798,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R4 = decanoyl}{ct:Amid},C10-Pat,Amidation,R4 = decanoyl,Linear,Mix,"R4 = decanoyl, Dab = 2,4-diaminobutyric acid",9,broad Antibacterial activity,37.2 ± 8.62 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8804,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R1 = hexanoyl}{ct:Amid},C6-Pat,Amidation,R1 = hexanoyl,Linear,Mix,"R1 = hexanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.48 ± 0.64 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8806,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.18 ± 0.54 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8808,29136469,2017,DabIDabfLDablLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7DLeu7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.96 ± 0.59 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8809,29136469,2017,DabFDabfLDablLS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7Phe2DLeu7-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.14 ± 0.20 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8810,29136469,2017,DabFDabfLDablFS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}FS{nt:R2 = heptanoyl}{ct:Amid},C7Phe2DLeu7Phe8-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.99 ± 0.31 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8811,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R3 = octanoyl}{ct:Amid},C8-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,0.93 ± 0.45 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic,NA,NA
8815,29136469,2017,DabIDabfLDabvLS,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R4 = decanoyl}{ct:Amid},C10-Pat,Amidation,R4 = decanoyl,Linear,Mix,"R4 = decanoyl, Dab = 2,4-diaminobutyric acid",9,Antibacterial,14.3 ± 4.25 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA,NA,NA
8898,28887200,2018,FLFTVA-Dhb,FLFTVA{nnr:Dhb}{ct:Acet},ASP-1,Acetylation,Free,Linear,L,Dhb = dehydrobutyrine,7,"Antibacterial, Anti-MRSA, Antibiofilm",~6 % Hemolysis at 128 μg/ml,Human,Bacillus Subtilis Urid 12.1,β-Sheet,Low hemolytic,NA,NA
8929,32624860,2018,KIIIPPLFH,KIIIPPLFH,barleycin,Free,Free,Linear,L,None,9,Antibacterial,0 % Hemolysis at 64 μg/ml,Human,Highland Barley Or Tibetan Barley,α-Helix,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)CC
8930,32624860,2018,KIIIPPLFH,KIIIPPLFH,barleycin,Free,Free,Linear,L,None,9,Antibacterial,0 % Hemolysis at 128 μg/ml,Human,Highland Barley Or Tibetan Barley,α-Helix,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)CC
8931,32624860,2018,KIIIPPLFH,KIIIPPLFH,barleycin,Free,Free,Linear,L,None,9,Antibacterial,3.2 ± 1.7 % Hemolysis at 256 μg/ml,Human,Highland Barley Or Tibetan Barley,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)CC
8932,32624860,2018,KIIIPPLFH,KIIIPPLFH,barleycin,Free,Free,Linear,L,None,9,Antibacterial,19.5 ± 3.5 % Hemolysis at 512 μg/ml,Human,Highland Barley Or Tibetan Barley,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)CC
8939,29198866,2018,Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys-Nspe-Nspe,{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid},Peptoid - 1,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",12,Antibacterial,100 % Hemolysis at 200 mM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
8940,29198866,2018,Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys-Nspe-Nspe,{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid},Peptoid - 2,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",9,Antibacterial,38.7 ± 5.4 % Hemolysis at 200 mM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
8941,29198866,2018,Nlys-Nspe(pCl)-Nspe(pCl)-Nlys-Nspe(pCl)-Nspe(pCl)-Nlys-Nspe(pCl)-Nspe(pCl)-Nlys-Nspe(pCl)-Nspe(pCl),{nnr:Nlys}-{nnr:Nspe(pCl)}-{nnr:Nspe(pCl)}-{nnr:Nlys}-{nnr:Nspe(pCl)}-{nnr:Nspe(pCl)}-{nnr:Nlys}-{nnr:Nspe(pCl)}-{nnr:Nspe(pCl)}-{nnr:Nlys}-{nnr:Nspe(pCl)}-{nnr:Nspe(pCl)}{nt:H}{ct:Amid},Peptoid - 3,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",12,Antibacterial,100 % Hemolysis at 200 mM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
8942,29198866,2018,Nlys-Nspe(pCH3)-Nspe(pCH3)-Nlys-Nspe(pCH3)-Nspe(pCH3)-Nlys-Nspe(pCH3)-Nspe(pCH3)-Nlys-Nspe(pCH3)-Nspe(pCH3),{nnr:Nlys}-{nnr:Nspe(pCH3)}-{nnr:Nspe(pCH3)}-{nnr:Nlys}-{nnr:Nspe(pCH3)}-{nnr:Nspe(pCH3)}-{nnr:Nlys}-{nnr:Nspe(pCH3)}-{nnr:Nspe(pCH3)}-{nnr:Nlys}-{nnr:Nspe(pCH3)}-{nnr:Nspe(pCH3)}{nt:H}{ct:Amid},Peptoid - 4,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",12,Antibacterial,100 % Hemolysis at 200 mM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
8943,29198866,2018,Nlys-Nspe(pF)-Nspe(pF)-Nlys-Nspe(pF)-Nspe(pF)-Nlys-Nspe(pF)-Nspe(pF)-Nlys-Nspe(pF)-Nspe(pF),{nnr:Nlys}-{nnr:Nspe(pF)}-{nnr:Nspe(pF)}-{nnr:Nlys}-{nnr:Nspe(pF)}-{nnr:Nspe(pF)}-{nnr:Nlys}-{nnr:Nspe(pF)}-{nnr:Nspe(pF)}-{nnr:Nlys}-{nnr:Nspe(pF)}-{nnr:Nspe(pF)}{nt:H}{ct:Amid},Peptoid - 5,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",12,Antibacterial,100 % Hemolysis at 200 mM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
8944,29198866,2018,Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys,{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}{nt:H}{ct:Amid},Peptoid - 6,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",13,Antibacterial,48.1 ± 3 % Hemolysis at 200 mM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
8945,29198866,2018,Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys,{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}{nt:H}{ct:Amid},Peptoid - 7,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",10,Antibacterial,9.8 ± 0.8 % Hemolysis at 200 mM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
8947,29198866,2018,Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys-Nspe-Nspe,{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid},Peptoid - 1,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",12,Antibacterial,10 % Hemolysis at 9.1 µM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
8948,29198866,2018,Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys-Nspe-Nspe,{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid},Peptoid - 2,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",9,Antibacterial,10 % Hemolysis at 119.5 µM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
8949,29198866,2018,Nlys-Nspe(pCl)-Nspe(pCl)-Nlys-Nspe(pCl)-Nspe(pCl)-Nlys-Nspe(pCl)-Nspe(pCl)-Nlys-Nspe(pCl)-Nspe(pCl),{nnr:Nlys}-{nnr:Nspe(pCl)}-{nnr:Nspe(pCl)}-{nnr:Nlys}-{nnr:Nspe(pCl)}-{nnr:Nspe(pCl)}-{nnr:Nlys}-{nnr:Nspe(pCl)}-{nnr:Nspe(pCl)}-{nnr:Nlys}-{nnr:Nspe(pCl)}-{nnr:Nspe(pCl)}{nt:H}{ct:Amid},Peptoid - 3,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",12,Antibacterial,10 % Hemolysis at <6.25 µM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
8950,29198866,2018,Nlys-Nspe(pCH3)-Nspe(pCH3)-Nlys-Nspe(pCH3)-Nspe(pCH3)-Nlys-Nspe(pCH3)-Nspe(pCH3)-Nlys-Nspe(pCH3)-Nspe(pCH3),{nnr:Nlys}-{nnr:Nspe(pCH3)}-{nnr:Nspe(pCH3)}-{nnr:Nlys}-{nnr:Nspe(pCH3)}-{nnr:Nspe(pCH3)}-{nnr:Nlys}-{nnr:Nspe(pCH3)}-{nnr:Nspe(pCH3)}-{nnr:Nlys}-{nnr:Nspe(pCH3)}-{nnr:Nspe(pCH3)}{nt:H}{ct:Amid},Peptoid - 4,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",12,Antibacterial,10 % Hemolysis at <6.25 µM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
8951,29198866,2018,Nlys-Nspe(pF)-Nspe(pF)-Nlys-Nspe(pF)-Nspe(pF)-Nlys-Nspe(pF)-Nspe(pF)-Nlys-Nspe(pF)-Nspe(pF),{nnr:Nlys}-{nnr:Nspe(pF)}-{nnr:Nspe(pF)}-{nnr:Nlys}-{nnr:Nspe(pF)}-{nnr:Nspe(pF)}-{nnr:Nlys}-{nnr:Nspe(pF)}-{nnr:Nspe(pF)}-{nnr:Nlys}-{nnr:Nspe(pF)}-{nnr:Nspe(pF)}{nt:H}{ct:Amid},Peptoid - 5,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",12,Antibacterial,10 % Hemolysis at <6.25 µM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
8952,29198866,2018,Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys,{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}{nt:H}{ct:Amid},Peptoid - 6,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",13,Antibacterial,10 % Hemolysis at 19.5 µM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
8953,29198866,2018,Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys,{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}{nt:H}{ct:Amid},Peptoid - 7,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",10,Antibacterial,10 % Hemolysis at >200 µM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
8955,29198866,2018,Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys-Nspe-Nspe,{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid},Peptoid - 1,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",12,Antibacterial,50 % Hemolysis at 63.4 µM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
8956,29198866,2018,Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys-Nspe-Nspe,{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid},Peptoid - 2,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",9,Antibacterial,50 % Hemolysis at 1>200 µM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
8957,29198866,2018,Nlys-Nspe(pCl)-Nspe(pCl)-Nlys-Nspe(pCl)-Nspe(pCl)-Nlys-Nspe(pCl)-Nspe(pCl)-Nlys-Nspe(pCl)-Nspe(pCl),{nnr:Nlys}-{nnr:Nspe(pCl)}-{nnr:Nspe(pCl)}-{nnr:Nlys}-{nnr:Nspe(pCl)}-{nnr:Nspe(pCl)}-{nnr:Nlys}-{nnr:Nspe(pCl)}-{nnr:Nspe(pCl)}-{nnr:Nlys}-{nnr:Nspe(pCl)}-{nnr:Nspe(pCl)}{nt:H}{ct:Amid},Peptoid - 3,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",12,Antibacterial,50 % Hemolysis at 10.4 µM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
8958,29198866,2018,Nlys-Nspe(pCH3)-Nspe(pCH3)-Nlys-Nspe(pCH3)-Nspe(pCH3)-Nlys-Nspe(pCH3)-Nspe(pCH3)-Nlys-Nspe(pCH3)-Nspe(pCH3),{nnr:Nlys}-{nnr:Nspe(pCH3)}-{nnr:Nspe(pCH3)}-{nnr:Nlys}-{nnr:Nspe(pCH3)}-{nnr:Nspe(pCH3)}-{nnr:Nlys}-{nnr:Nspe(pCH3)}-{nnr:Nspe(pCH3)}-{nnr:Nlys}-{nnr:Nspe(pCH3)}-{nnr:Nspe(pCH3)}{nt:H}{ct:Amid},Peptoid - 4,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",12,Antibacterial,50 % Hemolysis at 8.3 µM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
8959,29198866,2018,Nlys-Nspe(pF)-Nspe(pF)-Nlys-Nspe(pF)-Nspe(pF)-Nlys-Nspe(pF)-Nspe(pF)-Nlys-Nspe(pF)-Nspe(pF),{nnr:Nlys}-{nnr:Nspe(pF)}-{nnr:Nspe(pF)}-{nnr:Nlys}-{nnr:Nspe(pF)}-{nnr:Nspe(pF)}-{nnr:Nlys}-{nnr:Nspe(pF)}-{nnr:Nspe(pF)}-{nnr:Nlys}-{nnr:Nspe(pF)}-{nnr:Nspe(pF)}{nt:H}{ct:Amid},Peptoid - 5,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",12,Antibacterial,50 % Hemolysis at <6.25 µM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
8960,29198866,2018,Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys,{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}{nt:H}{ct:Amid},Peptoid - 6,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",13,Antibacterial,50 % Hemolysis at >200 µM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
8961,29198866,2018,Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys-Nspe-Nspe-Nlys,{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}{nt:H}{ct:Amid},Peptoid - 7,Amidation,H,Linear,NA,"Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine",10,Antibacterial,50 % Hemolysis at >200 µM,Rat,Synthetic Peptoid,α-Helical,NA,NA,NA
9000,29310083,2018,KWLKKWLKWLKK,KWLKKWLKWLKK{ct:Amid},A-12,Amidation,Free,Linear,L,None,12,Antibacterial,56 % Hemolysis at 250 μg/ml,Human,Analogues Of Α/Β Diastereomeric Peptide,α-Helical,NA,CCCCTTCCSCTTSSCCCCCCSSSSSCCSHHHHHHHHHHTHHHHSCTHHHHHHHTTSCCCCCCHHHHHHHHHHHTTCCCCCCCCCCCBSSSBTTSSCCCCCCCSSSCCCCCCCCCCCSSCCCCCCCCCCCCCCCCCCCCCSCCCCCCCCCCSSCCCCCCCCSSCCSCCSCCCCCCSSCSSCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
9001,29310083,2018,KWLKKWLKWLKK,KW{nnr:L}KKW{nnr:L}KW{nnr:L}KK{ct:Amid},βA-12,Amidation,Free,Linear,L,L = β-amino acid,12,Antibacterial,0 % Hemolysis at 250 μg/ml,Human,Analogues Of Α/Β Diastereomeric Peptide,α-Helical,Non-hemolytic,CCCCTTCCSCTTSSCCCCCCSSSSSCCSHHHHHHHHHHTHHHHSCTHHHHHHHTTSCCCCCCHHHHHHHHHHHTTCCCCCCCCCCCBSSSBTTSSCCCCCCCSSSCCCCCCCCCCCSSCCCCCCCCCCCCCCCCCCCCCSCCCCCCCCCCSSCCCCCCCCSSCCSCCSCCCCCCSSCSSCCCCCCCC,NA
9002,29310083,2018,kwLkkwLkwLkk,K{d}W{d}LK{d}K{d}W{d}LK{d}W{d}LK{d}K{d}{ct:Amid},DA-12,Amidation,Free,Linear,Mix,None,12,Antibacterial,0 % Hemolysis at 250 μg/ml,Human,Analogues Of Α/Β Diastereomeric Peptide,α-Helical,Non-hemolytic,CCCCTTCCSCTTSSCCCCCCSSSSSCCSHHHHHHHHHHTHHHHSCTHHHHHHHTTSCCCCCCHHHHHHHHHHHTTCCCCCCCCCCCBSSSBTTSSCCCCCCCSSSCCCCCCCCCCCSSCCCCCCCCCCCCCCCCCCCCCSCCCCCCCCCCSSCCCCCCCCSSCCSCCSCCCCCCSSCSSCCCCCCCC,NA
9003,29310083,2018,kwLkkwLkwLkk,K{d}W{d}{nnr:L}K{d}K{d}W{d}{nnr:L}K{d}W{d}{nnr:L}K{d}K{d}{ct:Amid},UNA-12,Amidation,Free,Linear,Mix,L = β-amino acid,12,Antibacterial,0 % Hemolysis at 250 μg/ml,Human,Analogues Of Α/Β Diastereomeric Peptide,α-Helical,Non-hemolytic,CCCCTTCCSCTTSSCCCCCCSSSSSCCSHHHHHHHHHHTHHHHSCTHHHHHHHTTSCCCCCCHHHHHHHHHHHTTCCCCCCCCCCCBSSSBTTSSCCCCCCCSSSCCCCCCCCCCCSSCCCCCCCCCCCCCCCCCCCCCSCCCCCCCCCCSSCCCCCCCCSSCCSCCSCCCCCCSSCSSCCCCCCCC,NA
9004,29310083,2018,ILPWKWPWWPWRR,ILPWKWPWWPWRR{ct:Amid},IL,Amidation,Free,Linear,L,None,13,Antibacterial,70 % Hemolysis at 250 μg/ml,Human,Control Host Defense Peptide,NA,NA,CCCCTTCCSCTTSSCCCCCCSSSSSCCSHHHHHHHHHHTHHHHSCTHHHHHHHTTSCCCCCCHHHHHHHHHHHTTCCCCCCCCCCCBSSSBTTSSCCCCCCCSSSCCCCCCCCCCCSSCCCCCCCCCCCCCCCCCCCCCSCCCCCCCCCCSSCCCCCCCCSSCCSCCSCCCCCCSSCSSCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
9039,29277569,2018,VYPFMWGGAYCFCKAKLV,VYPFMWGGAYCFCKAKLV{ct:Amid},VT18-KKLV,Amidation,Free,Linear,L,None,18,Antibacterial,3 % Hemolysis at 100 μg/ml,Human,Chikungunya Virus Fusion Domain Vt18-Derived Peptides,Double Strand β-Sheet,Low hemolytic,CCCCCSSGGGGTCCC,CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C
9040,29277569,2018,VYPFCWGGAYAFCKAKLV,VYPFCWGGAYAFCKAKLV{ct:Amid},VT18-CAKKLV,Amidation,Free,Linear,L,None,18,Antibacterial,3.8 % Hemolysis at 100 μg/ml,Human,Chikungunya Virus Fusion Domain Vt18-Derived Peptides,Double Strand β-Sheet,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
9041,29277569,2018,VYPFCWGGAYAFCKAKLV,VYPFCWGGAYAFCKAKLV{cyc:N-C}{ct:Amid},cVT18-CAKKLV,Amidation,Free,Cyclic,L,None,18,Antibacterial,1.8 % Hemolysis at 100 μg/ml,Human,Vt18-Cakklv Cyclized Between Cys88 And Cys96,Double Strand β-Sheet,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
9042,29551999,2018,RRWQWR,RRWQWR,Monomer LfcinB (20–25),Free,Free,Linear,L,None,6,Antibacterial,7.1 % Hemolysis at 25 µM,Human,Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides,NA,NA,NA,N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
9043,29551999,2018,RWQWRWQWR,RWQWRWQWR,Palindromic (PLS),Free,Free,Linear,L,None,9,Antibacterial,24.8 % Hemolysis at 100 µM,Human,Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides,NA,NA,NA,N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
9044,29551999,2018,FKCRRWQWRMKKLGA,FKCRRWQWRMKKLGA,Reference Peptide (LfcinB (17–31)),Free,Free,Linear,L,None,15,Antibacterial,6.6 % Hemolysis at 25 µM,Human,Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides,NA,NA,NA,CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)O
9045,29551999,2018,RRWQWRRRWQWRKAhx,RRWQWRRRWQWRK{nnr:Ahx},Dimeric (LfcinB (20–25)2),Free,Free,Branched,L,Ahx = hydrophobic spacer that prevents steric hindrance,15,Antibacterial,5.6 % Hemolysis at 100 µM,Human,Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides,NA,NA,NA,NA
9046,29551999,2018,RRWQWRRRWQWRRRWQWRRRWQWRKKAhxAhxCC,RRWQWRRRWQWRRRWQWRRRWQWRKK{nnr:Ahx}{nnr:Ahx}CC,Tetrameric (LfcinB (20–25)4),Free,Free,Branched,L,Ahx = hydrophobic spacer that prevents steric hindrance,30,Antibacterial,49.1 % Hemolysis at 100 µM,Human,Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides,NA,NA,NA,NA
9047,29551999,2018,RRWQWR,RRWQWR,Monomer LfcinB (20–25),Free,Free,Linear,L,None,6,Antibacterial,50 % Hemolysis at >100 µM,Human,Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides,NA,NA,CTHHHHHHHHTTTCCTTCCCCCCSSSSCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
9048,29551999,2018,RWQWRWQWR,RWQWRWQWR,Palindromic (PLS),Free,Free,Linear,L,None,9,Antibacterial,50 % Hemolysis at >100 µM,Human,Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides,NA,NA,CTHHHHHHHHTTTCCTTCCCCCCSSSSCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
9049,29551999,2018,FKCRRWQWRMKKLGA,FKCRRWQWRMKKLGA,Reference Peptide (LfcinB (17–31)),Free,Free,Linear,L,None,15,Antibacterial,50 % Hemolysis at >100 µM,Human,Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides,NA,NA,CTHHHHHHHHTTTCCTTCCCCCCSSSSCCC,CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)O
9050,29551999,2018,RRWQWRRRWQWRKAhx,RRWQWRRRWQWRK{nnr:Ahx},Dimeric (LfcinB (20–25)2),Free,Free,Branched,L,Ahx = hydrophobic spacer that prevents steric hindrance,15,Antibacterial,50 % Hemolysis at >100 µM,Human,Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides,NA,NA,NA,NA
9051,29551999,2018,RRWQWRRRWQWRRRWQWRRRWQWRKKAhxAhxCC,RRWQWRRRWQWRRRWQWRRRWQWRKK{nnr:Ahx}{nnr:Ahx}CC,Tetrameric (LfcinB (20–25)4),Free,Free,Branched,L,Ahx = hydrophobic spacer that prevents steric hindrance,30,Antibacterial,50 % Hemolysis at >100 µM,Human,Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides,NA,NA,C,NA
9053,29275987,2018,KKKKKK-AAFXAWAXFAA,KKKKKKAAF{nnr:X}AWA{nnr:X}FAA{ct:Amid},S-6K-F17,Amidation,6 Lys,Stapled,L,X = Ala residues replaced by 2-(40 -pentenyl)alanine residues are underlined,17,Antibacterial,2 % Hemolysis at 4 µM,Human,6K-F17 Hydrocarbon Staple,Random coil,NA,NA,NA
9054,29275987,2018,KKKKKK-AGFXAWAXFGA,KKKKKKAGF{nnr:X}AWA{nnr:X}FGA{ct:Amid},S-6K-F17-2G,Amidation,6 Lys,Stapled,L,X = Ala residues replaced by 2-(40 -pentenyl)alanine residues are underlined,17,Antibacterial,MHC at 15[5.8] µM,Human,6K-F17 Hydrocarbon Staple,NA,NA,NA,NA
9055,29275987,2018,KKKKKK-AGFXAWGXFGA,KKKKKKAGF{nnr:X}AWG{nnr:X}FGA{ct:Amid},S-6K-F17-3G,Amidation,6 Lys,Stapled,L,X = Ala residues replaced by 2-(40 -pentenyl)alanine residues are underlined,17,Antibacterial,MHC at 128[43.8] µM,Human,6K-F17 Hydrocarbon Staple,Random coil,NA,NA,NA
9056,29275987,2018,KKKKKK-NGFXAWGXFGA,KKKKKKNGF{nnr:X}AWG{nnr:X}FGA{ct:Amid},S-6K-F17-3GN,Amidation,6 Lys,Stapled,L,X = Ala residues replaced by 2-(40 -pentenyl)alanine residues are underlined,17,Antibacterial,MHC at 587[130.6] µM,Human,6K-F17 Hydrocarbon Staple,Helical,NA,NA,NA
9061,29264738,2018,K,K{nt:C16}{ct:Amid},1,Amidation,C16,Linear,L,C16,1,Antibacterial,10 % Hemolysis at 512 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CCCC,NA
9062,29264738,2018,KK,KK{nt:C16}{ct:Amid},2,Amidation,C16,Linear,L,C16,2,Antibacterial,10 % Hemolysis at 256 μg/ml,Human,Synthetic Lipopeptides,NA,NA,CC,NA
9063,29264738,2018,KKK,KKK{nt:C16}{ct:Amid},3,Amidation,C16,Linear,L,C16,3,Antibacterial,10 % Hemolysis at 32 μg/ml,Human,Synthetic Lipopeptides,NA,NA,CCC,NA
9064,29264738,2018,KKKK,KKKK{nt:C16}{ct:Amid},4,Amidation,C16,Linear,L,C16,4,Antibacterial,10 % Hemolysis at 16 μg/ml,Human,Synthetic Lipopeptides,NA,NA,CTTC,NA
9065,29264738,2018,KG,KG{nt:C16}{ct:Amid},5,Amidation,C16,Linear,L,C16,2,Antibacterial,10 % Hemolysis at 256 μg/ml,Human,Synthetic Lipopeptides,NA,NA,C,NA
9066,29264738,2018,KGK,KGK{nt:C16}{ct:Amid},6,Amidation,C16,Linear,L,C16,3,Antibacterial,10 % Hemolysis at 64 μg/ml,Human,Synthetic Lipopeptides,NA,NA,CC,NA
9067,29264738,2018,KGKG,KGKG{nt:C16}{ct:Amid},7,Amidation,C16,Linear,L,C16,4,Antibacterial,10 % Hemolysis at 64 μg/ml,Human,Synthetic Lipopeptides,NA,NA,CCC,NA
9068,29264738,2018,K,K{nt:C14}{ct:Amid},8,Amidation,C14,Linear,L,C14,1,Antibacterial,10 % Hemolysis at 512 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CCCC,NA
9069,29264738,2018,KK,KK{nt:C14}{ct:Amid},9,Amidation,C14,Linear,L,C14,2,Antibacterial,10 % Hemolysis at 128 μg/ml,Human,Synthetic Lipopeptides,NA,NA,CC,NA
9070,29264738,2018,KKK,KKK{nt:C14}{ct:Amid},10,Amidation,C14,Linear,L,C14,3,Antibacterial,10 % Hemolysis at 256 μg/ml,Human,Synthetic Lipopeptides,NA,NA,CCC,NA
9071,29264738,2018,KKKK,KKKK{nt:C14}{ct:Amid},11,Amidation,C14,Linear,L,C14,4,Antibacterial,10 % Hemolysis at 256 μg/ml,Human,Synthetic Lipopeptides,NA,NA,CTTC,NA
9072,29264738,2018,KG,KG{nt:C14}{ct:Amid},12,Amidation,C14,Linear,L,C14,2,Antibacterial,10 % Hemolysis at >1000 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,C,NA
9073,29264738,2018,KGK,KGK{nt:C14}{ct:Amid},13,Amidation,C14,Linear,L,C14,3,Antibacterial,10 % Hemolysis at 128 μg/ml,Human,Synthetic Lipopeptides,NA,NA,CC,NA
9074,29264738,2018,KGKG,KGKG{nt:C14}{ct:Amid},14,Amidation,C14,Linear,L,C14,4,Antibacterial,10 % Hemolysis at 512 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CCC,NA
9075,29264738,2018,K,K{nt:C12}{ct:Amid},15,Amidation,C12,Linear,L,C12,1,Antibacterial,10 % Hemolysis at >1000 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CCCC,NA
9076,29264738,2018,KK,KK{nt:C12}{ct:Amid},16,Amidation,C12,Linear,L,C12,2,Antibacterial,10 % Hemolysis at >4000 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CC,NA
9077,29264738,2018,KKK,KKK{nt:C12}{ct:Amid},17,Amidation,C12,Linear,L,C12,3,Antibacterial,10 % Hemolysis at 512 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CCC,NA
9078,29264738,2018,KKKK,KKKK{nt:C12}{ct:Amid},18,Amidation,C12,Linear,L,C12,4,Antibacterial,10 % Hemolysis at >1000 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CTTC,NA
9079,29264738,2018,KG,KG{nt:C12}{ct:Amid},19,Amidation,C12,Linear,L,C12,2,Antibacterial,10 % Hemolysis at >1000 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,C,NA
9080,29264738,2018,KGK,KGK{nt:C12}{ct:Amid},20,Amidation,C12,Linear,L,C12,3,Antibacterial,10 % Hemolysis at >1000 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CC,NA
9081,29264738,2018,KGKG,KGKG{nt:C12}{ct:Amid},21,Amidation,C12,Linear,L,C12,4,Antibacterial,10 % Hemolysis at 256 μg/ml,Human,Synthetic Lipopeptides,NA,NA,CCC,NA
9082,29264738,2018,K,K{nt:C10}{ct:Amid},22,Amidation,C10,Linear,L,C10,1,Antibacterial,10 % Hemolysis at >4000 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CCCC,NA
9083,29264738,2018,KK,KK{nt:C10}{ct:Amid},23,Amidation,C10,Linear,L,C10,2,Antibacterial,10 % Hemolysis at >4000 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CC,NA
9084,29264738,2018,KKK,KKK{nt:C10}{ct:Amid},24,Amidation,C10,Linear,L,C10,3,Antibacterial,10 % Hemolysis at >4000 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CCC,NA
9085,29264738,2018,KKKK,KKKK{nt:C10}{ct:Amid},25,Amidation,C10,Linear,L,C10,4,Antibacterial,10 % Hemolysis at >4000 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CTTC,NA
9086,29264738,2018,KG,KG{nt:C10}{ct:Amid},26,Amidation,C10,Linear,L,C10,2,Antibacterial,10 % Hemolysis at >4000 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CCCSTTCCCGGGTCCCC,NA
9087,29264738,2018,KGK,KGK{nt:C10}{ct:Amid},27,Amidation,C10,Linear,L,C10,3,Antibacterial,10 % Hemolysis at >4000 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CCGGGTTTTCCCCCSCC,NA
9088,29264738,2018,KGKG,KGKG{nt:C10}{ct:Amid},28,Amidation,C10,Linear,L,C10,4,Antibacterial,10 % Hemolysis at >4000 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CCTTHHHHHHHHHHHCC,NA
9089,29264738,2018,K,K{nt:C8}{ct:Amid},29,Amidation,C8,Linear,L,C8,1,Antibacterial,10 % Hemolysis at >4000 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CCHHHHHHHHHHHHHHHHHHHHHHHHHHTTTTTCCCC,NA
9090,29264738,2018,KK,KK{nt:C8}{ct:Amid},30,Amidation,C8,Linear,L,C8,2,Antibacterial,10 % Hemolysis at >4000 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CCCCCCSCCCTTC,NA
9091,29264738,2018,KKK,KKK{nt:C8}{ct:Amid},31,Amidation,C8,Linear,L,C8,3,Antibacterial,10 % Hemolysis at >4000 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CCTHHHHHHHHHHHHHHHTTCCSSCCSSCC,NA
9092,29264738,2018,KKKK,KKKK{nt:C8}{ct:Amid},32,Amidation,C8,Linear,L,C8,4,Antibacterial,10 % Hemolysis at >4000 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CCCCCCCCCSSCSSSBSSSBSCCSSCCCCCCC,NA
9093,29264738,2018,KG,KG{nt:C8}{ct:Amid},33,Amidation,C8,Linear,L,C8,2,Antibacterial,10 % Hemolysis at >4000 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CCCSTTCCCGGGTCCCC,NA
9094,29264738,2018,KGK,KGK{nt:C8}{ct:Amid},34,Amidation,C8,Linear,L,C8,3,Antibacterial,10 % Hemolysis at >4000 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CCGGGTTTTCCCCCSCC,NA
9095,29264738,2018,KGKG,KGKG{nt:C8}{ct:Amid},35,Amidation,C8,Linear,L,C8,4,Antibacterial,10 % Hemolysis at >4000 μg/ml,Human,Synthetic Lipopeptides,NA,Low hemolytic,CCTTHHHHHHHHHHHCC,NA
9110,29501941,2018,AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P,{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Cbz}{ct:NHCH2CH2OH},1,NHCH2CH2OH,Cbz,Linear,L,"Cbz = carboxybenzyl, AzPro = azaproline",16,Antibacterial,0 % Hemolysis at 50 µM,Human,Gas Hexadecameric Analogous Peptides,β 6.3-Helical,Non-hemolytic,NA,NA
9111,29501941,2018,AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P,{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Acet}{ct:NHCH2CH2OH},2,NHCH2CH2OH,Acetylation,Linear,L,"AzPro = azaproline, Ac = N-acetyl",16,Antibacterial,0 % Hemolysis at 50 µM,Human,Gas Hexadecameric Analogous Peptides,β 6.3-Helical,Non-hemolytic,NA,NA
9112,29501941,2018,AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P,{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Formyl}{ct:NHCH2CH2OH},3,NHCH2CH2OH,Formyl,Linear,L,"AzPro = azaproline, Formyl = Formyl",16,Antibacterial,0 % Hemolysis at 50 µM,Human,Gas Hexadecameric Analogous Peptides,β 6.3-Helical,Non-hemolytic,NA,NA
9113,29501941,2018,AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P,{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Formyl}{ct:NHCH2CH2OH},5,NHCH2CH2OH,Formyl,Linear,L,"AzPro = azaproline, Formyl = Formyl",14,Antibacterial,0 % Hemolysis at 50 µM,Human,Gas Shorter Peptide Analogs,β 6.3-Helical,Non-hemolytic,NA,NA
9114,29501941,2018,AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P,{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Formyl}{ct:NHCH2CH2OH},6,NHCH2CH2OH,Formyl,Linear,L,"AzPro = azaproline, Formyl = Formyl",12,Antibacterial,0 % Hemolysis at 50 µM,Human,Gas Shorter Peptide Analogs,β 6.3-Helical,Non-hemolytic,NA,NA
9115,29501941,2018,AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P,{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Formyl}{ct:NHCH2CH2OH},7,NHCH2CH2OH,Formyl,Linear,L,"AzPro = azaproline, Formyl = Formyl",10,Antibacterial,0 % Hemolysis at 50 µM,Human,Gas Shorter Peptide Analogs,β 6.3-Helical,Non-hemolytic,NA,NA
9116,29501941,2018,AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P,{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Cbz}{ct:OtBu},8,OtBu,Cbz,Linear,L,"AzPro = azaproline, OtBu = ortho-tert-butyl, Cbz = carboxybenzyl",16,Antibacterial,0 % Hemolysis at 50 µM,Human,Gas Hexadecameric Analogous Peptides,β 6.3-Helical,Non-hemolytic,NA,NA
9117,29501941,2018,P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro,P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}{nt:Boc}{ct:Cbz},10,Cbz,Boc,Linear,L,"AzPro = azaproline, Boc = tert-butyloxycarbonyl, Cbz = carboxybenzyl",16,Antibacterial,0 % Hemolysis at 50 µM,Human,Gas Hexadecameric Analogous Peptides,β 6.3-Helical,Non-hemolytic,NA,NA
9118,29501941,2018,AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P,{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Cbz}{ct:OtBu},11,OtBu,Cbz,Linear,L,"AzPro = azaproline, OtBu = ortho-tert-butyl, Cbz = carboxybenzyl",32,Antibacterial,0 % Hemolysis at 50 µM,Human,Gas Hexadecameric Analogous Peptides,β 6.3-Helical,Non-hemolytic,NA,NA
9119,29501941,2018,AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P,{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Cbz}{ct:OH},14,OH,Cbz,Linear,L,"AzPro = azaproline, Cbz = carboxybenzyl, OH = Hydroxyl",16,Antibacterial,0 % Hemolysis at 50 µM,Human,Gas Shorter Peptide Analogs,β 6.3-Helical,Non-hemolytic,NA,NA
9120,29501941,2018,AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P-AzPro-P,{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:HCl.H}{ct:OtBu},15,OtBu,HCl.H,Linear,L,"AzPro = azaproline, HCl = hydrochloric acid, OtBu = ortho-tert-butyl",16,Antibacterial,0 % Hemolysis at 50 µM,Human,Gas Shorter Peptide Analogs,β 6.3-Helical,Non-hemolytic,NA,NA
9121,29501941,2018,AzPro-P-AzPro-P-AzPro-P-AzPro-P,{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Cbz}{ct:OtBu},18,OtBu,Cbz,Linear,L,"AzPro = azaproline, OtBu = ortho-tert-butyl, Cbz = carboxybenzyl",8,Antibacterial,0 % Hemolysis at 50 µM,Human,Gas Shorter Peptide Analogs,β 6.3-Helical,Non-hemolytic,NA,NA
9122,29501941,2018,AzPro-P-AzPro-P-AzPro-P-AzPro-P,{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Cbz}{ct:OH},19,OH,Cbz,Linear,L,"AzPro = azaproline, Cbz = carboxybenzyl, OH = Hydroxyl",8,Antibacterial,0 % Hemolysis at 50 µM,Human,Gas Shorter Peptide Analogs,β 6.3-Helical,Non-hemolytic,NA,NA
9123,29501941,2018,AzPro-P-AzPro-P-AzPro-P-AzPro-P,{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:H}{ct:OtBu},20,OtBu,H,Linear,L,"AzPro = azaproline, OtBu = ortho-tert-butyl, H = Hydrogen",8,Antibacterial,0 % Hemolysis at 50 µM,Human,Gas Shorter Peptide Analogs,β 6.3-Helical,Non-hemolytic,NA,NA
9124,29501941,2018,P-AzPro-P-AzPro-P-AzPro-P-AzPro,P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}{nt:Boc}{ct:Cbz},21,Cbz,Boc,Linear,L,"AzPro = azaproline, Cbz = carboxybenzyl, Boc = tert-butyloxycarbonyl",8,Antibacterial,0 % Hemolysis at 50 µM,Human,Gas Shorter Peptide Analogs,β 6.3-Helical,Non-hemolytic,NA,NA
9125,29501941,2018,P-AzPro-P-AzPro-P-AzPro-P-AzPro,P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}{nt:Boc}{ct:H},22,H,Boc,Linear,L,"AzPro = azaproline, Boc = tert-butyloxycarbonyl, H = Hydrogen",8,Antibacterial,0 % Hemolysis at 50 µM,Human,Gas Shorter Peptide Analogs,β 6.3-Helical,Non-hemolytic,NA,NA
9126,29501941,2018,P-AzPro-P-AzPro-P-AzPro-P-AzPro,P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}{nt:HCl.H}{ct:Cbz},23,Cbz,HCl.H,Linear,L,"AzPro = azaproline, Cbz = carboxybenzyl, HCl = hydrochloric acid",8,Antibacterial,0 % Hemolysis at 50 µM,Human,Gas Shorter Peptide Analogs,β 6.3-Helical,Non-hemolytic,NA,NA
9127,29501941,2018,VGAlAvVvWlWlWlW,VGAL{d}AV{d}VV{d}WL{d}WL{d}WL{d}W{nt:Formyl}{ct:NHCH2CH2OH},24(Gramicidin A),NHCH2CH2OH,Formyl,Linear,Mix,N-Terminal = Formyl,15,Antibacterial,50 % Hemolysis at 5 µM,Human,Gramicidin A Amp,β 6.3-Helical,NA,CGGGHHHHHHHHHHHCC,NA
9131,29553266,2018,KIAKGALKALKIAKGALKAL,KIAKGALKALKIAKGALKAL{ct:Amid},kiadin-3,Amidation,Free,Linear,L,None,20,Antibacterial,50 % Hemolysis at 100± 5 µM,Human,Modification Of Kiadin-1 Natural Amp (Pgla-H),α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O
9133,29553266,2018,KIAGKAGKIAKIAGKAGKIA,KIAGKAGKIAKIAGKAGKIA{ct:Amid},kiadin-5,Amidation,Free,Linear,L,None,20,Antibacterial,50 % Hemolysis at 0 µM,Human,Ab Initio Designed,α-Helical,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
9180,29688003,2018,GIGKFLHSAKKFGKAFVGEIMNSC,GIGKFLHSAKKFGKAFVGEIMNSC,Magainin 2,Free,Free,Linear,L,None,24,Antibacterial,7 % Hemolysis,Human,Synthetic Peptide,NA,NA,CTHHHHTTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC)C(C)C
9193,29648811,2018,RRIRIIIRIRR,RRIRIIIRIRR{ct:Amid},13 - I6,Amidation,Free,Linear,L,None,11,"Antifungal, Antibacterial",10 % Hemolysis at >128 µM,Human,"Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W)",α-Helical,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
9204,29738954,2018,FGRKKRRQRRR,FGRKKRRQRRR{nt:Acet}{ct:Amid},ctrlTat peptide,Amidation,Acetylation,Linear,L,None,11,Antibacterial,12 % Hemolysis at 1 µM,Human,Human Immunodeficiency Virus 1 (Hiv-1) Tat Protein,"at water Random coil structure, at TFE α-Helical",NA,CHHHHHHHHTTCCHHHHHHHHHHHTTSTTCBTTTBC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
9205,29738954,2018,FGrKKRrQrRr-βA,FG{nnr:r}KKR{nnr:r}Q{nnr:r}R{nnr:r}-{nnr:βA}{nt:Acet}{ct:Amid},γTatM4,Amidation,Acetylation,Linear,Mix,"r = (2S,4S)-4-amino-N-(3-guanidinopropyl)-proline, βA = βAla(β-Alanine){nnr:Bala} – β-Alanine",11,Antibacterial and Anti-TB,10 % Hemolysis at 1 µM,Human,Tat Peptide Analogues,NA,NA,NA,NA
9206,29738954,2018,FGRKKRRQRRR,FGRKKRRQRRR{nt:Acet}{ct:Amid},ctrlTat peptide,Amidation,Acetylation,Linear,L,None,11,Antibacterial,14 % Hemolysis at 40 µM,Human,Human Immunodeficiency Virus 1 (Hiv-1) Tat Protein,"at water Random coil structure, at TFE α-Helical",NA,CHHHHHHHHTTHHHHHIIIIIITHHHHSCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
9207,29738954,2018,FGrKKRrQrRr-βA,FG{nnr:r}KKR{nnr:r}Q{nnr:r}R{nnr:r}-{nnr:βA}{nt:Acet}{ct:Amid},γTatM4,Amidation,Acetylation,Linear,Mix,"r = (2S,4S)-4-amino-N-(3-guanidinopropyl)-proline, βA = βAla(β-Alanine){nnr:Bala} – β-Alanine",11,Antibacterial and Anti-TB,12 % Hemolysis at 40 µM,Human,Tat Peptide Analogues,NA,NA,NA,NA
9247,28659061,2018,NLLNKALGTVNGLLGRS,NLLNKALGTVNGLLGRS,Dc1.1,Free,Free,Linear,L,None,17,Antibacterial,50 % Hemolysis at >256 µM,Human,Dc1 Analogue,"water = unordered structures , TFE = α-Helix",Non-hemolytic,NA,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O
9248,28659061,2018,NLLKSALKTVNKLLAAS,NLLKSALKTVNKLLAAS{ct:Amid},Dc1.2,Amidation,Free,Linear,L,None,17,Antibacterial,50 % Hemolysis at >256 µM,Human,Dc1 Analogue,"water = unordered structures , TFE = α-Helix",Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)O
9256,29621496,2018,NapNpmNapNpmNapNpm,{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{cyc:N-C},C1,Free,Free,Cyclic,Mix,"Nap = N-(3-aminopropyl)glycine, Npm = N-(1-phenylmethyl)glycine",6,Antibacterial,10 % Hemolysis at 250 μg/ml,Human,Synthetic Peptoids Mimic Antimicrobial Peptides,NA,NA,NA,NA
9257,29621496,2018,NapNdmbNapNdmbNapNdmb,{nnr:Nap}{nnr:Ndmb}{nnr:Nap}{nnr:Ndmb}{nnr:Nap}{nnr:Ndmb}{cyc:N-C},C2,Free,Free,Cyclic,Mix,"Nap = N-(3-aminopropyl)glycine, Ndmb = N-(3,5-dimethylbenzyl)glycine",6,Antibacterial,10 % Hemolysis at 125 μg/ml,Human,Synthetic Peptoids Mimic Antimicrobial Peptides,NA,NA,NA,NA
9258,29621496,2018,NapNsneNapNsneNapNsne,{nnr:Nap}{nnr:Nsne}{nnr:Nap}{nnr:Nsne}{nnr:Nap}{nnr:Nsne}{cyc:N-C},C3,Free,Free,Cyclic,Mix,"Nap = N-(3-aminopropyl)glycine, Nsne = (S)-N-(1-naphthylethyl)glycine",6,Antibacterial,10 % Hemolysis,Human,Synthetic Peptoids Mimic Antimicrobial Peptides,NA,NA,NA,NA
9259,29621496,2018,NapNdpNapNdpNapNdp,{nnr:Nap}{nnr:Ndp}{nnr:Nap}{nnr:Ndp}{nnr:Nap}{nnr:Ndp}{cyc:N-C},C4,Free,Free,Cyclic,Mix,"Nap = N-(3-aminopropyl)glycine, Ndp = N-(2,2-diphenylethyl)glycine",6,Antibacterial,10 % Hemolysis at 31.3 μg/ml,Human,Synthetic Peptoids Mimic Antimicrobial Peptides,NA,NA,NA,NA
9260,29621496,2018,NapNbtfmbNapNbtfmbNapNbtfmb,{nnr:Nap}{nnr:Nbtfmb}{nnr:Nap}{nnr:Nbtfmb}{nnr:Nap}{nnr:Nbtfmb}{cyc:N-C},C5,Free,Free,Cyclic,Mix,"Nap = N-(3-aminopropyl)glycine, Nbtfmb = N-(3,5-bis-trifluoromethylbenzyl)glycine",6,Antibacterial,10 % Hemolysis at 31.3 μg/ml,Human,Synthetic Peptoids Mimic Antimicrobial Peptides,NA,NA,NA,NA
9261,29621496,2018,NapNpmNapNpmNapNpmNapNpmNapNpm,{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{cyc:N-C},C1dec,Free,Free,Cyclic,Mix,"Nap = N-(3-aminopropyl)glycine, Npm = N-(1-phenylmethyl)glycine",10,Antibacterial,10 % Hemolysis at 250 μg/ml,Human,Synthetic Peptoids Mimic Antimicrobial Peptides,NA,NA,NA,NA
9262,29621496,2018,VOLfPVOLfP,V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C},CGS (gramicidin S),Free,Free,Cyclic,Mix,"O = L-Ornithine, f = D-phenylalanine",10,Antibacterial,10 % Hemolysis at >15.6 μg/ml,Human,Gram-Positive Bacterium Brevibacillus Brevis,NA,NA,NA,NA
9289,29984236,2018,RRWQWR,RRWQWR,Motif,Free,Free,Linear,L,None,6,Antibacterial,7.1 % Hemolysis at 25 µM,Human,Bovine Lactoferricin,branched conformation,NA,CCSCCCCCSSSCCSSCCSSCCCCCCCTTTSTTSSSCSSSCCCSSCSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
9290,29984236,2018,RWQWR WQWR,RWQWR WQWR,Palindromic,Free,Free,Linear,L,None,9,Antibacterial,24.8 % Hemolysis at 100 µM,Human,Synthesised From Motif,NA,NA,CCSCCCCCSSSCCSSCCSSCCCCCCCTTTSTTSSSCSSSCCCSSCSCC,N=C(N)NCCC[C@@H](C=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N.N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
9291,29984236,2018,FKC R RWQWRM KKLGA,FKCRRWQWRMKKLGA,LfcinB reference,Free,Free,Linear,L,None,15,Antibacterial,7.9 % Hemolysis at 12.5 µM,Human,Bovine Lactoferricin B,NA,NA,CCCSSGGGGTHHHHSSSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)O.CSCC[C@@H](C=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N.N=C(N)NCCC[C@H](N)C=O.NCCCC[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C=O)CS
9292,29984236,2018,RRWQWRRRWQWR-K-Ahx,RRWQWRRRWQWR-K-{nnr:Ahx},Dimeric,Free,Free,Linear,L,Ahx = Aminohexanoic acid,13,Antibacterial,<5 % Hemolysis at 100 µM,Human,Synthesised And Modified From Motif,NA,Low hemolytic,CCCCSTTCSCTTTSSHHHHSSSCCC,NA
9293,29984236,2018,RRWQWRRRWQWRK-Ahx-CRRWQWRRRWQWRK-Ahx-C,RRWQWRRRWQWRK-{nnr:Ahx}-CRRWQWRRRWQWRK-{nnr:Ahx}-C,Tetrameric,Free,Free,Linear,L,Ahx = Aminohexanoic acid,28,Antibacterial,49.1 % Hemolysis at 100 µM,Human,Synthesised And Modified From Motif,NA,NA,CTTHHHHHHHTTCSCC,NA
9294,29925795,2018,KWKLFKKIFKRIVQRIKDFLRN,KWKLFKKIFKRIVQRIKDFLRN,Synthesized C–L,Free,Free,Linear,L,None,20,Antibacterial,50 % Hemolysis at 219 ± 2.98 μg/ml,Sheep,Combination Of Cecropin A (C) And Ll-37 (L) Sequences,NA,NA,CCSCSSSSHHHHGGGGTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
9301,29799150,2018,AAGkwklfkklpkflhlakkf,AAGK{d}W{d}K{d}L{d}F{d}K{d}K{d}L{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{ct:Amid},AAG‐P18,Amidation,Free,Linear,Mix,None,18,Antibacterial,75 % Hemolysis at 250 µM,Human,Cecropin/Magainin Hybrid,NA,NA,CHHHHHHHHHHHHHHHCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
9303,29799150,2018,AAGwglrrllkygkrs,AAGW{d}G{d}L{d}R{d}R{d}L{d}L{d}K{d}Y{d}G{d}K{d}R{d}S{d}{ct:Amid},AAG‐WMR,Amidation,Free,Linear,Mix,None,13,Antibacterial,5 % Hemolysis at 10 µM,Human,Myxinidin Analogue From Hagfish,NA,NA,CCTTSSCCCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O
9312,29197569,2018,KWKLFKKYGRKKRRQRRR,KWKLFKKYGRKKRRQRRR,CA-TAT,Free,Free,Linear,L,None,18,Antibacterial,5 % Hemolysis at >128 µM,Human,Attaching Cecropin A (1-7)+ Tat(47-57),NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
9313,29197569,2018,YGRKKRRQRRR,YGRKKRRQRRR,TAT(47-57),Free,Free,Linear,L,None,11,Antibacterial,5 % Hemolysis at >128 µM,Human,Human Immunodeficiency Virus Type 1 (Hiv–1) Transactivation Of Transcription (Tat) Protein,NA,Low hemolytic,NA,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O
9314,29197569,2018,KWKLFKK,KWKLFKK,cecropin A(1-7),Free,Free,Linear,L,None,7,Antibacterial,5 % Hemolysis at >64 µM,Human,Hemolymph Of Giant Silk,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
9315,30052685,2018,KKLFKKILKYL,KKLFKKILKYL{ct:Amid},BP100,Amidation,Free,Linear,L,None,11,Antibacterial,43 ± 1.4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
9316,30052685,2018,C5H11CO-KKLFKKILKYL,KKLFKKILKYL{nt:hexanoyl}{ct:Amid},BP367,Amidation,hexanoyl,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,83 ± 6 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9317,30052685,2018,K(COC5H11)KLFKKILKYL,K{conj:COC5H11}KLFKKILKYL{nt:Acet}{ct:Amid},BP368,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,96 ± 0.9 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9318,30052685,2018,KK(COC5H11)LFKKILKYL,KK{conj:COC5H11}LFKKILKYL{nt:Acet}{ct:Amid},BP369,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,84 ± 8 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9320,30052685,2018,KKLK(COC5H11)KKILKYL,KKLK{conj:COC5H11}KKILKYL{nt:Acet}{ct:Amid},BP371,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,75 ± 4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9321,30052685,2018,KKLFK(COC5H11)KILKYL,KKLFK{conj:COC5H11}KILKYL{nt:Acet}{ct:Amid},BP372,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,97 ± 2 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9322,30052685,2018,KKLFKK(COC5H11)ILKYL,KKLFKK{conj:COC5H11}ILKYL{nt:Acet}{ct:Amid},BP373,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,92 ± 1 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9323,30052685,2018,KKLFKKK(COC5H11)LKYL,KKLFKKK{conj:COC5H11}LKYL{nt:Acet}{ct:Amid},BP374,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,19 ± 3 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9324,30052685,2018,KKLFKKIK(COC5H11)KYL,KKLFKKIK{conj:COC5H11}KYL{nt:Acet}{ct:Amid},BP375,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,70 ± 6 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9325,30052685,2018,KKLFKKILK(COC5H11)YL,KKLFKKILK{conj:COC5H11}YL{nt:Acet}{ct:Amid},BP376,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,90 ± 4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9326,30052685,2018,KKLFKKILKK(COC5H11)L,KKLFKKILKK{conj:COC5H11}L{nt:Acet}{ct:Amid},BP377,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,92 ± 5 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9328,30052685,2018,C3H7CO-KKLFKKILKYL,KKLFKKILKYL{nt:butanoyl}{ct:Amid},BP379,Amidation,butanoyl,Linear,L,COC3H7 = butanoyl,11,Antibacterial,93 ± 0.8 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9329,30052685,2018,K(COC3H7)KLFKKILKYL,K{conj:COC3H7}KLFKKILKYL{nt:Acet}{ct:Amid},BP380,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,93 ± 6 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9331,30052685,2018,KKK(COC3H7)FKKILKYL,KKK{conj:COC3H7}FKKILKYL{nt:Acet}{ct:Amid},BP382,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,100 ± 0.9 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9332,30052685,2018,KKLK(COC3H7)KKILKYL,KKLK{conj:COC3H7}KKILKYL{nt:Acet}{ct:Amid},BP383,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,22 ± 4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9333,30052685,2018,KKLFK(COC3H7)KILKYL,KKLFK{conj:COC3H7}KILKYL{nt:Acet}{ct:Amid},BP384,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,100 ± 4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9334,30052685,2018,KKLFKK(COC3H7)ILKYL,KKLFKK{conj:COC3H7}ILKYL{nt:Acet}{ct:Amid},BP385,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,100 ± 3 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9337,30052685,2018,KKLFKKILK(COC3H7)YL,KKLFKKILK{conj:COC3H7}YL{nt:Acet}{ct:Amid},BP388,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,38 ± 4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9339,30052685,2018,KKLFKKILKYK(COC3H7),KKLFKKILKYK{conj:COC3H7}{nt:Acet}{ct:Amid},BP390,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,5 ± 0.3 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,Low hemolytic,NA,NA
9340,30052685,2018,C11H23CO-KKLFKKILKYL,KKLFKKILKYL{nt:lauroyl}{ct:Amid},BP391,Amidation,lauroyl,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 0.9 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9341,30052685,2018,K(COC11H23)KLFKKILKYL,K{conj:COC11H23}KLFKKILKYL{nt:Acet}{ct:Amid},BP392,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 0.9 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9342,30052685,2018,KK(COC11H23)LFKKILKYL,KK{conj:COC11H23}LFKKILKYL{nt:Acet}{ct:Amid},BP393,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,97 ± 0.6 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9343,30052685,2018,KKK(COC11H23)FKKILKYL,KKK{conj:COC11H23}FKKILKYL{nt:Acet}{ct:Amid},BP394,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 1 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9344,30052685,2018,KKLK(COC11H23)KKILKYL,KKLK{conj:COC11H23}KKILKYL{nt:Acet}{ct:Amid},BP395,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 2 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9345,30052685,2018,KKLFK(COC11H23)KILKYL,KKLFK{conj:COC11H23}KILKYL{nt:Acet}{ct:Amid},BP396,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9346,30052685,2018,KKLFKK(COC11H23)ILKYL,KKLFKK{conj:COC11H23}ILKYL{nt:Acet}{ct:Amid},BP397,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9347,30052685,2018,KKLFKKK(COC11H23)LKYL,KKLFKKK{conj:COC11H23}LKYL{nt:Acet}{ct:Amid},BP398,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 3 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9348,30052685,2018,KKLFKKIK(COC11H23)KYL,KKLFKKIK{conj:COC11H23}KYL{nt:Acet}{ct:Amid},BP399,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 5 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9349,30052685,2018,KKLFKKILK(COC11H23)YL,KKLFKKILK{conj:COC11H23}YL{nt:Acet}{ct:Amid},BP400,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,99 ± 0.4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9350,30052685,2018,KKLFKKILKK(COC11H23)L,KKLFKKILKK{conj:COC11H23}L{nt:Acet}{ct:Amid},BP401,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 1 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9351,30052685,2018,KKLFKKILKYK(COC11H23),KKLFKKILKYK{conj:COC11H23}{nt:Acet}{ct:Amid},BP402,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9352,30052685,2018,KKLFKKILKYL,KKLFKKILKYL{ct:Amid},BP100,Amidation,Free,Linear,L,None,11,Antibacterial,57 ± 4.6 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
9353,30052685,2018,C5H11CO-KKLFKKILKYL,KKLFKKILKYL{nt:hexanoyl}{ct:Amid},BP367,Amidation,hexanoyl,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,95 ± 13 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9354,30052685,2018,K(COC5H11)KLFKKILKYL,K{conj:COC5H11}KLFKKILKYL{nt:Acet}{ct:Amid},BP368,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,97 ± 3 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9355,30052685,2018,KK(COC5H11)LFKKILKYL,KK{conj:COC5H11}LFKKILKYL{nt:Acet}{ct:Amid},BP369,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,86 ± 8 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9357,30052685,2018,KKLK(COC5H11)KKILKYL,KKLK{conj:COC5H11}KKILKYL{nt:Acet}{ct:Amid},BP371,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,95 ± 3 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9358,30052685,2018,KKLFK(COC5H11)KILKYL,KKLFK{conj:COC5H11}KILKYL{nt:Acet}{ct:Amid},BP372,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,100 ± 0.9 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9359,30052685,2018,KKLFKK(COC5H11)ILKYL,KKLFKK{conj:COC5H11}ILKYL{nt:Acet}{ct:Amid},BP373,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,95 ± 6 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9360,30052685,2018,KKLFKKK(COC5H11)LKYL,KKLFKKK{conj:COC5H11}LKYL{nt:Acet}{ct:Amid},BP374,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,28 ± 2 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9361,30052685,2018,KKLFKKIK(COC5H11)KYL,KKLFKKIK{conj:COC5H11}KYL{nt:Acet}{ct:Amid},BP375,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,86 ± 3 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9362,30052685,2018,KKLFKKILK(COC5H11)YL,KKLFKKILK{conj:COC5H11}YL{nt:Acet}{ct:Amid},BP376,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,89 ± 2 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9363,30052685,2018,KKLFKKILKK(COC5H11)L,KKLFKKILKK{conj:COC5H11}L{nt:Acet}{ct:Amid},BP377,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,89 ± 2 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9365,30052685,2018,C3H7CO-KKLFKKILKYL,KKLFKKILKYL{nt:butanoyl}{ct:Amid},BP379,Amidation,butanoyl,Linear,L,COC3H7 = butanoyl,11,Antibacterial,96 ± 1 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9366,30052685,2018,K(COC3H7)KLFKKILKYL,K{conj:COC3H7}KLFKKILKYL{nt:Acet}{ct:Amid},BP380,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,97 ± 5 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9368,30052685,2018,KKK(COC3H7)FKKILKYL,KKK{conj:COC3H7}FKKILKYL{nt:Acet}{ct:Amid},BP382,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,100 ± 2 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9369,30052685,2018,KKLK(COC3H7)KKILKYL,KKLK{conj:COC3H7}KKILKYL{nt:Acet}{ct:Amid},BP383,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,40 ± 4 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9370,30052685,2018,KKLFK(COC3H7)KILKYL,KKLFK{conj:COC3H7}KILKYL{nt:Acet}{ct:Amid},BP384,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,100 ± 2 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9371,30052685,2018,KKLFKK(COC3H7)ILKYL,KKLFKK{conj:COC3H7}ILKYL{nt:Acet}{ct:Amid},BP385,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,100 ± 4 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9374,30052685,2018,KKLFKKILK(COC3H7)YL,KKLFKKILK{conj:COC3H7}YL{nt:Acet}{ct:Amid},BP388,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,89 ± 10 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9376,30052685,2018,KKLFKKILKYK(COC3H7),KKLFKKILKYK{conj:COC3H7}{nt:Acet}{ct:Amid},BP390,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,7 ± 0.9 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,Low hemolytic,NA,NA
9377,30052685,2018,C11H23CO-KKLFKKILKYL,KKLFKKILKYL{nt:lauroyl}{ct:Amid},BP391,Amidation,lauroyl,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 0.5 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9378,30052685,2018,K(COC11H23)KLFKKILKYL,K{conj:COC11H23}KLFKKILKYL{nt:Acet}{ct:Amid},BP392,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 2 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9379,30052685,2018,KK(COC11H23)LFKKILKYL,KK{conj:COC11H23}LFKKILKYL{nt:Acet}{ct:Amid},BP393,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,99 ± 0.5 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9380,30052685,2018,KKK(COC11H23)FKKILKYL,KKK{conj:COC11H23}FKKILKYL{nt:Acet}{ct:Amid},BP394,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 2 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9381,30052685,2018,KKLK(COC11H23)KKILKYL,KKLK{conj:COC11H23}KKILKYL{nt:Acet}{ct:Amid},BP395,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 2 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9382,30052685,2018,KKLFK(COC11H23)KILKYL,KKLFK{conj:COC11H23}KILKYL{nt:Acet}{ct:Amid},BP396,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 7 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9383,30052685,2018,KKLFKK(COC11H23)ILKYL,KKLFKK{conj:COC11H23}ILKYL{nt:Acet}{ct:Amid},BP397,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 5 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9384,30052685,2018,KKLFKKK(COC11H23)LKYL,KKLFKKK{conj:COC11H23}LKYL{nt:Acet}{ct:Amid},BP398,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 5 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9385,30052685,2018,KKLFKKIK(COC11H23)KYL,KKLFKKIK{conj:COC11H23}KYL{nt:Acet}{ct:Amid},BP399,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 6 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9386,30052685,2018,KKLFKKILK(COC11H23)YL,KKLFKKILK{conj:COC11H23}YL{nt:Acet}{ct:Amid},BP400,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 14 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9387,30052685,2018,KKLFKKILKK(COC11H23)L,KKLFKKILKK{conj:COC11H23}L{nt:Acet}{ct:Amid},BP401,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 3 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9388,30052685,2018,KKLFKKILKYK(COC11H23),KKLFKKILKYK{conj:COC11H23}{nt:Acet}{ct:Amid},BP402,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 0.5 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9389,28072492,2018,FFPGIIKVASAILPTAICAITKRC,FFPGIIKVASAILPTAICAITKRC,Brevinin1 HYba1 B1/1 COOH,Free,Free,Linear,L,None,24,"Antimicrobial, Antibacterial",>40 % Hemolysis at 100 µM,Human,Frog Crude Skin Secretion Of Hydrophylax Bahuvistara,membrane-mimetic environment like trifluoroethanol (TFE) in water 30% (v/v = Alphα-Helical conformation,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
9390,28072492,2018,FFPGIIKVASAILPTAICAITKRC,FFPGIIKVASAILPTAICAITKRC{ct:Amid},Brevinin1 HYba1 B1/1 CONH2,Amidation,Free,Linear,L,None,24,"Antimicrobial, Antibacterial",>80 % Hemolysis at 100 µM,Human,Frog Crude Skin Secretion Of Hydrophylax Bahuvistara,membrane-mimetic environment like trifluoroethanol (TFE) in water 30% (v/v = Alphα-Helical conformation,NA,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
9391,28072492,2018,FFPGIIKVAGAILPTAICAITKRC,FFPGIIKVAGAILPTAICAITKRC,Brevinin1 HYba2 B1/2 COOH,Free,Free,Linear,L,None,24,"Antimicrobial, Antibacterial",>50 % Hemolysis at 100 µM,Human,Frog Crude Skin Secretion Of Hydrophylax Bahuvistara,membrane-mimetic environment like trifluoroethanol (TFE) in water 30% (v/v = Alphα-Helical conformation,NA,CCCSHHHHTTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
9392,28072492,2018,FFPGIIKVAGAILPTAICAITKRC,FFPGIIKVAGAILPTAICAITKRC{ct:Amid},Brevinin1 HYba2 B1/2 CONH2,Amidation,Free,Linear,L,None,24,"Antimicrobial, Antibacterial",>90 % Hemolysis at 100 µM,Human,Frog Crude Skin Secretion Of Hydrophylax Bahuvistara,membrane-mimetic environment like trifluoroethanol (TFE) in water 30% (v/v = Alphα-Helical conformation,NA,CCCHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
9393,29682907,2018,ACPIFTKIQGTYRGKAKCK,ACPIFTKIQGTYRGKAKCK{ct:myristoylated},MPhd1,myristoylated,Free,Linear,L,Myr = Myristic acid,19,Antibacterial,>70 % Hemolysis at 10 µM,Rat,Human-Β-Defensins,buffer = β-conformation,NA,CCTTHHHHTTTTC,NA
9394,29682907,2018,FCPRRYKQIGTGLPGTKCK,FCPRRYKQIGTGLPGTKCK{ct:myristoylated},MPhd2,myristoylated,Free,Linear,L,Myr = Myristic acid,19,Antibacterial,>20 % Hemolysis at 10 µM,Rat,Human-Β-Defensins,buffer = unordered conformation,NA,CHHHHIIIIITTC,NA
9395,29682907,2018,SCLPKEEQIGKSTRGRKCRRKK,SCLPKEEQIGKSTRGRKCRRKK{ct:myristoylated},MPhd3,myristoylated,Free,Linear,L,Myr = Myristic acid,22,"Antimicrobial, Antibacterial",>40 % Hemolysis at 10 µM,Rat,Human-Β-Defensins,buffer = unordered conformation,NA,CCCHHHHHHHHHC,NA
9399,29770868,2018,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid},melittin monomer,Amidation,Free,Linear,L,None,26,"Antibacterial, Anticancer",100 % Hemolysis at 10 µM,mouse,Bee Venom,α-Helix,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
9400,29770868,2018,GIGAVLKVLTTGLPALISWIKRKRQQ-(Dab-NH2)-GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{nnr:Dab-NH2}GIGAVLKVLTTGLPALISWIKRKRQQ,melittin dimer,Free,Free,Branched,L,"Dab = 3,3ʹ-diaminobenzidine",52,Antibacterial,100 % Hemolysis at 10 µM,mouse,Synthetic Dimer Of Melittin,NA,NA,NA,NA
9401,29842923,2018,FLPIVGRLISGIL,FLPIVGRLISGIL,Temporin-CPb,Free,Free,Linear,L,None,13,Antibacterial,50 % Hemolysis at >100 µM,Human,Gopher Frog Lithobates Capito,NA,NA,CTHHHHHHHHTTCHHHHTTTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
9402,29842923,2018,SILPTIVSFLSKVF,SILPTIVSFLSKVF,Temporin-1Ga,Free,Free,Linear,L,None,14,"Antibacterial, Antifungal, Anticancer",50 % Hemolysis at 12.5 µM,Human,Frog Rana Grylio,NA,NA,CTHHHHTTTSTHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
9403,29842923,2018,FLPFLKSILGKIL,FLPFLKSILGKIL,Temporin-1OLa,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal, Anticancer",50 % Hemolysis at 50 µM,Human,Frog Rana Okaloosae,α-Helical,NA,CGGGTHHHHHHHHHHHTGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
9404,29842923,2018,FLSAITSILGKFF,FLSAITSILGKFF,Temporin-1SPa,Free,Free,Linear,L,None,13,Antibacterial,50 % Hemolysis at 37.5 µM,Human,Frog Rana Septentrionalis,NA,NA,CCSCSCCCSSSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)O
9405,29842923,2018,FLPLLASLFSRLF,FLPLLASLFSRLF,Temporin-1Oc,Free,Free,Linear,L,None,13,Antibacterial,50 % Hemolysis at <12.5 µM,Human,Frog Rana Ornativentris,NA,NA,CCHHHHHHHHTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
9406,29842923,2018,IPPFIKKVLTTVF,IPPFIKKVLTTVF,Temporin-CPa,Free,Free,Linear,L,None,13,Antibacterial,50 % Hemolysis at >100 µM,Human,Gopher Frog Lithobates Capito,NA,NA,CCCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)CC
9407,29900628,2018,RVRWRlf-2-Abz-aRWRVR,RVRWRlF{d}{nnr:2-Abz}A{d}RWRVR,Peptide 2,Free,Free,Linear,Mix,"2-Abz = 2-aminobenzoic acid, f = D-Phenylalanine",13,"Antibacterial, Antifungal",<3 % Hemolysis at 200 µM,Mouse,Synthetic Amphipathic Antimicrobial Peptide,aqueous = β‐Hairpin,Low hemolytic,NA,NA
9408,29900628,2018,RIKWRlf-2-Abz-aRWKIR,RIKWRlF{d}{nnr:2-Abz}A{d}RWKIR,Peptide 3,Free,Free,Linear,Mix,"2-Abz = 2-aminobenzoic acid, f = D-Phenylalanine",13,Antibacterial,<3 % Hemolysis at 600 µM,Mouse,Synthetic Amphipathic Antimicrobial Peptide,aqueous = β‐Hairpin,Non-hemolytic,NA,NA
9425,30110916,2018,KLLKHKLLVTLA,KLLKHKLLVTLA,HJH-1,Free,Free,Linear,L,None,12,Antibacterial,20 % Hemolysis at 400 μg/ml,Rabbit,Hemoglobin Α-Subunit Of Bovine Erythrocytes P3,NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
9426,30021422,2018,VKEWIKYLKSLF,VKEWIKYLKSLF,LPcin-YK3,Free,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 1 μg/ml,Mouse,Bovine Lactophoricin-Derived Peptide,"aqueous = Random coils, DPC solution = α-Helical",Non-hemolytic,CCHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
9427,30021422,2018,VKEWIKYLKSLF,VKEWIKYLKSLF,LPcin-YK3,Free,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 10 μg/ml,Mouse,Bovine Lactophoricin-Derived Peptide,"aqueous = Random coils, DPC solution = α-Helical",Non-hemolytic,CCSSSCHHHHHHTTGGGGTSSTTSSHHHHHHHHHTTTCCCTHHHHTTCSCCCSCCTTSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
9428,30021422,2018,VKEWIKYLKSLF,VKEWIKYLKSLF,LPcin-YK3,Free,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 40 μg/ml,Mouse,Bovine Lactophoricin-Derived Peptide,"aqueous = Random coils, DPC solution = α-Helical",Non-hemolytic,CCHHHHHHHHHHHTTCSSCHHHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
9433,29760411,2018,A{d}-L/I-L/I-L/I-R{d}-L/I-L/I-V{d}-K-L/I-T-L/I-S{d}-K-K,A{d}-L/I-L/I-L/I-R{d}-L/I-L/I-V{d}-K-L/I-T-L/I-S{d}-K-K{cyc},Paenialvin-A,Free,Free,Bicyclic,Mix,None,23,"Antibacterial,Antitumor",3.61 % Hemolysis at 50 μg/ml,Rabbit,Bacteria Paenibacillus Alvei Dsm 29,NA,Non-hemolytic,NA,NA
9434,29760411,2018,L/I-A{d}-L/I-L/I-I/L-R{d}-L/I-L/I-V{d}-K-L/I-T-L/I-A{d}-K-K,L/I-A{d}-L/I-L/I-I/L-R{d}-L/I-L/I-V{d}-K-L/I-T-L/I-A{d}-K-K{cyc},Paenialvin-B,Free,Free,Bicyclic,Mix,None,23,Antibacterial,1.93 % Hemolysis at 50 μg/ml,Rabbit,Bacteria Paenibacillus Alvei Dsm 29,NA,Non-hemolytic,NA,NA
9435,29760411,2018,L-A{d}-L-L-V{d}-R{d}-L-L-V{d}-K-L-T-L-S{d}-K-K,L-A{d}-L-L-V{d}-R{d}-L-L-V{d}-K-L-T-L-S{d}-K-K{cyc},Paenialvin-C,Free,Free,Bicyclic,D,None,23,Antibacterial,0 % Hemolysis at 50 μg/ml,Rabbit,Bacteria Paenibacillus Alvei Dsm 29,NA,Non-hemolytic,NA,NA
9436,29760411,2018,L-A{d}-L-L-I-R{d}-L-L-V{d}-K-L-T-L-T-K-K,L-A{d}-L-L-I-R{d}-L-L-V{d}-K-L-T-L-T-K-K{cyc},Paenialvin-D,Free,Free,Linear,Mix,None,16,Antibacterial,0.64 % Hemolysis at 50 μg/ml,Rabbit,Bacteria Paenibacillus Alvei Dsm 29,NA,Non-hemolytic,CHHHHHHHCCSSSTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9437,29890152,2018,MNFNKFFVLFALIMVAVVGQSEAGWLKKLGKKIERVGQHTRDATIQTIGVAQQAVNVAATLKG,MNFNKFFVLFALIMVAVVGQSEAGWLKKLGKKIERVGQHTRDATIQTIGVAQQAVNVAATLKG,Lucilin,Free,Free,Linear,L,None,63,Antibacterial,0 % Hemolysis at 250 μg/ml,Human,Australian Sheep Blowfly (Lucilia Cuprina),α-Helix,Non-hemolytic,CCCTTSSSSCCCCTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C
9439,30468326,2018,MKFFTLLAALMALFAICNNFSMVSASRDSRPVQPRVQPPPPPPKQKPSIYDTPIRRPGGQKTMYA,MKFFTLLAALMALFAICNNFSMVSASRDSRPVQPRVQPPPPPPKQKPSIYDTPIRRPGGQKTMYA,MDAP-2,Free,Free,Linear,L,None,65,Antibacterial,3.4 % Hemolysis at 800 μg/ml,Rabbit,House Fly (Musca Domestica),"water = α-Helical and β-fold, 50% of TFA and SDS = α-Helical",Low hemolytic,CCSSSSSIIIIIHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C)C(C)C
9440,30177656,2018,MDSQYPKRIFHIIKIWLMIALIALILGLLIGFALGEGNPLKLFLPSTWVHFFKFLR,MDSQYPKRIFHIIKIWLMIALIALILGLLIGFALGEGNPLKLFLPSTWVHFFKFLR,LGH2,Free,Free,Linear,L,None,56,"Antibacterial, Antifungal",>5 % Hemolysis at 8 µM,Sheep,Lactobacillus Casei Hz1,"water = 4.35% α-Helix, 30 mM SDS, 25% TFE, and 50% TFE = α-Helix",NA,CCCCSSTTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O
9441,30177656,2018,MDSQYPKRIFHIIKIWLMIALIALILGLLIGFALGEGNPLKLFLPSTWVHFFKFLR,MDSQYPKRIFHIIKIWLMIALIALILGLLIGFALGEGNPLKLFLPSTWVHFFKFLR,LGH2,Free,Free,Linear,L,None,56,"Antibacterial, Antifungal",100 % Hemolysis at 64 µM,Sheep,Lactobacillus Casei Hz1,"water = 4.35% α-Helix, 30 mM SDS, 25% TFE, and 50% TFE = α-Helix",NA,CTHHHHHHHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O
9443,30192822,2018,KIFGAIWPLALGALKNLIK,KIFGAIWPLALGALKNLIK,K0-W6-Hy-a1,Free,Free,Linear,L,None,19,Antibacterial,1 % Hemolysis at 25 mM,Human,Analogue Of Hylin-A1,amphipathic α-Helix,Low hemolytic,CCCTTSSSSCCCCTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
9446,30192822,2018,IETFLKQLRSAANKIVGL,IETFLKQLRSAANKIVGL,Citrus-amp1,Free,Free,Linear,L,None,18,Antibacterial,1 % Hemolysis at 25 mM,Human,Citrus Sinensis,amphipathic α-Helix,Low hemolytic,CCCCSSTTTTCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)O
9449,30192822,2018,KIFGAIWPLALGALKNLIK,KIFGAIWPLALGALKNLIK,K0-W6-Hy-a1,Free,Free,Linear,L,None,19,Antibacterial,0 % Hemolysis at 50 mM,Human,Analogue Of Hylin-A1,amphipathic α-Helix,Low hemolytic,CCCTTSSSSCCCCTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
9452,30192822,2018,IETFLKQLRSAANKIVGL,IETFLKQLRSAANKIVGL,Citrus-amp1,Free,Free,Linear,L,None,18,Antibacterial,3 % Hemolysis at 50 mM,Human,Citrus Sinensis,amphipathic α-Helix,Low hemolytic,CCCCSSTTTTCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)O
9455,30192822,2018,KIFGAIWPLALGALKNLIK,KIFGAIWPLALGALKNLIK,K0-W6-Hy-a1,Free,Free,Linear,L,None,19,Antibacterial,0 % Hemolysis at 75 mM,Human,Analogue Of Hylin-A1,amphipathic α-Helix,Low hemolytic,CCCTTSSSSCCCCTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
9458,30192822,2018,IETFLKQLRSAANKIVGL,IETFLKQLRSAANKIVGL,Citrus-amp1,Free,Free,Linear,L,None,18,Antibacterial,10 % Hemolysis at 75 mM,Human,Citrus Sinensis,amphipathic α-Helix,Low hemolytic,CCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHTSCCCSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)O
9461,30192822,2018,KIFGAIWPLALGALKNLIK,KIFGAIWPLALGALKNLIK,K0-W6-Hy-a1,Free,Free,Linear,L,None,19,Antibacterial,0 % Hemolysis at 100 mM,Human,Analogue Of Hylin-A1,amphipathic α-Helix,Low hemolytic,CCBTTBC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
9464,30192822,2018,IETFLKQLRSAANKIVGL,IETFLKQLRSAANKIVGL,Citrus-amp1,Free,Free,Linear,L,None,18,Antibacterial,28 % Hemolysis at 100 mM,Human,Citrus Sinensis,amphipathic α-Helix,Low hemolytic,CCTTTCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)O
9468,29859288,2018,LGDFFRKSKEKIGKEFKRIVQRIKDFLRNLAKRHHGYKRKFH,LGDFFRKSKEKIGKEFKRIVQRIKDFLRNLAKRHHGYKRKFH,L31-P113,Free,Free,Linear,L,None,42,"Antibacterial, Antifungal",12.0±0.7 % Hemolysis at 500 μg/ml,Human,Hybrid Peptide Of Ll-37 And Hst-5,α-Helical,NA,CTTHHHHTTSHHHHHHHHGGGSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
9469,29859288,2018,ALGDFFRKSKEKIGKEFKRIVQRIKDFLRNLAKRHHGYKRKFHLEY,ALGDFFRKSKEKIGKEFKRIVQRIKDFLRNLAKRHHGYKRKFHLEY,AL32-P113 a,Free,Free,Linear,L,None,46,"Antibacterial, Antifungal",10.4±2.2 % Hemolysis at 500 μg/ml,Human,Recombinant Hybrid Peptide Of Ll-37 And Hst-5,α-Helical,NA,CHHHHHHHHHHGGGTTTGGGGTTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
9475,30095906,2018,GFAWNVCVYRNGVRVCHRRAN,GFAWNVCVYRNGVRVCHRRAN,2,Free,Free,Linear,L,None,21,Antibacterial,2.06 % Hemolysis at 100 µM,Human,Cathepsin-Cleavable Linker,NA,Non-hemolytic,CCCCCCCTTCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
9478,30216370,2018,RRWVRRVRRVWRRVVRVVRRWVRR,RRWVRRVRRVWRRVVRVVRRWVRR,WLBU2,Free,Free,Linear,L,None,24,Antibacterial,20 % Hemolysis at 100 µM,Human,Human Splunc1 (Short Palate Lung And Nasal Epithelial Clone 1),Helical amphipathic structure,NA,CCCCCCCCCCCC,CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
9485,30262770,2018,KWRRWQWRRWK,KWRRWQWRRWK{ct:Amid},KW-WK,Amidation,Free,Linear,L,None,11,Antibacterial,5 % Hemolysis at >256 µM,Human,Derived From Lfcinb18–28,"10 mM PBS = unordered conformations, 50% TFE = α-Helix (negative bands at 208 nm, 222 nm), 30 mM SDS = α-Helix",Non-hemolytic,NA,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
9486,30262770,2018,FPRRWQWRRPF,FPRRWQWRRPF{ct:Amid},FP-PF,Amidation,Free,Linear,L,None,11,Antibacterial,5 % Hemolysis at >256 µM,Human,Derived From Lfcinb18–28,"10 mM PBS = unordered conformations, 50% TFE = Disordered structure, 30 mM SDS = Disordered structure",Non-hemolytic,NA,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
9487,30262770,2018,FWRRWQWRRRWF,FWRRWQWRRRWF{ct:Amid},FW-WF,Amidation,Free,Linear,L,None,12,Antibacterial,5 % Hemolysis at 8 µM,Human,Derived From Lfcinb18–28,"10 mM PBS = unordered conformations, 50% TFE = α-Helix (negative bands at 208 nm, 222 nm), 30 mM SDS = α-Helix",NA,NA,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
9488,30262770,2018,FWRRWQWRRRWF,FWRRWQWRRRWF{ct:Amid},FW-WF,Amidation,Free,Linear,L,None,12,Antibacterial,52.91 % Hemolysis at 128 µM,Human,Derived From Lfcinb18–28,"10 mM PBS = unordered conformations, 50% TFE = α-Helix (negative bands at 208 nm, 222 nm), 30 mM SDS = α-Helix",NA,NA,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
9489,30262770,2018,KKRRWQWRRKK,KKRRWQWRRKK{ct:Amid},KK-KK,Amidation,Free,Linear,L,None,11,Antibacterial,5 % Hemolysis at >256 µM,Human,Derived From Lfcinb18–28,"10 mM PBS = unordered conformations, 50% TFE = α-Helix (negative bands at 208 nm, 222 nm), 30 mM SDS = Disordered structure",Non-hemolytic,NA,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
9490,30262770,2018,KCRRWQWRMKK,KCRRWQWRMKK{ct:Amid},LFcinB18–28,Amidation,Free,Linear,L,None,11,Antibacterial,5 % Hemolysis at >256 µM,Human,Truncated Peptide Of Lfcinb,"10 mM PBS = unordered conformations, 50% TFE = β-Sheet (positive peak 195-198 nm, negative peak 217-218 nm), 30 mM SDS = Disordered structure",Non-hemolytic,NA,CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
9491,29626331,2018,AILRKATRRLVKLIV,AILRKATRRLVKLIV{ct:Amid},P3-B,Amidation,Free,Linear,L,None,15,Antibacterial,4.4 % Hemolysis at 50 µM,Human,Synthetic Amps,α-Helix,Low hemolytic,CCCSTTHHHHHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O
9492,29626331,2018,AIWRKATRRLVKLIV,AIWRKATRRLVKLIV{ct:Amid},P3-C,Amidation,Free,Linear,L,None,15,Antibacterial,68.7 % Hemolysis at 50 µM,Human,Synthetic Amps,α-Helix Loop,NA,CCTTTTGGGGTHHHHHHHTTTSTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O
9493,30112781,2018,KβcfKK,K{nnr:β}{nnr:cf}KK{cyc:N-C},5a,Free,Free,Cyclic,Mix,"β = lipophilic β2,2‐amino acid, cf = 4-CF3 (β-phenylalanine derivative has a trifluoromethyl CF3 )",4,Antibacterial,50 % Hemolysis at >500 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9494,30112781,2018,KβcfGK,K{nnr:β}{nnr:cf}GK{cyc:N-C},5b,Free,Free,Cyclic,Mix,"β = lipophilic β2,2‐amino acid, cf = 4-CF3 (β-phenylalanine derivative has a trifluoromethyl CF3 )",4,Antibacterial,50 % Hemolysis at >500 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9495,30112781,2018,KβcfAK,K{nnr:β}{nnr:cf}AK{cyc:N-C},5c,Free,Free,Cyclic,Mix,"β = lipophilic β2,2‐amino acid, cf = 4-CF3 (β-phenylalanine derivative has a trifluoromethyl CF3 )",4,Antibacterial,50 % Hemolysis at >500 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9496,30112781,2018,KβcfFK,K{nnr:β}{nnr:cf}FK{cyc:N-C},5d,Free,Free,Cyclic,Mix,"β = lipophilic β2,2‐amino acid, cf = 4-CF3 (β-phenylalanine derivative has a trifluoromethyl CF3 )",4,Antibacterial,50 % Hemolysis at 88 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9497,30112781,2018,KβdicfKK,K{nnr:β}{nnr:dicf}KK{cyc:N-C},6a,Free,Free,Cyclic,Mix,"β = β^(2,2), dicf = 3,5diCF3(β-phenylalanine derivative has trifluoromethyl CF3 groups)",4,Antibacterial,50 % Hemolysis at 216 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9498,30112781,2018,KβdicfGK,K{nnr:β}{nnr:dicf}GK{cyc:N-C},6b,Free,Free,Cyclic,Mix,"β = β^(2,2), dicf = 3,5diCF3(β-phenylalanine derivative has trifluoromethyl CF3 groups)",4,Antibacterial,50 % Hemolysis at 100 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9499,30112781,2018,KβdicfAK,K{nnr:β}{nnr:dicf}AK{cyc:N-C},6c,Free,Free,Cyclic,Mix,"β = β^(2,2), dicf = 3,5diCF3(β-phenylalanine derivative has trifluoromethyl CF3 groups)",4,Antibacterial,50 % Hemolysis at 67 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9500,30112781,2018,KβdicfFK,K{nnr:β}{nnr:dicf}FK{cyc:N-C},6d,Free,Free,Cyclic,Mix,"β = β^(2,2), dicf = 3,5diCF3(β-phenylalanine derivative has trifluoromethyl CF3 groups)",4,Antibacterial,50 % Hemolysis at 84 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9501,30215282,2018,SMWSGMWRRKLKKLRNALKKKLKGE,SMWSGMWRRKLKKLRNALKKKLKGE,Ltc 1,Free,Free,Linear,L,None,25,Antibacterial,20 % Hemolysis at 80 µM,Rabbit,Spider Lachesana Tarabaevi,"water = Random coil, 50% trifluoroethano = α-helice",NA,CCHHHHHHHHHHHHTTSCCC,CSCC[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O
9502,30215282,2018,GLFGKLIKKFGRKAISYAVKKARGKH,GLFGKLIKKFGRKAISYAVKKARGKH,Ltc 2a,Free,Free,Linear,L,None,26,Antibacterial,20 % Hemolysis at 6 µM,Rabbit,Spider Lachesana Tarabaevi,"water = Random coil, 50% trifluoroethano = α-helice",NA,CCSSCCSCSSGGGGGGTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C
9503,30215282,2018,SWKSMAKKLKEYMEKLKQRA,SWKSMAKKLKEYMEKLKQRA{ct:Amid},Ltc 3a,Amidation,Free,Linear,L,None,20,Antibacterial,20 % Hemolysis at >120 µM,Rabbit,Spider Lachesana Tarabaevi,"water = Random coil, 50% trifluoroethano = α-helice",NA,CCCSSTTHHHHHHTTGGGTC,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O
9504,30215282,2018,SWASMAKKLKEYMEKLKQRA,SWASMAKKLKEYMEKLKQRA{ct:Amid},Ltc 3b,Amidation,Free,Linear,L,None,20,Antibacterial,20 % Hemolysis at >120 µM,Rabbit,Spider Lachesana Tarabaevi,"water = Random coil, 50% trifluoroethano = α-helice",NA,CCSHHHHHHHHHHHHHSCC,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O
9505,30215282,2018,GLKDKFKSMGEKLKQYIQTWKAKF,GLKDKFKSMGEKLKQYIQTWKAKF{ct:Amid},Ltc 4a,Amidation,Free,Linear,L,None,24,Antibacterial,20 % Hemolysis at >120 µM,Rabbit,Spider Lachesana Tarabaevi,"water = Random coil, 50% trifluoroethano = α-helice",NA,CCCHHHHHHHHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
9506,30215282,2018,SLKDKVKSMGEKLKQYIQTWKAKF,SLKDKVKSMGEKLKQYIQTWKAKF{ct:Amid},Ltc 4b,Amidation,Free,Linear,L,None,24,Antibacterial,20 % Hemolysis at >120 µM,Rabbit,Spider Lachesana Tarabaevi,"water = Random coil, 50% trifluoroethano = α-helice",NA,CCCCCCCCCCCCCCCSSCCCCCTTHHHHTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
9507,30215282,2018,GFFGKMKEYFKKFGASFKRRFANLKKRL,GFFGKMKEYFKKFGASFKRRFANLKKRL{ct:Amid},Ltc 5,Amidation,Free,Linear,L,None,28,Antibacterial,20 % Hemolysis at 40 µM,Rabbit,Spider Lachesana Tarabaevi,"water = Random coil, 50% trifluoroethano = α-helice",NA,CCCCCCCCCCCCCCSSCTTCCCTTSTTCSSSSCC,CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O
9508,30215282,2018,QAFQTFKPDWNKIRYDAMKMQTSLGQMKKRFNL,QAFQTFKPDWNKIRYDAMKMQTSLGQMKKRFNL,Ltc 6a,Free,Free,Linear,L,None,33,Antibacterial,20 % Hemolysis at >120 µM,Rabbit,Spider Lachesana Tarabaevi,"water = Random coil, 50% trifluoroethano = α-helice",NA,CCCHHHHHHHHHHHHHHHHHHHHHHHHHHTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
9509,30215282,2018,GETFDKLKEKLKTFYQKLVEKAEDLKGDLKAKLS,GETFDKLKEKLKTFYQKLVEKAEDLKGDLKAKLS,Ltc 7,Free,Free,Linear,L,None,34,Antibacterial,20 % Hemolysis at >120 µM,Rabbit,Spider Lachesana Tarabaevi,"water = Random coil, 50% trifluoroethano = α-helice",NA,CCSHHHHHSSSSSCSTTSSTTHHHHHHHHTCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CO)C(=O)O
9510,30215282,2018,GIRCPKSWKCKAFKQRVLKRLLAMLRQHAF,GIRCPKSWKCKAFKQRVLKRLLAMLRQHAF,Oxt 4a,Free,Free,Linear,L,None,30,Antibacterial,50 % Hemolysis at 7 µM,Human,Lynx Spider Peptide,"aqueous = Disordered, SDS= α-Helical",NA,CCTTTCSSSSSCSSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
9511,30215282,2018,KAFKQRVLKRKKAMKRQKAF,KAFKQRVLKRKKAMKRQKAF,P1,Free,Free,Linear,L,None,20,Antibacterial,0 % Hemolysis at 100 µM,Human,Mutation Oxki4A(11-30)4K,"aqueous = Random coil, SDS= α-Helical",Non-hemolytic,NA,CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
9512,30215282,2018,GIRAPKSWKAKAFKQRVLKR,GIRAPKSWKAKAFKQRVLKR,P2,Free,Free,Linear,L,None,20,Antibacterial,0 % Hemolysis at 100 µM,Human,Mutation Oxt 4A(1-20)(C→A),"aqueous = Random coil, SDS= α-Helical",Non-hemolytic,CTTGGGTTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
9513,30215282,2018,KSWKAKAFKQRVLKRLLAML,KSWKAKAFKQRVLKRLLAML,P3,Free,Free,Linear,L,None,20,Antibacterial,40 % Hemolysis at 100 µM,Human,Mutation Oxt 4A(6-25) (C→A),"aqueous = Random coil, SDS= α-Helical",NA,CCCTHHHHHSCSTHHHHTTTSCCC,CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
9514,30215282,2018,FAHQRLMALLRKLVRQKFAK,FAHQRLMALLRKLVRQKFAK,P4,Free,Free,Linear,L,None,20,Antibacterial,40 % Hemolysis at 100 µM,Human,Mutation Oxt 4A(10-30)Inversion,"aqueous = Random coil, SDS= α-Helical",NA,CCCGGGGGTCSSCCCCC,CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
9515,30215282,2018,SMWSGMWRKRLKAMLRQHAF,SMWSGMWRKRLKAMLRQHAF,P5,Free,Free,Linear,L,None,20,Antibacterial,>5 % Hemolysis at 100 µM,Human,Mutation Ltc1(1-8)Oxt 4A(19-30)(L22→K),"aqueous = Random coil, SDS= α-Helical",Low hemolytic,CCHHHHHTTBCSSSSCBCCCCCCC,CSCC[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
9516,30279591,2018,GFKLKGMARISCLPNGQWSNFPPKCIRECAMVSS,GFKLKGMARISCLPNGQWSNFPPKCIRECAMVSS,Sushi 1 Wild Type,Free,Free,Linear,L,None,34,Antibacterial,100 % Hemolysis at 50 µM,Human,Horseshoe Crabs,"aqueous = Random coil + Extended Strand, PBS = Random coil",NA,CTHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)CC
9517,30279591,2018,GFGLGGLARILCLGNRQWSNFFKKLNRKCAMVKK,GFGLGGLARILCLGNRQWSNFFKKLNRKCAMVKK,SRP-1,Free,Free,Linear,L,None,34,Antibacterial,0 % Hemolysis at 50 µM,Human,Designed From Horseshoe Crab Peptide,aqueous = α-Helix,Non-hemolytic,CCTHHHHSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
9518,30279591,2018,GFALAGLARILCLWFREFSGFFRRLNRRFAMRRR,GFALAGLARILCLWFREFSGFFRRLNRRFAMRRR,SRP-2,Free,Free,Linear,L,None,34,Antibacterial,0 % Hemolysis at 50 µM,Human,Designed From Horseshoe Crab Peptide,"aqueous = α-Helix, 50% TFE = α-Helix",Non-hemolytic,CCHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
9519,30279591,2018,GAALAGLAKILCLWAKEFTGAFKKLNKKFAMKKK,GAALAGLAKILCLWAKEFTGAFKKLNKKFAMKKK,SRP-3,Free,Free,Linear,L,None,34,Antibacterial,100 % Hemolysis at 50 µM,Human,Designed From Horseshoe Crab Peptide,aqueous = α-Helix,NA,CTHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
9521,30301180,2018,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid},Magainin 2,Amidation,Free,Linear,L,None,23,"Antibacterial, Antibiofilm",0 % Hemolysis at 64 µM,Mouse,African Clawed Fogs Xenopus Laevis,"50% TFE and 30mM SDS = α-Helical, 10 mM sodium phosphate buffer = Random coil",Non-hemolytic,CCHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
9523,30322120,2018,FLGAVLKVAGKLVPAAICKISKKC,FLGAVLKVAGKLVPAAICKISKKC,Brevinin-1GHa,Free,Free,Linear,L,None,24,"Antibiofilm, Antibacterial, Antifungal",20 % Hemolysis at 16 µM,Horse,Frog Hylarana Guentheri,α-Helix,NA,CCBTTTBCSSSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC
9524,30322120,2018,FLGAVLKVAGKLVPAAI,FLGAVLKVAGKLVPAAI,Brevinin-1GHb,Free,Free,Linear,L,None,17,Antibacterial,20 % Hemolysis at 512 µM,Horse,Analogue Of Brevinin-1Gha,α-Helix,Low hemolytic,CCCSSCCCCSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(C)C)C(=O)O
9525,30322120,2018,FLGAVLKVCKISKKCAGKLVPAAI,FLGAVLKVCKISKKCAGKLVPAAI,Brevinin-1GHc,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal",20 % Hemolysis at 128 µM,Horse,Analogue Of Brevinin-1Gha,α-Helix,NA,CCCSTHHHHGGGHHHHSSSCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O
9532,30360541,2018,GFWSSVWDGAKNVGTAIIKNAKVCVYAVCVSHK,GFWSSVWDGAKNVGTAIIKNAKVCVYAVCVSHK,Nicomicin-1,Free,Free,Linear,L,None,33,Antibacterial,50 % Hemolysis at 64 µM,Human,Polychaeta Tubeworm Nicomache Minor,"aqueous = Disordered, Membrane-Mimicking Environment = α-Helix",NA,CCCSTHHHHGGGHHHHSSSCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)CC
9533,30360541,2018,GFWSSVWDGAKNVGTAI,GFWSSVWDGAKNVGTAI,Nico(1-17),Free,Free,Linear,L,None,17,Antibacterial,1 % Hemolysis at 128 µM,Human,Fragment Of Nicomicin-1,"aqueous = α-Helix, Membrane-Mimicking Environment = α-Helix",Non-hemolytic,CHHHHHHHHHHHTTCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
9534,30360541,2018,IKNAKVCVYAVCVSHK,IKNAKVCVYAVCVSHK,Nico(18-33),Free,Free,Linear,L,None,16,Antibacterial,50 % Hemolysis at 128 µM,Human,Fragment Of Nicomicin-1,"aqueous = Random coil, Membrane-Mimicking Environment = Disordered",NA,CHHHHHHHHHHHTTCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
9535,30325956,2018,GVWGIAKIAGKVLGNILPHVFSSNQS,GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Carboxyl (COO-)},DMS-DA6-OH,Carboxyl (COO-),H3N = amine,Linear,L,None,26,Antibacterial,0.9 ± 1.5 % Hemolysis at 10 µM,Human,Frog Pachymedusa Dacnicolor,"phosphate buffer = Random coil, POPG = α-Helix",Non-hemolytic,CCCHHHHSSTTTCCSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
9536,30325956,2018,GVWGIAKIAGKVLGNILPHVFSSNQS,GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Amid},DMS-DA6-NH2,Amidation,H3N = amine,Linear,L,None,26,Antibacterial,1.2 ± 1.8 % Hemolysis at 10 µM,Human,Frog Pachymedusa Dacnicolor,"phosphate buffer = Random coil, POPG = α-Helix",Non-hemolytic,CCSSHHHHCCCCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
9537,30325956,2018,GVWGIAKIAGKVLGNILPHVFSSNQS,GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Carboxyl (COO-)},DMS-DA6-OH,Carboxyl (COO-),H3N = amine,Linear,L,None,26,Antibacterial,7.4 ± 5.5 % Hemolysis at 50 µM,Human,Frog Pachymedusa Dacnicolor,"phosphate buffer = Random coil, POPG = α-Helix",NA,CCBSSTTTTSGGGGSBC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
9538,30325956,2018,GVWGIAKIAGKVLGNILPHVFSSNQS,GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Amid},DMS-DA6-NH2,Amidation,H3N = amine,Linear,L,None,26,Antibacterial,3.7 ± 3.3 % Hemolysis at 50 µM,Human,Frog Pachymedusa Dacnicolor,"phosphate buffer = Random coil, POPG = α-Helix",Low hemolytic,CTTTCCCSCCCCCCSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
9539,30325956,2018,GVWGIAKIAGKVLGNILPHVFSSNQS,GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Carboxyl (COO-)},DMS-DA6-OH,Carboxyl (COO-),H3N = amine,Linear,L,None,26,Antibacterial,0 ± 2.8 % Hemolysis at 10 µM,Mouse,Frog Pachymedusa Dacnicolor,"phosphate buffer = Random coil, POPG = α-Helix",Non-hemolytic,CCSCCTTTHHHHHHHTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
9540,30325956,2018,GVWGIAKIAGKVLGNILPHVFSSNQS,GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Amid},DMS-DA6-NH2,Amidation,H3N = amine,Linear,L,None,26,Antibacterial,0 ± 1.1 % Hemolysis at 10 µM,Mouse,Frog Pachymedusa Dacnicolor,"phosphate buffer = Random coil, POPG = α-Helix",Non-hemolytic,CTTTHHHHHHHHSCSSCSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
9541,30325956,2018,GVWGIAKIAGKVLGNILPHVFSSNQS,GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Carboxyl (COO-)},DMS-DA6-OH,Carboxyl (COO-),H3N = amine,Linear,L,None,26,Antibacterial,5.4 ± 3.5 % Hemolysis at 50 µM,Mouse,Frog Pachymedusa Dacnicolor,"phosphate buffer = Random coil, POPG = α-Helix",NA,CCCCCCSCCCHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
9542,30325956,2018,GVWGIAKIAGKVLGNILPHVFSSNQS,GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Amid},DMS-DA6-NH2,Amidation,H3N = amine,Linear,L,None,26,Antibacterial,4.7 ± 5.6 % Hemolysis at 50 µM,Mouse,Frog Pachymedusa Dacnicolor,"phosphate buffer = Random coil, POPG = α-Helix",NA,CCCCTHHHHGGGHHHHHCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
9543,30365554,2018,FLRSLLRGAKAIYRGARAGWRG,FLRSLLRGAKAIYRGARAGWRG,dicentracin-like,Free,Free,Linear,L,None,22,Antibacterial,50 % Hemolysis at 2.34 μg/ml,Human,Fish Barramundi (Lates Calcarifer),α-Helix,NA,CCCCSCSSHHHHTCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
9544,30365554,2018,FLRSLLRGAKAIYRGARAGWRG,FLRSLLRGAKAIYRGARAGWRG,dicentracin-like,Free,Free,Linear,L,None,22,Antibacterial,<100 % Hemolysis at 75 μg/ml,Human,Fish Barramundi (Lates Calcarifer),α-Helix,NA,CCCCCSSCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
9545,30365554,2018,FFHHIFRGIVHVGKTIHRLVTG,FFHHIFRGIVHVGKTIHRLVTG,moronecidin,Free,Free,Linear,L,None,22,Antibacterial,50 % Hemolysis at 57 μg/ml,Human,Fish Striped Bass (Morone Saxatilis),α-Helix,NA,CCSSHHHHCCCCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
9548,30121851,2018,FIKIFHHIFKGNPKFSIIK,FIKIFHHIFKGNPKFSIIK,FK19,Free,Free,Linear,L,None,19,Antibacterial,0 % Hemolysis at 5 µM,Human,Fish (Sepia Ofcinalis),70%TFE = α-Helix,Non-hemolytic,CCSCCTTTHHHHHHHTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
9549,30121851,2018,KIRFTRTVSRLLKAALAST,KIRFTRTVSRLLKAALAST,KT19,Free,Free,Linear,L,None,19,Antibacterial,0 % Hemolysis at 5 µM,Human,Fish (Sepia Ofcinalis),70%TFE = α-Helix,Non-hemolytic,CTTTHHHHHHHHSCSSCSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O
9552,30121851,2018,VILTRFRFLNRIVEPLLKKA,VILTRFRFLNRIVEPLLKKA,VA20,Free,Free,Linear,L,None,20,Antibacterial,0 % Hemolysis at 5 µM,Human,Fish (Sepia Ofcinalis),ɑ-Helix,Non-hemolytic,CCCCSCSSHHHHTCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C
9553,30121851,2018,GSTSFHLIYNKWFAVKRRRKR,GSTSFHLIYNKWFAVKRRRKR,GR21,Free,Free,Linear,L,None,21,Antibacterial,0 % Hemolysis at 5 µM,Human,Fish (Sepia Ofcinalis),70%TFE = α-Helix,Non-hemolytic,CCCCCSSCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
9554,30121851,2018,FFHHIFDPQIKSGLLVSMYD,FFHHIFDPQIKSGLLVSMYD,FD20,Free,Free,Linear,L,None,20,Antibacterial,0 % Hemolysis at 5 µM,Human,Fish (Sepia Ofcinalis),NA,Non-hemolytic,CCSSHHHHCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C
9557,30121851,2018,FIKIFHHIFKGNPKFSIIK,FIKIFHHIFKGNPKFSIIK,FK19,Free,Free,Linear,L,None,19,Antibacterial,44.03 % Hemolysis at 50 µM,Human,Fish (Sepia Ofcinalis),70%TFE = α-Helix,NA,CCSCCTTTHHHHHHHTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
9558,30121851,2018,KIRFTRTVSRLLKAALAST,KIRFTRTVSRLLKAALAST,KT19,Free,Free,Linear,L,None,19,Antibacterial,0 % Hemolysis at 50 µM,Human,Fish (Sepia Ofcinalis),70%TFE = α-Helix,Non-hemolytic,CTTTHHHHHHHHSCSSCSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O
9561,30121851,2018,VILTRFRFLNRIVEPLLKKA,VILTRFRFLNRIVEPLLKKA,VA20,Free,Free,Linear,L,None,20,Antibacterial,10.79 % Hemolysis at 50 µM,Human,Fish (Sepia Ofcinalis),ɑ-Helix,NA,CCCCSCSSHHHHTCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C
9562,30121851,2018,GSTSFHLIYNKWFAVKRRRKR,GSTSFHLIYNKWFAVKRRRKR,GR21,Free,Free,Linear,L,None,21,Antibacterial,3.76 % Hemolysis at 50 µM,Human,Fish (Sepia Ofcinalis),70%TFE = α-Helix,NA,CCCCCSSCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
9563,30121851,2018,FFHHIFDPQIKSGLLVSMYD,FFHHIFDPQIKSGLLVSMYD,FD20,Free,Free,Linear,L,None,20,Antibacterial,0 % Hemolysis at 50 µM,Human,Fish (Sepia Ofcinalis),NA,Non-hemolytic,CCSSHHHHCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C
9566,30121851,2018,FIKIFHHIFKGNPKFSIIK,FIKIFHHIFKGNPKFSIIK,FK19,Free,Free,Linear,L,None,19,Antibacterial,63.35 % Hemolysis at 100 µM,Human,Fish (Sepia Ofcinalis),70%TFE = α-Helix,NA,CCSCCTTTHHHHHHHTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
9567,30121851,2018,KIRFTRTVSRLLKAALAST,KIRFTRTVSRLLKAALAST,KT19,Free,Free,Linear,L,None,19,Antibacterial,7.78 % Hemolysis at 100 µM,Human,Fish (Sepia Ofcinalis),70%TFE = α-Helix,NA,CTTTHHHHHHHHSCSSCSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O
9570,30121851,2018,VILTRFRFLNRIVEPLLKKA,VILTRFRFLNRIVEPLLKKA,VA20,Free,Free,Linear,L,None,20,Antibacterial,25.34 % Hemolysis at 100 µM,Human,Fish (Sepia Ofcinalis),ɑ-Helix,NA,CCCCSCSSHHHHTCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C
9571,30121851,2018,GSTSFHLIYNKWFAVKRRRKR,GSTSFHLIYNKWFAVKRRRKR,GR21,Free,Free,Linear,L,None,21,Antibacterial,7.15 % Hemolysis at 100 µM,Human,Fish (Sepia Ofcinalis),70%TFE = α-Helix,NA,CCCCCSSCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
9572,30121851,2018,FFHHIFDPQIKSGLLVSMYD,FFHHIFDPQIKSGLLVSMYD,FD20,Free,Free,Linear,L,None,20,Antibacterial,0 % Hemolysis at 100 µM,Human,Fish (Sepia Ofcinalis),NA,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C
9575,30121851,2018,FIKIFHHIFKGNPKFSIIK,FIKIFHHIFKGNPKFSIIK,FK19,Free,Free,Linear,L,None,19,Antibacterial,66.49 % Hemolysis at 200 µM,Human,Fish (Sepia Ofcinalis),70%TFE = α-Helix,NA,CCSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
9576,30121851,2018,KIRFTRTVSRLLKAALAST,KIRFTRTVSRLLKAALAST,KT19,Free,Free,Linear,L,None,19,Antibacterial,21.58 % Hemolysis at 200 µM,Human,Fish (Sepia Ofcinalis),70%TFE = α-Helix,NA,CCSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O
9579,30121851,2018,VILTRFRFLNRIVEPLLKKA,VILTRFRFLNRIVEPLLKKA,VA20,Free,Free,Linear,L,None,20,Antibacterial,42 % Hemolysis at 200 µM,Human,Fish (Sepia Ofcinalis),ɑ-Helix,NA,CCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C
9580,30121851,2018,GSTSFHLIYNKWFAVKRRRKR,GSTSFHLIYNKWFAVKRRRKR,GR21,Free,Free,Linear,L,None,21,Antibacterial,8.5 % Hemolysis at 200 µM,Human,Fish (Sepia Ofcinalis),70%TFE = α-Helix,NA,CCCCSSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
9581,30121851,2018,FFHHIFDPQIKSGLLVSMYD,FFHHIFDPQIKSGLLVSMYD,FD20,Free,Free,Linear,L,None,20,Antibacterial,9.2 % Hemolysis at 200 µM,Human,Fish (Sepia Ofcinalis),NA,NA,CTTSGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C
9584,30325566,2018,TELLVDLL,TELLVDLL{nt:Amid}{ct:Amid},SP1,Amidation,Amidation,Linear,L,None,8,Antibacterial,0 % Hemolysis at 100 µM,Human,Synthetic Peptide,NA,Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)O
9585,30325566,2018,SELLVDLL,SELLVDLL{nt:Amid}{ct:Amid},SP2,Amidation,Amidation,Linear,L,None,8,Antibacterial,0 % Hemolysis at 100 µM,Human,Synthetic Peptide,NA,Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CO)C(C)C)C(=O)O
9586,30325566,2018,EELLVDLL,EELLVDLL{nt:Amid}{ct:Amid},SP3,Amidation,Amidation,Linear,L,None,8,Antibacterial,0 % Hemolysis at 100 µM,Human,Synthetic Peptide,NA,Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(C)C)C(=O)O
9587,30325566,2018,TCELLVDLLC,TCELLVDLLC{nt:Amid}{ct:Amid},SP4,Amidation,Amidation,Linear,L,None,8,Antibacterial,0 % Hemolysis at 100 µM,Human,Synthetic Peptide,NA,Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CS)C(=O)O
9588,30325566,2018,DDDELLVDLL,DDDELLVDLL{nt:CH3-(CH2)16-(CO)-NH = fatty acid chain}{ct:Amid},LP5,Amidation,CH3-(CH2)16-(CO)-NH = fatty acid chain,Linear,L,CH3-(CH2)16-(CO)-NH = N-Terminal fatty acid chain,10,Antibacterial,0 % Hemolysis at 100 µM,Human,Synthetic Lipopeptide,NA,Non-hemolytic,NA,NA
9589,30325566,2018,HHHELLVDLL,HHHELLVDLL{nt:CH3-(CH2)16-(CO)-NH = fatty acid chain}{ct:Amid},LP6,Amidation,CH3-(CH2)16-(CO)-NH = fatty acid chain,Linear,L,CH3-(CH2)16-(CO)-NH = N-Terminal fatty acid chain,10,Antibacterial,0 % Hemolysis at 100 µM,Human,Synthetic Lipopeptide,NA,Non-hemolytic,NA,NA
9590,30325566,2018,RRRELLVDLL,RRRELLVDLL{nt:CH3-(CH2)16-(CO)-NH = fatty acid chain}{ct:Amid},LP7,Amidation,CH3-(CH2)16-(CO)-NH = fatty acid chain,Linear,L,CH3-(CH2)16-(CO)-NH = N-Terminal fatty acid chain,10,Antibacterial,0 % Hemolysis at 100 µM,Human,Synthetic Lipopeptide,NA,Non-hemolytic,NA,NA
9591,30325566,2018,YYYELLVDLL,YYYELLVDLL{nt:CH3-(CH2)16-(CO)-NH = fatty acid chain}{ct:Amid},LP8,Amidation,CH3-(CH2)16-(CO)-NH = fatty acid chain,Linear,L,CH3-(CH2)16-(CO)-NH = N-Terminal fatty acid chain,10,Antibacterial,high % Hemolysis at 100 µM,Human,Synthetic Lipopeptide,NA,NA,NA,NA
9593,30361948,2018,K*WKNle*K,K{nnr:*}WK{nnr:Nle}{nnr:*}K{ct:Amid},KKK,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,3 % Hemolysis at 50 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,Low hemolytic,NA,NA
9594,30361948,2018,R*WKNle*K,R{nnr:*}WK{nnr:Nle}{nnr:*}K{ct:Amid},RKK,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,4.3 % Hemolysis at 50 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,NA,NA,NA
9595,30361948,2018,K*WRNle*K,K{nnr:*}WR{nnr:Nle}{nnr:*}K{ct:Amid},KRK,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,2 % Hemolysis at 50 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,Low hemolytic,NA,NA
9596,30361948,2018,K*WKNle*R,K{nnr:*}WK{nnr:Nle}{nnr:*}R{ct:Amid},KKR,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,5.4 % Hemolysis at 50 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,NA,NA,NA
9597,30361948,2018,R*WRNle*K,R{nnr:*}WR{nnr:Nle}{nnr:*}K{ct:Amid},RRK,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,<1 % Hemolysis at 50 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,Non-hemolytic,NA,NA
9598,30361948,2018,R*WKNle*R,R{nnr:*}WK{nnr:Nle}{nnr:*}R{ct:Amid},RKR,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,17 % Hemolysis at 50 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,NA,NA,NA
9599,30361948,2018,K*WRNle*R,K{nnr:*}WR{nnr:Nle}{nnr:*}R{ct:Amid},KRR,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,5.6 % Hemolysis at 50 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,NA,NA,NA
9600,30361948,2018,R*WRNle*R,R{nnr:*}WR{nnr:Nle}{nnr:*}R{ct:Amid},RRR,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,3.2 % Hemolysis at 50 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,NA,NA,NA
9601,30361948,2018,K*WKNle*K,K{nnr:*}WK{nnr:Nle}{nnr:*}K{ct:Amid},KKK,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,1.5 % Hemolysis at 25 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,Low hemolytic,NA,NA
9602,30361948,2018,R*WKNle*K,R{nnr:*}WK{nnr:Nle}{nnr:*}K{ct:Amid},RKK,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,1.5 % Hemolysis at 25 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,Low hemolytic,NA,NA
9603,30361948,2018,K*WRNle*K,K{nnr:*}WR{nnr:Nle}{nnr:*}K{ct:Amid},KRK,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,< 1 % Hemolysis at 25 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,Non-hemolytic,NA,NA
9604,30361948,2018,K*WKNle*R,K{nnr:*}WK{nnr:Nle}{nnr:*}R{ct:Amid},KKR,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,1.4 % Hemolysis at 25 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,Low hemolytic,NA,NA
9605,30361948,2018,R*WRNle*K,R{nnr:*}WR{nnr:Nle}{nnr:*}K{ct:Amid},RRK,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,< 1 % Hemolysis at 25 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,Non-hemolytic,NA,NA
9606,30361948,2018,R*WKNle*R,R{nnr:*}WK{nnr:Nle}{nnr:*}R{ct:Amid},RKR,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,8.2 % Hemolysis at 25 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,NA,NA,NA
9607,30361948,2018,K*WRNle*R,K{nnr:*}WR{nnr:Nle}{nnr:*}R{ct:Amid},KRR,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,1.8 % Hemolysis at 25 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,Low hemolytic,NA,NA
9608,30361948,2018,R*WRNle*R,R{nnr:*}WR{nnr:Nle}{nnr:*}R{ct:Amid},RRR,Amidation,Free,Linear,Mix,"Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site",7,Antibacterial,< 1 % Hemolysis at 25 µM,Human,Synthetic Stapled Heptapeptides,ɑ-Helix,Non-hemolytic,NA,NA
9609,30409520,2018,RRRR,RRRR{nt:C16 - palmitic acid}{ct:Amid},C16-4R,Amidation,C16 - palmitic acid,Linear,L,C16 = palmitic acid,4,"Antifungal, Antibacterial",6.3 % Hemolysis at 32 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,NA,CCCC,NA
9610,30409520,2018,RRRR,RRRR{nt:C16 - palmitic acid}{ct:Amid},C16-4R,Amidation,C16 - palmitic acid,Linear,L,C16 = palmitic acid,4,"Antifungal, Antibacterial",36.1 % Hemolysis at 64 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,NA,CCCC,NA
9611,30409520,2018,RRRR,RRRR{nt:C16 - palmitic acid}{ct:Amid},C16-4R,Amidation,C16 - palmitic acid,Linear,L,C16 = palmitic acid,4,"Antifungal, Antibacterial",82.8 % Hemolysis at 128 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,NA,CCCC,NA
9612,30409520,2018,RRRR,RRRR{nt:C16 - palmitic acid}{ct:Amid},C16-4R,Amidation,C16 - palmitic acid,Linear,L,C16 = palmitic acid,4,"Antifungal, Antibacterial",96.4 % Hemolysis at 256 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,NA,CCCC,NA
9613,30409520,2018,RRRR,RRRR{nt:C16 - palmitic acid}{ct:Amid},C16-4R,Amidation,C16 - palmitic acid,Linear,L,C16 = palmitic acid,4,"Antifungal, Antibacterial",100 % Hemolysis at 512 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,NA,CCCC,NA
9614,30409520,2018,RRRR,RRRR{nt:C14 - myristic acid}{ct:Amid},C14-4R,Amidation,C14 - myristic acid,Linear,L,C14 = myristic acid,4,"Antifungal, Antibacterial",0 % Hemolysis at 32 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,Non-hemolytic,CTTC,NA
9615,30409520,2018,RRRR,RRRR{nt:C14 - myristic acid}{ct:Amid},C14-4R,Amidation,C14 - myristic acid,Linear,L,C14 = myristic acid,4,"Antifungal, Antibacterial",0 % Hemolysis at 64 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,Non-hemolytic,CTTC,NA
9616,30409520,2018,RRRR,RRRR{nt:C14 - myristic acid}{ct:Amid},C14-4R,Amidation,C14 - myristic acid,Linear,L,C14 = myristic acid,4,"Antifungal, Antibacterial",3.6 % Hemolysis at 128 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,NA,CTTC,NA
9617,30409520,2018,RRRR,RRRR{nt:C14 - myristic acid}{ct:Amid},C14-4R,Amidation,C14 - myristic acid,Linear,L,C14 = myristic acid,4,"Antifungal, Antibacterial",18.6 % Hemolysis at 256 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,NA,CTTC,NA
9618,30409520,2018,RRRR,RRRR{nt:C14 - myristic acid}{ct:Amid},C14-4R,Amidation,C14 - myristic acid,Linear,L,C14 = myristic acid,4,"Antifungal, Antibacterial",63.7 % Hemolysis at 512 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,NA,CTTC,NA
9619,30409520,2018,RRRR,RRRR{nt:C12 - lauric acid}{ct:Amid},C12-4R,Amidation,C12 - lauric acid,Linear,L,C12 = lauric acid,4,"Antifungal, Antibacterial",0 % Hemolysis at 32 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,Non-hemolytic,CTTC,NA
9620,30409520,2018,RRRR,RRRR{nt:C12 - lauric acid}{ct:Amid},C12-4R,Amidation,C12 - lauric acid,Linear,L,C12 = lauric acid,4,"Antifungal, Antibacterial",0 % Hemolysis at 64 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,Non-hemolytic,NA,NA
9621,30409520,2018,RRRR,RRRR{nt:C12 - lauric acid}{ct:Amid},C12-4R,Amidation,C12 - lauric acid,Linear,L,C12 = lauric acid,4,"Antifungal, Antibacterial",0 % Hemolysis at 128 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,Non-hemolytic,CTTTTTHHHHHCC,NA
9622,30409520,2018,RRRR,RRRR{nt:C12 - lauric acid}{ct:Amid},C12-4R,Amidation,C12 - lauric acid,Linear,L,C12 = lauric acid,4,"Antifungal, Antibacterial",0 % Hemolysis at 256 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,Non-hemolytic,CHHHHHHHSGGGTGGGGTCC,NA
9623,30409520,2018,RRRR,RRRR{nt:C12 - lauric acid}{ct:Amid},C12-4R,Amidation,C12 - lauric acid,Linear,L,C12 = lauric acid,4,"Antifungal, Antibacterial",0 % Hemolysis at 512 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,Non-hemolytic,CCSSSSCCHHHHHHHHHHHHHHHHHSTTTTHHHHCCC,NA
9624,30409520,2018,PRRR,PRRR{nt:C16 - palmitic acid}{ct:Amid},C16-P3R,Amidation,C16 - palmitic acid,Linear,L,C16 = palmitic acid,4,"Antifungal, Antibacterial",0 % Hemolysis at 14 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,Non-hemolytic,CCTHHHHHHHHHHHHHHHHHHHHHHHHSCC,NA
9625,30409520,2018,PRRR,PRRR{nt:C16 - palmitic acid}{ct:Amid},C16-P3R,Amidation,C16 - palmitic acid,Linear,L,C16 = palmitic acid,4,"Antifungal, Antibacterial",12.6 % Hemolysis at 30 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,NA,CCSCCCCSTTSCSSCCTTSSCSSCCCSCC,NA
9626,30409520,2018,PRRR,PRRR{nt:C16 - palmitic acid}{ct:Amid},C16-P3R,Amidation,C16 - palmitic acid,Linear,L,C16 = palmitic acid,4,"Antifungal, Antibacterial",57.6 % Hemolysis at 60 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,NA,CCCCSSCTTSSTTCSSTTCCSSSSSCCCC,NA
9627,30409520,2018,PRRR,PRRR{nt:C16 - palmitic acid}{ct:Amid},C16-P3R,Amidation,C16 - palmitic acid,Linear,L,C16 = palmitic acid,4,"Antifungal, Antibacterial",91 % Hemolysis at 128 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,NA,CCCCCSCSCTTTTCCCCCCCCCCCCCCCC,NA
9628,30409520,2018,PRRR,PRRR{nt:C16 - palmitic acid}{ct:Amid},C16-P3R,Amidation,C16 - palmitic acid,Linear,L,C16 = palmitic acid,4,"Antifungal, Antibacterial",97.1 % Hemolysis at 256 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,NA,CCSSTHHHHHHHHHCC,NA
9629,30409520,2018,PRRR,PRRR{nt:C16 - palmitic acid}{ct:Amid},C16-P3R,Amidation,C16 - palmitic acid,Linear,L,C16 = palmitic acid,4,"Antifungal, Antibacterial",100 % Hemolysis at 512 μg/ml,Human,Synthetic Arginine-Rich Lipopeptides,NA,NA,CCCSSCCSTTCC,NA
9630,30423858,2018,DEMKLDGFNMHLE,DEMKLDGFNMHLE{ct:Amid},P1-Ll-1577,Amidation,Free,Linear,L,None,13,Antibacterial,12 % Hemolysis at 320 µM,Human,Frog Leptodactylus Latrans,Random coil,NA,CCCCSSGGGTCC,CSCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O
9631,30423858,2018,AAGKGLVSNLLEK,AAGKGLVSNLLEK{ct:Amid},P2-Ll-1298,Amidation,Free,Linear,L,None,13,Antibacterial,100 % Hemolysis at 320 µM,Human,Frog Leptodactylus Latrans,TFE = ɑ-Helix,NA,CCTHHHHSCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
9632,30423858,2018,GLLDFLKAAGKGLVSNLLEK,GLLDFLKAAGKGLVSNLLEK{ct:Amid},P3-Ll-2085,Amidation,Free,Linear,L,None,20,Antibacterial,100 % Hemolysis at 40 µM,Human,Frog Leptodactylus Latrans,TFE = ɑ-Helix,NA,CCCCCCSCCC,CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
9633,30462698,2018,HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK,HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK,PACAP38,Free,Free,Linear,L,None,38,Antibacterial,0 % Hemolysis at 45 μg/ml,Human,Human,α-Helix,Non-hemolytic,CCCCCSCCSSSSCCCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
9634,30462698,2018,SYSRYRKQMAVKKYLAAVLGKRYKQRVKNK,SYSRYRKQMAVKKYLAAVLGKRYKQRVKNK,PACAP(9–38),Free,Free,Linear,L,None,30,Antibacterial,0 % Hemolysis at 45 μg/ml,Human,Human,α-Helix,Non-hemolytic,CHHHHHHHHHTTTTSSSCCCC,CSCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C
9638,30538681,2018,IHKFWRCRRRFCRWFKHI,IHKFWRCRRRFCRWFKHI{ct:Amid},PQ,Amidation,Free,Linear,L,None,18,Antibacterial,<5 % Hemolysis at 128 µM,Human,Synthetic Designs Amps,"10 mM PBS = unordered, 30 mM SDS and 50% TFE = α-Helix",Low hemolytic,CHHHHHHHHHTTTTSSSCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)O)[C@@H](C)CC
9639,30538681,2018,IHKFWRPGRWFKHI,IHKFWRPGRWFKHI{ct:Amid},PP,Amidation,Free,Linear,L,None,14,Antibacterial,<5 % Hemolysis at 128 µM,Human,Synthetic Designs Amps,"10 mM PBS = unordered, 30 mM SDS and 50% TFE = α-Helix",Low hemolytic,CHHHHHHHHHTTTTSSSCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)O)[C@@H](C)CC
9640,30538681,2018,IHKFWRGGRWFKHI,IHKFWRGGRWFKHI{ct:Amid},GG,Amidation,Free,Linear,L,None,14,Antibacterial,<5 % Hemolysis at 128 µM,Human,Synthetic Designs Amps,"10 mM PBS = unordered, 30 mM SDS and 50% TFE = α-Helix",Low hemolytic,CHHHHHHHHHTTTTSSSCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)O)[C@@H](C)CC
9641,30538681,2018,IHKFWRRWFKHI,IHKFWRRWFKHI{ct:Amid},Qa,Amidation,Free,Linear,L,None,12,Antibacterial,<5 % Hemolysis at 128 µM,Human,Synthetic Designs Amps,α-Helix,Low hemolytic,CHHHHHHHHHTTTTSSSCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)O)[C@@H](C)CC
9642,30538681,2018,IHFKWRRWKFHI,IHFKWRRWKFHI{ct:Amid},Qna,Amidation,Free,Linear,L,None,12,Antibacterial,<5 % Hemolysis at 128 µM,Human,Synthetic Designs Amps,unordered,Low hemolytic,CHHHHIIIIITTCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)O)[C@@H](C)CC
9643,30538681,2018,RGGRLCYCRRRFCVCVGR,RGGRLCYCRRRFCVCVGR{ct:Amid},PG-1,Amidation,Free,Linear,L,None,18,Antibacterial,<5 % Hemolysis at 128 µM,Human,Synthetic Designs Amps,β-Hairpin,Low hemolytic,CHHHHIIIIITTCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
9644,30555431,2018,GLLSGILGAGKKIVCGLSGLC,GLLSGILGAGKKIVCGLSGLC,Nigrocin-HL,Free,Free,Linear,L,None,21,Antibacterial,0 % Hemolysis at 2 µM,Horse,Frog Hylarana Latouchii,α-Helix,Non-hemolytic,CHHHHIIIIITTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC
9645,30555431,2018,GLLSGILGAGKKIVCGLSGLC,GLLSGILGAGKKIVCGLSGLC,Nigrocin-HL,Free,Free,Linear,L,None,21,Antibacterial,1 % Hemolysis at 4 µM,Horse,Frog Hylarana Latouchii,α-Helix,Non-hemolytic,CHHHHIIIIITTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC
9646,30555431,2018,GLLSGILGAGKKIVCGLSGLC,GLLSGILGAGKKIVCGLSGLC,Nigrocin-HL,Free,Free,Linear,L,None,21,Antibacterial,18.72 % Hemolysis at 16 µM,Horse,Frog Hylarana Latouchii,α-Helix,NA,CHHHHIIIIITTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC
9647,30555431,2018,GLLSGILGAGKKIVCGLSGLC,GLLSGILGAGKKIVCGLSGLC,Nigrocin-HL,Free,Free,Linear,L,None,21,Antibacterial,32 % Hemolysis at 32 µM,Horse,Frog Hylarana Latouchii,α-Helix,NA,CHHHHIIIIITTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC
9648,30555431,2018,GLLSGILGAGKKIVCGLSGLC,GLLSGILGAGKKIVCGLSGLC,Nigrocin-HL,Free,Free,Linear,L,None,21,Antibacterial,43 % Hemolysis at 64 µM,Horse,Frog Hylarana Latouchii,α-Helix,NA,CHHHHIIIIITTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC
9649,30555431,2018,GLLSGILGAGKKIVCGLSGLC,GLLSGILGAGKKIVCGLSGLC,Nigrocin-HL,Free,Free,Linear,L,None,21,Antibacterial,67 % Hemolysis at 128 µM,Horse,Frog Hylarana Latouchii,α-Helix,NA,CHHHHIIIIITTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC
9650,30555431,2018,GLLSGILGAGKKIVCGLSGLC,GLLSGILGAGKKIVCGLSGLC,Nigrocin-HL,Free,Free,Linear,L,None,21,Antibacterial,76 % Hemolysis at 256 µM,Horse,Frog Hylarana Latouchii,α-Helix,NA,CCCSSSCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC
9651,30555431,2018,GLLSGILGAGKKIVCGLSGLC,GLLSGILGAGKKIVCGLSGLC,Nigrocin-HL,Free,Free,Linear,L,None,21,Antibacterial,85 % Hemolysis at 512 µM,Horse,Frog Hylarana Latouchii,α-Helix,NA,CCCCCCCSCCSCCCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC
9652,30555431,2018,GLLSGILGAGKKIVF,GLLSGILGAGKKIVF{ct:Amid},Nigrocin-HLM,Amidation,Free,Linear,L,None,15,Antibacterial,0 % Hemolysis at 2 µM,Horse,Frog Hylarana Latouchii,α-Helix,Non-hemolytic,CCCCCCCCSCCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)CC
9653,30555431,2018,GLLSGILGAGKKIVF,GLLSGILGAGKKIVF{ct:Amid},Nigrocin-HLM,Amidation,Free,Linear,L,None,15,Antibacterial,0 % Hemolysis at 4 µM,Horse,Frog Hylarana Latouchii,α-Helix,Non-hemolytic,CCCSSCCCCCCSSSCSSSCSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)CC
9654,30555431,2018,GLLSGILGAGKKIVF,GLLSGILGAGKKIVF{ct:Amid},Nigrocin-HLM,Amidation,Free,Linear,L,None,15,Antibacterial,0 % Hemolysis at 16 µM,Horse,Frog Hylarana Latouchii,α-Helix,Non-hemolytic,CCCCCCHHHHHHHHSCSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)CC
9655,30555431,2018,GLLSGILGAGKKIVF,GLLSGILGAGKKIVF{ct:Amid},Nigrocin-HLM,Amidation,Free,Linear,L,None,15,Antibacterial,0 % Hemolysis at 32 µM,Horse,Frog Hylarana Latouchii,α-Helix,Non-hemolytic,CCTTTCCCCGGGGTSCSSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)CC
9656,30555431,2018,GLLSGILGAGKKIVF,GLLSGILGAGKKIVF{ct:Amid},Nigrocin-HLM,Amidation,Free,Linear,L,None,15,Antibacterial,1 % Hemolysis at 64 µM,Horse,Frog Hylarana Latouchii,α-Helix,Non-hemolytic,CCCHHHHSSTTTCCSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)CC
9657,30555431,2018,GLLSGILGAGKKIVF,GLLSGILGAGKKIVF{ct:Amid},Nigrocin-HLM,Amidation,Free,Linear,L,None,15,Antibacterial,4 % Hemolysis at 128 µM,Horse,Frog Hylarana Latouchii,α-Helix,NA,CGGGTHHHHTHHHHTTTSCCCCCCCCCCBTTTTBCHHHHHHHHHHHHHHSCTTCCHHHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)CC
9658,30555431,2018,GLLSGILGAGKKIVF,GLLSGILGAGKKIVF{ct:Amid},Nigrocin-HLM,Amidation,Free,Linear,L,None,15,Antibacterial,11 % Hemolysis at 256 µM,Horse,Frog Hylarana Latouchii,α-Helix,NA,CGGGGGCSHHHHGGGTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)CC
9659,30555431,2018,GLLSGILGAGKKIVF,GLLSGILGAGKKIVF{ct:Amid},Nigrocin-HLM,Amidation,Free,Linear,L,None,15,Antibacterial,35 % Hemolysis at 512 µM,Horse,Frog Hylarana Latouchii,α-Helix,NA,CGGGGGCSHHHHGGGTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)CC
9660,30555984,2018,YYHFWHRGVTKR,YYHFWHRGVTKR,YR12,Free,Free,Linear,L,None,12,Antibacterial,~5 % Hemolysis at 100 µM,Human,Human Prodomain Of Human Furin,NA,Low hemolytic,CCSSSSSSSSSSSSCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
9661,30555984,2018,YYHFWHRGVTKRSLSPHRPR,YYHFWHRGVTKRSLSPHRPR,YR20,Free,Free,Linear,L,None,20,Antibacterial,~5 % Hemolysis at 100 µM,Human,Human Prodomain Of Human Furin,NA,Low hemolytic,CCSSSSSSSSSSSSCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
9662,30555984,2018,YYHFWHRGVTKRSLSPHRPRHSR,YYHFWHRGVTKRSLSPHRPRHSR,YR23,Free,Free,Linear,L,None,23,Antibacterial,~5 % Hemolysis at 100 µM,Human,Human Prodomain Of Human Furin,NA,Low hemolytic,CCSSHHHHHHHHSCCGGGC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
9663,30555984,2018,YYHFWHRGVTKRSLSPHRPRHSRLQR,YYHFWHRGVTKRSLSPHRPRHSRLQR,YR26,Free,Free,Linear,L,None,26,Antibacterial,~8 % Hemolysis at 100 µM,Human,Human Prodomain Of Human Furin,SDS micelle = Helix-Turn-Helix,NA,CCHHHHHHHHHHHIIIIITTCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
9664,30555984,2018,RKHGFLNLQGIFGDYYHFWHRGV,RKHGFLNLQGIFGDYYHFWHRGV,RV23,Free,Free,Linear,L,None,23,Antibacterial,48 % Hemolysis at 100 µM,Human,Human Prodomain Of Human Furin,NA,NA,CCHHHHTTHHHHGGGTTTGGGC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C
9668,30570384,2018,RKYVRFLHRWVKYFRAYL,RKYVRFLHRWVKYFRAYL,Adevonin,Free,Free,Linear,L,None,18,Antibacterial,0 % Hemolysis at 87.5 µM,Human,Plant Adenanthera Pavonina Designed From Apti,SDS = α-Helix,Non-hemolytic,CCSSSCCCCCCSCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)O
9669,30570384,2018,RKYVRFLHRWVKYFRAYL,RKYVRFLHRWVKYFRAYL,Adevonin,Free,Free,Linear,L,None,18,Antibacterial,>70 % Hemolysis at 175 µM,Human,Plant Adenanthera Pavonina Designed From Apti,SDS = α-Helix,NA,CCCHHHHHHHTCCSSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)O
9670,30563217,2018,VGTDFSGNDDISDVQK,VGTDFSGNDDISDVQK,Lg-AMP1,Free,Free,Linear,L,None,16,Antibacterial,0.1 % Hemolysis at 68.5 µM,Human,Spider Venom (Loxosceles Gaucho),α-Helix,Non-hemolytic,CCTHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
9671,30563217,2018,VGTDFSGNDDISDVQK,VGTDFSGNDDISDVQK,Lg-AMP1,Free,Free,Linear,L,None,16,Antibacterial,0.15 % Hemolysis at 137 µM,Human,Spider Venom (Loxosceles Gaucho),α-Helix,Non-hemolytic,CCCCHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
9672,35559296,2018,WFGHLYRGITKVVKHVHGLLKG,WFGHLYRGITKVVKHVHGLLKG,KS-Cnd,Free,Free,Linear,L,None,22,Antibacterial,10 % Hemolysis at 8 µM,Human,Fish Derived From Chionodracine(Chionodraco Hamatus),"aqueous = Random coil, POPC = α-Helix",NA,CCGGGGGHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
9673,35559296,2018,WFGKLYRGITSVVKKVKGLLSG,WFGKLYRGITSVVKKVKGLLSG,KH-Cnd,Free,Free,Linear,L,None,22,Antibacterial,10 % Hemolysis at 9 µM,Human,Fish Derived From Chionodracine(Chionodraco Hamatus),"aqueous = Random coil, POPC = α-Helix",NA,CCCCHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
9674,35559296,2018,WFGKLYRGITKVVKKVKGLLKG,WFGKLYRGITKVVKKVKGLLKG,KHS_Cnd,Free,Free,Linear,L,None,22,Antibacterial,10 % Hemolysis at 13 µM,Human,Fish Derived From Chionodracine(Chionodraco Hamatus),"aqueous = Random coil, POPC = α-Helix",NA,CCCSSHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
9679,29523276,2018,QVKGAKLWLSLMKWGGI,QVKGAKLWLSLMKWGGI,GIBIM-P1,Free,Free,Linear,L,None,17,Antibacterial,~20 % Hemolysis at 50 µM,Sheep,Synthetic Peptide,30% TFE = α-Helix,NA,CCCCCCCSCHHHHTSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(=O)O
9680,29523276,2018,GFLGKGLFSVVKGVLKG,GFLGKGLFSVVKGVLKG,GIBIM-P2,Free,Free,Linear,L,None,17,Antibacterial,~20 % Hemolysis at 50 µM,Sheep,Synthetic Peptide,30% TFE = α-Helix,NA,CCCCCCSTTHHHHHTCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)C(C)C)C(C)C)C(C)C
9681,29523276,2018,GFLGKGLFSVVKGVLKI,GFLGKGLFSVVKGVLKI,GIBIM-P2G17I,Free,Free,Linear,L,None,17,Antibacterial,~20 % Hemolysis at 50 µM,Sheep,Synthetic Peptide,30% TFE = α-Helix,NA,CCCSSSHHHHGGGCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(=O)O
9682,29523276,2018,GFLGKGLFSVVKGVLKL,GFLGKGLFSVVKGVLKL,GIBIM-P2G17L,Free,Free,Linear,L,None,17,Antibacterial,~20 % Hemolysis at 50 µM,Sheep,Synthetic Peptide,30% TFE = α-Helix,NA,CCSCCCHHHHHHHHCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(=O)O
9683,29523276,2018,GFLGKGLFSVVKNVLKG,GFLGKGLFSVVKNVLKG,GIBIM-P2G13N,Free,Free,Linear,L,None,17,Antibacterial,10 % Hemolysis at 50 µM,Sheep,Synthetic Peptide,30% TFE = α-Helix,NA,CCSCCSGGGGTTTTCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)C(C)C)C(C)C)C(C)C
9684,29523276,2018,NVAATARGWLKKLGKRI,NVAATARGWLKKLGKRI,GIBIM-P3,Free,Free,Linear,L,None,17,Antibacterial,~20 % Hemolysis at 50 µM,Sheep,Synthetic Peptide,30% TFE = α-Helix,NA,CCSSSCTHHHHTSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)O)C(=O)O
9685,29523276,2018,NVGATARGWLKKLGKRI,NVGATARGWLKKLGKRI,GIBIM-P3A3G,Free,Free,Linear,L,None,17,Antibacterial,~20 % Hemolysis at 50 µM,Sheep,Synthetic Peptide,30% TFE = α-Helix,NA,CCCCCGGGGTCSSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)O)C(=O)O
9686,29523276,2018,NVAASARGWLKKLGKRI,NVAASARGWLKKLGKRI,GIBIM-P3T5S,Free,Free,Linear,L,None,17,Antibacterial,~20 % Hemolysis at 50 µM,Sheep,Synthetic Peptide,30% TFE = α-Helix,NA,CCCSSGGGTSCSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)O
9687,29523276,2018,NVAATKRGWLKKLGKRI,NVAATKRGWLKKLGKRI,GIBIM-P3A6K,Free,Free,Linear,L,None,17,Antibacterial,~15 % Hemolysis at 50 µM,Sheep,Synthetic Peptide,30% TFE = α-Helix,NA,CCSSTTGGGHHHHSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)O)C(=O)O
9688,29523276,2018,ANVAATARGWLKKIGKK,ANVAATARGWLKKIGKK,GIBIM-P4,Free,Free,Linear,L,None,17,Antibacterial,~20 % Hemolysis at 50 µM,Sheep,Synthetic Peptide,30% TFE = α-Helix,NA,CGGGGTTTGGGGGTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
9689,29523276,2018,INVAATARGWLKKIGKK,INVAATARGWLKKIGKK,GIBIM-P4A1I,Free,Free,Linear,L,None,17,Antibacterial,~20 % Hemolysis at 50 µM,Sheep,Synthetic Peptide,30% TFE = α-Helix,NA,CCCCCGGGGTCSSCSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
9690,29523276,2018,VNVAATARGWLKKIGKK,VNVAATARGWLKKIGKK,GIBIM-P4A1V,Free,Free,Linear,L,None,17,Antibacterial,11 % Hemolysis at 50 µM,Sheep,Synthetic Peptide,30% TFE = α-Helix,NA,CCCSSGGGTSCSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
9691,29523276,2018,AFVAATARGWLKKIGKK,AFVAATARGWLKKIGKK,GIBIM-P4N2F,Free,Free,Linear,L,None,17,Antibacterial,31 % Hemolysis at 50 µM,Sheep,Synthetic Peptide,30% TFE = α-Helix,NA,CCSSTTGGGHHHHSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
9692,29523276,2018,ATKKCGLFSILKGVGKI,ATKKCGLFSILKGVGKI,GIBIM-P5,Free,Free,Linear,L,None,17,Antibacterial,25 % Hemolysis at 50 µM,Sheep,Synthetic Peptide,30% TFE = α-Helix,NA,CGGGGTTTGGGGGTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(=O)O
9693,29523276,2018,AKKKCGLFSILKGVGKI,AKKKCGLFSILKGVGKI,GIBIM-P5T2K,Free,Free,Linear,L,None,17,Antibacterial,~20 % Hemolysis at 50 µM,Sheep,Synthetic Peptide,30% TFE = α-Helix,NA,CCTTTGGGGGCCSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)[C@@H](C)CC)C(C)C)C(=O)O
9694,29523276,2018,ATKKCGLFKILKGVGKI,ATKKCGLFKILKGVGKI,GIBIM-P5S9K,Free,Free,Linear,L,None,17,Antibacterial,30 % Hemolysis at 50 µM,Sheep,Synthetic Peptide,30% TFE = α-Helix,NA,CCCGGGGGCSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(=O)O
9706,30176540,2019,AKRHHGYKRKFH,AKRHHGYKRKFH{nt:Acet}{ct:Amid},P-113,Amidation,Acetylation,Linear,L,None,12,Antibacterial,0 % Hemolysis at 25 μg/ml,Human,Human Fragment Of The Saliva Protein Histatin 5,NA,Non-hemolytic,NA,C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
9711,30393205,2019,LLWIALRKK,LLWIALRKK{ct:Amid},CopW,Amidation,Free,Linear,L,None,9,Antibacterial,0.08 ± 0.04 % Hemolysis at 100 µM,Human,Derived From Coprisin Dung Beetle Copris Tripartitus,NA,Non-hemolytic,CCCBTTTBSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
9712,30393205,2019,LLWIALRKK(C10:0),LLWIALRKK{conj:C10:0}{ct:Amid},CopW3,Amidation,Free,Linear,L,C10 = decanoic acid,9,Antibacterial,11.84 ± 0.46 % Hemolysis at 100 µM,Human,Synthetic Copw With Fatty Acid-Conjugated,NA,NA,NA,NA
9713,30393205,2019,llwialrkk,L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{ct:Amid},dCopW,Amidation,Free,Linear,D,None,9,Antibacterial,2.32 ± 0.78 % Hemolysis at 100 µM,Human,Synthetic Copw With D-Amino,NA,Non-hemolytic,CCCBTTTBSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
9714,30393205,2019,llwialrkk(C6:0),L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C6:0}{ct:Amid},dCopW1,Amidation,Free,Linear,D,C6 = hexanoic acid,9,Antibacterial,0.39 ± 0.66 % Hemolysis at 100 µM,Human,Synthetic Copw With Fatty Acid-Conjugated,NA,Non-hemolytic,NA,NA
9715,30393205,2019,llwialrkk(C8:0),L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C8:0}{ct:Amid},dCopW2,Amidation,Free,Linear,D,C8 = Octanoic Acid,9,Antibacterial,0.68 ± 0.47 % Hemolysis at 100 µM,Human,Synthetic Copw With Fatty Acid-Conjugated,NA,Non-hemolytic,NA,NA
9716,30393205,2019,llwialrkk(C10:0),L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C10:0}{ct:Amid},dCopW3,Amidation,Free,Linear,D,C10 = decanoic acid,9,Antibacterial,3.66 ± 0.39 % Hemolysis at 100 µM,Human,Synthetic Copw With Fatty Acid-Conjugated,NA,Non-hemolytic,NA,NA
9717,30393205,2019,llwialrkk(C12:0),L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C12:0}{ct:Amid},dCopW4,Amidation,Free,Linear,D,C12 = Dodecanoic Acid,9,Antibacterial,7.10 ± 0.32 % Hemolysis at 100 µM,Human,Synthetic Copw With Fatty Acid-Conjugated,NA,NA,NA,NA
9718,30393205,2019,llwialrkk(C14:0),L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C14:0}{ct:Amid},dCopW5,Amidation,Free,Linear,D,C14 = Tetradecanoic Acid,9,Antibacterial,8.36 ± 0.26 % Hemolysis at 100 µM,Human,Synthetic Copw With Fatty Acid-Conjugated,NA,NA,NA,NA
9719,30393205,2019,llwialrkk(C16:0),L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C16:0}{ct:Amid},dCopW6,Amidation,Free,Linear,D,C16 = hexadecanoic acid,9,Antibacterial,11.67 ± 0.55 % Hemolysis at 100 µM,Human,Synthetic Copw With Fatty Acid-Conjugated,NA,NA,NA,NA
9720,30393205,2019,k(C10:0)krlaiwll,K{d}{conj:C10:0}K{d}R{d}L{d}A{d}I{d}W{d}L{d}L{d}{ct:Amid},Retro-dCopW3,Amidation,Free,Linear,D,C10 = decanoic acid,9,Antibacterial,20.88 ± 1.15 % Hemolysis at 100 µM,Human,Synthetic Copw With Fatty Acid-Conjugated,NA,NA,NA,NA
9725,34377965,2019,klLsllLtlsLakaaklLtllLalsL,K{d}L{d}LS{d}L{d}L{d}LT{d}L{d}S{d}LA{d}K{d}A{d}A{d}K{d}L{d}LT{d}L{d}L{d}LA{d}L{d}S{d}L{nt:Acet}{ct:Amid},D84 (Lys1-6 Lys-1),Amidation,Acetylation,Linear,Mix,None,26,Antibacterial,50 % Hemolysis at 54.3 µM,Human,Synthetic Cationic Antimicrobial Peptides,"aqueous = α-Helix, 50%TFE = α-Helix",NA,CGGGGGGHHHHTTSCCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(=O)O
9726,34377965,2019,klDabsllDabtlsDabakaaklDabtllDabalsDab,K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}{nnr:Dab}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:Dab}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}{nnr:Dab}{nt:Acet}{ct:Amid},D86 (Lys1-6 Dab-1),Amidation,Acetylation,Linear,Mix,"L-Dab = (2,4-diaminobutyric acid)",26,Antibacterial,50 % Hemolysis at >742 µM,Human,Synthetic Cationic Antimicrobial Peptides,"aqueous = α-Helix, 50%TFE = α-Helix",NA,NA,NA
9727,34377965,2019,klDapsllDaptlsDapakaaklDaptllDapalsDap,K{d}L{d}{nnr:Dap}S{d}L{d}L{d}{nnr:Dap}T{d}L{d}S{d}{nnr:Dap}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:Dap}T{d}L{d}L{d}{nnr:Dap}A{d}L{d}S{d}{nnr:Dap}{nt:Acet}{ct:Amid},D105 (Lys1-6 Dap-1),Amidation,Acetylation,Linear,Mix,"L-Dap = (2,3-diaminopropionic acid)",26,Antibacterial,50 % Hemolysis at >1148 µM,Human,Synthetic Cationic Antimicrobial Peptides,"aqueous = α-Helix, 50%TFE = α-Helix",NA,NA,NA
9728,34377965,2019,klLsllLtlsLakaaklLtllLalsS,K{d}L{d}LS{d}L{d}L{d}LT{d}L{d}S{d}LA{d}K{d}A{d}A{d}K{d}L{d}LT{d}L{d}L{d}LA{d}L{d}S{d}S{nt:Acet}{ct:Amid},D101 (Lys1Ser26-5 Lys-1),Amidation,Acetylation,Linear,Mix,None,26,Antibacterial,50 % Hemolysis at 103.9 µM,Human,Synthetic Cationic Antimicrobial Peptides,"aqueous = α-Helix, 50%TFE = α-Helix",NA,CHHHHHHHHHHHTTSCCTTTSCSSSSCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
9729,34377965,2019,klDabsllDabtlsDabakaaklDabtllDabalsS,K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}{nnr:Dab}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:Dab}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}S{nt:Acet}{ct:Amid},D102 (Lys1Ser26-5 Dab-1),Amidation,Acetylation,Linear,Mix,"L-Dab = (2,4-diaminobutyric acid)",26,Antibacterial,50 % Hemolysis at >708 µM,Human,Synthetic Cationic Antimicrobial Peptides,"aqueous = α-Helix, 50%TFE = α-Helix",NA,NA,NA
9730,34377965,2019,klLsllLtlsaakLLklatllLalsL,K{d}L{d}LS{d}L{d}L{d}LT{d}L{d}S{d}A{d}A{d}K{d}LLK{d}L{d}A{d}T{d}L{d}L{d}LA{d}L{d}S{d}L{nt:Acet}{ct:Amid},D88 (Lys1-6 Lys-2),Amidation,Acetylation,Linear,Mix,None,26,Antibacterial,50 % Hemolysis at 80.6 µM,Human,Synthetic Cationic Antimicrobial Peptides,"aqueous = α-Helix, 50%TFE = α-Helix",NA,CCGGGGGHHHHTTSCSHHHHSSCCSCSSSCSSCCCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(=O)O
9731,34377965,2019,klDabsllDabtlsaakDabDabklatllDabalsDab,AKR{nnr:bip}{nnr:bip}GYKRKF{nnr:bip}{nt:Acet}{ct:Amid},D89 (Lys1-6 Dab-2),Amidation,Acetylation,Linear,Mix,"L-Dab = (2,4-diaminobutyric acid)",26,Antibacterial,50 % Hemolysis at >1112 µM,Human,Synthetic Cationic Antimicrobial Peptides,"aqueous = α-Helix, 50%TFE = α-Helix",NA,NA,NA
9732,34377965,2019,klDapsllDaptlsaakDapDapklatllDapalsDap,K{d}L{d}{nnr:Dap}S{d}L{d}L{d}{nnr:Dap}T{d}L{d}S{d}A{d}A{d}K{d}{nnr:Dap}{nnr:Dap}K{d}L{d}A{d}T{d}L{d}L{d}{nnr:Dap}A{d}L{d}S{d}{nnr:Dap}{nt:Acet}{ct:Amid},D106 (Lys1-6 Dap-2),Amidation,Acetylation,Linear,Mix,"L-Dap = (2,3-diaminopropionic acid)",26,Antibacterial,50 % Hemolysis at 340.2 µM,Human,Synthetic Cationic Antimicrobial Peptides,"aqueous = α-Helix, 50%TFE = α-Helix",NA,NA,NA
9733,34377965,2019,klLsllLtlsaakLLklatllLalsS,K{d}L{d}LS{d}L{d}L{d}LT{d}L{d}S{d}A{d}A{d}K{d}LLK{d}L{d}A{d}T{d}L{d}L{d}LA{d}L{d}S{d}S{nt:Acet}{ct:Amid},D103 (Lys1Ser26-5 Lys-2),Amidation,Acetylation,Linear,Mix,None,26,Antibacterial,50 % Hemolysis at 134.9 µM,Human,Synthetic Cationic Antimicrobial Peptides,"aqueous = α-Helix, 50%TFE = α-Helix",NA,CCCSHHHHTTCCCCSSSTHHHHHCCCCSSCHHHHTSSSCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
9734,34377965,2019,klDabsllDabtlsaakDabDabklatllDabalsS,K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}A{d}A{d}K{d}{nnr:Dab}{nnr:Dab}K{d}L{d}A{d}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}S{nt:Acet}{ct:Amid},D104 (Lys1Ser26-5 Dab-2),Amidation,Acetylation,Linear,Mix,"L-Dab = (2,4-diaminobutyric acid)",26,Antibacterial,50 % Hemolysis at >1490 µM,Human,Synthetic Cationic Antimicrobial Peptides,"aqueous = α-Helix, 50%TFE = α-Helix",NA,NA,NA
9739,30658410,2019,IWGALLGTLIPAITSAIQ,IWGALLGTLIPAITSAIQ{ct:Amid},PLP5,Amidation,Free,Linear,L,None,18,Antibacterial,94.8 % Hemolysis at 50 µM,Human,Ant Odontomachus Monticola,α-Helix,NA,CTTHHHHHHHHHTTTCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O
9745,30658410,2019,IWGALLGTLIPAITSAIQ,IWGALLGTLIPAITSAIQ{ct:Amid},PLP5,Amidation,Free,Linear,L,None,18,Antibacterial,6.9 % Hemolysis at 10 µM,Human,Ant Odontomachus Monticola,α-Helix,NA,CCSCSCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O
9747,30701481,2019,GLPLLISWIKRKRQQGSKKPVPIIYCNRRTGKCQRM,GLPLLISWIKRKRQQGSKKPVPIIYCNRRTGKCQRM,Hybrid Peptide,Free,Free,Linear,L,None,36,"Antibacterial, Anticancer",0 % Hemolysis at 45 μmol/L,Sheep,Mutant Fragments Of Melittin And Thanatin,x,Non-hemolytic,CCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C
9751,30389515,2019,CPAIQRCC,CPAIQRCC,Mo-CBP3-PepI,Free,Free,Linear,L,None,8,"Antibacterial, Anticandidal",0 % Hemolysis at 70 µM,Human,Plant Moringa Oleifera Seeds,75% α-Helix and 25% β-Turns,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O
9752,30389515,2019,NIQPPCRCC,NIQPPCRCC,Mo-CBP3-PepII,Free,Free,Linear,L,None,9,"Antibacterial, Anticandidal",0 % Hemolysis at 70 µM,Human,Plant Moringa Oleifera Seeds,60% α-Helix and 40% β-Turns,Non-hemolytic,CCHHHHHHHCSCSSSTTSCSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O
9753,30389515,2019,AIQRCC,AIQRCC,Mo-CBP3-PepIII,Free,Free,Linear,L,None,6,"Antibacterial, Anticandidal",0 % Hemolysis at 70 µM,Human,Plant Moringa Oleifera Seeds,75% α-Helix and 25% β-Turns,Non-hemolytic,CCSSGGGCSCHHHHTTCSCCSSSTTCCCSCTTTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O
9754,30389515,2019,CPAIQRCC,CPAIQRCC,Mo-CBP3-PepI,Free,Free,Linear,L,None,8,"Antibacterial, Anticandidal",0 % Hemolysis at 280 µM,Human,Plant Moringa Oleifera Seeds,75% α-Helix and 25% β-Turns,Non-hemolytic,CCTHHHHSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O
9755,30389515,2019,NIQPPCRCC,NIQPPCRCC,Mo-CBP3-PepII,Free,Free,Linear,L,None,9,"Antibacterial, Anticandidal",0 % Hemolysis at 280 µM,Human,Plant Moringa Oleifera Seeds,60% α-Helix and 40% β-Turns,Non-hemolytic,CCHHHIIIIITC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O
9756,30389515,2019,AIQRCC,AIQRCC,Mo-CBP3-PepIII,Free,Free,Linear,L,None,6,"Antibacterial, Anticandidal",0 % Hemolysis at 280 µM,Human,Plant Moringa Oleifera Seeds,75% α-Helix and 25% β-Turns,Non-hemolytic,CCHHHHHCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O
9762,30508627,2019,GWGSFFKKAAHVGKHVGKAALTHYL,GWGSFFKKAAHVGKHVGKAALTHYL,Pleurocidin,Free,Free,Linear,L,None,25,"Antibiofilm, Antibacterial",10 % Hemolysis at 32 µM,Mouse,Fish Winter Flounder (Pseudopleuronectes Americanus),"10 mM sodium phosphate buffer = Random coil, SDS and TFE = α-Helix",NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
9763,30607494,2019,KWKLFKKIHKVGQNIRKGIIKAGPAVAVVGQAAQIAK,KWKLFKKIHKVGQNIRKGIIKAGPAVAVVGQAAQIAK,PEW300,Free,Free,Linear,L,None,37,Antibacterial,0 % Hemolysis at 224 μg/ml,Sheep,Synthetic Cecropin A-Derived,α-Helix,Non-hemolytic,CCTTSSCCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)CC
9772,30384016,2019,SISLL,SISLL,BRCA1(782–786),Free,Free,Linear,L,None,5,Antibacterial,5 % Hemolysis at >250 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
9773,30384016,2019,YGRKKRRQRRR,YGRKKRRQRRR,TAT(47–57),Free,Free,Linear,L,None,11,Antibacterial,5 % Hemolysis at >62.5 μg/ml,Human,Synthetic Peptide,NA,NA,NA,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O
9774,30384016,2019,YGRKKRRQRRRSISLL,YGRKKRRQRRRSISLL,TAT–SISLL,Free,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at >250 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,CTHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
9775,30384016,2019,SISLLYGRKKRRQRRR,SISLLYGRKKRRQRRR,SISLL–TAT,Free,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at >250 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
9776,30702120,2019,RRWVRRVRRWVRRVVRVVRRWVRR,RRWVRRVRRWVRRVVRVVRRWVRR,WLBU2,Free,Free,Linear,L,None,24,Antibacterial,14 ± 1 % Hemolysis at 50 µM,Human,Synthetic Peptide,NA,NA,CCHHHHHHHHHHHHCGGGSCCSCCC,CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
9777,30702120,2019,RRWvRRvRRWvRRvvRvvRRWvRR,RRWV{d}RRV{d}RRWV{d}RRV{d}V{d}RV{d}V{d}RRWV{d}RR,D8,Free,Free,Linear,Mix,None,24,Antibacterial,0 ± 1 % Hemolysis at 50 µM,Human,Synthetic Peptide,NA,Non-hemolytic,NA,CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
9778,30789942,2019,lRIWR,RIWR{nt:Lau}{ct:Amid},Lp-I,Amidation,Lau,Linear,L,l = Lau(lauric acid (C12)),4,"Antibacterial, Antifungal",≤10 % Hemolysis at 25 μg/ml,Human,Synthetic Argrich Ultra-Short Cationic Lipopeptides,NA,NA,NA,NA
9779,30789942,2019,lRRIWRR,RRIWRR{nt:Lau}{ct:Amid},Lp-IRR,Amidation,Lau,Linear,L,l = Lau(lauric acid (C12)),6,"Antibacterial, Antifungal",≤10 % Hemolysis at 25 μg/ml,Human,Synthetic Argrich Ultra-Short Cationic Lipopeptides,NA,NA,NA,NA
9780,30789942,2019,lRIWR,RIWR{nt:Lau}{ct:Amid},Lp-I,Amidation,Lau,Linear,L,l = Lau(lauric acid (C12)),4,"Antibacterial, Antifungal",≤60 % Hemolysis at 50 μg/ml,Human,Synthetic Argrich Ultra-Short Cationic Lipopeptides,NA,NA,NA,NA
9781,30789942,2019,lRRIWRR,RRIWRR{nt:Lau}{ct:Amid},Lp-IRR,Amidation,Lau,Linear,L,l = Lau(lauric acid (C12)),6,"Antibacterial, Antifungal",≤10 % Hemolysis at 50 μg/ml,Human,Synthetic Argrich Ultra-Short Cationic Lipopeptides,NA,NA,NA,NA
9782,30789942,2019,lRIWR,RIWR{nt:Lau}{ct:Amid},Lp-I,Amidation,Lau,Linear,L,l = Lau(lauric acid (C12)),4,"Antibacterial, Antifungal",100 % Hemolysis at 100 μg/ml,Human,Synthetic Argrich Ultra-Short Cationic Lipopeptides,NA,NA,NA,NA
9783,30789942,2019,lRRIWRR,RRIWRR{nt:Lau}{ct:Amid},Lp-IRR,Amidation,Lau,Linear,L,l = Lau(lauric acid (C12)),6,"Antibacterial, Antifungal",≤60 % Hemolysis at 100 μg/ml,Human,Synthetic Argrich Ultra-Short Cationic Lipopeptides,NA,NA,NA,NA
9784,32254776,2019,KLAKLAKKLAKLAK,KLAKLAKKLAKLAK,KLA,Free,Free,Linear,L,None,7,Antibacterial,0.025 % Hemolysis at 50 µM,mouse,Synthetic Peptide,α-Helix,Non-hemolytic,CCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
9785,32254776,2019,PpIX-PEG8-KLAKLAKKLAKLAK-PEG8-KLAKLAKKLAKLAK,{conj:PpIX}-{conj:PEG8}-KLAKLAKKLAKLAK-{conj:PEG8}-KLAKLAKKLAKLAK,PPK,Free,Free,Linear,L,"conjugating a photosensitizer PpIX = photosensitizer protoporphyrin IX conjugating, PEG = Polyethylene glycol linker",7,Antibacterial,0.025 % Hemolysis at 50 µM,mouse,Chimeric Synthetic Peptide,α-Helix,Non-hemolytic,NA,NA
9786,30811391,2019,KLKNFAKGVAQSLLNKASCKLSGQC,KLKNFAKGVAQSLLNKASCKLSGQC,Brevinin 2R,Free,Free,Linear,L,None,25,"Antibacterial, Anti-leishmanial",0 % Hemolysis at 500 μg/ml,Human,Frog Skin (Rana Brevipoda),NA,Non-hemolytic,CCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)O
9787,30811391,2019,KLKNFAKGVAQSLLNKASCKLSGQC,KLKNFAKGVAQSLLNKASCKLSGQC{nt:lauric acid},L- Brevinin 2R,Free,lauric acid,Linear,L,l = Lau(lauric acid),25,"Antibacterial, Anti-leishmanial",50 % Hemolysis at 250 μg/ml,Human,Modified Brevinin 2R,NA,NA,CCCC,NA
9788,30811391,2019,LPKPPKPVSKMRMATPLLMQALPM,LPKPPKPVSKMRMATPLLMQALPM,CLIP,Free,Free,Linear,L,None,24,"Antibacterial, Anti-leishmanial",0 % Hemolysis at 500 μg/ml,Human,Derived From The Mhc Class Ii Associated Invariant Chain,NA,Non-hemolytic,CCCC,CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)O)C(=O)O
9789,30811391,2019,LPKPPKPVSKMRMATPLLMQALPM,LPKPPKPVSKMRMATPLLMQALPM{nt:lauric acid},L-CLIP,Free,lauric acid,Linear,L,l = Lau(lauric acid),24,"Antibacterial, Anti-leishmanial",30 % Hemolysis at 500 μg/ml,Human,Modified Clip,NA,NA,CCCC,NA
9790,30392097,2019,KKKK,KKKK{nt:Dilipid C7 acylation}{ct:Amid},1,Amidation,Dilipid C7 acylation,Linear,L,None,4,Antibacterial,1.03 % Hemolysis at 50 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,Non-hemolytic,CCCC,NA
9791,30392097,2019,KKKK,KKKK{nt:Dilipid C9 acylation}{ct:Amid},2,Amidation,Dilipid C9 acylation,Linear,L,None,4,Antibacterial,1.53 % Hemolysis at 50 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,Non-hemolytic,CCCC,NA
9792,30392097,2019,KKKK,KKKK{nt:Dilipid C11 acylation}{ct:Amid},3,Amidation,Dilipid C11 acylation,Linear,L,None,4,Antibacterial,2.32 % Hemolysis at 50 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,Non-hemolytic,CCCC,NA
9793,30392097,2019,KKKK,KKKK{nt:Dilipid C14 acylation}{ct:Amid},4,Amidation,Dilipid C14 acylation,Linear,L,None,4,Antibacterial,1 % Hemolysis at 50 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,Non-hemolytic,CCCC,NA
9794,30392097,2019,KKGK,KKGK{nt:Dilipid C7 acylation}{ct:Amid},5,Amidation,Dilipid C7 acylation,Linear,L,None,4,Antibacterial,1 % Hemolysis at 50 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,Non-hemolytic,CCCC,NA
9795,30392097,2019,KKGK,KKGK{nt:Dilipid C9 acylation}{ct:Amid},6,Amidation,Dilipid C9 acylation,Linear,L,None,4,Antibacterial,1.21 % Hemolysis at 50 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,Non-hemolytic,CCCC,NA
9796,30392097,2019,KKGK,KKGK{nt:Dilipid C11 acylation}{ct:Amid},7,Amidation,Dilipid C11 acylation,Linear,L,None,4,Antibacterial,13.66 % Hemolysis at 50 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,NA,CCCC,NA
9797,30392097,2019,KKGK,KKGK{nt:Dilipid C14 acylation}{ct:Amid},8,Amidation,Dilipid C14 acylation,Linear,L,None,4,Antibacterial,22.23 % Hemolysis at 50 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,NA,CCCC,NA
9798,30392097,2019,KKKK,KKKK{nt:Dilipid C7 acylation}{ct:Amid},1,Amidation,Dilipid C7 acylation,Linear,L,None,4,Antibacterial,0.75 % Hemolysis at 100 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,Non-hemolytic,CCCC,NA
9799,30392097,2019,KKKK,KKKK{nt:Dilipid C9 acylation}{ct:Amid},2,Amidation,Dilipid C9 acylation,Linear,L,None,4,Antibacterial,2.07 % Hemolysis at 100 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,Non-hemolytic,CCCC,NA
9800,30392097,2019,KKKK,KKKK{nt:Dilipid C11 acylation}{ct:Amid},3,Amidation,Dilipid C11 acylation,Linear,L,None,4,Antibacterial,23.72 % Hemolysis at 100 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,NA,CCCC,NA
9801,30392097,2019,KKKK,KKKK{nt:Dilipid C14 acylation}{ct:Amid},4,Amidation,Dilipid C14 acylation,Linear,L,None,4,Antibacterial,42.1 % Hemolysis at 100 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,NA,CCCC,NA
9802,30392097,2019,KKGK,KKGK{nt:Dilipid C7 acylation}{ct:Amid},5,Amidation,Dilipid C7 acylation,Linear,L,None,4,Antibacterial,1.1 % Hemolysis at 100 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,Non-hemolytic,CCCC,NA
9803,30392097,2019,KKGK,KKGK{nt:Dilipid C9 acylation}{ct:Amid},6,Amidation,Dilipid C9 acylation,Linear,L,None,4,Antibacterial,3.78 % Hemolysis at 100 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,NA,CCCC,NA
9804,30392097,2019,KKGK,KKGK{nt:Dilipid C11 acylation}{ct:Amid},7,Amidation,Dilipid C11 acylation,Linear,L,None,4,Antibacterial,19.73 % Hemolysis at 100 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,NA,CCSCSSCCCSCCCCC,NA
9805,30392097,2019,KKGK,KKGK{nt:Dilipid C14 acylation}{ct:Amid},8,Amidation,Dilipid C14 acylation,Linear,L,None,4,Antibacterial,30.5 % Hemolysis at 100 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,NA,CCCHHHHHHHHHHHHHHHHHHHTC,NA
9806,30392097,2019,KKKK,KKKK{nt:Dilipid C7 acylation}{ct:Amid},1,Amidation,Dilipid C7 acylation,Linear,L,None,4,Antibacterial,1.03 % Hemolysis at 500 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,Non-hemolytic,CTTTCSTHHHHTTTCSSSCSSCCGGGHHHHTTSCC,NA
9807,30392097,2019,KKKK,KKKK{nt:Dilipid C9 acylation}{ct:Amid},2,Amidation,Dilipid C9 acylation,Linear,L,None,4,Antibacterial,22.44 % Hemolysis at 500 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,NA,CCCCSSCCHHHHHHHHHHHHHHHHHHHHHHHHTTSCC,NA
9808,30392097,2019,KKKK,KKKK{nt:Dilipid C11 acylation}{ct:Amid},3,Amidation,Dilipid C11 acylation,Linear,L,None,4,Antibacterial,96.4 % Hemolysis at 500 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,NA,CCCCSSCCHHHHHHHHHHHHHHHHHHHHHHHHTTSCC,NA
9809,30392097,2019,KKKK,KKKK{nt:Dilipid C14 acylation}{ct:Amid},4,Amidation,Dilipid C14 acylation,Linear,L,None,4,Antibacterial,97.97 % Hemolysis at 500 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,NA,CCCCSSCCHHHHHHHHHHHHHHHHHHHHHHHHTTSCC,NA
9810,30392097,2019,KKGK,KKGK{nt:Dilipid C7 acylation}{ct:Amid},5,Amidation,Dilipid C7 acylation,Linear,L,None,4,Antibacterial,2.21 % Hemolysis at 500 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,Non-hemolytic,CCCCSSCCHHHHHHHHHHHHHHHHHHHHHHHHTTSCC,NA
9811,30392097,2019,KKGK,KKGK{nt:Dilipid C9 acylation}{ct:Amid},6,Amidation,Dilipid C9 acylation,Linear,L,None,4,Antibacterial,74.28 % Hemolysis at 500 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,NA,CCCCSSCCHHHHHHHHHHHHHHHHHHHHHHHHTTSCC,NA
9812,30392097,2019,KKGK,KKGK{nt:Dilipid C11 acylation}{ct:Amid},7,Amidation,Dilipid C11 acylation,Linear,L,None,4,Antibacterial,36.78 % Hemolysis at 500 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,NA,CCCCSSCCHHHHHHHHHHHHHHHHHHHHHHHHTTSCC,NA
9813,30392097,2019,KKGK,KKGK{nt:Dilipid C14 acylation}{ct:Amid},8,Amidation,Dilipid C14 acylation,Linear,L,None,4,Antibacterial,77 % Hemolysis at 500 μg/ml,Pig,Synthetic Dilipid Ultrashort Cationic Lipopeptides,NA,NA,NA,NA
9814,30414293,2019,RNCTWLFSTKLKLPA,RNCTWLFSTKLKLPA,RN15,Free,Free,Linear,L,None,15,Antibacterial,<10 % Hemolysis at 200 μg/ml,Human,Siamese Crocodile Crocodylus Siamensis,α-Helix,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O
9823,30824786,2019,AGYLLGKINLKALAALAKKIL,"AGYLLGKINLKALAALAKKIL{nt:Van-NH-PEG3-Tra(1,4)-C(O)}{ct:Amid}",Van-PEG3-TP10,Amidation,"Van-NH-PEG3-Tra(1,4)-C(O)",Linear,L,"Van = vancomycin, PEG3 = 3,6,9-trioxaundecane linker, Tra = 1,2,3-triazole ring",21,Antibacterial,15 % Hemolysis at 12.5 µM,Sheep,Synthetic Conjugate Transportan 10 (Tp10) Peptide,α-Helix,NA,NA,NA
9824,30824786,2019,AGYLLGKINLKALAALAKKIL,"AGYLLGKINLKALAALAKKIL{nt:Van-C(O)-PEG4-Tra(1,4)-C(O)}{ct:Amid}",Van-PEG4-TP10,Amidation,"Van-C(O)-PEG4-Tra(1,4)-C(O)",Linear,L,"Van = vancomycin, PEG4 = 4,7,10,13-tetraoxapentadecane linker, Tra = 1,2,3-triazole ring",21,Antibacterial,5 % Hemolysis at 12.5 µM,Sheep,Synthetic Conjugate Transportan 10 (Tp10) Peptide,α-Helix,NA,NA,NA
9825,30824786,2019,AGYLLGKINLKALAALAKKIL,"AGYLLGKINLKALAALAKKIL{nt:Van-NH-PEG3-Tra(1,4)-C(O)}{ct:Amid}",Van-PEG3-TP10,Amidation,"Van-NH-PEG3-Tra(1,4)-C(O)",Linear,L,"Van = vancomycin, PEG3 = 3,6,9-trioxaundecane linker, Tra = 1,2,3-triazole ring",21,Antibacterial,93 % Hemolysis at 100 µM,Sheep,Synthetic Conjugate Transportan 10 (Tp10) Peptide,α-Helix,NA,NA,NA
9826,30824786,2019,AGYLLGKINLKALAALAKKIL,"AGYLLGKINLKALAALAKKIL{nt:Van-C(O)-PEG4-Tra(1,4)-C(O)}{ct:Amid}",Van-PEG4-TP10,Amidation,"Van-C(O)-PEG4-Tra(1,4)-C(O)",Linear,L,"Van = vancomycin, PEG4 = 4,7,10,13-tetraoxapentadecane linker, Tra = 1,2,3-triazole ring",21,Antibacterial,77 % Hemolysis at 100 µM,Sheep,Synthetic Conjugate Transportan 10 (Tp10) Peptide,α-Helix,NA,NA,NA
9828,30842436,2019,K-K-(NBu)Gly-K-(N1-Nal)Gly-(NPhe)Gly-(N1-Nal)Gly,K-K-{nnr:(NBu)Gly}-K-{nnr:(N1-Nal)Gly}-{nnr:(NPhe)Gly}-{nnr:(N1-Nal)Gly},2,Free,Free,Linear,L,"(NBu)Gly = N-(4-aminobutyl)glycine, (N1-Nal)Gly = N-(1-naphthyl)glycine, (NPhe)Gly = N-Phenylalanine glycine",7,Antibacterial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,Low hemolytic,NA,NA
9829,30842436,2019,K-K-K-(NBu)Gly-(N1-Nal)Gly-(NPhe)Gly-(N1-Nal)Gly,K-K-K-{nnr:(NBu)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(NPhe)Gly}-{nnr:(N1-Nal)Gly},3,Free,Free,Linear,L,"(NBu)Gly = N-(4-aminobutyl)glycine, (N1-Nal)Gly = N-(1-naphthyl)glycine, (NPhe)Gly = N-Phenylalanine glycine",7,Antibacterial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,Low hemolytic,NA,NA
9830,30842436,2019,(N1-Nal)Gly-(NPhe)Gly-(N1-Nal)Gly-(NBu)Gly-K-K-K,{nnr:(N1-Nal)Gly}-{nnr:(NPhe)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(NBu)Gly}-K-K-K,4,Free,Free,Linear,L,"(NBu)Gly = N-(4-aminobutyl)glycine, (N1-Nal)Gly = N-(1-naphthyl)glycine, (NPhe)Gly = N-Phenylalanine glycine",7,Antibacterial,24 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9831,30842436,2019,(N1-Nal)Gly-(NPhe)Gly-(N1-Nal)Gly-K-(NBu)Gly-K-K,{nnr:(N1-Nal)Gly}-{nnr:(NPhe)Gly}-{nnr:(N1-Nal)Gly}-K-{nnr:(NBu)Gly}-K-K,5,Free,Free,Linear,L,"(NBu)Gly = N-(4-aminobutyl)glycine, (N1-Nal)Gly = N-(1-naphthyl)glycine, (NPhe)Gly = N-Phenylalanine glycine",7,Antibacterial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,Low hemolytic,NA,NA
9832,30842436,2019,K-K-L-K-(1-Nal)Ala-F-(1-Nal)Ala,K-K-L-K-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala},6,Free,Free,Linear,L,(1-Nal)Ala = 1-Naphthylalanine,7,Antibacterial,96 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9833,30842436,2019,K-K-K-L-(1-Nal)Ala-F-(1-Nal)Ala,K-K-K-L-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala},7,Free,Free,Linear,L,(1-Nal)Ala = 1-Naphthylalanine,7,Antibacterial,55 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9834,30842436,2019,K-K-L-K-(2-Nal)Ala-F-(2-Nal)Ala,K-K-L-K-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala},8,Free,Free,Linear,L,(2-Nal)Ala = 2-Naphthylalanine,7,Antibacterial,34 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9835,30842436,2019,K-K-K-L-(2-Nal)Ala-F-(2-Nal)Ala,K-K-K-L-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala},9,Free,Free,Linear,L,(2-Nal)Ala = 2-Naphthylalanine,7,Antibacterial,39 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9836,30842436,2019,(1-Nal)Ala-F-(1-Nal)Ala-K-L-K-K,{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-K-L-K-K,10,Free,Free,Linear,L,(1-Nal)Ala = 1-Naphthylalanine,7,Antibacterial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,Low hemolytic,NA,NA
9837,30842436,2019,(2-Nal)Ala-F -(2-Nal)Ala-K-L-K-K,{nnr:(2-Nal)Ala}-F -{nnr:(2-Nal)Ala}-K-L-K-K,11,Free,Free,Linear,L,(2-Nal)Ala = 2-Naphthylalanine,7,Antibacterial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,Low hemolytic,NA,NA
9838,30842436,2019,(1-Nal)Ala-F-(1-Nal)Ala-L-K-K-K,{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-L-K-K-K,12,Free,Free,Linear,L,(1-Nal)Ala = 1-Naphthylalanine,7,Antibacterial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,Low hemolytic,NA,NA
9839,30842436,2019,(2-Nal)Ala-F-(2-Nal)Ala-L-K-K-K,{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala}-L-K-K-K,13,Free,Free,Linear,L,(2-Nal)Ala = 2-Naphthylalanine,7,Antibacterial,15 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9840,30842436,2019,K-K-L-K-(1-Nal)ala-f-(1-Nal)ala,K-K-L-K-{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala},14,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,58 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9841,30842436,2019,K-K-K-l-(1-Nal)ala-f-(1-Nal)ala,K-K-K-L{d}-{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala},15,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,88 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9842,30842436,2019,K-K-K-l-(2-Nal)ala-f-(2-Nal)ala,K-K-K-L{d}-{nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala},16,Free,Free,Linear,Mix,(2-Nal)ala = D-2-Naphthylalanine,7,Antibacterial,60 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9843,30842436,2019,K-K-l-K-(2-Nal)ala-f-(2-Nal)ala,K-K-L{d}-K-{nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala},17,Free,Free,Linear,Mix,(2-Nal)ala = D-2-Naphthylalanine,7,Antibacterial,40 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9844,30842436,2019,(2-Nal)ala-f-(2-Nal)ala-K-l-K-K,{nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala}-K-L{d}-K-K,18,Free,Free,Linear,Mix,(2-Nal)ala = D-2-Naphthylalanine,7,Antibacterial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,Low hemolytic,NA,NA
9845,30842436,2019,(2-Nal)ala-f-(2-Nal)ala-l-K-K-K,{nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala}-L{d}-K-K-K,19,Free,Free,Linear,Mix,(2-Nal)ala = D-2-Naphthylalanine,7,Antibacterial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,Low hemolytic,NA,NA
9846,30842436,2019,(1-Nal)ala-f-(1-Nal)ala-K-l-K-K,{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala}-K-L{d}-K-K,20,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,Low hemolytic,NA,NA
9847,30842436,2019,(1-Nal)ala-f-(1-Nal)ala-l-K-K-K,{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala}-L{d}-K-K-K,21,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,Low hemolytic,NA,NA
9848,30842436,2019,K-K-K-L-(2-Nal)Ala-Y-(2-Nal)Ala,K-K-K-L-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala},22,Free,Free,Linear,L,(2-Nal)Ala = 2-Naphthylalanine,7,Antibacterial,14 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9850,30842436,2019,K-K-K-Nle-(1-Nal)Ala-F-(1-Nal)Ala,K-K-K-{nnr:Nle}-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala},24,Free,Free,Linear,L,"(1-Nal)Ala = 1-Naphthylalanine, Nle= norleucine",7,Antibacterial,60 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9851,30842436,2019,K-K-K-l-(1-Nal)ala-y-(1-Nal)ala,K-K-K-L{d}-{nnr:(1-Nal)ala}-Y{d}-{nnr:(1-Nal)ala},25,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,53 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9853,30842436,2019,K-K-K-Nle-(2-Nal)Ala-Y-(2-Nal)Ala,K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala},27,Free,Free,Linear,L,"(2-Nal)Ala = 2-Naphthylalanine, Nle= norleucine",7,Antibacterial,54 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9854,30842436,2019,K-K-K-l-(2-Nal)ala-y-(2-Nal)ala,K-K-K-L{d}-(2-Nal)ala-Y{d}-(2-Nal)ala,28,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,64 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9855,30842436,2019,NLys-NLys-NLys-L-(2-Nal)Ala-F-(2-Nal)Ala,{nnr:NLys}-{nnr:NLys}-{nnr:NLys}-L-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala},29,Free,Free,Linear,L,"(2-Nal)Ala = D-2-Naphthylalanine, NLys",7,Antibacterial,46 % Hemolysis at 150 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9857,30842436,2019,(N1-Nal)Gly-(NPhe)Gly-(N1-Nal)Gly-(NBu)Gly-K-K-K,{nnr:(N1-Nal)Gly}-{nnr:(NPhe)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(NBu)Gly}-K-K-K,4,Free,Free,Linear,L,"(NBu)Gly = N-(4-aminobutyl)glycine, (N1-Nal)Gly = N-(1-naphthyl)glycine, (NPhe)Gly = N-Phenylalanine glycine",7,Antibacterial,10 % Hemolysis at 54 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9858,30842436,2019,K-K-L-K-(1-Nal)Ala-F-(1-Nal)Ala,K-K-L-K-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala},6,Free,Free,Linear,L,(1-Nal)Ala = 1-Naphthylalanine,7,Antibacterial,10 % Hemolysis at 5 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,Low hemolytic,NA,NA
9859,30842436,2019,K-K-K-L-(1-Nal)Ala-F-(1-Nal)Ala,K-K-K-L-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala},7,Free,Free,Linear,L,(1-Nal)Ala = 1-Naphthylalanine,7,Antibacterial,10 % Hemolysis at 8 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9860,30842436,2019,K-K-L-K-(2-Nal)Ala-F-(2-Nal)Ala,K-K-L-K-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala},8,Free,Free,Linear,L,(2-Nal)Ala = 2-Naphthylalanine,7,Antibacterial,10 % Hemolysis at 56 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9861,30842436,2019,K-K-K-L-(2-Nal)Ala-F-(2-Nal)Ala,K-K-K-L-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala},9,Free,Free,Linear,L,(2-Nal)Ala = 2-Naphthylalanine,7,Antibacterial,10 % Hemolysis at 46 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9862,30842436,2019,(2-Nal)Ala-F-(2-Nal)Ala-L-K-K-K,{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala}-L-K-K-K,13,Free,Free,Linear,L,(2-Nal)Ala = 2-Naphthylalanine,7,Antibacterial,10 % Hemolysis at 110 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9863,30842436,2019,K-K-L-K-(1-Nal)ala-f-(1-Nal)ala,K-K-L-K-{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala},14,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,10 % Hemolysis at 28 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9864,30842436,2019,K-K-K-l-(1-Nal)ala-f-(1-Nal)ala,K-K-K-L{d}-{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala},15,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,10 % Hemolysis at 8 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9865,30842436,2019,K-K-K-l-(2-Nal)ala-f-(2-Nal)ala,K-K-K-L{d}-{nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala},16,Free,Free,Linear,Mix,(2-Nal)ala = D-2-Naphthylalanine,7,Antibacterial,10 % Hemolysis at 18 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9866,30842436,2019,K-K-l-K-(2-Nal)ala-f-(2-Nal)ala,K-K-L{d}-K-{nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala},17,Free,Free,Linear,Mix,(2-Nal)ala = D-2-Naphthylalanine,7,Antibacterial,10 % Hemolysis at 8 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9867,30842436,2019,K-K-K-L-(2-Nal)Ala-Y-(2-Nal)Ala,K-K-K-L-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala},22,Free,Free,Linear,L,(2-Nal)Ala = 2-Naphthylalanine,7,Antibacterial,10 % Hemolysis at 117 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9869,30842436,2019,K-K-K-Nle-(1-Nal)Ala-F-(1-Nal)Ala,K-K-K-{nnr:Nle}-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala},24,Free,Free,Linear,L,"(1-Nal)Ala = 1-Naphthylalanine, Nle= norleucine",7,Antibacterial,10 % Hemolysis at 3 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,Low hemolytic,NA,NA
9870,30842436,2019,K-K-K-l-(1-Nal)ala-y-(1-Nal)ala,K-K-K-L{d}-{nnr:(1-Nal)ala}-Y{d}-{nnr:(1-Nal)ala},25,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,10 % Hemolysis at 38 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9871,30842436,2019,K-K-K-Nle-(2-Nal)Ala-Y-(2-Nal)Ala,K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala},27,Free,Free,Linear,L,"(2-Nal)Ala = 2-Naphthylalanine, Nle= norleucine",7,Antibacterial,10 % Hemolysis at 3 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,Low hemolytic,NA,NA
9872,30842436,2019,K-K-K-l-(2-Nal)ala-y-(2-Nal)ala,K-K-K-L{d}-{nnr:(2-Nal)ala}-Y{d}-{nnr:(2-Nal)ala},28,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,10 % Hemolysis at 6 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9873,30842436,2019,NLys-NLys-NLys-L-(2-Nal)Ala-F-(2-Nal)Ala,NLys-NLys-NLys-L-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala},29,Free,Free,Linear,L,"(2-Nal)Ala = D-2-Naphthylalanine, NLys",7,Antibacterial,10 % Hemolysis at 9 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9875,30842436,2019,K-K-L-K-(1-Nal)Ala-F-(1-Nal)Ala,K-K-L-K-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala},6,Free,Free,Linear,L,(1-Nal)Ala = 1-Naphthylalanine,7,Antibacterial,50 % Hemolysis at 58 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9876,30842436,2019,K-K-K-L-(1-Nal)Ala-F-(1-Nal)Ala,K-K-K-L-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala},7,Free,Free,Linear,L,(1-Nal)Ala = 1-Naphthylalanine,7,Antibacterial,50 % Hemolysis at 140 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9877,30842436,2019,K-K-L-K-(1-Nal)ala-f-(1-Nal)ala,K-K-L-K-{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala},14,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,50 % Hemolysis at 128 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9878,30842436,2019,K-K-K-l-(1-Nal)ala-f-(1-Nal)ala,K-K-K-L{d}-{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala},15,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,50 % Hemolysis at 40 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9879,30842436,2019,K-K-K-l-(2-Nal)ala-f-(2-Nal)ala,K-K-K-L{d}-{nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala},16,Free,Free,Linear,Mix,(2-Nal)ala = D-2-Naphthylalanine,7,Antibacterial,50 % Hemolysis at 118 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9881,30842436,2019,K-K-K-Nle-(1-Nal)Ala-F-(1-Nal)Ala,K-K-K-{nnr:Nle}-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala},24,Free,Free,Linear,L,"(1-Nal)Ala = 1-Naphthylalanine, Nle= norleucine",7,Antibacterial,50 % Hemolysis at 41 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9882,30842436,2019,K-K-K-l-(1-Nal)ala-y-(1-Nal)ala,K-K-K-L{d}-{nnr:(1-Nal)ala}-Y{d}-{nnr:(1-Nal)ala},25,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,50 % Hemolysis at 138 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9884,30842436,2019,K-K-K-Nle-(2-Nal)Ala-Y-(2-Nal)Ala,K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala},27,Free,Free,Linear,L,"(2-Nal)Ala = 2-Naphthylalanine, Nle= norleucine",7,Antibacterial,50 % Hemolysis at 56 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9885,30842436,2019,K-K-K-l-(2-Nal)ala-y-(2-Nal)ala,K-K-K-L{d}-{nnr:(2-Nal)ala}-Y{d}-{nnr:(2-Nal)ala},28,Free,Free,Linear,Mix,(1-Nal)ala = D-1-Naphthylalanine,7,Antibacterial,50 % Hemolysis at 50 µM,Human,Synthetic Peptide-Peptoid Hybrid,Random coil,NA,NA,NA
9888,30872680,2019,FLPKLFAKITKKNMAHIR,FLPKLFAKITKKNMAHIR,Andersonin-Y1 (AY1),Free,Free,Linear,L,None,18,Antibacterial,5 % Hemolysis at 100 µM,Human,Frog Odorrana Andersonii,"membrane bound structure = Helical Hairpin (Helix-Loop-Helix) structure, Aqueous = unstructured",Low hemolytic,CCCSCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
9890,30886247,2019,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL-37,Free,Free,Linear,L,None,37,Antibacterial,30 % Hemolysis at 40 µM,Porcine,Human,α-Helix,NA,CCCCSCCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
9891,30886247,2019,RFGRFLRKIRRFRPKVTITIQGSARF,RFGRFLRKIRRFRPKVTITIQGSARF{ct:Amid},CATH-2,Amidation,Free,Linear,L,None,26,"Antibacterial, Antifungal",<10 % Hemolysis at 40 µM,Porcine,Chicken,α-Helix and α-Helix,NA,CCSCTTTTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
9892,30886247,2019,GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGCG,GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGCG{nt:Acet},PMAP-36,Free,Acetylation,Linear,L,None,36,Antibacterial,<10 % Hemolysis at 40 µM,Porcine,Porcine Cathelicidin,α-Helix,NA,CCSSCCCSTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C
9905,30967458,2019,ILKPGGGTSGGLLGGLLGKVTSVIPGLNNI,ILKPGGGTSGGLLGGLLGKVTSVIPGLNNI,α4,Free,Free,Linear,L,None,30,"Antibacterial, Antiiofilm",0 % Hemolysis at 64 µM,Human,Derived From The Human Respiratory Host Defense Protein Splunc1,α-Helix,Non-hemolytic,NA,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O
9906,30967458,2019,LKKWW K TS K GLLGGLLGKVTSVIK,LKKWW K TS K GLLGGLLGKVTSVIK,α4-short,Free,Free,Linear,L,None,24,"Antibacterial, Antiiofilm",0 % Hemolysis at 64 µM,Human,Modified Α4,NA,Non-hemolytic,NA,CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C=O)Cc1c[nH]c2ccccc12.CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O.C[C@@H](O)[C@H](N)C(=O)N[C@H](C=O)CO.NCCCC[C@H](N)C=O.NCCCC[C@H](N)C=O
9927,31118709,2019,KFKKLFKKLSPVFKRIVQRIKDFLR,KFKKLFKKLSPVFKRIVQRIKDFLR{nt:Amid},B1,Free,Amidation,Linear,L,None,25,"Antibiofilm, Antibacterial",37 % Hemolysis at 150 µM,Human,Hybrid Peptide From Ll-37 And Bmap-27,α-Helix = 88% and Random coils = 12%,NA,CCHHHHHHHHHHHHHHHHHHHHHHHHHHTTTTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
9939,31016971,2019,LLGDFFRKSKEKIGKEFKRI,LLGDFFRKSKEKIGKEFKRI,Fragment LL-20,Free,Free,Linear,L,None,20,Antibacterial,0 % Hemolysis at 10 µM,Human,Fragment Of Cathelicidin Ll-37,α-Helix,Non-hemolytic,CCSSCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)C(=O)O
9940,30127331,2019,FLPFFAACAITRKC,FLPFFAACAITRKC{cyc:8-14}{ct:Amid},Amurin-9KY,Amidation,Free,Linear,L,C8-C14 = heptapeptide ring,14,Antibacterial,2 % Hemolysis at 100 μg/ml,Human,Frog Rana Kunyuensis China,"water = Random coil, 50% TFE-water = α-Helix",Non-hemolytic,CCCGGGGGCCC,NA
9941,30127331,2019,FLPFFAACAITRKC,FLPFFAACAITRKC{ct:Amid},Amurin-9KY1,Amidation,Free,Linear,L,None,14,"Antibacterial, Antifungal",15.4 % Hemolysis at 100 μg/ml,Human,Derived From Amurin-9Ky,NA,NA,CGGGGGTTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
9944,30919848,2019,GKKLGLWLGLKKG,GKKLGLWLGLKKG{ct:Amid},F1,Amidation,Free,Linear,L,None,13,Antibacterial,<5 % Hemolysis at 128 µM,Human,Synthetic Peptide,30 mM SDS and 50% TFE = α-Helix,Non-hemolytic,CCCSCCHHHHC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
9945,30919848,2019,KKLLGWGLLKK,KKLLGWGLLKK{ct:Amid},F2,Amidation,Free,Linear,L,None,11,Antibacterial,<5 % Hemolysis at 128 µM,Human,Synthetic Peptide,30 mM SDS and 50% TFE = unordered conformations,Non-hemolytic,CCSSCCCSTTC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
9946,30919848,2019,KKLGWGLKK,KKLGWGLKK{ct:Amid},F3,Amidation,Free,Linear,L,None,9,Antibacterial,<5 % Hemolysis at 128 µM,Human,Synthetic Peptide,30 mM SDS and 50% TFE = unordered conformations,Non-hemolytic,CCHHHHHHHHHHTCHHHIIIIITTCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
9947,30919848,2019,KKLGLWLGLKK,KKLGLWLGLKK{ct:Amid},F4,Amidation,Free,Linear,L,None,11,Antibacterial,<5 % Hemolysis at 128 µM,Human,Synthetic Peptide,30 mM SDS and 50% TFE = α-Helix,Non-hemolytic,CCSSCTTCCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
9948,30919848,2019,GKKLLWLLKKG,GKKLLWLLKKG{ct:Amid},F5,Amidation,Free,Linear,L,None,11,Antibacterial,<5 % Hemolysis at 128 µM,Human,Synthetic Peptide,30 mM SDS and 50% TFE = α-Helix,Non-hemolytic,CCSCCCCSSTTCSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
9949,30919848,2019,LKGKLWLKGKL,LKGKLWLKGKL{ct:Amid},F6,Amidation,Free,Linear,L,None,11,Antibacterial,<5 % Hemolysis at 128 µM,Human,Synthetic Peptide,30 mM SDS and 50% TFE = α-Helix,Non-hemolytic,CCSSHHHHTTTSCSSGGGTCSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)O
9950,30919848,2019,KLLGKWKGLLK,KLLGKWKGLLK{ct:Amid},F7,Amidation,Free,Linear,L,None,11,Antibacterial,<5 % Hemolysis at 128 µM,Human,Synthetic Peptide,NA,Non-hemolytic,CCCCGGGTTTTSCCCGGGSCSSCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
9951,30919848,2019,KKLLKGLLKGW,KKLLKGLLKGW{ct:Amid},F8,Amidation,Free,Linear,L,None,11,Antibacterial,<5 % Hemolysis at 128 µM,Human,Synthetic Peptide,NA,Non-hemolytic,CCSCHHHHTTTTSSCCGGGIIIIICSSCCSSCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
9952,30919848,2019,KKIGIWIGIKK,KKIGIWIGIKK{ct:Amid},F9,Amidation,Free,Linear,L,None,11,Antibacterial,<5 % Hemolysis at 128 µM,Human,Synthetic Peptide,30 mM SDS and 50% TFE = α-Helix,Non-hemolytic,CCSSIIIIISCCCTTTTTTTTTTCTTCEETTEEC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
9953,30919848,2019,RRLGLWLGLRR,RRLGLWLGLRR{ct:Amid},F10,Amidation,Free,Linear,L,None,11,Antibacterial,<5 % Hemolysis at 128 µM,Human,Synthetic Peptide,30 mM SDS and 50% TFE = α-Helix,Non-hemolytic,CTTCSCSSSCSCSCCCTTSSCCEETTEEC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
9954,30919848,2019,KKLTLWLTLKK,KKLTLWLTLKK{ct:Amid},F11,Amidation,Free,Linear,L,None,11,Antibacterial,<5 % Hemolysis at 128 µM,Human,Synthetic Peptide,30 mM SDS and 50% TFE = α-Helix,Non-hemolytic,CHHHHHHHHHTTCSCGGGGGGTTTCSCEETTEEC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
9955,30919848,2019,KKLGLCLGLKK,KKLGLCLGLKK{ct:Amid},F12,Amidation,Free,Linear,L,None,11,Antibacterial,<5 % Hemolysis at 128 µM,Human,Synthetic Peptide,NA,Non-hemolytic,CCBGGGTBCSSSCTTTTHHHHTTTCCSSCCCCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
10338,30951211,2019,Nlys-Ntrp-Nlys-Nlys-Ntrp-Ntrp-Nlys-Ntrp-Nile,{nnr:Nlys}-{nnr:Ntrp}-{nnr:Nlys}-{nnr:Nlys}-{nnr:Ntrp}-{nnr:Ntrp}-{nnr:Nlys}-{nnr:Ntrp}-{nnr:Nile}{nt:H}{ct:Amid},GN-2,Amidation,H,Linear,L,"Nlys = Nlys, Ntrp = Ntrp, Nile = Nile",9,"Anti-biofilm, Antibacterial",<10 % Hemolysis at 128 μg/ml,Human,Synthetic Peptoids Of Gn-2,NA,Low hemolytic,NA,NA
10339,30951211,2019,Nlys-Nlys-Nlys-Nlys-Ntrp-Ntrp-Ntrp-Ntrp-Nile,{nnr:Nlys}-{nnr:Nlys}-{nnr:Nlys}-{nnr:Nlys}-{nnr:Ntrp}-{nnr:Ntrp}-{nnr:Ntrp}-{nnr:Ntrp}-{nnr:Nile}{nt:H}{ct:Amid},GN-2-Nlys1-4Ntrp5-8,Amidation,H,Linear,L,"Nlys = Nlys, Ntrp = Ntrp, Nile = Nile",9,"Anti-biofilm, Antibacterial",<10 % Hemolysis at 128 μg/ml,Human,Synthetic Peptoids Of Gn-2,NA,Low hemolytic,NA,NA
10340,30951211,2019,Nlys-Ntrp-Nlys-Nlys-Ntrp-Ntrp-Nlys-Ntrp-Npm,{nnr:Nlys}-{nnr:Ntrp}-{nnr:Nlys}-{nnr:Nlys}-{nnr:Ntrp}-{nnr:Ntrp}-{nnr:Nlys}-{nnr:Ntrp}-{nnr:Npm}{nt:H}{ct:Amid},GN-2-Npm9,Amidation,H,Linear,L,"Nlys = Nlys, Ntrp = Ntrp, Npm = Npm",9,"Anti-biofilm, Antibacterial",<10 % Hemolysis at 128 μg/ml,Human,Synthetic Peptoids Of Gn-2,NA,NA,NA,NA
10341,30951211,2019,RWKRWWRWI,RWKRWWRWI{ct:Amid},GN-2,Amidation,Free,Linear,L,None,9,"Anti-biofilm, Antibacterial",<10 % Hemolysis at 128 μg/ml,Human,Synthetic Peptide,"water = α-Helix, TFE = α-Helix",NA,CCGGGHHHHHHHHSCTTTSCCCCCCSCCCSSSCSSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
10342,30951211,2019,RWRRWWRWI,RWRRWWRWI{ct:Amid},"GN-2-Arg1,3,4,7",Amidation,Free,Linear,L,None,9,"Anti-biofilm, Antibacterial",<10 % Hemolysis at 128 μg/ml,Human,Synthetic Analogue Peptide,"water = Random coil, TFE = Random coil",Low hemolytic,CGGGGHHHHHHHHTTTTCSSCCSCSSCCCSSGGGTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
10343,30951211,2019,KWKKWWKWI,KWKKWWKWI{ct:Amid},"GN-2-Lys1,3,4,7",Amidation,Free,Linear,L,None,9,"Anti-biofilm, Antibacterial",<10 % Hemolysis at 128 μg/ml,Human,Synthetic Analogue Peptide,"water = Random coil, TFE = Random coil",Low hemolytic,CCSSTHHHHHHHHHHHHHTTTSCCTTHHHHHHHTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)O
10344,30951211,2019,KKKKWWWWI,KKKKWWWWI{ct:Amid},GN-2-Lys1-4Trp5-8,Amidation,Free,Linear,L,None,9,"Anti-biofilm, Antibacterial",<10 % Hemolysis at 128 μg/ml,Human,Synthetic Analogue Peptide,NA,Low hemolytic,CCSCTTHHHHTTCSSSSTTTSCCCCCCTTSGGGSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
10345,30951211,2019,KWKKWWKWF,KWKKWWKWF{ct:Amid},"GN-2-Lys1,3,4,7Phe9",Amidation,Free,Linear,L,None,9,"Anti-biofilm, Antibacterial",<10 % Hemolysis at 128 μg/ml,Human,Synthetic Analogue Peptide,"water = Random coil, TFE = Random coil",NA,CCGGGHHHHHHHHTTSTTTCCSTTHHHHHHHHHHHTTCC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
10368,31303986,2019,H-KKKKKKKKKGGGLLALLALLA,KKKKKKKKKGGGLLALLALLA{nt:H}{ct:Amid},Block,Amidation,H,Linear,L,None,21,Antibacterial,50 % Hemolysis at 25 µM,Human,Synthetic Peptide,20 mM phosphate buffer solution with 1% SDS solution = α-Helix,NA,CHHHHHHIIIIITCTHHHHHHHHHHHHHCC,CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
10369,31303986,2019,H-KLLKKAGKLLKKAGKLLKKAG,KLLKKAGKLLKKAGKLLKKAG{nt:H}{ct:Amid},Stripe,Amidation,H,Linear,L,None,21,Antibacterial,50 % Hemolysis at >100 µM,Human,Synthetic Peptide,20 mM phosphate buffer solution with 1% SDS solution = α-Helix,Non-hemolytic,CCSCCHHHHHHHHHHHHHHHHHHHHHTSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)O
10370,31303986,2019,H-KKKLAKLKLGAKLKLKGKLGA,KKKLAKLKLGAKLKLKGKLGA{nt:H}{ct:Amid},Random,Amidation,H,Linear,L,None,21,Antibacterial,50 % Hemolysis at 100 µM,Human,Synthetic Peptide,20 mM phosphate buffer solution with 1% SDS solution = α-Helix,Low hemolytic,CHHHHHHIIIIITCTHHHHHHHHHHHHHCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](C)C(=O)O
10372,31199859,2019,FIGAIARLLSKI,FIGAIARLLSKI,BmKn-21,Free,Free,Linear,L,None,12,"Antibiofilm, Antibacterial",100 % Hemolysis at 800 µM,Sheep,Bmkn–2 Truncated Derivatives,NA,NA,CTTTHHHHHHHHHHHHHTTTTTTSCSCCCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
10373,31199859,2019,FIGAIARLLSK,FIGAIARLLSK,BmKn-22,Free,Free,Linear,L,None,11,"Antibiofilm, Antibacterial",10 % Hemolysis at 800 µM,Sheep,Bmkn–2 Truncated Derivatives,NA,Low hemolytic,CTTTHHHHHHHHHHHHHTTTSSTTCCCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O
10374,31199859,2019,FIGAIARLLS,FIGAIARLLS,BmKn-23,Free,Free,Linear,L,None,10,"Antibiofilm, Antibacterial",5 % Hemolysis at 800 µM,Sheep,Bmkn–2 Truncated Derivatives,NA,Non-hemolytic,CHHHHHHHHHTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O
10375,31199859,2019,FIGAIARLL,FIGAIARLL,BmKn-24,Free,Free,Linear,L,None,9,"Antibiofilm, Antibacterial",0 % Hemolysis at 800 µM,Sheep,Bmkn–2 Truncated Derivatives,NA,Non-hemolytic,CTTTHHHHHHHHHHHHHTTTTTTSCSCCCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
10376,31199859,2019,FIGAIARL,FIGAIARL,BmKn-25,Free,Free,Linear,L,None,8,"Antibiofilm, Antibacterial",10 % Hemolysis at 800 µM,Sheep,Bmkn–2 Truncated Derivatives,NA,Low hemolytic,CTTTHHHHHHHHHHHHHTTTSSTTCCCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O
10377,31199859,2019,FIGAIAR,FIGAIAR,BmKn-26,Free,Free,Linear,L,None,7,"Antibiofilm, Antibacterial",0 % Hemolysis at 800 µM,Sheep,Bmkn–2 Truncated Derivatives,NA,Non-hemolytic,CHHHHHHHHHTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10378,31216348,2019,TVIEVASKMCSKMRLLKGLCKSITKRFLRR,TVIEVASKMCSKMRLLKGLCKSITKRFLRR,bNK2A-C10C20,Free,Free,Linear,L,None,30,Antibacterial,<2 % Hemolysis at 5 µM,Cattle,Nk-Lysin-Derived Peptides,"TFE = α-Helix, NaPB = Random coil",Non-hemolytic,CCCCSCCSSCTTBGGGGSSSCCSSSTTSCSSSSBSTTTTHHHHTCCCCSSCCCCCCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
10379,31216348,2019,TVIEVASKMSSKMRLLKGLSKSITKRFLRR,TVIEVASKMSSKMRLLKGLSKSITKRFLRR,bNK2A-S10S20,Free,Free,Linear,L,None,30,Antibacterial,<2 % Hemolysis at 5 µM,Cattle,Nk-Lysin-Derived Peptides,"TFE = α-Helix, NaPB = Random coil",Non-hemolytic,CCCCCSTTHHIIIIITTSGGGGTCCSCSCCCCCCSHHHHHHHHTTTSCSSCCSSCCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
10380,31216348,2019,TVIEVASKMCSKMRLLKGLCKSITKRFLRR,TVIEVASKMCSKMRLLKGLCKSITKRFLRR,bNK2A-C10C20,Free,Free,Linear,L,None,30,Antibacterial,<2 % Hemolysis at 20 µM,Cattle,Nk-Lysin-Derived Peptides,"TFE = α-Helix, NaPB = Random coil",Non-hemolytic,CCSSGGGTTTTTTTTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
10381,31216348,2019,TVIEVASKMSSKMRLLKGLSKSITKRFLRR,TVIEVASKMSSKMRLLKGLSKSITKRFLRR,bNK2A-S10S20,Free,Free,Linear,L,None,30,Antibacterial,<2 % Hemolysis at 20 µM,Cattle,Nk-Lysin-Derived Peptides,"TFE = α-Helix, NaPB = Random coil",Non-hemolytic,CCSSGGGTTTTTTTTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
10390,30790604,2019,WFGKLYRGKTKVVKKVKGLLKG,WFGKLYRGKTKVVKKVKGLLKG{nt:Amid},Cnd-m3a,Free,Amidation,Linear,L,None,22,Antibacterial,5 % Hemolysis at 3 µM,Human,Mutant Of Cnd(Icefish Chionodraco Hamatus),α-Helix,NA,CCBCCSSSSSBSCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
10391,30790604,2019,WFGKLYRGKTKVVKKVKGLLKG,WFGKLYRGKTKVVKKVKGLLKG{nt:Amid},Cnd-m3a,Free,Amidation,Linear,L,None,22,Antibacterial,30 % Hemolysis at 50 µM,Human,Mutant Of Cnd(Icefish Chionodraco Hamatus),α-Helix,NA,NA,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
10401,32641937,2019,cyclo(CGAGHVPC)-Yy(GABA)fYG,CGAGHVPC-YY{d}{nnr:GABA}F{d}YG{cyc:1-8},MccJ25-derived peptide,Free,Free,Cyclic,Mix,GABA = gamma amino butyric acid,14,Antibacterial,0.26 ± 0.01 % Hemolysis at 200 µM,Human,Bacteria Enterobacteriacea Mccj25- Derived Peptide,β-Sheet,Non-hemolytic,NA,NA
10406,31016969,2019,KKLRLKIAFK,KKLRLKIAFK,PaDBS1R6F10,Free,Free,Linear,L,None,10,"Antibiofilm, Antibacterial, Anti-infective",50 % Hemolysis at >100 µM,Human,Derived From A Pyrobaculum Aerophilum Ribosomal Protein,NA,Low hemolytic,CCCCCCSCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
10407,31145591,2019,RWKRHISEQLRRRDRLQR,RWKRHISEQLRRRDRLQR,K17,Free,Free,Linear,L,None,18,Antibacterial,>1 % Hemolysis at 500 µM,Mouse,Synthetic Amp,NA,Non-hemolytic,CCCCCCSCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10408,31145591,2019,RWKRHISEQLRRRDRLQRQAF,RWKRHISEQLRRRDRLQRQAF,K18,Free,Free,Linear,L,None,21,Antibacterial,>1 % Hemolysis at 500 µM,Mouse,Synthetic Amp,NA,Non-hemolytic,CCCGGGTSCHHHHHHHHHHHHHSCCHHHHHHHHHHHHHHHHCGGGTSCTTCSSCCSGGGGGGGTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
10409,31145591,2019,RWKRHISEQLRRRDRLQRQAJ,RWKRHISEQLRRRDRLQRQA{nnr:J},K22,Free,Free,Linear,L,J = 2-naphthyl alanine (2-Nal),21,Antibacterial,>1 % Hemolysis at 500 µM,Mouse,Analogue Of K18,NA,Non-hemolytic,NA,NA
10410,31145591,2019,RWKRHISEQLRRRDRLQRQAJ,RWKRHISEQLRRRDRLQRQA{nnr:J}{ct:Amid},K22.2,Amidation,Free,Linear,L,J = 2-naphthyl alanine (2-Nal),21,Antibacterial,>1 % Hemolysis at 500 µM,Mouse,Synthetic Amp,NA,Non-hemolytic,NA,NA
10411,31145591,2019,R1-RWKRHISEQLRRRDRLQRQAJ,{conj:R1}RWKRHISEQLRRRDRLQRQA{nnr:J}{ct:Amid},K30,Amidation,R1,Linear,L,"R1 = 4-methylhexanoyl, J = 2-naphthyl alanine (2-Nal)",21,Antibacterial,>1 % Hemolysis at 500 µM,Mouse,Fatty Acid Conjugated With K22.2,"D8PG at 206nm = Random coil, D8PG at 220nm = α-Helix",Non-hemolytic,NA,NA
10412,31145591,2019,R2−RWKRHISEQLRRRDRLQRQAJ,{conj:R2}RWKRHISEQLRRRDRLQRQA{nnr:J}{ct:Amid},K31,Amidation,R2,Linear,L,"R2 = myristoyl, J = 2-naphthyl alanine (2-Nal)",21,Antibacterial,>80 % Hemolysis at 500 µM,Mouse,Fatty Acid Conjugated With K22.2,NA,NA,NA,NA
10413,31145591,2019,R3 −RWKRHISEQLRRRDRLQRQAJ,{conj:R3}RWKRHISEQLRRRDRLQRQA{nnr:J}{ct:Amid},K33,Amidation,R3,Linear,L,"R3 = palmitoyl, J = 2-naphthyl alanine (2-Nal)",21,Antibacterial,100 % Hemolysis at 500 µM,Mouse,Fatty Acid Conjugated With K22.2,NA,NA,NA,NA
10414,31145591,2019,R5 −RWKRHISEQLRRRDRLQRQAJ,{conj:R5}RWKRHISEQLRRRDRLQRQA{nnr:J}{ct:Amid},K36,Amidation,R5,Linear,L,"R5 = Fmoc, J = 2-naphthyl alanine (2-Nal)",21,Antibacterial,>20 % Hemolysis at 500 µM,Mouse,Fatty Acid Conjugated With K22.2,NA,NA,NA,NA
10415,31145591,2019,R4−RWKRHISEQLRRRDRLQRQAJ,{conj:R4}RWKRHISEQLRRRDRLQRQA{nnr:J}{ct:Amid},K46,Amidation,R4,Linear,L,"R4 = capryl, J = 2-naphthyl alanine (2-Nal)",21,Antibacterial,>10 % Hemolysis at 500 µM,Mouse,Fatty Acid Conjugated With K22.2,NA,NA,NA,NA
10419,31363941,2019,KWKKLLKKPLLKKLLKKL,KWKKLLKKPLLKKLLKKL{ct:Amid},P5,Amidation,Free,Linear,L,None,18,"Antibacterial, Antibiofilms",14 % Hemolysis at 100 µM,mouse,Cecropin A-Magainin 2 Hybrid Analog Peptide,"10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix",NA,CCTTTTCSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)O
10420,31363941,2019,KWKKLLKKPLLKKLLK,KWKKLLKKPLLKKLLK{ct:Amid},P5-CT1,Amidation,Free,Linear,L,None,16,"Antibacterial, Antibiofilms",0 % Hemolysis at 100 µM,mouse,Truncated Peptides P5,"10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix",Non-hemolytic,CCCCTTTSSSSTTSCCCCSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
10421,31363941,2019,KWKKLLKKPLLKKL,KWKKLLKKPLLKKL{ct:Amid},P5-CT2,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiofilms",0 % Hemolysis at 100 µM,mouse,Truncated Peptides P5,"10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = Random coil, LTA and LPS = Random coil",Non-hemolytic,CCCCTTTSSSSTTSCCCCSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)O
10422,31363941,2019,KWKKLLKKPLLK,KWKKLLKKPLLK{ct:Amid},P5-CT3,Amidation,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 100 µM,mouse,Truncated Peptides P5,"10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = Random coil, LTA and LPS = Random coil",Non-hemolytic,CCCCTTTSSSSTTSCCCCSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
10423,31363941,2019,KKLLKKPLLKKLLKKL,KKLLKKPLLKKLLKKL{ct:Amid},P5-NT1,Amidation,Free,Linear,L,None,16,"Antibacterial, Antibiofilms",0 % Hemolysis at 100 µM,mouse,Truncated Peptides P5,"10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix",Non-hemolytic,CCCCTTTSSSSTTSCCCCSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
10424,31363941,2019,LLKKPLLKKLLKKL,LLKKPLLKKLLKKL{ct:Amid},P5-NT2,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiofilms",0 % Hemolysis at 100 µM,mouse,Truncated Peptides P5,"10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix",Non-hemolytic,CCCCTTTSSSSTTSCCCCSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)O
10425,31363941,2019,KKPLLKKLLKKL,KKPLLKKLLKKL{ct:Amid},P5-NT3,Amidation,Free,Linear,L,None,12,"Antibacterial, Antibiofilms",0 % Hemolysis at 100 µM,mouse,Truncated Peptides P5,"10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix",Non-hemolytic,CCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
10435,31241636,2019,YNHNF,YNHNF,F3-3-a,Free,Free,Linear,L,None,5,Antibacterial,3.89±0.18 % Hemolysis at 300 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Low hemolytic,CTTTCC,NC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
10436,31241636,2019,WPTSFT,WPTSFT,F3-3-b,Free,Free,Linear,L,None,6,Antibacterial,4.73±0.23 % Hemolysis at 300 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Low hemolytic,CCSSCC,C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(=O)O
10437,31241636,2019,AVDRAV,AVDRAV,F3-3-c,Free,Free,Linear,L,None,6,Antibacterial,4.71±0.21 % Hemolysis at 300 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Low hemolytic,CCCC,CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)O
10438,31241636,2019,YNHNF,YNHNF,F3-3-a,Free,Free,Linear,L,None,5,Antibacterial,2.86±0.11 % Hemolysis at 150 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Low hemolytic,CTTTCC,NC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
10439,31241636,2019,WPTSFT,WPTSFT,F3-3-b,Free,Free,Linear,L,None,6,Antibacterial,3.60±0.20 % Hemolysis at 150 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Low hemolytic,CCSSCC,C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(=O)O
10440,31241636,2019,AVDRAV,AVDRAV,F3-3-c,Free,Free,Linear,L,None,6,Antibacterial,2.07±0.07 % Hemolysis at 150 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Low hemolytic,CCCC,CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)O
10441,31241636,2019,YNHNF,YNHNF,F3-3-a,Free,Free,Linear,L,None,5,Antibacterial,2.02±0.03 % Hemolysis at 10 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Low hemolytic,CTTTCC,NC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
10442,31241636,2019,WPTSFT,WPTSFT,F3-3-b,Free,Free,Linear,L,None,6,Antibacterial,2.53±0.11 % Hemolysis at 10 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Low hemolytic,CCSSCC,C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(=O)O
10443,31241636,2019,AVDRAV,AVDRAV,F3-3-c,Free,Free,Linear,L,None,6,Antibacterial,1.32±0.03 % Hemolysis at 10 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Non-hemolytic,CCCC,CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)O
10444,31241636,2019,YNHNF,YNHNF,F3-3-a,Free,Free,Linear,L,None,5,Antibacterial,3.91 ± 0.21 % Hemolysis at 250 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Low hemolytic,CTTTCC,NC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
10445,31241636,2019,WPTSFT,WPTSFT,F3-3-b,Free,Free,Linear,L,None,6,Antibacterial,4.24 ± 0.13 % Hemolysis at 250 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Low hemolytic,CCSSCC,C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(=O)O
10446,31241636,2019,AVDRAV,AVDRAV,F3-3-c,Free,Free,Linear,L,None,6,Antibacterial,3.82 ± 0.09 % Hemolysis at 250 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Low hemolytic,CCSCCBTTBCSSCBTTBCCCC,CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)O
10447,31241636,2019,YNHNF,YNHNF,F3-3-a,Free,Free,Linear,L,None,5,Antibacterial,3.56 ± 0.09 % Hemolysis at 200 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Low hemolytic,CCSCCBTTBCSSCBTTBCCCC,NC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
10448,31241636,2019,WPTSFT,WPTSFT,F3-3-b,Free,Free,Linear,L,None,6,Antibacterial,3.63 ± 0.09 % Hemolysis at 200 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Low hemolytic,CCSCCBTTBCSSCBTTBCCCC,C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(=O)O
10449,31241636,2019,AVDRAV,AVDRAV,F3-3-c,Free,Free,Linear,L,None,6,Antibacterial,2.31 ± 0.03 % Hemolysis at 200 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Low hemolytic,CCSCCBTTBCSSCBTTBCCCC,CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)O
10450,31241636,2019,YNHNF,YNHNF,F3-3-a,Free,Free,Linear,L,None,5,Antibacterial,2.24 ± 0.03 % Hemolysis at 100 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Low hemolytic,CCSCCBTTBCSSCBTTBCCCC,NC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
10451,31241636,2019,WPTSFT,WPTSFT,F3-3-b,Free,Free,Linear,L,None,6,Antibacterial,3.19 ± 0.18 % Hemolysis at 100 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Low hemolytic,CCCCCCSSSSSCCCCCCCCCC,C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(=O)O
10452,31241636,2019,AVDRAV,AVDRAV,F3-3-c,Free,Free,Linear,L,None,6,Antibacterial,1.41± 0.12 % Hemolysis at 100 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Low hemolytic,CCCCCCSSSSSCCCCCCCCCC,CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)O
10453,31241636,2019,YNHNF,YNHNF,F3-3-a,Free,Free,Linear,L,None,5,Antibacterial,2.15 ± 0.05 % Hemolysis at 50 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Low hemolytic,CCCCCCSSSSSCCCCCCCCCC,NC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
10454,31241636,2019,WPTSFT,WPTSFT,F3-3-b,Free,Free,Linear,L,None,6,Antibacterial,2.97 ± 0.14 % Hemolysis at 50 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Low hemolytic,CCCCCCSSSSSCCCCCCCCCC,C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(=O)O
10455,31241636,2019,AVDRAV,AVDRAV,F3-3-c,Free,Free,Linear,L,None,6,Antibacterial,1.41 ± 0.08 % Hemolysis at 50 µM,Mouse,Laba Garlic (Allium Sativum L.),"PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet",Non-hemolytic,CCCCCCSSSSSCCCCCCCCCC,CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)O
10456,31321199,2019,KDRPKKPGLCPLIWWLIIKVG,KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid},omw1,Amidation,Amidation,Linear,L,None,21,"Antibiofilm, Antibacterial",4.30 ± 0.15 % Hemolysis at 31.25 μg/ml,Human,"Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus)",NA,Low hemolytic,CTHHHHHHHTHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC
10457,31321199,2019,KDRPKKPGLCPLIWWLIIKVG,KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid},omw1,Amidation,Amidation,Linear,L,None,21,"Antibiofilm, Antibacterial",4.82 ± 0.33 % Hemolysis at 62.5 μg/ml,Human,"Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus)",NA,Low hemolytic,CTTHHHHSSGGGSGGGHHHHTTCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC
10458,31321199,2019,KDRPKKPGLCPLIWWLIIKVG,KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid},omw1,Amidation,Amidation,Linear,L,None,21,"Antibiofilm, Antibacterial",6.58 ± 0.25 % Hemolysis at 125 μg/ml,Human,"Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus)",NA,NA,CCCSSCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC
10459,31321199,2019,KDRPKKPGLCPLIWWLIIKVG,KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid},omw1,Amidation,Amidation,Linear,L,None,21,"Antibiofilm, Antibacterial",10.01 ± 0.52 % Hemolysis at 250 μg/ml,Human,"Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus)",NA,NA,CCTTHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC
10460,31321199,2019,KDRPKKPGLCPLIWWLIIKVG,KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid},omw1,Amidation,Amidation,Linear,L,None,21,"Antibiofilm, Antibacterial",14.46 ± 1.82 % Hemolysis at 500 μg/ml,Human,"Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus)",NA,NA,CHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC
10461,31321199,2019,KDRPKKPGLCPAAKKAAAAKA,KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid},omw2,Amidation,Amidation,Linear,L,None,21,"Antibiofilm, Antibacterial",1.26 ± 0.38 % Hemolysis at 31.25 μg/ml,Human,"Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus)",NA,Low hemolytic,CHHHHHHHTTTCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
10462,31321199,2019,KDRPKKPGLCPAAKKAAAAKA,KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid},omw2,Amidation,Amidation,Linear,L,None,21,"Antibiofilm, Antibacterial",3.12 ± 0.38 % Hemolysis at 62.5 μg/ml,Human,"Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus)",NA,Low hemolytic,CTHHHHTGGGTTC,CC(C)C[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
10463,31321199,2019,KDRPKKPGLCPAAKKAAAAKA,KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid},omw2,Amidation,Amidation,Linear,L,None,21,"Antibiofilm, Antibacterial",2.32 ± 0.43 % Hemolysis at 125 μg/ml,Human,"Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus)",NA,Low hemolytic,CHHHHHHHHHHTC,CC(C)C[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
10464,31321199,2019,KDRPKKPGLCPAAKKAAAAKA,KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid},omw2,Amidation,Amidation,Linear,L,None,21,"Antibiofilm, Antibacterial",4.82 ± 0.74 % Hemolysis at 250 μg/ml,Human,"Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus)",NA,Low hemolytic,CHHHHHHGGGTCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
10465,31321199,2019,KDRPKKPGLCPAAKKAAAAKA,KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid},omw2,Amidation,Amidation,Linear,L,None,21,"Antibiofilm, Antibacterial",9.27 ± 0.27 % Hemolysis at 500 μg/ml,Human,"Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus)",NA,NA,CHHHHHHHHHHTC,CC(C)C[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
10468,31359624,2019,GIIAGIIIKIKK,GIIAGIIIKIKK{ct:Amid},zp3,Amidation,Free,Linear,L,None,12,Antibacterial,<5 % Hemolysis at 256 µM,Rat,Derived From Phenol-Soluble Modulins (Psms) Virulent Staphylococcus Aureus Strains,"water = Random coil, SDS = α-Helix",Low hemolytic,CHHHHHGGGTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
10596,31291603,2019,RIVELTLPRVSVRL,RIVELTLPRVSVRL{ct:Amid},CF-14,Amidation,Free,Linear,L,None,14,Antibacterial,<5 % Hemolysis at 500 μg/ml,Sheep,Catfish Skin Mucus Of Pelteobagrus Fulvidraco,"PBS buffer = Random coil, membrane-mimetic 2.5% SDS micelle = α-Helix",Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C
10613,31448597,2019,KWKLFKKIGAVLKVL,KWKLFKKIGAVLKVL{ct:Amid},CM15,Amidation,Free,Linear,L,None,15,"Antibacterial, Antibiofilm",40 ± 5 % Hemolysis at 2 µM,mouse,Derived From Citropin1.1,α-Helix,NA,CCSCSCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
10614,31448597,2019,GGHKWKLFKKIGAVLKVL,GGHKWKLFKKIGAVLKVL{ct:Amid},GGH-CM15,Amidation,Free,Linear,L,None,18,"Antibacterial, Antibiofilm",29 ± 2 % Hemolysis at 2 µM,mouse,Variant Of Cm15,α-Helix,NA,CCSCSCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
10615,31448597,2019,VIHKWKLFKKIGAVLKVL,VIHKWKLFKKIGAVLKVL{ct:Amid},VIH-CM15,Amidation,Free,Linear,L,None,18,"Antibacterial, Antibiofilm",29 ± 3 % Hemolysis at 1 µM,mouse,Variant Of Cm15,α-Helix,NA,CCSCSCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
10616,31448597,2019,GLFDVIKKVASVIGGL,GLFDVIKKVASVIGGL{ct:Amid},citropin1.1,Amidation,Free,Linear,L,None,16,"Antibacterial, Antibiofilm",16.5 ± 3 % Hemolysis at 10 µM,mouse,Tree Frog Of The Litora Genus,α-Helix,NA,CCSCSCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O
10617,31448597,2019,GGHGLFDVIKKVASVIGGL,GGHGLFDVIKKVASVIGGL{ct:Amid},GGH-citropin1.1,Amidation,Free,Linear,L,None,19,"Antibacterial, Antibiofilm",0.2 ± 0.05 % Hemolysis at 34 µM,mouse,Modified Citropin1.1,α-Helix,Non-hemolytic,CGGGTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O
10618,31448597,2019,VIHGLFDVIKKVASVIGGL,VIHGLFDVIKKVASVIGGL{ct:Amid},VIH-citropin1.1,Amidation,Free,Linear,L,None,19,"Antibacterial, Antibiofilm",0.9 ± 0.1 % Hemolysis at >33 µM,mouse,Modified Citropin1.1,α-Helix,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)CC)C(C)C
10633,31207076,2019,LRWWLWKLLRRMR,LRWWLWKLLRRMR{ct:Amid},LR-10,Amidation,Free,Linear,L,None,13,"Antibacterial. Antibiofilm,",0 % Hemolysis at 3.3 µM(PBS),Rabbit,"Analogue Of Lr‐1 (Reutericin 6 And/Or Gassericin A,)",NA,Non-hemolytic,CHHHHHHHHTCTTSHHHHHHHHHGGGCC,CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10634,31207076,2019,LRWWLWKLLRRMR,LRWWLWKLLRRMR{ct:Amid},LR-10,Amidation,Free,Linear,L,None,13,"Antibacterial. Antibiofilm,",0 % Hemolysis at 3.3 µM(IGF),Rabbit,"Analogue Of Lr‐1 (Reutericin 6 And/Or Gassericin A,)",NA,Non-hemolytic,CTHHHHHHHHHHHHCCCCC,CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10635,31207076,2019,LRWWLWKLLRRMR,LRWWLWKLLRRMR{ct:Amid},LR-10,Amidation,Free,Linear,L,None,13,"Antibacterial. Antibiofilm,",>80 % Hemolysis at 52.3 µM(PBS),Rabbit,"Analogue Of Lr‐1 (Reutericin 6 And/Or Gassericin A,)",NA,NA,CHHHHTCCCC,CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10636,31207076,2019,LRWWLWKLLRRMR,LRWWLWKLLRRMR{ct:Amid},LR-10,Amidation,Free,Linear,L,None,13,"Antibacterial. Antibiofilm,",100 % Hemolysis at 52.3 µM(IGF),Rabbit,"Analogue Of Lr‐1 (Reutericin 6 And/Or Gassericin A,)",NA,NA,NA,CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10637,31513374,2019,CFQWKRAMRKVR,CFQWKRAMRKVR{ct:Amid},HLopt2-NH2,Amidation,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 200 μg/ml,Human,Antimicrobial Analogue,NA,Non-hemolytic,CCCSSSSTTTCSCCTTTCCC,CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
10638,31513374,2019,(Cip)-CFQWKRAMRKVR,{conj:CIP-CH2CO}CFQWKRAMRKVR{ct:Amid},CIP-CH2CO-HLopt2-NH2,Amidation,CIP-CH2CO,Linear,L,Cip = ciprofloxacin,12,Antibacterial,0 % Hemolysis at 200 μg/ml,Human,Hlopt2 With Conjugate,NA,Non-hemolytic,NA,NA
10639,31513374,2019,(Cip)-CFQWKRAMRKVR,{conj:CIP-Cys-S-S}CFQWKRAMRKVR{ct:Amid},CIP-Cys-S-S-HLopt2-NH2,Amidation,CIP-Cys-S-S,Linear,L,Cip = ciprofloxacin,13,Antibacterial,0 % Hemolysis at 200 μg/ml,Human,Hlopt2 With Conjugate,NA,Non-hemolytic,NA,NA
10640,31513374,2019,(Lvx)-CFQWKRAMRKVR,{conj:LVX}CFQWKRAMRKVR{ct:Amid},LVX-HLopt2-NH2,Amidation,LVX,Linear,L,Lvx = levofloxacin,12,Antibacterial,0 % Hemolysis at 200 μg/ml,Human,Hlopt2 With Conjugate,NA,Non-hemolytic,NA,NA
10656,31749789,2019,RLCRIVVIRVCR,RLCRIVVIRVCR{ct:Amid},L2C3V10C11,Amidation,Free,Linear,L,None,12,Antibacterial,5 % Hemolysis at 64 µM,Human,Derivatives Of Bactenecin,microbial membrane mimetic environments α-Helix,Low hemolytic,CTTTCTTSTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
10657,31749789,2019,RRFRIVVIRWLR,RRFRIVVIRWLR{ct:Amid},R2F3W10L11,Amidation,Free,Linear,L,None,12,Antibacterial,5 % Hemolysis at 128 µM,Human,Derivatives Of Bactenecin,microbial membrane mimetic environments α-Helix,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
10658,31749789,2019,RRWRIVVIRWRR,RRWRIVVIRWRR{ct:Amid},R2W3W10R11,Amidation,Free,Linear,L,None,12,Antibacterial,5 % Hemolysis at 128 µM,Human,Derivatives Of Bactenecin,microbial membrane mimetic environments α-Helix,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
10659,31749789,2019,RKWRIVVIRVRR,RKWRIVVIRVRR{ct:Amid},K2W3V10R11,Amidation,Free,Linear,L,None,12,Antibacterial,5 % Hemolysis at >256 µM,Human,Derivatives Of Bactenecin,microbial membrane mimetic environments α-Helix,Non-hemolytic,CCSSHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
10660,31749789,2019,RWRRIVVIRVRR,RWRRIVVIRVRR{ct:Amid},W2R3V10R11,Amidation,Free,Linear,L,None,12,Antibacterial,5 % Hemolysis at >256 µM,Human,Derivatives Of Bactenecin,microbial membrane mimetic environments α-Helix,Non-hemolytic,CHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
10661,31749789,2019,RWKRIVVIRKRR,RWKRIVVIRKRR{ct:Amid},W2K3K10R11,Amidation,Free,Linear,L,None,12,Antibacterial,5 % Hemolysis at >256 µM,Human,Derivatives Of Bactenecin,microbial membrane mimetic environments α-Helix,Non-hemolytic,CGGGTGGGGCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
10662,31749789,2019,RKRRIVVIRRKR,RKRRIVVIRRKR{ct:Amid},K2R3R10K11,Amidation,Free,Linear,L,None,12,Antibacterial,5 % Hemolysis at >256 µM,Human,Derivatives Of Bactenecin,microbial membrane mimetic environments α-Helix,Non-hemolytic,CCSSHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
10663,31710627,2019,FPFLLSLIPSAISAIKRL,FPFLLSLIPSAISAIKRL{ct:Amid},Uy234,Amidation,Free,Linear,L,None,18,Antibacterial,26.18 % Hemolysis at 380 µM,Human,Scorpion Urodacus Yaschenkoi,α-Helix,Low hemolytic,CCSSHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
10664,31710627,2019,ILSAIWSGIKGLL,ILSAIWSGIKGLL{ct:Amid},Uy17,Amidation,Free,Linear,L,None,13,Antibacterial,25 % Hemolysis at >380 µM,Human,Scorpion Urodacus Yaschenkoi,α-Helix,Low hemolytic,CHHHHIIIIITTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
10665,31710627,2019,FLSTIWNGIKGLL,FLSTIWNGIKGLL{ct:Amid},Uy192,Amidation,Free,Linear,L,None,13,Antibacterial,25 % Hemolysis at >380 µM,Human,Scorpion Urodacus Yaschenkoi,α-Helix,Low hemolytic,CGGGTGGGGCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
10666,31710627,2019,FFSLIPSLISGLI,FFSLIPSLISGLI{ct:Amid},QnCs-BUAP,Amidation,Free,Linear,L,None,13,Antibacterial,25 % Hemolysis at >380 µM,Human,Synthetic Peptide From Conserved Region,α-Helix,Low hemolytic,CCSSHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
10677,31667994,2019,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS{nt:H}{ct:Amid},Mag 2,Amidation,H,Linear,L,None,23,Antibacterial,Hemolysis at >100 µM,Human,Frogs,1%SDS = α-Helix,NA,CCCCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
10678,31667994,2019,GIGKFLHSAKKFGKAFV,GIGKFLHSAKKFGKAFV{nt:H}{ct:Amid},peptide-7,Amidation,H,Linear,L,None,17,Antibacterial,Hemolysis at >100 µM,Human,Truncated Peptide,1%SDS = Random coil,NA,CCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
10679,31667994,2019,GIKKFLKSAKKFVKAFK,GIKKFLKSAKKFVKAFK{nt:H}{ct:Amid},peptide-8,Amidation,H,Linear,L,None,17,Antibacterial,Hemolysis at 50 µM,Human,Truncated Peptide,1%SDS = α-Helix,NA,CCSSSSCCCCCSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
10680,31667994,2019,GIGKFLHSUKKFGKUFV,GIGKFLHS{nnr:U}KKFGK{nnr:U}FV{nt:H}{ct:Amid},peptide-9,Amidation,H,Linear,L,U = Aib(2-aminoisobutyric acid),17,Antibacterial,Hemolysis at >100 µM,Human,Truncated Peptide,1%SDS = α-Helix,NA,NA,NA
10681,31667994,2019,GIGKFLHSZKKFGKZFV,GIGKFLHS{nnr:Z}KKFGK{nnr:Z}FV{nt:H}{ct:Amid},peptide-10,Amidation,H,Linear,L,Z = Ac6c(1-aminocyclohexylcarboxylic acid),17,Antibacterial,Hemolysis at 3 µM,Human,Truncated Peptide,NA,NA,NA,NA
10682,31667994,2019,GIKKFLKSUKKFVKUFK,GIKKFLKS{nnr:U}KKFVK{nnr:U}FK{nt:H}{ct:Amid},peptide-11,Amidation,H,Linear,L,U = Aib(2-aminoisobutyric acid),17,Antibacterial,Hemolysis at 50 µM,Human,Truncated Peptide,1%SDS = Helical,NA,NA,NA
10683,31667994,2019,GIKKFLKSZKKFVKZFK,GIKKFLKS{nnr:Z}KKFVK{nnr:Z}FK{nt:H}{ct:Amid},peptide-12,Amidation,H,Linear,L,Z = Ac6c(1-aminocyclohexylcarboxylic acid),17,Antibacterial,Hemolysis at 3 µM,Human,Truncated Peptide,1%SDS = Helical,NA,NA,NA
10684,31775224,2019,IRPIRP,IRPIRP{cyc:N-C},OIR1,Free,Free,Cyclic,L,None,6,Antibacterial,≥5 % Hemolysis at >128 µM,Human,Synthetic Cyclic Amps,"aqueous = unordered, β-Hairpin",Low hemolytic,CCSSSCSTTSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC
10685,31775224,2019,IRIRPIRIRP,IRIRPIRIRP{cyc:N-C},OIR2,Free,Free,Cyclic,L,None,10,Antibacterial,≥5 % Hemolysis at >128 µM,Human,Synthetic Cyclic Amps,"aqueous = unordered, β-Hairpin",Low hemolytic,CCSSSSTTSSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
10686,31775224,2019,IRIRIRPIRIRIRP,IRIRIRPIRIRIRP{cyc:N-C},OIR3,Free,Free,Cyclic,L,None,14,"Antibacterial, Anti-Inflammatory",≥5 % Hemolysis at >128 µM,Human,Synthetic Cyclic Amps,"aqueous = unordered, β-Hairpin",Low hemolytic,CCSSTTSCSSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
10687,31775224,2019,IRPIRP,IRPIRP,IR1,Free,Free,Linear,L,None,6,Antibacterial,≥5 % Hemolysis at >128 µM,Human,Synthetic Linear Amps,"aqueous = unordered, 30 mM anionic = unordered",Low hemolytic,CCCTHHHHSCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC
10688,31775224,2019,IRIRPIRIRP,IRIRPIRIRP,IR2,Free,Free,Linear,L,None,10,Antibacterial,≥5 % Hemolysis at >128 µM,Human,Synthetic Linear Amps,"aqueous = unordered, 30 mM anionic = unordered",Low hemolytic,CCSCCSSSSHHHHTTCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
10689,31775224,2019,IRIRIRPIRIRIRP,IRIRIRPIRIRIRP,IR3,Free,Free,Linear,L,None,14,"Antibacterial, Anti-Inflammatory",≥5 % Hemolysis at >128 µM,Human,Synthetic Linear Amps,"aqueous = unordered, 30 mM anionic = unordered",Low hemolytic,CCTTTTCSSSSTTTSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
10690,31775224,2019,IRpIRp,IRP{d}IRP{d},DIR1,Free,Free,Linear,Mix,p = D-Proline,6,Antibacterial,≥5 % Hemolysis at >128 µM,Human,Synthetic D-Proline Amps,50% TFE = β-Sheet,Low hemolytic,CCGGGTTTHHHHTTTCCC,NA
10691,31775224,2019,IRIRpIRIRp,IRIRP{d}IRIRP{d},DIR2,Free,Free,Linear,Mix,p = D-Proline,10,Antibacterial,≥5 % Hemolysis at >128 µM,Human,Synthetic D-Proline Amps,"aqueous = unordered, 50% TFE = β-Sheet",Low hemolytic,CCTTGGGTHHHHHHHTCC,NA
10692,31775224,2019,IRIRIRpIRIRIRp,IRIRIRP{d}IRIRIRP{d},DIR3,Free,Free,Linear,Mix,p = D-Proline,14,"Antibacterial, Anti-Inflammatory",≥5 % Hemolysis at >128 µM,Human,Synthetic D-Proline Amps,"aqueous = unordered, 50% TFE = β-Hairpin",Low hemolytic,CCTTHHHHHHHHHHHTCC,NA
10693,31442359,2019,WLKAAAKAAAKLW,WLKAAAKAAAKLW{ct:Amid},WL,Amidation,Free,Linear,L,None,13,Antibacterial,5 % Hemolysis at 256 µM,Human,Synthetic Peptide,30 mM SDS or 50% TFE = α‐Helix,Low hemolytic,CHHHHHHHHHHHTTTSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
10694,31442359,2019,LWKAAAKAAAKWL,LWKAAAKAAAKWL{ct:Amid},LW,Amidation,Free,Linear,L,None,13,Antibacterial,5 % Hemolysis at >256 µM,Human,Synthetic Peptide,30 mM SDS or 50% TFE = α‐Helix,Low hemolytic,CCTTTHHHHHHHTCSCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)O
10695,31442359,2019,LWKAAAKAAAKLL,LWKAAAKAAAKLL{ct:Amid},LW-1,Amidation,Free,Linear,L,None,13,Antibacterial,5 % Hemolysis at 256 µM,Human,Synthetic Peptide,30 mM SDS or 50% TFE = α‐Helix,Low hemolytic,CCSCHHHHHHHGGGGGGC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)O
10696,31442359,2019,LWKAAAKAAAKLW,LWKAAAKAAAKLW{ct:Amid},LW-2,Amidation,Free,Linear,L,None,13,Antibacterial,5 % Hemolysis at 256 µM,Human,Synthetic Peptide,30 mM SDS or 50% TFE = α‐Helix,Low hemolytic,CCCSSSSSSHHHHHHCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
10697,31442359,2019,AAKAWLKLWAKAA,AAKAWLKLWAKAA{ct:Amid},LW-3,Amidation,Free,Linear,L,None,13,Antibacterial,5 % Hemolysis at >256 µM,Human,Synthetic Peptide,30 mM SDS or 50% TFE = α‐Helix,Low hemolytic,CCSTTTSSSSHHHHHCCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
10698,31520928,2019,YEIKINRHFKTLKKNLKK,YEIKINRHFKTLKKNLKK{ct:Amid},H5,Amidation,Free,Linear,L,None,18,Antibacterial,10 % Hemolysis at >640 μg/ml,Murine,Bighead Carp Aristicluthys Nobilia Ifn-I,NA,Low hemolytic,CGGGTSSCTTCCTHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
10699,31520928,2019,YIRKINRHFKTLKKNLKK,YIRKINRHFKTLKKNLKK{ct:Amid},P1,Amidation,Free,Linear,L,None,18,Antibacterial,10 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,NA,Low hemolytic,CTTGGGHHHHHHTGGGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
10700,31520928,2019,YIRKIRRFFKTLNKNLKK,YIRKIRRFFKTLNKNLKK{ct:Amid},P2,Amidation,Free,Linear,L,None,18,Antibacterial,10 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,NA,Low hemolytic,CCSSSCCTTCSGGGSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
10701,31520928,2019,YIRKIRRFFKKLNKNLKK,YIRKIRRFFKKLNKNLKK{ct:Amid},P3,Amidation,Free,Linear,L,None,18,Antibacterial,10 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,NA,Low hemolytic,CCSCCSSSSHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
10702,31520928,2019,YFRTIRRFFKKLFKTLKK,YFRTIRRFFKKLFKTLKK{ct:Amid},P4,Amidation,Free,Linear,L,None,18,Antibacterial,10 % Hemolysis at 640 μg/ml,Murine,H5-Derived Peptides,MME = α‐Helical,Low hemolytic,CCTTTTCSSSSTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
10703,31520928,2019,YIRKIRRFFKKLKKILKK,YIRKIRRFFKKLKKILKK{ct:Amid},P5,Amidation,Free,Linear,L,None,18,"Antibacterial, Antibiofilm",10 % Hemolysis at 640 μg/ml,Murine,H5-Derived Peptides,Helical,Low hemolytic,CCGGGTTTHHHHTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
10704,31520928,2019,YIRKIRRFFKKRFKFRKK,YIRKIRRFFKKRFKFRKK{ct:Amid},P6,Amidation,Free,Linear,L,None,18,Antibacterial,10 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,NA,Low hemolytic,CCTTGGGTHHHHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
10705,31520928,2019,WVRKVRRWWKKVKKVVKK,WVRKVRRWWKKVKKVVKK{ct:Amid},P7,Amidation,Free,Linear,L,None,18,Antibacterial,10 % Hemolysis at 80.04 ± 7.2 μg/ml,Murine,H5-Derived Peptides,MME = β-Turn,NA,CCTTHHHHHHHHHHHTCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C
10706,31520928,2019,SYEIKINRHFKTLKKNLKKK,SYEIKINRHFKTLKKNLKKK{ct:Amid},P8,Amidation,Free,Linear,L,None,20,Antibacterial,10 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,NA,Low hemolytic,CHHHHHHHHHHHTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
10707,31520928,2019,SYERKINRHFKTLKKNLKKK,SYERKINRHFKTLKKNLKKK{ct:Amid},P9,Amidation,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",10 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,NA,Low hemolytic,CCTTTHHHHHHHTCSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
10708,31520928,2019,WYERLINRKFKWLKGRLSKK,WYERLINRKFKWLKGRLSKK{ct:Amid},P10,Amidation,Free,Linear,L,None,20,Antibacterial,10 % Hemolysis at 178.82 ± 12.6 μg/ml,Murine,H5-Derived Peptides,MME = β-Turn,NA,CCSCHHHHHHHGGGGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
10709,31520928,2019,LYKRYILRKFKFLKKKLKKK,LYKRYILRKFKFLKKKLKKK{ct:Amid},P11,Amidation,Free,Linear,L,None,20,Antibacterial,10 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,NA,Low hemolytic,CCCSSSSSSHHHHHHCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
10710,31520928,2019,VWKRWVVRKWKWVKKKVKKK,VWKRWVVRKWKWVKKKVKKK{ct:Amid},P12,Amidation,Free,Linear,L,None,20,Antibacterial,10 % Hemolysis at 57.24 ± 5.2 μg/ml,Murine,H5-Derived Peptides,MME = β-Turn,NA,CCSTTTSSSSHHHHHCCCC,CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
10711,31520928,2019,YEIKINRHFKTLKKNLKK,YEIKINRHFKTLKKNLKK{ct:Amid},H5,Amidation,Free,Linear,L,None,18,Antibacterial,50 % Hemolysis at >640 μg/ml,Murine,Bighead Carp Aristicluthys Nobilia Ifn-I,NA,Low hemolytic,CGGGTSSCTTCCTHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
10712,31520928,2019,YIRKINRHFKTLKKNLKK,YIRKINRHFKTLKKNLKK{ct:Amid},P1,Amidation,Free,Linear,L,None,18,Antibacterial,50 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,NA,Low hemolytic,CTTGGGHHHHHHTGGGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
10713,31520928,2019,YIRKIRRFFKTLNKNLKK,YIRKIRRFFKTLNKNLKK{ct:Amid},P2,Amidation,Free,Linear,L,None,18,Antibacterial,50 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,NA,Low hemolytic,CCSSSCCTTCSGGGSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
10714,31520928,2019,YIRKIRRFFKKLNKNLKK,YIRKIRRFFKKLNKNLKK{ct:Amid},P3,Amidation,Free,Linear,L,None,18,Antibacterial,50 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,NA,Low hemolytic,CHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
10715,31520928,2019,YFRTIRRFFKKLFKTLKK,YFRTIRRFFKKLFKTLKK{ct:Amid},P4,Amidation,Free,Linear,L,None,18,Antibacterial,50 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,MME = α‐Helical,Low hemolytic,CGGGGGTTGGGTC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
10716,31520928,2019,YIRKIRRFFKKLKKILKK,YIRKIRRFFKKLKKILKK{ct:Amid},P5,Amidation,Free,Linear,L,None,18,"Antibacterial, Antibiofilm",50 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,Helical,Low hemolytic,CCTHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
10717,31520928,2019,YIRKIRRFFKKRFKFRKK,YIRKIRRFFKKRFKFRKK{ct:Amid},P6,Amidation,Free,Linear,L,None,18,Antibacterial,50 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,NA,Low hemolytic,CTHHIIIIIHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
10718,31520928,2019,WVRKVRRWWKKVKKVVKK,WVRKVRRWWKKVKKVVKK{ct:Amid},P7,Amidation,Free,Linear,L,None,18,Antibacterial,50 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,MME = β-Turn,Low hemolytic,CCHHHHHHHTTTC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C
10719,31520928,2019,SYEIKINRHFKTLKKNLKKK,SYEIKINRHFKTLKKNLKKK{ct:Amid},P8,Amidation,Free,Linear,L,None,20,Antibacterial,50 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,NA,Low hemolytic,CCCCTTTTGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
10720,31520928,2019,SYERKINRHFKTLKKNLKKK,SYERKINRHFKTLKKNLKKK{ct:Amid},P9,Amidation,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",50 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,NA,Low hemolytic,CCSSHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
10721,31520928,2019,WYERLINRKFKWLKGRLSKK,WYERLINRKFKWLKGRLSKK{ct:Amid},P10,Amidation,Free,Linear,L,None,20,Antibacterial,50 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,MME = β-Turn,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
10722,31520928,2019,LYKRYILRKFKFLKKKLKKK,LYKRYILRKFKFLKKKLKKK{ct:Amid},P11,Amidation,Free,Linear,L,None,20,Antibacterial,50 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,NA,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
10723,31520928,2019,VWKRWVVRKWKWVKKKVKKK,VWKRWVVRKWKWVKKKVKKK{ct:Amid},P12,Amidation,Free,Linear,L,None,20,Antibacterial,50 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,MME = β-Turn,Low hemolytic,CCCCBTTBSSCCCTTTTTSTTC,CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
10733,31713951,2019,KGIRGYKGGYCKGAFKQTCKCY,KGIRGYKGGYCKGAFKQTCKCY,Os,Free,Free,Linear,L,None,22,Antibacterial,0 % Hemolysis at 25 µM,Human,Soft Tick Ornithodoros Savignyi,NA,Non-hemolytic,CCSHHHHCSSTTHHHHHHHTTTSCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O
10734,31713951,2019,IRGYKGGYCK,IRGYKGGYCK{ct:Amid},Os(3‐12)NH2,Amidation,Free,Linear,L,None,10,Antibacterial,0 % Hemolysis at 25 µM,Human,Synthetic Peptide Analogues Of Os,"water = unstructured, SDS = unstructured",Non-hemolytic,NA,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O
10735,31713951,2019,CKGAFKQTCKCY,CKGAFKQTCKCY{ct:Amid},Os(11‐22)NH2,Amidation,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 25 µM,Human,Synthetic Peptide Analogues Of Os,"water = Random coil, SDS = Random coil",Non-hemolytic,NA,C[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O
10736,31713951,2019,KGIRGYKGGYCKGAFKQTCKCY,KGIRGYKGGYCKGAFKQTCKCY,Os,Free,Free,Linear,L,None,22,Antibacterial,0 % Hemolysis at 100 µM,Human,Soft Tick Ornithodoros Savignyi,NA,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O
10737,31713951,2019,IRGYKGGYCK,IRGYKGGYCK{ct:Amid},Os(3‐12)NH2,Amidation,Free,Linear,L,None,10,Antibacterial,0 % Hemolysis at 100 µM,Human,Synthetic Peptide Analogues Of Os,"water = unstructured, SDS = unstructured",Non-hemolytic,NA,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O
10738,31713951,2019,CKGAFKQTCKCY,CKGAFKQTCKCY{ct:Amid},Os(11‐22)NH2,Amidation,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 100 µM,Human,Synthetic Peptide Analogues Of Os,"water = Random coil, SDS = Random coil",Non-hemolytic,NA,C[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O
10739,31827113,2019,G-dab-GswS-Dab-dab-IEI-aIle-S,G-{nnr:dab}-GS{d}W{d}S-{nnr:Dab}-{nnr:dab}-IEI-{nnr:aIle}-S,M1 (or M),Free,Free,Linear,Mix,"dab = D-2,4-diaminobutyric acid (D-Dab), aile = D-aIle, Dab = 2,4-diaminobutyric acid",13,Antibacterial,10 % Hemolysis at 128 μg/ml,Rabbit,"Tridecaptin M A Mud Bacterium, Paenibacillus Sp. M-152",NA,Low hemolytic,NA,NA
10740,31827113,2019,G-dab-GswS-Dab-dab-IEVvS,G-{nnr:dab}-GS{d}W{d}S-{nnr:Dab}-{nnr:dab}-IEVV{d}S,M2,Free,Free,Linear,Mix,"dab = D-2,4-diaminobutyric acid (D-Dab), Dab = 2,4-diaminobutyric acid",13,Antibacterial,2 % Hemolysis at 128 μg/ml,Rabbit,Variants Of Tridecaptin M,NA,Non-hemolytic,NA,NA
10741,31827113,2019,G-dab-GsDFS-Dab-dab-IEIvS,G-{nnr:dab}-GS{d}DFS-{nnr:Dab}-{nnr:dab}-IEIV{d}S,M5,Free,Free,Linear,Mix,"dab = D-2,4-diaminobutyric acid (D-Dab), Dab = 2,4-diaminobutyric acid",13,Antibacterial,0 % Hemolysis at 128 μg/ml,Rabbit,Variants Of Tridecaptin M,NA,Non-hemolytic,NA,NA
10742,31827113,2019,G-dab-GswS-Dab-dab-IEIvS,G-{nnr:dab}-GS{d}W{d}S-{nnr:Dab}-{nnr:dab}-IEIV{d}S,M6,Free,Free,Linear,Mix,"dab = D-2,4-diaminobutyric acid (D-Dab), Dab = 2,4-diaminobutyric acid",13,Antibacterial,>15 % Hemolysis at 128 μg/ml,Rabbit,Variants Of Tridecaptin M,NA,NA,NA,NA
10743,31827113,2019,G-dab-GswS-Dab-dab-VEI-aIle-S,G-{nnr:dab}-GS{d}W{d}S-{nnr:Dab}-{nnr:dab}-VEI-{nnr:aIle}-S,M7,Free,Free,Linear,Mix,"dab = D-2,4-diaminobutyric acid (D-Dab), aile = D-aIle, Dab = 2,4-diaminobutyric acid",13,Antibacterial,1 % Hemolysis at 128 μg/ml,Rabbit,Variants Of Tridecaptin M,NA,Non-hemolytic,NA,NA
10744,31827113,2019,G-dab-GsDFS-Dab-dab-IEI-aIle-S,G-{nnr:dab}-GS{d}DFS-{nnr:Dab}-{nnr:dab}-IEI-{nnr:aIle}-S,M8,Free,Free,Linear,Mix,"dab = D-2,4-diaminobutyric acid (D-Dab), aile = D-aIle, Dab = 2,4-diaminobutyric acid",13,Antibacterial,>9 % Hemolysis at 128 μg/ml,Rabbit,Variants Of Tridecaptin M,NA,Low hemolytic,NA,NA
10745,31827113,2019,dab-FEI-aIle-S,{nnr:dab}-FEI-{nnr:aIle}-S,M11,Free,Free,Linear,Mix,"dab = D-2,4-diaminobutyric acid (D-Dab), aile = D-aIle, Dab = 2,4-diaminobutyric acid",6,Antibacterial,50 % Hemolysis at 128 μg/ml,Rabbit,Variants Of Tridecaptin M,NA,NA,NA,NA
10803,31676352,2019,GLLk(C4)RIkTLL,GLLK{d}{conj:C4}RIK{d}TLL{ct:Amid},"Ano-D4,7-4C4",Amidation,Free,Linear,Mix,C4 = C4,10,"Antibacterial,",10 % Hemolysis at >256 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",Low hemolytic,NA,NA
10804,31676352,2019,GLLk(C6)RIkTLL,GLLK{d}{conj:C6}RIK{d}TLL{ct:Amid},"Ano-D4,7-4C6",Amidation,Free,Linear,Mix,C6 = C6,10,Antibacterial,10 % Hemolysis at >256 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",Low hemolytic,NA,NA
10805,31676352,2019,GLLk(C8)RIkTLL,GLLK{d}{conj:C8}RIK{d}TLL{ct:Amid},"Ano-D4,7-4C8",Amidation,Free,Linear,Mix,C8 = C8,10,"Antibacterial, Antibiofilm",10 % Hemolysis at >256 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",Low hemolytic,NA,NA
10806,31676352,2019,GLLk(C10)RIkTLL,GLLK{d}{conj:C10}RIK{d}TLL{ct:Amid},"Ano-D4,7-4C10",Amidation,Free,Linear,Mix,C10 = C10,10,"Antibacterial, Antibiofilm",10 % Hemolysis at 256 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",Low hemolytic,NA,NA
10807,31676352,2019,GLLk(C12)RIkTLL,GLLK{d}{conj:C12}RIK{d}TLL{ct:Amid},"Ano-D4,7-4C12",Amidation,Free,Linear,Mix,C12 = C12,10,"Antibacterial, Antibiofilm",10 % Hemolysis at 32 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",NA,NA,NA
10808,31676352,2019,GLLk(C14)RIkTLL,GLLK{d}{conj:C14}RIK{d}TLL{ct:Amid},"Ano-D4,7-4C14",Amidation,Free,Linear,Mix,C14 = C14,10,Antibacterial,10 % Hemolysis at 32 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",NA,NA,NA
10809,31676352,2019,GLLk(C16)RIkTLL,GLLK{d}{conj:C16}RIK{d}TLL{ct:Amid},"Ano-D4,7-4C16",Amidation,Free,Linear,Mix,C16 = C16,10,Antibacterial,10 % Hemolysis at 16 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",NA,NA,NA
10810,31676352,2019,GLLkRIk(C4)TLL,GLLK{d}RIK{d}{conj:C4}TLL{ct:Amid},"Ano-D4,7-7C4",Amidation,Free,Linear,Mix,C4 = C4,10,Antibacterial,10 % Hemolysis at >256 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",Low hemolytic,NA,NA
10811,31676352,2019,GLLkRIk(C6)TLL,GLLK{d}RIK{d}{conj:C6}TLL{ct:Amid},"Ano-D4,7-7C6",Amidation,Free,Linear,Mix,C6 = C6,10,Antibacterial,10 % Hemolysis at >256 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",Low hemolytic,NA,NA
10812,31676352,2019,GLLkRIk(C8)TLL,GLLK{d}RIK{d}{conj:C8}TLL{ct:Amid},"Ano-D4,7-7C8",Amidation,Free,Linear,Mix,C8 = C8,10,"Antibacterial, Antibiofilm",10 % Hemolysis at 256 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",Low hemolytic,NA,NA
10813,31676352,2019,GLLkRIk(C10)TLL,GLLK{d}RIK{d}{conj:C10}TLL{ct:Amid},"Ano-D4,7-7C10",Amidation,Free,Linear,Mix,C10 = C10,10,"Antibacterial, Antibiofilm",10 % Hemolysis at 128 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",Low hemolytic,NA,NA
10814,31676352,2019,GLLkRIk(C12)TLL,GLLK{d}RIK{d}{conj:C12}TLL{ct:Amid},"Ano-D4,7-7C12",Amidation,Free,Linear,Mix,C12 = C12,10,"Antibacterial, Antibiofilm",10 % Hemolysis at 32 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",NA,NA,NA
10815,31676352,2019,GLLkRIk(C14)TLL,GLLK{d}RIK{d}{conj:C14}TLL{ct:Amid},"Ano-D4,7-7C14",Amidation,Free,Linear,Mix,C14 = C14,10,Antibacterial,10 % Hemolysis at 16 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",NA,NA,NA
10816,31676352,2019,GLLkRIk(C16)TLL,GLLK{d}RIK{d}{conj:C16}TLL{ct:Amid},"Ano-D4,7-7C16",Amidation,Free,Linear,Mix,C16 = C16,10,Antibacterial,10 % Hemolysis at 16 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",NA,NA,NA
10817,31676352,2019,GLLKRIKTLL,GLLKRIKTLL{ct:Amid},Anoplin,Amidation,Free,Linear,L,None,10,"Antibacterial, Antibiofilm",10 % Hemolysis at >256 µM,mouse,Venom Sac Of Solitary Spider Wasps,α-Helical,Low hemolytic,CTHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
10818,31676352,2019,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid},Melittin,Amidation,Free,Linear,L,None,26,"Antibacterial, Antibiofilm",75 % Hemolysis at 2 µM,mouse,Honey Bee Apis Mellifera,α-Helical,NA,CHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
10820,31938070,2020,GIGKFLKKAKKFGK,GIGKFLKKAKKFGK,MSI-78,Free,Free,Linear,L,None,14,Antibacterial,50 % Hemolysis at >400 µM,Sheep,Derived From The Magainin 2 Peptide,α-Helix,Low hemolytic,CC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O
10821,31938070,2020,GIWKFLKKAKKFWK,GIWKFLKKAKKFWK,MSI-1,Free,Free,Linear,L,None,14,Antibacterial,50 % Hemolysis at >400 µM,Sheep,Msi-78 Analogs,SDS = α-Helix,Low hemolytic,CC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
10822,31938070,2020,GIWKFLKKAKKFW,GIWKFLKKAKKFW,MSI-3,Free,Free,Linear,L,None,13,Antibacterial,50 % Hemolysis at >400 µM,Sheep,Msi-78 Analogs,Helical,Low hemolytic,CC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
10823,31938070,2020,WIRKFLKRVKKFG,WIRKFLKRVKKFG,MSI-4,Free,Free,Linear,L,None,13,Antibacterial,50 % Hemolysis at >400 µM,Sheep,Msi-78 Analogs,Helical,Low hemolytic,CC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O)C(C)C
10870,31887002,2020,LKKLCARLKKLCAR,LKKLCARLKKLCAR{ct:Amid},CAR2,Amidation,Free,Linear,L,None,14,"Antifungal, Antibacterial",10 % Hemolysis at >128 µM,Human,Heptad Repeat Sequence Antifungal Peptide,"PBS = Random coil, PBS(208-222nm) = α-Helical, SDS/TFE = α-Helical",Low hemolytic,CCSGGGGTHHHHHHHHHHHHHHHHSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10871,31887002,2020,LKKLCARLKKLCARLKKLCAR,LKKLCARLKKLCARLKKLCAR{ct:Amid},CAR3,Amidation,Free,Linear,L,None,21,"Antifungal, Antibacterial",10 % Hemolysis at >128 µM,Human,Heptad Repeat Sequence Antifungal Peptide,"PBS = Random coil, PBS(208-222nm) = α-Helical, SDS/TFE = α-Helical",Low hemolytic,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10872,31887002,2020,LKKLCARLKKLCARLKKLCARLKKLCAR,LKKLCARLKKLCARLKKLCARLKKLCAR{ct:Amid},CAR4,Amidation,Free,Linear,L,None,28,"Antifungal, Antibacterial",10 % Hemolysis at 8 µM,Human,Heptad Repeat Sequence Antifungal Peptide,"PBS = Random coil, SDS/TFE = α-Helical",NA,CCSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10873,31887002,2020,LKKLACRLKKLACR,LKKLACRLKKLACR{ct:Amid},ACR2,Amidation,Free,Linear,L,None,14,"Antifungal, Antibacterial",10 % Hemolysis at >128 µM,Human,Heptad Repeat Sequence Antifungal Peptide,"PBS = Random coil, PBS(208-222nm) = α-Helical, SDS/TFE = α-Helical",Low hemolytic,CTTSSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10874,31887002,2020,LKKLACRLKKLACRLKKLACR,LKKLACRLKKLACRLKKLACR{ct:Amid},ACR3,Amidation,Free,Linear,L,None,21,"Antibiofilm, Antifungal, Antibacterial",10 % Hemolysis at >128 µM,Human,Heptad Repeat Sequence Antifungal Peptide,"PBS = Random coil, PBS(208-222nm) = α-Helical, SDS/TFE = α-Helical",Low hemolytic,CCCBTTBC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10875,31887002,2020,LKKLACRLKKLACRLKKLACRLKKLACR,LKKLACRLKKLACRLKKLACRLKKLACR{ct:Amid},ACR4,Amidation,Free,Linear,L,None,28,"Antifungal, Antibacterial",10 % Hemolysis at 32 µM,Human,Heptad Repeat Sequence Antifungal Peptide,"PBS = Random coil, PBS(208-222nm) = α-Helical, SDS/TFE = α-Helical",NA,CCSCSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10876,31887002,2020,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid},Melittin (MLT),Amidation,Free,Linear,L,None,26,"Antifungal, Antibacterial",10 % Hemolysis at 1 µM,Human,Heptad Repeat Sequence Antifungal Peptide,"PBS = Random coil, PBS(208-222nm) = α-Helical, SDS/TFE = α-Helical",NA,CCSSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
10887,31483516,2020,VGGTICGPACAVAGAHYLPI,VGGTICGPACAVAGAHYLPI,1,Free,Free,Linear,L,None,20,Antibacterial,Low Hemolysis at 128 µM,Sheep,Synthetic Peptide,"low helicity, Random coil",Low hemolytic,CCCGGGGTGGGTCCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](N)C(C)C)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(=O)O
10888,31483516,2020,GWFKTYKDWPVIISNVPGVI,GWFKTYKDWPVIISNVPGVI,2,Free,Free,Linear,L,None,20,Antibacterial,increased % Hemolysis at 128 µM,Sheep,Synthetic Peptide,"low helicity, Random coil",NA,CCSSSSCSCTTSTTCSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C)C(=O)O
10889,31483516,2020,IKKIGKKAAKKVIVKAIQAI,IKKIGKKAAKKVIVKAIQAI,3,Free,Free,Linear,L,None,20,Antibacterial,Low Hemolysis at 128 µM,Sheep,Synthetic Peptide,α-Helical,Low hemolytic,CTTTCCCCGGGGTTTCCTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
10890,31483516,2020,KKIGKKAAKKVIVKAIQAIV,KKIGKKAAKKVIVKAIQAIV,4,Free,Free,Linear,L,None,20,Antibacterial,Low Hemolysis at 128 µM,Sheep,Synthetic Peptide,α-Helical,Low hemolytic,CCTTHHHHHHSSCCGGGCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)CC
10891,31483516,2020,FLGEWLFVTRKAKRKHKHAA,FLGEWLFVTRKAKRKHKHAA,5,Free,Free,Linear,L,None,20,Antibacterial,Low Hemolysis at 128 µM,Sheep,Synthetic Peptide,Helical,Low hemolytic,CCSHHHHSCSCSTTSCCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
10892,31483516,2020,VKFAIKKIGKKAAKKVIVKA,VKFAIKKIGKKAAKKVIVKA,6,Free,Free,Linear,L,None,20,Antibacterial,Low Hemolysis at 128 µM,Sheep,Synthetic Peptide,Helical,Low hemolytic,CCSSSCCTTGGGSSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
10893,31483516,2020,SFLGEWLFVTRKAKRKHKHA,SFLGEWLFVTRKAKRKHKHA,7,Free,Free,Linear,L,None,20,Antibacterial,Low Hemolysis at 128 µM,Sheep,Synthetic Peptide,Helical,Low hemolytic,CCCSCSSSHHHHHHHSCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
10894,31483516,2020,QAAKKMSNKEKAAKRWIAMR,QAAKKMSNKEKAAKRWIAMR,8,Free,Free,Linear,L,None,20,Antibacterial,Low Hemolysis at 128 µM,Sheep,Synthetic Peptide,Helical,Low hemolytic,CTTTSSSTTSSSCCSTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10895,31483516,2020,AKAIVRTIEQAPKTAKAKKS,AKAIVRTIEQAPKTAKAKKS,9,Free,Free,Linear,L,None,20,Antibacterial,Low Hemolysis at 128 µM,Sheep,Synthetic Peptide,Helical,Low hemolytic,CHHHHHHHHCCSSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
10896,31483516,2020,EVVPKVKKHFKDKENKKKLF,EVVPKVKKHFKDKENKKKLF,10,Free,Free,Linear,L,None,20,Antibacterial,increased % Hemolysis at 128 µM,Sheep,Synthetic Peptide,Helical,NA,CCCCCSSCCTTCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
10897,31483516,2020,KKIAIITKNLKNFFIMLNII,KKIAIITKNLKNFFIMLNII,11,Free,Free,Linear,L,None,20,Antibacterial,Low Hemolysis at 128 µM,Sheep,Synthetic Peptide,β-Sheet,Low hemolytic,CCSSCCCCSSSSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
10898,31483516,2020,KKSINSLHLAMLKKQRLNRD,KKSINSLHLAMLKKQRLNRD,12,Free,Free,Linear,L,None,20,Antibacterial,Low Hemolysis at 128 µM,Sheep,Synthetic Peptide,Helical,Low hemolytic,CTHHHHHHHHHHHHHCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O
10899,31483516,2020,LLLGIKYKKIGANNFREVKK,LLLGIKYKKIGANNFREVKK,13,Free,Free,Linear,L,None,20,Antibacterial,Low Hemolysis at 128 µM,Sheep,Synthetic Peptide,Helical,Low hemolytic,CHHHHHHHHHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)CC
10900,31483516,2020,FMKKIVKIGKIARYSHKAKK,FMKKIVKIGKIARYSHKAKK,14,Free,Free,Linear,L,None,20,Antibacterial,Low Hemolysis at 128 µM,Sheep,Synthetic Peptide,Helical,Low hemolytic,CHHHHHHHHHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
10901,31483516,2020,LFRKKRHHWFVRTKNSLSKN,LFRKKRHHWFVRTKNSLSKN,15,Free,Free,Linear,L,None,20,Antibacterial,Low Hemolysis at 128 µM,Sheep,Synthetic Peptide,Helical,Low hemolytic,CCGGGTTTHHHHTSCTTSSCCCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O
10902,31483516,2020,VNHGYRKVTLTKTVRIKKFM,VNHGYRKVTLTKTVRIKKFM,16,Free,Free,Linear,L,None,20,Antibacterial,Low Hemolysis at 128 µM,Sheep,Synthetic Peptide,"low helicity, Random coil",Low hemolytic,CCTHHHHHHHHTSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCSC)C(=O)O
10903,31778756,2020,RIVQRIKKWLLKWKKLGY,RIVQRIKKWLLKWKKLGY,peptide 5,Free,Free,Linear,L,None,18,"Antibiofilm, Antibacterial",<10 % Hemolysis at 1024 μg/ml,mouse,Synthetic Peptide,SDS = α-Helix,Low hemolytic,CCHHHHTTHHHHSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
10904,31778756,2020,GLLRKWGKKWKEFLRRVWK,GLLRKWGKKWKEFLRRVWK,peptide 6.2,Free,Free,Linear,L,None,19,"Antibiofilm, Antibacterial",<5 % Hemolysis at 128 μg/ml,mouse,Synthetic Peptide,α-Helix,Low hemolytic,CCHHHHGGGTCC,CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
10905,31778756,2020,GLLRKWGKKWKEFLRRVWK,GLLRKWGKKWKEFLRRVWK,peptide 6.2,Free,Free,Linear,L,None,19,"Antibiofilm, Antibacterial",30 % Hemolysis at 1024 μg/ml,mouse,Synthetic Peptide,α-Helix,Low hemolytic,CCGGGTTTTTCC,CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
10907,31802582,2020,GWWRRTVDKVRNAGRK,GWWRRTVDKVRNAGRK{ct:-OH},P2-HC(1‐16),#NAME?,Free,Linear,L,None,16,Antibacterial,0 % Hemolysis at 200 µM,Human,Truncated P1 Pepetide,NA,Non-hemolytic,CTTGGGGGGTCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10908,31802582,2020,GWWRRTVAKVRNAGRK,GWWRRTVAKVRNAGRK{ct:Amid},P3-HC(1‐16)A8,Amidation,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at 200 µM,Human,Truncated P1 Pepetide,NA,Low hemolytic,CCCTHHHHHHCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10909,31802582,2020,AWWRRTVAKVRK,AWWRRTVAKVRK{ct:Amid},P8-G1A,Amidation,Free,Linear,L,None,12,Antibacterial,1.6 % Hemolysis at 200 µM,Human,Truncated P1 Pepetide,NA,Low hemolytic,CCGGGTTTTSCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10910,31802582,2020,GAWRRTVAKVRK,GAWRRTVAKVRK{ct:Amid},P9-W2A,Amidation,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 200 µM,Human,Truncated P1 Pepetide,NA,Non-hemolytic,CCCCSCTTTCCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10911,31802582,2020,GWARRTVAKVRK,GWARRTVAKVRK{ct:Amid},P10-W3A,Amidation,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 200 µM,Human,Truncated P1 Pepetide,NA,Non-hemolytic,CCHHHHGGGTCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10912,31802582,2020,GWWARTVAKVRK,GWWARTVAKVRK{ct:Amid},P11-R4A,Amidation,Free,Linear,L,None,12,Antibacterial,3.6 % Hemolysis at 200 µM,Human,Truncated P1 Pepetide,NA,Low hemolytic,CCSGGGGGGTCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10913,31802582,2020,GWWRATVAKVRK,GWWRATVAKVRK{ct:Amid},P12-R5A,Amidation,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 200 µM,Human,Truncated P1 Pepetide,NA,Non-hemolytic,CCSBSSSBCCCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10914,31802582,2020,GWWRRAVAKVRK,GWWRRAVAKVRK{ct:Amid},P13-T6A,Amidation,Free,Linear,L,None,12,Antibacterial,4.1 % Hemolysis at 200 µM,Human,Truncated P1 Pepetide,NA,Low hemolytic,CCGGGTGGGTCC,CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
10915,31802582,2020,GWWRRTAAKVRK,GWWRRTAAKVRK{ct:Amid},P14-V7A,Amidation,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 200 µM,Human,Truncated P1 Pepetide,NA,Non-hemolytic,CCGGGTTTTCCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10916,31802582,2020,GWWRRTVAKVRK,GWWRRTVAKVRK{ct:Amid},P6-HC(1‐12)A8K12,Amidation,Free,Linear,L,None,12,Antibacterial,25.1 % Hemolysis at 200 µM,Human,Truncated P1 Pepetide,α‐‐Helical,NA,CCGGGTTTHHHHTSCTTSSCCCCCCCCCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10917,31802582,2020,GWWRRTVAAVRK,GWWRRTVAAVRK{ct:Amid},P15-K9A,Amidation,Free,Linear,L,None,12,Antibacterial,5.1 % Hemolysis at 200 µM,Human,Truncated P1 Pepetide,NA,Low hemolytic,CCTHHHHHHHHTSSCC,CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10918,31802582,2020,GWWRRTVAKARK,GWWRRTVAKARK{ct:Amid},P16-V10A,Amidation,Free,Linear,L,None,12,Antibacterial,1 % Hemolysis at 200 µM,Human,Truncated P1 Pepetide,NA,Non-hemolytic,CCHHHHTTHHHHSSCC,CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10919,31802582,2020,GWWRRTVAKVAK,GWWRRTVAKVAK{ct:Amid},P17-R11A,Amidation,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 200 µM,Human,Truncated P1 Pepetide,NA,Non-hemolytic,CCHHHHGGGTCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
10920,31802582,2020,GWWRRTVAKVRA,GWWRRTVAKVRA{ct:Amid},P18-K12A,Amidation,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 200 µM,Human,Truncated P1 Pepetide,NA,Non-hemolytic,CCGGGTTTTTCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O
10922,31802582,2020,GWWRRTVDKVRNAGRK,GWWRRTVDKVRNAGRK{ct:-OH},P2-HC(1‐16),#NAME?,Free,Linear,L,None,16,Antibacterial,0 % Hemolysis at 25 µM,Human,Truncated P1 Pepetide,NA,Non-hemolytic,CTTGGGGGGTCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10923,31802582,2020,GWWRRTVAKVRNAGRK,GWWRRTVAKVRNAGRK{ct:Amid},P3-HC(1‐16)A8,Amidation,Free,Linear,L,None,16,Antibacterial,0 % Hemolysis at 25 µM,Human,Truncated P1 Pepetide,NA,Non-hemolytic,CCCTHHHHHHCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10924,31802582,2020,AWWRRTVAKVRK,AWWRRTVAKVRK{ct:Amid},P8-G1A,Amidation,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 25 µM,Human,Truncated P1 Pepetide,NA,Non-hemolytic,CCGGGTTTTSCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10925,31802582,2020,GAWRRTVAKVRK,GAWRRTVAKVRK{ct:Amid},P9-W2A,Amidation,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 25 µM,Human,Truncated P1 Pepetide,NA,Non-hemolytic,CCCCSCTTTCCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10926,31802582,2020,GWARRTVAKVRK,GWARRTVAKVRK{ct:Amid},P10-W3A,Amidation,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 25 µM,Human,Truncated P1 Pepetide,NA,Non-hemolytic,CCHHHHGGGTCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10927,31802582,2020,GWWARTVAKVRK,GWWARTVAKVRK{ct:Amid},P11-R4A,Amidation,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 25 µM,Human,Truncated P1 Pepetide,NA,Non-hemolytic,CCSGGGGGGTCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10928,31802582,2020,GWWRATVAKVRK,GWWRATVAKVRK{ct:Amid},P12-R5A,Amidation,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 25 µM,Human,Truncated P1 Pepetide,NA,Non-hemolytic,CCSBSSSBCCCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10929,31802582,2020,GWWRRAVAKVRK,GWWRRAVAKVRK{ct:Amid},P13-T6A,Amidation,Free,Linear,L,None,12,Antibacterial,0.9 % Hemolysis at 25 µM,Human,Truncated P1 Pepetide,NA,Low hemolytic,CCGGGTGGGTCC,CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
10930,31802582,2020,GWWRRTAAKVRK,GWWRRTAAKVRK{ct:Amid},P14-V7A,Amidation,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 25 µM,Human,Truncated P1 Pepetide,NA,Non-hemolytic,CCGGGTTTTCCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10931,31802582,2020,GWWRRTVAKVRK,GWWRRTVAKVRK{ct:Amid},P6-HC(1‐12)A8K12,Amidation,Free,Linear,L,None,12,Antibacterial,2.4 % Hemolysis at 25 µM,Human,Truncated P1 Pepetide,α‐‐Helical,NA,CCCCCCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10932,31802582,2020,GWWRRTVAAVRK,GWWRRTVAAVRK{ct:Amid},P15-K9A,Amidation,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 25 µM,Human,Truncated P1 Pepetide,NA,Non-hemolytic,CCCCCCC,CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10933,31802582,2020,GWWRRTVAKARK,GWWRRTVAKARK{ct:Amid},P16-V10A,Amidation,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 25 µM,Human,Truncated P1 Pepetide,NA,Non-hemolytic,CCCTTCCTTGGGCCCSSCCSSCCC,CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
10934,31802582,2020,GWWRRTVAKVAK,GWWRRTVAKVAK{ct:Amid},P17-R11A,Amidation,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 25 µM,Human,Truncated P1 Pepetide,NA,Non-hemolytic,CCCTTCCTTGGGCCCSSCCSSCCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
10935,31802582,2020,GWWRRTVAKVRA,GWWRRTVAKVRA{ct:Amid},P18-K12A,Amidation,Free,Linear,L,None,12,Antibacterial,0 % Hemolysis at 25 µM,Human,Truncated P1 Pepetide,NA,Non-hemolytic,CCCCSSCCCCCCCCCCSSSCCSCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O
10936,31862270,2020,PFKISIHL,PFKISIHL,Jellein,Free,Free,Linear,L,None,8,"Antibacterial, Anti-leishmanial activity, inhibition of Leishmania major promastigotes",8 % Hemolysis at 500 μg/ml,Human,Royal Jelly Of Honeybee,NA,Low hemolytic,CCCCSSCCCCCCCCCCSSSCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O
10939,31862270,2020,LPKPPKPVSKMRMATPLLMQALPM,{conj:Lauric acid}LPKPPKPVSKMRMATPLLMQALPM,Lauric acid-LIP (L-CLIP),Free,Lauric acid,Linear,L,None,24,Antibacterial,58 % Hemolysis at 319 μg/ml,Human,Lauric Acid Conjugated Clip,NA,NA,CCSCHHHHHHHHCSSCCCC,NA
10953,32153547,2020,RNGCIVDPRCPYQQCRRPLYCRRR,RNGCIVDPRCPYQQCRRPLYCRRR,NCR247,Free,Free,Linear,L,None,24,Antibacterial,1.75 % Hemolysis at 100 µM,Human,Plant Medicago Truncatula Nodule-Specific Cysteine-Rich (Ncr) Peptides,NA,Low hemolytic,CCTTCCCHHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
10954,32153547,2020,QQCRRPLYCRRR,QQCRRPLYCRRR,NCR247C,Free,Free,Linear,L,None,12,Antibacterial,0.88 % Hemolysis at 100 µM,Human,Derivatives Of Ncr247,NA,Low hemolytic,CCTTSCCTHHHHHHHHHHHGGGTSCSSSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10955,32153547,2020,QQCRRPLYCRRRWSHPQFEK,QQCRRPLYCRRRWSHPQFEK,NCR247C-StrepII,Free,Free,Linear,L,None,20,Antibacterial,1.75 % Hemolysis at 100 µM,Human,Derivatives Of Ncr247,NA,Low hemolytic,CCGGGTGGGCBCSTTTTTTBCCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
10956,32153547,2020,RPLNFKMLRFWGQQQCRRPLYCRRR,RPLNFKMLRFWGQQQCRRPLYCRRR,X1-NCR247C,Free,Free,Linear,L,None,25,Antibacterial,3.51 % Hemolysis at 100 µM,Human,Derivatives Of Ncr247,NA,Low hemolytic,CCGGGTTTTCC,CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10957,32153547,2020,RPLNFKMLRFWGQQQCRRPLYCRRRWSHPQFEK,RPLNFKMLRFWGQQQCRRPLYCRRRWSHPQFEK,X1-NCR247C-StrepII,Free,Free,Linear,L,None,33,Antibacterial,3.51 % Hemolysis at 100 µM,Human,Derivatives Of Ncr247,NA,Low hemolytic,CCCCCCSSCCSCCSCHHHHHHTGGGCC,CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
10958,32153547,2020,QQCRRPLYCRRRKALAALAKKIL,QQCRRPLYCRRRKALAALAKKIL,NCR247C-X2,Free,Free,Linear,L,None,23,Antibacterial,7.02 % Hemolysis at 100 µM,Human,Derivatives Of Ncr247,NA,NA,CCCCCCCTTSSSTTSSSCCSTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O
10959,32153547,2020,QQCRRPLYCRRRKALAALAKKILWSHPQFEK,QQCRRPLYCRRRKALAALAKKILWSHPQFEK,NCR247C-X2-StrepII,Free,Free,Linear,L,None,31,Antibacterial,11.4 % Hemolysis at 100 µM,Human,Derivatives Of Ncr247,NA,NA,CCSCCCTTSTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
10960,32153547,2020,KALAALAKKILQQCRRPLYCRRR,KALAALAKKILQQCRRPLYCRRR,X2-NCR247C,Free,Free,Linear,L,None,23,Antibacterial,6.14 % Hemolysis at 100 µM,Human,Derivatives Of Ncr247,NA,NA,CCCCSCCSCCSCCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10961,32153547,2020,KALAALAKKIL,KALAALAKKIL,X2,Free,Free,Linear,L,None,11,Antibacterial,1.75 % Hemolysis at 100 µM,Human,Derivatives Of Ncr247,NA,Low hemolytic,CCCCHHHHHHHHHHHHSSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
10962,32153547,2020,GWTLNSAGYLLGKINLKALAALAKKIL,GWTLNSAGYLLGKINLKALAALAKKIL,Transportan,Free,Free,Linear,L,None,27,Antibacterial,95.61 % Hemolysis at 100 µM,Human,Derivatives Of Ncr247,NA,NA,CCCCHHHHHHHHHHTTSCCTTSSSCSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
10963,32153547,2020,RNGCIVDPRCPYQQCRRPLYCRRR,RNGCIVDPRCPYQQCRRPLYCRRR,NCR247,Free,Free,Linear,L,None,24,Antibacterial,0.88 % Hemolysis at 25 µM,Human,Plant Medicago Truncatula Nodule-Specific Cysteine-Rich (Ncr) Peptides,NA,Low hemolytic,CCTTCCCHHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
10964,32153547,2020,QQCRRPLYCRRR,QQCRRPLYCRRR,NCR247C,Free,Free,Linear,L,None,12,Antibacterial,0.88 % Hemolysis at 25 µM,Human,Derivatives Of Ncr247,NA,Low hemolytic,CCTTSCCTHHHHHHHHHHHGGGTSCSSSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10965,32153547,2020,QQCRRPLYCRRRWSHPQFEK,QQCRRPLYCRRRWSHPQFEK,NCR247C-StrepII,Free,Free,Linear,L,None,20,Antibacterial,1.75 % Hemolysis at 25 µM,Human,Derivatives Of Ncr247,NA,Low hemolytic,CCGGGTGGGCBCSTTTTTTBCCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
10966,32153547,2020,RPLNFKMLRFWGQQQCRRPLYCRRR,RPLNFKMLRFWGQQQCRRPLYCRRR,X1-NCR247C,Free,Free,Linear,L,None,25,Antibacterial,1.75 % Hemolysis at 25 µM,Human,Derivatives Of Ncr247,NA,Low hemolytic,CCGGGTTTTCC,CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10967,32153547,2020,RPLNFKMLRFWGQQQCRRPLYCRRRWSHPQFEK,RPLNFKMLRFWGQQQCRRPLYCRRRWSHPQFEK,X1-NCR247C-StrepII,Free,Free,Linear,L,None,33,Antibacterial,1.75 % Hemolysis at 25 µM,Human,Derivatives Of Ncr247,NA,Low hemolytic,CCCCCCSSCCSCCSCHHHHHHTGGGCC,CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
10968,32153547,2020,QQCRRPLYCRRRKALAALAKKIL,QQCRRPLYCRRRKALAALAKKIL,NCR247C-X2,Free,Free,Linear,L,None,23,Antibacterial,1.75 % Hemolysis at 25 µM,Human,Derivatives Of Ncr247,NA,Low hemolytic,CCCCCSTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O
10969,32153547,2020,QQCRRPLYCRRRKALAALAKKILWSHPQFEK,QQCRRPLYCRRRKALAALAKKILWSHPQFEK,NCR247C-X2-StrepII,Free,Free,Linear,L,None,31,Antibacterial,6.14 % Hemolysis at 25 µM,Human,Derivatives Of Ncr247,NA,NA,CCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
10970,32153547,2020,KALAALAKKILQQCRRPLYCRRR,KALAALAKKILQQCRRPLYCRRR,X2-NCR247C,Free,Free,Linear,L,None,23,Antibacterial,1.75 % Hemolysis at 25 µM,Human,Derivatives Of Ncr247,NA,Low hemolytic,CCSCCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10971,32153547,2020,KALAALAKKIL,KALAALAKKIL,X2,Free,Free,Linear,L,None,11,Antibacterial,0.88 % Hemolysis at 25 µM,Human,Derivatives Of Ncr247,NA,Low hemolytic,CCSCCCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
10972,32153547,2020,GWTLNSAGYLLGKINLKALAALAKKIL,GWTLNSAGYLLGKINLKALAALAKKIL,Transportan,Free,Free,Linear,L,None,27,Antibacterial,38.6 % Hemolysis at 25 µM,Human,Derivatives Of Ncr247,NA,NA,CCCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
10985,32258871,2020,ACPIFTKIQGTYRGKAKCK,ACPIFTKIQGTYRGKAKCK,Phd1,Free,Free,Linear,L,None,19,Antibacterial,>12.5 % Hemolysis at 5 µM,Rat,Human-Β-Defensins Hbd1 Analogues,NA,NA,CTTHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](C)N)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
10986,32258871,2020,SCLPKEEQIGKSTRGRKCRRKK,SCLPKEEQIGKSTRGRKCRRKK,Phd3,Free,Free,Linear,L,None,22,Antibacterial,>12.5 % Hemolysis at 12 µM,Rat,Human-Β-Defensins Hbd3 Analogues,NA,NA,CHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
10987,32258871,2020,ACPIFTKIQGTYRGKAKCK,ACPIFTKIQGTYRGKAKCK{nt:Myr = myristoylated},MPhd1,Free,Myr = myristoylated,Linear,L,None,19,Antibacterial,>80 % Hemolysis at 5 µM,Rat,Myristoylated Mphd1,NA,NA,CTTTTTTTTTC,NA
10988,32258871,2020,SCLPKEEQIGKSTRGRKCRRKK,SCLPKEEQIGKSTRGRKCRRKK{nt:Myr = myristoylated},MPhd3,Free,Myr = myristoylated,Linear,L,None,22,Antibacterial,>50 % Hemolysis at 12 µM,Rat,Myristoylated Mphd3,NA,NA,CTTTHHHHTTC,NA
11004,32003561,2020,kwcfrvcyrglcyrrcrx,K{d}W{d}C{d}F{d}R{d}V{d}C{d}Y{d}R{d}G{d}L{d}C{d}Y{d}R{d}R{d}C{d}R{d}X{d},TPAD,Free,Free,Linear,D,None,18,Antibacterial,10 % Hemolysis at 16 μg/ml,Human,D-Amino Acid Analogue Of Tpi,β-Hairpin,NA,CCSSSCSSCBTTBCCCCCCCCCCCSSCCCCCCCSBCSSSBCCSSSCCCSCC,NA
11005,32242658,2020,RRRRRRRRRRRR,RRRRRRRRRRRR,R12,Free,Free,Linear,L,None,12,Antibacterial,5 % Hemolysis at >4000 μg/ml,Rat,Arginine-Based Four-Armed Copolypeptides,NA,Non-hemolytic,CCCCCTTCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
11006,32242658,2020,RRRRRRRRRRRRKKK,RRRRRRRRRRRRKKK{ct:Amid},4R3,Amidation,Free,Linear,L,None,15,Antibacterial,5 % Hemolysis at >4000 μg/ml,Rat,Arginine-Based Four-Armed Copolypeptides,NA,Non-hemolytic,CCEETTEEEEC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
11007,32242658,2020,RRRRRRRRRRRRRRRRRRRRRRRRKKK,RRRRRRRRRRRRRRRRRRRRRRRRKKK{ct:Amid},4R6,Amidation,Free,Linear,L,None,27,Antibacterial,5 % Hemolysis at >4000 μg/ml,Rat,Arginine-Based Four-Armed Copolypeptides,NA,Non-hemolytic,CHHHHHHHHHTCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
11008,32242658,2020,RGRGRGRGRGRGRGRGRGRGRGRGKKK,RGRGRGRGRGRGRGRGRGRGRGRGKKK{ct:Amid},4R3G3,Amidation,Free,Linear,L,None,27,Antibacterial,5 % Hemolysis at >4000 μg/ml,Rat,Arginine-Based Four-Armed Copolypeptides,NA,Non-hemolytic,CCHHHHTTTCCC,N=C(N)NCCC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
11009,32242658,2020,RGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGKKK,RGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGKKK{ct:Amid},4R6G6,Amidation,Free,Linear,L,None,51,Antibacterial,5 % Hemolysis at >4000 μg/ml,Rat,Arginine-Based Four-Armed Copolypeptides,NA,Non-hemolytic,CCCTTCTTSSCC,N=C(N)NCCC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
11010,32134261,2020,FIIWPLRYRK,FIIWPLRYRK{ct:Amid},somuncurin-1,Amidation,Free,Linear,L,None,10,Antibacterial,<5 % Hemolysis at 180 µM,Human,Frog Pleurodema Somuncurence,"water = Random coil, TFE = α-Helical",Low hemolytic,CCCCCSCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
11011,32134261,2020,FILKRSYPQYY,FILKRSYPQYY{ct:Amid},somuncurin-2,Amidation,Free,Linear,L,None,11,Antibacterial,<5 % Hemolysis at 180 µM,Human,Frog Pleurodema Somuncurence,"water = Random coil, TFE = Random coil",Low hemolytic,CCCCCSCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
11012,32134261,2020,NLVGSLLGGILKK,NLVGSLLGGILKK{ct:Amid},thaulin-3,Amidation,Free,Linear,L,None,13,Antibacterial,<5 % Hemolysis at 180 µM,Human,Frog Pleurodema Somuncurence,"water = Random coil, TFE = α-Helix",Low hemolytic,CCCCHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
11013,32342079,2020,RLKKIGKVLKWI,RLKKIGKVLKWI{ct:Amid},RI12,Amidation,Free,Linear,L,None,12,Antibacterial,5 % Hemolysis at >128 µM,Human,Dodecapeptide From Pig (Porcine Myeloid Antimicrobial Peptide-36 (Pmap-36),"10 mM PBS = Random coil + <30% α-Helical, TFE = α-Helical",Low hemolytic,CCCCCSCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)O
11014,32342079,2020,RWKKIGKVWKWI,RWKKIGKVWKWI{ct:Amid},"RI12[L2W,L9W]",Amidation,Free,Linear,L,None,12,Antibacterial,5 % Hemolysis at >128 µM,Human,Dodecapeptide From Pig (Porcine Myeloid Antimicrobial Peptide-36 (Pmap-36),10 mM PBS & TFE = TrpZip Hairpin,Low hemolytic,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)O
11015,32342079,2020,RWKKIGWVWKWI,RWKKIGWVWKWI{ct:Amid},"RI12[L2W,K7W,L9W]",Amidation,Free,Linear,L,None,12,Antibacterial,5 % Hemolysis at 128 µM,Human,Dodecapeptide From Pig (Porcine Myeloid Antimicrobial Peptide-36 (Pmap-36),10 mM PBS & TFE = TrpZip Hairpin,Low hemolytic,CCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)O
11016,32342079,2020,RLKKIGWVLKWI,RLKKIGWVLKWI{ct:Amid},RI12[K7W],Amidation,Free,Linear,L,None,12,Antibacterial,5 % Hemolysis at 128 µM,Human,Dodecapeptide From Pig (Porcine Myeloid Antimicrobial Peptide-36 (Pmap-36),"10 mM PBS = Random coil + <30% α-Helical, TFE = α-Helical",Low hemolytic,CCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)O
11017,32342079,2020,RLWKIGKVLKWI,RLWKIGKVLKWI{ct:Amid},RI12[K3W],Amidation,Free,Linear,L,None,12,Antibacterial,5 % Hemolysis at >128 µM,Human,Dodecapeptide From Pig (Porcine Myeloid Antimicrobial Peptide-36 (Pmap-36),"10 mM PBS = Random coil + <30% α-Helical, TFE = α-Helical",Low hemolytic,CCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)O
11018,32342079,2020,RLWKIGWVLKWI,RLWKIGWVLKWI{ct:Amid},"RI12[K3W,K7W]",Amidation,Free,Linear,L,None,12,Antibacterial,5 % Hemolysis at 32 µM,Human,Dodecapeptide From Pig (Porcine Myeloid Antimicrobial Peptide-36 (Pmap-36),"10 mM PBS = Random coil + <30% α-Helical, TFE = α-Helical",NA,CCTTHHHHHHHHHHTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)O
11020,32367434,2020,PFKISIHL,PFKISIHL{ct:Amid},JI (Jelleine-I),Amidation,Free,Linear,L,None,8,"Antibacterial, Antifungal",50 % Hemolysis at 500 µmol /L,Human,"Buffer = Random Coil, Anionic Environments = Β-Strands",octapeptide royal jelly honey bee,Low hemolytic,CHHHIIIIIIIICHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O
11021,32367434,2020,PWKISIHL,PWKISIHL{ct:Amid},JIF2W,Amidation,Free,Linear,L,None,8,"Antibacterial, Antifungal",50 % Hemolysis at 500 µmol /L,Human,"Buffer = Random Coil, Anionic Environments = Β-Strands",analogs of Jelleine-I,Low hemolytic,CHHHHHHHTSCTTHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O
11022,32367434,2020,PWRISIRL,PWRISIRL{ct:Amid},JIF2WR,Amidation,Free,Linear,L,None,8,"Antibacterial, Antifungal",50 % Hemolysis at 91 µmol /L,Human,"Buffer = Random Coil, Anionic Environments = Β-Strands",analogs of Jelleine-I,NA,CHHHHHHHHSSHHHHHHHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O
11025,33937618,2020,LLKELWTKMKGAGKAVLGKIKGLL,LLKELWTKMKGAGKAVLGKIKGLL,L1,Free,Free,Linear,L,None,24,Antibacterial,1 % Hemolysis at 15 µM,Human,Ponerine Ant Neoponera Goeldii,"water = Random/dosordered structure, lipid vesicles = α-Helix",Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
11026,33937618,2020,LLKQLWTKMKGAGKAVLGKIKGLL,LLKQLWTKMKGAGKAVLGKIKGLL,L1-Q,Free,Free,Linear,L,None,24,Antibacterial,1 % Hemolysis at 15 µM,Human,L1 Variants,"water = Random/dosordered structure, lipid vesicles = α-Helix",Low hemolytic,CCCCCCSSSSSSCSTTTTCSCCSSSTTTTSCSSCCCEESSSCEESGGGHHHHHHGGGTSCCCTTSCCCCCHHHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
11027,33937618,2020,LLKKLWTKMKGAGKAVLGKIKGLL,LLKKLWTKMKGAGKAVLGKIKGLL,L1-K,Free,Free,Linear,L,None,24,Antibacterial,1 % Hemolysis at 15 µM,Human,L1 Variants,"water = Random/dosordered structure, lipid vesicles = α-Helix",Low hemolytic,CHHHHHHHHTTTTCSGGGHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
11028,33937618,2020,LLRELWTRMRGAGRAVLGRIRGLL,LLRELWTRMRGAGRAVLGRIRGLL,L1-R,Free,Free,Linear,L,None,24,Antibacterial,<5 % Hemolysis at 15 µM,Human,L1 Variants,"water = Random/dosordered structure, lipid vesicles = α-Helix",Low hemolytic,CHHHHHHHHGGGGTTSSSSSCSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
11029,33937618,2020,LLOELWTOMOGAGOAVLGOIOGLL,LL{nnr:O}ELWT{nnr:O}M{nnr:O}GAG{nnr:O}AVLG{nnr:O}I{nnr:O}GLL,L1-O,Free,Free,Linear,L,O = L-Ornithine,24,Antibacterial,1 % Hemolysis at 15 µM,Human,L1 Variants,"water = Helical, lipid vesicles = α-Helix",Low hemolytic,NA,NA
11030,33937618,2020,LLXELWTXMXGAGXAVLGXIXGLL,LL{nnr:X}ELWT{nnr:X}M{nnr:X}GAG{nnr:X}AVLG{nnr:X}I{nnr:X}GLL,L1-X,Free,Free,Linear,L,X = L-di-amino-propionic acid,24,Antibacterial,1 % Hemolysis at 15 µM,Human,L1 Variants,"water = Random/dosordered structure, lipid vesicles = α-Helix",Low hemolytic,NA,NA
11035,32443921,2020,FLGAILKIGHALAKTVLPMVTNAFKPKQ,FLGAILKIGHALAKTVLPMVTNAFKPKQ,Figainin 2,Free,Free,Linear,L,None,28,"Antibacterial, Anticancer, Anti-Epimastigote, Antiviral, Antitrypanosomal, exhibits immunomodulatory effects in human neutrophils",50 % Hemolysis at 48.9 µM,Human,"Skin Chaco Tree Frog, Boana Raniceps","α-Helix, Milli-Q water and 10% (v/v) TFE = Random coil, 30% and 50% (v/v) TFE = α-Helix",NA,CCSCCSCSSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)CC
11036,32443921,2020,FLGAILKIGHALAKTVLPMVTNAFKPKQ,FLGAILKIGHALAKTVLPMVTNAFKPKQ,Figainin 2,Free,Free,Linear,L,None,28,"Antibacterial, Anticancer, Anti-Epimastigote, Antiviral, Antitrypanosomal, exhibits immunomodulatory effects in human neutrophils",23 % Hemolysis at 32 µM,Human,"Skin Chaco Tree Frog, Boana Raniceps","α-Helix, Milli-Q water and 10% (v/v) TFE = Random coil, 30% and 50% (v/v) TFE = α-Helix",NA,CCTTSSSSCCCSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)CC
11037,32443921,2020,FLGAILKIGHALAKTVLPMVTNAFKPKQ,FLGAILKIGHALAKTVLPMVTNAFKPKQ,Figainin 2,Free,Free,Linear,L,None,28,"Antibacterial, Anticancer, Anti-Epimastigote, Antiviral, Antitrypanosomal, exhibits immunomodulatory effects in human neutrophils",9 % Hemolysis at 16 µM,Human,"Skin Chaco Tree Frog, Boana Raniceps","α-Helix, Milli-Q water and 10% (v/v) TFE = Random coil, 30% and 50% (v/v) TFE = α-Helix",NA,CCTTSCCCGGGGSTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)CC
11038,32670215,2020,KRFWQLVPLAIKIYRAWKRR,KRFWQLVPLAIKIYRAWKRR{ct:Amid},dCATH,Amidation,Free,Linear,L,None,20,Antibacterial,10 % Hemolysis at 4 µM,Human,Cath Amp From Duck,α-Helix,NA,CCCGGGCTHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
11039,32670215,2020,KRFAQLVPLAIKIYRAAKRR,KRFAQLVPLAIKIYRAAKRR{ct:Amid},dCATH-AA,Amidation,Free,Linear,L,None,20,Antibacterial,10 % Hemolysis at 256 µM,Human,Modified Verison Of Dcath,α-Helix,Low hemolytic,CTTCGGGCGGGGTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
11040,32670215,2020,KRFWQLVPLAIKIYRA,KRFWQLVPLAIKIYRA{ct:Amid},dCATH(1–16),Amidation,Free,Linear,L,None,16,Antibacterial,10 % Hemolysis at 256 µM,Human,Modified Verison Of Dcath,α-Helix,Low hemolytic,CCCCCSCCCTTHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC
11041,32670215,2020,KRFWQLVPLAIKIYRAW,KRFWQLVPLAIKIYRAW{ct:Amid},dCATH(1–17),Amidation,Free,Linear,L,None,17,Antibacterial,10 % Hemolysis at 8 µM,Human,Modified Verison Of Dcath,α-Helix,NA,CCCSSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC
11042,32670215,2020,KRFWQLVPLAIKIYRAWK,KRFWQLVPLAIKIYRAWK{ct:Amid},dCATH(1–18),Amidation,Free,Linear,L,None,18,Antibacterial,10 % Hemolysis at 8 µM,Human,Modified Verison Of Dcath,α-Helix,NA,CCGGGSSSCCSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
11043,32670215,2020,QLVPLAIKIYRAWKRR,QLVPLAIKIYRAWKRR{ct:Amid},dCATH(5–20),Amidation,Free,Linear,L,None,16,Antibacterial,10 % Hemolysis at 128 µM,Human,Modified Verison Of Dcath,α-Helix,Low hemolytic,CCCGGGSTTTSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
11044,32670215,2020,WQLVPLAIKIYRAWKRR,WQLVPLAIKIYRAWKRR{ct:Amid},dCATH(4–20),Amidation,Free,Linear,L,None,17,Antibacterial,10 % Hemolysis at 16 µM,Human,Modified Verison Of Dcath,α-Helix,NA,CCTTHHHHHTTTCHHHHHHSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
11045,32670215,2020,FWQLVPLAIKIYRAWKRR,FWQLVPLAIKIYRAWKRR{ct:Amid},dCATH(3–20),Amidation,Free,Linear,L,None,18,Antibacterial,10 % Hemolysis at 4 µM,Human,Modified Verison Of Dcath,α-Helix,NA,CCHHHHTTTSSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
11046,32670215,2020,QLVPLAIKIYRA,QLVPLAIKIYRA{ct:Amid},dCATH(5–16),Amidation,Free,Linear,L,None,12,Antibacterial,10 % Hemolysis at 256 µM,Human,Modified Verison Of Dcath,unordered conformation,Low hemolytic,CTHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC
11047,32670215,2020,KRFAQLVPLAIKIYRA,KRFAQLVPLAIKIYRA{ct:Amid},dCATH(1–16)-4A,Amidation,Free,Linear,L,None,16,Antibacterial,10 % Hemolysis at 256 µM,Human,Modified Verison Of Dcath,α-Helix,Low hemolytic,CHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC
11048,32670215,2020,QLVPLAIKIYRAAKRR,QLVPLAIKIYRAAKRR{ct:Amid},dCATH(5–20)-17A,Amidation,Free,Linear,L,None,16,Antibacterial,10 % Hemolysis at 256 µM,Human,Modified Verison Of Dcath,α-Helix,Low hemolytic,CTHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
11050,32499514,2020,RKEKIKKRIGKIDRL,RKEKIKKRIGKIDRL{ct:Amid},P0,Amidation,Free,Linear,L,None,15,Antibacterial,10 % Hemolysis at >250 μg/ml,Human,Designed From The Conserved Sequences Of Cathelicidin,α-Helical,Low hemolytic,CTTHHHHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
11051,32499514,2020,KIAKRIWKILRR,KIAKRIWKILRR{ct:Amid},P7,Amidation,Free,Linear,L,None,12,Antibacterial,10 % Hemolysis at 250 μg/ml,Human,Modification By Truncation Of P0,NA,Low hemolytic,CTHHHHTTTGGGGTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
11052,32499514,2020,GLFDIVKKVAG,GLFDIVKKVAG{ct:Amid},A0,Amidation,Free,Linear,L,None,11,Antibacterial,10 % Hemolysis at >250 μg/ml,Human,Designed From The Conserved Sequences Of Aurein,α-Helical,Low hemolytic,CTHHHHTTTTHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)O)C(C)C)C(C)C
11053,32499514,2020,RLFRRVKKVAG,RLFRRVKKVAG{ct:Amid},A3,Amidation,Free,Linear,L,None,11,Antibacterial,10 % Hemolysis at >250 μg/ml,Human,Modification By Truncation Of A0,NA,Low hemolytic,CGGGGTHHHHTTTCC,CC(C)C[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)O)C(C)C)C(C)C
11054,32499514,2020,KIAKRIWKILRRRLFRRVKKVAG,KIAKRIWKILRRRLFRRVKKVAG{ct:Amid},P7A3,Amidation,Free,Linear,L,None,23,Antibacterial,10 % Hemolysis at 3.91 μg/ml,Human,Hybrid Peptide Derivatives Of P7 & A3,NA,NA,CGGGGTHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)O)C(C)C)C(C)C)[C@@H](C)CC
11055,32499514,2020,KIAKRIWKILRRRLFRRV,KIAKRIWKILRRRLFRRV{ct:Amid},PA-18,Amidation,Free,Linear,L,None,18,Antibacterial,10 % Hemolysis at 3.91 μg/ml,Human,Truncated Derivatives Of The Hybrid Analogue (P7A3),α-Helical,NA,CGGGGTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)CC
11056,32499514,2020,KIAKRIWKILRRRLFRR,KIAKRIWKILRRRLFRR{ct:Amid},PA-17,Amidation,Free,Linear,L,None,17,Antibacterial,10 % Hemolysis at 3.91 μg/ml,Human,Truncated Derivatives Of The Hybrid Analogue (P7A3),NA,NA,CTHHHHHHHHHTTSSSCCCSTGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
11057,32499514,2020,KIAKRIWKILRRRLFR,KIAKRIWKILRRRLFR{ct:Amid},PA-16,Amidation,Free,Linear,L,None,16,Antibacterial,10 % Hemolysis at 3.91 μg/ml,Human,Truncated Derivatives Of The Hybrid Analogue (P7A3),NA,NA,CTHHHHHHHHHTTSSSCCCSTGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
11058,32499514,2020,KIAKRIWKILRRRLF,KIAKRIWKILRRRLF{ct:Amid},PA-15,Amidation,Free,Linear,L,None,15,Antibacterial,10 % Hemolysis at 3.91 μg/ml,Human,Truncated Derivatives Of The Hybrid Analogue (P7A3),NA,NA,CCCTTGGGGGHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11059,32499514,2020,KIAKRIWKILRRRL,KIAKRIWKILRRRL{ct:Amid},PA-14,Amidation,Free,Linear,L,None,14,Antibacterial,10 % Hemolysis at 15.63 μg/ml,Human,Truncated Derivatives Of The Hybrid Analogue (P7A3),NA,NA,CTTTHHHHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
11060,32499514,2020,KIAKRIWKILRRR,KIAKRIWKILRRR{ct:Amid},PA-13,Amidation,Free,Linear,L,None,13,Antibacterial,10 % Hemolysis at 125 μg/ml,Human,Truncated Derivatives Of The Hybrid Analogue (P7A3),"aqueous = Random coil, 30mM SDS, 50% TFE, and 0.05% LPS (MME) = α-Helical",NA,CTTHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
11063,32521823,2020,RYRRKKKMKKALQYIKLLKE,RYRRKKKMKKALQYIKLLKE{ct:Amid},35409,Amidation,Free,Linear,L,None,20,Antibacterial,10 % Hemolysis at 1.56 µM,Human,Parasite Plasmodium Falciparum Rifin Protein-Derived Peptide,"1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm)",NA,CCCGGGTHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O
11064,32521823,2020,RKKKMKKALQYIKLLKE,RKKKMKKALQYIKLLKE{ct:Amid},35409-1,Amidation,Free,Linear,L,None,17,"Antibacterial, Antibiotic Synergy",10 % Hemolysis at >200 µM,Human,35409 Seven Truncated Modification Sequence Peptide,"1X PBS = Disordered, PBS with 10 mM SDS = α-Helix (200 to 260nm)",Non-hemolytic,CCTTSTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O
11065,32521823,2020,KKKMKKALQYIKLLKE,KKKMKKALQYIKLLKE{ct:Amid},35409-2,Amidation,Free,Linear,L,None,16,"Antibacterial, Antibiotic Synergy",10 % Hemolysis at >200 µM,Human,35409 Seven Truncated Modification Sequence Peptide,"1X PBS = Disordered, PBS with 10 mM SDS = α-Helix (200 to 260nm)",Non-hemolytic,CCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O
11066,32521823,2020,KKMKKALQYIKLLKE,KKMKKALQYIKLLKE{ct:Amid},35409-3,Amidation,Free,Linear,L,None,15,Antibacterial,10 % Hemolysis at >200 µM,Human,35409 Seven Truncated Modification Sequence Peptide,"1X PBS = Disordered, PBS with 10 mM SDS = Helical",Non-hemolytic,CCCTTTTHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O
11067,32521823,2020,KMKKALQYIKLLKE,KMKKALQYIKLLKE{ct:Amid},35409-4,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiotic Synergy",10 % Hemolysis at >200 µM,Human,35409 Seven Truncated Modification Sequence Peptide,"1X PBS = Disordered, PBS with 10 mM SDS = α-Helix (200 to 260nm)",Non-hemolytic,CCCTTGGGTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O
11068,32521823,2020,MKKALQYIKLLKE,MKKALQYIKLLKE{ct:Amid},35409-5,Amidation,Free,Linear,L,None,13,Antibacterial,10 % Hemolysis at >200 µM,Human,35409 Seven Truncated Modification Sequence Peptide,"1X PBS = Disordered, PBS with 10 mM SDS = Helical",Non-hemolytic,CCCGGGTSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O
11069,32521823,2020,ALQYIKLLKE,ALQYIKLLKE{ct:Amid},35409-6,Amidation,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at >200 µM,Human,35409 Seven Truncated Modification Sequence Peptide,"1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm)",Non-hemolytic,CCCTTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O
11070,32521823,2020,YIKLLKE,YIKLLKE{ct:Amid},35409-7,Amidation,Free,Linear,L,None,7,Antibacterial,10 % Hemolysis at >200 µM,Human,35409 Seven Truncated Modification Sequence Peptide,"1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm)",Non-hemolytic,CCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O
11071,32521823,2020,RYRRKKKMKKALQYIKL,RYRRKKKMKKALQYIKL{ct:Amid},35409-8,Amidation,Free,Linear,L,None,17,Antibacterial,10 % Hemolysis at >200 µM,Human,35409 Five Truncated Modification Sequence Peptide,"1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm)",Non-hemolytic,CTHHHHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
11072,32521823,2020,RYRRKKKMKKALQY,RYRRKKKMKKALQY{ct:Amid},35409-9,Amidation,Free,Linear,L,None,14,Antibacterial,10 % Hemolysis at >200 µM,Human,35409 Five Truncated Modification Sequence Peptide,"1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm)",Non-hemolytic,CHHHHHHHHHTC,CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
11073,32521823,2020,RYRRKKKMKKA,RYRRKKKMKKA{ct:Amid},35409-10,Amidation,Free,Linear,L,None,11,Antibacterial,10 % Hemolysis at >200 µM,Human,35409 Five Truncated Modification Sequence Peptide,"1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm)",Non-hemolytic,CCTTSHHHHCC,CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
11074,32521823,2020,RYRRKKKMKK,RYRRKKKMKK{ct:Amid},35409-11,Amidation,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at >200 µM,Human,35409 Five Truncated Modification Sequence Peptide,"1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm)",Non-hemolytic,CCCCSSCC,CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
11075,32521823,2020,RYRRKKK,RYRRKKK{ct:Amid},35409-12,Amidation,Free,Linear,L,None,7,Antibacterial,10 % Hemolysis at >200 µM,Human,35409 Five Truncated Modification Sequence Peptide,"1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm)",Non-hemolytic,CCSCSSSSSSSCSSGGGGTTSSCTTSCCSCTTCBSSSBSSTTSBSSSSGGGSSCTTTTCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
11076,32521823,2020,KKMKKALQYIKLLK,KKMKKALQYIKLLK{ct:Amid},35409-13,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiotic Synergy",10 % Hemolysis at >200 µM,Human,35409 Four Truncated Modification Sequence Peptide,"1X PBS = Disordered, PBS with 10 mM SDS = α-Helix (200 to 260nm)",Non-hemolytic,CCSSCCCCCCCSSCCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
11077,32521823,2020,KKMKKALQYIKL,KKMKKALQYIKL{ct:Amid},35409-14,Amidation,Free,Linear,L,None,12,Antibacterial,10 % Hemolysis at 100 µM,Human,35409 Four Truncated Modification Sequence Peptide,"1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm)",NA,CCCCCCCSTTCCSSCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
11078,32521823,2020,RKKKMKKALQY,RKKKMKKALQY{ct:Amid},35409-15,Amidation,Free,Linear,L,None,11,Antibacterial,10 % Hemolysis at 200 µM,Human,35409 Four Truncated Modification Sequence Peptide,"1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm)",Non-hemolytic,CCSSCCCBCSSSSCBCCCSCC,CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
11079,32521823,2020,KMKKALQY,KMKKALQY{ct:Amid},35409-16,Amidation,Free,Linear,L,None,8,Antibacterial,10 % Hemolysis at >200 µM,Human,35409 Four Truncated Modification Sequence Peptide,"1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm)",Non-hemolytic,CCCCCCSCCCCCSSCCCTTCC,CSCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
11081,32576824,2020,GFCWYVCVYRNGVRVCYRRCN,GFCWYVCVYRNGVRVCYRRCN,Arenicin-3,Free,Free,Linear,L,None,21,Antibacterial,10 % Hemolysis at 204 μg/ml,Human,Marine Lugworm Arenicola Marina,(twisted β-Hairpin) anti-parallel β-Sheet and two stabilizing disulfide bonds,NA,CCCSSCCBCSSSSBCSGGGGC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
11082,32576824,2020,GFCWYVCARRNGARVCYRRCN,GFCWYVCARRNGARVCYRRCN,AA139,Free,Free,Linear,L,None,21,Antibacterial,10 % Hemolysis at >300 μg/ml,Human,Arenicin-3 Analogs,NA,Non-hemolytic,CCCTTTTTSSCCTTSSCCCC,CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
11083,32576824,2020,GFCWRVCASRNGLRVCYRRCN,GFCWRVCASRNGLRVCYRRCN,NZ17125,Free,Free,Linear,L,None,21,Antibacterial,10 % Hemolysis at 181 μg/ml,Human,Arenicin-3 Analogs,NA,NA,CCSSCSSTTCSSSCCCCSCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
11084,32576824,2020,GFCWYACAKRNGLRVCYRRCN,GFCWYACAKRNGLRVCYRRCN,NZ17126,Free,Free,Linear,L,None,21,Antibacterial,10 % Hemolysis at 232 μg/ml,Human,Arenicin-3 Analogs,NA,NA,CCCCSCSSSCCGGGTSGGGCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
11085,32576824,2020,GFCWNVCVRRNGVRVCHRRCN,GFCWNVCVRRNGVRVCHRRCN,NZ17143,Free,Free,Linear,L,None,21,Antibacterial,10 % Hemolysis at >300 μg/ml,Human,Arenicin-3 Analogs,NA,Non-hemolytic,CCSSSSSSCCSSSCCCCTTCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
11086,32576824,2020,GFCWYVCVKRNGVRSCYRRCN,GFCWYVCVKRNGVRSCYRRCN,NZ17160,Free,Free,Linear,L,None,21,Antibacterial,10 % Hemolysis at >300 μg/ml,Human,Arenicin-3 Analogs,NA,Non-hemolytic,CHHHHHHHHGGGGGSCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)O
11087,32576824,2020,GFCWNVCVYRNGVRICHRRCN,GFCWNVCVYRNGVRICHRRCN,NZ17211,Free,Free,Linear,L,None,21,Antibacterial,10 % Hemolysis at >300 μg/ml,Human,Arenicin-3 Analogs,NA,Non-hemolytic,CCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)O
11088,32576824,2020,GFCWHVCARRNGVRVCYRRCN,GFCWHVCARRNGVRVCYRRCN,NZ17224,Free,Free,Linear,L,None,21,Antibacterial,10 % Hemolysis at >300 μg/ml,Human,Arenicin-3 Analogs,NA,Non-hemolytic,CCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
11089,32576824,2020,GFCWRACVYRNGVRACYRRCN,GFCWRACVYRNGVRACYRRCN,NZ17228,Free,Free,Linear,L,None,21,Antibacterial,10 % Hemolysis at >300 μg/ml,Human,Arenicin-3 Analogs,NA,Non-hemolytic,CCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)O
11090,32576824,2020,GFCWRACVYRNGVRVCYRRCN,GFCWRACVYRNGVRVCYRRCN,NZ17230,Free,Free,Linear,L,None,21,Antibacterial,10 % Hemolysis at >300 μg/ml,Human,Arenicin-3 Analogs,NA,Non-hemolytic,CCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
11091,32576874,2020,GFLSILKKVLPKVMAHMK,GFLSILKKVLPKVMAHMK{ct:Amid},Melectin,Amidation,Free,Linear,L,None,18,"Antibacterial, Anti-inflammatory",0 % Hemolysis at 32 µM,Sheep,Bee Venom Melecta Albifrons,LTA and LPS (208 and 222nm) = α-Helical,Non-hemolytic,CCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C
11092,32334835,2020,QAK,QAK{nt:Amid},QAK,Free,Amidation,Linear,L,None,3,"Antibacterial, Anti-biofilm",12 % Hemolysis at 30 μg/ml,Rabbit,Hemolymph Non-Mulberry Silkworm Antheraea Mylitta,NA,NA,CCC,C[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
11093,32334835,2020,QAK,QAK{nt:Amid},QAK,Free,Amidation,Linear,L,None,3,"Antibacterial, Anti-biofilm",18 % Hemolysis at 60 μg/ml,Rabbit,Hemolymph Non-Mulberry Silkworm Antheraea Mylitta,NA,NA,NA,C[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
11094,32334835,2020,QAK,QAK{nt:Acet}{ct:Acet},acetylated-QAK,Acetylation,Acetylation,Linear,L,None,3,"Antibacterial, Anti-biofilm",1 % Hemolysis at 3.75 μg/ml,Rabbit,Synthesized-Qak,NA,Low hemolytic,NA,C[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
11095,32334835,2020,QAK,QAK{nt:Acet}{ct:Acet},acetylated-QAK,Acetylation,Acetylation,Linear,L,None,3,"Antibacterial, Anti-biofilm",2 % Hemolysis at 7.5 μg/ml,Rabbit,Synthesized-Qak,NA,Low hemolytic,NA,C[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
11096,32334835,2020,QAK,QAK{nt:Acet}{ct:Acet},acetylated-QAK,Acetylation,Acetylation,Linear,L,None,3,"Antibacterial, Anti-biofilm",19.55 % Hemolysis at 100 μg/ml,Rabbit,Synthesized-Qak,NA,Low hemolytic,CCHHHHGGGCHHHHHHHC,C[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
11097,32334835,2020,QAK,QAK{nt:Acet}{ct:Acet},acetylated-QAK,Acetylation,Acetylation,Linear,L,None,3,"Antibacterial, Anti-biofilm",38.28 % Hemolysis at 200 μg/ml,Rabbit,Synthesized-Qak,NA,NA,CCCSSHHHHHHHHTTTTTCC,C[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
11101,32636607,2020,RNFFKRIRRAGKRIRKAI,RNFFKRIRRAGKRIRKAI{nt:Amid},CAMP-CecD,Free,Amidation,Linear,L,None,18,Antibacterial,0 % Hemolysis at 256 μg/ml,Human,Derived Δm2 Greater Wax Moth Galleria Mellonella,Helical,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
11102,32439180,2020,ARLDVASEFRKKWNKWALSR,ARLDVASEFRKKWNKWALSR{ct:Amid},PAMP,Amidation,Free,Linear,L,None,20,Antibacterial,>10 % Hemolysis at >256 µM,Sheep,Proadrenomedullin,NA,Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11103,32439180,2020,FRKKWNKWALSR,FRKKWNKWALSR{ct:Amid},PAMP(9-20),Amidation,Free,Linear,L,None,12,Antibacterial,>10 % Hemolysis at >256 µM,Sheep,Derived From Pamp,NA,Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11104,32629881,2020,KNalKKBip-O2Oc-NalKN,K{nnr:Nal}KK{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}KN{cyc:N-C},BSI-9,Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid",9,Antibacterial,33 % Hemolysis at 150 µM,Human,Synthetic Cyclic Amp,NA,NA,NA,NA
11105,32629881,2020,KNalKKBip-O2Oc-NalNK,K{nnr:Nal}KK{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}NK{cyc:N-C},BSI-9 stage-1 (1),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid",9,Antibacterial,Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11106,32629881,2020,KNalKNBip-O2Oc-NalKK,K{nnr:Nal}KN{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}KK{cyc:N-C},BSI-9 stage-1 (2),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid",9,Antibacterial,Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11107,32629881,2020,KNalNKBip-O2Oc-NalKK,K{nnr:Nal}NK{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}KK{cyc:N-C},BSI-9 stage-1 (3),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid",9,Antibacterial,Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11108,32629881,2020,NNalKKBip-O2Oc-NalKK,N{nnr:Nal}KK{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}KK{cyc:N-C},BSI-9 stage-1 (4),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid",9,Antibacterial,Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11109,32629881,2020,KFKKBip-O2Oc-NalKN,KFKK{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}KN{cyc:N-C},BSI-9 stage-2 (5),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid",9,Antibacterial,4 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,Non-hemolytic,NA,NA
11110,32629881,2020,KNalKKF-O2Oc-NalKN,K{nnr:Nal}KKF-{nnr:O2Oc}-{nnr:Nal}KN{cyc:N-C},BSI-9 stage-2 (6),Free,Free,Cyclic,L,"Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid",9,Antibacterial,6 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,Non-hemolytic,NA,NA
11111,32629881,2020,KNalKKBip-O2Oc-FKN,K{nnr:Nal}KK{nnr:Bip}-{nnr:O2Oc}-FKN{cyc:N-C},BSI-9 stage-2 (7),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid",9,Antibacterial,7 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,Non-hemolytic,NA,NA
11112,32629881,2020,KFKKF-O2Oc-FKN,KFKKF-{nnr:O2Oc}-FKN{cyc:N-C},BSI-9 stage-2 (8),Free,Free,Cyclic,L,"O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid",9,Antibacterial,3 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,Non-hemolytic,NA,NA
11113,32629881,2020,DabNalDabDabBip-O2Oc-NalDabN,{nnr:Dab}{nnr:Nal}{nnr:Dab}{nnr:Dab}{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C},BSI-9 stage-2 (9),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid",9,Antibacterial,76 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11114,32629881,2020,RNalDabDabBip-O2Oc-NalDabN,R{nnr:Nal}{nnr:Dab}{nnr:Dab}{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C},BSI-9 stage-3 (10),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid",9,Antibacterial,66 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11115,32629881,2020,DabNalRDabBip-O2Oc-NalDabN,{nnr:Dab}{nnr:Nal}R{nnr:Dab}{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C},BSI-9 stage-3 (11),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid",9,Antibacterial,36 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11116,32629881,2020,DabNalDabRBip-O2Oc-NalDabN,{nnr:Dab}{nnr:Nal}{nnr:Dab}R{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C},BSI-9 stage-3 (12),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid",9,Antibacterial,98 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11117,32629881,2020,DabNalDabDabBip-O2Oc-NalRN,{nnr:Dab}{nnr:Nal}{nnr:Dab}{nnr:Dab}{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}RN{cyc:N-C},BSI-9 stage-3 (13),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid",9,Antibacterial,80 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11118,32629881,2020,RNalRRBip-O2Oc-NalRN,R{nnr:Nal}RR{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}RN{cyc:N-C},BSI-9 stage-3 (14),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid",9,Antibacterial,68 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11119,32629881,2020,RNalRDapBip-O2Oc-NalDabN,R{nnr:Nal}RDap{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C},BSI-9 stage-4 (15),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11120,32629881,2020,RNalRDabF-O2Oc-NalDabN,R{nnr:Nal}R{nnr:Dab}F-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C},BSI-9 stage-4 (16),Free,Free,Cyclic,L,"Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid",9,Antibacterial,16 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11121,32629881,2020,RNalDabDabF-O2Oc-NalDabN,R{nnr:Nal}{nnr:Dab}{nnr:Dab}F-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C},BSI-9 stage-4 (17),Free,Free,Cyclic,L,"Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid",9,Antibacterial,3 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,Non-hemolytic,NA,NA
11122,32629881,2020,DabNalRDabF-O2Oc-NalDabN,{nnr:Dab}{nnr:Nal}R{nnr:Dab}F-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C},BSI-9 stage-4 (18),Free,Free,Cyclic,L,"Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid",9,Antibacterial,30 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11123,32151610,2020,LLL-CE-LL-CE-LLL-CE-L,LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH},analogs of 1 (12res),OH,H,Linear,L,CE = 21-crown-7-modified phenylalanine,12,Antibacterial,−1 ± 1 % Hemolysis at 100 µM,Sheep,Synthetic Peptide,α-Helical,NA,NA,NA
11124,32151610,2020,CE-LLL-CE-LL-CE-LLL-CE-L,{nnr:CE}-LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH},analogs of 1 (13res),OH,H,Linear,L,CE = 21-crown-7-modified phenylalanine,13,Antibacterial,−1 ± 1 % Hemolysis at 100 µM,Sheep,Synthetic Peptide,α-Helical,NA,NA,NA
11125,32151610,2020,L-CE-LLL-CE-LL-CE-LLL-CE-L,L-{nnr:CE}-LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH},analogs of 1 (14res),OH,H,Linear,L,CE = 21-crown-7-modified phenylalanine,14,Antibacterial,0 ± 3 % Hemolysis at 100 µM,Sheep,Synthetic Peptide,α-Helical,Non-hemolytic,NA,NA
11126,32151610,2020,LL-CE-LLL-CE-LL-CE-LLL-CE-L,LL-{nnr:CE}-LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH},analogs of 1 (15res),OH,H,Linear,L,CE = 21-crown-7-modified phenylalanine,15,Antibacterial,0 ± 1 % Hemolysis at 100 µM,Sheep,Synthetic Peptide,α-Helical,NA,NA,NA
11127,32151610,2020,LLL-CE-LLL-CE-LL-CE-LLL-CE-L,LLL-{nnr:CE}-LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH},analogs of 1 (16res),OH,H,Linear,L,CE = 21-crown-7-modified phenylalanine,16,Antibacterial,−1 ± 1 % Hemolysis at 100 µM,Sheep,Synthetic Peptide,α-Helical,Non-hemolytic,NA,NA
11128,32151610,2020,LRL-CE-LL-CE-LRL-CE-L,LRL-{nnr:CE}-LL-{nnr:CE}-LRL-{nnr:CE}-L{nt:H}{ct:OH},12-residue R4R11,OH,H,Linear,L,CE = 21-crown-7-modified phenylalanine,12,Antibacterial,−1 ± 1 % Hemolysis at 100 µM,Sheep,Synthetic Peptide,"β-Sheet, TFE = α-Helical",Non-hemolytic,NA,NA
11129,32151610,2020,CE-LRL-CE-LL-CE-LRL-CE-L,{nnr:CE}-LRL-{nnr:CE}-LL-{nnr:CE}-LRL-{nnr:CE}-L{nt:H}{ct:OH},13-residue R4R11,OH,H,Linear,L,CE = 21-crown-7-modified phenylalanine,12,Antibacterial,−1 ± 1 % Hemolysis at 100 µM,Sheep,Synthetic Peptide,"β-Sheet, TFE = α-Helical",Non-hemolytic,NA,NA
11130,32151610,2020,LL-CE-LRL-CE-LL-CE-LRL-CE-L,LL-{nnr:CE}-LRL-{nnr:CE}-LL-{nnr:CE}-LRL-{nnr:CE}-L{nt:H}{ct:OH},15-residue R4R11,OH,H,Linear,L,CE = 21-crown-7-modified phenylalanine,15,Antibacterial,0 ± 1 % Hemolysis at 100 µM,Sheep,Synthetic Peptide,"β-Sheet, TFE = α-Helical",Non-hemolytic,NA,NA
11131,32151610,2020,LLL-CE-LRL-CE-LL-CE-LRL-CE-L,LLL-{nnr:CE}-LRL-{nnr:CE}-LL-{nnr:CE}-LRL-{nnr:CE}-L{nt:H}{ct:OH},16-residue R4R11,OH,H,Linear,L,CE = 21-crown-7-modified phenylalanine,16,Antibacterial,−1 ± 1 % Hemolysis at 100 µM,Sheep,Synthetic Peptide,"β-Sheet, TFE = α-Helical",NA,NA,NA
11132,32151610,2020,LLR-CE-LL-CE-R-LL-CE-L,LLR-{nnr:CE}-LL-{nnr:CE}-R-LL-{nnr:CE}-L{nt:H}{ct:OH},12-residue R5R10,OH,H,Linear,L,CE = 21-crown-7-modified phenylalanine,12,Antibacterial,96 ± 6 % Hemolysis at 100 µM,Sheep,Synthetic Peptide,α-Helical,NA,NA,NA
11133,32151610,2020,CE-LLR-CE-LL-CE-RLL-CE-L,{nnr:CE}-LLR-{nnr:CE}-LL-{nnr:CE}-RLL-{nnr:CE}-L{nt:H}{ct:OH},13-residue R5R10,OH,H,Linear,L,CE = 21-crown-7-modified phenylalanine,13,Antibacterial,28 ± 7 % Hemolysis at 100 µM,Sheep,Synthetic Peptide,α-Helical,NA,NA,NA
11134,32151610,2020,LL-CE-LLR-CE-LL-CE-RLL-CE-L,LL-{nnr:CE}-LLR-{nnr:CE}-LL-{nnr:CE}-RLL-{nnr:CE}-L{nt:H}{ct:OH},15-residue R5R10,OH,H,Linear,L,CE = 21-crown-7-modified phenylalanine,15,Antibacterial,102 ± 10 % Hemolysis at 100 µM,Sheep,Synthetic Peptide,α-Helical,NA,NA,NA
11135,32151610,2020,LLL-CE-LLR-CE-LL-CE-RLL-CE-L,LLL-{nnr:CE}-LLR-{nnr:CE}-LL-{nnr:CE}-RLL-{nnr:CE}-L{nt:H}{ct:OH},16-residue R5R10,OH,H,Linear,L,CE = 21-crown-7-modified phenylalanine,16,Antibacterial,104 ± 5 % Hemolysis at 100 µM,Sheep,Synthetic Peptide,α-Helical,NA,NA,NA
11136,32151610,2020,L-CE-LLL-CE-LL-CE-LLL-CE-L,L-{nnr:CE}-LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH},15C5 1,OH,H,Linear,L,CE = 21-crown-7-modified phenylalanine,14,Antibacterial,0 ± 1 % Hemolysis at 100 µM,Sheep,Synthetic Peptide,NA,Non-hemolytic,NA,NA
11137,32151610,2020,L-CE-LRL-CE-LL-CE-LRL-CE-L,L-{nnr:CE}-LRL-{nnr:CE}-LL-{nnr:CE}-LRL-{nnr:CE}-L{nt:H}{ct:OH},15C5 R4R11,OH,H,Linear,L,CE = 21-crown-7-modified phenylalanine,14,Antibacterial,1 ± 1 % Hemolysis at 100 µM,Sheep,Synthetic Peptide,NA,Non-hemolytic,NA,NA
11138,32151610,2020,L-CE-LLR-CE-LL-CE-RLL-CE-L,L-{nnr:CE}-LLR-{nnr:CE}-LL-{nnr:CE}-RLL-{nnr:CE}-L{nt:H}{ct:OH},15C5 R5R10,OH,H,Linear,L,CE = 21-crown-7-modified phenylalanine,14,Antibacterial,13 ± 1 % Hemolysis at 100 µM,Sheep,Synthetic Peptide,NA,NA,NA,NA
11139,32151610,2020,L-CE-LLL-CE-LL-CE-LLL-CE-L,L-{nnr:CE}-LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH},18C6 1,OH,H,Linear,L,CE = 21-crown-7-modified phenylalanine,14,Antibacterial,2 ± 1 % Hemolysis at 100 µM,Sheep,Synthetic Peptide,NA,NA,NA,NA
11140,32151610,2020,L-CE-LRL-CE-LL-CE-LRL-CE-L,L-{nnr:CE}-LRL-{nnr:CE}-LL-{nnr:CE}-LRL-{nnr:CE}-L{nt:H}{ct:OH},18C6 R4R11,OH,H,Linear,L,CE = 21-crown-7-modified phenylalanine,14,Antibacterial,0 ± 1 % Hemolysis at 100 µM,Sheep,Synthetic Peptide,NA,Non-hemolytic,NA,NA
11141,32151610,2020,L-CE-LLR-CE-LL-CE-RLL-CE-L,L-{nnr:CE}-LLR-{nnr:CE}-LL-{nnr:CE}-RLL-{nnr:CE}-L{nt:H}{ct:OH},18C6 R5R10,OH,H,Linear,L,CE = 21-crown-7-modified phenylalanine,14,Antibacterial,22 ± 2 % Hemolysis at 100 µM,Sheep,Synthetic Peptide,NA,NA,NA,NA
11142,32333997,2020,MSLLERKLLMHFLRV,MSLLERKLLMHFLRV,La-AMP1,Free,Free,Linear,L,None,15,Antibacterial,52 % Hemolysis at 128 μg/ml,Human,Plant Lippia Alba,α-Helix,NA,CHHHHHHHHHHHHHCC,CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C
11143,32333997,2020,GLMKLLRELLHMFSRVG,GLMKLLRELLHMFSRVG,La-AMP1a,Free,Free,Linear,L,None,17,Antibacterial,0.5 % Hemolysis at 128 μg/ml,Human,Derived From La-Amp1 Plant Lippia Alba,α-Helix,Non-hemolytic,CCCHHHHHHHHHSCC,CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C
11144,32333997,2020,MRIGLRFVLM,MRIGLRFVLM,Lr-AMP1,Free,Free,Linear,L,None,10,Antibacterial,71.5 % Hemolysis at 128 μg/ml,Human,Plant Lippia Rotundifolia,Random coil,NA,CTHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)O)C(C)C
11145,32333997,2020,SVAGRAMRIGLRFVLM,SVAGRAMRIGLRFVLM,Lr-AMP1d,Free,Free,Linear,L,None,16,Antibacterial,0 % Hemolysis at 128 μg/ml,Human,Derived From Lr-Amp1 Plant Lippia Rotundifolia,α-Helix,Non-hemolytic,CGGGGGGHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)O)C(C)C
11146,32333997,2020,GIAGLLRSFVRMLAKIMGG,GIAGLLRSFVRMLAKIMGG,Lr-AMP1e,Free,Free,Linear,L,None,19,Antibacterial,50 % Hemolysis at 128 μg/ml,Human,Derived From Lr-Amp1 Plant Lippia Rotundifolia,α-Helix,NA,CGGGGGSHHHHHC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)NCC(=O)O)[C@@H](C)CC)C(C)C
11147,32333997,2020,GSVLRAIMRMFAKLMG,GSVLRAIMRMFAKLMG,Lr-AMP1f,Free,Free,Linear,L,None,16,Antibacterial,0 % Hemolysis at 128 μg/ml,Human,Derived From Lr-Amp1 Plant Lippia Rotundifolia,α-Helix,Non-hemolytic,CGGGGHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)O
11148,32333997,2020,GIHGVVRSFMRMLGHLG,GIHGVVRSFMRMLGHLG,Lr-AMP1g,Free,Free,Linear,L,None,17,Antibacterial,0 % Hemolysis at 128 μg/ml,Human,Derived From Lr-Amp1 Plant Lippia Rotundifolia,α-Helix,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(C)C)C(C)C
11149,32333997,2020,GSVIRALMRMFARLVG,GSVIRALMRMFARLVG,Lr-AMP1h,Free,Free,Linear,L,None,16,Antibacterial,2.3 % Hemolysis at 128 μg/ml,Human,Derived From Lr-Amp1 Plant Lippia Rotundifolia,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C
11150,32567085,2020,FKRIVQRIKDFLR,FKRIVQRIKDFLR{ct:Amid},1,Amidation,NA,Linear,L,None,13,"Antibacterial,Antifungal, Anticancer",50 % Hemolysis at 0 μg/ml,Human,Derivedm From Cathelicidin Ll-37,α-Helix,Non-hemolytic,CTTHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11151,32567085,2020,LKRIVQRIKDFLR,LKRIVQRIKDFLR{ct:Amid},2,Amidation,NA,Linear,L,None,13,"Antibacterial, Anticancer",50 % Hemolysis at 0 μg/ml,Human,Derivedm From Cathelicidin Ll-37,α-Helix,Non-hemolytic,CTTHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11152,32567085,2020,AKRIVQRIKDFLR,AKRIVQRIKDFLR{ct:Amid},3,Amidation,NA,Linear,L,None,13,"Antibacterial, Anticancer",50 % Hemolysis at 0 μg/ml,Human,Derivedm From Cathelicidin Ll-37,α-Helix,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11153,32567085,2020,FκRIVQRILDFLR,F{nnr:κ}RIVQRILDFLR{nt:Acet}{ct:Amid},4,Amidation,Acetylation,Linear,L,κ = κ,13,"Antibacterial, Anticancer",50 % Hemolysis at 450 μg/ml,Human,Derivedm From Cathelicidin Ll-37,α-Helix,NA,NA,NA
11154,32567085,2020,FK(SA)RIVQRILDFLR,FK{nnr:SA}RIVQRILDFLR{nt:Acet}{ct:Amid},5,Amidation,Acetylation,Linear,L,SA = SA,14,"Antibacterial, Anticancer",50 % Hemolysis at 0 μg/ml,Human,Derivedm From Cathelicidin Ll-37,α-Helix,Non-hemolytic,NA,NA
11155,32567085,2020,FKRIVQRIRDFLR,FKRIVQRIRDFLR{ct:Amid},6,Amidation,NA,Linear,L,None,13,"Antibacterial,Antifungal, Anticancer",50 % Hemolysis at 0 μg/ml,Human,Derivedm From Cathelicidin Ll-37,α-Helix,Non-hemolytic,CGGGGGGHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11156,32567085,2020,FKRIVQRIRDFLR,FKRIVQRIRDFLR{nt:Acet}{ct:Amid},7,Amidation,Acetylation,Linear,L,None,13,"Antibacterial, Anticancer",50 % Hemolysis at 0 μg/ml,Human,Derivedm From Cathelicidin Ll-37,α-Helix,Non-hemolytic,CGGGGGGHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11157,32567085,2020,FKRIVQκIKDFLR,FKRIVQ{nnr:κ}IKDFLR{ct:Amid},8,Amidation,NA,Linear,L,κ = κ,13,"Antibacterial, Anticancer",50 % Hemolysis at 0 μg/ml,Human,Derivedm From Cathelicidin Ll-37,α-Helix,Non-hemolytic,NA,NA
11158,32567085,2020,FKRIVQLIKDFLR,FKRIVQLIKDFLR{ct:Amid},9,Amidation,NA,Linear,L,None,13,"Antibacterial,Antifungal, Anticancer",50 % Hemolysis at 114 μg/ml,Human,Derivedm From Cathelicidin Ll-37,α-Helix,NA,CTTHHHHHTTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11159,32567085,2020,FKRIVQLIKDFLR,FKRIVQLIKDFLR{nt:Acet}{ct:Amid},10,Amidation,Acetylation,Linear,L,None,13,"Antibacterial,Antifungal, Anticancer",50 % Hemolysis at 227 μg/ml,Human,Derivedm From Cathelicidin Ll-37,α-Helix,NA,CGGGHHHHTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11160,32567085,2020,FKRIVQRIKDLLR,FKRIVQRIKDLLR{ct:Amid},11,Amidation,NA,Linear,L,None,13,"Antibacterial,Antifungal, Anticancer",50 % Hemolysis at 0 μg/ml,Human,Derivedm From Cathelicidin Ll-37,α-Helix,Non-hemolytic,CGGGHHHHTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11161,32567085,2020,FKRIVQRIKDLLR,FKRIVQRIKDLLR{nt:Acet}{ct:Amid},12,Amidation,Acetylation,Linear,L,None,13,"Antibacterial,Antifungal, Anticancer",50 % Hemolysis at 0 μg/ml,Human,Derivedm From Cathelicidin Ll-37,α-Helix,Non-hemolytic,CGGGGGGHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11162,32567085,2020,FKRIVQIIKKFLR,FKRIVQIIKKFLR{ct:Amid},13,Amidation,NA,Linear,L,None,13,"Antibacterial,Antifungal, Anticancer",50 % Hemolysis at 361 μg/ml,Human,Derivedm From Cathelicidin Ll-37,α-Helix,NA,CGGGGGGHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C
11163,32567085,2020,FKRIVQIIKKFLR,FKRIVQIIKKFLR{nt:Acet}{ct:Amid},14,Amidation,Acetylation,Linear,L,None,13,"Antibacterial,Antifungal, Anticancer",50 % Hemolysis at 292 μg/ml,Human,Derivedm From Cathelicidin Ll-37,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C
11164,32567085,2020,FKRIVQLLKKLLR,FKRIVQLLKKLLR{ct:Amid},15,Amidation,NA,Linear,L,None,13,"Antibacterial,Antifungal, Anticancer",50 % Hemolysis at 411 μg/ml,Human,Derivedm From Cathelicidin Ll-37,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
11165,32567085,2020,FKRIVQLLKKLLR,FKRIVQLLKKLLR{nt:Acet}{ct:Amid},16,Amidation,Acetylation,Linear,L,None,13,"Antibacterial,Antifungal, Anticancer",50 % Hemolysis at 185 μg/ml,Human,Derivedm From Cathelicidin Ll-37,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
11166,32567085,2020,FKRILQRIKDFLR,FKRILQRIKDFLR{ct:Amid},17,Amidation,NA,Linear,L,None,13,"Antibacterial,Antifungal, Anticancer",50 % Hemolysis at 0 μg/ml,Human,Derivedm From Cathelicidin Ll-37,α-Helix,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11167,32567085,2020,FKRILQRIKDFLR,FKRILQRIKDFLR{nt:Acet}{ct:Amid},18,Amidation,Acetylation,Linear,L,None,13,"Antibacterial,Antifungal, Anticancer",50 % Hemolysis at 0 μg/ml,Human,Derivedm From Cathelicidin Ll-37,α-Helix,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11168,32654770,2020,AβLLKRIKTLL,{nnr:Aβ}LLKRIKTLL{ct:Amid},Ano-1β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11169,32654770,2020,GAβLKRIKTLL,G{nnr:Aβ}LKRIKTLL{ct:Amid},Ano-2β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11170,32654770,2020,GLAβKRIKTLL,GL{nnr:Aβ}KRIKTLL{ct:Amid},Ano-3β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11171,32654770,2020,GLLAβRIKTLL,GLL{nnr:Aβ}RIKTLL{ct:Amid},Ano-4β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11172,32654770,2020,GLLKAβIKTLL,GLLK{nnr:Aβ}IKTLL{ct:Amid},Ano-5β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11173,32654770,2020,GLLKRAβKTLL,GLLKR{nnr:Aβ}KTLL{ct:Amid},Ano-6β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11174,32654770,2020,GLLKRIAβTLL,GLLKRI{nnr:Aβ}TLL{ct:Amid},Ano-7β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11175,32654770,2020,GLLKRIKAβLL,GLLKRIK{nnr:Aβ}LL{ct:Amid},Ano-8β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11176,32654770,2020,GLLKRIKTAβL,GLLKRIKT{nnr:Aβ}L{ct:Amid},Ano-9β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11177,32654770,2020,GLLKRIKTLAβ,GLLKRIKTL{nnr:Aβ}{ct:Amid},Ano-10β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11178,32654770,2020,AβLLKRIKAβLL,{nnr:Aβ}LLKRIK{nnr:Aβ}LL{ct:Amid},Ano-1β8β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11179,32654770,2020,GLLKRIKTLL,GLLKRIKTLL{ct:Amid},Anoplin,Amidation,Free,Linear,L,None,10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Venom Sac Of Solitary Spider Wasps,30 mM SDS = α-Helix,Low hemolytic,CCSCCCCCCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
11184,32569466,2020,WFQVKTRVRTKVQFW,WFQVKTRVRTKVQFW,WF-1,Free,Free,Linear,L,None,15,Antibacterial,5 % Hemolysis at 64 µM,Human,Mutagenesis Modification Peptide Of Wi-6,SDS = β-Sheet,NA,CCSCCCSCCCCSSCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
11185,32569466,2020,FWRRYKKVKKYRRWF,FWRRYKKVKKYRRWF,FW-2,Free,Free,Linear,L,None,15,Antibacterial,5 % Hemolysis at >256 µM,Human,Mutagenesis Modification Peptide Of Wi-6,"PBS (aqueous)= Disordered, TFE = α-Helical",Low hemolytic,CCSCCC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11186,32569466,2020,FWQVIKKVKKIVQWF,FWQVIKKVKKIVQWF,FW-3,Free,Free,Linear,L,None,15,Antibacterial,5 % Hemolysis at 64 µM,Human,Mutagenesis Modification Peptide Of Wi-6,"PBS (aqueous)= Disordered, TFE = α-Helical",NA,CCSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
11187,32569466,2020,FKQFYRRVRRYFQKF,FKQFYRRVRRYFQKF,FK-4,Free,Free,Linear,L,None,15,Antibacterial,5 % Hemolysis at 128 µM,Human,Mutagenesis Modification Peptide Of Wi-6,"PBS (aqueous)= Disordered, TFE = α-Helical",NA,CCSCCC,CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11188,32569466,2020,FRQWYRRVRRYWQRF,FRQWYRRVRRYWQRF,FR-5,Free,Free,Linear,L,None,15,Antibacterial,5 % Hemolysis at 64 µM,Human,Mutagenesis Modification Peptide Of Wi-6,"PBS (aqueous)= Disordered, TFE = α-Helical",NA,CCSCCC,CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11189,32569466,2020,WIQPKTKVIPYVRYL,WIQPKTKVIPYVRYL,WI-6,Free,Free,Linear,L,None,15,Antibacterial,5 % Hemolysis at 256 µM,Human,Bovine Αs2-Casein F21 (193-207),PBS (aqueous)= Disordered,Low hemolytic,CCSCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O
11190,32704013,2020,KLKLKL,KLKLKL{ct:Amid},KL6,Amidation,Free,Linear,L,None,6,Antibacterial,0 % Hemolysis at 1 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC (pH ≈ 6) = Random coil, DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet)",Non-hemolytic,CCSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11191,32704013,2020,KLKLKL,KLKLKL{ct:Amid},KL6,Amidation,Free,Linear,L,None,6,Antibacterial,1 % Hemolysis at 2 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC (pH ≈ 6) = Random coil, DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet)",NA,CCSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11192,32704013,2020,KLKLKL,KLKLKL{ct:Amid},KL6,Amidation,Free,Linear,L,None,6,Antibacterial,1 % Hemolysis at 4 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC (pH ≈ 6) = Random coil, DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet)",NA,CCSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11193,32704013,2020,KLKLKL,KLKLKL{ct:Amid},KL6,Amidation,Free,Linear,L,None,6,Antibacterial,3 % Hemolysis at 8 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC (pH ≈ 6) = Random coil, DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet)",NA,CCSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11194,32704013,2020,KLKLKL,KLKLKL{ct:Amid},KL6,Amidation,Free,Linear,L,None,6,Antibacterial,2 % Hemolysis at 16 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC (pH ≈ 6) = Random coil, DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet)",NA,CCCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11195,32704013,2020,KLKLKL,KLKLKL{ct:Amid},KL6,Amidation,Free,Linear,L,None,6,Antibacterial,2 % Hemolysis at 32 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC (pH ≈ 6) = Random coil, DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet)",NA,CCCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11196,32704013,2020,KLKLKL,KLKLKL{ct:Amid},KL6,Amidation,Free,Linear,L,None,6,Antibacterial,4 % Hemolysis at 64 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC (pH ≈ 6) = Random coil, DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet)",NA,CCCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11197,32704013,2020,KLKLKL,KLKLKL{ct:Amid},KL6,Amidation,Free,Linear,L,None,6,Antibacterial,6 % Hemolysis at 128 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC (pH ≈ 6) = Random coil, DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet)",NA,CCCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11198,32704013,2020,KLKLKL,KLKLKL{ct:Amid},KL6,Amidation,Free,Linear,L,None,6,Antibacterial,7 % Hemolysis at 256 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC (pH ≈ 6) = Random coil, DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet)",NA,CCCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11199,32704013,2020,KLKLKLKLKL,KLKLKLKLKL{ct:Amid},KL10,Amidation,Free,Linear,L,None,10,Antibacterial,11 % Hemolysis at 1 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11200,32704013,2020,KLKLKLKLKL,KLKLKLKLKL{ct:Amid},KL10,Amidation,Free,Linear,L,None,10,Antibacterial,12 % Hemolysis at 2 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11201,32704013,2020,KLKLKLKLKL,KLKLKLKLKL{ct:Amid},KL10,Amidation,Free,Linear,L,None,10,Antibacterial,16 % Hemolysis at 4 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11202,32704013,2020,KLKLKLKLKL,KLKLKLKLKL{ct:Amid},KL10,Amidation,Free,Linear,L,None,10,Antibacterial,20 % Hemolysis at 8 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11203,32704013,2020,KLKLKLKLKL,KLKLKLKLKL{ct:Amid},KL10,Amidation,Free,Linear,L,None,10,Antibacterial,28 % Hemolysis at 16 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCSCSCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11204,32704013,2020,KLKLKLKLKL,KLKLKLKLKL{ct:Amid},KL10,Amidation,Free,Linear,L,None,10,Antibacterial,40 % Hemolysis at 32 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCSCSCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11205,32704013,2020,KLKLKLKLKL,KLKLKLKLKL{ct:Amid},KL10,Amidation,Free,Linear,L,None,10,Antibacterial,59 % Hemolysis at 64 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCSCSCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11206,32704013,2020,KLKLKLKLKL,KLKLKLKLKL{ct:Amid},KL10,Amidation,Free,Linear,L,None,10,Antibacterial,81 % Hemolysis at 128 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCSCSCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11207,32704013,2020,KLKLKLKLKL,KLKLKLKLKL{ct:Amid},KL10,Amidation,Free,Linear,L,None,10,Antibacterial,94 % Hemolysis at 256 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCSCSCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11208,32704013,2020,KLKLKLKLKLKLKL,KLKLKLKLKLKLKL{ct:Amid},KL14,Amidation,Free,Linear,L,None,14,Antibacterial,47 % Hemolysis at 1 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCSCSCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11209,32704013,2020,KLKLKLKLKLKLKL,KLKLKLKLKLKLKL{ct:Amid},KL14,Amidation,Free,Linear,L,None,14,Antibacterial,86 % Hemolysis at 2 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCSCSCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11210,32704013,2020,KLKLKLKLKLKLKL,KLKLKLKLKLKLKL{ct:Amid},KL14,Amidation,Free,Linear,L,None,14,Antibacterial,96 % Hemolysis at 4 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCSCSCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11211,32704013,2020,KLKLKLKLKLKLKL,KLKLKLKLKLKLKL{ct:Amid},KL14,Amidation,Free,Linear,L,None,14,Antibacterial,96 % Hemolysis at 8 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCSCSCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11212,32704013,2020,KLKLKLKLKLKLKL,KLKLKLKLKLKLKL{ct:Amid},KL14,Amidation,Free,Linear,L,None,14,Antibacterial,95 % Hemolysis at 16 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCCCCTTTCCSSCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11213,32704013,2020,KLKLKLKLKLKLKL,KLKLKLKLKLKLKL{ct:Amid},KL14,Amidation,Free,Linear,L,None,14,Antibacterial,94 % Hemolysis at 32 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCCCCTTTCCSSCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11214,32704013,2020,KLKLKLKLKLKLKL,KLKLKLKLKLKLKL{ct:Amid},KL14,Amidation,Free,Linear,L,None,14,Antibacterial,94 % Hemolysis at 64 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCCCCTTTCCSSCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11215,32704013,2020,KLKLKLKLKLKLKL,KLKLKLKLKLKLKL{ct:Amid},KL14,Amidation,Free,Linear,L,None,14,Antibacterial,91 % Hemolysis at 128 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCCCCTTTCCSSCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11216,32704013,2020,KLKLKLKLKLKLKL,KLKLKLKLKLKLKL{ct:Amid},KL14,Amidation,Free,Linear,L,None,14,Antibacterial,89 % Hemolysis at 256 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCCCCTTTCCSSCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11217,32704013,2020,KLKLKLKLKLKLKLKLKL,KLKLKLKLKLKLKLKLKL{ct:Amid},KL18,Amidation,Free,Linear,L,None,18,Antibacterial,33 % Hemolysis at 1 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCCCCTTTCCSSCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11218,32704013,2020,KLKLKLKLKLKLKLKLKL,KLKLKLKLKLKLKLKLKL{ct:Amid},KL18,Amidation,Free,Linear,L,None,18,Antibacterial,80 % Hemolysis at 2 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCCCCTTTCCSSCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11219,32704013,2020,KLKLKLKLKLKLKLKLKL,KLKLKLKLKLKLKLKLKL{ct:Amid},KL18,Amidation,Free,Linear,L,None,18,Antibacterial,95 % Hemolysis at 4 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCCCCTTTCCSSCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11220,32704013,2020,KLKLKLKLKLKLKLKLKL,KLKLKLKLKLKLKLKLKL{ct:Amid},KL18,Amidation,Free,Linear,L,None,18,Antibacterial,95 % Hemolysis at 8 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCCCCTTTCCSSCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11221,32704013,2020,KLKLKLKLKLKLKLKLKL,KLKLKLKLKLKLKLKLKL{ct:Amid},KL18,Amidation,Free,Linear,L,None,18,Antibacterial,90 % Hemolysis at 16 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCGGGTHHHHHHTTSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11222,32704013,2020,KLKLKLKLKLKLKLKLKL,KLKLKLKLKLKLKLKLKL{ct:Amid},KL18,Amidation,Free,Linear,L,None,18,Antibacterial,82 % Hemolysis at 32 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCHIIIIIHHHHTTTTSTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11223,32704013,2020,KLKLKLKLKLKLKLKLKL,KLKLKLKLKLKLKLKLKL{ct:Amid},KL18,Amidation,Free,Linear,L,None,18,Antibacterial,79 % Hemolysis at 64 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCHHHHCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11224,32704013,2020,KLKLKLKLKLKLKLKLKL,KLKLKLKLKLKLKLKLKL{ct:Amid},KL18,Amidation,Free,Linear,L,None,18,Antibacterial,78 % Hemolysis at 128 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCCCCCSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11225,32704013,2020,KLKLKLKLKLKLKLKLKL,KLKLKLKLKLKLKLKLKL{ct:Amid},KL18,Amidation,Free,Linear,L,None,18,Antibacterial,78 % Hemolysis at 256 μg/ml,Human,Kl Peptides,"Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet",NA,CCHHHHHHHHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11226,32722535,2020,GIFSKLAGKKLKNLLISG,GIFSKLAGKKLKNLLISG{ct:Amid},Esc(1-18),Amidation,Free,Linear,L,None,18,Antibacterial,~10 % Hemolysis at 64 µM,Sheep,Frog Derived Esculentin Peptide,NA,NA,CCCSHHHHHHTTCCTTCCCCCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)[C@@H](C)CC
11227,32722535,2020,GIFSKLAGKKIKNLLISGLKG,GIFSKLAGKKIKNLLISGLKG{ct:Amid},Esc(1-21),Amidation,Free,Linear,L,None,21,Antibacterial,~10 % Hemolysis at 64 µM,Sheep,Frog Derived Esculentin Peptide,NA,NA,CCSHHHHCSSTTHHHHHHHTTTSCCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)[C@@H](C)CC)[C@@H](C)CC
11230,32229648,2020,LVGALVSTLLSLVPSLMK,LVGALVSTLLSLVPSLMK{ct:Amid},Dq-1840,Amidation,Free,Linear,L,None,18,Antibacterial,7.8 % Hemolysis at 10 µM,Rat,Giant Ant Dinoponera Quadriceps,NA,NA,CCHHHHHHHHHHHHHHTC,CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
11231,32229648,2020,FWGTLAKWALKAIPAAMGMKQNK,FWGTLAKWALKAIPAAMGMKQNK,Dq-2562,Free,Free,Linear,L,None,23,"Antibacterial, Antifungal, histamine-releasing",5.1 % Hemolysis at 10 µM,Rat,Giant Ant Dinoponera Quadriceps,NA,NA,CCCSHHHHHHTTCCTTCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
11232,32229648,2020,GLKDWWNKHKDKIVKVVKEMGKAGINAA,GLKDWWNKHKDKIVKVVKEMGKAGINAA{ct:Amid},Dq-3162,Amidation,Free,Linear,L,None,28,"Antibacterial, Antifungal, histamine-releasing",0 % Hemolysis at 10 µM,Rat,Giant Ant Dinoponera Quadriceps,NA,Non-hemolytic,CCSHHHHCSSTTHHHHHHHTTTSCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
11235,32229648,2020,LVGALVSTLLSLVPSLMK,LVGALVSTLLSLVPSLMK{ct:Amid},Dq-1840,Amidation,Free,Linear,L,None,18,Antibacterial,35.3 % Hemolysis at 50 µM,Rat,Giant Ant Dinoponera Quadriceps,NA,NA,NA,CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
11236,32229648,2020,FWGTLAKWALKAIPAAMGMKQNK,FWGTLAKWALKAIPAAMGMKQNK,Dq-2562,Free,Free,Linear,L,None,23,"Antibacterial, Antifungal, histamine-releasing",82.9 % Hemolysis at 50 µM,Rat,Giant Ant Dinoponera Quadriceps,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
11237,32229648,2020,GLKDWWNKHKDKIVKVVKEMGKAGINAA,GLKDWWNKHKDKIVKVVKEMGKAGINAA{ct:Amid},Dq-3162,Amidation,Free,Linear,L,None,28,"Antibacterial, Antifungal, histamine-releasing",5.6 % Hemolysis at 50 µM,Rat,Giant Ant Dinoponera Quadriceps,NA,NA,CCCCSSSSSSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
11288,32130974,2020,RIRIRWIIR,RIRIRWIIR{nt:Amid}{ct:Amid},A1,Amidation,Amidation,Linear,L,None,9,Antibacterial,50 % Hemolysis at >250 μg/ml,Human,Synthetic Amp,NA,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
11289,32130974,2020,(β-Ala)-(β-Ala)-Lys-RIRIRWIIR,RIRIRWIIR{nt:(β-Ala)(β-Ala)(Lys)}{ct:Amid},A2,Amidation,(β-Ala)(β-Ala)(Lys),Linear,L,Ala spacers and Lys,9,Antibacterial,50 % Hemolysis at >250 μg/ml,Human,Modification Of A1 With Ala Spacers And Lys,NA,Low hemolytic,NA,NA
11290,32130974,2020,Caprylicacid(C8)-RIRIRWIIR,RIRIRWIIR{nt:Caprylic acid (C8)}{ct:Amid},A3,Amidation,Caprylic acid (C8),Linear,L,C8 = Caprylic acid,9,Antibacterial,50 % Hemolysis at 132 μg/ml,Human,Modification Of A1 With Caprylic Acid (C8),NA,NA,NA,NA
11291,32130974,2020,Capricacid(C10)-RIRIRWIIR,RIRIRWIIR{nt:Capric acid (C10)}{ct:Amid},A4,Amidation,Capric acid (C10),Linear,L,C10 = Capric acid,9,Antibacterial,50 % Hemolysis at 73 μg/ml,Human,Modification Of A1 With Capric Acid (C10),NA,NA,NA,NA
11292,32130974,2020,Lauricacid(C12)-RIRIRWIIR,RIRIRWIIR{nt:Lauric acid (C12)}{ct:Amid},A5,Amidation,Lauric acid (C12),Linear,L,C12 = Lauric acid,9,Antibacterial,50 % Hemolysis at 35 μg/ml,Human,Modification Of A1 With Lauric Acid (C12),NA,NA,NA,NA
11293,32130974,2020,Myristicacid(C14)-RIRIRWIIR,RIRIRWIIR{nt:Myristic acid (C14)}{ct:Amid},A6,Amidation,Myristic acid (C14),Linear,L,C14 = Myristic acid,9,Antibacterial,50 % Hemolysis at 28 μg/ml,Human,Modification Of A1 With Myristic Acid (C14),NA,NA,NA,NA
11294,32130974,2020,Ser-Glucose-RIRIRWIIR,RIRIRWIIR{nt:Ser-Glucose}{ct:Amid},A7,Amidation,Ser-Glucose,Linear,L,Glucose = Glucose,9,Antibacterial,50 % Hemolysis at >250 μg/ml,Human,Modification Of A1 With Glucose,NA,Low hemolytic,NA,NA
11295,32130974,2020,Ser-N-Acetylglucosamine(GlcNac)-RIRIRWIIR,RIRIRWIIR{nt:Ser-N-Acetylglucosamine (GlcNac)}{ct:Amid},A8,Amidation,Ser-N-Acetylglucosamine (GlcNac),Linear,L,GlcNAc = GlcNAc,9,Antibacterial,50 % Hemolysis at >250 μg/ml,Human,Modification Of A1 With Glcnac,NA,Low hemolytic,NA,NA
11296,32130974,2020,Ser-Galactose-RIRIRWIIR,RIRIRWIIR{nt:Ser-Galactose}{ct:Amid},A9,Amidation,Ser-Galactose,Linear,L,Galactose = Galactose,9,Antibacterial,50 % Hemolysis at >250 μg/ml,Human,Modification Of A1 With Galactose,NA,Low hemolytic,NA,NA
11297,32130974,2020,Ser-Mannose-RIRIRWIIR,RIRIRWIIR{nt:Ser-Mannose}{ct:Amid},A10,Amidation,Ser-Mannose,Linear,L,Mannose = Mannose,9,Antibacterial,50 % Hemolysis at >250 μg/ml,Human,Modification Of A1 With Mannose,NA,Low hemolytic,NA,NA
11298,32130974,2020,Ser-Lactose-RIRIRWIIR,RIRIRWIIR{nt:Ser-Lactose}{ct:Amid},A11,Amidation,Ser-Lactose,Linear,L,Lactose = Lactose,9,Antibacterial,50 % Hemolysis at >250 μg/ml,Human,Modification Of A1 With Lactose,NA,Low hemolytic,NA,NA
11299,32130974,2020,Meo-PEG-RIRIRWIIR,RIRIRWIIR{nt:Meo-PEG}{ct:Amid},A12,Amidation,Meo-PEG,Linear,L,PEG = PEG,9,Antibacterial,50 % Hemolysis at >250 μg/ml,Human,Modification Of A1 With Peg,NA,Low hemolytic,NA,NA
11300,32130974,2020,KRRVRWIIW,KRRVRWIIW{nt:Amid}{ct:Amid},B1,Amidation,Amidation,Linear,L,None,9,Antibacterial,50 % Hemolysis at >250 μg/ml,Human,Synthetic Amp,NA,Low hemolytic,CCCSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC
11301,32130974,2020,βAla-βAla-K-KRRVRWIIW,KRRVRWIIW{nt:(β-Ala)(β-Ala)(Lys)}{ct:Amid},B2,Amidation,(β-Ala)(β-Ala)(Lys),Linear,L,Ala spacers and Lys,9,Antibacterial,50 % Hemolysis at >250 μg/ml,Human,Modification Of B1 With Ala Spacers And Lys,NA,Low hemolytic,NA,NA
11302,32130974,2020,KRRVRWIIW,KRRVRWIIW{nt:Caprylic acid (C8)}{ct:Amid},B3,Amidation,Caprylic acid (C8),Linear,L,C8 = Caprylic acid,9,Antibacterial,50 % Hemolysis at >250 μg/ml,Human,Modification Of B1 With Caprylic Acid (C8),NA,Low hemolytic,CTHHHHHHHTSCCCCSSCGGGGCCCCHHHHTTSGGGGCCSCSSCC,NA
11303,32130974,2020,KRRVRWIIW,KRRVRWIIW{nt:Capric acid (C10)}{ct:Amid},B4,Amidation,Capric acid (C10),Linear,L,C10 = Capric acid,9,Antibacterial,50 % Hemolysis at 50 μg/ml,Human,Modification Of B1 With Capric Acid (C10),NA,NA,CTHHHHHHHHHHHHHHSCGGGGSCCCHHHHHHHHTSSCCCCSSCC,NA
11304,32130974,2020,KRRVRWIIW,KRRVRWIIW{nt:Lauric acid (C12)}{ct:Amid},B5,Amidation,Lauric acid (C12),Linear,L,C12 = Lauric acid,9,Antibacterial,50 % Hemolysis at 38 μg/ml,Human,Modification Of B1 With Lauric Acid (C12),NA,NA,CTHHHHHHHHHHHHHHHHTTTSCCSCCC,NA
11305,32130974,2020,KRRVRWIIW,KRRVRWIIW{nt:Myristic acid (C14)}{ct:Amid},B6,Amidation,Myristic acid (C14),Linear,L,C14 = Myristic acid,9,Antibacterial,50 % Hemolysis at 25 μg/ml,Human,Modification Of B1 With Myristic Acid (C14),NA,NA,CHHHHHHHHHHHHHHHHSCCCCCC,NA
11306,32171739,2020,GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK,GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK,hBD-3,Free,Free,Linear,L,None,45,Antibacterial,>15 % Hemolysis at 250 μg/ml,Human,Human Beta Defensin-3,LPS aggregates = α-Helical,Low hemolytic,CHHHHHHHHHHHHHHHHSCCCCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)CC
11307,32171739,2020,GIINTLQKYYCRVRGGRSAVLSSLPKEEQIGKSSTRGRKCSRRKK,GIINTLQKYYCRVRGGRSAVLSSLPKEEQIGKSSTRGRKCSRRKK{cyc:N-C},hBD-3-c,Free,Free,Cyclic,L,None,45,Antibacterial,>15 % Hemolysis at 250 μg/ml,Human,Hbd-3 Cyclic Variant With One Disulfide Bond,LPS aggregates = α-Helical,Low hemolytic,CHHHHHHHHHHHHHHHHHSSSCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)CC
11308,32171739,2020,GIINTLQKYYSRVRGGRSAVLSSLPKEEQIGKSSTRGRKSSRRKK,GIINTLQKYYSRVRGGRSAVLSSLPKEEQIGKSSTRGRKSSRRKK,hBD-3-l,Free,Free,Linear,L,None,45,Antibacterial,>15 % Hemolysis at 250 μg/ml,Human,Hbd-3 Linear Variant Without Disulfide Bond,LPS aggregates = α-Helical,Low hemolytic,CTHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)CC
11309,32406577,2020,ALWKTLLKKVLKAAAKAALNAVLVGANA,ALWKTLLKKVLKAAAKAALNAVLVGANA,K4S4,Free,Free,Linear,L,None,28,Antibacterial,50 % Hemolysis at 27.92 ± 8.1 µM,Human,Dermaseptin S4 Peptide Derivatives,α-Helix,NA,CTHHHHHHHHGGGTC,CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
11310,32406577,2020,TLLKKVLKAAAKAALNAVLVGANA,TLLKKVLKAAAKAALNAVLVGANA,S4(5–28),Free,Free,Linear,L,None,24,Antibacterial,50 % Hemolysis at >100 ± 0.0 µM,Human,Dermaseptin S4 Peptide Derivatives,α-Helix,NA,CTHHHHHHHHHHHHCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
11311,32406577,2020,TLLKKVLKAAAKAALNAVLVGANA,TLLKKVLKAAAKAALNAVLVGANA{ct:Amid},S4(5–28)a,Amidation,Free,Linear,L,None,24,Antibacterial,50 % Hemolysis at >100 ± 0.0 µM,Human,Dermaseptin S4 Peptide Derivatives,α-Helix,NA,CCSTTCCCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
11312,32406577,2020,TLLKKVLKAAAKAALKAVLVGANA,TLLKKVLKAAAKAALKAVLVGANA,K20S4(5–28),Free,Free,Linear,L,None,24,Antibacterial,50 % Hemolysis at >100 ± 0.0 µM,Human,Dermaseptin S4 Peptide Derivatives,α-Helix,NA,CCSSCCCSCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
11313,32406577,2020,ALWKTLLKKVLKAAAK,ALWKTLLKKVLKAAAK{ct:Amid},K4S4(1–16)a,Amidation,Free,Linear,L,None,16,Antibacterial,50 % Hemolysis at 88.21 ± 5.1 µM,Human,Dermaseptin S4 Peptide Derivatives,α-Helix,NA,CCSTTCCCCC,CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O
11314,32406577,2020,ALWKTLLKKVLKAAA,ALWKTLLKKVLKAAA{ct:Amid},K4S4(1–15)a,Amidation,Free,Linear,L,None,15,Antibacterial,50 % Hemolysis at 83.25 ± 7.0 µM,Human,Dermaseptin S4 Peptide Derivatives,α-Helix,NA,CCSSCCCSCC,CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)O
11315,32406577,2020,ALWKTLLKKVLKAAAK,ALWKTLLKKVLKAAAK,K4S4(1–15),Free,Free,Linear,L,None,16,Antibacterial,50 % Hemolysis at >100 ± 0.0 µM,Human,Dermaseptin S4 Peptide Derivatives,α-Helix,NA,CCSTTCCCCC,CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O
11324,32738898,2020,MNFSRVLVFVFACLVAMCA-VSAAPEPRWKVFKKIEKMGRNIRDGIIKAGPAVAVLGDAKALGK,MNFSRVLVFVFACLVAMCA-VSAAPEPRWKVFKKIEKMGRNIRDGIIKAGPAVAVLGDAKALGK,"Armyworm cecropin 1, AC-1",Free,Free,Linear,L,None,63,Antibacterial,14.47 ± 1.03 % Hemolysis at 500 μg/ml,Chicken,Armyworm Mythimna Separata,"20 mM PBS, pH 7.4 = anti-parallel (44.5%), β-Turn (22.6%), and Random coil (32.6%)",Low hemolytic,CHHHHHHHHHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)[C@@H](C)CC
11355,32764602,2020,K-K-L-K-(2-Nal)Ala-F-(2-Nal-)Ala,K-K-L-K-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal-)Ala},1,Free,Free,Linear,L,(2-Nal)Ala = 2-napthylalanine,7,"Antibacterial, Anticancer",<8 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,Low hemolytic,NA,NA
11356,32764602,2020,(N1-Nal)Gly-(N-Phe)Gly-(N1-Nal)Gly-(N-Bu)Gly-K-K-K,{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(N-Bu)Gly}-K-K-K,2,Free,Free,Linear,L,"(N-Phe)Gly = N-benzylglycine, (N1-Nal)Gly = N-1-naphthylmethylglycine, (N-Bu)Gly = N-butylglycine",7,"Antibacterial, Anticancer",78.1 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11357,32764602,2020,(2-nal)ala-f-(2-nal)ala-K-l-K-K,{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-K-L{d}-K-K,3,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,Low hemolytic,NA,NA
11358,32764602,2020,(2-nal)ala-f-(2-nal)ala-l-K-K-K,{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-L{d}-K-K-K,4,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,"Antibacterial, Anticancer",<8 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,Low hemolytic,NA,NA
11359,32764602,2020,(1-Nal)Ala-F-(1-Nal)Ala-L-K-K-K,{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-L-K-K-K,5,Free,Free,Linear,L,(1-Nal)Ala = 1-napthylalanine,7,"Antibacterial, Anticancer",36 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11360,32764602,2020,K-K-L-K-(1-Nal)Ala-F-(1-Nal)Ala,K-K-L-K-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala},6,Free,Free,Linear,L,(1-Nal)Ala = 1-napthylalanine,7,Antibacterial,42.7 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11361,32764602,2020,K-K-K-L-(1-Nal)Ala-F(1-Nal)Ala,K-K-K-L-{nnr:(1-Nal)Ala}-F{nnr:(1-Nal)Ala},7,Free,Free,Linear,L,(1-Nal)Ala = 1-napthylalanine,7,Antibacterial,83.8 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11362,32764602,2020,(1-nal)ala-f-(1-nal)ala-K-l-K-K,{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-K-L{d}-K-K,8,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,34.3 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11363,32764602,2020,(1-nal)ala-f-(1-nal)ala-l-K-K-K,{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-L{d}-K-K-K,9,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,30.8 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11364,32764602,2020,K-K-l-K-(1-nal)ala-f-(1-nal)ala,K-K-L{d}-K-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala},10,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,Low hemolytic,NA,NA
11365,32764602,2020,K-K-K-l-(1-nal)ala-f-(1-nal)ala,K-K-K-L{d}-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala},11,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,"Antibacterial, Anticancer",33.3 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11366,32764602,2020,K-K-K-l-(2-nal)ala-f-(2-nal)ala,K-K-K-L{d}-{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala},12,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,Antibacterial,43.5 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11367,32764602,2020,(2-Nal)Ala-F-(2-Nal)Ala-K-L-K-K,{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala}-K-L-K-K,13,Free,Free,Linear,L,(2-Nal)Ala = 2-napthylalanine,7,Antibacterial,55.3 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11368,32764602,2020,K-K-(N-Bu)Gly-K-(N1-Nal)Gly-(N-Phe)Gly-(N1-Nal)Gly,K-K-{nnr:(N-Bu)Gly}-K-{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly},14,Free,Free,Linear,L,"(N-Bu)Gly = N-butylglycine, (N1-Nal)Gly = N-1-napthylmethylglycine, (N-Phe)Gly = N-benyzylglycine",7,Antibacterial,66.4 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11369,32764602,2020,K-K-K-(N-Bu)Gly-(N1-Nal)Gly-(N-Phe)Gly-(N1-Nal)Gly,K-K-K-{nnr:(N-Bu)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly},15,Free,Free,Linear,L,"(N-Bu)Gly = N-butylglycine, (N1-Nal)Gly = N-1-napthylmethylglycine, (N-Phe)Gly = N-benyzylglycine",7,"Antibacterial, Anticancer",94.2 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11370,32764602,2020,(1-Nal)Ala-F-(1-Nal)Ala-K-L-K-K,{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-K-L-K-K,16,Free,Free,Linear,L,(1-Nal)Ala = 1-napthylalanine,7,Antibacterial,55.5 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11371,32764602,2020,K-K-K-L-(2-Nal)Ala-Y-(2-Nal)Ala,K-K-K-L-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala},17,Free,Free,Linear,L,(2-Nal)Ala = 2-napthylalanine,7,Antibacterial,78.1 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11372,32764602,2020,K-K-K-Nle-(2-Nal)Ala-F-(2-Nal)Ala,K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala},18,Free,Free,Linear,L,"(2-Nal)Ala = 2-napthylalanine, Nle= norleucine",7,Antibacterial,58.8 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11373,32764602,2020,K-K-K-Leu(1-Nal)Ala-Y-(1-Nal)Ala,K-K-K-Leu{nnr:(1-Nal)Ala}-Y-{nnr:(1-Nal)Ala},19,Free,Free,Linear,L,(1-Nal)Ala = 1-napthylalanine,7,Antibacterial,82.7 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11374,32764602,2020,K-K-K-Nle-(1-Nal)Ala-F-(1-Nal)Ala,K-K-K-{nnr:Nle}-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala},20,Free,Free,Linear,L,"(1-Nal)Ala = 1-napthylalanine, Nle= norleucine",7,Antibacterial,27.5 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11375,32764602,2020,K-K-K-l--(1-nal)ala-y-(1-nal)ala,K-K-K-l--{nnr:(1-nal)ala}-Y{d}-{nnr:(1-nal)ala},21,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, y = D-Tyr",7,Antibacterial,<8 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,Low hemolytic,NA,NA
11376,32764602,2020,K-K-K-Nle-(2-Nal)Ala-Y-(2-Nal)Ala,K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala},22,Free,Free,Linear,L,"(2-Nal)Ala = 2-napthylalanine, Nle= norleucine",7,Antibacterial,23.7 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11377,32764602,2020,N-Lys-N-Lys-N-Lys-L-(2-Nal)Ala-F-(2-Nal)Ala,{nnr:N-Lys}-{nnr:N-Lys}-{nnr:N-Lys}-L-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala},23,Free,Free,Linear,L,"N-Lys = N-(4-aminobutyl)glycine, (2-Nal)Ala = 2-napthylalanine",7,Antibacterial,35.9 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11378,32764602,2020,K-K-K-l-(2-nal)ala-y-(2-nal)ala,K-K-K-L{d}-{nnr:(2-nal)ala}-Y{d}-{nnr:(2-nal)ala},24,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanine, y = D-Tyr, l = D-Leu",7,Antibacterial,23.4 % Hemolysis at 150 µM,Human,Synthetic Amps,NA,NA,NA,NA
11379,32764602,2020,K-K-L-K-(2-Nal)Ala-F-(2-Nal-)Ala,K-K-L-K-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal-)Ala},1,Free,Free,Linear,L,(2-Nal)Ala = 2-napthylalanine,7,"Antibacterial, Anticancer",19.7 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11380,32764602,2020,(N1-Nal)Gly-(N-Phe)Gly-(N1-Nal)Gly-(N-Bu)Gly-K-K-K,{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(N-Bu)Gly}-K-K-K,2,Free,Free,Linear,L,"(N-Phe)Gly = N-benzylglycine, (N1-Nal)Gly = N-1-naphthylmethylglycine, (N-Bu)Gly = N-butylglycine",7,"Antibacterial, Anticancer",100.1 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11381,32764602,2020,(2-nal)ala-f-(2-nal)ala-K-l-K-K,{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-K-L{d}-K-K,3,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,Antibacterial,10.5 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11382,32764602,2020,(2-nal)ala-f-(2-nal)ala-l-K-K-K,{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-L{d}-K-K-K,4,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,"Antibacterial, Anticancer",<8 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,Low hemolytic,NA,NA
11383,32764602,2020,(1-Nal)Ala-F-(1-Nal)Ala-L-K-K-K,{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-L-K-K-K,5,Free,Free,Linear,L,(1-Nal)Ala = 1-napthylalanine,7,"Antibacterial, Anticancer",22.5 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11384,32764602,2020,K-K-L-K-(1-Nal)Ala-F-(1-Nal)Ala,K-K-L-K-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala},6,Free,Free,Linear,L,(1-Nal)Ala = 1-napthylalanine,7,Antibacterial,101.2 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11385,32764602,2020,K-K-K-L-(1-Nal)Ala-F(1-Nal)Ala,K-K-K-L-{nnr:(1-Nal)Ala}-F{nnr:(1-Nal)Ala},7,Free,Free,Linear,L,(1-Nal)Ala = 1-napthylalanine,7,Antibacterial,102.1 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11386,32764602,2020,(1-nal)ala-f-(1-nal)ala-K-l-K-K,{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-K-L{d}-K-K,8,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,25.8 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11387,32764602,2020,(1-nal)ala-f-(1-nal)ala-l-K-K-K,{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-L{d}-K-K-K,9,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,25.5 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11388,32764602,2020,K-K-l-K-(1-nal)ala-f-(1-nal)ala,K-K-L{d}-K-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala},10,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,36.3 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11389,32764602,2020,K-K-K-l-(1-nal)ala-f-(1-nal)ala,K-K-K-L{d}-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala},11,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,"Antibacterial, Anticancer",40.7 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11390,32764602,2020,K-K-K-l-(2-nal)ala-f-(2-nal)ala,K-K-K-L{d}-{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala},12,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,Antibacterial,50.2 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11391,32764602,2020,(2-Nal)Ala-F-(2-Nal)Ala-K-L-K-K,{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala}-K-L-K-K,13,Free,Free,Linear,L,(2-Nal)Ala = 2-napthylalanine,7,Antibacterial,27.4 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11392,32764602,2020,K-K-(N-Bu)Gly-K-(N1-Nal)Gly-(N-Phe)Gly-(N1-Nal)Gly,K-K-{nnr:(N-Bu)Gly}-K-{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly},14,Free,Free,Linear,L,"(N-Bu)Gly = N-butylglycine, (N1-Nal)Gly = N-1-napthylmethylglycine, (N-Phe)Gly = N-benyzylglycine",7,Antibacterial,28.1 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11393,32764602,2020,K-K-K-(N-Bu)Gly-(N1-Nal)Gly-(N-Phe)Gly-(N1-Nal)Gly,K-K-K-{nnr:(N-Bu)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly},15,Free,Free,Linear,L,"(N-Bu)Gly = N-butylglycine, (N1-Nal)Gly = N-1-napthylmethylglycine, (N-Phe)Gly = N-benyzylglycine",7,"Antibacterial, Anticancer",87.1 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11394,32764602,2020,(1-Nal)Ala-F-(1-Nal)Ala-K-L-K-K,{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-K-L-K-K,16,Free,Free,Linear,L,(1-Nal)Ala = 1-napthylalanine,7,Antibacterial,27.7 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11395,32764602,2020,K-K-K-L-(2-Nal)Ala-Y-(2-Nal)Ala,K-K-K-L-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala},17,Free,Free,Linear,L,(2-Nal)Ala = 2-napthylalanine,7,Antibacterial,100 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11396,32764602,2020,K-K-K-Nle-(2-Nal)Ala-F-(2-Nal)Ala,K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala},18,Free,Free,Linear,L,"(2-Nal)Ala = 2-napthylalanine, Nle= norleucine",7,Antibacterial,100.7 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11397,32764602,2020,K-K-K-Leu(1-Nal)Ala-Y-(1-Nal)Ala,K-K-K-Leu{nnr:(1-Nal)Ala}-Y-{nnr:(1-Nal)Ala},19,Free,Free,Linear,L,(1-Nal)Ala = 1-napthylalanine,7,Antibacterial,100.8 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11398,32764602,2020,K-K-K-Nle-(1-Nal)Ala-F-(1-Nal)Ala,K-K-K-{nnr:Nle}-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala},20,Free,Free,Linear,L,"(1-Nal)Ala = 1-napthylalanine, Nle= norleucine",7,Antibacterial,36 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11399,32764602,2020,K-K-K-l--(1-nal)ala-y-(1-nal)ala,K-K-K-l--{nnr:(1-nal)ala}-Y{d}-{nnr:(1-nal)ala},21,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, y = D-Tyr",7,Antibacterial,19.9 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11400,32764602,2020,K-K-K-Nle-(2-Nal)Ala-Y-(2-Nal)Ala,K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala},22,Free,Free,Linear,L,"(2-Nal)Ala = 2-napthylalanine, Nle= norleucine",7,Antibacterial,83 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11401,32764602,2020,N-Lys-N-Lys-N-Lys-L-(2-Nal)Ala-F-(2-Nal)Ala,{nnr:N-Lys}-{nnr:N-Lys}-{nnr:N-Lys}-L-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala},23,Free,Free,Linear,L,"N-Lys = N-(4-aminobutyl)glycine, (2-Nal)Ala = 2-napthylalanine",7,Antibacterial,35.1 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11402,32764602,2020,K-K-K-l-(2-nal)ala-y-(2-nal)ala,K-K-K-L{d}-{nnr:(2-nal)ala}-Y{d}-{nnr:(2-nal)ala},24,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanine, y = D-Tyr, l = D-Leu",7,Antibacterial,38.5 % Hemolysis at 150 µM,Canine,Synthetic Amps,NA,NA,NA,NA
11403,32764602,2020,K-K-L-K-(2-Nal)Ala-F-(2-Nal-)Ala,K-K-L-K-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal-)Ala},1,Free,Free,Linear,L,(2-Nal)Ala = 2-napthylalanine,7,"Antibacterial, Anticancer",<8 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,Low hemolytic,NA,NA
11404,32764602,2020,(N1-Nal)Gly-(N-Phe)Gly-(N1-Nal)Gly-(N-Bu)Gly-K-K-K,{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(N-Bu)Gly}-K-K-K,2,Free,Free,Linear,L,"(N-Phe)Gly = N-benzylglycine, (N1-Nal)Gly = N-1-naphthylmethylglycine, (N-Bu)Gly = N-butylglycine",7,"Antibacterial, Anticancer",100 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,NA,NA,NA
11405,32764602,2020,(2-nal)ala-f-(2-nal)ala-K-l-K-K,{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-K-L{d}-K-K,3,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,Low hemolytic,NA,NA
11406,32764602,2020,(2-nal)ala-f-(2-nal)ala-l-K-K-K,{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-L{d}-K-K-K,4,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,"Antibacterial, Anticancer",<8 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,Low hemolytic,NA,NA
11407,32764602,2020,(1-Nal)Ala-F-(1-Nal)Ala-L-K-K-K,{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-L-K-K-K,5,Free,Free,Linear,L,(1-Nal)Ala = 1-napthylalanine,7,"Antibacterial, Anticancer",10.2 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,NA,NA,NA
11408,32764602,2020,K-K-L-K-(1-Nal)Ala-F-(1-Nal)Ala,K-K-L-K-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala},6,Free,Free,Linear,L,(1-Nal)Ala = 1-napthylalanine,7,Antibacterial,18.2 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,NA,NA,NA
11409,32764602,2020,K-K-K-L-(1-Nal)Ala-F(1-Nal)Ala,K-K-K-L-{nnr:(1-Nal)Ala}-F{nnr:(1-Nal)Ala},7,Free,Free,Linear,L,(1-Nal)Ala = 1-napthylalanine,7,Antibacterial,54.3 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,NA,NA,NA
11410,32764602,2020,(1-nal)ala-f-(1-nal)ala-K-l-K-K,{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-K-L{d}-K-K,8,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,Low hemolytic,NA,NA
11411,32764602,2020,(1-nal)ala-f-(1-nal)ala-l-K-K-K,{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-L{d}-K-K-K,9,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,Low hemolytic,NA,NA
11412,32764602,2020,K-K-l-K-(1-nal)ala-f-(1-nal)ala,K-K-L{d}-K-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala},10,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,NA,NA,NA
11413,32764602,2020,K-K-K-l-(1-nal)ala-f-(1-nal)ala,K-K-K-L{d}-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala},11,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,"Antibacterial, Anticancer",11.3 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,NA,NA,NA
11414,32764602,2020,K-K-K-l-(2-nal)ala-f-(2-nal)ala,K-K-K-L{d}-{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala},12,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,Antibacterial,17.9 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,NA,NA,NA
11415,32764602,2020,(2-Nal)Ala-F-(2-Nal)Ala-K-L-K-K,{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala}-K-L-K-K,13,Free,Free,Linear,L,(2-Nal)Ala = 2-napthylalanine,7,Antibacterial,<8 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,Low hemolytic,NA,NA
11416,32764602,2020,K-K-(N-Bu)Gly-K-(N1-Nal)Gly-(N-Phe)Gly-(N1-Nal)Gly,K-K-{nnr:(N-Bu)Gly}-K-{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly},14,Free,Free,Linear,L,"(N-Bu)Gly = N-butylglycine, (N1-Nal)Gly = N-1-napthylmethylglycine, (N-Phe)Gly = N-benyzylglycine",7,Antibacterial,31.6 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,NA,NA,NA
11417,32764602,2020,K-K-K-(N-Bu)Gly-(N1-Nal)Gly-(N-Phe)Gly-(N1-Nal)Gly,K-K-K-{nnr:(N-Bu)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly},15,Free,Free,Linear,L,"(N-Bu)Gly = N-butylglycine, (N1-Nal)Gly = N-1-napthylmethylglycine, (N-Phe)Gly = N-benyzylglycine",7,"Antibacterial, Anticancer",99.5 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,NA,NA,NA
11418,32764602,2020,(1-Nal)Ala-F-(1-Nal)Ala-K-L-K-K,{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-K-L-K-K,16,Free,Free,Linear,L,(1-Nal)Ala = 1-napthylalanine,7,Antibacterial,11 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,NA,NA,NA
11419,32764602,2020,K-K-K-L-(2-Nal)Ala-Y-(2-Nal)Ala,K-K-K-L-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala},17,Free,Free,Linear,L,(2-Nal)Ala = 2-napthylalanine,7,Antibacterial,100.1 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,NA,NA,NA
11420,32764602,2020,K-K-K-Nle-(2-Nal)Ala-F-(2-Nal)Ala,K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala},18,Free,Free,Linear,L,"(2-Nal)Ala = 2-napthylalanine, Nle= norleucine",7,Antibacterial,98.6 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,NA,NA,NA
11421,32764602,2020,K-K-K-Leu(1-Nal)Ala-Y-(1-Nal)Ala,K-K-K-Leu{nnr:(1-Nal)Ala}-Y-{nnr:(1-Nal)Ala},19,Free,Free,Linear,L,(1-Nal)Ala = 1-napthylalanine,7,Antibacterial,100.6 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,NA,NA,NA
11422,32764602,2020,K-K-K-Nle-(1-Nal)Ala-F-(1-Nal)Ala,K-K-K-{nnr:Nle}-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala},20,Free,Free,Linear,L,"(1-Nal)Ala = 1-napthylalanine, Nle= norleucine",7,Antibacterial,<8 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,Low hemolytic,NA,NA
11423,32764602,2020,K-K-K-l--(1-nal)ala-y-(1-nal)ala,K-K-K-l--{nnr:(1-nal)ala}-Y{d}-{nnr:(1-nal)ala},21,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, y = D-Tyr",7,Antibacterial,<8 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,Low hemolytic,NA,NA
11424,32764602,2020,K-K-K-Nle-(2-Nal)Ala-Y-(2-Nal)Ala,K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala},22,Free,Free,Linear,L,"(2-Nal)Ala = 2-napthylalanine, Nle= norleucine",7,Antibacterial,24.2 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,NA,NA,NA
11425,32764602,2020,N-Lys-N-Lys-N-Lys-L-(2-Nal)Ala-F-(2-Nal)Ala,{nnr:N-Lys}-{nnr:N-Lys}-{nnr:N-Lys}-L-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala},23,Free,Free,Linear,L,"N-Lys = N-(4-aminobutyl)glycine, (2-Nal)Ala = 2-napthylalanine",7,Antibacterial,<8 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,Low hemolytic,NA,NA
11426,32764602,2020,K-K-K-l-(2-nal)ala-y-(2-nal)ala,K-K-K-L{d}-{nnr:(2-nal)ala}-Y{d}-{nnr:(2-nal)ala},24,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanine, y = D-Tyr, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Rat,Synthetic Amps,NA,Low hemolytic,NA,NA
11427,32764602,2020,K-K-L-K-(2-Nal)Ala-F-(2-Nal-)Ala,K-K-L-K-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal-)Ala},1,Free,Free,Linear,L,(2-Nal)Ala = 2-napthylalanine,7,"Antibacterial, Anticancer",32.5 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,NA,NA,NA
11428,32764602,2020,(N1-Nal)Gly-(N-Phe)Gly-(N1-Nal)Gly-(N-Bu)Gly-K-K-K,{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(N-Bu)Gly}-K-K-K,2,Free,Free,Linear,L,"(N-Phe)Gly = N-benzylglycine, (N1-Nal)Gly = N-1-naphthylmethylglycine, (N-Bu)Gly = N-butylglycine",7,"Antibacterial, Anticancer",<8 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,Low hemolytic,NA,NA
11429,32764602,2020,(2-nal)ala-f-(2-nal)ala-K-l-K-K,{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-K-L{d}-K-K,3,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,Low hemolytic,NA,NA
11430,32764602,2020,(2-nal)ala-f-(2-nal)ala-l-K-K-K,{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-L{d}-K-K-K,4,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,"Antibacterial, Anticancer",<8 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,Low hemolytic,NA,NA
11431,32764602,2020,(1-Nal)Ala-F-(1-Nal)Ala-L-K-K-K,{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-L-K-K-K,5,Free,Free,Linear,L,(1-Nal)Ala = 1-napthylalanine,7,"Antibacterial, Anticancer",<8 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,Low hemolytic,NA,NA
11432,32764602,2020,K-K-L-K-(1-Nal)Ala-F-(1-Nal)Ala,K-K-L-K-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala},6,Free,Free,Linear,L,(1-Nal)Ala = 1-napthylalanine,7,Antibacterial,39.9 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,NA,NA,NA
11433,32764602,2020,K-K-K-L-(1-Nal)Ala-F(1-Nal)Ala,K-K-K-L-{nnr:(1-Nal)Ala}-F{nnr:(1-Nal)Ala},7,Free,Free,Linear,L,(1-Nal)Ala = 1-napthylalanine,7,Antibacterial,16 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,NA,NA,NA
11434,32764602,2020,(1-nal)ala-f-(1-nal)ala-K-l-K-K,{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-K-L{d}-K-K,8,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,Low hemolytic,NA,NA
11435,32764602,2020,(1-nal)ala-f-(1-nal)ala-l-K-K-K,{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-L{d}-K-K-K,9,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,Low hemolytic,NA,NA
11436,32764602,2020,K-K-l-K-(1-nal)ala-f-(1-nal)ala,K-K-L{d}-K-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala},10,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,Low hemolytic,NA,NA
11437,32764602,2020,K-K-K-l-(1-nal)ala-f-(1-nal)ala,K-K-K-L{d}-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala},11,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu",7,"Antibacterial, Anticancer",17.4 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,NA,NA,NA
11438,32764602,2020,K-K-K-l-(2-nal)ala-f-(2-nal)ala,K-K-K-L{d}-{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala},12,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu",7,Antibacterial,<8 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,Low hemolytic,NA,NA
11439,32764602,2020,(2-Nal)Ala-F-(2-Nal)Ala-K-L-K-K,{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala}-K-L-K-K,13,Free,Free,Linear,L,(2-Nal)Ala = 2-napthylalanine,7,Antibacterial,17.6 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,NA,NA,NA
11440,32764602,2020,K-K-(N-Bu)Gly-K-(N1-Nal)Gly-(N-Phe)Gly-(N1-Nal)Gly,K-K-{nnr:(N-Bu)Gly}-K-{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly},14,Free,Free,Linear,L,"(N-Bu)Gly = N-butylglycine, (N1-Nal)Gly = N-1-napthylmethylglycine, (N-Phe)Gly = N-benyzylglycine",7,Antibacterial,13.9 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,NA,NA,NA
11441,32764602,2020,K-K-K-(N-Bu)Gly-(N1-Nal)Gly-(N-Phe)Gly-(N1-Nal)Gly,K-K-K-{nnr:(N-Bu)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly},15,Free,Free,Linear,L,"(N-Bu)Gly = N-butylglycine, (N1-Nal)Gly = N-1-napthylmethylglycine, (N-Phe)Gly = N-benyzylglycine",7,"Antibacterial, Anticancer",<8 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,Low hemolytic,NA,NA
11442,32764602,2020,(1-Nal)Ala-F-(1-Nal)Ala-K-L-K-K,{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-K-L-K-K,16,Free,Free,Linear,L,(1-Nal)Ala = 1-napthylalanine,7,Antibacterial,30.6 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,NA,NA,NA
11443,32764602,2020,K-K-K-L-(2-Nal)Ala-Y-(2-Nal)Ala,K-K-K-L-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala},17,Free,Free,Linear,L,(2-Nal)Ala = 2-napthylalanine,7,Antibacterial,19.9 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,NA,NA,NA
11444,32764602,2020,K-K-K-Nle-(2-Nal)Ala-F-(2-Nal)Ala,K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala},18,Free,Free,Linear,L,"(2-Nal)Ala = 2-napthylalanine, Nle= norleucine",7,Antibacterial,<8 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,Low hemolytic,NA,NA
11445,32764602,2020,K-K-K-Leu(1-Nal)Ala-Y-(1-Nal)Ala,K-K-K-Leu{nnr:(1-Nal)Ala}-Y-{nnr:(1-Nal)Ala},19,Free,Free,Linear,L,(1-Nal)Ala = 1-napthylalanine,7,Antibacterial,<8 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,Low hemolytic,NA,NA
11446,32764602,2020,K-K-K-Nle-(1-Nal)Ala-F-(1-Nal)Ala,K-K-K-{nnr:Nle}-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala},20,Free,Free,Linear,L,"(1-Nal)Ala = 1-napthylalanine, Nle= norleucine",7,Antibacterial,20.1 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,NA,NA,NA
11447,32764602,2020,K-K-K-l--(1-nal)ala-y-(1-nal)ala,K-K-K-l--{nnr:(1-nal)ala}-Y{d}-{nnr:(1-nal)ala},21,Free,Free,Linear,Mix,"(1-nal)ala = D-1-napthylalanine, y = D-Tyr",7,Antibacterial,16 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,NA,NA,NA
11448,32764602,2020,K-K-K-Nle-(2-Nal)Ala-Y-(2-Nal)Ala,K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala},22,Free,Free,Linear,L,"(2-Nal)Ala = 2-napthylalanine, Nle= norleucine",7,Antibacterial,<8 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,Low hemolytic,NA,NA
11449,32764602,2020,N-Lys-N-Lys-N-Lys-L-(2-Nal)Ala-F-(2-Nal)Ala,{nnr:N-Lys}-{nnr:N-Lys}-{nnr:N-Lys}-L-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala},23,Free,Free,Linear,L,"N-Lys = N-(4-aminobutyl)glycine, (2-Nal)Ala = 2-napthylalanine",7,Antibacterial,11.1 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,NA,NA,NA
11450,32764602,2020,K-K-K-l-(2-nal)ala-y-(2-nal)ala,K-K-K-L{d}-{nnr:(2-nal)ala}-Y{d}-{nnr:(2-nal)ala},24,Free,Free,Linear,Mix,"(2-nal)ala = D-2-napthylalanine, y = D-Tyr, l = D-Leu",7,Antibacterial,29.8 % Hemolysis at 150 µM,Bovine,Synthetic Amps,NA,NA,NA,NA
11451,32781587,2020,FLPLIAGLAAKFLPKIFCAITKKC,FLPLIAGLAAKFLPKIFCAITKKC,B1A,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal",10 % Hemolysis at 1.576 µM,Horse,Modified From Brevinin-1 (Lithobates Palustris (Rana Palustris)) Frog,"aqueous, 1% SDS micelle solution = α-Helix",NA,CCCCCSCCTTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11452,32781587,2020,FLPLIAGLAAKCAITKKC,FLPLIAGLAAKCAITKKC,B1A1,Free,Free,Linear,L,None,18,"Antibacterial, Antifungal",10 % Hemolysis at >512 µM,Horse,Truncated Analogue Of B1A,"aqueous = Random coil, 1% SDS micelle solution = α-Helix",Low hemolytic,CCSCCCSCGGGTCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11453,32781587,2020,FLPKIFCAITKKC,FLPKIFCAITKKC,B1A2,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal",10 % Hemolysis at >512 µM,Horse,Truncated Analogue Of B1A,"aqueous = Random coil, 1% SDS micelle solution = α-Helix",Low hemolytic,CCCSSSCCGGGSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11454,32781587,2020,KFLPKIFCAITKKC,KFLPKIFCAITKKC,KB2,Free,Free,Linear,L,None,14,"Antibacterial, Antifungal",10 % Hemolysis at 154 µM,Horse,Derived From B1A2,"aqueous = Random coil, 1% SDS micelle solution = α-Helix",NA,CCCCCSSHHHHSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11455,32781587,2020,KKFLPKIFCAITKKC,KKFLPKIFCAITKKC,KKB2,Free,Free,Linear,L,None,15,"Antibacterial, Antifungal",10 % Hemolysis at 207 µM,Horse,Modification Of Kb2,"aqueous = Random coil, 1% SDS micelle solution = α-Helix",NA,CCCCCCCCCSCCSSSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11456,32781587,2020,KFLPWKIFCAITKKC,KFLPWKIFCAITKKC,KWB2,Free,Free,Linear,L,None,15,"Antibacterial, Antifungal",10 % Hemolysis at 99.81 µM,Horse,Modified From Kb2,"aqueous = Random coil, 1% SDS micelle solution = α-Helix",NA,CCCCCCCCCSCCSSSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11457,32781587,2020,KKFLPWKIFCAITKKC,KKFLPWKIFCAITKKC,KKWB2,Free,Free,Linear,L,None,16,"Antibacterial, Antifungal",10 % Hemolysis at 140.04 µM,Horse,Modification Of Kwb,"aqueous = Random coil, 1% SDS micelle solution = α-Helix",NA,CCCCCCCCCSCCSSSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11458,32781587,2020,KFWPWKIFCAITKKC,KFWPWKIFCAITKKC,"KW3,5B2",Free,Free,Linear,L,None,15,"Antibacterial, Antifungal",10 % Hemolysis at 32.07 µM,Horse,B1A Analogues,"aqueous = Random coil, 1% SDS micelle solution = α-Helix",NA,CCCCCCCCCSCCSSSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11459,32781587,2020,KFLPWKWFCAITKKC,KFLPWKWFCAITKKC,"KW5,7B2",Free,Free,Linear,L,None,15,"Antibacterial, Antifungal",10 % Hemolysis at 58.42 µM,Horse,B1A Analogues,"aqueous = Random coil, 1% SDS micelle solution = α-Helix",NA,CCCCCCCCCCCCBTTTBCCSSCSTTHHHHTTTGGGTTTSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11460,32770019,2020,QNLCNIYYIQHADHCLAVINS,QNLCNIYYIQHADHCLAVINS,AtR100,Free,Free,Linear,L,None,21,"Antibacterial, Antifungal",0.49 % Hemolysis at 125 μg/ml,Porcine,Plant Aegilops Tauschii Cosson,α-Helix β-Strand,Non-hemolytic,CCCCCCCCCCCCBTTTBCCSSCSTTHHHHTTTGGGTTTSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
11461,32770019,2020,QNLCNIYYIQHADHCLAVINS,QNLCNIYYIQHADHCLAVINS,AtR100,Free,Free,Linear,L,None,21,"Antibacterial, Antifungal",0.98 % Hemolysis at 250 μg/ml,Porcine,Plant Aegilops Tauschii Cosson,α-Helix β-Strand,Non-hemolytic,CCCCCCCCCCCCBTTTBCCSSCSTTHHHHTTTGGGTTTSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
11462,32770019,2020,QNLCNIYYIQHADHCLAVINS,QNLCNIYYIQHADHCLAVINS,AtR100,Free,Free,Linear,L,None,21,"Antibacterial, Antifungal",1.35 % Hemolysis at 500 μg/ml,Porcine,Plant Aegilops Tauschii Cosson,α-Helix β-Strand,Non-hemolytic,CCCCCCCCCCCCBTTTBCCSSCSTTHHHHTTTGGGTTTSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
11463,32770019,2020,QNLCNIYYIQHADHCLAVINS,QNLCNIYYIQHADHCLAVINS,AtR100,Free,Free,Linear,L,None,21,"Antibacterial, Antifungal",2.09 % Hemolysis at 1000 μg/ml,Porcine,Plant Aegilops Tauschii Cosson,α-Helix β-Strand,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
11464,32770019,2020,LCVSYSVRPSCKFVGRSNWKRNTCLEWCDQLFLFCFLIGGEMANS,LCVSYSVRPSCKFVGRSNWKRNTCLEWCDQLFLFCFLIGGEMANS,AtR472,Free,Free,Linear,L,None,45,"Antibacterial, Antifungal",0.73 % Hemolysis at 125 μg/ml,Porcine,Plant Aegilops Tauschii Cosson,α-Helix β-Strand,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O
11465,32770019,2020,LCVSYSVRPSCKFVGRSNWKRNTCLEWCDQLFLFCFLIGGEMANS,LCVSYSVRPSCKFVGRSNWKRNTCLEWCDQLFLFCFLIGGEMANS,AtR472,Free,Free,Linear,L,None,45,"Antibacterial, Antifungal",1.11 % Hemolysis at 250 μg/ml,Porcine,Plant Aegilops Tauschii Cosson,α-Helix β-Strand,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O
11466,32770019,2020,LCVSYSVRPSCKFVGRSNWKRNTCLEWCDQLFLFCFLIGGEMANS,LCVSYSVRPSCKFVGRSNWKRNTCLEWCDQLFLFCFLIGGEMANS,AtR472,Free,Free,Linear,L,None,45,"Antibacterial, Antifungal",1.35 % Hemolysis at 500 μg/ml,Porcine,Plant Aegilops Tauschii Cosson,α-Helix β-Strand,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O
11467,32770019,2020,LCVSYSVRPSCKFVGRSNWKRNTCLEWCDQLFLFCFLIGGEMANS,LCVSYSVRPSCKFVGRSNWKRNTCLEWCDQLFLFCFLIGGEMANS,AtR472,Free,Free,Linear,L,None,45,"Antibacterial, Antifungal",1.97 % Hemolysis at 1000 μg/ml,Porcine,Plant Aegilops Tauschii Cosson,α-Helix β-Strand,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O
11468,32823798,2020,Dab-Nal-R-Dab-Bip-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},S3(B),Free,Free,Cyclic,L,"Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,77 % Hemolysis at 150 µM,Human,Cyclic Antimicrobial Peptide S3(B),NA,NA,NA,NA
11469,32823798,2020,Dab(C10)-Nal-R-Dab-Bip-O2Oc-Nal-Dab-N,{nnr:Dab(C10)}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C10)1,Free,Free,Cyclic,L,"Dab(C10) = Dab(C10), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11470,32823798,2020,Dab-Dab(C10)-R-Dab-Bip-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Dab(C10)}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C10)2,Free,Free,Cyclic,L,"Dab(C10) = Dab(C10), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11471,32823798,2020,Dab-Dab(C12)-R-Dab-Bip-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Dab(C12)}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C12)2,Free,Free,Cyclic,L,"Dab(C12) = Dab(C12), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11472,32823798,2020,Dab-Dab(C14)-R-Dab-Bip-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Dab(C14)}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C14)2,Free,Free,Cyclic,L,"Dab(C14) = Dab(C14), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11473,32823798,2020,Dab-Nal-R-Dab(C10)-Bip-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab(C10)}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C10)4,Free,Free,Cyclic,L,"Dab(C10) = Dab(C10), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11474,32823798,2020,Dab-Nal-R-Dab-Dab(C4)-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Dab(C4)}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C4)5,Free,Free,Cyclic,L,"Dab(C4) = Dab(C4), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,5 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,Low hemolytic,NA,NA
11475,32823798,2020,Dab-Nal-R-Dab-Dab(C6)-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Dab(C6)}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C6)5,Free,Free,Cyclic,L,"Dab(C6) = Dab(C6), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,13 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11476,32823798,2020,Dab-Nal-R-Dab-Dab(C8)-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Dab(C8)}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C8)5,Free,Free,Cyclic,L,"Dab(C8) = Dab(C8), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,42 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11477,32823798,2020,Dab-Nal-R-Dab-Dab(C10)-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Dab(C10)}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C10)5,Free,Free,Cyclic,L,"Dab(C10) = Dab(C10), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11478,32823798,2020,Dab-Nal-R-Dab-Dab(C12)-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Dab(C12)}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C12)5,Free,Free,Cyclic,L,"Dab(C12) = Dab(C12), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11479,32823798,2020,Dab-Nal-R-Dab-Dab(C14)-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Dab(C14)}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C14)5,Free,Free,Cyclic,L,"Dab(C14) = Dab(C14), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11480,32823798,2020,Dab-Nal-R-Dab-Bip-O2Oc-Dab(C4)-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Dab(C4)}-{nnr:Dab}-N{cyc:N-C},(C4)7,Free,Free,Cyclic,L,"Dab(C4) = Dab(C4), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,4 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,Low hemolytic,NA,NA
11481,32823798,2020,Dab-Nal-R-Dab-Bip-O2Oc-Dab(C6)-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Dab(C6)}-{nnr:Dab}-N{cyc:N-C},(C6)7,Free,Free,Cyclic,L,"Dab(C6) = Dab(C6), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,8 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11482,32823798,2020,Dab-Nal-R-Dab-Bip-O2Oc-Dab(C8)-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Dab(C8)}-{nnr:Dab}-N{cyc:N-C},(C8)7,Free,Free,Cyclic,L,"Dab(C8) = Dab(C8), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,56 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11483,32823798,2020,Dab-Nal-R-Dab-Bip-O2Oc-Dab(C10)-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Dab(C10)}-{nnr:Dab}-N{cyc:N-C},(C10)7,Free,Free,Cyclic,L,"Dab(C10) = Dab(C10), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11484,32823798,2020,Dab-Nal-R-Dab-Bip-O2Oc-Dab(C12)-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Dab(C12)}-{nnr:Dab}-N{cyc:N-C},(C12)7,Free,Free,Cyclic,L,"Dab(C12) = Dab(C12), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,96 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11485,32823798,2020,Dab-Nal-R-Dab-Bip-O2Oc-Dab(C14)-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Dab(C14)}-{nnr:Dab}-N{cyc:N-C},(C14)7,Free,Free,Cyclic,L,"Dab(C14) = Dab(C14), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,98 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11486,32823798,2020,Dab-Nal-R-Dab-Bip-O2Oc-Nal-Dab(C10)-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab(C10)}-N{cyc:N-C},(C10)8,Free,Free,Cyclic,L,"Dab(C10) = Dab(C10), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11487,32847054,2020,ASSFLTPRLSSLGKRSWAV,ASSFLTPRLSSLGKRSWAV,AV19,Free,Free,Linear,L,None,19,Antibacterial,0 % Hemolysis at 5 µM,Human,Cuttlefish (Sepia Officinalis),α-Helix,Non-hemolytic,CCCSSSGGGHHHHTTCSCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C
11488,32847054,2020,GFCNFMHLKPISRELRRELYGRTRRRRK,GFCNFMHLKPISRELRRELYGRTRRRRK,GK28,Free,Free,Linear,L,None,28,Antibacterial,0 % Hemolysis at 5 µM,Human,Cuttlefish (Sepia Officinalis),NA,Non-hemolytic,CCCCCSSCCSSSGGGTGGGTTCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
11489,32847054,2020,NYWLLVLRRLLITKKVMWF,NYWLLVLRRLLITKKVMWF,NF19,Free,Free,Linear,L,None,19,Antibacterial,0 % Hemolysis at 5 µM,Human,Cuttlefish (Sepia Officinalis),α-Helix,Non-hemolytic,CCCCTTHHHHTTSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O
11492,32847054,2020,ASSFLTPRLSSLGKRSWAV,ASSFLTPRLSSLGKRSWAV,AV19,Free,Free,Linear,L,None,19,Antibacterial,33 % Hemolysis at 100 µM,Human,Cuttlefish (Sepia Officinalis),α-Helix,NA,CCCCCSSCCSSSGGGTGGGTTCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C
11493,32847054,2020,GFCNFMHLKPISRELRRELYGRTRRRRK,GFCNFMHLKPISRELRRELYGRTRRRRK,GK28,Free,Free,Linear,L,None,28,Antibacterial,0 % Hemolysis at 100 µM,Human,Cuttlefish (Sepia Officinalis),NA,Non-hemolytic,CCSSSSSSCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
11494,32847054,2020,NYWLLVLRRLLITKKVMWF,NYWLLVLRRLLITKKVMWF,NF19,Free,Free,Linear,L,None,19,Antibacterial,50 % Hemolysis at 100 µM,Human,Cuttlefish (Sepia Officinalis),α-Helix,Non-hemolytic,CCCCCCSSSCCSGGGSCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O
11497,32847054,2020,GFCNFMHLKPISRELRRELYGRTRRRRK,GFCNFMHLKPISRELRRELYGRTRRRRK,GK28,Free,Free,Linear,L,None,28,Antibacterial,0 % Hemolysis at 20 µM,Human,Cuttlefish (Sepia Officinalis),NA,Non-hemolytic,CCSSSSSSCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
11500,32847054,2020,GFCNFMHLKPISRELRRELYGRTRRRRK,GFCNFMHLKPISRELRRELYGRTRRRRK,GK28,Free,Free,Linear,L,None,28,Antibacterial,0 % Hemolysis at 50 µM,Human,Cuttlefish (Sepia Officinalis),NA,Non-hemolytic,CCTTSSCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
11501,32847054,2020,NYWLLVLRRLLITKKVMWF,NYWLLVLRRLLITKKVMWF,NF19,Free,Free,Linear,L,None,19,Antibacterial,35 % Hemolysis at 50 µM,Human,Cuttlefish (Sepia Officinalis),α-Helix,Non-hemolytic,CCSCCCCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O
11507,32350599,2020,RFRRLRWKTRWRLKKIRFGRFLRKIRRFRPK,RFRRLRWKTRWRLKKIRFGRFLRKIRRFRPK{ct:Amid},PR-FO,Amidation,Free,Linear,L,None,31,Antibacterial,10 % Hemolysis at 128 µM,Human,Hybrid Peptide Of Prw4 And Fowlicidin-2,α-Helix,Low hemolytic,CTHHHHHHHHHHTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
11510,32590058,2020,gfgsllgkalrlganvl,G{d}F{d}G{d}S{d}L{d}L{d}G{d}K{d}A{d}L{d}R{d}L{d}G{d}A{d}N{d}V{d}L{d}{ct:Amid},DCPF-C1,Amidation,Free,Linear,D,None,17,Antibacterial,≥10 % Hemolysis at 128 μg/ml,Mouse,Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ),50% TFE = α-Helical (reverse Helical),NA,CTHHHHHHHHHHHHTTC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(=O)O
11511,32590058,2020,kFwSLLkKALRLwANVL,K{d}FW{d}SLLK{d}KALRLW{d}ANVL{ct:Amid},CPF-2,Amidation,Free,Linear,Mix,None,17,"Antibiofilm, Antibacterial",100 % Hemolysis at 128 μg/ml,Mouse,Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ),50% TFE = Random coil,NA,CTHHHHHHHHHHHHTTC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)O
11512,32590058,2020,kfwsllkkalrlwanvl,K{d}F{d}W{d}S{d}L{d}L{d}K{d}K{d}A{d}L{d}R{d}L{d}W{d}A{d}N{d}V{d}L{d}{ct:Amid},DCPF-2,Amidation,Free,Linear,Mix,None,17,Antibacterial,100 % Hemolysis at 128 μg/ml,Mouse,Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ),50% TFE = α-Helical (reverse Helical),NA,CTHHHHHHHHHHHHTTC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)O
11513,32590058,2020,kFwSLLkKAlrLwKkVL,K{d}FW{d}SLLK{d}KAL{d}R{d}LW{d}KK{d}VL{ct:Amid},CPF-2-1,Amidation,Free,Linear,Mix,None,17,Antibacterial,0 % Hemolysis at 128 μg/ml,Mouse,Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ),50% TFE = Random coil,Non-hemolytic,CCCCCCCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)O
11514,32590058,2020,kFwSLLkKAlrLwAkVL,K{d}FW{d}SLLK{d}KAL{d}R{d}LW{d}AK{d}VL{ct:Amid},CPF-2-2,Amidation,Free,Linear,Mix,None,17,Antibacterial,0 % Hemolysis at 128 μg/ml,Mouse,Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ),50% TFE = Random coil,Non-hemolytic,CCCCCCCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)O
11515,32590058,2020,GFGSLLGKALRLWKKVL,GFGSLLGKALRLWKKVL{ct:Amid},CPF-13,Amidation,Free,Linear,D,None,17,Antibacterial,≥75 % Hemolysis at 128 μg/ml,Mouse,Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ),50% TFE = α-Helical,NA,CCCCCCCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(=O)O
11516,32590058,2020,GFGSLLGKALRLwKkVL,GFGSLLGKALRLW{d}KK{d}VL{ct:Amid},CPF-14,Amidation,Free,Linear,Mix,None,17,Antibacterial,≥10 % Hemolysis at 128 μg/ml,Mouse,Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ),50% TFE = α-Helical,NA,CCCCCCCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(=O)O
11517,32590058,2020,GFGSLLGKAlrLwKkVL,GFGSLLGKAL{d}R{d}LW{d}KK{d}VL{ct:Amid},CPF-15,Amidation,Free,Linear,Mix,None,17,Antibacterial,≥75 % Hemolysis at 128 μg/ml,Mouse,Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ),50% TFE = Random coil,NA,CCCCCSSSTTCSSCSSTTSCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(=O)O
11546,32841003,2020,GITDLRGMLKRLKKMK,GITDLRGMLKRLKKMK,Sm-A1,Free,Free,Linear,L,None,16,"Antibacterial, Anti-biofilm",10 % Hemolysis at 80 µM,Human,Derived From Turbot Viscera Hydrolysate,α-Helix,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
11547,32841003,2020,ATLTAKDLTFLQDYKKTKKRVK,ATLTAKDLTFLQDYKKTKKRVK,Sm-A2,Free,Free,Linear,L,None,22,Antibacterial,10 % Hemolysis at 20 µM,Human,Derived From Turbot Viscera Hydrolysate,α-Helix,NA,CTTHHHHHHHHTTC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O
11548,32841003,2020,HTMWRCVRLSACLFSVRRR,HTMWRCVRLSACLFSVRRR,Sm-A3,Free,Free,Linear,L,None,19,Antibacterial,10 % Hemolysis at 10 µM,Human,Derived From Turbot Viscera Hydrolysate,α-Helix,NA,CCSCSSSHHHHHHHCCC,CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
11549,32967114,2020,FIGTLIPLALGALTKLFK,FIGTLIPLALGALTKLFK{ct:Amid},Figainin 1,Amidation,Free,Linear,L,None,18,"Antibacterial, Anticancer, Anti-infective, Antitrypanosomal",50 % Hemolysis at 10 µM,Human,Frog Boana Raniceps,"water and 10% (v/v) TFE = Disordered, 30% (v/v) and 50% (v/v) TFE = α-Helical",NA,CCSCSSSHHHHHHHCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O
11550,32967333,2020,ALWKKLLKK-Cha,ALWKKLLKK-{nnr:Cha}{ct:Amid},DMPC-10A,Amidation,Free,Linear,L,Cha = Cyclohexanylalanine,10,"Antibacterial, Antibiofilm",≥20 % Hemolysis at 128 µM,Horse,Derived From A Dermaseptin (Phyllomedusa Frogs),amphipathic environment = α-Helix,NA,NA,NA
11551,32967333,2020,AlWkkllkk-Cha,AL{d}WK{d}K{d}L{d}L{d}K{d}K{d}-{nnr:Cha}{ct:Amid},DMPC-10B,Amidation,Free,Linear,Mix,Cha = Cyclohexanylalanine,10,"Antibacterial, Antibiofilm",0 % Hemolysis at 128 µM,Horse,Modificaiton Of Dmpc-10A,TFE = α-Helix,Non-hemolytic,NA,NA
11552,32959824,2020,LKLLKKLLKLLKKL,LKLLKKLLKLLKKL,LK Free,Free,Free,Linear,L,None,14,Antibacterial,~100 % Hemolysis at 50 μg/ml,Human,Synthetic Peptide,NA,NA,CCCCCCCHHHHHHHHTTC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)O
11553,32710881,2020,FQRYFHRYARFLAKIWKG,FQRYFHRYARFLAKIWKG,Adepamycin,Free,Free,Linear,L,None,18,"Antibacterial, Antifungal",< 10 % Hemolysis at 1.3 µM,Human,Synthetic Peptide,"aqueous = Disordered, TFE = α-Helix",NA,CCCCCHHHHHTHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
11554,32710881,2020,FQRYFHRYARFLAKIWKG,FQRYFHRYARFLAKIWKG,Adepamycin,Free,Free,Linear,L,None,18,"Antibacterial, Antifungal",< 10 % Hemolysis at 10.4 µM,Human,Synthetic Peptide,"aqueous = Disordered, TFE = α-Helix",NA,CCSSCHHHHHTHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
11555,32710881,2020,FQRYFHRYARFLAKIWKG,FQRYFHRYARFLAKIWKG,Adepamycin,Free,Free,Linear,L,None,18,"Antibacterial, Antifungal",60 % Hemolysis at 335 µM,Human,Synthetic Peptide,"aqueous = Disordered, TFE = α-Helix",NA,CCCCCSHHHHTHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
11562,32591801,2020,AFRPIPTHSC,AFRPIPTHSC,P1,Free,Free,Linear,L,None,10,Antibacterial,<20 % Hemolysis at 50 µM,Human,Synthetic Peptide,NA,Low hemolytic,CCCCCSSTTC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11563,32591801,2020,YNYSYIITRS,YNYSYIITRS,P2,Free,Free,Linear,L,None,10,Antibacterial,<20 % Hemolysis at 50 µM,Human,Synthetic Peptide,NA,Low hemolytic,CCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)CC
11564,32591801,2020,PTTVHIIYRI,PTTVHIIYRI,P3,Free,Free,Linear,L,None,10,Antibacterial,<20 % Hemolysis at 50 µM,Human,Synthetic Peptide,NA,NA,CCTTSCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
11565,32591801,2020,ASVTWLLYAM,ASVTWLLYAM,P4,Free,Free,Linear,L,None,10,Antibacterial,<20 % Hemolysis at 50 µM,Human,Synthetic Peptide,NA,Low hemolytic,CCCCCCCCC,CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)O
11566,32591801,2020,LRCLMLKFPI,LRCLMLKFPI,P5,Free,Free,Linear,L,None,10,Antibacterial,<20 % Hemolysis at 50 µM,Human,Synthetic Peptide,NA,NA,CCCSSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)O
11567,32591801,2020,CLRPSIISRA,CLRPSIISRA,P6,Free,Free,Linear,L,None,10,Antibacterial,<20 % Hemolysis at 50 µM,Human,Synthetic Peptide,NA,Low hemolytic,CCGGGTGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC
11568,32591801,2020,WRYQWTILFI,WRYQWTILFI,P7,Free,Free,Linear,L,None,10,Antibacterial,<20 % Hemolysis at 50 µM,Human,Synthetic Peptide,NA,Low hemolytic,CCCSSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)[C@@H](C)CC)C(=O)O
11569,32591801,2020,FCIRLATYVI,FCIRLATYVI,P8,Free,Free,Linear,L,None,10,Antibacterial,<20 % Hemolysis at 50 µM,Human,Synthetic Peptide,NA,Low hemolytic,CCGGGTGGGTC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(=O)O
11570,32591801,2020,PGHRVSCWLS,PGHRVSCWLS,P9,Free,Free,Linear,L,None,10,Antibacterial,<20 % Hemolysis at 50 µM,Human,Synthetic Peptide,NA,NA,CCCSSTTTTTHHHHTTTTTC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@@H]1CCCN1)C(C)C)C(=O)N[C@@H](CO)C(=O)O
11571,32715598,2020,RKIKVYLPRMK,RKIKVYLPRMK,TK9.1,Free,Free,Linear,L,None,11,"Antibacterial, Antifungal",0 % Hemolysis at 42 μg/ml,Mouse,Ovalbumin Peptide Fragment,α-Helix,Non-hemolytic,CCCCSSGGGCSHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
11572,32715598,2020,RKIKRYLRRMI,RKIKRYLRRMI,TK9.1.3,Free,Free,Linear,L,None,11,"Antibacterial, Antifungal",0 % Hemolysis at 42 μg/ml,Mouse,Ovalbumin Peptide Fragment,α-Helix,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)O
11573,32715598,2020,RKIKVYLPRMK,RKIKVYLPRMK,TK9.1,Free,Free,Linear,L,None,11,"Antibacterial, Antifungal",10 % Hemolysis at 1660 μg/ml,Mouse,Ovalbumin Peptide Fragment,α-Helix,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
11574,32715598,2020,RKIKRYLRRMI,RKIKRYLRRMI,TK9.1.3,Free,Free,Linear,L,None,11,"Antibacterial, Antifungal",10 % Hemolysis at 1660 μg/ml,Mouse,Ovalbumin Peptide Fragment,α-Helix,Non-hemolytic,CCCSTTGGGSSSSGGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)O
11594,33063186,2020,FTILKKLKSFIK,FTILKKLKSFIK,Coco1,Free,Free,Linear,L,None,12,Antibacterial,10 % Hemolysis at 100 µM,Human,Derived From The Green Algae Coccomyxa Subellipsoidea,NA,NA,CCHHHHHHHHHHHTTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)O
11595,33063186,2020,KLVKKLLKKYITF,KLVKKLLKKYITF,Coco2,Free,Free,Linear,L,None,13,Antibacterial,10 % Hemolysis at 100 µM,Human,Derived From The Green Algae Coccomyxa Subellipsoidea,NA,NA,CTTHHHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
11596,33063186,2020,LARFVLRILKYGFK,LARFVLRILKYGFK,Coco3,Free,Free,Linear,L,None,14,Antibacterial,10 % Hemolysis at 9.38 µM,Human,Derived From The Green Algae Coccomyxa Subellipsoidea.,α‐Helix,NA,CCHHHHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
11597,33063186,2020,IPLLRKGKKIIWW,IPLLRKGKKIIWW,Opero1,Free,Free,Linear,L,None,13,Antibacterial,10 % Hemolysis at 100 µM,Human,Derived From The Invertebrate Operophtera Brumata,NA,NA,CCHHIIIIISSCCC,CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
11598,33063186,2020,GLKKVIKLLRPLL,GLKKVIKLLRPLL,Opero2,Free,Free,Linear,L,None,13,Antibacterial,10 % Hemolysis at 100 µM,Human,Derived From The Invertebrate Operophtera Brumata,NA,NA,CCTTTTTTHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
11599,33063186,2020,IVIKSLGKFLKNVGGFAG,IVIKSLGKFLKNVGGFAG,Pyro1,Free,Free,Linear,L,None,18,Antibacterial,10 % Hemolysis at 100 µM,Human,Derived From The Thermophilic Bacteria Pyrococcus,NA,NA,CCCCCBTTBC,CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)C(C)C
11601,33063186,2020,ITKWLLNAIKKGFKL,ITKWLLNAIKKGFKL,Thermo1,Free,Free,Linear,L,None,15,Antibacterial,10 % Hemolysis at 21.9 µM,Human,Derived From The Thermophilic Bacteria Thermococcus Onnurineus.,NA,NA,CGGGTHHHHTTC,CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)O
11602,33063186,2020,IHKLVKLWLNLGKKF,IHKLVKLWLNLGKKF,Thermo2,Free,Free,Linear,L,None,15,Antibacterial,10 % Hemolysis at 39.3 µM,Human,Derived From The Thermophilic Bacteria Thermococcus Onnurineus.,NA,NA,CGGGTSGGGTGGGC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
11603,33063186,2020,LFSIIWKLNRKLIKA,LFSIIWKLNRKLIKA,Thermo3,Free,Free,Linear,L,None,15,Antibacterial,10 % Hemolysis at 37.3 µM,Human,Derived From The Thermophilic Bacteria Thermococcus Onnurineus.,NA,NA,CGGGGTGGGTTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
11604,33074344,2020,EKKRLLKWWR,EKKRLLKWWR{nt:H}{ct:Amid},AMP-2,Amidation,H,Linear,L,None,10,Antibacterial,<1 % Hemolysis at 0.2 mg/ml,Sheep,Synthetic Peptide,Helix,Non-hemolytic,CCCCCCCCCCCCCCCSSSSSSSSCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11605,33074344,2020,KWWKLLRKKR,KWWKLLRKKR{nt:H}{ct:Amid},AMP-3,Amidation,H,Linear,L,None,10,Antibacterial,<1 % Hemolysis at 0.2 mg/ml,Sheep,Synthetic Peptide,Helix,Non-hemolytic,CCCCCCCCCCCCCCCSSSSSSSSCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11606,32909733,2020,KIKKIIKKIIKI,KIKKIIKKIIKI{ct:Amid},KI,Amidation,Free,Linear,L,None,12,Antibacterial,10 % Hemolysis at 4000 µM,Human,Synthetic Peptide,Random coil,Non-hemolytic,CCCCSCCSSSCCCCCCSCCGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
11607,32909733,2020,GIIKKIIKKIIKKI,GIIKKIIKKIIKKI{ct:Amid},G3,Amidation,Free,Linear,L,None,14,Antibacterial,50 % Hemolysis at 800 µM,Human,Synthetic Peptide,Random coil,Low hemolytic,CCCCSCCSSSCCCCCCSCCGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
11608,32909733,2020,GILKKILKKILKKL,GILKKILKKILKKL{ct:Amid},G7,Amidation,Free,Linear,L,None,14,Antibacterial,50 % Hemolysis at 80 µM,Human,Synthetic Peptide,aqueous = α-Helical,NA,CCCCSSCCGGGCSCCCCCCCSSSGGGTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
11610,33194795,2020,RFRLPFRRPPIRIHPPPFYPPFRRFL,RFRLPFRRPPIRIHPPPFYPPFRRFL,ChBac3.4-COOH,Free,Free,Linear,L,None,26,Antibacterial,<5 % Hemolysis at 64 µM,Human,Chbac3.4 Full-Lenght Variants,NA,Low hemolytic,CCCCCCCCSSCSSCSSCSSSTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
11611,33194795,2020,RFRLPFRRIHPPPFVRIHPPPFYRRFL,RFRLPFRRIHPPPFVRIHPPPFYRRFL{ct:Amid},ChBac3.4-1-NH2,Amidation,Free,Linear,L,None,27,Antibacterial,<5 % Hemolysis at 64 µM,Human,Chbac3.4 Full-Lenght Variants,NA,Low hemolytic,CCSCSSSSSSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
11612,33194795,2020,RFRLPFRRIHPPPFVRIHPPPFYRRFL,RFRLPFRRIHPPPFVRIHPPPFYRRFL,ChBac3.4-1-COOH,Free,Free,Linear,L,None,27,"Antitumor, Antibacterial",<5 % Hemolysis at 64 µM,Human,Chbac3.4 Full-Lenght Variants,NA,Low hemolytic,CCCCSCSSCCSCCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
11613,33194795,2020,RFRRFRLPFRRIHPPPFVRIHPPPFYRRFL,RFRRFRLPFRRIHPPPFVRIHPPPFYRRFL{ct:Amid},RFR-ChBac3.4-1-NH2,Amidation,Free,Linear,L,None,30,"Antibacterial, Antibiofilm",<5 % Hemolysis at 64 µM,Human,Chbac3.4 Full-Lenght Variants,NA,Low hemolytic,CCCCCCCSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
11614,33194795,2020,RFRLPFRRPWPIRIHPPPFYPWPFRRFL,RFRLPFRRPWPIRIHPPPFYPWPFRRFL,ChBac3.4-2-COOH,Free,Free,Linear,L,None,28,Antibacterial,<5 % Hemolysis at 64 µM,Human,Chbac3.4 Full-Lenght Variants,NA,Low hemolytic,CCCCCSSSCCCCSTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
11615,33194795,2020,RFRLPFRRPPIRIPPPFYPPFRRFL,RFRLPFRRPPIRIPPPFYPPFRRFL{ct:Amid},ChBac3.4(Н-),Amidation,Free,Linear,L,None,25,Antibacterial,<5 % Hemolysis at 64 µM,Human,Chbac3.4 Full-Lenght Variants,NA,Low hemolytic,CHHHHHHHHSTTTTSSSSCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
11616,33194795,2020,RIHPPPFYPPFRRFL,RIHPPPFYPPFRRFL{ct:Amid},ChBac3.4 (12-26),Amidation,Free,Linear,L,None,15,Antibacterial,<5 % Hemolysis at 64 µM,Human,Chbac3.4 Truncated Variants,NA,Low hemolytic,CCHHHHTTCTTCTTSCTTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
11617,33194795,2020,RFRLPFRRPPIRIHPPPFY,RFRLPFRRPPIRIHPPPFY{ct:Amid},ChBac3.4(1-19)-NH2,Amidation,Free,Linear,L,None,19,Antibacterial,<5 % Hemolysis at 64 µM,Human,Chbac3.4 Truncated Variants,NA,Low hemolytic,CCSSGGGGTTTHHHHHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
11618,33194795,2020,RFRLPFRRPPIRIH,RFRLPFRRPPIRIH{ct:Amid},ChBac3.4(1-14)-NH2,Amidation,Free,Linear,L,None,14,Antibacterial,<5 % Hemolysis at 64 µM,Human,Chbac3.4 Truncated Variants,NA,Low hemolytic,CHHHHHHHHHTSGGGTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
11619,33194795,2020,RFRRFRLPFRRPPIRIH,RFRRFRLPFRRPPIRIH{ct:Amid},RFR-ChBac3.4(1-14)-NH2,Amidation,Free,Linear,L,None,17,"Antibacterial, Antibiofilm",<5 % Hemolysis at 64 µM,Human,Chbac3.4 Truncated Variants,NA,Low hemolytic,CCCCCCSSSCHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
11620,33092132,2020,GLLDLLKGAGKGLLTHLASQI,GLLDLLKGAGKGLLTHLASQI{ct:Amid},Ocellatin-1I,Amidation,Free,Linear,L,None,21,Antibacterial,50 % Hemolysis at > 250 μg/ml,Mouse,Ocellatins Frog Leptodactylus Insularum,"α-Helical at 2–9, 13–19",Low hemolytic,CCCCCCSSSCHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)C(=O)O
11621,33092132,2020,GLLDFFKGAGKELLTHLASQI,GLLDFFKGAGKELLTHLASQI{ct:Amid},Ocellatin-2I,Amidation,Free,Linear,L,None,21,Antibacterial,50 % Hemolysis at > 250 μg/ml,Mouse,Ocellatins Frog Leptodactylus Insularum,α-Helical at 11–19,Low hemolytic,CHHHIIIIIITCCHHHHHHHCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)C(=O)O
11622,33092132,2020,GAVVDILKGAGKNLLSLALNKLSEKVA,GAVVDILKGAGKNLLSLALNKLSEKVA{ct:Amid},Ocellatin-1N,Amidation,Free,Linear,L,None,26,Antibacterial,50 % Hemolysis at >500 μg/ml,Mouse,Ocellatins Frog Leptodactylus Nesiotus,"α-Helical at 3–10, 12–24",Non-hemolytic,CGGGGGGGGGGCTTHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C
11623,33092132,2020,GIFDVLKNLAKGVITSLAS,GIFDVLKNLAKGVITSLAS{ct:Amid},Ocellatin-3N,Amidation,Free,Linear,L,None,19,Antibacterial,50 % Hemolysis at 210 μg/ml,Mouse,Ocellatins Frog Leptodactylus Nesiotus,"α-Helical at 4–11, 13–18",NA,CHHHHHTTGGGCSHHHHTTTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C
11637,33084564,2020,RRWRRFFQKAKRLLRRFG,RRWRRFFQKAKRLLRRFG,DRGN-6,Free,Free,Linear,L,None,18,Antibacterial,~10 % Hemolysis at 10 μg/ml,Sheep,Synthetic Peptides Komodo Dragon Cathelicidin-Inspired Antimicrobial Peptides,Helical,NA,CTTHHHHHHHHHHHHTTTHHHHHHHHGGGGGGGGTCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O
11638,33084564,2020,RRWRRFFQKAKRLLRRFG,RRWRRFFQKAKRLLRRFG,DRGN-7,Free,Free,Linear,L,None,18,Antibacterial,~10 % Hemolysis at 10 μg/ml,Sheep,Synthetic Peptides Komodo Dragon Cathelicidin-Inspired Antimicrobial Peptides,Helical,NA,CTTHHHHHHHHHHHHTTTHHHHHHHHGGGGGGGGTCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O
11639,33084564,2020,RRWRRFFRKAKRLLRRFG,RRWRRFFRKAKRLLRRFG{ct:Amid},DRGN-8,Amidation,Free,Linear,L,None,18,Antibacterial,~10 % Hemolysis at 10 μg/ml,Sheep,Synthetic Peptides Komodo Dragon Cathelicidin-Inspired Antimicrobial Peptides,Helical,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O
11640,33084564,2020,KRFKKFFKKLKNSVKKRAKKFFKKPKVIGVTFPF,KRFKKFFKKLKNSVKKRAKKFFKKPKVIGVTFPF,NACATH,Free,Free,Linear,L,None,34,Antibacterial,<10 % Hemolysis at 100 μg/ml,Sheep,Cathelicidin Peptide From The Chinese Cobra,Helical,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)C(C)C
11641,33138816,2020,GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSEFFQS,GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSEFFQS,PMAP-37,Free,Free,Linear,L,None,37,Antibacterial,<5 % Hemolysis at 1280 μg/ml,Mouse,Porcine Myeloma Cells,α-Helix,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC
11642,33138816,2020,GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSERFQS,GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSERFQS,PMAP-37(F34-R),Free,Free,Linear,L,None,37,Antibacterial,<5 % Hemolysis at 1280 μg/ml,Mouse,Modified Pmap-37,NA,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC
11643,33138816,2020,GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSERFQS,GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSERFQS{nt:Chol},Chol-37(F34-R),Free,Chol,Linear,L,Chol = cholesterol,37,"Antibacterial, Wound healing and abscess reduction",<5 % Hemolysis at 1280 μg/ml,Mouse,Addition Of Cholesterol,NA,Non-hemolytic,NA,NA
11644,33085895,2020,fXXL,F{d}{nnr:X}{nnr:X}L{nt:C16},C16-fXXL,Free,C16,Linear,Mix,"X = L-2,4-diaminobutyric acid, f = D-phenylalanine",4,Antibacterial,~10 % Hemolysis at 5 μg/ml,Horse,Synthetic Lipopeptide,NA,NA,NA,NA
11645,33085895,2020,fXXL,F{d}{nnr:X}{nnr:X}L{nt:C14},C14-fXXL,Free,C14,Linear,Mix,"X = L-2,4-diaminobutyric acid, f = D-phenylalanine",4,Antibacterial,~10 % Hemolysis at 5 μg/ml,Horse,Synthetic Lipopeptide,NA,NA,NA,NA
11646,33085895,2020,fXXL,F{d}{nnr:X}{nnr:X}{nnr:L}{nt:C12},C12-fXXL,Free,C12,Linear,Mix,"X = L-2,4-diaminobutyric acid, f = D-phenylalanine, L = L-leucine",4,Antibacterial,<5 % Hemolysis at 5 μg/ml,Horse,Synthetic Lipopeptide,NA,NA,NA,NA
11647,33085895,2020,fXXL,F{d}{nnr:X}{nnr:X}L{nt:C16},C16-fXXL,Free,C16,Linear,Mix,"X = L-2,4-diaminobutyric acid, f = D-phenylalanine",4,Antibacterial,<5 % Hemolysis at 5 μg/ml,Sheep,Synthetic Lipopeptide,NA,NA,NA,NA
11648,33085895,2020,fXXL,F{d}{nnr:X}{nnr:X}L{nt:C14},C14-fXXL,Free,C14,Linear,Mix,"X = L-2,4-diaminobutyric acid, f = D-phenylalanine",4,Antibacterial,~10 % Hemolysis at 5 μg/ml,Sheep,Synthetic Lipopeptide,NA,NA,NA,NA
11649,33085895,2020,fXXL,F{d}{nnr:X}{nnr:X}{nnr:L}{nt:C12},C12-fXXL,Free,C12,Linear,Mix,"X = L-2,4-diaminobutyric acid, f = D-phenylalanine, L = L-leucine",4,Antibacterial,0 % Hemolysis at 5 μg/ml,Sheep,Synthetic Lipopeptide,NA,Non-hemolytic,NA,NA
11650,33224970,2020,MKLLLLALPMLVLLPQVIPAYSGEKKCWNRSGHCRKQCKDGEAVKDTCKNLRACCIPSNEDHRRVPATSPTPLSDSTPGIIDDILTVRFTTDYFEVSSKKDMVEESEAGRGTETSLPNVHHSS,MKLLLLALPMLVLLPQVIPAYSGEKKCWNRSGHCRKQCKDGEAVKDTCKNLRACCIPSNEDHRRVPATSPTPLSDSTPGIIDDILTVRFTTDYFEVSSKKDMVEESEAGRGTETSLPNVHHSS,β-Defensin 118 (DEFB118),Free,Free,Linear,L,None,123,"Antibacterial, Anti-inflammatory",<2 % Hemolysis at 256 μg/ml,Pig,Human Host Defense Peptide (Hdp),Betα-ring conformation,Non-hemolytic,CCSSTTHHHHHHHHHHTTTTHHHHHC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC
11651,33175275,2020,AFALIAGALYRIFHRR,AFALIAGALYRIFHRR,LHH1,Free,Free,Linear,L,None,16,Antibacterial,50 % Hemolysis at 187.2 µM,Goat,Lactobacillus Casei Hz1,"water = Random coil, 50% TFE and 30 mM SDS = α-Helical",Low hemolytic,CCGGGCSSSHHHHCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
11652,33218175,2020,LVDIYTHVYNCTSSEKHTHCYEIRKSIS,LVDIYTHVYNCTSSEKHTHCYEIRKSIS,OrR214,Free,Free,Linear,L,None,28,Antibacterial,0.142 % Hemolysis at 150 µM,Goat,Plant Oryza Rufipogon Griff,α-Helix Random coil,Non-hemolytic,CTTHHHHHHHHGGGSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)O
11653,33218175,2020,LGVPVSSTLRLNNTTMNPCLPS,LGVPVSSTLRLNNTTMNPCLPS,OrR935,Free,Free,Linear,L,None,22,Antibacterial,0.306 % Hemolysis at 150 µM,Goat,Plant Oryza Rufipogon Griff,Random coil,Non-hemolytic,CCSSHHHHGGGGGSCC,CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O
11654,33233541,2020,FFGSLLSLGSKLLPSVFKLFQRKKE,FFGSLLSLGSKLLPSVFKLFQRKKE{ct:Amid},Css54,Amidation,Free,Linear,L,None,25,"Antibacterial, Antibiofilm",40 % Hemolysis at 16 µM,Sheep,Scorpion Venom Of Centruroides Suffusus,"aqueous(10mM sodium phosphate) = Random coil, TFE and SDS = α-Helix",NA,CTHHHHTTTHHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C
11655,32445120,2020,DFFRKSKEKIGKEFKRIVQRIKDFLR,DFFRKSKEKIGKEFKRIVQRIKDFLR,Human CAP18,Free,Free,Linear,L,None,26,Antibacterial,≥20 % Hemolysis at 1000 μg/ml,Human,Human Cap18 Peptide,NA,Low hemolytic,CCBTTTBCSSSCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
11656,32445120,2020,RKRLRKFRNKKKIGQKIQ,RKRLRKFRNKKKIGQKIQ,Rabbit CAP18,Free,Free,Linear,L,None,18,Antibacterial,≥50 % Hemolysis at 1000 μg/ml,Human,Rabbit Cap18 Peptides,NA,Low hemolytic,CTHHHHTTTTHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC
11657,32445120,2020,WKFFRKLLKKIRKKFKR,WKFFRKLLKKIRKKFKR,hCap18,Free,Free,Linear,L,None,17,Antibacterial,95 % Hemolysis at 1000 μg/ml,Human,Truncated Human Cap18 Peptides,Random coil,Low hemolytic,CTHHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11658,32445120,2020,WRKRLRKFRLKKKILQ,WRKRLRKFRLKKKILQ,rCap18,Free,Free,Linear,L,None,16,Antibacterial,≥5 % Hemolysis at 1000 μg/ml,Human,Truncated Rabbit Cap18 Peptides,Random coil,Non-hemolytic,CCBTTTBCSSSCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O
11659,32569448,2020,GGLRRLGRKILRAVKKYG,GGLRRLGRKILRAVKKYG,CP,Free,Free,Linear,L,None,18,Antibacterial,0.2 ± 0.2 % Hemolysis at 100 µM,Human,Modified Bmap28(1-18) Synthetic Peptide,NA,Non-hemolytic,CTHHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O)C(C)C
11660,32569448,2020,GGLRSLGLKILLAWKKYG,GGLRSLGLKILLAWKKYG,DP,Free,Free,Linear,L,None,18,Antibacterial,14.9 ± 2.5 % Hemolysis at 100 µM,Human,Modified Bmap28(1-18) Synthetic Peptide,NA,NA,CCCGGGGTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O
11661,32569448,2020,RGLRRLGRKIKKGLKKYG,RGLRRLGRKIKKGLKKYG,Mapcon,Free,Free,Linear,L,None,18,Antibacterial,0 ± 0.02 % Hemolysis at 100 µM,Human,Map Family Consensus Peptide,NA,Non-hemolytic,CCCGGGGTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O
11662,32569448,2020,GGLRSLGRKILRAWKKYG,GGLRSLGRKILRAWKKYG,BMAP28(1-18),Free,Free,Linear,L,None,18,Antibacterial,4.6 ± 1.2 % Hemolysis at 100 µM,Human,Map Family Peptide,NA,NA,CCCGGGGTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O
11663,32569448,2020,GGLRSLGLKILLAWKKYG,GGLRSLGLKILLAWKKYG,DP,Free,Free,Linear,L,None,18,Antibacterial,0.27 ± 0.44 % Hemolysis at 6.25 µM,Human,Modified Bmap28(1-18) Synthetic Peptide,NA,NA,CTHHHHHHHHHHHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O
11664,32569448,2020,GGLRSLGRKILRAWKKYG,GGLRSLGRKILRAWKKYG,BMAP28(1-18),Free,Free,Linear,L,None,18,Antibacterial,1.11 ± 1.24 % Hemolysis at 25 µM,Human,Map Family Peptide,NA,NA,CCHHHHHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O
11665,33316868,2020,RRWYRRWYRRWY,RRWYRRWYRRWY{ct:Amid},RY12WY,Amidation,Free,Linear,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 1437.1 µM,Fish,Synthetic Short Amps,right-handed α-Helical,Non-hemolytic,NA,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
11666,33316868,2020,RRWYRRWYRRWY,RRWYRRWYRRWY{ct:Amid},RY12WY,Amidation,Free,Linear,L,None,12,"Antibacterial, Antifungal",0 % Hemolysis at 125 µM,Fish,Synthetic Short Amps,right-handed α-Helical,Non-hemolytic,NA,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
11667,33316868,2020,RRWYRRWYRRWY,RRWYRRWYRRWY{ct:Amid},RY12WY,Amidation,Free,Linear,L,None,12,"Antibacterial, Antifungal",10 % Hemolysis at 250 µM,Fish,Synthetic Short Amps,right-handed α-Helical,Non-hemolytic,NA,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
11668,33369262,2020,KLLKKAGKLLKKAGKLLKKAG,KLLKKAGKLLKKAGKLLKKAG,Stripe,Free,Free,Linear,L,None,21,Antibacterial,No Hemolysis at >100 µM,Human,Synthetic Rationally Designed Amphipathic Amp,20mM PBS (PH7.5) with 1%SDS at 202-222nm = α-Helical,Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)O
11669,33369262,2020,KLLKKGGKLLKKGGKLLKKGG,KLLKKGGKLLKKGGKLLKKGG,1,Free,Free,Linear,L,None,21,Antibacterial,No Hemolysis at >100 µM,Human,Stripe Side-Chain Stapling Analogue Peptide,20mM PBS (PH7.5) with 1%SDS at 202-222nm = Helical,Non-hemolytic,CGGGTHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)O
11670,33369262,2020,KLLKKXGKLLKKXGKLLKKXG,KLLKK{nnr:X}GKLLKK{nnr:X}GKLLKK{nnr:X}G,2,Free,Free,Linear,L,X = Aib (2-aminoisobutyric acid),21,Antibacterial,No Hemolysis at >100 µM,Human,Stripe Side-Chain Stapling Analogue Peptide,20mM PBS (PH7.5) with 1%SDS at 202-222nm = α-Helical,Non-hemolytic,NA,NA
11671,33369262,2020,KLLKKZGKLLKKZGKLLKKZG,KLLKK{nnr:Z}GKLLKK{nnr:Z}GKLLKK{nnr:Z}G,3,Free,Free,Linear,L,Z = Ac6c(1-aminocyclohexanecarboxylic acid),21,Antibacterial,Hemolysis at 1.56 µM,Human,Stripe Side-Chain Stapling Analogue Peptide,20mM PBS (PH7.5) with 1%SDS at 202-222nm = α-Helical,NA,NA,NA
11672,33369262,2020,KLLKKAGKLLKK(R)GKLLKK(S)G,KLLKKAGKLLKK{nnr:R}GKLLKK{nnr:S}G,4,Free,Free,Linear,L,"R8 = (R)-(7-octenyl)alanine, S5 = (S)-(4-pentenyl)alanine, R8 and S5 in peptides 4 and 5 denote side-stapling produced by (R)-(7-octenyl)alanine and (S)-(4-pentenyl)alanine.",21,Antibacterial,Hemolysis at 0.78 µM,Human,Stripe Side-Chain Stapling Analogue Peptide,20mM PBS (PH7.5) with 1%SDS at 202-222nm = α-Helical,NA,NA,NA
11673,33369262,2020,KLLKK(R)GKLLKK(S)GKLLKKAG,KLLKK{nnr:R}GKLLKK{nnr:S}GKLLKKAG,5,Free,Free,Linear,L,"R8 = (R)-(7-octenyl)alanine, S5 = (S)-(4-pentenyl)alanine, R8 and S5 in peptides 4 and 5 denote side-stapling produced by (R)-(7-octenyl)alanine and (S)-(4-pentenyl)alanine.",21,Antibacterial,Hemolysis at 1.56 µM,Human,Stripe Side-Chain Stapling Analogue Peptide,20mM PBS (PH7.5) with 1%SDS at 202-222nm = α-Helical,NA,NA,NA
11674,33291521,2020,FLQRIIGALGRLF,FLQRIIGALGRLF,GHaR,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal",10 % Hemolysis at 13.6 µM,Human,Synthetic Temporin-Gha (Gha) Analogue,α-Helical,NA,CGGGTGGGTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11675,33291521,2020,FLQRIRGALGRLF,FLQRIRGALGRLF,GHaR6R,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal, Anti-biofilm",10 % Hemolysis at 156 µM,Human,Synthetic Temporin-Gha (Gha) Analogue,α-Helical,NA,CGGGTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11676,33291521,2020,FLQRIIRALGRLF,FLQRIIRALGRLF,GHaR7R,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal, Anti-biofilm",10 % Hemolysis at 11.6 µM,Human,Synthetic Temporin-Gha (Gha) Analogue,α-Helical,NA,CCGGGGGTSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11677,33291521,2020,FLQRIIGRLGRLF,FLQRIIGRLGRLF,GHaR8R,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal, Anti-biofilm",10 % Hemolysis at 22.3 µM,Human,Synthetic Temporin-Gha (Gha) Analogue,α-Helical,NA,CTHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11678,33291521,2020,FLQRIIGARGRLF,FLQRIIGARGRLF,GHaR9R,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal",10 % Hemolysis at >200 µM,Human,Synthetic Temporin-Gha (Gha) Analogue,NA,Low hemolytic,CHHHHHHHHSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11679,33291521,2020,FLQRIIGAWGRLF,FLQRIIGAWGRLF,GHaR9W,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal, Anti-biofilm",10 % Hemolysis at 32.8 µM,Human,Synthetic Temporin-Gha (Gha) Analogue,α-Helical,NA,CHHHHTCCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11680,33291521,2020,FLQRIIGALGRLF,FLQRIIGALGRLF,GHaR,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal",50 % Hemolysis at 46.4 µM,Human,Synthetic Temporin-Gha (Gha) Analogue,α-Helical,NA,CGGGTGGGTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11681,33291521,2020,FLQRIRGALGRLF,FLQRIRGALGRLF,GHaR6R,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal, Anti-biofilm",50 % Hemolysis at >200 µM,Human,Synthetic Temporin-Gha (Gha) Analogue,α-Helical,Low hemolytic,CCCCCCCCCSSSSSSCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11682,33291521,2020,FLQRIIRALGRLF,FLQRIIRALGRLF,GHaR7R,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal, Anti-biofilm",50 % Hemolysis at 10.9 µM,Human,Synthetic Temporin-Gha (Gha) Analogue,α-Helical,NA,CCCCCCCCCSSSSSSCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11683,33291521,2020,FLQRIIGRLGRLF,FLQRIIGRLGRLF,GHaR8R,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal, Anti-biofilm",50 % Hemolysis at 167.6 µM,Human,Synthetic Temporin-Gha (Gha) Analogue,α-Helical,NA,CCCHHHHTTCCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11684,33291521,2020,FLQRIIGARGRLF,FLQRIIGARGRLF,GHaR9R,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal",50 % Hemolysis at >200 µM,Human,Synthetic Temporin-Gha (Gha) Analogue,NA,Low hemolytic,CHHHHHHHHHHHHHHCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11685,33291521,2020,FLQRIIGAWGRLF,FLQRIIGAWGRLF,GHaR9W,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal, Anti-biofilm",50 % Hemolysis at 86.3 µM,Human,Synthetic Temporin-Gha (Gha) Analogue,α-Helical,NA,CTTTHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11686,33291782,2020,SPRVCIRVCRNGVCYRRCWG,SPRVCIRVCRNGVCYRRCWG,Capitellacin,Free,Free,Linear,L,None,20,"Antibacterial, Anti-infective",0 % Hemolysis at 64 µM,Human,Marine Polychaeta Capitella Teleta,membrane mimicking media = β-Hairpin,Non-hemolytic,CTTTHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O)C(C)C)C(C)C
11687,33291782,2020,SPRVCIRVCRNGVCYRRCWG,SPRVCIRVCRNGVCYRRCWG,Capitellacin,Free,Free,Linear,L,None,20,"Antibacterial, Anti-infective",≥2 % Hemolysis at 128 µM,Human,Marine Polychaeta Capitella Teleta,membrane mimicking media = β-Hairpin,Non-hemolytic,CHHHHTTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O)C(C)C)C(C)C
11688,33291782,2020,KWCFRVCYRGICYRRCR,KWCFRVCYRGICYRRCR,Tachyplesin-1,Free,Free,Linear,L,None,17,"Antibacterial, Anti-infective",50 % Hemolysis at 128 µM,Human,Horseshoe Crab Tachypleus Tridentatus,membrane mimicking media = β-Hairpin right-handed twist,NA,CHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11689,33236874,2020,FKRLKKLISWIKRKRQQC,FKRLKKLISWIKRKRQQC{ct:Amid},HnMc,Amidation,Free,Linear,L,None,18,Antibacterial,≥10 % Hemolysis at 1 mg/mL,Rat,Analogue Helicobacter Pylori Ribosomal Protein L1 (Hpa3Nt3),NA,Low hemolytic,CTTTHHHHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC
11690,33205989,2020,LKKLLKLLKKLLKL,LKKLLKLLKKLLKL{nt:Acet}{ct:Amid},LK,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at 5 µM,Human,Proline Hinged Amphipathic Α‑Helical Peptide,PPB + TFE = α-Helical,NA,CCCCHHHHTTSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)O
11691,33205989,2020,LKKLLPLLKKLLKL,LKKLLPLLKKLLKL{nt:Acet}{ct:Amid},LK-K6P,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at 1.25 µM,Human,Lk Pro-Scanning Peptides,PPB + TFE = α-Helical,NA,CTTTHHHHHHHTTC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)O
11692,33205989,2020,LKKLLKLLPKLLKL,LKKLLKLLPKLLKL{nt:Acet}{ct:Amid},LK-K9P,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at 5 µM,Human,Lk Pro-Scanning Peptides,PPB + TFE = α-Helical,NA,CHHHHHHHTTCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)O
11693,33205989,2020,LKKLLKLLKPLLKL,LKKLLKLLKPLLKL{nt:Acet}{ct:Amid},LK-K10P,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at 5 µM,Human,Lk Pro-Scanning Peptides,PPB + TFE = α-Helical,NA,CTTTTHHHHHCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)O
11694,33205989,2020,LKKPLKLGKKLLKL,LKKPLKLGKKLLKL{nt:Acet}{ct:Amid},LK-L4P,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at 160 µM,Human,Lk Pro-Scanning Peptides,PPB + TFE = α-Helical,Low hemolytic,CHHHHHHHTSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)O
11695,33205989,2020,LKKLPKLSKKLLKL,LKKLPKLSKKLLKL{nt:Acet}{ct:Amid},LK-L5P,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at 80 µM,Human,Lk Pro-Scanning Peptides,PPB + TFE = α-Helical,NA,CTHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)O
11696,33205989,2020,LKKLLKPLKKLLKL,LKKLLKPLKKLLKL{nt:Acet}{ct:Amid},LK-L7P,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at 160 µM,Human,Lk Pro-Scanning Peptides,PPB + TFE = α-Helical,Low hemolytic,CTHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)O
11697,33205989,2020,LKKLLKLLKKLPKL,LKKLLKLLKKLPKL{nt:Acet}{ct:Amid},LK-L12P,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at 40 µM,Human,Lk Pro-Scanning Peptides,PPB + TFE = α-Helical,NA,CCHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)O
11698,33205989,2020,LKKLLKLPKKLLKL,LKKLLKLPKKLLKL{nt:Acet}{ct:Amid},LK-L8P,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at 640 µM,Human,Lk Pro-Scanning Peptides,PPB + TFE = α-Helical,Non-hemolytic,CCGGGHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)O
11699,33205989,2020,LKKLLKLLKKPLKL,LKKLLKLLKKPLKL{nt:Acet}{ct:Amid},LK-L11P,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at 320 µM,Human,Lk Pro-Scanning Peptides,PPB + TFE = α-Helical,Non-hemolytic,CTHHHHHHHTTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)O
11700,33205989,2020,KLLKLLKKLLKLLK,KLLKLLKKLLKLLK{nt:Acet}{ct:Amid},KL,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at 0.625 µM,Human,Proline Hinged Amphipathic Α‑Helical Peptide,PPB + TFE = α-Helical,NA,CTTTTHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
11701,33205989,2020,KPLKLLKKLLKLLK,KPLKLLKKLLKLLK{nt:Acet}{ct:Amid},KL-L2P,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at 5 µM,Human,Kl Pro-Scanning Peptides,PPB + TFE = α-Helical,NA,CTHHHHTTHHHHCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
11702,33205989,2020,KLPKLLKKLLKLLK,KLPKLLKKLLKLLK{nt:Acet}{ct:Amid},KL-L3P,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at 10 µM,Human,Kl Pro-Scanning Peptides,PPB + TFE = α-Helical,NA,CTHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
11703,33205989,2020,KLLKLLPKLLKLLK,KLLKLLPKLLKLLK{nt:Acet}{ct:Amid},KL-K7P,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at 5 µM,Human,Kl Pro-Scanning Peptides,PPB + TFE = α-Helical,NA,CTHHHHHHHTTCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
11704,33205989,2020,KLLKLLKPLLKLLK,KLLKLLKPLLKLLK{nt:Acet}{ct:Amid},KL-K8P,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at 2.5 µM,Human,Kl Pro-Scanning Peptides,PPB + TFE = α-Helical,NA,CCTTCHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
11705,33205989,2020,KLLKPLKKLLKLLK,KLLKPLKKLLKLLK{nt:Acet}{ct:Amid},KL-L5P,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at 80 µM,Human,Kl Pro-Scanning Peptides,PPB + TFE = α-Helical,NA,CTHHHHTTGGGTCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
11706,33205989,2020,KLLKLLKKLPKLLK,KLLKLLKKLPKLLK{nt:Acet}{ct:Amid},KL-L10P,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at 80 µM,Human,Kl Pro-Scanning Peptides,PPB + TFE = α-Helical,NA,CCCCCCCTTCCCSSCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
11707,33205989,2020,KLLKLLKKLLKPLK,KLLKLLKKLLKPLK{nt:Acet}{ct:Amid},KL-L12P,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at 40 µM,Human,Kl Pro-Scanning Peptides,PPB + TFE = α-Helical,NA,CCCCCCCTTCCCSSCCSTTCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
11708,33205989,2020,KLLKLLKKLLKLPK,KLLKLLKKLLKLPK{nt:Acet}{ct:Amid},KL-L13P,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at 40 µM,Human,Kl Pro-Scanning Peptides,PPB + TFE = α-Helical,NA,CCSSCSSCCCCCCCCSCTTCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
11709,33205989,2020,KLLKLPKKLLKLLK,KLLKLPKKLLKLLK{nt:Acet}{ct:Amid},KL-L6P,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at 640 µM,Human,Kl Pro-Scanning Peptides,PPB + TFE = α-Helical,Non-hemolytic,CCCCCCSTTCCSGGGCCSCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
11710,33205989,2020,KLLKLLKKPLKLLK,KLLKLLKKPLKLLK{nt:Acet}{ct:Amid},KL-L9P,Amidation,Acetylation,Linear,L,None,14,Antibacterial,10 % Hemolysis at >1280 µM,Human,Kl Pro-Scanning Peptides,PPB + TFE = α-Helical,Non-hemolytic,CCCCCCSTTCCSGGGCCSCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
11711,33321960,2020,RWCVYAYVRVRGVLVRYRRCW,RWCVYAYVRVRGVLVRYRRCW,Ar-1,Free,Free,Linear,L,None,21,Antibacterial,10 % Hemolysis at 2.9 ± 1.2 µM,Human,Sea Polychaete Arenicola Marina,"Aqueous = right-twisted and kinked β-Hairpin, SDS = β-Sheet",NA,CCCCSCSCCCCCCCSSCCCCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
11712,33321960,2020,RWCVYAYVRIRGVLVRYRRCW,RWCVYAYVRIRGVLVRYRRCW,Ar-2,Free,Free,Linear,L,None,21,Antibacterial,10 % Hemolysis at 1.8 ± 0.9 µM,Human,Sea Polychaete Arenicola Marina,"Aqueous = right-twisted and kinked β-Hairpin, SDS = β-Sheet",NA,CCCSSCCSSEESSSEECCCSGGGSSSCSSTTCCCCSGGGTSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(C)C
11713,33321960,2020,RWAVYAYVRVRGVLVRYRRAW,RWAVYAYVRVRGVLVRYRRAW,Ar-1-(C/A),Free,Free,Linear,L,None,21,Antibacterial,10 % Hemolysis at 11.1 ± 2.3 µM,Human,Synthetic Derivative Of Ar-1,"Aqueous = right-twisted antiparallel β-Sheet, SDS = relaxed antiparallel and parallel β-Sheets",NA,CCHHHHHHHTTSCTTGGGGSCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
11714,33348729,2020,GFAWNVCVYRNGVRVCHRRAN,GFAWNVCVYRNGVRVCHRRAN{ct:Amid},N6NH2,Amidation,Free,Linear,L,None,21,Antibacterial,0.19 % Hemolysis at 256 μg/ml,Mouse,Marine Peptide-N6,"ddH2O = coil and antiparallel Strand or β-Turn, SDS solution = α-Helix and antiparallel Strand, 50% TFE = β-Turn, coil and antiparallel Sheet",Non-hemolytic,CCSTTTTTSSSSSGGGTTTSCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
11715,33348729,2020,GFAWNVCVYRNGVRVCHRRAN,GFAWNVCVYRNGVRVCHRRAN,N6,Free,Free,Linear,L,None,21,Antibacterial,1.9 % Hemolysis at 256 μg/ml,Mouse,N6 Anaog Amidated,"ddH2O = coil and antiparallel Strand or β-Turn, SDS solution = α-Helix and antiparallel Strand, 50% TFE = β-Turn, coil and antiparallel Sheet",Non-hemolytic,CCHHHHHHHTTSCTTGGGGSCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
11716,33374458,2020,GSKKPVPIIYCNRRSGKCQRM,GSKKPVPIIYCNRRSGKCQRM,TS,Free,Free,Linear,L,None,21,Antibacterial,<10 % Hemolysis at 160 µM,Human,Modified From Thanatin (Hemipteran Insect Podisus Maculiventris),β-Helix,Non-hemolytic,CHHHHTTHHHHSSGGGTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)CN)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)O
11725,32798369,2021,AIPWIWIWRLLRKG,AIPWIWIWRLLRKG,WWW,Free,Free,Linear,L,None,14,Antibacterial,100 % Hemolysis at 15 µM,Human,Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)),NA,NA,CCCSCHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
11726,32798369,2021,AIPYIWIYRLLRKG,AIPYIWIYRLLRKG,YWY,Free,Free,Linear,L,None,14,Antibacterial,~2 % Hemolysis at 15 µM,Human,Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)),NA,Low hemolytic,CCSSHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
11727,32798369,2021,AIPFIWIFRLLRKG,AIPFIWIFRLLRKG,FWF,Free,Free,Linear,L,None,14,Antibacterial,~80 % Hemolysis at 15 µM,Human,Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)),NA,NA,CCTTCHIIIIITCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
11728,32798369,2021,AIPYIYIYRLLRKG,AIPYIYIYRLLRKG,YYY,Free,Free,Linear,L,None,14,Antibacterial,~2 % Hemolysis at 15 µM,Human,Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)),NA,Low hemolytic,CCCCCGGGGTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
11729,32798369,2021,AIPFIFIFRLLRKG,AIPFIFIFRLLRKG,FFF,Free,Free,Linear,L,None,14,Antibacterial,~2 % Hemolysis at 15 µM,Human,Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)),NA,Low hemolytic,CTHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
11730,32798369,2021,AIPYIYIWRLLRKG,AIPYIYIWRLLRKG,YYW,Free,Free,Linear,L,None,14,Antibacterial,~5 % Hemolysis at 15 µM,Human,Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)),NA,NA,CTHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
11731,32798369,2021,AIPFIFIWRLLRKG,AIPFIFIWRLLRKG,FFW,Free,Free,Linear,L,None,14,Antibacterial,~40 % Hemolysis at 15 µM,Human,Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)),NA,NA,CTHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
11732,32798369,2021,AIPWIYIYRLLRKG,AIPWIYIYRLLRKG,WYY,Free,Free,Linear,L,None,14,Antibacterial,~40 % Hemolysis at 15 µM,Human,Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)),NA,NA,CCCCCHHHHCCSSSCCSCCCCSCCCSSSBTTBSCCCSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
11733,32798369,2021,AIPWIFIFRLLRKG,AIPWIFIFRLLRKG,WFF,Free,Free,Linear,L,None,14,Antibacterial,~60 % Hemolysis at 15 µM,Human,Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)),NA,NA,CCCCCTTTSSCCSSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
11734,33398076,2021,rivqrikkwlr,R{d}I{d}V{d}Q{d}R{d}I{d}K{d}K{d}W{d}L{d}R{d}{ct:Amid},D-11,Amidation,Free,Linear,D,None,11,Antibacterial,10 % Hemolysis at 1200 µM,Human,Subsitituted With D Amino Acid In L-11 (Synthetic Peptides ),NA,Non-hemolytic,CCCSSTTCSCSTTCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11735,33398076,2021,rivqrikkwlr,R{d}I{d}V{d}Q{d}R{d}I{d}K{d}K{d}W{d}L{d}R{d}{ct:Amid},D-11,Amidation,Free,Linear,D,None,11,Antibacterial,0 % Hemolysis at 500 µM,Human,Subsitituted With D Amino Acid In L-11 (Synthetic Peptides ),NA,Non-hemolytic,CCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11736,33398076,2021,rivqrikkwlr,R{d}I{d}V{d}Q{d}R{d}I{d}K{d}K{d}W{d}L{d}R{d}{ct:Amid},D-11,Amidation,Free,Linear,D,None,11,Antibacterial,0 % Hemolysis at 600 µM,Human,Subsitituted With D Amino Acid In L-11 (Synthetic Peptides ),NA,Non-hemolytic,CCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11743,33296183,2021,FLKILKKLL,FLKILKKLL{ct:Amid},Feleucin-K46,Amidation,Free,Linear,L,None,9,Antibacterial,<10 % Hemolysis at 128 μg/ml,Mouse,Feleucin-K3 Analogues (Frog Bombina Orientalis),50% TFE = α-Helix,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
11744,33296183,2021,FLKFLKKLL,FLKFLKKLL{ct:Amid},Feleucin-K48,Amidation,Free,Linear,L,None,9,Antibacterial,≥20 % Hemolysis at 128 μg/ml,Mouse,Feleucin-K3 Analogues (Frog Bombina Orientalis),TFE = α-Helix,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
11745,33296183,2021,FLKWLKKLL,FLKWLKKLL{ct:Amid},Feleucin-K52,Amidation,Free,Linear,L,None,9,Antibacterial,≥60 % Hemolysis at 128 μg/ml,Mouse,Feleucin-K3 Analogues (Frog Bombina Orientalis),TFE = α-Helix,NA,CCCCCCCCCSSCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
11746,33296183,2021,FLKYLKKLL,FLKYLKKLL{ct:Amid},Feleucin-K53,Amidation,Free,Linear,L,None,9,Antibacterial,≥10 % Hemolysis at 128 μg/ml,Mouse,Feleucin-K3 Analogues (Frog Bombina Orientalis),TFE = α-Helix,Low hemolytic,CCCCCCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
11747,33296183,2021,FLK(2-nal)LKKLL,FLK{nnr:L-2-Nal}LKKLL{ct:Amid},Feleucin-K55,Amidation,Free,Linear,L,L-2-NAL = L-2-NAL,9,Antibacterial,≥80 % Hemolysis at 128 μg/ml,Mouse,Feleucin-K3 Analogues (Frog Bombina Orientalis),TFE = α-Helix,NA,NA,NA
11748,33296183,2021,FLK(2-NaI)LKKLL,FLK{nnr:D-2-NaI}LKKLL{ct:Amid},Feleucin-K56,Amidation,Free,Linear,Mix,D-2-nal = D-2-nal,9,Antibacterial,≥10 % Hemolysis at 128 μg/ml,Mouse,Feleucin-K3 Analogues (Frog Bombina Orientalis),TFE = α-Helix,Low hemolytic,NA,NA
11749,33296183,2021,FLKα-(4-pentenyl)-AlaLKKLL,FLK{nnr:α-(4-pentenyl)-Ala}LKKLL{ct:Amid},Feleucin-K59,Amidation,Free,Linear,L,α-(4-pentenyl)-Ala,9,"Antibacterial, Antibiofilm",≥60 % Hemolysis at 128 μg/ml,Mouse,Feleucin-K3 Analogues (Frog Bombina Orientalis),TFE = α-Helix,NA,NA,NA
11756,33495505,2021,VRNSQSCRRNKGICVPIRCPGSMRQIGTCLGAQVKCCRRK,VRNSQSCRRNKGICVPIRCPGSMRQIGTCLGAQVKCCRRK,cystine dense peptide CDP-B11,Free,Free,Linear,L,None,40,Antibacterial,0 % Hemolysis at 200 μg/ml,Sheep,Bubalus Bubalis (Domestic Water Buffalo),NA,Non-hemolytic,CCCCCCSCCCTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C
11757,33532575,2021,KYKKALKKLAKLL,KYKKALKKLAKLL,L-SB1,Free,Free,Linear,L,None,13,Antibacterial. Antibiofilm,MHC at >2000 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Non-hemolytic,CCCCCCSCCCTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCCN)C(=O)O
11758,33532575,2021,kykkalkklakll,K{d}Y{d}K{d}K{d}A{d}L{d}K{d}K{d}L{d}A{d}K{d}L{d}L{d},D-SB1,Free,Free,Linear,D,None,13,Antibacterial. Antibiofilm,MHC at >2000 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Non-hemolytic,CCCCCTTSCCCCGGGHHHHHHHHHHHHHHHHTTTTCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCCN)C(=O)O
11759,33532575,2021,VQWRAIRVRVIR,VQWRAIRVRVIR,L-DJK5,Free,Free,Linear,L,None,12,Antibacterial. Antibiofilm,MHC at >2000 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Non-hemolytic,CCCCCTTSCCCCGGGHHHHHHHHHHHHHHHHTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
11760,33532575,2021,vqwrairvrvir,V{d}Q{d}W{d}R{d}A{d}I{d}R{d}V{d}R{d}V{d}I{d}R{d},D-DJK5,Free,Free,Linear,D,None,12,Antibacterial. Antibiofilm,MHC at 1000 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
11761,33532575,2021,ILPWKWPWWPWRR,ILPWKWPWWPWRR,L-Indo,Free,Free,Linear,L,None,13,Antibacterial. Antibiofilm,MHC at 125 μg/ml,Human,Derived From Bovin,PB and 20%TFE = α-Helical,NA,NA,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11762,33532575,2021,ilpwkwpwwpwrr,I{d}L{d}P{d}W{d}K{d}W{d}P{d}W{d}W{d}P{d}W{d}R{d}R{d},D-Indo,Free,Free,Linear,D,None,13,Antibacterial. Antibiofilm,MHC at 125 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,NA,CTTCCCCCCCGGGHHHHHHHHHHHHHHHHHHHHHTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11763,33532575,2021,KLKLKLKLKLKLKLKLKKLKKLKKLKKLKKLKKLKKL,KLKLKLKLKLKLKLKLKKLKKLKKLKKLKKLKKLKKL,L-G3KL,Free,Free,Branched,L,None,37,Antibacterial. Antibiofilm,MHC at 1000 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Non-hemolytic,CTTCCCCCCCGGGHHHHHHHHHHHHHHHHHHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11764,33532575,2021,klklklklklklklklkklkklkklkklkklkklkkl,K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d},D-G3KL,Free,Free,Branched,D,None,37,Antibacterial. Antibiofilm,MHC at 1000 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Non-hemolytic,CCSTTTSCSSCCCCCCSSSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11765,33532575,2021,OFOFOFOFKBLKBLKKLK(C10),OFOFOFOFKBLKBLKKLK{ct:C10},L-TNS18,C10,Free,Branched,L,C10,18,Antibacterial. Antibiofilm,MHC at 1000 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Non-hemolytic,CGGGGTTTTSCSCCCCCCCSCCC,NA
11766,33532575,2021,ofofofofkblkblkklk(C10),O{d}F{d}O{d}F{d}O{d}F{d}O{d}F{d}K{d}B{d}L{d}K{d}B{d}L{d}K{d}K{d}L{d}K{d}{ct:C10},D-TNS18,Free,Free,Branched,D,None,18,Antibacterial. Antibiofilm,MHC at 500 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Low hemolytic,CCSTTTSTTCCCSSCCCCCCCCC,NA
11767,33532575,2021,KLKLKLKLKLKLKLKLKKLKKLKKLKKLKLLKLLKKLL,KLKLKLKLKLKLKLKLKKLKKLKKLKKLKLLKLLKKLL,L-T25,Free,Free,Branched,L,None,38,Antibacterial. Antibiofilm,MHC at 62.5 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,NA,CTTHHHHTTSCCCSSCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11768,33532575,2021,klklklklklklklklkklkklkklkklkllkllkkll,K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}L{d}L{d}K{d}L{d}L{d}K{d}K{d}L{d}L{d},D-T25,Free,Free,Branched,D,None,38,Antibacterial. Antibiofilm,MHC at 125 μg/ml,Human,Synthetic Peptide,NA,NA,CCCTTHHHHHHHHHHHHHHCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11769,32666297,2021,RIIDLLWRVRRPQKPKFVTVWVR,RIIDLLWRVRRPQKPKFVTVWVR,PMAP-23,Free,Free,Linear,L,None,23,Antibacterial,<4 % Hemolysis at 1000 μg/ml,Mouse,Synthetic Peptide,two α-Helix regions,Non-hemolytic,CCCTTHHHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C
11770,32666297,2021,RIIDRLWRVRRPQKPKFVTVWVR,RIIDRLWRVRRPQKPKFVTVWVR,PMAP-23R,Free,Free,Linear,L,None,23,Antibacterial,<4 % Hemolysis at 1000 μg/ml,Mouse,Pmap-23 Analogs,NA,Non-hemolytic,CCCTTHHHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C
11771,32666297,2021,RIIDLLWRVRRPQKPKFVIVWVR,RIIDLLWRVRRPQKPKFVIVWVR,PMAP-23I,Free,Free,Linear,L,None,23,Antibacterial,<4 % Hemolysis at 1000 μg/ml,Mouse,Pmap-23 Analogs,NA,Non-hemolytic,CCBTTBTTCCSSTTTTCSSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
11772,32666297,2021,RIIDRLWRVRRPQKPKFVIVWVR,RIIDRLWRVRRPQKPKFVIVWVR,PMAP-23RI,Free,Free,Linear,L,None,23,Antibacterial,<4 % Hemolysis at 1000 μg/ml,Mouse,Pmap-23 Analogs,NA,Non-hemolytic,CTTTTTHHHHHHHHHHHTSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
11773,32812694,2021,FALGAVTKVLPKLFCLITRKC,FALGAVTKVLPKLFCLITRKC,Brevinin-1H,Free,Free,Linear,L,None,21,"Antibacterial, Antibiofilm, Antifungal",>20 % Hemolysis at 32 µM,Horse,Frog Amolops Hainanensis,Helix,NA,CCSTTTSCSSCCCCCCSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11774,32812694,2021,FALGAVTKVLPKLFCLITRKC,FALGAVTKVLPKLFCLITRKC,Brevinin-1H,Free,Free,Linear,L,None,21,"Antibacterial, Antibiofilm, Antifungal",50 % Hemolysis at 53.12 µM,Horse,Frog Amolops Hainanensis,Helix,NA,CTTHHHHTTSCCCSSCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11775,32812694,2021,FALGAVTKVLPKLFCLITRKC,FALGAVTKVLPKLFCLITRKC,Brevinin-1H,Free,Free,Linear,L,None,21,"Antibacterial, Antibiofilm, Antifungal",9.49 % Hemolysis at 4 µM,Horse,Frog Amolops Hainanensis,Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11776,32812694,2021,FALGAVTCLIRTKCKVLPKLF,FALGAVTCLIRTKCKVLPKLF,Brevinin-1Ha,Free,Free,Linear,L,None,21,"Antibacterial, Antibiofilm",22.1 % Hemolysis at 128 µM,Horse,Brevinin-1H Analogues,NA,NA,CTTHHHHHHHHHHHSSHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O
11777,32812694,2021,FALGAVTKVLYKLFCLITRKC,FALGAVTKVLYKLFCLITRKC,Brevinin-1HY,Free,Free,Linear,L,None,21,"Antibacterial, Antibiofilm",28.48 % Hemolysis at 4 µM,Horse,Brevinin-1H Analogues,Helix,NA,CCSHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11778,33141035,2021,RIIDLLWRVRRPQKPKFVTVWVR,RIIDLLWRVRRPQKPKFVTVWVR,PMAP-23,Free,Free,Linear,L,None,23,"Antibacterial, Antibiofilm",≤4 % Hemolysis at 1280 μg/ml,Mouse,Porcine Myeloid,two α-Helical,Non-hemolytic,CCHHHHHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C
11779,33141035,2021,RIIDRLWRVRRPQKPKFVIVWVR,RIIDRLWRVRRPQKPKFVIVWVR,PMAP-23R,Free,Free,Linear,L,None,23,"Antibacterial, Antibiofilm",≤4 % Hemolysis at 1280 μg/ml,Mouse,Pmap-23 Analogs,NA,Non-hemolytic,CCHHHHHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
11780,33141035,2021,RIIDRLWRVRRPQKPKFVIVWVR-K-Dec,RIIDRLWRVRRPQKPKFVIVWVR-K{ct:Dec},PMAP-23RI-Dec,Dec,Free,Linear,L,Dec = Decanoic acid,24,"Antibacterial, Antibiofilm",≤4 % Hemolysis at 1280 μg/ml,Mouse,Pmap-23 Analogs With Decanoic Acid,NA,Non-hemolytic,NA,NA
11781,33175610,2021,IWLTALKFLGKNLGKHLAKQQLAKL,IWLTALKFLGKNLGKHLAKQQLAKL{nt:H}{ct:Amid},LyeTx I,Amidation,H,Linear,L,None,25,"Antibacterial, Antifungal",50 % Hemolysis at 32.35 µM,Rabbit,Spider Lycosa Erythrognatha,"water = Random coil, TFE = α-Helix",NA,CCSHHHHHHHHHHTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
11782,33175610,2021,IWLTALKFLGKNLGK,IWLTALKFLGKNLGK{nt:H}{ct:Amid},LyeTx I mn,Amidation,H,Linear,L,None,15,"Antibacterial, Antifungal",50 % Hemolysis at 381.4 µM,Rabbit,Lyetx I Analogs,"water = Random coil, TFE = α-Helix",Low hemolytic,CCHHHHHHHHHHHSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
11783,33175610,2021,IWLTKALKFLGKNLGK,IWLTKALKFLGKNLGK{nt:H}{ct:Amid},LyeTx I mnΔK,Amidation,H,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at 506.5 µM,Rabbit,Lyetx I Analogs,"water = Random coil, TFE = α-Helix",Low hemolytic,CCHHHHHHHHHHHSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
11784,33175610,2021,IWLTKALKFLGKNLGK,IWLTKALKFLGKNLGK{nt:Acet}{ct:Amid},LyeTx I mnΔKAc,Amidation,Acetylation,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at 207.5 µM,Rabbit,Lyetx I Analogs,"water = Random coil, TFE = α-Helix",Low hemolytic,CCGGGTSTTSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
11785,33175610,2021,IWLTALKFLGKNLGKHLAKQQLAKL,IWLTALKFLGKNLGKHLAKQQLAKL{nt:H}{ct:Amid},LyeTx I,Amidation,H,Linear,L,None,25,"Antibacterial, Antifungal",1 % Hemolysis at 5.06 µM,Rabbit,Spider Lycosa Erythrognatha,"water = Random coil, TFE = α-Helix",NA,CGGGGGGTTTSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
11786,33175610,2021,IWLTALKFLGKNLGK,IWLTALKFLGKNLGK{nt:H}{ct:Amid},LyeTx I mn,Amidation,H,Linear,L,None,15,"Antibacterial, Antifungal",1 % Hemolysis at 48.06 µM,Rabbit,Lyetx I Analogs,"water = Random coil, TFE = α-Helix",Low hemolytic,CHHHHHHHHTTCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
11787,33175610,2021,IWLTKALKFLGKNLGK,IWLTKALKFLGKNLGK{nt:H}{ct:Amid},LyeTx I mnΔK,Amidation,H,Linear,L,None,16,"Antibacterial, Antifungal",1 % Hemolysis at 44.67 µM,Rabbit,Lyetx I Analogs,"water = Random coil, TFE = α-Helix",Low hemolytic,CHHHHTHHHHTCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
11788,33175610,2021,IWLTKALKFLGKNLGK,IWLTKALKFLGKNLGK{nt:Acet}{ct:Amid},LyeTx I mnΔKAc,Amidation,Acetylation,Linear,L,None,16,"Antibacterial, Antifungal",1 % Hemolysis at 27.44 µM,Rabbit,Lyetx I Analogs,"water = Random coil, TFE = α-Helix",Low hemolytic,CCGGGTSTTSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
11789,33271197,2021,GLFDIIKKIAESF,GLFDIIKKIAESF{ct:Amid},Aurein 1.2,Amidation,Free,Linear,L,None,13,Antibacterial,<5 % Hemolysis at 50 μg/ml,Human,Southern Bell Frog Litoria Aurea And Litoria Raniformis,20 mM phosphate buffer with 10mM SDS = α-Helix,NA,CGGGGGGTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11790,33271197,2021,GLFDIIKKIWESF,GLFDIIKKIWESF{ct:Amid},Aurein M1,Amidation,Free,Linear,L,None,13,Antibacterial,<5 % Hemolysis at 25 μg/ml,Human,Aurein 1.2 Analogs,20 mM phosphate buffer with 10mM SDS = α-Helix,NA,CHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11791,33271197,2021,GLFKIIKKIAKSF,GLFKIIKKIAKSF{ct:Amid},Aurein M2,Amidation,Free,Linear,L,None,13,Antibacterial,<5 % Hemolysis at 100 μg/ml,Human,Aurein 1.2 Analogs,20 mM phosphate buffer with 10mM SDS = α-Helix,NA,CHHHHTHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11792,33271197,2021,GLFKIIKKIWKSF,GLFKIIKKIWKSF{ct:Amid},Aurein M3,Amidation,Free,Linear,L,None,13,Antibacterial,<5 % Hemolysis at 25 μg/ml,Human,Aurein 1.2 Analogs,20 mM phosphate buffer with 10mM SDS = α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11793,33271197,2021,GLFDIIKKIAESF,GLFDIIKKIAESF{ct:Amid},Aurein 1.2,Amidation,Free,Linear,L,None,13,Antibacterial,39.96 % Hemolysis at 200 μg/ml,Human,Southern Bell Frog Litoria Aurea And Litoria Raniformis,20 mM phosphate buffer with 10mM SDS = α-Helix,NA,CCCCCCTTCGGGGGGTSCCCSSSCCCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11794,33271197,2021,GLFDIIKKIWESF,GLFDIIKKIWESF{ct:Amid},Aurein M1,Amidation,Free,Linear,L,None,13,Antibacterial,~50 % Hemolysis at 200 μg/ml,Human,Aurein 1.2 Analogs,20 mM phosphate buffer with 10mM SDS = α-Helix,NA,CTTTSSSSSHHHHHTTHHHHGGGGGGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11795,33271197,2021,GLFKIIKKIAKSF,GLFKIIKKIAKSF{ct:Amid},Aurein M2,Amidation,Free,Linear,L,None,13,Antibacterial,15.48 % Hemolysis at 200 μg/ml,Human,Aurein 1.2 Analogs,20 mM phosphate buffer with 10mM SDS = α-Helix,NA,CCSGGGTTSCCCSSCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11796,33271197,2021,GLFKIIKKIWKSF,GLFKIIKKIWKSF{ct:Amid},Aurein M3,Amidation,Free,Linear,L,None,13,Antibacterial,43.86 % Hemolysis at 200 μg/ml,Human,Aurein 1.2 Analogs,20 mM phosphate buffer with 10mM SDS = α-Helix,NA,CCCCCHHHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11798,33242568,2021,KKCNFFCKLKKKVKSVGSRNLIGSATHHHRIYRV,KKCNFFCKLKKKVKSVGSRNLIGSATHHHRIYRV,PN-CATH1,Free,Free,Linear,L,None,34,"Antibacterial, Antifungal, Anti-biofilm, Anti-inflammatory, anitoxidant",5.9 % Hemolysis at 200 μg/ml,Mouse,"Black-Spotted Frog, Pelophylax Nigromaculata",SDS = α-Helical,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)O
11799,33242568,2021,EGCNILCLLKRKVKAVKNVVKNVVKSVVG,EGCNILCLLKRKVKAVKNVVKNVVKSVVG,PN-CATH2,Free,Free,Linear,L,None,29,"Antibacterial, Antifungal, Anti-biofilm, Anti-inflammatory, anitoxidant",7.5 % Hemolysis at 200 μg/ml,Mouse,"Black-Spotted Frog, Pelophylax Nigromaculata",SDS = α-Helical,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
11800,33807972,2021,LARLRRLCFLWAAAWPWPWR,LARLRRLCFLWAAAWPWPWR,ZM-804,Free,Free,Linear,L,None,20,Antibacterial,10 % Hemolysis at 256 µM,Mouse,Plant Maize Zea Mays B73,α-Helix,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11801,33809374,2021,AIPWIWIWRLLRKG,AIPWIWIWRLLRKG,WWW,Free,Free,Linear,L,None,14,Antibacterial,~34 % Hemolysis at 15 µM,Sheep,Bucathl4B Peptides,phospholipid POPC (1-palmitoyl-2-oleoyl-glycero-3-phosphocholine) = α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
11802,33809374,2021,AIPWIWIWRLLRKG,AIPWIWIWRLLRKG,WWW,Free,Free,Linear,L,None,14,Antibacterial,~15 % Hemolysis at 7.5 µM,Sheep,Variants Of Bucathl-4B,phospholipid POPC (1-palmitoyl-2-oleoyl-glycero-3-phosphocholine) = α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
11803,33809374,2021,AIPZIWIWRLLRKG,AIPZIWIWRLLRKG,Z4,Free,Free,Linear,L,AzAla = Azulenyl-Alanine,14,Antibacterial,~9 % Hemolysis at 15 µM,Sheep,Variants Of Bucathl-4B,phospholipid POPC (1-palmitoyl-2-oleoyl-glycero-3-phosphocholine) = α-Helical,NA,NA,NA
11804,33809374,2021,AIPWIZIWRLLRKG,AIPWIZIWRLLRKG,Z6,Free,Free,Linear,L,AzAla = Azulenyl-Alanine,14,Antibacterial,~14 % Hemolysis at 15 µM,Sheep,Variants Of Bucathl-4B,phospholipid POPC (1-palmitoyl-2-oleoyl-glycero-3-phosphocholine) = α-Helical,NA,NA,NA
11805,33809374,2021,AIPWIWIZRLLRKG,AIPWIWIZRLLRKG,Z8,Free,Free,Linear,L,AzAla = Azulenyl-Alanine,14,Antibacterial,~9 % Hemolysis at 15 µM,Sheep,Variants Of Bucathl-4B,phospholipid POPC (1-palmitoyl-2-oleoyl-glycero-3-phosphocholine) = α-Helical,NA,NA,NA
11806,32889698,2021,A(Nle)WKK(Nle)(Nle)KK(Nle)(Nle)KSAKK(Nle)G,A{nnr:Nle}WKK{nnr:Nle}{nnr:Nle}KK{nnr:Nle}{nnr:Nle}KSAKK{nnr:Nle}G,C18G-Nle,Free,Free,Linear,L,Nle = Norleucine,18,Antibacterial,24 % Hemolysis at 10 µM,Human,Variants Of C18G (Human Platelet Factor Iv Protein),"PBS = Disordered, TFE = α-Helix",NA,NA,NA
11807,32889698,2021,A(Nva)WKK(Nva)(Nva)KK(Nva)(Nva)KSAKK(Nva)G,A{nnr:Nva}WKK{nnr:Nva}{nnr:Nva}KK{nnr:Nva}{nnr:Nva}KSAKK{nnr:Nva}G,C18G-Nva,Free,Free,Linear,L,Nva = Norvaline,18,Antibacterial,<5 % Hemolysis at 10 µM,Human,Variants Of C18G (Human Platelet Factor Iv Protein),"PBS = Disordered, TFE = α-Helix",NA,NA,NA
11808,32889698,2021,A(Cha)WKK(Cha)(Cha)KK(Cha)(Cha)KSAKK(Cha)G,A{nnr:Cha}WKK{nnr:Cha}{nnr:Cha}KK{nnr:Cha}{nnr:Cha}KSAKK{nnr:Cha}G,C18G-Cha,Free,Free,Linear,L,Cha = Cyclohexylalanine,18,Antibacterial,65 % Hemolysis at 10 µM,Human,Variants Of C18G (Human Platelet Factor Iv Protein),"PBS = Disordered, TFE = α-Helix",NA,NA,NA
11809,32889698,2021,A(Abu)WKK(Abu)(Abu)KK(Abu)(Abu)KSAKK(Abu)G,A{nnr:Abu}WKK{nnr:Abu}{nnr:Abu}KK{nnr:Abu}{nnr:Abu}KSAKK{nnr:Abu}G,C18G-Abu,Free,Free,Linear,L,Abu = Aminobutyric,18,Antibacterial,<5 % Hemolysis at 10 µM,Human,Variants Of C18G (Human Platelet Factor Iv Protein),"PBS = Disordered, TFE = α-Helix",NA,NA,NA
11810,32889698,2021,AAWKKAAKKAAKSAKKAG,AAWKKAAKKAAKSAKKAG,C18G-Ala,Free,Free,Linear,L,None,18,Antibacterial,<5 % Hemolysis at 10 µM,Human,Variants Of C18G (Human Platelet Factor Iv Protein),"PBS = Disordered, TFE = α-Helix",NA,NA,C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)O
11811,33206284,2021,MASKRDCNLMKATCAGQAVTYAIHSLLNRLGGDSSDPAGC NDIVRKYCK,MASKRDCNLMKATCAGQAVTYAIHSLLNRLGGDSSDPAGC NDIVRKYCK,C13T,Free,Free,Linear,L,None,49,Antibacterial,15-20 % Hemolysis at 600 µM,Human,Variant Of Ent96,NA,Low hemolytic,CCSCCCCCHHHHTTSCCSHHHHHHHHHHHHTSSCCCCCTTTTHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C=O)CS.CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
11812,33206284,2021,MASKYYGNGVKRDCNLMKACCAGQAVTYAIHSLLNRLGGDSSDPAGCNDIVRKYCK,MASK{ins:YYGNGV}KRDCNLMKACCAGQAVTYAIHSLLNRLGGDSSDPAGCNDIVRKYCK,Ent96-K4_K5insYYGNGV#,Free,Free,Linear,L,diglycosylated,56,Antibacterial,15-20 % Hemolysis at 600 µM,Human,Variant Of Ent96,NA,Low hemolytic,CTHHHHTTTC,NA
11813,33206284,2021,MASKRDCNLMKACCAGQAVTYAIHSLLNRLGGDCSDPAGCNDIVRKYCK,MASKRDCNLMKACCAGQAVTYAIHSLLNRLGGDCSDPAGCNDIVRKYCK,S34C,Free,Free,Linear,L,None,49,Antibacterial,15-20 % Hemolysis at 600 µM,Human,Variant Of Ent96,NA,Low hemolytic,CHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)CC
11814,33206284,2021,MASKACCAGQAVTYAIHSLLNRLGGDSSDPAGCNDIVRKYCK,MASK{del:RDCNLMK}ACCAGQAVTYAIHSLLNRLGGDSSDPAGCNDIVRKYCK,Ent96-R5_K11del#,Free,Free,Linear,L,diglycosylated,42,Antibacterial,15-20 % Hemolysis at 600 µM,Human,Variant Of Ent96,NA,Low hemolytic,CHHHHHTTTC,NA
11815,33206284,2021,MASKRDCNLMKACCAGQAVTYAIHSLLNRLGGDSSGPAGC NDIVRKYCK,MASKRDCNLMKACCAGQAVTYAIHSLLNRLGGDSSGPAGC NDIVRKYCK,D36G,Free,Free,Linear,L,None,49,Antibacterial,15-20 % Hemolysis at 600 µM,Human,Variant Of Ent96,NA,Low hemolytic,CHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C=O)CS.CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
11816,33206284,2021,MASKRDCNLMKACCAEQAVTYAIQSLLNRLGGDSSDPAGCNDIVRKYCK,MASKRDCNLMKACCAEQAVTYAIQSLLNRLGGDSSDPAGCNDIVRKYCK,G16E-H24Q,Free,Free,Linear,L,None,49,Antibacterial,15-20 % Hemolysis at 600 µM,Human,Variant Of Ent96,NA,Low hemolytic,CHHHHGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)CC
11817,33506605,2021,GLLKRIKTLL,GLLKRIKTLL{ct:Amid},Anoplin,Amidation,Free,Linear,L,None,10,"Antibacterial, Antifungal",50 % Hemolysis at >200 μg/ml,Human,Solitary Wasp Anoplius Samariensis,"PBS = Random Coil, SDS = α-Helix",Low hemolytic,CHHHHGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
11818,33506605,2021,GLLKIIKKLL,GLLKIIKKLL{ct:Amid},Ano 1-F,Amidation,Free,Linear,L,None,10,"Antibacterial, Antifungal",50 % Hemolysis at >200 μg/ml,Human,Anoplin Analogs,"PBS = Random Coil, SDS = α-Helix",Low hemolytic,CHHHHGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
11819,33506605,2021,GLLKIIKKLL,GLLKIIKKLL{nt:C8 = octanoic acid}{ct:Amid},Ano 1-C8,Amidation,C8 = octanoic acid,Linear,L,C8 = Octanoic Acid,10,"Antibacterial, Antifungal",50 % Hemolysis at >200 μg/ml,Human,Anoplin Analogs,"PBS = Helical, SDS = α-Helix",Low hemolytic,CTHHHHHHHC,NA
11820,33506605,2021,GLLKIIKKLL,GLLKIIKKLL{nt:C10 = decanoic acid}{ct:Amid},Ano 1-C10,Amidation,C10 = decanoic acid,Linear,L,C10 = decanoic acid,10,"Antibacterial, Antifungal",50 % Hemolysis at 44.6 μg/ml,Human,Anoplin Analogs,"PBS = Helical, SDS = α-Helix",NA,CTHHHHHHHC,NA
11821,33506605,2021,GLKKIIKKLL,#ERROR!,Ano 2-F,Amidation,Free,Linear,L,None,10,"Antibacterial, Antifungal",50 % Hemolysis at >200 μg/ml,Human,Anoplin Analogs,"PBS = Random Coil, SDS = α-Helix",Low hemolytic,CHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
11822,33506605,2021,GLKKIIKKLL,GLKKIIKKLL{nt:C8 = octanoic acid}{ct:Amid},Ano 2-C8,Amidation,C8 = octanoic acid,Linear,L,C8 = Octanoic Acid,10,"Antibacterial, Antifungal",50 % Hemolysis at 80.8 μg/ml,Human,Anoplin Analogs,"PBS = Random Coil, SDS = α-Helix",NA,CHHHHHTTTC,NA
11823,33506605,2021,GLKKIIKKLL,GLKKIIKKLL{nt:C10 = decanoic acid}{ct:Amid},Ano 2-C10,Amidation,C10 = decanoic acid,Linear,L,C10 = decanoic acid,10,"Antibacterial, Antifungal",50 % Hemolysis at 75.5 μg/ml,Human,Anoplin Analogs,"PBS = Random Coil, SDS = α-Helix",NA,CTHHHHTTTC,NA
11824,33506605,2021,GLLKFIKRLL,GLLKFIKRLL{ct:Amid},Ano 3-F,Amidation,Free,Linear,L,None,10,"Antibacterial, Antifungal",50 % Hemolysis at >200 μg/ml,Human,Anoplin Analogs,"PBS = Random Coil, SDS = α-Helix",Low hemolytic,CTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
11825,33506605,2021,GLLKFIKRLL,GLLKFIKRLL{nt:C10 = decanoic acid}{ct:Amid},Ano 3-C10,Amidation,C10 = decanoic acid,Linear,L,C10 = decanoic acid,10,"Antibacterial, Antifungal",50 % Hemolysis at 175.2 μg/ml,Human,Anoplin Analogs,"PBS = Helical, SDS = α-Helix",NA,CTHHHHHHHTSSSSHHHHTTTTTTGGGC,NA
11826,33506605,2021,GLLKKIKRLL,GLLKKIKRLL{ct:Amid},Ano 4-F,Amidation,Free,Linear,L,None,10,"Antibacterial, Antifungal",50 % Hemolysis at >200 μg/ml,Human,Anoplin Analogs,"PBS = Random Coil, SDS = α-Helix",Low hemolytic,CHHHHIIIIIIHHHHTTCTHHHHCGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
11827,33506605,2021,GLLKKIKRLL,GLLKKIKRLL{nt:C10 = decanoic acid}{ct:Amid},Ano 4-C10,Amidation,C10 = decanoic acid,Linear,L,C10 = decanoic acid,10,"Antibacterial, Antifungal",50 % Hemolysis at 44.2 μg/ml,Human,Anoplin Analogs,"PBS = Random Coil, SDS = α-Helix",NA,CGGGGGSTTTC,NA
11828,33506605,2021,GLLKIIKRLL,GLLKIIKRLL{ct:Amid},Ano 5-F,Amidation,Free,Linear,L,None,10,"Antibacterial, Antifungal",50 % Hemolysis at >200 μg/ml,Human,Anoplin Analogs,"PBS = Helical, SDS = α-Helix",Low hemolytic,CHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
11829,33506605,2021,GLLKIIKRLL,GLLKIIKRLL{nt:C10 = decanoic acid}{ct:Amid},Ano 5-C10,Amidation,C10 = decanoic acid,Linear,L,C10 = decanoic acid,10,"Antibacterial, Antifungal",50 % Hemolysis at 68.1 μg/ml,Human,Anoplin Analogs,"PBS = Random Coil, SDS = α-Helix",NA,CCCHHHHHHHHHHHHTTTCC,NA
11832,33917850,2021,KKLFKKILKYL,KKLFKKILKYL{ct:Amid},BP100,Amidation,Free,Linear,L,None,11,Antibacterial,50 % Hemolysis at 163 µM,Human,Combines The Sequence Of Melittin And Cecropin A,α-Helical,NA,CCTHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
11833,33917850,2021,AAKKLFKKILKYL,{conj:Naphthalimide}AAKKLFKKILKYL{ct:Amid},NAPHT-BP100,Amidation,Naphthalimide,Linear,L,None,13,Antibacterial,50 % Hemolysis at 23 µM,Human,Naphthalimide-Conjugated Bp10 Peptide,"aqueous = Random/flexible structure, POPG = α-Helix",NA,CCTHHHHTTTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
11834,33920239,2021,GANAAKKFATIAKKFINYLW,GANAAKKFATIAKKFINYLW,GW-Q4,Free,Free,Linear,L,None,20,Antibacterial,50 % Hemolysis at 128 μg/ml,NA,Synthetic Peptide,NA,NA,CCTHHHHTTTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
11835,33920239,2021,GANAAKKFATIAKKFINYLW,GANAAKKFATIAKKFINYLW{ct:Amid},GW-Q4a,Amidation,Free,Linear,L,None,20,Antibacterial,50 % Hemolysis at 32 μg/ml,NA,Analogs Gw-Q4,NA,NA,CCTHHHHTTTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
11836,33920239,2021,KKFATIAKKFINYLW,KKFATIAKKFINYLW,Q4-15,Free,Free,Linear,L,None,15,Antibacterial,50 % Hemolysis at 128 μg/ml,NA,Derived From Truncation Of Gw-Q4,NA,NA,CCTHHHHTTTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
11837,33920239,2021,KKFATIAKKFINYLW,KKFATIAKKFINYLW{ct:Amid},Q4-15a,Amidation,Free,Linear,L,None,15,Antibacterial,50 % Hemolysis at 16 μg/ml,NA,C-Terminal Amide Derivative Of Q4-15,NA,NA,CCSHHHHGGGTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
11838,33920239,2021,KKFATIAKKFINKLW,KKFATIAKKFINKLW,Q4-15-1,Free,Free,Linear,L,None,15,Antibacterial,50 % Hemolysis at 256 μg/ml,NA,Derived From Q4-15 With A Substitution,NA,Low hemolytic,CCSSSSSSSTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
11839,33920239,2021,KKFATIAKKFINKLW,KKFATIAKKFINKLW{ct:Amid},Q4-15a-1,Amidation,Free,Linear,L,None,15,Antibacterial,50 % Hemolysis at 256 μg/ml,NA,C-Terminal Amide Derivative Of Q4-15-1,NA,Low hemolytic,CCHHHHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
11840,33920239,2021,KKFATIAKKFINWLW,KKFATIAKKFINWLW,Q4-15-2,Free,Free,Linear,L,None,15,Antibacterial,50 % Hemolysis at 32 μg/ml,NA,Derived From Q4-15 With A Substitution,NA,NA,CCHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
11841,33920239,2021,KKFATIAKKFINWLW,KKFATIAKKFINWLW{ct:Amid},Q4-15a-2,Amidation,Free,Linear,L,None,15,Antibacterial,50 % Hemolysis at 16 μg/ml,NA,C-Terminal Amide Derivative Of Q4-15-2,NA,NA,CCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
11849,33676184,2021,KWKLFKKIKFLHSAKKF,KWKLFKKIKFLHSAKKF,CE-MA,Free,Free,Linear,L,None,17,"Antibacterial, Antiviral, Antiparasitic, Antifungal, Anti-cancer",>20 % Hemolysis at 500 μg/ml,Human,Synthetic Peptide Consisting Of Cecropin A And Magenin B,α-Helix,NA,CTHHHHGGGGCCCTTCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11860,33981626,2021,KKLFKKILKYL,KKLFKKILKYL{ct:Amid},BP100,Amidation,Free,Linear,L,None,11,Antibacterial,10 % Hemolysis at 45 µM,Human,Synthetic Peptide,micelles and lipid bilayers = α-Helix,NA,CCCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
11861,33981626,2021,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS,MAG2,Free,Free,Linear,L,None,23,Antibacterial,10 % Hemolysis at >100 µM,Human,Frog Xenopus Laevis,NA,Low hemolytic,CGGGTTTTTTSTTHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
11862,33981626,2021,GMASKAGAIAGKIAKVALKAL,GMASKAGAIAGKIAKVALKAL{ct:Amid},PGLa,Amidation,Free,Linear,L,None,21,Antibacterial,10 % Hemolysis at 16 µM,Human,Frog Xenopus Laevis,NA,NA,CGGGTTTTTTSTTHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)CN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC
11863,33981626,2021,KIAGKIAKIAGKIAKIAGKIA,KIAGKIAKIAGKIAKIAGKIA{ct:Amid},MSI-103,Amidation,Free,Linear,L,None,21,Antibacterial,10 % Hemolysis at 9 µM,Human,Pgla Analog,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
11864,33981626,2021,KLALKLALKALKAALKLA,KLALKLALKALKAALKLA{ct:Amid},MAP,Amidation,Free,Linear,L,None,18,Antibacterial,10 % Hemolysis at 2 µM,Human,Synthetic Peptide,Helical,NA,NA,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
11865,33981626,2021,GRKKRRQRRRPPQ,GRKKRRQRRRPPQ,TAT,Free,Free,Linear,L,None,13,Antibacterial,10 % Hemolysis at >>100 µM,Human,Synthetic Peptide,NA,Low hemolytic,NA,N=C(N)NCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O
11871,34093476,2021,FKFLARTGKFL,FKFLARTGKFL,PN5,Free,Free,Linear,L,None,11,Antibacterial,5 % Hemolysis at 200 μg/ml,Mouse,Pinus Densiflora,α-Helical,Low hemolytic,CCCTTTTTTGGGTC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)O
11872,34073939,2021,GILGKLWEGVKSIF,GILGKLWEGVKSIF{ct:Amid},Hp1404,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiofilm",49.2 % Hemolysis at 50 µM,Mouse,Scorpion Heterometrus Petersii,"10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix",NA,CCCTTTTTTGGGTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)C(C)C
11873,34073939,2021,GILGKLWEGVKSIA,GILGKLWEGVKSIA{ct:Amid},Hp1404-A,Amidation,Free,Linear,L,None,14,Antibacterial,0 % Hemolysis at 50 µM,Mouse,Hp404 Analogs,"10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix",Non-hemolytic,CHHHHHHHTGGGTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC)C(C)C
11874,34073939,2021,GILGKLWEGVKSIK,GILGKLWEGVKSIK{ct:Amid},Hp1404-K,Amidation,Free,Linear,L,None,14,Antibacterial,0 % Hemolysis at 50 µM,Mouse,Hp404 Analogs,"10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix",Non-hemolytic,CCCHHHHGGGGTCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C
11875,34073939,2021,GILGKLWEGVKSIV,GILGKLWEGVKSIV{ct:Amid},Hp1404-V,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiofilm",0 % Hemolysis at 50 µM,Mouse,Hp404 Analogs,"10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix",Non-hemolytic,CCCHHHHGGGGTCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)CC)C(C)C
11876,34073939,2021,GILGKLWEGVKSIL,GILGKLWEGVKSIL{ct:Amid},Hp1404-L,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiofilm",45.8 % Hemolysis at 50 µM,Mouse,Hp404 Analogs,"10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix",NA,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C
11877,34073939,2021,GILGKLWEGVKSIL,GILGKLWEGVKSIL{ct:Amid},Hp1404-L,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiofilm",21.3 % Hemolysis at 25 µM,Mouse,Hp404 Analogs,"10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix",NA,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C
11878,34073939,2021,GILGKLWEGVKSII,GILGKLWEGVKSII{ct:Amid},Hp1404-I,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiofilm",0 % Hemolysis at 25 µM,Mouse,Hp404 Analogs,"10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix",Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)O
11879,34073939,2021,GILGKLWEGVKSIW,GILGKLWEGVKSIW{ct:Amid},Hp1404-W,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiofilm",15.9 % Hemolysis at 50 µM,Mouse,Hp404 Analogs,"10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix",NA,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC)C(C)C
11880,34073939,2021,GILGKLWEGVKSIW,GILGKLWEGVKSIW{ct:Amid},Hp1404-W,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiofilm",1.7 % Hemolysis at 25 µM,Mouse,Hp404 Analogs,"10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix",Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC)C(C)C
11881,34070683,2021,hArg-βNPhe-hArg-βNPhe-hArg-βNPhe-hArg-βNPhehArg-βNPhe-hArg-βNPhe-hArg-βNPhe-hArg-βNPhe,{nnr:hArg}-{nnr:βNPhe}-{nnr:hArg}-{nnr:βNPhe}-{nnr:hArg}-{nnr:βNPhe}-{nnr:hArg}-{nnr:βNPhe}{nnr:hArg}-{nnr:βNPhe}-{nnr:hArg}-{nnr:βNPhe}-{nnr:hArg}-{nnr:βNPhe}-{nnr:hArg}-{nnr:βNPhe}{nt:Acet}{ct:Amid},Subclass I-1,Amidation,Acetylation,Linear,NA,"hArg = homoarginine, βNPhe = N-benzyl-β-alanine",16,Antibacterial,6.1 % Hemolysis at 400 μg/ml,Human,Synthetic Peptide/Β-Peptoid Hybrids,NA,Low hemolytic,NA,NA
11882,34070683,2021,hArg-βNsce-hArg-βNsce-hArg-βNsce-hArg-βNsce-hArg-βNsce-hArg-βNsce,{nnr:hArg}-{nnr:βNsce}-{nnr:hArg}-{nnr:βNsce}-{nnr:hArg}-{nnr:βNsce}-{nnr:hArg}-{nnr:βNsce}-{nnr:hArg}-{nnr:βNsce}-{nnr:hArg}-{nnr:βNsce}{nt:Acet}{ct:Amid},Subclass I-2,Amidation,Acetylation,Linear,NA,"hArg = homoarginine, βNsce = N-(S)-1-cyclohexylethyl-β-alanine",12,Antibacterial,98.4 % Hemolysis at 400 μg/ml,Human,Synthetic Peptide/Β-Peptoid Hybrids,NA,NA,NA,NA
11883,34070683,2021,hArg-βNspe-K-βNspe-hArg-βNspe-K-βNspe-hArg-βNspe-K-βNspe,{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}{nt:SpermineAc = H2N(CH2)3NH(CH2)4NH(CH2)3NHCH2(C=O)-}{ct:Amid},Subclass II-3,Amidation,SpermineAc = H2N(CH2)3NH(CH2)4NH(CH2)3NHCH2(C=O)-,Linear,L,"hArg = homoarginine, βNspe = N-(S)-1-phenylethyl-β-alanine",13,Antibacterial,0.6 % Hemolysis at 400 μg/ml,Human,Synthetic Peptide/Β-Peptoid Hybrids,NA,Non-hemolytic,NA,NA
11884,34070683,2021,hArg-βNspe-K-βNspe-hArg-βNspe-K-βNspe-hArg-βNspe-K-βNspe-hArg-βNspe-K-βNspe,{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}{nt:H}{ct:Amid},Subclass II-4,Amidation,H,Linear,L,"hArg = homoarginine, βNspe = N-(S)-1-phenylethyl-β-alanine",16,Antibacterial,2.6 % Hemolysis at 400 μg/ml,Human,Synthetic Peptide/Β-Peptoid Hybrids,NA,Non-hemolytic,NA,NA
11885,34070683,2021,hArg-βNsce-K-βNspe-hArg-βNsce-K-βNspe-hArg-βNsce-K-βNspe,{nnr:hArg}-{nnr:βNsce}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNsce}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNsce}-K-{nnr:βNspe}{nt:Acet}{ct:Amid},Subclass II-5,Amidation,Acetylation,Linear,L,"hArg = homoarginine, βNspe = N-(S)-1-phenylethyl-β-alanine, βNsce = N-(S)-1-cyclohexylethyl-β-alanine",12,Antibacterial,9.4 % Hemolysis at 400 μg/ml,Human,Synthetic Peptide/Β-Peptoid Hybrids,NA,Low hemolytic,NA,NA
11886,34070683,2021,hArg-βNspe-K-βNspe-hArg-βNspe-K-βNspe-hArg-βNspe-K-βNspe,{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}{nt:Cinn = cinnamoyl}{ct:Amid},Subclass II-6,Amidation,Cinn = cinnamoyl,Linear,L,"hArg = homoarginine, βNspe = N-(S)-1-phenylethyl-β-alanine",13,Antibacterial,15.7 % Hemolysis at 400 μg/ml,Human,Synthetic Peptide/Β-Peptoid Hybrids,NA,Low hemolytic,NA,NA
11887,34070683,2021,K-βNPhe(F)-K-βNPhe(F)-K-βNPhe(F)-K-βNPhe(F)-K-βNPhe(F)-K-βNPhe(F)-K-βNPhe(F)-K-βNPhe(F),K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}{nt:H}{ct:Amid},Subclass III-7,Amidation,H,Linear,L,βNPhe(F) = N-(4-fluorobenzyl)-β-alanine,16,Antibacterial,1.5 % Hemolysis at 400 μg/ml,Human,Synthetic Peptide/Β-Peptoid Hybrids,NA,Non-hemolytic,NA,NA
11888,34070683,2021,K-βNPhe(F3)-K-βNPhe(F3)-K-βNPhe(F3)-K-βNPhe(F3)-K-βNPhe(F3)-K-βNPhe(F3),K-{nnr:βNPhe(F3)}-K-{nnr:βNPhe(F3)}-K-{nnr:βNPhe(F3)}-K-{nnr:βNPhe(F3)}-K-{nnr:βNPhe(F3)}-K-{nnr:βNPhe(F3)}{nt:H}{ct:Amid},Subclass III-8,Amidation,H,Linear,L,"βNPhe(F3) = N-(3,4,5-trifluorobenzyl)-β-alanine",12,Antibacterial,28.8 % Hemolysis at 400 μg/ml,Human,Synthetic Peptide/Β-Peptoid Hybrids,NA,Low hemolytic,NA,NA
11889,34070683,2021,K-βNCha-K-βNCha-K-βNCha-K-βNCha-K-βNCha-K-βNCha-K-βNCha-K-βNCha,K-{nnr:βNCha}-K-{nnr:βNCha}-K-{nnr:βNCha}-K-{nnr:βNCha}-K-{nnr:βNCha}-K-{nnr:βNCha}-K-{nnr:βNCha}-K-{nnr:βNCha}{nt:H}{ct:Amid},Subclass III-9,Amidation,H,Linear,L,βNCha = N-cyclohexylmethyl-β-alanine,16,Antibacterial,23 % Hemolysis at 400 μg/ml,Human,Synthetic Peptide/Β-Peptoid Hybrids,NA,Low hemolytic,NA,NA
11890,34070683,2021,K-βNspe-K-βNspe-K-βNspe-K-βNspe-K-βNspe-K-βNspe,K-{nnr:βNspe}-K-{nnr:βNspe}-K-{nnr:βNspe}-K-{nnr:βNspe}-K-{nnr:βNspe}-K-{nnr:βNspe}{nt:Oct = octanoyl}{ct:Amid},Subclass III-10,Amidation,Oct = octanoyl,Linear,L,βNspe = N-(S)-1-phenylethyl-β-alanine,13,Antibacterial,6.9 % Hemolysis at 400 μg/ml,Human,Synthetic Peptide/Β-Peptoid Hybrids,NA,Low hemolytic,NA,NA
11891,34070683,2021,K-βNPhe-K-βNPhe-K-βNPhe-K-βNPhe-K-βNPhe-K-βNPhe,K-{nnr:βNPhe}-K-{nnr:βNPhe}-K-{nnr:βNPhe}-K-{nnr:βNPhe}-K-{nnr:βNPhe}-K-{nnr:βNPhe}{nt:Lau = lauroyl}{ct:Amid},Subclass III-11,Amidation,Lau = lauroyl,Linear,L,βNPhe = N-benzyl-β-alanine,13,Antibacterial,95.6 % Hemolysis at 400 μg/ml,Human,Synthetic Peptide/Β-Peptoid Hybrids,NA,NA,NA,NA
11909,34158805,2021,PSAWQITKCAGSIAWALGSGIF,PSAWQITKCAGSIAWALGSGIF,CBP22,Free,Free,Linear,L,None,22,Antibacterial,<10 % Hemolysis at 256 μg/ml,Human,Bacteriocin Clostridium Butyricum Zju-F1,NA,Low hemolytic,CCHHHHHHHHHHHHHHHHHHHHHHHHHHTTTTTCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11910,34198776,2021,KKLFKKILKKL,KKLFKKILKKL{ct:Amid},BP16,Amidation,Free,Linear,L,None,11,Antibacterial,3 ± 3.5 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CGGGGTGGGCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
11911,34198776,2021,RINSAKDDAAGLQIA,RINSAKDDAAGLQIA{ct:OH},flg15,OH,Free,Linear,L,None,15,Antibacterial,0 ± 0 % Hemolysis at 375 µM,Horse,Bacterial Flagellin,NA,Non-hemolytic,CGGGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
11912,34198776,2021,RINSAKDDAAGLQIA-KKLFKKILKKL,RINSAKDDAAGLQIA-KKLFKKILKKL{ct:Amid},BP358 (flg15-BP16),Amidation,Free,Linear,L,None,26,Antibacterial,5 ± 0.2 % Hemolysis at 375 µM,Horse,Combination Of Flg15 And Bp16,NA,Low hemolytic,CTTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
11913,34198776,2021,KKLFKKILKKL-RINSAKDDAAGLQIA,KKLFKKILKKL-RINSAKDDAAGLQIA{ct:OH},BP359 (BP16-flg15),OH,Free,Linear,L,None,26,Antibacterial,0.8 ± 0.5 % Hemolysis at 375 µM,Horse,Combination Of Bp16 And Flg15,NA,Non-hemolytic,CCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
11914,33890759,2021,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES{ct:Amid},LL-37,Amidation,Free,Linear,L,None,37,Antibacterial,50 % Hemolysis at 170 µM,Human,Human Cathelicidin Ll-37,Helical,NA,CCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
11915,33890759,2021,KRIWQRIKDFLR,KRIWQRIKDFLR{ct:Amid},KR12,Amidation,Free,Linear,L,None,12,Antibacterial,50 % Hemolysis at >340 µM,Human,Fragement Of Ll-37,NA,Low hemolytic,CGGGGTGGGCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11916,33890759,2021,KRIWQRIKDF,KRIWQRIKDF{nt:C14}{ct:Amid},C14-KR10,Amidation,C14,Linear,L,None,10,Antibacterial,50 % Hemolysis at <25 µM,Human,Synthetic Peptide,NA,NA,CGGGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11917,33890759,2021,KRIWQRIK,KRIWQRIK{nt:C14}{ct:Amid},C14-KR8,Amidation,C14,Linear,L,None,8,Antibacterial,50 % Hemolysis at <25 µM,Human,Synthetic Peptide,NA,NA,CTTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)O
11918,33890759,2021,KRIWQR,KRIWQR{nt:C14}{ct:Amid},C14-KR6,Amidation,C14,Linear,L,None,6,Antibacterial,50 % Hemolysis at <25 µM,Human,Synthetic Peptide,NA,NA,CCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11919,33890759,2021,KRIW,KRIW{nt:C14}{ct:Amid},C14-KR4,Amidation,C14,Linear,L,None,4,Antibacterial,50 % Hemolysis at <25 µM,Human,Synthetic Peptide,NA,NA,CCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
11920,33890759,2021,KRIWQRIKDFLR,KRIWQRIKDFLR{nt:C12}{ct:Amid},C12-KR12,Amidation,C12,Linear,L,None,12,Antibacterial,50 % Hemolysis at <25 µM,Human,Synthetic Peptide,NA,NA,CGGGGTGGGCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11921,33890759,2021,KRIWQRIKDF,KRIWQRIKDF{nt:C12}{ct:Amid},C12-KR10,Amidation,C12,Linear,L,None,10,Antibacterial,50 % Hemolysis at <25 µM,Human,Synthetic Peptide,NA,NA,CGGGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11922,33890759,2021,KRIWQRIK,KRIWQRIK{nt:C12}{ct:Amid},C12-KR8,Amidation,C12,Linear,L,None,8,Antibacterial,50 % Hemolysis at 35 µM,Human,Synthetic Peptide,NA,NA,CTTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)O
11923,33890759,2021,KRIWQR,KRIWQR{nt:C12}{ct:Amid},C12-KR6,Amidation,C12,Linear,L,None,6,Antibacterial,50 % Hemolysis at 75 µM,Human,Synthetic Peptide,NA,NA,CTTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11924,33890759,2021,KRIW,KRIW{nt:C12}{ct:Amid},C12-KR4,Amidation,C12,Linear,L,None,4,Antibacterial,50 % Hemolysis at 30 µM,Human,Synthetic Peptide,NA,NA,CCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
11925,33890759,2021,KRIWQRIKDFLR,KRIWQRIKDFLR{nt:C10}{ct:Amid},C10-KR12,Amidation,C10,Linear,L,None,12,Antibacterial,50 % Hemolysis at <25 µM,Human,Synthetic Peptide,NA,NA,CCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11926,33890759,2021,KRIWQRIKDF,KRIWQRIKDF{nt:C10}{ct:Amid},C10-KR10,Amidation,C10,Linear,L,None,10,Antibacterial,50 % Hemolysis at 50 µM,Human,Synthetic Peptide,NA,NA,CGGGGTGGGCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11927,33890759,2021,KRIWQRIK,KRIWQRIK{nt:C10}{ct:Amid},C10-KR8,Amidation,C10,Linear,L,None,8,Antibacterial,50 % Hemolysis at 300 µM,Human,Synthetic Peptide,Helical,Low hemolytic,CGGGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)O
11928,33890759,2021,kriwqrik,K{d}R{d}I{d}W{d}Q{d}R{d}I{d}K{d}{nt:C10}{ct:Amid},C10-KR8d,Amidation,C10,Linear,D,nter = C10,8,Antibacterial,50 % Hemolysis at 300 µM,Human,Synthetic Peptide,NA,Low hemolytic,CGGGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)O
11929,33890759,2021,KRIWQR,KRIWQR{nt:C10}{ct:Amid},C10-KR6,Amidation,C10,Linear,L,None,6,Antibacterial,50 % Hemolysis at >340 µM,Human,Synthetic Peptide,NA,Low hemolytic,CTTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11930,33890759,2021,KRIW,KRIW{nt:C10}{ct:Amid},C10-KR4,Amidation,C10,Linear,L,None,4,Antibacterial,50 % Hemolysis at 150 µM,Human,Synthetic Peptide,NA,NA,CCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
11931,33890759,2021,KRIWQRIKDFLR,KRIWQRIKDFLR{nt:C8}{ct:Amid},C8-KR12,Amidation,C8,Linear,L,None,12,Antibacterial,50 % Hemolysis at <25 µM,Human,Synthetic Peptide,NA,NA,CCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11932,33890759,2021,KRIWQRIKDF,KRIWQRIKDF{nt:C8}{ct:Amid},C8-KR10,Amidation,C8,Linear,L,None,10,Antibacterial,50 % Hemolysis at 250 µM,Human,Synthetic Peptide,NA,Low hemolytic,CGGGGTGGGCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11933,33890759,2021,kriwqrikdf,K{d}R{d}I{d}W{d}Q{d}R{d}I{d}K{d}D{d}F{d}{nt:C8}{ct:Amid},C8-KR10d,Amidation,C8,Linear,D,nter = C8,10,Antibacterial,50 % Hemolysis at 150 µM,Human,Synthetic Peptide,NA,NA,CGGGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11934,33890759,2021,KRIWQRIK,KRIWQRIK{nt:C8}{ct:Amid},C8-KR8,Amidation,C8,Linear,L,None,8,Antibacterial,50 % Hemolysis at >200 µM,Human,Synthetic Peptide,NA,Low hemolytic,CTTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)O
11935,33890759,2021,KRIWQR,KRIWQR{nt:C8}{ct:Amid},C8-KR6,Amidation,C8,Linear,L,None,6,Antibacterial,50 % Hemolysis at >200 µM,Human,Synthetic Peptide,NA,Low hemolytic,CCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11936,33890759,2021,KRIW,KRIW{nt:C8}{ct:Amid},C8-KR4,Amidation,C8,Linear,L,None,4,Antibacterial,50 % Hemolysis at >200 µM,Human,Synthetic Peptide,NA,Low hemolytic,CCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
11937,33890759,2021,KRIWQRIKDFLR,KRIWQRIKDFLR{nt:C6}{ct:Amid},C6-KR12,Amidation,C6,Linear,L,None,12,Antibacterial,50 % Hemolysis at 25 µM,Human,Synthetic Peptide,NA,NA,CTTTHHHHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11938,33890759,2021,KRIWQRIKDF,KRIWQRIKDF{nt:C6}{ct:Amid},C6-KR10,Amidation,C6,Linear,L,None,10,Antibacterial,50 % Hemolysis at >200 µM,Human,Synthetic Peptide,NA,Low hemolytic,CTTTTTGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11939,33890759,2021,KRIWQRIK,KRIWQRIK{nt:C6}{ct:Amid},C6-KR8,Amidation,C6,Linear,L,None,8,Antibacterial,50 % Hemolysis at >200 µM,Human,Synthetic Peptide,NA,Low hemolytic,CTTTTTTGGGGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)O
11940,33890759,2021,KRIWQR,KRIWQR{nt:C6}{ct:Amid},C6-KR6,Amidation,C6,Linear,L,None,6,Antibacterial,50 % Hemolysis at >200 µM,Human,Synthetic Peptide,NA,Low hemolytic,CTTTTTTGGGGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11941,33890759,2021,KRIW,KRIW{nt:C6}{ct:Amid},C6-KR4,Amidation,C6,Linear,L,None,4,Antibacterial,50 % Hemolysis at >200 µM,Human,Synthetic Peptide,NA,Low hemolytic,CHHHHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
11942,34220763,2021,WKKLKKLLKKLKKL,WKKLKKLLKKLKKL{nt:Acet}{ct:Amid},pepD2,Amidation,Acetylation,Linear,L,None,14,"Antibacterial, Antibiofilm",9.6 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
11943,34220763,2021,WKKLKKLLKKL,WKKLKKLLKKL{nt:Acet}{ct:Amid},pepD3,Amidation,Acetylation,Linear,L,None,14,"Antibacterial, Antibiofilm",3.15 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,PE/PG liposomes = α-Helical,Low hemolytic,CTTTHHHHHHHTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
11944,34220763,2021,WKKVKKVVKKVKKV,WKKVKKVVKKVKKV{nt:Acet}{ct:Amid},pepV2,Amidation,Acetylation,Linear,L,None,14,"Antibacterial, Antibiofilm",0.31 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Non-hemolytic,NA,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)O
11945,34220763,2021,WKKIKKIIKKIKKI,WKKIKKIIKKIKKI{nt:Acet}{ct:Amid},pepI2,Amidation,Acetylation,Linear,L,None,14,"Antibacterial, Antibiofilm",0.27 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
11946,34220763,2021,WRRLRRLLRRLRRL,WRRLRRLLRRLRRL{nt:Acet}{ct:Amid},pepR2,Amidation,Acetylation,Linear,L,None,14,"Antibacterial, Antibiofilm",105.65 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
11947,34220763,2021,WOOLOOLLOOLOOL,W{nnr:O}{nnr:O}L{nnr:O}{nnr:O}LL{nnr:O}{nnr:O}L{nnr:O}{nnr:O}L{nt:Acet}{ct:Amid},pepO2,Amidation,Acetylation,Linear,L,O = L-Ornithine,14,"Antibacterial, Antibiofilm",0.23 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Non-hemolytic,NA,NA
11948,34220763,2021,Wkklkkllkklkkl,WK{d}K{d}L{d}K{d}K{d}L{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}{nt:Acet}{ct:Amid},pepdD2,Amidation,Acetylation,Linear,Mix,None,14,"Antibacterial, Antibiofilm",2.9 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
11949,34220763,2021,WKKLKKLLKKLKKL,WKKLKKLLKKLKKL{nt:Myr = myristyl}{ct:Amid},pepD2M,Amidation,Myr = myristyl,Linear,L,Myr = myristyl,14,"Antibacterial, Antibiofilm",93.63 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Low hemolytic,NA,CSCC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
11950,34220763,2021,WKKLKKLLKKLKKL,WKKLKKLLKKLKKL{nt:Pal = palmitoyl}{ct:Amid},pepD2P,Amidation,Pal = palmitoyl,Linear,L,Pal = palmitoyl,14,"Antibacterial, Antibiofilm",83.45 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)O
11951,34220763,2021,WKKLKKLLKKLKKL,WKKLKKLLKKLKKL{nt:Ste = stearyl}{ct:Amid},pepD2S,Amidation,Ste = stearyl,Linear,L,Ste = stearyl,14,"Antibacterial, Antibiofilm",60.7 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)O
11952,34220763,2021,WKKLKKLLKKL,WKKLKKLLKKL{nt:Oct = octanoyl}{ct:Amid},pepD3O,Amidation,Oct = octanoyl,Linear,L,Oct = octanoyl,11,"Antibacterial, Antibiofilm",86.03 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Low hemolytic,NA,NA
11953,34220763,2021,WKKLKKLLKKL,WKKLKKLLKKL{nt:Hex = hexanoyl}{ct:Amid},pepD3H,Amidation,Hex = hexanoyl,Linear,L,Hex = hexanoyl,11,"Antibacterial, Antibiofilm",54.07 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Low hemolytic,NA,NA
11954,34220763,2021,WKKLKKLLKKL,WKKLKKLLKKL{nt:But = butanoyl}{ct:Amid},pepD3B,Amidation,But = butanoyl,Linear,L,But = butanoyl,11,"Antibacterial, Antibiofilm",7.89 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Low hemolytic,NA,NA
11955,34205705,2021,KKLfKKILKYL,KKLF{d}KKILKYL{nt:C5H11CO}{ct:Amid},BP472,Amidation,C5H11CO,Linear,Mix,nter = C5H11CO,11,"Antifungal, Antibacterial",78 ± 5 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
11956,34205705,2021,KKLfKK(COC3H7)ILKYL,KKL{d}F{d}KK{conj:COC3H7}IL{d}KYL{d}{nt:Acet}{ct:Amid},BP473,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",84 ± 11 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11957,34205705,2021,KKLfKKIK(COC3H7)KYL,KKL{d}F{d}KKIK{conj:COC3H7}KYL{d}{nt:Acet}{ct:Amid},BP474,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",0 ± 0 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,Non-hemolytic,NA,NA
11958,34205705,2021,KKLfKKILKK(COC3H7)L,KKL{d}F{d}KKIL{d}KK{conj:COC3H7}L{d}{nt:Acet}{ct:Amid},BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",0 ± 0 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,α-Helical,Non-hemolytic,NA,NA
11959,34205705,2021,KKLfKKILKYK(COC11H23),KKL{d}F{d}KKIL{d}KYK{conj:COC11H23}{nt:Acet}{ct:Amid},BP476,Amidation,Acetylation,Linear,Mix,COC11H23 = lauroyl,11,"Antifungal, Antibacterial",94 ± 10 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11960,34205705,2021,KKLk(COC5H11)KKILKYL,KKL{d}k{conj:COC5H11}KKIL{d}KYL{d}{nt:Acet}{ct:Amid},BP484,Amidation,Acetylation,Linear,Mix,COC5H11 = hexanoyl,11,"Antifungal, Antibacterial",10 ± 2 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,Non-hemolytic,NA,NA
11961,34205705,2021,KKLfKKILKYL,KKL{d}F{d}{d}KKIL{d}KYL{d}{nt:C3H7CO}{ct:Amid},BP485,Amidation,C3H7CO,Linear,Mix,nter = C3H7CO,11,"Antifungal, Antibacterial",24 ± 9 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
11962,34205705,2021,KK(COC3H7)LfKKILKYL,KK{conj:COC3H7}L{d}F{d}KKIL{d}KYL{d}{nt:Acet}{ct:Amid},BP486,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",14 ± 5 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11963,34205705,2021,KKLk(COC11H23)KKILKYL,KKL{d}k{conj:COC11H23}KKIL{d}KYL{d}{nt:Acet}{ct:Amid},BP488,Amidation,Acetylation,Linear,Mix,COC11H23 = lauroyl,11,"Antifungal, Antibacterial",86 ± 14 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11964,34205705,2021,KKLfKKK(COC11H23)LKYL,KKL{d}F{d}KKK{conj:COC11H23}L{d}KYL{d}{nt:Acet}{ct:Amid},BP489,Amidation,Acetylation,Linear,Mix,COC11H23 = lauroyl,11,"Antifungal, Antibacterial",100 ± 6 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11965,34205705,2021,KKLfKKIK(COC11H23)KYL,KKL{d}F{d}KKIK{conj:COC11H23}KYL{d}{nt:Acet}{ct:Amid},BP490,Amidation,Acetylation,Linear,Mix,COC11H23 = lauroyl,11,"Antifungal, Antibacterial",100 ± 6 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11966,34205705,2021,KKLfKKK(COC5H11)LKYL,KKL{d}F{d}KKK{conj:COC5H11}L{d}KYL{d}{nt:Acet}{ct:Amid},BP494,Amidation,Acetylation,Linear,Mix,COC5H11 = hexanoyl,11,"Antifungal, Antibacterial",0.2 ± 0.2 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,Non-hemolytic,NA,NA
11967,34205705,2021,KKLfKKILKYK(COC5H11),KKL{d}F{d}KKIL{d}KYK{conj:COC5H11}{nt:Acet}{ct:Amid},BP495,Amidation,Acetylation,Linear,Mix,COC5H11 = hexanoyl,11,"Antifungal, Antibacterial",0.6 ± 1 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,Non-hemolytic,NA,NA
11968,34205705,2021,KKLfKKILKYK(COC3H7),KKL{d}F{d}KKIL{d}KYK{conj:COC3H7}{nt:Acet}{ct:Amid},BP496,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",1 ± 1 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,Non-hemolytic,NA,NA
11969,34205705,2021,KKLfKKILK(COC11H23)YL,KKL{d}F{d}KKIL{d}K{conj:COC11H23}YL{d}{nt:Acet}{ct:Amid},BP497,Amidation,Acetylation,Linear,Mix,COC11H23 = lauroyl,11,"Antifungal, Antibacterial",100 ± 2 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11970,34205705,2021,KKLfK(COC3H7)KILKYL,KKL{d}F{d}K{conj:COC3H7}KIL{d}KYL{d}{nt:Acet}{ct:Amid},BP498,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",21 ± 3 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11971,34205705,2021,KKLfKKILK(COC3H7)YL,KKL{d}F{d}KKIL{d}K{conj:COC3H7}YL{d}{nt:Acet}{ct:Amid},BP499,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",11 ± 1 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11972,34205705,2021,KKK(COC11H23)fKKILKYL,KKK{conj:COC11H23}F{d}KKIL{d}KYL{d}{nt:Acet}{ct:Amid},BP500,Amidation,Acetylation,Linear,Mix,COC11H23 = lauroyl,11,"Antifungal, Antibacterial",71 ± 8 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11973,33862164,2021,FWSTLLSIGKSLL,FWSTLLSIGKSLL{ct:Amid},VpCT1,Amidation,Free,Linear,L,None,13,"Antibacterial, Antifungal",50 % Hemolysis at 10.5±0.4 µM,Human,Scorpion Mesomexovis Variegatu,60 % aqueous TFE = α-Helix,NA,CCHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
11974,33862164,2021,FWSTIWNAAKSLI,FWSTIWNAAKSLI{ct:Amid},VpCT2,Amidation,Free,Linear,L,None,13,"Antibacterial, Antifungal",50 % Hemolysis at 10.8±0.4 µM,Human,Scorpion Mesomexovis Variegatu,60 % aqueous TFE = α-Helix,NA,CTTHHHHHHHHHHHSSHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)[C@@H](C)CC)C(=O)O
11975,33862164,2021,FLQGIIDTVGKWL,FLQGIIDTVGKWL{ct:Amid},VpCT3,Amidation,Free,Linear,L,None,13,"Antibacterial, Antifungal",50 % Hemolysis at 83.7±1.8 µM,Human,Scorpion Mesomexovis Variegatu,60 % aqueous TFE = α-Helix,NA,CCHHHHHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)CC
11976,33862164,2021,FLQGIWDTVGKWL,FLQGIWDTVGKWL{ct:Amid},VpCT3W,Amidation,Free,Linear,L,None,13,"Antibacterial, Antifungal",50 % Hemolysis at 37.9±0.4 µM,Human,Scorpion Mesomexovis Variegatu,60 % aqueous TFE = α-Helix,NA,CCCCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O
11977,33862164,2021,FLSKIWDGVKSLL,FLSKIWDGVKSLL{ct:Amid},VpCTConsensus,Amidation,Free,Linear,L,None,13,"Antibacterial, Antifungal",50 % Hemolysis at 4.8±0.7 µM,Human,Scorpion Mesomexovis Variegatu,60 % aqueous TFE = α-Helix,NA,CCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
11978,33862164,2021,LWGALLGLGSTLLSKL,LWGALLGLGSTLLSKL{ct:Amid},VpCT4,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at 39.9±0.4 µM,Human,Scorpion Mesomexovis Variegatu,60 % aqueous TFE = α-Helix,NA,CCCCSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)O
11979,33972716,2021,IWLTALKFLGKNLGKHLAKQQLAKL,IWLTALKFLGKNLGKHLAKQQLAKL{nt:H}{ct:Amid},LyeTx I,Amidation,H,Linear,L,None,25,"Antibacterial, Antifungal",50 % Hemolysis at 32.35 µM,Human,Lycosa Erythrognatha Spider Venom,NA,NA,CCHHHHHHHTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
11980,33972716,2021,IWLTKALKFLGKNLGK,IWLTKALKFLGKNLGK{nt:H}{ct:Amid},LyeTx I mnΔK,Amidation,H,Linear,L,None,16,"Antibacterial, Antifungal",50 % Hemolysis at 55.31 ± 5 µM,Human,Lycosa Erythrognatha Spider Venom,NA,NA,CHHHHHHHHTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
11984,34335511,2021,FIGAIARLLSKIF,FIGAIARLLSKIF,BmKn2,Free,Free,Linear,L,None,13,Antibacterial,91.8 % Hemolysis at 25 μg/ml,Human,Scorpion Mesobuthus Martensii Karsch,α-Helical,NA,CHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11985,34335511,2021,FIKAIARLLSKIF,FIKAIARLLSKIF,Kn2(G3K),Free,Free,Linear,L,None,13,Antibacterial,69 % Hemolysis at 25 μg/ml,Human,Mutant Of Bmkn2-7,NA,NA,CCHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11986,34335511,2021,FIGRIARLLSKIF,FIGRIARLLSKIF,Kn2(A4R),Free,Free,Linear,L,None,13,Antibacterial,100 % Hemolysis at 25 μg/ml,Human,Mutant Of Bmkn2-7,NA,NA,CHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11987,34335511,2021,FIGAIARLLRKIF,FIGAIARLLRKIF,Kn2(S10R),Free,Free,Linear,L,None,13,Antibacterial,50.9 % Hemolysis at 25 μg/ml,Human,Mutant Of Bmkn2-7,NA,NA,CTTHHHHHHHHHHHTTHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11988,34335511,2021,FIKRIARLLSKIF,FIKRIARLLSKIF,Kn2(G3K_A4R),Free,Free,Linear,L,None,13,Antibacterial,8.3 % Hemolysis at 25 μg/ml,Human,Mutant Of Bmkn2-7,NA,NA,CTTTHHHHHHHTTTCCSTHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11989,34335511,2021,FIKAIARLLRKIF,FIKAIARLLRKIF,Kn2(G3K_S10R),Free,Free,Linear,L,None,13,Antibacterial,77.5 % Hemolysis at 25 μg/ml,Human,Mutant Of Bmkn2-7,NA,NA,CGGGHHHHHHHHTCHHHHTHHHHTHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11990,34335511,2021,FIGRIARLLRKIF,FIGRIARLLRKIF,Kn2(A4R_S10R),Free,Free,Linear,L,None,13,Antibacterial,18 % Hemolysis at 25 μg/ml,Human,Mutant Of Bmkn2-7,NA,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11991,34335511,2021,FIKRIARLLRKIF,FIKRIARLLRKIF,BmKn2-7,Free,Free,Linear,L,None,13,Antibacterial,6.9 % Hemolysis at 25 μg/ml,Human,Mutant Of Bmkn2-7,"aqueous = Random coil, 30% or 70% TFE solutions = α-Helical",NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11992,34301247,2021,FKRIVQRIKRFLRFKRIVQRIKRFLR,FKRIVQRIKRFLRFKRIVQRIKRFLR,(FR)2,Free,Free,Linear,L,None,26,Antibacterial,20 % Hemolysis at 16 µM,Human,Synthetic Peptide,NA,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11993,34301247,2021,FKRIVQRIKRFLRGGGGSFKRIVQRIKRFLR,FKRIVQRIKRFLRGGGGSFKRIVQRIKRFLR,LG,Free,Free,Linear,L,None,31,Antibacterial,20 % Hemolysis at 64 µM,Human,Synthetic Peptide,NA,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11994,34301247,2021,FKRIVQRIKRFLRAEAAAKAFKRIVQRIKRFLR,FKRIVQRIKRFLRAEAAAKAFKRIVQRIKRFLR,LA,Free,Free,Linear,L,None,33,Antibacterial,20 % Hemolysis at 32 µM,Human,Synthetic Peptide,NA,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12035,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLVGANA,ALWMTLLKKVLKAAAKAALNAVLVGANA,DS4 (1–28) dermaseptin S4 (DS4),Free,Free,Linear,L,None,28,"Antibacterial, Anti-proliferative on SW620 colon cancer",54.2±5.43 % Hemolysis at 8 μg/ml,Human,Frog Skin Of Phyllomedusa Sauvagii,lipid bilayers = amphipathic α-Helical,NA,CHHHHHHHHHHHHHHHHHHHHSCCCCCC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12036,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLVGANA,ALWMTLLKKVLKAAAKAALNAVLVGANA,DS4 (1–28) dermaseptin S4 (DS4),Free,Free,Linear,L,None,28,"Antibacterial, Anti-proliferative on SW620 colon cancer",60±3.94 % Hemolysis at 16 μg/ml,Human,Frog Skin Of Phyllomedusa Sauvagii,lipid bilayers = amphipathic α-Helical,NA,CHHHHHHHHHHHHHHHHHHHHSCCCCCC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12037,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLVGANA,ALWMTLLKKVLKAAAKAALNAVLVGANA,DS4 (1–28) dermaseptin S4 (DS4),Free,Free,Linear,L,None,28,"Antibacterial, Anti-proliferative on SW620 colon cancer",65.7±4.57 % Hemolysis at 32 μg/ml,Human,Frog Skin Of Phyllomedusa Sauvagii,lipid bilayers = amphipathic α-Helical,NA,CHHHHHHHHHHHHHHHHHHHHSCCCCCC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12038,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLVGANA,ALWMTLLKKVLKAAAKAALNAVLVGANA,DS4 (1–28) dermaseptin S4 (DS4),Free,Free,Linear,L,None,28,"Antibacterial, Anti-proliferative on SW620 colon cancer",85.7±7.6 % Hemolysis at 64 μg/ml,Human,Frog Skin Of Phyllomedusa Sauvagii,lipid bilayers = amphipathic α-Helical,NA,CHHHHHHHHHHHHHHHHHHHHSCCCCCC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12039,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLVGANA,ALWMTLLKKVLKAAAKAALNAVLVGANA,DS4 (1–28) dermaseptin S4 (DS4),Free,Free,Linear,L,None,28,"Antibacterial, Anti-proliferative on SW620 colon cancer",85.7±9.28 % Hemolysis at 128 μg/ml,Human,Frog Skin Of Phyllomedusa Sauvagii,lipid bilayers = amphipathic α-Helical,NA,CHHHHHHHHHHHHHHHHHHHHSCCCCCC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12040,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLVGANA,ALWMTLLKKVLKAAAKAALNAVLVGANA,DS4 (1–28) dermaseptin S4 (DS4),Free,Free,Linear,L,None,28,"Antibacterial, Anti-proliferative on SW620 colon cancer",80±3.32 % Hemolysis at 256 μg/ml,Human,Frog Skin Of Phyllomedusa Sauvagii,lipid bilayers = amphipathic α-Helical,NA,CHHHHHHHHHHHHHHHHHHHHSCCCCCC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12041,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLVGANA,ALWMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (1–28)a,Amidation,Free,Linear,L,None,28,"Antibacterial, Anti-proliferative on SW620 colon cancer",0 % Hemolysis at 8 μg/ml,Human,Analogs Of Ds4,NA,Non-hemolytic,CHHHHHHHHHHHHHHHHHHHHSCCCCCC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12042,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLVGANA,ALWMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (1–28)a,Amidation,Free,Linear,L,None,28,"Antibacterial, Anti-proliferative on SW620 colon cancer",2.8±0.86 % Hemolysis at 16 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHTTSSCCCC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12043,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLVGANA,ALWMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (1–28)a,Amidation,Free,Linear,L,None,28,"Antibacterial, Anti-proliferative on SW620 colon cancer",22.8±4.88 % Hemolysis at 32 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHTTSSCCCC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12044,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLVGANA,ALWMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (1–28)a,Amidation,Free,Linear,L,None,28,"Antibacterial, Anti-proliferative on SW620 colon cancer",31.4±4.28 % Hemolysis at 64 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHTTSSCCCC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12045,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLVGANA,ALWMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (1–28)a,Amidation,Free,Linear,L,None,28,"Antibacterial, Anti-proliferative on SW620 colon cancer",51.4±6.05 % Hemolysis at 128 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHTTSSCCCC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12046,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLVGANA,ALWMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (1–28)a,Amidation,Free,Linear,L,None,28,"Antibacterial, Anti-proliferative on SW620 colon cancer",68.5±10.83 % Hemolysis at 256 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHTTSSCCCC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12047,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLVGA,ALWMTLLKKVLKAAAKAALNAVLVGA{ct:Amid},DS4 (1–26)a,Amidation,Free,Linear,L,None,26,"Antibacterial, Anti-proliferative on SW620 colon cancer",28.5±5.01 % Hemolysis at 8 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHTTSSCCCC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12048,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLVGA,ALWMTLLKKVLKAAAKAALNAVLVGA{ct:Amid},DS4 (1–26)a,Amidation,Free,Linear,L,None,26,"Antibacterial, Anti-proliferative on SW620 colon cancer",31.4±5.98 % Hemolysis at 16 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHTTTTTC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12049,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLVGA,ALWMTLLKKVLKAAAKAALNAVLVGA{ct:Amid},DS4 (1–26)a,Amidation,Free,Linear,L,None,26,"Antibacterial, Anti-proliferative on SW620 colon cancer",54.2±6.91 % Hemolysis at 32 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHTTTTTC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12050,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLVGA,ALWMTLLKKVLKAAAKAALNAVLVGA{ct:Amid},DS4 (1–26)a,Amidation,Free,Linear,L,None,26,"Antibacterial, Anti-proliferative on SW620 colon cancer",65.7±7.01 % Hemolysis at 64 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHTTTTTC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12051,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLVGA,ALWMTLLKKVLKAAAKAALNAVLVGA{ct:Amid},DS4 (1–26)a,Amidation,Free,Linear,L,None,26,"Antibacterial, Anti-proliferative on SW620 colon cancer",68.5±5.1 % Hemolysis at 128 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHTTTTTC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12052,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLVGA,ALWMTLLKKVLKAAAKAALNAVLVGA{ct:Amid},DS4 (1–26)a,Amidation,Free,Linear,L,None,26,"Antibacterial, Anti-proliferative on SW620 colon cancer",74.2±5.82 % Hemolysis at 256 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHTTTTTC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12053,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLV,ALWMTLLKKVLKAAAKAALNAVLV{ct:Amid},DS4 (1–24)a,Amidation,Free,Linear,L,None,24,"Antibacterial, Anti-proliferative on SW620 colon cancer",2.8±1.03 % Hemolysis at 8 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHTTTTTC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12054,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLV,ALWMTLLKKVLKAAAKAALNAVLV{ct:Amid},DS4 (1–24)a,Amidation,Free,Linear,L,None,24,"Antibacterial, Anti-proliferative on SW620 colon cancer",11.4±2.8 % Hemolysis at 16 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHHHHC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12055,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLV,ALWMTLLKKVLKAAAKAALNAVLV{ct:Amid},DS4 (1–24)a,Amidation,Free,Linear,L,None,24,"Antibacterial, Anti-proliferative on SW620 colon cancer",31.4±3.83 % Hemolysis at 32 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHHHHC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12056,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLV,ALWMTLLKKVLKAAAKAALNAVLV{ct:Amid},DS4 (1–24)a,Amidation,Free,Linear,L,None,24,"Antibacterial, Anti-proliferative on SW620 colon cancer",40±3.5 % Hemolysis at 64 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHHHHC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12057,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLV,ALWMTLLKKVLKAAAKAALNAVLV{ct:Amid},DS4 (1–24)a,Amidation,Free,Linear,L,None,24,"Antibacterial, Anti-proliferative on SW620 colon cancer",51.4±8.1 % Hemolysis at 128 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHHHHC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12058,33774792,2021,ALWMTLLKKVLKAAAKAALNAVLV,ALWMTLLKKVLKAAAKAALNAVLV{ct:Amid},DS4 (1–24)a,Amidation,Free,Linear,L,None,24,"Antibacterial, Anti-proliferative on SW620 colon cancer",57.1±6.34 % Hemolysis at 256 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHHHHC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12059,33774792,2021,ALWMTLLKKVLKAAAKAALNAV,ALWMTLLKKVLKAAAKAALNAV{ct:Amid},DS4 (1–22)a,Amidation,Free,Linear,L,None,24,"Antibacterial, Anti-proliferative on SW620 colon cancer",5.7±1.21 % Hemolysis at 8 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHHHHC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
12060,33774792,2021,ALWMTLLKKVLKAAAKAALNAV,ALWMTLLKKVLKAAAKAALNAV{ct:Amid},DS4 (1–22)a,Amidation,Free,Linear,L,None,22,"Antibacterial, Anti-proliferative on SW620 colon cancer",31.4±3.8 % Hemolysis at 16 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHHSCSSCCC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
12061,33774792,2021,ALWMTLLKKVLKAAAKAALNAV,ALWMTLLKKVLKAAAKAALNAV{ct:Amid},DS4 (1–22)a,Amidation,Free,Linear,L,None,22,"Antibacterial, Anti-proliferative on SW620 colon cancer",40±5.06 % Hemolysis at 32 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHHSCSSCCC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
12062,33774792,2021,ALWMTLLKKVLKAAAKAALNAV,ALWMTLLKKVLKAAAKAALNAV{ct:Amid},DS4 (1–22)a,Amidation,Free,Linear,L,None,22,"Antibacterial, Anti-proliferative on SW620 colon cancer",54.2±4.41 % Hemolysis at 64 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHHSCSSCCC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
12063,33774792,2021,ALWMTLLKKVLKAAAKAALNAV,ALWMTLLKKVLKAAAKAALNAV{ct:Amid},DS4 (1–22)a,Amidation,Free,Linear,L,None,22,"Antibacterial, Anti-proliferative on SW620 colon cancer",68.5±7.85 % Hemolysis at 128 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHHSCSSCCC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
12064,33774792,2021,ALWMTLLKKVLKAAAKAALNAV,ALWMTLLKKVLKAAAKAALNAV{ct:Amid},DS4 (1–22)a,Amidation,Free,Linear,L,None,22,"Antibacterial, Anti-proliferative on SW620 colon cancer",80±1.12 % Hemolysis at 256 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHHHSCSSCCC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
12065,33774792,2021,WMTLLKKVLKAAAKAALNAVLVGANA,WMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (3–28)a,Amidation,Free,Linear,L,None,26,"Antibacterial, Anti-proliferative on SW620 colon cancer",0 % Hemolysis at 8 μg/ml,Human,Analogs Of Ds4,NA,Non-hemolytic,CHHHHHHHHHHHHHHHHHHSCSSCCC,CSCC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12066,33774792,2021,WMTLLKKVLKAAAKAALNAVLVGANA,WMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (3–28)a,Amidation,Free,Linear,L,None,26,"Antibacterial, Anti-proliferative on SW620 colon cancer",25.7±5.81 % Hemolysis at 16 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHSCCCCCC,CSCC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12067,33774792,2021,WMTLLKKVLKAAAKAALNAVLVGANA,WMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (3–28)a,Amidation,Free,Linear,L,None,26,"Antibacterial, Anti-proliferative on SW620 colon cancer",40±5.25 % Hemolysis at 32 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHSCCCCCC,CSCC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12068,33774792,2021,WMTLLKKVLKAAAKAALNAVLVGANA,WMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (3–28)a,Amidation,Free,Linear,L,None,26,"Antibacterial, Anti-proliferative on SW620 colon cancer",48.5±9.3 % Hemolysis at 64 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHSCCCCCC,CSCC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12069,33774792,2021,WMTLLKKVLKAAAKAALNAVLVGANA,WMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (3–28)a,Amidation,Free,Linear,L,None,26,"Antibacterial, Anti-proliferative on SW620 colon cancer",57.1±7.45 % Hemolysis at 128 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHSCCCCCC,CSCC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12070,33774792,2021,WMTLLKKVLKAAAKAALNAVLVGANA,WMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (3–28)a,Amidation,Free,Linear,L,None,26,"Antibacterial, Anti-proliferative on SW620 colon cancer",68.5±7.58 % Hemolysis at 256 μg/ml,Human,Analogs Of Ds4,NA,NA,CHHHHHHHHHHHHHHHHSCCCCCC,CSCC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12071,33774792,2021,TLLKKVLKAAAKAALNAVLVGANA,TLLKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (5–28)a,Amidation,Free,Linear,L,None,24,"Antibacterial, Anti-proliferative on SW620 colon cancer",0 % Hemolysis at 8 μg/ml,Human,Analogs Of Ds4,NA,Non-hemolytic,CHHHHHHHHHHHHHHHHSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
12072,33774792,2021,TLLKKVLKAAAKAALNAVLVGANA,TLLKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (5–28)a,Amidation,Free,Linear,L,None,24,"Antibacterial, Anti-proliferative on SW620 colon cancer",5.7±3.14 % Hemolysis at 16 μg/ml,Human,Analogs Of Ds4,NA,NA,CGGGHHHHHHHHTTTSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
12073,33774792,2021,TLLKKVLKAAAKAALNAVLVGANA,TLLKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (5–28)a,Amidation,Free,Linear,L,None,24,"Antibacterial, Anti-proliferative on SW620 colon cancer",8.5±2.79 % Hemolysis at 32 μg/ml,Human,Analogs Of Ds4,NA,NA,CGGGHHHHHHHHTTTSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
12074,33774792,2021,TLLKKVLKAAAKAALNAVLVGANA,TLLKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (5–28)a,Amidation,Free,Linear,L,None,24,"Antibacterial, Anti-proliferative on SW620 colon cancer",34.2±4.43 % Hemolysis at 64 μg/ml,Human,Analogs Of Ds4,NA,NA,CGGGHHHHHHHHTTTSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
12075,33774792,2021,TLLKKVLKAAAKAALNAVLVGANA,TLLKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (5–28)a,Amidation,Free,Linear,L,None,24,"Antibacterial, Anti-proliferative on SW620 colon cancer",54.2±6.9 % Hemolysis at 128 μg/ml,Human,Analogs Of Ds4,NA,NA,CGGGHHHHHHHHTTTSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
12076,33774792,2021,TLLKKVLKAAAKAALNAVLVGANA,TLLKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (5–28)a,Amidation,Free,Linear,L,None,24,"Antibacterial, Anti-proliferative on SW620 colon cancer",57.1±7.64 % Hemolysis at 256 μg/ml,Human,Analogs Of Ds4,NA,NA,CGGGHHHHHHHHTTTSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
12077,33774792,2021,LKKVLKAAAKAALNAVLVGANA,LKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (7–28)a,Amidation,Free,Linear,L,None,22,"Antibacterial, Anti-proliferative on SW620 colon cancer",0 % Hemolysis at 8 μg/ml,Human,Analogs Of Ds4,NA,Non-hemolytic,CGGGHHHHHHHHTTTSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
12078,33774792,2021,LKKVLKAAAKAALNAVLVGANA,LKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (7–28)a,Amidation,Free,Linear,L,None,22,"Antibacterial, Anti-proliferative on SW620 colon cancer",0 % Hemolysis at 16 μg/ml,Human,Analogs Of Ds4,NA,Non-hemolytic,CCSSSSSSSCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
12079,33774792,2021,LKKVLKAAAKAALNAVLVGANA,LKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (7–28)a,Amidation,Free,Linear,L,None,22,"Antibacterial, Anti-proliferative on SW620 colon cancer",3.2±0.62 % Hemolysis at 32 μg/ml,Human,Analogs Of Ds4,NA,NA,CCCHHHHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
12080,33774792,2021,LKKVLKAAAKAALNAVLVGANA,LKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (7–28)a,Amidation,Free,Linear,L,None,22,"Antibacterial, Anti-proliferative on SW620 colon cancer",6.4±1.74 % Hemolysis at 64 μg/ml,Human,Analogs Of Ds4,NA,NA,CCGGGSHHHHHHHHHHTTC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
12081,33774792,2021,LKKVLKAAAKAALNAVLVGANA,LKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (7–28)a,Amidation,Free,Linear,L,None,22,"Antibacterial, Anti-proliferative on SW620 colon cancer",6.4±2.88 % Hemolysis at 128 μg/ml,Human,Analogs Of Ds4,NA,NA,CCSSSHHHHHHHHHHHHHHHHHCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
12082,33774792,2021,LKKVLKAAAKAALNAVLVGANA,LKKVLKAAAKAALNAVLVGANA{ct:Amid},DS4 (7–28)a,Amidation,Free,Linear,L,None,22,"Antibacterial, Anti-proliferative on SW620 colon cancer",35.4±6.28 % Hemolysis at 256 μg/ml,Human,Analogs Of Ds4,NA,NA,CCSSGGGCCCCCCCCBTTTBSCCCTTTTCSSCCTTHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
12095,34129853,2021,INWKGIAAMAKRLL,INWKGIAAMAKRLL,Vp1b,Free,Free,Linear,L,None,14,"Antioxidant, Antibacterial",4.08 % Hemolysis at 120 µM,mouse,Asian Hornet Vespa Velutina,NA,Non-hemolytic,CCHHHHHHHHHHHHHHHHHHHHHHHHHHTTTTTCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
12096,34129853,2021,FFPIIAKLLGGFLGKK,FFPIIAKLLGGFLGKK,Vp2a,Free,Free,Linear,L,None,16,"Antioxidant, Antibacterial",3.46 % Hemolysis at 120 µM,mouse,Asian Hornet Vespa Velutina,NA,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
12098,34282000,2021,RLELITTGGQKIGEKIRRIGQRIKDFFKNLQPREEKS,RLELITTGGQKIGEKIRRIGQRIKDFFKNLQPREEKS,K9CATH,Free,Free,Linear,L,None,37,"Antibacterial, Anti-inflammatory",>40 % Hemolysis at 80 µM,Human,Cathelicidin In Canines (Dogs),0.1% SDS or 50 μM LPS = α-Helical,NA,CCSCTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
12099,34282000,2021,(Cit)LKELITTGGQKIGEKI(Cit)(Cit)IGQ(Cit)IKDFFKNLQP(Cit)EEKS,{nnr:Cit}LKELITTGGQKIGEKI{nnr:Cit}{nnr:Cit}IGQ{nnr:Cit}IKDFFKNLQP{nnr:Cit}EEKS,K9CATHCit5,Free,Free,Linear,L,Cit = citrulline,38,Antibacterial,0 % Hemolysis at 80 µM,Human,Cathelicidins Modified K9Cath,0.1% SDS or 50 μM LPS = α-Helical,Non-hemolytic,NA,NA
12100,34282000,2021,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL-37,Free,Free,Linear,L,None,37,Antibacterial,>25 % Hemolysis at 80 µM,Human,Human Cathelicidin Hcap18,α-Helical,NA,CCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
12107,34180670,2021,GLLKRIKTLL,GLLKRIKTLL,anoplin,Free,Free,Linear,L,None,10,"Antibacterial, Anti-biofilm",10 % Hemolysis at ≥512 µM,Human,Venom Of Wasps (Anoplius Samariensis),α-Helical,Non-hemolytic,CGGGTGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
12108,34180670,2021,GAAKRAKTAA,GAAKRAKTAA,A-1,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at ≥512 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",Non-hemolytic,CHHHHHTTTC,C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)C(=O)O
12109,34180670,2021,GAAKRAKTAL,GAAKRAKTAL,A-2,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at ≥512 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",Non-hemolytic,CTTSSSCCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)C(=O)O
12110,34180670,2021,GALKRAKTAL,GALKRAKTAL,A-3,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at ≥512 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",Non-hemolytic,CBCSSSBCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)C(=O)O
12111,34180670,2021,GLAKRAKTLL,GLAKRAKTLL,A-4,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at ≥512 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",Non-hemolytic,CTHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)C(=O)O
12112,34180670,2021,GLLKRLKTLA,GLLKRLKTLA,A-5,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at ≥512 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",Non-hemolytic,CGGGGGGGTC,CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O
12113,34180670,2021,GLLKRFKTLL,GLLKRFKTLL,A-6,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at ≥512 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",Non-hemolytic,CCSTTGGGTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)C(=O)O
12114,34180670,2021,GWFKRIKTFW,GWFKRIKTFW,A-7,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at 384 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",Low hemolytic,CCSSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O
12115,34180670,2021,GWWKRWKTWW,GWWKRWKTWW,A-8,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at 40.79 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",NA,CGGGGCCCCC,C[C@@H](O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12116,34180670,2021,GFLKRFKTLF,GFLKRFKTLF,A-9,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at 384 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",Low hemolytic,CTTSSCCCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
12117,34180670,2021,GLLKRWKTLL,GLLKRWKTLL,A-10,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at ≥512 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",Non-hemolytic,CTHHHHTTCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)C(=O)O
12118,34180670,2021,GFFKRWKTFF,GFFKRWKTFF,A-11,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at ≥512 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",Non-hemolytic,CTHHHHTTCC,C[C@@H](O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12119,34180670,2021,GWLKRWKTLW,GWLKRWKTLW,A-12,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at 320 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",Low hemolytic,CGGGTTTTCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O
12120,34180670,2021,GWWKRIKTWW,GWWKRIKTWW,A-13,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at 102.54 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",NA,CCGGGGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O
12121,34180670,2021,GIRWKFWKFT,GIRWKFWKFT,A-14,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at ≥512 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",Non-hemolytic,CGGGGGGGTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O
12122,34180670,2021,KWFKRIKTFW,KWFKRIKTFW,A-15,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at ≥512 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",Non-hemolytic,CHHHHTTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O
12123,34180670,2021,GLWKRWKKFW,GLWKRWKKFW,A-16,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at 83.63 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",NA,CCHHHHTTCC,CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12124,34180670,2021,KWWKRWKKWW,KWWKRWKKWW,A-17,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at 77.65 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",NA,CCHHHHTTCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12125,34180670,2021,GFFRRIKTFF,GFFRRIKTFF,A-18,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at ≥512 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",Non-hemolytic,CCCCCCSCCCCCCCSSCCCCCCSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
12126,34180670,2021,GFFKRIRTFF,GFFKRIRTFF,A-19,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at ≥512 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
12127,34180670,2021,GFFRRIRTFF,GFFRRIRTFF,A-20,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at ≥512 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
12128,34180670,2021,KWWKKWKKWW,KWWKKWKKWW,A-21,Free,Free,Linear,L,None,10,"Antibacterial, Anti-biofilm",10 % Hemolysis at 134.38 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",NA,NA,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12129,34180670,2021,RWWRRWRRWW,RWWRRWRRWW,A-22,Free,Free,Linear,L,None,10,Antibacterial,10 % Hemolysis at 43.67 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",NA,NA,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12131,34342438,2021,OPFTOAQWFAIQHISPOTIAMOAINNYOWO,{nnr:O}PFT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O},Orn analog,Free,Free,Linear,L,O = L-Ornithine,30,Antibacterial,10 ± 2 % Hemolysis at 250 µM,Horse,Hecp30 Analogs,"aqueous = Random coil, SDS micelles (1 mM) = α-Helical",NA,NA,NA
12132,34342438,2021,XPFTXAQWFAIQHISPXTIAMXAINNYXWX,{nnr:X}PFT{nnr:X}AQWFAIQHISP{nnr:X}TIAM{nnr:X}AINNY{nnr:X}W{nnr:X},Dab analog,Free,Free,Linear,L,"X = L-2,4-diaminobutyric acid",30,Antibacterial,14 ± 6 % Hemolysis at 250 µM,Horse,Hecp30 Analogs,NA,NA,NA,NA
12133,34342438,2021,ZPFTZAQWFAIQHISPZTIAMZAINNYZWZ,{nnr:Z}PFT{nnr:Z}AQWFAIQHISP{nnr:Z}TIAM{nnr:Z}AINNY{nnr:Z}W{nnr:Z},Har analog,Free,Free,Linear,L,Z = L-homoarginine,30,Antibacterial,43 ± 1 % Hemolysis at 250 µM,Horse,Hecp30 Analogs,NA,NA,NA,NA
12134,34342438,2021,FTOAQWFAIQHISPOTIAMOAINNYOWO,FT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O},Des[Orn1-Pro2] analog,Free,Free,Linear,L,O = L-Ornithine,28,Antibacterial,11 ± 4 % Hemolysis at 250 µM,Horse,Hecp30 Analogs,NA,NA,NA,NA
12135,34342438,2021,OpFTOAQWFAIQHISPOTIAMOAINNYOWO,{nnr:O}P{d}FT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O},"[Orn,1D-Pro2] analog",Free,Free,Linear,Mix,"O = L-Ornithine, p = D-Proline",30,Antibacterial,1.1 ± 0.9 % Hemolysis at 250 µM,Horse,Hecp30 Analogs,"aqueous = Random coil, SDS micelles (1 mM) = α-Helical",Low hemolytic,NA,NA
12136,34342438,2021,opFTOAQWFAIQHISPOTIAMOAINNYOWO,{nnr:o}P{d}FT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O},"[D-Orn,1D-Pro2] analog",Free,Free,Linear,Mix,"o = D-Ornithine, p = D-Proline",30,Antibacterial,3.6 ± 0.7 % Hemolysis at 250 µM,Horse,Hecp30 Analogs,"aqueous = Random coil, SDS micelles (1 mM) = α-Helical",Low hemolytic,NA,NA
12137,34227804,2021,NLys-F-NLys-F-NLys-F-NLys-F-NLys-F-NLys-F,{nnr:NLys}-F-{nnr:NLys}-F-{nnr:NLys}-F-{nnr:NLys}-F-{nnr:NLys}-F-{nnr:NLys}-F{nt:H}{ct:Amid},CEP-124,Amidation,H,Linear,L,NLys = N-(4-aminobutyl)glycine,12,Antibacterial,2.7 % Hemolysis at 400 μg/ml,Human,Synthetic Peptidomimetics,NA,Low hemolytic,NA,NA
12138,34227804,2021,NLys-L-NLys-L-NLys-L-NLys-L-NLys-L-NLys-L,{nnr:NLys}-L-{nnr:NLys}-L-{nnr:NLys}-L-{nnr:NLys}-L-{nnr:NLys}-L-{nnr:NLys}-L{nt:H}{ct:Amid},CEP-126,Amidation,H,Linear,L,NLys = N-(4-aminobutyl)glycine,12,Antibacterial,1.5 % Hemolysis at 400 μg/ml,Human,Synthetic Peptidomimetics,NA,Low hemolytic,NA,NA
12139,34227804,2021,NLys-Y-NLys-Y-NLys-Y-NLys-Y-NLys-Y-NLys-Y,{nnr:NLys}-Y-{nnr:NLys}-Y-{nnr:NLys}-Y-{nnr:NLys}-Y-{nnr:NLys}-Y-{nnr:NLys}-Y{nt:H}{ct:Amid},CEP-129,Amidation,H,Linear,L,NLys = N-(4-aminobutyl)glycine,12,Antibacterial,1.6 % Hemolysis at 400 μg/ml,Human,Synthetic Peptidomimetics,NA,Low hemolytic,NA,NA
12140,34227804,2021,NLys-Tyr(Me)-NLys-Tyr(Me)-NLys-Tyr(Me)-NLys-Tyr(Me)-NLys-Tyr(Me)-NLys-Tyr(Me),{nnr:NLys}-{nnr:Tyr(Me)}-{nnr:NLys}-{nnr:Tyr(Me)}-{nnr:NLys}-{nnr:Tyr(Me)}-{nnr:NLys}-{nnr:Tyr(Me)}-{nnr:NLys}-{nnr:Tyr(Me)}-{nnr:NLys}-{nnr:Tyr(Me)}{nt:H}{ct:Amid},CEP-130,Amidation,H,Linear,L,"NLys = N-(4-aminobutyl)glycine, Tyr(Me) = Tyr(Me)",12,Antibacterial,3 % Hemolysis at 400 μg/ml,Human,Synthetic Peptidomimetics,NA,Low hemolytic,NA,NA
12141,34227804,2021,NLys-tBuAla-NLys-tBuAla-NLys-tBuAla-NLys-tBuAla-NLys-tBuAla-NLys-tBuAla,{nnr:NLys}-{nnr:tBuAla}-{nnr:NLys}-{nnr:tBuAla}-{nnr:NLys}-{nnr:tBuAla}-{nnr:NLys}-{nnr:tBuAla}-{nnr:NLys}-{nnr:tBuAla}-{nnr:NLys}-{nnr:tBuAla}{nt:H}{ct:Amid},CEP-136,Amidation,H,Linear,L,"NLys = N-(4-aminobutyl)glycine, tBuAla = tBuAla",12,Antibacterial,3.9 (±2.0) % Hemolysis at 400 μg/ml,Human,Synthetic Peptidomimetics,NA,Low hemolytic,NA,NA
12142,34227804,2021,NLys-Phe(4)-NLys-Phe(4)-NLys-Phe(4)-NLys-Phe(4)-NLys-Phe(4)-NLys-Phe(4),{nnr:NLys}-{nnr:Phe(4)}-{nnr:NLys}-{nnr:Phe(4)}-{nnr:NLys}-{nnr:Phe(4)}-{nnr:NLys}-{nnr:Phe(4)}-{nnr:NLys}-{nnr:Phe(4)}-{nnr:NLys}-{nnr:Phe(4)}{nt:H}{ct:Amid},CEP-140,Amidation,H,Linear,L,"NLys = N-(4-aminobutyl)glycine, Phe(4-NH2) = Phe(4-NH2)",12,Antibacterial,0.1 % Hemolysis at 400 μg/ml,Human,Synthetic Peptidomimetics,NA,Non-hemolytic,NA,NA
12143,34227804,2021,NOrn-F-NOrn-F-NOrn-F-NOrn-F-NOrn-F-NOrn-F,{nnr:NOrn}-F-{nnr:NOrn}-F-{nnr:NOrn}-F-{nnr:NOrn}-F-{nnr:NOrn}-F-{nnr:NOrn}-F{nt:H}{ct:Amid},CEP-144,Amidation,H,Linear,L,NOrn = NOrn,12,Antibacterial,5.5 (±2.5) % Hemolysis at 400 μg/ml,Human,Synthetic Peptidomimetics,NA,Low hemolytic,NA,NA
12144,34227804,2021,NLys-W-NLys-W-NLys-W-NLys-W,{nnr:NLys}-W-{nnr:NLys}-W-{nnr:NLys}-W-{nnr:NLys}-W{nt:H}{ct:Amid},CEP-246,Amidation,H,Linear,L,NLys = N-(4-aminobutyl)glycine,8,Antibacterial,4.6 (±3) % Hemolysis at 400 μg/ml,Human,Synthetic Peptidomimetics,NA,Low hemolytic,NA,NA
12145,34227804,2021,NLys-Cha-NLys-Cha-NLys-Cha,{nnr:NLys}-{nnr:Cha}-{nnr:NLys}-{nnr:Cha}-{nnr:NLys}-{nnr:Cha}{nt:H}{ct:Amid},CEP-391,Amidation,H,Linear,L,"NLys = N-(4-aminobutyl)glycine, Cha = Cha",6,Antibacterial,22.6 (±2) % Hemolysis at 400 μg/ml,Human,Synthetic Peptidomimetics,NA,NA,NA,NA
12147,34577539,2021,CRRRGSPHC,CRRRGSPHC,mCA4-4,Free,Free,Linear,L,None,9,Antibacterial,<6 % Hemolysis at 100 µM,Chicken,Chicken Angiogenin 4 (Chang4),NA,Low hemolytic,CHHHHTTSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CS)C(=O)NCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)O
12148,34577539,2021,CRFKFRIVIC,CRFKFRIVIC,mCA4-5,Free,Free,Linear,L,None,10,Antibacterial,<6 % Hemolysis at 100 µM,Chicken,Chicken Angiogenin 4 (Chang4),NA,Low hemolytic,CCSCTTGGGGSBTTBCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC)C(C)C
12149,34564152,2021,FFKRLKNAFKSARQAWRDYK,FFKRLKNAFKSARQAWRDYK,β-Pte20,Free,Free,Linear,L,None,20,Antibacterial,<5 % Hemolysis at 50 µM,Human,Lionfish (Pterois Volitans),75% trifluoroethanol (TFE) = α-Helix,Low hemolytic,CCSSTTTHHHHSSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O
12150,34564152,2021,FFKRLKNAFKSARQAWR,FFKRLKNAFKSARQAWR,β-Pte17,Free,Free,Linear,L,None,17,Antibacterial,<5 % Hemolysis at 50 µM,Human,Lionfish (Pterois Volitans),75% trifluoroethanol (TFE) = α-Helix,Low hemolytic,CCSCHHHHHSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12151,34564152,2021,FFKRLKNAFKSAR,FFKRLKNAFKSAR,β-Pte13,Free,Free,Linear,L,None,13,Antibacterial,<5 % Hemolysis at 50 µM,Human,Lionfish (Pterois Volitans),75% trifluoroethanol (TFE) = α-Helix,Low hemolytic,CCSSSSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12152,34564152,2021,FFKRLKNAFK,FFKRLKNAFK,β-Pte10,Free,Free,Linear,L,None,10,Antibacterial,<5 % Hemolysis at 50 µM,Human,Lionfish (Pterois Volitans),NA,Low hemolytic,CCSCTTGGGGSBTTBCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
12153,34564152,2021,FFRHLKSLWKGAKAAFRGAR,FFRHLKSLWKGAKAAFRGAR,γ-Pte20,Free,Free,Linear,L,None,20,Antibacterial,<10 % Hemolysis at 50 µM,Human,Lionfish (Pterois Volitans),75% trifluoroethanol (TFE) = α-Helix,Low hemolytic,CCSSTTTHHHHSSSCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12154,34564152,2021,FFRHLKSLWKGAKAAFR,FFRHLKSLWKGAKAAFR,γ-Pte17,Free,Free,Linear,L,None,17,Antibacterial,<10 % Hemolysis at 50 µM,Human,Lionfish (Pterois Volitans),75% trifluoroethanol (TFE) = α-Helix,Low hemolytic,CCCCHHHHHHHHHHHHHHHTTTCCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12155,34564152,2021,FFRHLKSLWKGAK,FFRHLKSLWKGAK,γ-Pte13,Free,Free,Linear,L,None,13,Antibacterial,<10 % Hemolysis at 50 µM,Human,Lionfish (Pterois Volitans),75% trifluoroethanol (TFE) = α-Helix,Low hemolytic,CCTTCCTTGGGTGGGGGGBTTBSCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
12156,34564152,2021,FFRHLKSLWK,FFRHLKSLWK,γ-Pte10,Free,Free,Linear,L,None,10,Antibacterial,<10 % Hemolysis at 50 µM,Human,Lionfish (Pterois Volitans),NA,Low hemolytic,CCCGGGTSCCCSSTTTCCSSCGGGC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
12157,34564152,2021,FFRHLKSLWKGAKAAFRGAR,FFRHLKSLWKGAKAAFRGAR,γ-Pte20,Free,Free,Linear,L,None,20,Antibacterial,19 % Hemolysis at 200 µM,Human,Lionfish (Pterois Volitans),75% trifluoroethanol (TFE) = α-Helix,NA,CTTGGGHHHHHHHHHHHHHTTSCCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12158,34564152,2021,FFRHLKSLWKGAKAAFR,FFRHLKSLWKGAKAAFR,γ-Pte17,Free,Free,Linear,L,None,17,Antibacterial,43 % Hemolysis at 200 µM,Human,Lionfish (Pterois Volitans),75% trifluoroethanol (TFE) = α-Helix,NA,CCCCSSCCCGGGTTHHHHTTSCCCC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12159,34423969,2021,WLGSALKIGAKLLPSVVGLFKKKKQ,WLGSALKIGAKLLPSVVGLFKKKKQ{nt:NH3}{ct:Amid},Ponericin W1,Amidation,NH3,Linear,L,None,25,Antibacterial,80 % Hemolysis at 50 µM,Human,Ants Pachycondyla Goeldii,negatively charged liposomes = α-Helix,NA,CCCCTTSCCSCSHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C
12160,34423969,2021,WLKKALKIGAKLLPSVVKLFKGSGQ,WLKKALKIGAKLLPSVVKLFKGSGQ{nt:NH3}{ct:Amid},PonAmp,Amidation,NH3,Linear,L,None,25,Antibacterial,70 % Hemolysis at 100 µM,Human,Ponericin W1 Analogues,NA,NA,CCSSTTHHHHHHHHHHHHHHTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C
12161,34423969,2021,KKKKKKWLGSALIGALLPSVVGLFQ,KKKKKKWLGSALIGALLPSVVGLFQ{nt:NH3}{ct:Amid},PonN,Amidation,NH3,Linear,L,None,25,Antibacterial,20 % Hemolysis at 100 µM,Human,Ponericin W1 Analogues,NA,NA,CCCCCSCCSSSSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C
12162,34423969,2021,WLGSALIGALLPSVVGLFQKKKKKK,WLGSALIGALLPSVVGLFQKKKKKK{nt:NH3}{ct:Amid},PonC,Amidation,NH3,Linear,L,None,25,Antibacterial,90 % Hemolysis at 100 µM,Human,Ponericin W1 Analogues,Helical and unstructured,NA,CCCCHHHHTTSCCCTTCCCCCCSCSSSSSCCSSSSSCCEEEETTEEECSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C
12163,34423969,2021,WAKKAAKIGAKLLPSVVKLFKGSGQ,WAKKAAKIGAKLLPSVVKLFKGSGQ{nt:NH3}{ct:Amid},PonAmp 2A,Amidation,NH3,Linear,L,None,25,Antibacterial,0 % Hemolysis at 100 µM,Human,Ponericin W1 Analogues,NA,Non-hemolytic,CGGGGGHHHHHHHHGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C
12164,34423969,2021,KKKKKKWAGSAAIGALLPSVVGLFQ,KKKKKKWAGSAAIGALLPSVVGLFQ{nt:NH3}{ct:Amid},PonN 2A,Amidation,NH3,Linear,L,None,25,Antibacterial,0 % Hemolysis at 100 µM,Human,Ponericin W1 Analogues,NA,Non-hemolytic,CCCSTTHHHHHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C
12165,34423969,2021,WAGSAAIGALLPSVVGLFQKKKKKK,WAGSAAIGALLPSVVGLFQKKKKKK{nt:NH3}{ct:Amid},PonC 2A,Amidation,NH3,Linear,L,None,25,Antibacterial,0 % Hemolysis at 100 µM,Human,Ponericin W1 Analogues,NA,Non-hemolytic,CCTTTTGGGGTHHHHHHHTTTSTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C
12166,34159664,2021,RGGRLCYCRRRFCVCVGR,RGGRLCYCRRRFCVCVGR{nt:H}{ct:Amid},PG-1,Amidation,H,Linear,L,None,18,Antibacterial,50 % Hemolysis at 6.3±1.6 µM,Human,Wild Boar Porcine Leukocytes (Sus Scrofa),antiparallel β-Sheet,NA,CHHHHHHHHHHTGGGTTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
12167,34159664,2021,GGVCPKILQRCRRDSDCPGACICRGNGYCGSGSGGRLCYCRRRFCVCVGRR,GGVCPKILQRCRRDSDCPGACICRGNGYCGSGSGGRLCYCRRRFCVCVGRR{cyc:N-C},MCo-PG2,Free,Free,Cyclic,L,None,51,Antibacterial,50 % Hemolysis at 88± 5 µM,Human,Cyclotide Mcoti-I Modified From Pg-1,NA,NA,CCCSTTTHHHHHHHHHHHHHHCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
12168,34526600,2021,KRIVQRIKDWLRKLCKKW,KRIVQRIKDWLRKLCKKW,CaD23,Free,Free,Linear,L,None,18,Antibacterial,7.1 % Hemolysis at 200 μg/ml,Human,2Nd Generation Hyhdps (Human-Derived Hybrid Host Defense Peptides),NA,Low hemolytic,CCTTTGGGTTTTSTTTTHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12169,34576320,2021,SMWSGMWRRKLKKLRNALKKKLKGE,SMWSGMWRRKLKKLRNALKKKLKGE,Ltc1,Free,Free,Linear,L,None,25,Antibacterial,100 % Hemolysis at 256 μg/ml,Human,Spider Lachesana Tarabaevi,vesicles composed of DMPC/DMPG (7/3) = α-Helix,NA,CGGGGGSCCCCSSSSTTHHHHHHHHHHHHHSCC,CSCC[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O
12170,34576320,2021,GLFGKLIKKFGRKAISYAVKKARGKH,GLFGKLIKKFGRKAISYAVKKARGKH,Ltc2a,Free,Free,Linear,L,None,26,Antibacterial,36 % Hemolysis at 256 μg/ml,Human,Spider Lachesana Tarabaevi,vesicles composed of DMPC/DMPG (7/3) = α-Helix,NA,CCCHHHHHHHHHHHHHHHHTTTSCCCTHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C
12171,34576320,2021,SWKSMAKKLKEYMEKLKQRA,SWKSMAKKLKEYMEKLKQRA{ct:Amid},Ltc3a,Amidation,Free,Linear,L,None,20,Antibacterial,16 % Hemolysis at 256 μg/ml,Human,Spider Lachesana Tarabaevi,vesicles composed of DMPC/DMPG (7/3) = α-Helix,Low hemolytic,CCSCSSSCCCSCCCCCCSSGGGTSCCBTTTBCCSCC,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O
12172,34576320,2021,GLKDKFKSMGEKLKQYIQTWKAKF,GLKDKFKSMGEKLKQYIQTWKAKF{ct:Amid},Ltc4a,Amidation,Free,Linear,L,None,24,Antibacterial,12 % Hemolysis at 256 μg/ml,Human,Spider Lachesana Tarabaevi,vesicles composed of DMPC/DMPG (7/3) = α-Helix,Low hemolytic,CCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
12173,34576320,2021,GFFGKMKEYFKKFGASFKRRFANLKKRL,GFFGKMKEYFKKFGASFKRRFANLKKRL{ct:Amid},Ltc5,Amidation,Free,Linear,L,None,28,Antibacterial,27 % Hemolysis at 256 μg/ml,Human,Spider Lachesana Tarabaevi,vesicles composed of DMPC/DMPG (7/3) = α-Helix,Low hemolytic,CCCCTTCC,CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O
12174,34576320,2021,QAFQTFKPDWNKIRYDAMKMQTSLGQMKKRFNL,QAFQTFKPDWNKIRYDAMKMQTSLGQMKKRFNL,Ltc6a,Free,Free,Linear,L,None,33,Antibacterial,3 % Hemolysis at 256 μg/ml,Human,Spider Lachesana Tarabaevi,vesicles composed of DMPC/DMPG (7/3) = α-Helix,Low hemolytic,CCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
12175,34576320,2021,GETFDKLKEKLKTFYQKLVEKAEDLKGDLKAKLS,GETFDKLKEKLKTFYQKLVEKAEDLKGDLKAKLS,Ltc7,Free,Free,Linear,L,None,34,Antibacterial,2 % Hemolysis at 256 μg/ml,Human,Spider Lachesana Tarabaevi,vesicles composed of DMPC/DMPG (7/3) = α-Helix,Low hemolytic,CCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CO)C(=O)O
12177,34028137,2021,VRLLRRRI,VRLLRRRI{nt:H}{ct:Amid},SAMP-A4,Amidation,H,Linear,L,None,8,"Antibacterial, Antifungal, Antibiofilm",5 % Hemolysis at 69.26 μg/ml,Human,Synthesized Antimicrobial Peptide A4,NA,Low hemolytic,CCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)O
12178,34028137,2021,VRLLRRRI,VRLLRRRI{nt:Acet}{ct:Amid},SAMP-A4-C2,Amidation,Acetylation,Linear,L,None,8,"Antibacterial, Antifungal, Antibiofilm",5 % Hemolysis at 34.56 μg/ml,Human,Samp-A4 Analogue,NA,Low hemolytic,CCCCCCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)O
12179,34028137,2021,VRLLRRRI,VRLLRRRI{nt:Butyryl}{ct:Amid},SAMP-A4-C4,Amidation,Butyryl,Linear,L,None,8,"Antibacterial, Antifungal, Antibiofilm",5 % Hemolysis at 73.84 μg/ml,Human,Samp-A4 Analogue,NA,Low hemolytic,CCCTTHHHHHHHTGGGSSSSCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)O
12180,34028137,2021,VRLLRRRI,VRLLRRRI{nt:Hexanoyl}{ct:Amid},SAMP-A4-C6,Amidation,Hexanoyl,Linear,L,None,8,"Antibacterial, Antifungal, Antibiofilm",5 % Hemolysis at 84.98 μg/ml,Human,Samp-A4 Analogue,NA,Low hemolytic,CTHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)O
12181,34028137,2021,VRLLRRRI,VRLLRRRI{nt:PEG}{ct:Amid},SAMP-A4-PEG3,Amidation,PEG,Linear,L,None,8,"Antibacterial, Antifungal, Antibiofilm",5 % Hemolysis at 19.95 μg/ml,Human,Samp-A4 Analogue,NA,Low hemolytic,CTHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)O
12182,34028137,2021,VRLLRRRI,VRLLRRRI{nt:Gluconyl}{ct:Amid},SAMP-A4-GlcA,Amidation,Gluconyl,Linear,L,None,8,"Antibacterial, Antifungal, Antibiofilm",5 % Hemolysis at 22.16 μg/ml,Human,Samp-A4 Analogue,NA,Low hemolytic,CHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)O
12184,34037941,2021,KRNGFRKFMRRLKKFFAGGGSSIAHIKLH,KRNGFRKFMRRLKKFFAGGGSSIAHIKLH{ct:Amid},CATHPb2,Amidation,Free,Linear,L,None,29,"Antibacterial, Antifungal",<5 % Hemolysis at 512 μg/ml,Sheep,Cathelicidin In Snake Python Bivittatus,α-Helical,Non-hemolytic,CHHHHGGGSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)CC
12185,34037941,2021,GFRKFMRRLKKFF,GFRKFMRRLKKFF{ct:Amid},Pb2-1,Amidation,Free,Linear,L,None,13,"Antibacterial, Antifungal",<5 % Hemolysis at 512 μg/ml,Sheep,Mutant Of Cathpb2,α-Helical,Non-hemolytic,CTTTTHHHHTC,CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12186,34037941,2021,GFRKFMRRLKK,GFRKFMRRLKK{ct:Amid},Pb2-2,Amidation,Free,Linear,L,None,11,"Antibacterial, Antifungal",<5 % Hemolysis at 512 μg/ml,Sheep,Mutant Of Cathpb2,NA,Non-hemolytic,CCHHHHHHHHHHHHHHHHHHHHSCC,CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
12187,34037941,2021,FFRKFFRRFKK,FFRKFFRRFKK{ct:Amid},Pb2-3F,Amidation,Free,Linear,L,None,11,"Antibacterial, Antifungal",<5 % Hemolysis at 512 μg/ml,Sheep,Mutant Of Cathpb2,NA,Non-hemolytic,CCCCTHHHHHHHSGGGGGGTSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
12188,34037941,2021,GFRKFWRRWKK,GFRKFWRRWKK{ct:Amid},Pb2-2W,Amidation,Free,Linear,L,None,11,"Antibacterial, Antifungal",<5 % Hemolysis at 512 μg/ml,Sheep,Mutant Of Cathpb2,NA,Non-hemolytic,CTTTHHHHHHHHCCCSSCBTTBCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
12189,34037941,2021,GWRKWWRRWKK,GWRKWWRRWKK{ct:Amid},Pb2-4W,Amidation,Free,Linear,L,None,11,"Antibacterial, Antifungal",<5 % Hemolysis at 512 μg/ml,Sheep,Mutant Of Cathpb2,NA,Non-hemolytic,CHHHHHHHHHHGGGGSSCTHHHHTTCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
12190,34037941,2021,WWRKWWRRWKK,WWRKWWRRWKK{ct:Amid},Pb2-5W,Amidation,Free,Linear,L,None,11,"Antibacterial, Antifungal",<5 % Hemolysis at 512 μg/ml,Sheep,Mutant Of Cathpb2,NA,Non-hemolytic,CCSTTTHHHHHHHTTTSSSSSCCSSSSSCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
12199,34482475,2021,ZQPVSSPK,{nnr:Z}QPVSSPK,Pep-Bax8,Free,Free,Linear,L,Z = pyroglutamic acid,8,Antibacterial,1.6 % Hemolysis at 250 μg/ml,Human,Snake Venom Of Bothrops Atrox,NA,Non-hemolytic,NA,NA
12200,34482475,2021,ZKW,{nnr:Z}KW,SVMPi-Bax/Bj,Free,Free,Linear,L,Z = pyroglutamic acid,3,Antibacterial,1.7 % Hemolysis at 250 μg/ml,Human,Snake Venoms Of Bothrops Atrox And Bothrops Jararacussu,NA,Non-hemolytic,NA,NA
12201,34482475,2021,GRVPDNPKAPP,GRVPDNPKAPP,BPP-Bax11,Free,Free,Linear,L,None,11,Antibacterial,1.8 % Hemolysis at 250 μg/ml,Human,Snake Venom Of Bothrops Atrox,NA,Non-hemolytic,NA,CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)O
12202,34680789,2021,INLLKIAKGIIKSL,INLLKIAKGIIKSL{ct:Amid},EMP-AF-OR,Amidation,Free,Linear,L,None,14,"Antibacterial, Antifungal",100 % Hemolysis at 100 μg/ml,Human,Wasp Eumenine Anterhynchium Flavomarginatum Micado,"water = 17.73% Helical, 50% TFE = Helical",NA,NA,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
12206,34680789,2021,FKIM*GLIKKVAGAL,FKI{nnr:M*}GLIKKVAGAL{ct:Amid},EMP-ER-D2K2,Amidation,Free,Linear,L,M* = Methionine in sulfoxide form,14,"Antibacterial, Antifungal",~50 % Hemolysis at 100 μg/ml,Human,Emp-Er Analog,50% TFE = Helical,NA,NA,NA
12208,34721331,2021,VKKLVKKAVKKLVKKA,VKKLVKKAVKKLVKKA{ct:Amid},VL1,Amidation,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at >128 µM,Human,Synthetic Trp-Rich Peptides,NA,Low hemolytic,CHHHHGGGGGGTTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C
12209,34721331,2021,VKKLVKKLVKKAVKKA,VKKLVKKLVKKAVKKA{ct:Amid},VL2,Amidation,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at >128 µM,Human,Synthetic Trp-Rich Peptides,NA,Low hemolytic,CGGGHHHHGGGCSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
12210,34721331,2021,VKKLVKKLVKKLVKKA,VKKLVKKLVKKLVKKA{ct:Amid},VL3,Amidation,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at >128 µM,Human,Synthetic Trp-Rich Peptides,NA,Low hemolytic,CTTTHHHHHHHHTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C
12211,34721331,2021,VKKLVKKLVKKAVKKL,VKKLVKKLVKKAVKKL{ct:Amid},VL4,Amidation,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at >128 µM,Human,Synthetic Trp-Rich Peptides,NA,Low hemolytic,CTTTTHHHHTTGGGGC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)O
12212,34721331,2021,VKKLVKKLVKKLVKKL,VKKLVKKLVKKLVKKL{ct:Amid},VL5,Amidation,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at >128 µM,Human,Synthetic Trp-Rich Peptides,NA,Low hemolytic,CTTTGGGTHHHHTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)O
12213,34721331,2021,VKKWVKKAVKKWVKKA,VKKWVKKAVKKWVKKA{ct:Amid},VW1,Amidation,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at >128 µM,Human,Synthetic Trp-Rich Peptides,NA,Low hemolytic,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C
12214,34721331,2021,VKKWVKKWVKKAVKKA,VKKWVKKWVKKAVKKA{ct:Amid},VW2,Amidation,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at >128 µM,Human,Synthetic Trp-Rich Peptides,NA,Low hemolytic,CCCCSSCC,CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C
12215,34721331,2021,VKKWVKKWVKKAVKKW,VKKWVKKWVKKAVKKW{ct:Amid},VW3,Amidation,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at >128 µM,Human,Synthetic Trp-Rich Peptides,NA,Low hemolytic,CCSCCCCC,CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(C)C)C(C)C
12216,34721331,2021,VKKWVKKWVKKWVKKA,VKKWVKKWVKKWVKKA{ct:Amid},VW4,Amidation,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at >128 µM,Human,Synthetic Trp-Rich Peptides,NA,Low hemolytic,CCBSSSBC,CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C
12217,34721331,2021,VKKWVKKWVKKWVKKW,VKKWVKKWVKKWVKKW{ct:Amid},VW5,Amidation,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at >128 µM,Human,Synthetic Trp-Rich Peptides,"sodium phosphate buffer = unordered, 50% TFE = α-Helical",Low hemolytic,CCSSSSCC,CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(C)C)C(C)C
12218,34721331,2021,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid},Melittin,Amidation,Free,Linear,L,None,26,Antibacterial,5 % Hemolysis at 1 µM,Human,Honeybee Venom,α-Helical,Low hemolytic,CCTHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
12322,34780520,2021,GGLRSLGRKILRAWKKY,GGLRSLGRKILRAWKKY,S61,Free,Free,Linear,L,None,17,Antibacterial,13.03±0.00 % Hemolysis at 400 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CTHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
12323,34780520,2021,GGLRSLGRKILRAWKKY,GGLRSLGRKILRAWKKY,S61,Free,Free,Linear,L,None,17,Antibacterial,11.44±0.25 % Hemolysis at 200 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CTHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
12324,34780520,2021,GGLRSLGRKILRAWKKY,GGLRSLGRKILRAWKKY,S61,Free,Free,Linear,L,None,17,Antibacterial,10.74±0.75 % Hemolysis at 100 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CTHHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
12325,34780520,2021,GGLRSLGRKILRAWKKY,GGLRSLGRKILRAWKKY,S61,Free,Free,Linear,L,None,17,Antibacterial,9.15±1.99 % Hemolysis at 50 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CTHHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
12326,34780520,2021,GGLRSLGRKILRAWKKY,GGLRSLGRKILRAWKKY,S61,Free,Free,Linear,L,None,17,Antibacterial,6.34±4.98 % Hemolysis at 25 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CTHHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
12327,34780520,2021,GGLRSLGRKILRAWKKY,GGLRSLGRKILRAWKKY,S61,Free,Free,Linear,L,None,17,Antibacterial,4.58±4.48 % Hemolysis at 12.5 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CTHHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
12328,34780520,2021,GGLRSLGRKILRAWKKY,GGLRSLGRKILRAWKKY,S61,Free,Free,Linear,L,None,17,Antibacterial,-0.18±0.75 % Hemolysis at 6.25 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CTHHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
12329,34780520,2021,GGLRSLGRKILRAWKK,GGLRSLGRKILRAWKK,S62,Free,Free,Linear,L,None,16,Antibacterial,11.44±1.24 % Hemolysis at 400 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CTHHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
12330,34780520,2021,GGLRSLGRKILRAWKK,GGLRSLGRKILRAWKK,S62,Free,Free,Linear,L,None,16,Antibacterial,9.33±1.74 % Hemolysis at 200 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CTHHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
12331,34780520,2021,GGLRSLGRKILRAWKK,GGLRSLGRKILRAWKK,S62,Free,Free,Linear,L,None,16,Antibacterial,8.63±3.24 % Hemolysis at 100 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CTHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
12332,34780520,2021,GGLRSLGRKILRAWKK,GGLRSLGRKILRAWKK,S62,Free,Free,Linear,L,None,16,Antibacterial,7.22±3.73 % Hemolysis at 50 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CTHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
12333,34780520,2021,GGLRSLGRKILRAWKK,GGLRSLGRKILRAWKK,S62,Free,Free,Linear,L,None,16,Antibacterial,5.99±3.98 % Hemolysis at 25 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CTHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
12334,34780520,2021,GGLRSLGRKILRAWKK,GGLRSLGRKILRAWKK,S62,Free,Free,Linear,L,None,16,Antibacterial,4.05±3.24 % Hemolysis at 12.5 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CTHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
12335,34780520,2021,GGLRSLGRKILRAWKK,GGLRSLGRKILRAWKK,S62,Free,Free,Linear,L,None,16,Antibacterial,0.35±0.50 % Hemolysis at 6.25 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CTHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
12336,34780520,2021,GGLRSLGRKILRAWK,GGLRSLGRKILRAWK,S63,Free,Free,Linear,L,None,15,Antibacterial,10.56±1.99 % Hemolysis at 400 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CTHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
12337,34780520,2021,GGLRSLGRKILRAWK,GGLRSLGRKILRAWK,S63,Free,Free,Linear,L,None,15,Antibacterial,9.68±2.74 % Hemolysis at 200 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CTHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
12338,34780520,2021,GGLRSLGRKILRAWK,GGLRSLGRKILRAWK,S63,Free,Free,Linear,L,None,15,Antibacterial,8.27±3.73 % Hemolysis at 100 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
12339,34780520,2021,GGLRSLGRKILRAWK,GGLRSLGRKILRAWK,S63,Free,Free,Linear,L,None,15,Antibacterial,7.04±3.98 % Hemolysis at 50 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
12340,34780520,2021,GGLRSLGRKILRAWK,GGLRSLGRKILRAWK,S63,Free,Free,Linear,L,None,15,Antibacterial,5.81±3.73 % Hemolysis at 25 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
12341,34780520,2021,GGLRSLGRKILRAWK,GGLRSLGRKILRAWK,S63,Free,Free,Linear,L,None,15,Antibacterial,3.52±4.98 % Hemolysis at 12.5 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
12342,34780520,2021,GGLRSLGRKILRAWK,GGLRSLGRKILRAWK,S63,Free,Free,Linear,L,None,15,Antibacterial,-0.53±0.75 % Hemolysis at 6.25 μg/ml,Human,Bovine Myeloid Cells,NA,Low hemolytic,CCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
12343,34780520,2021,KLKLLLLLKL,KLKLLLLLKL,KLK1,Free,Free,Linear,L,None,10,Antibacterial,22.18±1.99 % Hemolysis at 400 μg/ml,Human,Sarcophaga Peregrina (Flesh Fly),NA,NA,CCCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
12344,34780520,2021,KLKLLLLLKL,KLKLLLLLKL,KLK1,Free,Free,Linear,L,None,10,Antibacterial,18.13±0.25 % Hemolysis at 200 μg/ml,Human,Sarcophaga Peregrina (Flesh Fly),NA,NA,CCCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
12345,34780520,2021,KLKLLLLLKL,KLKLLLLLKL,KLK1,Free,Free,Linear,L,None,10,Antibacterial,15.85±1.49 % Hemolysis at 100 μg/ml,Human,Sarcophaga Peregrina (Flesh Fly),NA,NA,CGGGGHHHHHHHCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
12346,34780520,2021,KLKLLLLLKL,KLKLLLLLKL,KLK1,Free,Free,Linear,L,None,10,Antibacterial,12.15±0.25 % Hemolysis at 50 μg/ml,Human,Sarcophaga Peregrina (Flesh Fly),NA,NA,CCCCBSSSBCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
12347,34780520,2021,KLKLLLLLKL,KLKLLLLLKL,KLK1,Free,Free,Linear,L,None,10,Antibacterial,8.27±1.74 % Hemolysis at 25 μg/ml,Human,Sarcophaga Peregrina (Flesh Fly),NA,NA,CCCCCCCCSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
12348,34780520,2021,KLKLLLLLKL,KLKLLLLLKL,KLK1,Free,Free,Linear,L,None,10,Antibacterial,4.93±2.49 % Hemolysis at 12.5 μg/ml,Human,Sarcophaga Peregrina (Flesh Fly),NA,NA,CCHHHHHHHTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
12349,34780520,2021,KLKLLLLLKL,KLKLLLLLKL,KLK1,Free,Free,Linear,L,None,10,Antibacterial,0.7±0.50 % Hemolysis at 6.25 μg/ml,Human,Sarcophaga Peregrina (Flesh Fly),NA,NA,CCCCTTTTTTHHHHTTTTTTTSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
12350,34867843,2021,FLLKIVALLKKKLL,FLLKIVALLKKKLL,PHNX-1,Free,Free,Linear,L,None,14,Antibacterial,~40 % Hemolysis at 100 μg/ml,Human,Synthetic Peptide,Helical,NA,CCTHHHHHHHHHHHHHHHHHTTSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
12351,34867843,2021,FLLKLGLGKKKLL,FLLKLGLGKKKLL,PHNX-4,Free,Free,Linear,L,None,13,Antibacterial,~10 % Hemolysis at 100 μg/ml,Human,Synthetic Peptide,Random coil,NA,CCHHHHHHHHHHTTTTCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
12352,34867843,2021,FLIKILKGGKGGK,FLIKILKGGKGGK,PHNX-5,Free,Free,Linear,L,None,13,Antibacterial,~10 % Hemolysis at 100 μg/ml,Human,Synthetic Peptide,Random coil,NA,CCHHHHHHHHHHHHHHHHHHHHHHHHHHTTTTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O
12353,34867843,2021,FIGAIASYLKKFR,FIGAIASYLKKFR,PHNX-6,Free,Free,Linear,L,None,13,Antibacterial,<10 % Hemolysis at 100 μg/ml,Human,Synthetic Peptide,Random coil Helical,Low hemolytic,CCCGGGTTTHHHHTCHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12354,34867843,2021,GVVDIIKGAGKKFAKGLAGKIANKK,GVVDIIKGAGKKFAKGLAGKIANKK,PHNX-7,Free,Free,Linear,L,None,25,Antibacterial,~10 % Hemolysis at 100 μg/ml,Human,Synthetic Peptide,Helical,NA,CHHHHHHHHHHHTTTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
12355,34867843,2021,GLMDTVKNAAKNLAGQLLDKIKCKITG,GLMDTVKNAAKNLAGQLLDKIKCKITG,PHNX-8,Free,Free,Linear,L,None,27,Antibacterial,~10 % Hemolysis at 100 μg/ml,Human,Synthetic Peptide,Helical,NA,CGGGGGHHHHTHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)[C@@H](C)CC
12357,34959645,2021,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL-37,Free,Free,Linear,L,None,37,Antibacterial,70 % Hemolysis at 200 µM,Human,Host Defense Peptide,"PBS, 60mMSDS = Helical",NA,CGGGGGGTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
12358,34959645,2021,SKEKIGKEFKRIVQRIKDFLRNLV,SKEKIGKEFKRIVQRIKDFLRNLV{ct:Amid},SK-24,Amidation,Free,Linear,L,None,24,"Antibacterial, Antibiofilm",<25 % Hemolysis at 200 µM,Human,Ll-37 Derived Peptide,"PBS, 60mMSDS = Helical",Low hemolytic,CTHHHHHHHHHHHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
12359,34959645,2021,GIKEFKRIVQRIKDFLRNLV,GIKEFKRIVQRIKDFLRNLV{ct:Amid},GI-20,Amidation,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",50 % Hemolysis at ~160 µM,Human,Ll-37 Derived Peptide,"PBS, 60mMSDS = Helical",NA,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
12360,34959645,2021,GFKRIVQRIKDFLRNLV,GFKRIVQRIKDFLRNLV{ct:Amid},GF-17,Amidation,Free,Linear,L,None,17,"Antibacterial, Antibiofilm",50 % Hemolysis at 175 µM,Human,Ll-37 Derived Peptide,"PBS, 60mMSDS = Helical",NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C
12361,34959645,2021,GXKRlVQRlKDXLRNLV,G{nnr:X}KRlVQRlKD{nnr:X}LRNLV{ct:Amid},17BIPHE2,Amidation,Free,Linear,Mix,X = biphenylalanines,17,"Antibacterial, Antibiofilm",50 % Hemolysis at ~200 µM,Human,Ll-37 Derived Peptide,"PBS = distorted, 60mMSDS = Helical",NA,NA,NA
12362,34959645,2021,RIVQRIKDFL,RIVQRIKDFL{ct:Amid},RI-10,Amidation,Free,Linear,L,None,10,Antibacterial,<25 % Hemolysis at 200 µM,Human,Ll-37 Derived Peptide,"PBS = distorted, 60mMSDS = Helical",Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
12363,34164880,2021,KLLKKAGKLLKKAGKLLKKAG,KLLKKAGKLLKKAGKLLKKAG{nt:H}{ct:Amid},Stripe,Amidation,H,Linear,L,None,21,Antibacterial,0 % Hemolysis at 100 µM,Human,Synthetic Amp,phosphate buffer solution (pH 7.4) contain 1%SDS = right-handed Helical,Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)O
12364,34164880,2021,KLLKKAXKLLKKAXKLLKKAX,KLLKKA{nnr:X}KLLKKA{nnr:X}KLLKKA{nnr:X}{nt:H}{ct:Amid},Stripe1,Amidation,H,Linear,L,X = sarcosine,21,Antibacterial,0 % Hemolysis at 100 µM,Human,Stripe Modification With Sarcosine,phosphate buffer solution (pH 7.4) contain 1%SDS = Random coil,Non-hemolytic,NA,NA
12365,34164880,2021,KLLKKXGKLLKKXGKLLKKXG,KLLKK{nnr:X}GKLLKK{nnr:X}GKLLKK{nnr:X}G{nt:H}{ct:Amid},Stripe2,Amidation,H,Linear,L,X = sarcosine,21,Antibacterial,0 % Hemolysis at 100 µM,Human,Stripe Modification With Sarcosine,phosphate buffer solution (pH 7.4) contain 1%SDS = Random coil,Non-hemolytic,NA,NA
12366,34164880,2021,KLLKKXXKLLKKXXKLLKKXX,KLLKK{nnr:X}{nnr:X}KLLKK{nnr:X}{nnr:X}KLLKK{nnr:X}{nnr:X}{nt:H}{ct:Amid},Stripe3,Amidation,H,Linear,L,X = sarcosine,21,Antibacterial,0 % Hemolysis at 100 µM,Human,Stripe Modification With Sarcosine,phosphate buffer solution (pH 7.4) contain 1%SDS = Random coil,Non-hemolytic,NA,NA
12370,34977576,2021,BKKLLKCLKCL,{nnr:B}KKLLKCLKCL{cyc:7-10},bp3,Free,Free,Bicyclic,L,"B = 3,5-bis(methylene)toluoyl",11,Antibacterial,MHC at 500 μg/ml,Human,Synthetic Peptide,5 mM DPC = α-Helical,Low hemolytic,NA,NA
12371,34977576,2021,BKKLLKCLKCLL,{nnr:B}KKLLKCLKCLL{cyc:7-10},bp65,Free,Free,Bicyclic,L,"B = 3,5-bis(methylene)toluoyl",12,Antibacterial,MHC at 16.6 μg/ml,Human,Synthetic Peptide,5 mM DPC = α-Helical,NA,NA,NA
12372,34977576,2021,BkKlLkClKcLl,{nnr:B}K{d}KL{d}LK{d}CL{d}KC{d}LL{d}{cyc:7-10},bp67,Free,Free,Bicyclic,Mix,"B = 3,5-bis(methylene)toluoyl",12,Antibacterial,MHC at >2000 μg/ml,Human,Synthetic Peptide,5 mM DPC = α-Helical,Low hemolytic,NA,NA
12373,34977576,2021,BKKLLKcLKcLL,{nnr:B}KKLLKC{d}LKC{d}LL{cyc:7-10},bp68,Free,Free,Bicyclic,Mix,"B = 3,5-bis(methylene)toluoyl",12,Antibacterial,MHC at 16.6 μg/ml,Human,Synthetic Peptide,5 mM DPC = α-Helical,NA,NA,NA
12374,34977576,2021,BkkLLkCLkCLL,{nnr:B}K{d}K{d}LLK{d}CLK{d}CLL{cyc:7-10},bp69,Free,Free,Bicyclic,Mix,"B = 3,5-bis(methylene)toluoyl",12,Antibacterial,MHC at 16.6 μg/ml,Human,Synthetic Peptide,5 mM DPC = α-Helical,NA,NA,NA
12375,34977576,2021,KKLLKLLKLLL,KKLLKLLKLLL,ln65,Free,Free,Linear,L,None,12,Antibacterial,MHC at 125 μg/ml,Human,Synthetic Peptide,5 mM DPC = α-Helical,NA,CCCSCCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
12376,34977576,2021,Tol-KKLLK-Cm-LK-Cm-LL,{nnr:Tol}-KKLLK-{nnr:Cm}-LK-{nnr:Cm}-LL,ln65b,Free,Free,Linear,L,"Tol = toluoyl group, Cm = S-methyl cysteine",12,Antibacterial,MHC at 16.6 μg/ml,Human,Synthetic Peptide,5 mM DPC = α-Helical,NA,NA,NA
12377,34977576,2021,kkLLkLLkLLL,K{d}K{d}LLK{d}LLK{d}LLL,ln69,Free,Free,Linear,Mix,None,12,Antibacterial,MHC at 1000 μg/ml,Human,Synthetic Peptide,5 mM DPC = α-Helical,Low hemolytic,CCCCSSCCCCCSCCCCCSSSTTCCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
12378,34977576,2021,Tol-kkLLk-Cm-Lk-Cm-LL,{nnr:Tol}-K{d}K{d}LLK{d}-{nnr:Cm}-LK{d}-{nnr:Cm}-LL,ln69b,Free,Free,Linear,Mix,"Tol = toluoyl group, Cm = S-methyl cysteine",12,Antibacterial,MHC at 1000 μg/ml,Human,Synthetic Peptide,5 mM DPC = α-Helical,Low hemolytic,NA,NA
12379,34966279,2021,KIILRIRWR,KIILRIRWR{ct:Amid},optP1,Amidation,Free,Linear,L,None,9,Antibacterial,50 % Hemolysis at 205 µM,Human,Optimized 9Mer,NA,Low hemolytic,CCSSSSCSSCCCCCSSSTTCCSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12380,34966279,2021,KRRVRWIIW,KRRVRWIIW{ct:Amid},optP7,Amidation,Free,Linear,L,None,9,Antibacterial,50 % Hemolysis at >195 µM,Human,Optimized 9Mer,NA,Low hemolytic,CCSCCCCTTSSSCCSSSCSCCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC
12381,34966279,2021,VRKPPYLPRPRPRPL,VRKPPYLPRPRPRPL{ct:Amid},consP1,Amidation,Free,Linear,L,None,15,Antibacterial,50 % Hemolysis at >139 µM,Human,Consensus Sequence Derived From Multiple Alignment,NA,Low hemolytic,CCSCGGGSSCCCCSCCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)O
12382,34966279,2021,KIILRIRWRGGGVRKPPYLPRPRPRPL,KIILRIRWRGGGVRKPPYLPRPRPRPL{ct:Amid},hyP1CoG1,Amidation,Free,Linear,L,None,27,Antibacterial,50 % Hemolysis at >157 µM,Human,"Hybrid Peptide With Gly Linker, Optp1 C-Terminal",NA,Low hemolytic,CCCCTTTTSCSSSSCGGGCCTTTCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
12383,34966279,2021,VRKPPYLPRPRPRPLGGGKIILRIRWR,VRKPPYLPRPRPRPLGGGKIILRIRWR{ct:Amid},hyP1CoG2,Amidation,Free,Linear,L,None,27,Antibacterial,50 % Hemolysis at >157 µM,Human,"Hybrid Peptide With Gly Linker, Optp1 C-Terminal",NA,Low hemolytic,CCCCGGGGCCCCCCSTTTCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12384,34966279,2021,VRKPPYLPRPRPRPLGGGKRRVRWIIW,VRKPPYLPRPRPRPLGGGKRRVRWIIW{ct:Amid},hyP7CoG1,Amidation,Free,Linear,L,None,27,Antibacterial,50 % Hemolysis at >154 µM,Human,"Hybrid Peptide With Gly Linker, Optp7 C-Terminal",NA,Low hemolytic,CCSCSCCSCCCCCCCSSSCSSCCCCCCSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC
12385,34966279,2021,KRRVRWIIWGGGVRKPPYLPRPRPRPL,KRRVRWIIWGGGVRKPPYLPRPRPRPL{ct:Amid},hyP7CoG2,Amidation,Free,Linear,L,None,27,Antibacterial,50 % Hemolysis at >154 µM,Human,"Hybrid Peptide With Gly Linker, Optp7 N-Terminal",NA,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC
12386,34966279,2021,RWRRPIRRRPIRPPFWR,RWRRPIRRRPIRPPFWR{ct:Amid},Bac5-v291,Amidation,Free,Linear,L,None,17,Antibacterial,50 % Hemolysis at >278 µM,Human,Optimized Bac5(1–17) Variant 291,NA,Low hemolytic,CCHHHHHHHHHHHCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
12387,34966279,2021,RWRRPIRRRPIRPPFWRGGGKRRVRWIIW,RWRRPIRRRPIRPPFWRGGGKRRVRWIIW{ct:Amid},hyP7B5G,Amidation,Free,Linear,L,None,29,Antibacterial,50 % Hemolysis at 102 µM,Human,"Hybrid Peptide With Gly Linker, Optp7 C-Terminal",NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC
12388,34966279,2021,RWRRPIRRRPIRPPFWRKKKKRRVRWIIW,RWRRPIRRRPIRPPFWRKKKKRRVRWIIW{ct:Amid},hyP7B5K,Amidation,Free,Linear,L,None,29,Antibacterial,50 % Hemolysis at 82 µM,Human,"Hybrid Peptide With Lys Linker, Optp7 C-Terminal",NA,NA,CTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC
12389,34966279,2021,RWRRPIRRRPIRPPFWRKGKGKGKRRVRWIIW,RWRRPIRRRPIRPPFWRKGKGKGKRRVRWIIW{ct:Amid},hyP7B5GK,Amidation,Free,Linear,L,None,32,Antibacterial,50 % Hemolysis at >120 µM,Human,"Hybrid Peptide With Gly-Lys Linker, Optp7 C-Terminal",NA,Low hemolytic,CTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC
12390,34966279,2021,RWRRPIRRRPIRPPFWRKGKC-S-S-CKGKRRVRWIIW,RWRRPIRRRPIRPPFWRKGKC-S-S-CKGKRRVRWIIW{ct:Amid},hyP7B5Cys,Amidation,Free,Linear,L,None,35,Antibacterial,50 % Hemolysis at 102 µM,Human,"Hybrid Peptide With Disulfide Bridge, Designed To Be Cleaved In The Cytosol, Optp7 C-Terminal",NA,NA,CTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC
12393,34966367,2021,GLLKRIKTLL,GLLKRIKTLL{ct:Amid},Anoplin,Amidation,Free,Linear,L,None,10,Antibacterial,2.3 % Hemolysis at 64 µM,Sheep,Venom Sac Of The Solitary Wasp,"phosphate buffer = Random coil, membrane-mimicking environments = α-Helical",Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
12394,34966367,2021,GLLKRIKTLL,GLLKRIKTLL{ct:Amid},Anoplin,Amidation,Free,Linear,L,None,10,Antibacterial,0.6 % Hemolysis at 32 µM,Sheep,Venom Sac Of The Solitary Wasp,"phosphate buffer = Random coil, membrane-mimicking environments = α-Helical",Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
12395,34966367,2021,GLLKRIKTLL,GLLKRIKTLL{ct:Amid},Anoplin,Amidation,Free,Linear,L,None,10,Antibacterial,0.7 % Hemolysis at 16 µM,Sheep,Venom Sac Of The Solitary Wasp,"phosphate buffer = Random coil, membrane-mimicking environments = α-Helical",Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
12396,34966367,2021,GLLKRIKTLL,GLLKRIKTLL{ct:Amid},Anoplin,Amidation,Free,Linear,L,None,10,Antibacterial,1.3 % Hemolysis at 8 µM,Sheep,Venom Sac Of The Solitary Wasp,"phosphate buffer = Random coil, membrane-mimicking environments = α-Helical",Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
12397,34966367,2021,GLLKRIKTLL,GLLKRIKTLL{ct:Amid},Anoplin,Amidation,Free,Linear,L,None,10,Antibacterial,0.5 % Hemolysis at 4 µM,Sheep,Venom Sac Of The Solitary Wasp,"phosphate buffer = Random coil, membrane-mimicking environments = α-Helical",Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
12398,34966367,2021,G-S5-LKR-S5-KTLL,G-{nnr:S5}-LKR-{nnr:S5}-KTLL{ct:Amid},Anoplin[2-6],Amidation,Free,Stapled,L,S5 = Olefinic,8,Antibacterial,9.1 % Hemolysis at 64 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12399,34966367,2021,G-S5-LKR-S5-KTLL,G-{nnr:S5}-LKR-{nnr:S5}-KTLL{ct:Amid},Anoplin[2-6],Amidation,Free,Stapled,L,S5 = Olefinic,8,Antibacterial,4 % Hemolysis at 32 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12400,34966367,2021,G-S5-LKR-S5-KTLL,G-{nnr:S5}-LKR-{nnr:S5}-KTLL{ct:Amid},Anoplin[2-6],Amidation,Free,Stapled,L,S5 = Olefinic,8,Antibacterial,2.8 % Hemolysis at 16 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12401,34966367,2021,G-S5-LKR-S5-KTLL,G-{nnr:S5}-LKR-{nnr:S5}-KTLL{ct:Amid},Anoplin[2-6],Amidation,Free,Stapled,L,S5 = Olefinic,8,Antibacterial,2.4 % Hemolysis at 8 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12402,34966367,2021,G-S5-LKR-S5-KTLL,G-{nnr:S5}-LKR-{nnr:S5}-KTLL{ct:Amid},Anoplin[2-6],Amidation,Free,Stapled,L,S5 = Olefinic,8,Antibacterial,2.1 % Hemolysis at 4 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12403,34966367,2021,GLLK-S5-IKT-S5-L,GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid},Anoplin[5-9],Amidation,Free,Stapled,L,S5 = Olefinic,8,Antibacterial,62.7 % Hemolysis at 64 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12404,34966367,2021,GLLK-S5-IKT-S5-L,GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid},Anoplin[5-9],Amidation,Free,Stapled,L,S5 = Olefinic,8,Antibacterial,43.2 % Hemolysis at 32 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12405,34966367,2021,GLLK-S5-IKT-S5-L,GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid},Anoplin[5-9],Amidation,Free,Stapled,L,S5 = Olefinic,8,Antibacterial,29.8 % Hemolysis at 16 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12406,34966367,2021,GLLK-S5-IKT-S5-L,GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid},Anoplin[5-9],Amidation,Free,Stapled,L,S5 = Olefinic,8,Antibacterial,16.6 % Hemolysis at 8 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12407,34966367,2021,GLLK-S5-IKT-S5-L,GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid},Anoplin[5-9],Amidation,Free,Stapled,L,S5 = Olefinic,8,Antibacterial,6.5 % Hemolysis at 4 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12408,34966367,2021,GLLK-S5-IKT-S5-L,GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid},"AnoplinS5(5,9)",Amidation,Free,Linear,L,S5 = Olefinic,8,Antibacterial,14.2 % Hemolysis at 64 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12409,34966367,2021,GLLK-S5-IKT-S5-L,GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid},"AnoplinS5(5,9)",Amidation,Free,Linear,L,S5 = Olefinic,8,Antibacterial,11.9 % Hemolysis at 32 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12410,34966367,2021,GLLK-S5-IKT-S5-L,GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid},"AnoplinS5(5,9)",Amidation,Free,Linear,L,S5 = Olefinic,8,Antibacterial,8.9 % Hemolysis at 16 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12411,34966367,2021,GLLK-S5-IKT-S5-L,GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid},"AnoplinS5(5,9)",Amidation,Free,Linear,L,S5 = Olefinic,8,Antibacterial,7.2 % Hemolysis at 8 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12412,34966367,2021,GLLK-S5-IKT-S5-L,GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid},"AnoplinS5(5,9)",Amidation,Free,Linear,L,S5 = Olefinic,8,Antibacterial,6.7 % Hemolysis at 4 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12418,34908502,2021,GMFTNMLKGIGKLAGKAALGAVKTLA,GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid},Dermaseptin-AC,Amidation,Free,Linear,L,None,26,"Antibacterial, Antibiofilm",50 % Hemolysis at 76.55 µM,Horse,Frog Agalychnis Callidryas,50% TFE-10 mM NH4Ac solution = α-Helix,NA,CCSSCSCTTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)CN)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
12419,34908502,2021,GMFTNMLKGIGKLAGKAALGAVKTLA,GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid},Dermaseptin-AC,Amidation,Free,Linear,L,None,26,"Antibacterial, Antibiofilm",2.73 % Hemolysis at 2 µM,Horse,Frog Agalychnis Callidryas,50% TFE-10 mM NH4Ac solution = α-Helix,NA,CCGGGCTTCSSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)CN)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
12420,34908502,2021,GMFTNMLKGIGKLAGKAALGAVKTLA,GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid},Dermaseptin-AC,Amidation,Free,Linear,L,None,26,"Antibacterial, Antibiofilm",4.31 % Hemolysis at 4 µM,Horse,Frog Agalychnis Callidryas,50% TFE-10 mM NH4Ac solution = α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)CN)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
12421,34908502,2021,GMFTNMLKGIGKLAGKAALGAVKTLA,GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid},Dermaseptin-AC,Amidation,Free,Linear,L,None,26,"Antibacterial, Antibiofilm",7.47 % Hemolysis at 8 µM,Horse,Frog Agalychnis Callidryas,50% TFE-10 mM NH4Ac solution = α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)CN)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
12422,34825276,2022,INWLKLGKMVIDAL,INWLKLGKMVIDAL{ct:Amid},MPII,Amidation,Free,Linear,L,None,14,"Antibacterial, Antifungal",100 % Hemolysis at 256 µM,Mouse,Social Wasp Polybia Paulista,α-Helix,NA,NA,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C
12423,34825276,2022,INWLHLGHMVIDAL,INWLHLGHMVIDAL{ct:Amid},HMPII,Amidation,Free,Linear,L,None,14,"Antibacterial, Antifungal",>30 % Hemolysis at 256 µM,Mouse,Mpii Analogs,"10 mM PBS, pH 7.4 = unordered, 50% TFE in PBS = Helical",NA,NA,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C
12424,34825276,2022,INWLRLGRMVIDAL,INWLRLGRMVIDAL{ct:Amid},RMPII,Amidation,Free,Linear,L,None,14,"Antibacterial, Antifungal",100 % Hemolysis at 256 µM,Mouse,Mpii Analogs,"10 mM PBS, pH 7.4 = unordered, 50% TFE in PBS = Helical",NA,NA,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C
12425,34825276,2022,INWLOLGOMVIDAL,INWL{nnr:O}LG{nnr:O}MVIDAL{ct:Amid},OMPII,Amidation,Free,Linear,L,O = L-Ornithine,14,"Antibacterial, Antifungal",100 % Hemolysis at 256 µM,Mouse,Mpii Analogs,"10 mM PBS, pH 7.4 = unordered, 50% TFE in PBS = Helical",NA,NA,NA
12426,34825276,2022,INWL-Dab-LG-Dab-MVIDAL,INWL-{nnr:Dab}-LG-{nnr:Dab}-MVIDAL{ct:Amid},BMPII,Amidation,Free,Linear,L,"Dab = L-2, 4-Diamino butyric acids",14,"Antibacterial, Antifungal",100 % Hemolysis at 256 µM,Mouse,Mpii Analogs,"10 mM PBS, pH 7.4 = unordered, 50% TFE in PBS = Helical",NA,NA,NA
12427,34825276,2022,INWL-Dap-LG-Dap-MVIDAL,INWL-{nnr:Dap}-LG-{nnr:Dap}-MVIDAL{ct:Amid},PMPII,Amidation,Free,Linear,L,"Dap = L-2,3-Diamino-propionic",14,"Antibacterial, Antifungal, Antibiofilm",0 % Hemolysis at 256 µM,Mouse,Mpii Analogs,"10 mM PBS, pH 7.4 = unordered, 50% TFE in PBS = Helical",Non-hemolytic,NA,NA
12428,35013238,2022,KK WRK WLK WLA KK,KK WRK WLK WLA KK,W3_p1,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal",5 % Hemolysis at 120 μg/ml,Human,Synthetic Peptide,Helical,NA,CCCCGGGTHHHHCC,CC(C)C[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C=O.CC(C)C[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C=O)CCCCN.N=C(N)NCCC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C=O)CCCCN.NCCCC[C@@H](C=O)NC(=O)[C@@H](N)CCCCN.NCCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)O
12429,35013238,2022,KK WLK WLK WLK KK,KK WLK WLK WLK KK,W3_p2,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal",5 % Hemolysis at 90 μg/ml,Human,Synthetic Peptide,Helical,NA,CCTHHHHTTCC,CC(C)C[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C=O)CCCCN.CC(C)C[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C=O)CCCCN.CC(C)C[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C=O)CCCCN.NCCCC[C@@H](C=O)NC(=O)[C@@H](N)CCCCN.NCCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)O
12430,35013238,2022,KK WKC WAR WRL KK,KK WKC WAR WRL KK,W3_db5,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal",5 % Hemolysis at >>240 μg/ml,Human,Synthetic Peptide,Helical,Non-hemolytic,CCTHHHHTTCCC,CC(C)C[C@@H](C=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12.C[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C=O)CCCNC(=N)N.NCCCC[C@@H](C=O)NC(=O)[C@@H](N)CCCCN.NCCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)O.NCCCC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C=O)CS
12431,35056876,2022,INLKAIAAFAKKLI,INLKAIAAFAKKLI,MpVT,Free,Free,Linear,L,None,14,Antibacterial,<10 % Hemolysis at 50 μg/ml,Human,"Vespa Tropica, The Greater Banded Horne","Water = unordered, 40% TFE, = α-Helix",Low hemolytic,CCTHHHHTTCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)[C@@H](C)CC
12432,35056876,2022,INLKAIAAFAKKFI,INLKAIAAFAKKFI,MpVT1,Free,Free,Linear,L,None,14,Antibacterial,<10 % Hemolysis at 50 μg/ml,Human,Mpvt Analog,"Water = unordered, 40% TFE, = α-Helix",Low hemolytic,CCTHHHHTTCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)[C@@H](C)CC
12433,35056876,2022,INLKAIAAFAKALI,INLKAIAAFAKALI,MpVT3,Free,Free,Linear,L,None,14,Antibacterial,50 % Hemolysis at 100 μg/ml,Human,Mpvt Analog,"Water = unordered, 40% TFE, = α-Helix",NA,CCSCCCCCTTTCCSCCSCCCTTCCCCCCCCSSGGGHHHHTTSSCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)[C@@H](C)CC
12434,35056876,2022,KAIAAFAKKFI,KAIAAFAKKFI,MpVT4,Free,Free,Linear,L,None,11,Antibacterial,<10 % Hemolysis at 50 μg/ml,Human,Mpvt Analog,"Water = unordered, 40% TFE, = Random coil",Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)O
12435,35056876,2022,KAIAAFAKKFFI,KAIAAFAKKFFI,MpVT5,Free,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 50 μg/ml,Human,Mpvt Analog,"Water = unordered, 40% TFE, = Random coil",Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)O
12436,35056876,2022,KAIAAFAKALFI,KAIAAFAKALFI,MpVT6,Free,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 50 μg/ml,Human,Mpvt Analog,"Water = unordered, 40% TFE, = Random coil",Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)O
12437,35056876,2022,KAIAAFAAKLFI,KAIAAFAAKLFI,MpVT7,Free,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 50 μg/ml,Human,Mpvt Analog,"Water = unordered, 40% TFE, = Random coil",Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)O
12439,35145500,2022,RRLFRRILRWL,RRLFRRILRWL{ct:Amid},RW-BP-100,Amidation,Free,Linear,L,None,11,"Antibacterial, Antifungal, Antibiofilm",3.10 ± 0.77 % Hemolysis at 50 μg/ml,Sheep,Bp100 (Hybrid Of Cecropin A And Melittin M) Analogues,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12440,35145500,2022,rRLFRRILRWL,R{d}RLFRRILRWL{ct:Amid},RW-BP100-1D,Amidation,Free,Linear,Mix,None,11,Antibacterial,4.61 ± 0.47 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12441,35145500,2022,RrLFRRILRWL,RR{d}LFRRILRWL{ct:Amid},RW-BP100-2D,Amidation,Free,Linear,Mix,None,11,Antibacterial,4.83 ± 1.08 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12442,35145500,2022,RRlFRRILRWL,RRL{d}FRRILRWL{ct:Amid},RW-BP100-3D,Amidation,Free,Linear,Mix,None,11,Antibacterial,3.49 ± 0.76 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12443,35145500,2022,RRLfRRILRWL,RRLF{d}RRILRWL{ct:Amid},RW-BP100-4D*,Amidation,Free,Linear,Mix,None,11,"Antibacterial, Antifungal, Antibiofilm",0.11 ± 0.19 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12444,35145500,2022,RRLFrRILRWL,RRLFR{d}RILRWL{ct:Amid},RW-BP100-5D,Amidation,Free,Linear,Mix,None,11,Antibacterial,1.26 ± 0.54 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12445,35145500,2022,RRLFRrILRWL,RRLFRR{d}ILRWL{ct:Amid},RW-BP100-6D,Amidation,Free,Linear,Mix,None,11,Antibacterial,2.33 ± 1.51 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12446,35145500,2022,RRLFRRiLRWL,RRLFRRI{d}LRWL{ct:Amid},RW-BP100-7D,Amidation,Free,Linear,Mix,None,11,Antibacterial,0.53 ± 1.12 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12447,35145500,2022,RRLFRRIlRWL,RRLFRRIL{d}RWL{ct:Amid},RW-BP100-8D,Amidation,Free,Linear,Mix,None,11,Antibacterial,0.91 ± 0.38 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12448,35145500,2022,RRLFRRILrWL,RRLFRRILR{d}WL{ct:Amid},RW-BP100-9D,Amidation,Free,Linear,Mix,None,11,Antibacterial,0.63 ± 0.24 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12449,35145500,2022,RRLFRRILRwL,RRLFRRILRW{d}L{ct:Amid},RW-BP100-10D,Amidation,Free,Linear,Mix,None,11,Antibacterial,0.31 ± 0.37 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12450,35145500,2022,RRLFRRILRWl,RRLFRRILRWL{d}{ct:Amid},RW-BP100-11D,Amidation,Free,Linear,Mix,None,11,Antibacterial,0.65 ± 0.60 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12451,35145500,2022,rrlfrrilrwl,R{d}R{d}L{d}F{d}R{d}R{d}I{d}L{d}R{d}W{d}L{d}{ct:Amid},RW-BP100-All-D,Amidation,Free,Linear,D,None,11,Antibacterial,1.94 ± 0.94 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12452,35145500,2022,RRLFRRILRWL,RRLFRRILRWL{cyc:N-C}{ct:Amid},RW-BP100-cycle,Amidation,Free,Cyclic,L,None,11,Antibacterial,0.47 ± 0.61 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12453,35145500,2022,RRLFRRILRWL,RRLFRRILRWL{ct:Amid},RW-BP-100,Amidation,Free,Linear,L,None,11,"Antibacterial, Antifungal, Antibiofilm",4.70 ± 0.49 % Hemolysis at 100 μg/ml,Sheep,Bp100 (Hybrid Of Cecropin A And Melittin M) Analogues,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12454,35145500,2022,rRLFRRILRWL,R{d}RLFRRILRWL{ct:Amid},RW-BP100-1D,Amidation,Free,Linear,Mix,None,11,Antibacterial,5.49 ± 0.23 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12455,35145500,2022,RrLFRRILRWL,RR{d}LFRRILRWL{ct:Amid},RW-BP100-2D,Amidation,Free,Linear,Mix,None,11,Antibacterial,5.99 ± 0.79 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12456,35145500,2022,RRlFRRILRWL,RRL{d}FRRILRWL{ct:Amid},RW-BP100-3D,Amidation,Free,Linear,Mix,None,11,Antibacterial,4.04 ± 0.20 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12457,35145500,2022,RRLfRRILRWL,RRLF{d}RRILRWL{ct:Amid},RW-BP100-4D*,Amidation,Free,Linear,Mix,None,11,"Antibacterial, Antifungal, Antibiofilm",3.69 ± 0.01 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12458,35145500,2022,RRLFrRILRWL,RRLFR{d}RILRWL{ct:Amid},RW-BP100-5D,Amidation,Free,Linear,Mix,None,11,Antibacterial,2.49 ± 0.72 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12459,35145500,2022,RRLFRrILRWL,RRLFRR{d}ILRWL{ct:Amid},RW-BP100-6D,Amidation,Free,Linear,Mix,None,11,Antibacterial,3.25 ± 0.23 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12460,35145500,2022,RRLFRRiLRWL,RRLFRRI{d}LRWL{ct:Amid},RW-BP100-7D,Amidation,Free,Linear,Mix,None,11,Antibacterial,1.11 ± 0.19 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12461,35145500,2022,RRLFRRIlRWL,RRLFRRIL{d}RWL{ct:Amid},RW-BP100-8D,Amidation,Free,Linear,Mix,None,11,Antibacterial,1.38 ± 0.58 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12462,35145500,2022,RRLFRRILrWL,RRLFRRILR{d}WL{ct:Amid},RW-BP100-9D,Amidation,Free,Linear,Mix,None,11,Antibacterial,1.53 ± 0.09 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12463,35145500,2022,RRLFRRILRwL,RRLFRRILRW{d}L{ct:Amid},RW-BP100-10D,Amidation,Free,Linear,Mix,None,11,Antibacterial,1.28 ± 0.19 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12464,35145500,2022,RRLFRRILRWl,RRLFRRILRWL{d}{ct:Amid},RW-BP100-11D,Amidation,Free,Linear,Mix,None,11,Antibacterial,1.42 ± 0.15 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12465,35145500,2022,rrlfrrilrwl,R{d}R{d}L{d}F{d}R{d}R{d}I{d}L{d}R{d}W{d}L{d}{ct:Amid},RW-BP100-All-D,Amidation,Free,Linear,D,None,11,Antibacterial,2.75 ± 0.23 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12466,35145500,2022,RRLFRRILRWL,RRLFRRILRWL{cyc:N-C}{ct:Amid},RW-BP100-cycle,Amidation,Free,Cyclic,L,None,11,Antibacterial,1.19 ± 0.05 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12467,35145500,2022,RRLFRRILRWL,RRLFRRILRWL{ct:Amid},RW-BP-100,Amidation,Free,Linear,L,None,11,"Antibacterial, Antifungal, Antibiofilm",41.82 ± 2.27 % Hemolysis at 150 μg/ml,Sheep,Bp100 (Hybrid Of Cecropin A And Melittin M) Analogues,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12468,35145500,2022,rRLFRRILRWL,R{d}RLFRRILRWL{ct:Amid},RW-BP100-1D,Amidation,Free,Linear,Mix,None,11,Antibacterial,39.81 ± 0.20 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12469,35145500,2022,RrLFRRILRWL,RR{d}LFRRILRWL{ct:Amid},RW-BP100-2D,Amidation,Free,Linear,Mix,None,11,Antibacterial,39.16 ± 1.75 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12470,35145500,2022,RRlFRRILRWL,RRL{d}FRRILRWL{ct:Amid},RW-BP100-3D,Amidation,Free,Linear,Mix,None,11,Antibacterial,38.13 ± 3.12 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12471,35145500,2022,RRLfRRILRWL,RRLF{d}RRILRWL{ct:Amid},RW-BP100-4D*,Amidation,Free,Linear,Mix,None,11,"Antibacterial, Antifungal, Antibiofilm",18.75 ± 0.42 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12472,35145500,2022,RRLFrRILRWL,RRLFR{d}RILRWL{ct:Amid},RW-BP100-5D,Amidation,Free,Linear,Mix,None,11,Antibacterial,29.72 ± 0.94 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12473,35145500,2022,RRLFRrILRWL,RRLFRR{d}ILRWL{ct:Amid},RW-BP100-6D,Amidation,Free,Linear,Mix,None,11,Antibacterial,32.57 ± 1.20 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12474,35145500,2022,RRLFRRiLRWL,RRLFRRI{d}LRWL{ct:Amid},RW-BP100-7D,Amidation,Free,Linear,Mix,None,11,Antibacterial,16.17 ± 3.36 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12475,35145500,2022,RRLFRRIlRWL,RRLFRRIL{d}RWL{ct:Amid},RW-BP100-8D,Amidation,Free,Linear,Mix,None,11,Antibacterial,26.19 ± 0.10 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12476,35145500,2022,RRLFRRILrWL,RRLFRRILR{d}WL{ct:Amid},RW-BP100-9D,Amidation,Free,Linear,Mix,None,11,Antibacterial,18.14 ± 0.20 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12477,35145500,2022,RRLFRRILRwL,RRLFRRILRW{d}L{ct:Amid},RW-BP100-10D,Amidation,Free,Linear,Mix,None,11,Antibacterial,19.20 ± 2.16 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12478,35145500,2022,RRLFRRILRWl,RRLFRRILRWL{d}{ct:Amid},RW-BP100-11D,Amidation,Free,Linear,Mix,None,11,Antibacterial,17.36 ± 1.92 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12479,35145500,2022,rrlfrrilrwl,R{d}R{d}L{d}F{d}R{d}R{d}I{d}L{d}R{d}W{d}L{d}{ct:Amid},RW-BP100-All-D,Amidation,Free,Linear,D,None,11,Antibacterial,30.39 ± 2.11 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12480,35145500,2022,RRLFRRILRWL,RRLFRRILRWL{cyc:N-C}{ct:Amid},RW-BP100-cycle,Amidation,Free,Cyclic,L,None,11,Antibacterial,17.23 ± 3.08 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12481,35145500,2022,RRLFRRILRWL,RRLFRRILRWL{ct:Amid},RW-BP-100,Amidation,Free,Linear,L,None,11,"Antibacterial, Antifungal, Antibiofilm",56.67 ± 6.33 % Hemolysis at 300 μg/ml,Sheep,Bp100 (Hybrid Of Cecropin A And Melittin M) Analogues,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12482,35145500,2022,rRLFRRILRWL,R{d}RLFRRILRWL{ct:Amid},RW-BP100-1D,Amidation,Free,Linear,Mix,None,11,Antibacterial,52.88 ± 3.06 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12483,35145500,2022,RrLFRRILRWL,RR{d}LFRRILRWL{ct:Amid},RW-BP100-2D,Amidation,Free,Linear,Mix,None,11,Antibacterial,62.12 ± 6.27 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12484,35145500,2022,RRlFRRILRWL,RRL{d}FRRILRWL{ct:Amid},RW-BP100-3D,Amidation,Free,Linear,Mix,None,11,Antibacterial,55.73 ± 5.27 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12485,35145500,2022,RRLfRRILRWL,RRLF{d}RRILRWL{ct:Amid},RW-BP100-4D*,Amidation,Free,Linear,Mix,None,11,"Antibacterial, Antifungal, Antibiofilm",48.55 ± 2.53 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12486,35145500,2022,RRLFrRILRWL,RRLFR{d}RILRWL{ct:Amid},RW-BP100-5D,Amidation,Free,Linear,Mix,None,11,Antibacterial,51.41 ± 4.64 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12487,35145500,2022,RRLFRrILRWL,RRLFRR{d}ILRWL{ct:Amid},RW-BP100-6D,Amidation,Free,Linear,Mix,None,11,Antibacterial,55.81 ± 2.87 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12488,35145500,2022,RRLFRRiLRWL,RRLFRRI{d}LRWL{ct:Amid},RW-BP100-7D,Amidation,Free,Linear,Mix,None,11,Antibacterial,45.65 ± 5.13 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12489,35145500,2022,RRLFRRIlRWL,RRLFRRIL{d}RWL{ct:Amid},RW-BP100-8D,Amidation,Free,Linear,Mix,None,11,Antibacterial,50.11 ± 3.17 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12490,35145500,2022,RRLFRRILrWL,RRLFRRILR{d}WL{ct:Amid},RW-BP100-9D,Amidation,Free,Linear,Mix,None,11,Antibacterial,45.18 ± 2.41 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CCHHHHHHHHCSCSSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12491,35145500,2022,RRLFRRILRwL,RRLFRRILRW{d}L{ct:Amid},RW-BP100-10D,Amidation,Free,Linear,Mix,None,11,Antibacterial,45.08 ± 4.70 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CCHHHHHHHHCSCSSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12492,35145500,2022,RRLFRRILRWl,RRLFRRILRWL{d}{ct:Amid},RW-BP100-11D,Amidation,Free,Linear,Mix,None,11,Antibacterial,46.97 ± 6.45 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12493,35145500,2022,rrlfrrilrwl,R{d}R{d}L{d}F{d}R{d}R{d}I{d}L{d}R{d}W{d}L{d}{ct:Amid},RW-BP100-All-D,Amidation,Free,Linear,D,None,11,Antibacterial,51.40 ± 1.94 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12494,35145500,2022,RRLFRRILRWL,RRLFRRILRWL{cyc:N-C}{ct:Amid},RW-BP100-cycle,Amidation,Free,Cyclic,L,None,11,Antibacterial,48.67 ± 2.17 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CCSSEETTEECCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12495,34506798,2022,VWLSALKFIGKHLAKHQLSKL,VWLSALKFIGKHLAKHQLSKL{ct:Amid},Lycosin-II,Amidation,Free,Linear,L,None,21,"Antibacterial, Antibiofilm",1 % Hemolysis at 2 µM,Sheep,Venom Of The Spider Lycosa Singoriensis,30 mM SDS and 50% TFE = α-Helical,Low hemolytic,CTTHHHHHHHHHHHHHGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
12496,34506798,2022,VWLSALKFIGKHLAKHQLSKL,VWLSALKFIGKHLAKHQLSKL{ct:Amid},Lycosin-II,Amidation,Free,Linear,L,None,21,"Antibacterial, Antibiofilm",<5 % Hemolysis at 16 µM,Sheep,Venom Of The Spider Lycosa Singoriensis,30 mM SDS and 50% TFE = α-Helical,Low hemolytic,CTTHHHHHHHHHHHHHGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
12497,33749557,2022,RhoB-KRFKKFFKK,{conj:RhoB}-KRFKKFFKK{ct:Amid},RhoB-Ctn[1-9],Amidation,RhoB,Linear,L,"RhoB = rhodamine B (N termianl conjugate) Crotalicidin fragment, residues 1 to 9, with a N-terminal conjugated rhodamine B",9,"Antibacterial, Antifungal",0.6 % Hemolysis at 12.5 µM,Human,Crotalicidin (Rattlesnake (Crotalus Durissus Terrificus))-Derived Peptides,Helical,Low hemolytic,NA,NA
12498,33749557,2022,RhoB-KRFKKFFKK,{conj:RhoB}-KRFKKFFKK{ct:Amid},RhoB-Ctn[1-9],Amidation,RhoB,Linear,L,"RhoB = rhodamine B (N termianl conjugate) Crotalicidin fragment, residues 1 to 9, with a N-terminal conjugated rhodamine B",9,"Antibacterial, Antifungal",1.6 % Hemolysis at 25 µM,Human,Crotalicidin (Rattlesnake (Crotalus Durissus Terrificus))-Derived Peptides,Helical,Low hemolytic,NA,NA
12499,35100952,2022,KFVRSRRPRTASCALAFVN,KFVRSRRPRTASCALAFVN,ARF (26-44),Free,Free,Linear,L,None,19,"Antibacterial, Anticancer",5 % Hemolysis at 250 µM,Mouse,Arf(Alternative Reading Frame) Proteins Are P19Arf In Mice,"phosphate buffer = Random coil, 50% v/v TFE = α-Helix",Low hemolytic,CTTHHHHHHHHHHHHHGGGGTCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
12500,35792128,2022,GLKSLGRKILRAWRKAVRIVQRI,GLKSLGRKILRAWRKAVRIVQRI,MAA-41,Free,Free,Linear,L,None,23,"Antibacterial, Antibiofilm",0.6 % Hemolysis at 5 µM,Human,Hybrid Of (Bamp-28/Ll37),α-Helical,NA,CTTHHHHHHHHHHHHHGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O
12501,35792128,2022,GLKSLGRKILRAWRKAVRIVQRI,GLKSLGRKILRAWRKAVRIVQRI,MAA-41,Free,Free,Linear,L,None,23,"Antibacterial, Antibiofilm",0.8 % Hemolysis at 10 µM,Human,Hybrid Of (Bamp-28/Ll37),α-Helical,NA,CTTHHHHHHHHHHHHHGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O
12502,35792128,2022,GLKSLGRKILRAWRKAVRIVQRI,GLKSLGRKILRAWRKAVRIVQRI,MAA-41,Free,Free,Linear,L,None,23,"Antibacterial, Antibiofilm",2.5 % Hemolysis at 20 µM,Human,Hybrid Of (Bamp-28/Ll37),α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O
12503,35792128,2022,GLKSLGRKILRAWRKAVRIVQRI,GLKSLGRKILRAWRKAVRIVQRI,MAA-41,Free,Free,Linear,L,None,23,"Antibacterial, Antibiofilm",8.7 % Hemolysis at 40 µM,Human,Hybrid Of (Bamp-28/Ll37),α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O
12504,35792128,2022,GLKSLGRKILRAWRKAVRIVQRI,GLKSLGRKILRAWRKAVRIVQRI,MAA-41,Free,Free,Linear,L,None,23,"Antibacterial, Antibiofilm",10.1 % Hemolysis at 60 µM,Human,Hybrid Of (Bamp-28/Ll37),α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O
12505,35792128,2022,GLKSLGRKILRAWRKAVRIVQRI,GLKSLGRKILRAWRKAVRIVQRI,MAA-41,Free,Free,Linear,L,None,23,"Antibacterial, Antibiofilm",14.8 % Hemolysis at 80 µM,Human,Hybrid Of (Bamp-28/Ll37),α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O
12506,35792128,2022,GLKSLGRKILRAWRKAVRIVQRI,GLKSLGRKILRAWRKAVRIVQRI,MAA-41,Free,Free,Linear,L,None,23,"Antibacterial, Antibiofilm",37.2 % Hemolysis at 100 µM,Human,Hybrid Of (Bamp-28/Ll37),α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O
12507,34978443,2022,R-R-R-Bip-Bip-Bip,R-R-R-{nnr:Bip}-{nnr:Bip}-{nnr:Bip}{nt:Amid}{ct:OH},1L,OH,Amidation,Linear,L,"Bip = 4,4′-biphenyl-L-alanine",6,Antibacterial,50 % Hemolysis,Human,Synthetic Peptide,NA,NA,NA,NA
12508,34978443,2022,R-R-R-Dip-Dip-Dip,R-R-R-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{nt:Amid}{ct:OH},2L,OH,Amidation,Linear,L,"Dip = 3,3-diphenyl-L-alanine",6,Antibacterial,50 % Hemolysis at 120 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12509,34978443,2022,R-R-R-Nal-Nal-Nal,R-R-R-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{nt:Amid}{ct:OH},3L,OH,Amidation,Linear,L,Nal = 3-(2-naphthyl)-L-alanine,6,Antibacterial,50 % Hemolysis at 105 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12510,34978443,2022,R-R-R-R-Bip-Bip-Bip-Bip,R-R-R-R-{nnr:Bip}-{nnr:Bip}-{nnr:Bip}-{nnr:Bip}{nt:Amid}{ct:OH},4L,OH,Amidation,Linear,L,"Bip = 4,4′-biphenyl-L-alanine",8,Antibacterial,50 % Hemolysis,Human,Synthetic Peptide,NA,NA,NA,NA
12511,34978443,2022,R-R-R-R-Dip-Dip-Dip-Dip,R-R-R-R-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{nt:Amid}{ct:OH},5L,OH,Amidation,Linear,L,"Dip = 3,3-diphenyl-L-alanine",8,Antibacterial,50 % Hemolysis at 75 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12512,34978443,2022,R-R-R-R-Nal-Nal-Nal-Nal,R-R-R-R-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{nt:Amid}{ct:OH},6L,OH,Amidation,Linear,L,Nal = 3-(2-naphthyl)-L-alanine,8,Antibacterial,50 % Hemolysis at 70 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12513,34978443,2022,R-R-R-R-Bip-Bip-Bip,R-R-R-R-{nnr:Bip}-{nnr:Bip}-{nnr:Bip}{nt:Amid}{ct:OH},7L,OH,Amidation,Linear,L,"Bip = 4,4′-biphenyl-L-alanine",7,Antibacterial,50 % Hemolysis,Human,Synthetic Peptide,NA,NA,NA,NA
12514,34978443,2022,R-R-R-R-Dip-Dip-Dip,R-R-R-R-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{nt:Amid}{ct:OH},8L,OH,Amidation,Linear,L,"Dip = 3,3-diphenyl-L-alanine",7,Antibacterial,50 % Hemolysis at 145 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12515,34978443,2022,R-R-R-R-Nal-Nal-Nal,R-R-R-R-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{nt:Amid}{ct:OH},9L,OH,Amidation,Linear,L,Nal = 3-(2-naphthyl)-L-alanine,7,Antibacterial,50 % Hemolysis at 130 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12516,34978443,2022,R-R-R-R-Dip-Dip,R-R-R-R-{nnr:Dip}-{nnr:Dip}{nt:Amid}{ct:OH},10L,OH,Amidation,Linear,L,"Dip = 3,3-diphenyl-L-alanine",6,Antibacterial,50 % Hemolysis at 185 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12517,34978443,2022,R-R-R-R-Nal-Nal,R-R-R-R-{nnr:Nal}-{nnr:Nal}{nt:Amid}{ct:OH},11L,OH,Amidation,Linear,L,Nal = 3-(2-naphthyl)-L-alanine,6,Antibacterial,50 % Hemolysis at 180 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12518,34978443,2022,R-R-R-R-R-Dip-Dip-Dip,R-R-R-R-R-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{nt:Amid}{ct:OH},12L,OH,Amidation,Linear,L,"Dip = 3,3-diphenyl-L-alanine",8,Antibacterial,50 % Hemolysis at 165 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12519,34978443,2022,R-R-R-R-R-Nal-Nal-Nal,R-R-R-R-R-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{nt:Amid}{ct:OH},13L,OH,Amidation,Linear,L,Nal = 3-(2-naphthyl)-L-alanine,8,Antibacterial,50 % Hemolysis at 190 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12520,34978443,2022,K-K-K-K-Dip-Dip-Dip,K-K-K-K-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{nt:Amid}{ct:OH},14L,OH,Amidation,Linear,L,"Dip = 3,3-diphenyl-L-alanine",7,Antibacterial,50 % Hemolysis at 255 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12521,34978443,2022,K-K-K-K-K-Dip-Dip-Dip,K-K-K-K-K-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{nt:Amid}{ct:OH},15L,OH,Amidation,Linear,L,"Dip = 3,3-diphenyl-L-alanine",8,Antibacterial,50 % Hemolysis at 280 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12522,34978443,2022,R-Dip-R-R-Dip-Dip-R,R-{nnr:Dip}-R-R-{nnr:Dip}-{nnr:Dip}-R{nt:Amid}{ct:OH},16L,OH,Amidation,Linear,L,"Dip = 3,3-diphenyl-L-alanine",7,Antibacterial,50 % Hemolysis at 220 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12523,34978443,2022,R-R-Dip-Dip-R-R-Dip,R-R-{nnr:Dip}-{nnr:Dip}-R-R-{nnr:Dip}{nt:Amid}{ct:OH},17L,OH,Amidation,Linear,L,"Dip = 3,3-diphenyl-L-alanine",7,Antibacterial,50 % Hemolysis at 240 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12524,34978443,2022,R-Nal-R-R-Nal-Nal-R,R-{nnr:Nal}-R-R-{nnr:Nal}-{nnr:Nal}-R{nt:Amid}{ct:OH},18L,OH,Amidation,Linear,L,Nal = 3-(2-naphthyl)-L-alanine,7,Antibacterial,50 % Hemolysis at 205 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12525,34978443,2022,R-R-Nal-Nal-R-R-Nal,R-R-{nnr:Nal}-{nnr:Nal}-R-R-{nnr:Nal}{nt:Amid}{ct:OH},19L,OH,Amidation,Linear,L,Nal = 3-(2-naphthyl)-L-alanine,7,Antibacterial,50 % Hemolysis at 195 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12526,34978443,2022,R-R-R-Bip-Bip-Bip,R-R-R-{nnr:Bip}-{nnr:Bip}-{nnr:Bip}{cyc:N-C},1C,Free,Free,Cyclic,L,"Bip = 4,4′-biphenyl-L-alanine",6,Antibacterial,50 % Hemolysis,Human,Synthetic Peptide,NA,NA,NA,NA
12527,34978443,2022,R-R-R-Dip-Dip-Dip,R-R-R-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{cyc:N-C},2C,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",6,Antibacterial,50 % Hemolysis at 45 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12528,34978443,2022,R-R-R-Nal-Nal-Nal,R-R-R-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{cyc:N-C},3C,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,6,Antibacterial,50 % Hemolysis at 50 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12529,34978443,2022,R-R-R-R-Bip-Bip-Bip-Bip,R-R-R-R-{nnr:Bip}-{nnr:Bip}-{nnr:Bip}-{nnr:Bip}{cyc:N-C},4C,Free,Free,Cyclic,L,"Bip = 4,4′-biphenyl-L-alanine",8,Antibacterial,50 % Hemolysis,Human,Synthetic Peptide,NA,NA,NA,NA
12530,34978443,2022,R-R-R-R-Dip-Dip-Dip-Dip,R-R-R-R-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{cyc:N-C},5C,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",8,Antibacterial,50 % Hemolysis at 40 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12531,34978443,2022,R-R-R-R-Nal-Nal-Nal-Nal,R-R-R-R-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{cyc:N-C},6C,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,8,Antibacterial,50 % Hemolysis at 30 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12532,34978443,2022,R-R-R-R-Bip-Bip-Bip,R-R-R-R-{nnr:Bip}-{nnr:Bip}-{nnr:Bip}{cyc:N-C},7C,Free,Free,Cyclic,L,"Bip = 4,4′-biphenyl-L-alanine",7,Antibacterial,50 % Hemolysis,Human,Synthetic Peptide,NA,NA,NA,NA
12533,34978443,2022,R-R-R-R-Dip-Dip-Dip,R-R-R-R-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{cyc:N-C},8C,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",7,Antibacterial,50 % Hemolysis at 70 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12534,34978443,2022,R-R-R-R-Nal-Nal-Nal,R-R-R-R-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{cyc:N-C},9C,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,7,Antibacterial,50 % Hemolysis at 80 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12535,34978443,2022,R-R-R-R-Dip-Dip,R-R-R-R-{nnr:Dip}-{nnr:Dip}{cyc:N-C},10C,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",6,Antibacterial,50 % Hemolysis at 110 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12536,34978443,2022,R-R-R-R-Nal-Nal,R-R-R-R-{nnr:Nal}-{nnr:Nal}{cyc:N-C},11C,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,6,Antibacterial,50 % Hemolysis at 125 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12537,34978443,2022,R-R-R-R-R-Dip-Dip-Dip,R-R-R-R-R-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{cyc:N-C},12C,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",8,Antibacterial,50 % Hemolysis at 100 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12538,34978443,2022,R-R-R-R-R-Nal-Nal-Nal,R-R-R-R-R-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{cyc:N-C},13C,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,8,Antibacterial,50 % Hemolysis at 90 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12539,34978443,2022,K-K-K-K-Dip-Dip-Dip,K-K-K-K-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{cyc:N-C},14C,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",7,Antibacterial,50 % Hemolysis at 165 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12540,34978443,2022,K-K-K-K-K-Dip-Dip-Dip,K-K-K-K-K-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{cyc:N-C},15C,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",8,Antibacterial,50 % Hemolysis at 180 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12541,34978443,2022,R-Dip-R-R-Dip-Dip-R,R-{nnr:Dip}-R-R-{nnr:Dip}-{nnr:Dip}-R{cyc:N-C},16C,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",7,Antibacterial,50 % Hemolysis at 130 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12542,34978443,2022,R-R-Dip-Dip-R-R-Dip,R-R-{nnr:Dip}-{nnr:Dip}-R-R-{nnr:Dip}{cyc:N-C},17C,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",7,Antibacterial,50 % Hemolysis at 145 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12543,34978443,2022,R-Nal-R-R-Nal-Nal-R,R-{nnr:Nal}-R-R-{nnr:Nal}-{nnr:Nal}-R{cyc:N-C},18C,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,7,Antibacterial,50 % Hemolysis at 105 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12544,34978443,2022,R-R-Nal-Nal-R-R-Nal,R-R-{nnr:Nal}-{nnr:Nal}-R-R-{nnr:Nal}{cyc:N-C},19C,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,7,Antibacterial,50 % Hemolysis at 110 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12545,36465844,2022,GVKFAKRFWRFAKKAFKRFEK,GVKFAKRFWRFAKKAFKRFEK{nt:Amid},HAZ,Free,Amidation,Linear,L,None,21,"Antibacterial, Antibiofilm, Anticancer",20 % Hemolysis at 120 µM,Human,Synthetic Hybride (Palustrin-1D And Hp(2–20)) Peptide,α-Helical,NA,CTTCCCSSTTCGGGGHHHHHHHC,CC(C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
12547,36350889,2022,RKSKEKIGKEFKRIVQRIKDFLR,RKSKEKIGKEFKRIVQRIKDFLR{nt:Acet}{ct:Amid},ACLL37-1,Amidation,Acetylation,Linear,L,None,23,Antibacterial,≤5 % Hemolysis at 1.5 µM,Human,Ll37 Analogous,α-Helical,NA,CTTCCCSSTTCGGGGHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
12548,36350889,2022,GRKSAKIGKRAKRIVQRIKDFLR,GRKSAKIGKRAKRIVQRIKDFLR{nt:Acet}{ct:Amid},ACLL37-2,Amidation,Acetylation,Linear,L,None,23,Antibacterial,≤5 % Hemolysis at 1.5 µM,Human,Ll37 Analogous,α-Helical,NA,CTTCCCSSTTCGGGGHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
12549,36350889,2022,GRKSAKIGKRAKRIVQRIKDfLR,GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid},DLL37-1,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acid,23,"Antibacterial, Antibiofilm",≤5 % Hemolysis at 1.5 µM,Human,Ll37 Analogous,α-Helical,NA,CTTCCCSSTTCGGGGHHHHHHHC,NA
12551,36350889,2022,RKSKEKIGKEFKRIVQRIKDFLR,RKSKEKIGKEFKRIVQRIKDFLR{nt:Acet}{ct:Amid},ACLL37-1,Amidation,Acetylation,Linear,L,None,23,Antibacterial,≤5 % Hemolysis at 2.5 µM,Human,Ll37 Analogous,α-Helical,NA,CTTCCCSSTTCGGGGHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
12552,36350889,2022,GRKSAKIGKRAKRIVQRIKDFLR,GRKSAKIGKRAKRIVQRIKDFLR{nt:Acet}{ct:Amid},ACLL37-2,Amidation,Acetylation,Linear,L,None,23,Antibacterial,≤5 % Hemolysis at 2.5 µM,Human,Ll37 Analogous,α-Helical,NA,CTTCCCSSTTCGGGGHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
12553,36350889,2022,GRKSAKIGKRAKRIVQRIKDfLR,GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid},DLL37-1,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acid,23,"Antibacterial, Antibiofilm",≤5 % Hemolysis at 2.5 µM,Human,Ll37 Analogous,α-Helical,NA,CTTCCCSSTTCGGGGHHHHHHHC,NA
12555,36350889,2022,RKSKEKIGKEFKRIVQRIKDFLR,RKSKEKIGKEFKRIVQRIKDFLR{nt:Acet}{ct:Amid},ACLL37-1,Amidation,Acetylation,Linear,L,None,23,Antibacterial,≤5 % Hemolysis at 5 µM,Human,Ll37 Analogous,α-Helical,NA,CTTCCCSSTTCGGGGHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
12556,36350889,2022,GRKSAKIGKRAKRIVQRIKDFLR,GRKSAKIGKRAKRIVQRIKDFLR{nt:Acet}{ct:Amid},ACLL37-2,Amidation,Acetylation,Linear,L,None,23,Antibacterial,≤5 % Hemolysis at 5 µM,Human,Ll37 Analogous,α-Helical,NA,CTTCCCSSTTCGGGGHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
12557,36350889,2022,GRKSAKIGKRAKRIVQRIKDfLR,GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid},DLL37-1,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acid,23,"Antibacterial, Antibiofilm",≤5 % Hemolysis at 5 µM,Human,Ll37 Analogous,α-Helical,NA,CHHHHGGGTC,NA
12559,36350889,2022,RKSKEKIGKEFKRIVQRIKDFLR,RKSKEKIGKEFKRIVQRIKDFLR{nt:Acet}{ct:Amid},ACLL37-1,Amidation,Acetylation,Linear,L,None,23,Antibacterial,≤20 % Hemolysis at 10 µM,Human,Ll37 Analogous,α-Helical,NA,CTTTHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
12560,36350889,2022,GRKSAKIGKRAKRIVQRIKDFLR,GRKSAKIGKRAKRIVQRIKDFLR{nt:Acet}{ct:Amid},ACLL37-2,Amidation,Acetylation,Linear,L,None,23,Antibacterial,≤20 % Hemolysis at 10 µM,Human,Ll37 Analogous,α-Helical,NA,CHHHHGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
12561,36350889,2022,GRKSAKIGKRAKRIVQRIKDfLR,GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid},DLL37-1,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acid,23,"Antibacterial, Antibiofilm",≤20 % Hemolysis at 10 µM,Human,Ll37 Analogous,α-Helical,NA,CTHHHHTTTC,NA
12562,36358242,2022,WLKKWLKKLL,WLKKWLKKLL{ct:Amid},WALK244.01,Amidation,Free,Linear,L,None,10,Antibacterial,5 % Hemolysis at 16 μg/ml,Human,Synthetic Walk Peptides,"10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix",NA,CTTHHHHTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
12563,36358242,2022,KWLLKWLKKL,KWLLKWLKKL{ct:Amid},WALK244.02,Amidation,Free,Linear,L,None,10,Antibacterial,5 % Hemolysis at 32 μg/ml,Human,Synthetic Walk Peptides,"10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix",NA,CTTTHHHHCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)O
12564,36358242,2022,LKWLLKWLKK,LKWLLKWLKK{ct:Amid},WALK244.03,Amidation,Free,Linear,L,None,10,Antibacterial,5 % Hemolysis at 64 μg/ml,Human,Synthetic Walk Peptides,"10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix",Low hemolytic,CHHHHHHHCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
12565,36358242,2022,LLKWLKKWLK,LLKWLKKWLK{ct:Amid},WALK244.04,Amidation,Free,Linear,L,None,10,"Antibacterial, Anti-inflammatory",5 % Hemolysis at 64 μg/ml,Human,Synthetic Walk Peptides,"10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix",Low hemolytic,CTHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
12566,36358242,2022,KLLKWLKKWL,KLLKWLKKWL{ct:Amid},WALK244.05,Amidation,Free,Linear,L,None,10,Antibacterial,5 % Hemolysis at 32 μg/ml,Human,Synthetic Walk Peptides,"10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix",NA,CTTHHHHTTC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
12567,36358242,2022,KKLLKWLLKW,KKLLKWLLKW{ct:Amid},WALK244.06,Amidation,Free,Linear,L,None,10,Antibacterial,5 % Hemolysis at 32 μg/ml,Human,Synthetic Walk Peptides,"10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix",NA,CTHHHHTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12568,36358242,2022,LKKWLKWLLK,LKKWLKWLLK{ct:Amid},WALK244.07,Amidation,Free,Linear,L,None,10,Antibacterial,5 % Hemolysis at 32 μg/ml,Human,Synthetic Walk Peptides,"10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix",NA,CCTHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
12569,36358242,2022,WLKKLLKWLK,WLKKLLKWLK{ct:Amid},WALK244.08,Amidation,Free,Linear,L,None,10,Antibacterial,5 % Hemolysis at 8 μg/ml,Human,Synthetic Walk Peptides,"10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix",NA,CHHHHTTCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
12570,36358242,2022,KWLKKLLKWL,KWLKKLLKWL{ct:Amid},WALK244.09,Amidation,Free,Linear,L,None,10,Antibacterial,5 % Hemolysis at 8 μg/ml,Human,Synthetic Walk Peptides,"10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix",NA,CHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)O
12571,36358242,2022,LKWLKKLLKW,LKWLKKLLKW{ct:Amid},WALK244.10,Amidation,Free,Linear,L,None,10,Antibacterial,5 % Hemolysis at 32 μg/ml,Human,Synthetic Walk Peptides,"10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix",NA,CTHHHHSCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12572,36358242,2022,WLLKWLKKL,WLLKWLKKL{ct:Amid},WALK243.01,Amidation,Free,Linear,L,None,9,Antibacterial,5 % Hemolysis at 32 μg/ml,Human,Synthetic Walk Peptides,"10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix",NA,CHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
12573,36358242,2022,KWLLKWLLK,KWLLKWLLK{ct:Amid},WALK243.02,Amidation,Free,Linear,L,None,9,Antibacterial,5 % Hemolysis at 64 μg/ml,Human,Synthetic Walk Peptides,"10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix",Low hemolytic,CGGGGGGTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
12574,36358242,2022,LKWLLKWLK,LKWLLKWLK{ct:Amid},WALK243.03,Amidation,Free,Linear,L,None,9,"Antibacterial, Anti-inflammatory",5 % Hemolysis at 32 μg/ml,Human,Synthetic Walk Peptides,"10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix",NA,CHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
12575,36358242,2022,LLKWLKKWL,LLKWLKKWL{ct:Amid},WALK243.04,Amidation,Free,Linear,L,None,9,"Antibacterial, Anti-inflammatory",5 % Hemolysis at 64 μg/ml,Human,Synthetic Walk Peptides,"10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix",Low hemolytic,CTHHHHSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)O
12576,36358242,2022,KLLKWLLKW,KLLKWLLKW{ct:Amid},WALK243.05,Amidation,Free,Linear,L,None,9,Antibacterial,5 % Hemolysis at 64 μg/ml,Human,Synthetic Walk Peptides,"10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix",Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12577,36358242,2022,LKWLKWLLK,LKWLKWLLK{ct:Amid},WALK243.06,Amidation,Free,Linear,L,None,9,Antibacterial,5 % Hemolysis at 32 μg/ml,Human,Synthetic Walk Peptides,"10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix",NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
12578,36358242,2022,LKKWLKWLL,LKKWLKWLL{ct:Amid},WALK243.07,Amidation,Free,Linear,L,None,9,Antibacterial,5 % Hemolysis at 16 μg/ml,Human,Synthetic Walk Peptides,"10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix",NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)O
12579,36358242,2022,WLKKLLKWL,WLKKLLKWL{ct:Amid},WALK243.08,Amidation,Free,Linear,L,None,9,Antibacterial,5 % Hemolysis at 8 μg/ml,Human,Synthetic Walk Peptides,"10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix",NA,NA,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
12580,36358242,2022,KWLLKLLKW,KWLLKLLKW{ct:Amid},WALK243.09,Amidation,Free,Linear,L,None,9,Antibacterial,5 % Hemolysis at 64 μg/ml,Human,Synthetic Walk Peptides,"10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix",Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12581,36430320,2022,CGKKWWGWKCKL,CGKKWWGWKCKL{cyc:1-10}{ct:Amid},cTurg-2,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at >1045 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,NA,NA
12582,36430320,2022,CGKKWGWWKCKL,CGKKWGWWKCKL{cyc:1-10}{ct:Amid},cTurg-3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 849 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,CTTCCSSCCSCC,NA
12583,36430320,2022,CGKKPWWWKCKL,CGKKPWWWKCKL{cyc:1-10}{ct:Amid},cTurg-4,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at >1065 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,CTTCCSSCCSCC,NA
12584,36430320,2022,CGRRWWGWRCRL,CGRRWWGWRCRL{cyc:1-10}{ct:Amid},cTurg-5,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at >1101 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,CTTCCSSCCSCC,NA
12585,36430320,2022,CGRRWGWWRCRL,CGRRWGWWRCRL{cyc:1-10}{ct:Amid},cTurg-6,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 1101 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,CTTSCCSCCCCC,NA
12586,36430320,2022,CGRRPWWWRCRL,CGRRPWWWRCRL{cyc:1-10}{ct:Amid},cTurg-7,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 197 μg/ml,Human,Synthetic Peptide,NA,NA,CTTSCCSCCCCC,NA
12587,36430320,2022,CGKKPGGWKCKL,CGKKPGGWKCKL{nt:C8}{ct:Amid},C8-Turg-1,Amidation,C8,Linear,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at >943 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,CTTSCCSCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)O
12588,36430320,2022,CGKKPGGWKCKL,CGKKPGGWKCKL{nt:C10}{ct:Amid},C10-Turg-1,Amidation,C10,Linear,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at >957 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,CTTTSSSCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)O
12589,36430320,2022,CGKKPGGWKCKL,CGKKPGGWKCKL{nt:C12}{ct:Amid},C12-Turg-1,Amidation,C12,Linear,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at >971 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,CTTTSSSCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)O
12590,36430320,2022,CGKKWWGWKCKL,CGKKWWGWKCKL{nt:C8}{ct:Amid},C8-Turg-2,Amidation,C8,Linear,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 198 μg/ml,Human,Synthetic Peptide,NA,NA,CTTTSSSCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)O
12591,36430320,2022,CGKKWWGWKCKL,CGKKWWGWKCKL{nt:C10}{ct:Amid},C10-Turg-2,Amidation,C10,Linear,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 64 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)O
12592,36430320,2022,CGKKWWGWKCKL,CGKKWWGWKCKL{nt:C12}{ct:Amid},C12-Turg-2,Amidation,C12,Linear,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 55 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)O
12593,36430320,2022,CGRRWGWWRCRL,CGRRWGWWRCRL{nt:C8}{ct:Amid},C8-Turg-6,Amidation,C8,Linear,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 54 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)O
12594,36430320,2022,CGRRWGWWRCRL,CGRRWGWWRCRL{nt:C10}{ct:Amid},C10-Turg-6,Amidation,C10,Linear,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 21 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)O
12595,36430320,2022,CGRRWGWWRCRL,CGRRWGWWRCRL{nt:C12}{ct:Amid},C12-Turg-6,Amidation,C12,Linear,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 39 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)O
12596,36430320,2022,(CGKKPGGWKC)KL,CGKKPGGWKCKL{cyc:N-C}{nt:C8}{ct:Amid},C8-cTurg-1,Amidation,C8,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at >942 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,NA,NA
12597,36430320,2022,(CGKKPGGWKC)KL,CGKKPGGWKCKL{cyc:N-C}{nt:C10}{ct:Amid},C10-cTurg-1,Amidation,C10,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at >956 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,NA,NA
12598,36430320,2022,(CGKKPGGWKC)KL,CGKKPGGWKCKL{cyc:N-C}{nt:C12}{ct:Amid},C12-cTurg-1,Amidation,C12,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 219 μg/ml,Human,Synthetic Peptide,NA,NA,NA,NA
12599,36430320,2022,(CGKKWWGWKC)KL,CGKKWWGWKCKL{cyc:N-C}{nt:C8}{ct:Amid},C8-cTurg-2,Amidation,C8,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 439 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,NA,NA
12600,36430320,2022,(CGKKWWGWKC)KL,CGKKWWGWKCKL{cyc:N-C}{nt:C10}{ct:Amid},C10-cTurg-2,Amidation,C10,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 106 μg/ml,Human,Synthetic Peptide,NA,NA,CGGGGHHHHHHHHTTTCCC,NA
12601,36430320,2022,(CGKKWWGWKC)KL,CGKKWWGWKCKL{cyc:N-C}{nt:C12}{ct:Amid},C12-cTurg-2,Amidation,C12,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 32 μg/ml,Human,Synthetic Peptide,NA,NA,CHHHHHHTTHHHHSSSCC,NA
12602,36430320,2022,(CGRRWGWWRC)RL,CGRRWGWWRCRL{cyc:N-C}{nt:C8}{ct:Amid},C8-cTurg-6,Amidation,C8,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 30 μg/ml,Human,Synthetic Peptide,NA,NA,CHHHHTTTTCCSCCCC,NA
12603,36430320,2022,(CGRRWGWWRC)RL,CGRRWGWWRCRL{cyc:N-C}{nt:C10}{ct:Amid},C10-cTurg-6,Amidation,C10,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 16 μg/ml,Human,Synthetic Peptide,NA,NA,NA,NA
12604,36430320,2022,(CGRRWGWWRC)RL,CGRRWGWWRCRL{cyc:N-C}{nt:C12}{ct:Amid},C12-cTurg-6,Amidation,C12,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 9 μg/ml,Human,Synthetic Peptide,NA,NA,NA,NA
12605,36432731,2022,TGLGKIGYLMKKLLSKAKV,TGLGKIGYLMKKLLSKAKV,LS-AMP-F1,Free,Free,Linear,L,None,19,"Antibacterial, Antibiofilm",17 % Hemolysis at 200 µM,Mouse,Spider Lycosa Sinensis,α-Helical,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C
12606,36432731,2022,AGMKNIIDAIKKKLGGKL,AGMKNIIDAIKKKLGGKL,LS-AMP-E1,Free,Free,Linear,L,None,18,"Antibacterial, Antibiofilm",<37.5 % Hemolysis at 200 µM,Mouse,Spider Lycosa Sinensis,α-Helical,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
12607,36559073,2022,GWFSLVRKVVGGVGSL,GWFSLVRKVVGGVGSL{ct:Amid},Ramosin,Amidation,Free,Linear,L,None,16,Antibacterial,0 % Hemolysis at 128 µM,Human,Colombian Salamander Bolitoglossa Ramosi,"TFE 30% = α-Helical, water = Random coil",Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)O
12608,36704429,2022,RBRBR,{conj:2-(6-Methoxy-2-naphthyl)propionic acid}RBRBR{ct:Amid},naprolyginine,Amidation,2-(6-Methoxy-2-naphthyl)propionic acid,Linear,L,2-(6-Methoxy-2-naphthyl)propionic acid,5,Antibacterial,0 % Hemolysis at 5 µM,Human,Synthetic Conjugated Ultrashort Antimicrobial Peptide,NA,Non-hemolytic,NA,NA
12609,36704429,2022,RBRBR,{conj:2-(6-Methoxy-2-naphthyl)propionic acid}RBRBR{ct:Amid},naprolyginine,Amidation,2-(6-Methoxy-2-naphthyl)propionic acid,Linear,L,2-(6-Methoxy-2-naphthyl)propionic acid,5,Antibacterial,0 % Hemolysis at 10 µM,Human,Synthetic Conjugated Ultrashort Antimicrobial Peptide,NA,Non-hemolytic,NA,NA
12610,36704429,2022,RBRBR,{conj:2-(6-Methoxy-2-naphthyl)propionic acid}RBRBR{ct:Amid},naprolyginine,Amidation,2-(6-Methoxy-2-naphthyl)propionic acid,Linear,L,2-(6-Methoxy-2-naphthyl)propionic acid,5,Antibacterial,0 % Hemolysis at 20 µM,Human,Synthetic Conjugated Ultrashort Antimicrobial Peptide,NA,Non-hemolytic,CHHHHHHHHSCCSCC,NA
12611,36704429,2022,RBRBR,{conj:2-(6-Methoxy-2-naphthyl)propionic acid}RBRBR{ct:Amid},naprolyginine,Amidation,2-(6-Methoxy-2-naphthyl)propionic acid,Linear,L,2-(6-Methoxy-2-naphthyl)propionic acid,5,Antibacterial,0 % Hemolysis at 40 µM,Human,Synthetic Conjugated Ultrashort Antimicrobial Peptide,NA,Non-hemolytic,CHHHHHHHHSCCSCC,NA
12612,36704429,2022,RBRBR,{conj:2-(6-Methoxy-2-naphthyl)propionic acid}RBRBR{ct:Amid},naprolyginine,Amidation,2-(6-Methoxy-2-naphthyl)propionic acid,Linear,L,2-(6-Methoxy-2-naphthyl)propionic acid,5,Antibacterial,0 % Hemolysis at 60 µM,Human,Synthetic Conjugated Ultrashort Antimicrobial Peptide,NA,Non-hemolytic,CHHHHHHHHSCCSCC,NA
12613,36704429,2022,RBRBR,{conj:2-(6-Methoxy-2-naphthyl)propionic acid}RBRBR{ct:Amid},naprolyginine,Amidation,2-(6-Methoxy-2-naphthyl)propionic acid,Linear,L,2-(6-Methoxy-2-naphthyl)propionic acid,5,Antibacterial,0 % Hemolysis at 80 µM,Human,Synthetic Conjugated Ultrashort Antimicrobial Peptide,NA,Non-hemolytic,CHHHHHHHHSCCSCC,NA
12614,36704429,2022,RBRBR,{conj:2-(6-Methoxy-2-naphthyl)propionic acid}RBRBR{ct:Amid},naprolyginine,Amidation,2-(6-Methoxy-2-naphthyl)propionic acid,Linear,L,2-(6-Methoxy-2-naphthyl)propionic acid,5,Antibacterial,1 % Hemolysis at 100 µM,Human,Synthetic Conjugated Ultrashort Antimicrobial Peptide,NA,Non-hemolytic,CCCCCHHHHHHSSSHHHHHHHHHHHHSCC,NA
12615,36500545,2022,VVVNVLVKVLPPPVV,VVVNVLVKVLPPPVV{nt:Amid},P1,Free,Amidation,Linear,L,None,15,"Anti-MRSA, Antibacterial",3.40 ± 0.29 % Hemolysis at 2 μg/ml,Human,Soil Bacterium Brevibacillus Sp. Spr-20,"H2O = β-Strand and Random coil, 50 mM SDS = β-Strand, Random coil and α-Helical",NA,CCSCCHHHHHHSSTTTTTTTC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
12616,36500545,2022,VVVNVLVKVLPPPVV,VVVNVLVKVLPPPVV{nt:Amid},P1,Free,Amidation,Linear,L,None,15,"Anti-MRSA, Antibacterial",62.23 ± 0.69 % Hemolysis at 64 μg/ml,Human,Soil Bacterium Brevibacillus Sp. Spr-20,"H2O = β-Strand and Random coil, 50 mM SDS = β-Strand, Random coil and α-Helical",NA,CCSHHHHHHHHHHHSSHHHHHTTC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
12617,36500545,2022,VVVNVLVKVLPPPVV,VVVNVLVKVLPPPVV{nt:Amid},P1,Free,Amidation,Linear,L,None,15,"Anti-MRSA, Antibacterial",1.64 ± 0.17 % Hemolysis at 0.25 μg/ml,Human,Soil Bacterium Brevibacillus Sp. Spr-20,"H2O = β-Strand and Random coil, 50 mM SDS = β-Strand, Random coil and α-Helical",NA,CCCTHHHHTTTHHHHHHHSSSSSSCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
12618,36500545,2022,VVVNVLVKVLPPPVV,VVVNVLVKVLPPPVV{nt:Amid},P1,Free,Amidation,Linear,L,None,15,"Anti-MRSA, Antibacterial",5.52 ± 0.92 % Hemolysis at 32 μg/ml,Human,Soil Bacterium Brevibacillus Sp. Spr-20,"H2O = β-Strand and Random coil, 50 mM SDS = β-Strand, Random coil and α-Helical",NA,CTTCCHHHHHHHHHCCCCCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
12619,36548751,2022,MVWLLPLKFLASHVAMEQLSKLGSKIATKL,MVWLLPLKFLASHVAMEQLSKLGSKIATKL{ct:Amid},M-lycotoxin-Lp1a,Amidation,Free,Linear,L,None,30,Antibacterial,50 % Hemolysis at >100 µM,Sheep,Spider Lycosa Poonaensis,50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix,Non-hemolytic,CCSSCTHHHHHHHTCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
12620,36548751,2022,VIWLPALKFLASHIAMEQLSKL,VIWLPALKFLASHIAMEQLSKL{ct:Amid},M-lycotoxin-Lp1b,Amidation,Free,Linear,L,None,22,Antibacterial,50 % Hemolysis at >100 µM,Sheep,Spider Lycosa Poonaensis,50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix,Non-hemolytic,CHHHHHHHHHHHHSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
12621,36548751,2022,IWLTALKFIGKNLGKHFAKQQLSKL,IWLTALKFIGKNLGKHFAKQQLSKL{ct:Amid},M-lycotoxin-Lp3a,Amidation,Free,Linear,L,None,25,Antibacterial,50 % Hemolysis at >100 µM,Sheep,Spider Lycosa Poonaensis,50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix,Non-hemolytic,CCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)O
12622,36548751,2022,KIKWFKAMKSIAKVAKKQLKKHLGGEN,KIKWFKAMKSIAKVAKKQLKKHLGGEN{ct:Amid},M-lycotoxin-Lp4,Amidation,Free,Linear,L,None,27,Antibacterial,50 % Hemolysis at >100 µM,Sheep,Spider Lycosa Poonaensis,50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix,Non-hemolytic,CCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
12623,36548751,2022,AGLGKIGAFIKKAAIKAKAA,AGLGKIGAFIKKAAIKAKAA{ct:Amid},M-lycotoxin-Lp5a,Amidation,Free,Linear,L,None,20,Antibacterial,50 % Hemolysis at >100 µM,Sheep,Spider Lycosa Poonaensis,50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix,Non-hemolytic,CCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
12624,36548751,2022,AGLGKIGALIKKAAIKAKAA,AGLGKIGALIKKAAIKAKAA{ct:Amid},M-lycotoxin-Lp5b,Amidation,Free,Linear,L,None,20,Antibacterial,50 % Hemolysis at >100 µM,Sheep,Spider Lycosa Poonaensis,50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix,Non-hemolytic,CCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
12625,36548751,2022,SKWKAFLAKMKEIASEAL,SKWKAFLAKMKEIASEAL{ct:Amid},M-lycotoxin-Lp6,Amidation,Free,Linear,L,None,18,Antibacterial,50 % Hemolysis at >100 µM,Sheep,Spider Lycosa Poonaensis,50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix,Non-hemolytic,CCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O
12626,36442155,2022,RRRRWWWW,RRRRWWWW{cyc:N-C},1,Free,Free,Cyclic,L,None,8,Antibacterial,50 % Hemolysis at 175 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12627,36442155,2022,RRWWW,RRWWW{cyc:N-C},2a,Free,Free,Cyclic,L,None,5,Antibacterial,50 % Hemolysis at 120 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12628,36442155,2022,RRWWWW,RRWWWW{cyc:N-C},2b,Free,Free,Cyclic,L,None,6,Antibacterial,50 % Hemolysis at 85 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12629,36442155,2022,RRRWWW,RRRWWW{cyc:N-C},3a,Free,Free,Cyclic,L,None,6,Antibacterial,50 % Hemolysis at 155 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12630,36442155,2022,RRRWWWW,RRRWWWW{cyc:N-C},3b,Free,Free,Cyclic,L,None,7,Antibacterial,50 % Hemolysis at 105 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12631,36442155,2022,RRRWWWWW,RRRWWWWW{cyc:N-C},3c,Free,Free,Cyclic,L,None,8,Antibacterial,50 % Hemolysis at 80 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12632,36442155,2022,RRRWWWWWW,RRRWWWWWW{cyc:N-C},3d,Free,Free,Cyclic,L,None,9,Antibacterial,50 % Hemolysis at 65 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12633,36442155,2022,RRRWWWWWWW,RRRWWWWWWW{cyc:N-C},3e,Free,Free,Cyclic,L,None,10,Antibacterial,50 % Hemolysis at 60 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12634,36442155,2022,rrrrWWWW,R{d}R{d}R{d}R{d}WWWW{cyc:N-C},4a,Free,Free,Cyclic,Mix,r = D-Arginine,8,Antibacterial,50 % Hemolysis at 110 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCSCC,NA
12635,36442155,2022,RRRRWWWWW,RRRRWWWWW{cyc:N-C},4b,Free,Free,Cyclic,L,None,9,Antibacterial,50 % Hemolysis at 100 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12636,36442155,2022,RRRRWWWWWW,RRRRWWWWWW{cyc:N-C},4c,Free,Free,Cyclic,L,None,10,Antibacterial,50 % Hemolysis at 75 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12637,36442155,2022,RRRRWWWWWWW,RRRRWWWWWWW{cyc:N-C},4d,Free,Free,Cyclic,L,None,11,Antibacterial,50 % Hemolysis at 60 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCSCCSSSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12638,36442155,2022,RRRRRWWWW,RRRRRWWWW{cyc:N-C},5a,Free,Free,Cyclic,L,None,9,Antibacterial,50 % Hemolysis at 340 μg/ml,Human,Synthetic Cyclic Peptide,NA,Low hemolytic,CCCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12639,36442155,2022,RRRRRWWWWW,RRRRRWWWWW{cyc:N-C},5b,Free,Free,Cyclic,L,None,10,Antibacterial,50 % Hemolysis at 230 μg/ml,Human,Synthetic Cyclic Peptide,NA,Low hemolytic,CCCCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12640,36442155,2022,RRRRRWWWWWW,RRRRRWWWWWW{cyc:N-C},5c,Free,Free,Cyclic,L,None,11,Antibacterial,50 % Hemolysis at 140 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12641,36442155,2022,RRRRRWWWWWWW,RRRRRWWWWWWW{cyc:N-C},5d,Free,Free,Cyclic,L,None,12,Antibacterial,50 % Hemolysis at 115 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCSSCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12642,36442155,2022,RRRRRRWWWW,RRRRRRWWWW{cyc:N-C},6a,Free,Free,Cyclic,L,None,10,Antibacterial,50 % Hemolysis at 265 μg/ml,Human,Synthetic Cyclic Peptide,NA,Low hemolytic,CCCCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12643,36442155,2022,RRRRRRWWWWW,RRRRRRWWWWW{cyc:N-C},6b,Free,Free,Cyclic,L,None,11,Antibacterial,50 % Hemolysis at 255 μg/ml,Human,Synthetic Cyclic Peptide,NA,Low hemolytic,CCCCCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12644,36442155,2022,RRRRRRWWWWWW,RRRRRRWWWWWW{cyc:N-C},6c,Free,Free,Cyclic,L,None,12,Antibacterial,50 % Hemolysis at 170 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCCCSSSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12645,36442155,2022,RRRRRRWWWWWWW,RRRRRRWWWWWWW{cyc:N-C},6d,Free,Free,Cyclic,L,None,13,Antibacterial,50 % Hemolysis at 85 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCSCCSSSSCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12646,36442155,2022,RRRRRRRWWWW,RRRRRRRWWWW{cyc:N-C},7a,Free,Free,Cyclic,L,None,11,Antibacterial,50 % Hemolysis at 190 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CHHHHHHHHTTTTTC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12647,36442155,2022,RRRRRRRWWWWW,RRRRRRRWWWWW{cyc:N-C},7b,Free,Free,Cyclic,L,None,12,Antibacterial,50 % Hemolysis at 175 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12648,36442155,2022,RRRRRRRWWWWWW,RRRRRRRWWWWWW{cyc:N-C},7c,Free,Free,Cyclic,L,None,13,Antibacterial,50 % Hemolysis at 170 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCSSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12649,36442155,2022,RRRRRRRWWWWWWW,RRRRRRRWWWWWWW{cyc:N-C},7d,Free,Free,Cyclic,L,None,14,Antibacterial,50 % Hemolysis at 140 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCSSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12655,36480332,2022,WFKFFKKFFKKWK,WFKFFKKFFKKWK,Pm11,Free,Free,Linear,L,None,13,Antibacterial,10.19 ± 2.29 % Hemolysis at 160 µM,Sheep,Flatfish Pleuronecies Americanus,α-Helix,Low hemolytic,CCTTGGGTTTTCC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
12656,36480332,2022,WFKFFKKFFKKWK,WFKFFKKFFKKWK,Pm11,Free,Free,Linear,L,None,13,Antibacterial,1.96 ± 0.13 % Hemolysis at 80 µM,Sheep,Flatfish Pleuronecies Americanus,α-Helix,Low hemolytic,CCTTGGGTTTTCC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
12657,36480332,2022,WFKFFKKFFKKWK,WFKFFKKFFKKWK,Pm11,Free,Free,Linear,L,None,13,Antibacterial,0.44 ± 0.44 % Hemolysis at 40 µM,Sheep,Flatfish Pleuronecies Americanus,α-Helix,Low hemolytic,CCTTGGGTTTTCC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
12658,36480332,2022,WFKFFKKFFKKWK,WFKFFKKFFKKWK,Pm11,Free,Free,Linear,L,None,13,Antibacterial,0.15 ± 0.23 % Hemolysis at 20 µM,Sheep,Flatfish Pleuronecies Americanus,α-Helix,Low hemolytic,CCTTGGGTTTTCC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
12659,36480332,2022,WFKFFKKFFKKWK,WFKFFKKFFKKWK,Pm11,Free,Free,Linear,L,None,13,Antibacterial,0.65 ± 0.22 % Hemolysis at 10 µM,Sheep,Flatfish Pleuronecies Americanus,α-Helix,Low hemolytic,CCTTGGGTTTTCC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
12660,36480332,2022,WFKFFKKFFKKWK,WFKFFKKFFKKWK,Pm11,Free,Free,Linear,L,None,13,Antibacterial,0.34 ± 0.31 % Hemolysis at 5 µM,Sheep,Flatfish Pleuronecies Americanus,α-Helix,Low hemolytic,CCCSSCCSSEESSSEECCCSGGGSSSCSSTTCCCCSGGGTSCCCCCC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
12661,36480332,2022,WFKFFKKFFKKWK,WFKFFKKFFKKWK,Pm11,Free,Free,Linear,L,None,13,Antibacterial,0.06 ± 0.08 % Hemolysis at 2.5 µM,Sheep,Flatfish Pleuronecies Americanus,α-Helix,Low hemolytic,CCCSSCCSSEESSSEECCCSGGGSSSCSSTTCCCCSGGGTSCCCCCC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
12662,36480332,2022,WFKFFKKFFKKWK,WFKFFKKFFKKWK,Pm11,Free,Free,Linear,L,None,13,Antibacterial,0.22 ± 0.20 % Hemolysis at 1.2 µM,Sheep,Flatfish Pleuronecies Americanus,α-Helix,Low hemolytic,CCCSSCCSSEESSSEECCCSGGGSSSCSSTTCCCCSGGGTSCCCCCC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
12663,36480332,2022,WFKFFKKFFKKWK,WFKFFKKFFKKWK,Pm11,Free,Free,Linear,L,None,13,Antibacterial,0.13 ± 0.23 % Hemolysis at 0.6 µM,Sheep,Flatfish Pleuronecies Americanus,α-Helix,Low hemolytic,CCCSSCCSSEESSSEECCCSGGGSSSCSSTTCCCCSGGGTSCCCCCC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
12664,36480332,2022,WFKFFKKFFKKWK,WFKFFKKFFKKWK,Pm11,Free,Free,Linear,L,None,13,Antibacterial,0.09 ± 0.16 % Hemolysis at 0.3 µM,Sheep,Flatfish Pleuronecies Americanus,α-Helix,Low hemolytic,CCSCCC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
12692,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 5 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CCTTTTTTTHHHHGGGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12693,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 10 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CCTTTTTTTHHHHGGGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12694,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 20 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CTHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12695,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 40 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CTHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12696,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 60 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CTHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12697,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 80 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CCGGGCSSHHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12698,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 100 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CCGGGCSSHHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12699,36668862,2023,LLKKVLALLKKVL,LLKKVLALLKKVL{nt:Amid},Hp-MAP3,Free,Amidation,Linear,L,None,13,"Antibacterial, Antibiofilm, Antifungal, Anticancer",~15 % Hemolysis at 10.8 µM,mouse,Temporin-Pta Analog,50% TFE or SDS = α-Helix,NA,CCCCCSGGGTTTCCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(=O)O
12700,36668862,2023,LLKKVLALLKKVL,LLKKVLALLKKVL{nt:Amid},Hp-MAP3,Free,Amidation,Linear,L,None,13,"Antibacterial, Antibiofilm, Antifungal, Anticancer",25 % Hemolysis at 21.6 µM,mouse,Temporin-Pta Analog,50% TFE or SDS = α-Helix,NA,CCSSCCCTTTTTTCCTTSSSTTSBSSSBC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(=O)O
12701,36668862,2023,LLKKVLALLKKVL,LLKKVLALLKKVL{nt:Amid},Hp-MAP3,Free,Amidation,Linear,L,None,13,"Antibacterial, Antibiofilm, Antifungal, Anticancer",~85 % Hemolysis at 43.3 µM,mouse,Temporin-Pta Analog,50% TFE or SDS = α-Helix,NA,CCSGGGGGHHHHHHHTTCCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(=O)O
12702,36760504,2023,VNFKLLSHSLLVTLRSHL,VNFKLLSHSLLVTLRSHL,HJH-3,Free,Free,Linear,L,None,18,Antibacterial,7.31 % Hemolysis at 100 μg/ml,Chicken,Synthetic Peptide,α-Helix,Low hemolytic,CCCSSCHHHHHHHHHHHHHHHHHTTC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
12703,36760504,2023,VNFKLLSHSLLVTLRSHL,VNFKLLSHSLLVTLRSHL,HJH-3,Free,Free,Linear,L,None,18,Antibacterial,13.37 % Hemolysis at 400 μg/ml,Chicken,Synthetic Peptide,α-Helix,Low hemolytic,CCSSCCCTTTTTTCCTTSSSTTSBSSSBC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
12704,36327032,2023,RNCKWLFKTWLKLPK,RNCKWLFKTWLKLPK{nt:Amid},RN15m4,Free,Amidation,Linear,L,None,15,Antibacterial,<12 % Hemolysis at 200 μg/ml,Human,Analog Of Rn15 (Cathelin Domain Of Crocodylus Siamensis),73.33% α-Helix,Low hemolytic,CCSGGGGGHHHHHHHTTCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
12705,36769243,2023,MNLVDRAILIRKRRRAALQLRDKVLRYLK,MNLVDRAILIRKRRRAALQLRDKVLRYLK,AMP 1,Free,Free,Linear,L,None,29,Antibacterial,29.2 ± 32 % Hemolysis at 100 µM,Mouse,Synthetic Peptide,NA,NA,CCCSSCHHHHHHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)CC
12706,36769243,2023,MKRKKKILIKKVLKLKSSAY,MKRKKKILIKKVLKLKSSAY,AMP 2,Free,Free,Linear,L,None,20,Antibacterial,14.9 ± 14.9 % Hemolysis at 100 µM,Mouse,Synthetic Peptide,NA,NA,CCSSCCCTTTTTTCCTTSSSTTSBSSSBC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
12707,36769243,2023,MTDGRYLIKRVKKKKKAVLQLILKFL,MTDGRYLIKRVKKKKKAVLQLILKFL,AMP 3,Free,Free,Linear,L,None,26,Antibacterial,50.1 ± 14.4 % Hemolysis at 100 µM,Mouse,Synthetic Peptide,NA,NA,CCSGGGGGHHHHHHHTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
12708,36769243,2023,MNLVDRAILIRKRRRAALQLRDKVLRYLK,MNLVDRAILIRKRRRAALQLRDKVLRYLK,AMP 1,Free,Free,Linear,L,None,29,Antibacterial,12.9 ± 1.7 % Hemolysis at 100 µM,Rat,Synthetic Peptide,NA,NA,CCCSSCHHHHHHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)CC
12709,36769243,2023,MKRKKKILIKKVLKLKSSAY,MKRKKKILIKKVLKLKSSAY,AMP 2,Free,Free,Linear,L,None,20,Antibacterial,5.2 ± 1.9 % Hemolysis at 100 µM,Rat,Synthetic Peptide,NA,NA,CCSSCCCTTTTTTCCTTSSSTTSBSSSBC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
12710,36769243,2023,MTDGRYLIKRVKKKKKAVLQLILKFL,MTDGRYLIKRVKKKKKAVLQLILKFL,AMP 3,Free,Free,Linear,L,None,26,Antibacterial,29.5 ± 8.2 % Hemolysis at 100 µM,Rat,Synthetic Peptide,NA,NA,CCSGGGGGHHHHHHHTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
12711,36769243,2023,MNLVDRAILIRKRRRAALQLRDKVLRYLK,MNLVDRAILIRKRRRAALQLRDKVLRYLK,AMP 1,Free,Free,Linear,L,None,29,Antibacterial,7.1 ± 1.1 % Hemolysis at 100 µM,Rabbit,Synthetic Peptide,NA,NA,CCCSSCHHHHHHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)CC
12712,36769243,2023,MKRKKKILIKKVLKLKSSAY,MKRKKKILIKKVLKLKSSAY,AMP 2,Free,Free,Linear,L,None,20,Antibacterial,4.6 ± 0.7 % Hemolysis at 100 µM,Rabbit,Synthetic Peptide,NA,NA,CCCTTHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
12713,36769243,2023,MTDGRYLIKRVKKKKKAVLQLILKFL,MTDGRYLIKRVKKKKKAVLQLILKFL,AMP 3,Free,Free,Linear,L,None,26,Antibacterial,53.2 ± 7.4 % Hemolysis at 100 µM,Rabbit,Synthetic Peptide,NA,NA,CCCTTHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
12714,36769243,2023,MNLVDRAILIRKRRRAALQLRDKVLRYLK,MNLVDRAILIRKRRRAALQLRDKVLRYLK,AMP 1,Free,Free,Linear,L,None,29,Antibacterial,22.3 ± 4 % Hemolysis at 100 µM,Human,Synthetic Peptide,NA,NA,CGGGGTHHHHGGGHHHHHTTCTTSCSCSSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)CC
12715,36769243,2023,MKRKKKILIKKVLKLKSSAY,MKRKKKILIKKVLKLKSSAY,AMP 2,Free,Free,Linear,L,None,20,Antibacterial,8.5 ± 1.4 % Hemolysis at 100 µM,Human,Synthetic Peptide,NA,NA,CCCCTTSSCSCCCCCCCSSCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
12716,36769243,2023,MTDGRYLIKRVKKKKKAVLQLILKFL,MTDGRYLIKRVKKKKKAVLQLILKFL,AMP 3,Free,Free,Linear,L,None,26,Antibacterial,37 ± 5.1 % Hemolysis at 100 µM,Human,Synthetic Peptide,NA,NA,CCCCCHHHHHHHHIIIIIHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
12717,36837754,2023,INLKAIAALAKKLF,INLKAIAALAKKLF{ct:Amid},Mastoparan-AF,Amidation,Free,Linear,L,None,14,Antibacterial,<5 % Hemolysis at 256 μg/ml,Sheep,Hornet Venom Of Vespa Affinis,"Water = Disordered, SDS = Helical",Low hemolytic,CCCCCCSSCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12718,36837754,2023,INLKAIAALAKKLF,INLKAIAALAKKLF{ct:Amid},Mastoparan-AF,Amidation,Free,Linear,L,None,14,Antibacterial,>35 % Hemolysis at 256 μg/ml,Chicken,Hornet Venom Of Vespa Affinis,"Water = Disordered, SDS = Helical",NA,CCCCCHHHHHHHHHHHHHTTTSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12719,36903328,2023,KRFKKFFKKLRKSVKKRVKKFFKKPKVIGVSIPF,KRFKKFFKKLRKSVKKRVKKFFKKPKVIGVSIPF,Hydrostatin-AMP2,Free,Free,Linear,L,None,34,"Antibacterial, Anti-biofilm",4.6 % Hemolysis at 250 μg/ml,Human,Sea Snake Hydrophis Cyanocinctus,"Water = Random coil, SDS = α-Helical",Low hemolytic,CCCEEETTEEECCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)C(C)C
12720,36908510,2023,RFRPPIRRPPIRPPFRPPFRPPVR,RFRPPIRRPPIRPPFRPPFRPPVR,OaBac5mini,Free,Free,Linear,L,None,24,Antibacterial,−1.26 to 1.59 % Hemolysis at 400 μg/ml,Rabbit,Active Fragment Of The Sheep-Derived,Random coil,Non-hemolytic,CCCCCSSTTTTTSCCCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC
12726,36979401,2023,KWKWRPLKRKLVLRM,KWKWRPLKRKLVLRM,PAM-5,Free,Free,Linear,L,None,15,Antibacterial,<1 % Hemolysis at 256 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,CGGGTTTTTTSSTTC,CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)O
12727,36914718,2023,LGIKILWSAYKHRKTI,LGIKILWSAYKHRKTI{ct:CH3-(CH2)3-CONH},L-6-C5,CH3-(CH2)3-CONH,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at > 100 µM,Human,Synthetic Lippopeptide,NA,Low hemolytic,CGGGTTTTTTSSTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)O
12728,36914718,2023,LGIKILWSAYKHRKTI,LGIKILWSAYKHRKTI{ct:CH3-(CH2)3-CONH},D-6-C5,CH3-(CH2)3-CONH,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at > 100 µM,Human,Synthetic Lippopeptide,NA,Low hemolytic,CCCSSGGGGTSCSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)O
12729,36914718,2023,LGLKLLWSAYKHRKTL,LGLKLLWSAYKHRKTL{ct:CH3-(CH2)3-CONH},L-6-C5-Leu,CH3-(CH2)3-CONH,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at > 100 µM,Human,Synthetic Lippopeptide,NA,Low hemolytic,CCCSSGGGGTSCSCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)O
12730,36914718,2023,LGLKLLWSAYKHRKTL,LGLKLLWSAYKHRKTL{ct:CH3-(CH2)3-CONH},D-6-C5-Leu,CH3-(CH2)3-CONH,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at > 100 µM,Human,Synthetic Lippopeptide,NA,Low hemolytic,CGGGTTTTTTSSTTC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)O
12731,36914718,2023,LGIKILWSAYKHRKTI,LGIKILWSAYKHRKTI{ct:CH3-(CH2)4-CONH},L-6-C6,CH3-(CH2)4-CONH,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at > 100 µM,Human,Synthetic Lippopeptide,NA,Low hemolytic,CGGGTTTTTTSSTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)O
12732,36914718,2023,LGIKILWSAYKHRKTI,LGIKILWSAYKHRKTI{ct:CH3-(CH2)4-CONH},D-6-C6,CH3-(CH2)4-CONH,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at > 100 µM,Human,Synthetic Lippopeptide,NA,Low hemolytic,CCCSSGGGGTSCSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)O
12733,36914718,2023,LGLKLLWSAYKHRKTL,LGLKLLWSAYKHRKTL{ct:CH3-(CH2)4-CONH},L-6-C6-Leu,CH3-(CH2)4-CONH,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at 60 µM,Human,Synthetic Lippopeptide,NA,NA,CCCSSGGGGTSCSCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)O
12734,36914718,2023,LGLKLLWSAYKHRKTL,LGLKLLWSAYKHRKTL{ct:CH3-(CH2)4-CONH},D-6-C6-Leu,CH3-(CH2)4-CONH,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at 65 µM,Human,Synthetic Lippopeptide,NA,NA,CGGGTTCTTTTC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)O
12735,36914718,2023,LGIKILWSAYKHRKTI,LGIKILWSAYKHRKTI{ct:CH3-(CH2)5-CONH},L-6-C7,CH3-(CH2)5-CONH,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at 80 µM,Human,Synthetic Lippopeptide,NA,NA,CGGGTTCTTTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)O
12736,36914718,2023,LGIKILWSAYKHRKTI,LGIKILWSAYKHRKTI{ct:CH3-(CH2)5-CONH},D-6-C7,CH3-(CH2)5-CONH,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at 65 µM,Human,Synthetic Lippopeptide,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)O
12737,36914718,2023,LGLKLLWSAYKHRKTL,LGLKLLWSAYKHRKTL{ct:CH3-(CH2)5-CONH},L-6-C7-Leu,CH3-(CH2)5-CONH,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at 30 µM,Human,Synthetic Lippopeptide,NA,NA,CGGGGGGHHHHTC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)O
12738,36914718,2023,LGLKLLWSAYKHRKTL,LGLKLLWSAYKHRKTL{ct:CH3-(CH2)5-CONH},D-6-C7-Leu,CH3-(CH2)5-CONH,Free,Linear,L,None,16,Antibacterial,5 % Hemolysis at 35 µM,Human,Synthetic Lippopeptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)O
12739,36982579,2023,KRIVQRIKDFLR,KRIVQRIKDFLR{ct:Amid},KR12-NH2,Amidation,Free,Linear,L,None,12,Antibacterial,5 % Hemolysis at ≥512 μg/ml,Human,Ll-37-Derived Peptide Fragment,POPG and POPC = α-Helical,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12740,36982579,2023,KRIVQRIKDFLR,KRIVQRIKDFLR{nt:C8}{ct:Amid},C8α-KR12-NH2,Amidation,C8,Linear,L,None,12,Antibacterial,5 % Hemolysis at 64 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12741,36982579,2023,K(C8)RIVQRIKDFLR,K{conj:C8}RIVQRIKDFLR{ct:Amid},C8ε-KR12-NH2,Amidation,Free,Linear,L,C8 = C8,12,Antibacterial,5 % Hemolysis at ≥512 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,Non-hemolytic,NA,NA
12742,36982579,2023,KKRIVQRIKDFLR,KKRIVQRIKDFLR{nt:C8}{ct:Amid},C8α-Lys-KR12-NH2,Amidation,C8,Linear,L,C8 = C8,13,Antibacterial,5 % Hemolysis at 256 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,Low hemolytic,NA,NA
12743,36982579,2023,K(C8)KRIVQRIKDFLR,K{conj:C8}KRIVQRIKDFLR{ct:Amid},C8ε-Lys-KR12-NH2,Amidation,Free,Linear,L,C8 = C8,13,Antibacterial,5 % Hemolysis at 256 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,Low hemolytic,NA,NA
12744,36982579,2023,KRIVQRIKDFLRK(C8),KRIVQRIKDFLRK{conj:C8}{ct:Amid},KR12-Lysε(C8)-NH2,Amidation,Free,Linear,L,C8 = C8,13,Antibacterial,5 % Hemolysis at ≥512 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,Non-hemolytic,NA,NA
12745,36982579,2023,KRIVQRIKDFLK(C8),KRIVQRIKDFLK{conj:C8}{ct:Amid},[Lysε(C8)]12KR12-NH2,Amidation,Free,Linear,L,C8 = C8,12,Antibacterial,5 % Hemolysis at ≥512 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,Non-hemolytic,NA,NA
12746,36982579,2023,KRIVQRIK(C8)DFLR,KRIVQRIK{conj:C8}DFLR{ct:Amid},[Lysε(C8)]8KR12-NH2,Amidation,Free,Linear,L,C8 = C8,12,Antibacterial,5 % Hemolysis at 64 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,NA,NA,NA
12747,36982579,2023,K(C8)RIVQRIKDFLR,K{conj:C8}RIVQRIKDFLR{nt:C8}{ct:Amid},"C8α,C8ε-KR12-NH2",Amidation,C8,Linear,L,C8 = C8,12,Antibacterial,5 % Hemolysis at 8 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,NA,NA,NA
12748,36982579,2023,K(C4)RIVQRIKDFLR,K{conj:C4}RIVQRIKDFLR{nt:C4}{ct:Amid},"C4α, C4ε-KR12-NH2",Amidation,C4,Linear,L,C4 = C4,12,Antibacterial,5 % Hemolysis at ≥512 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,Non-hemolytic,NA,NA
12749,36982579,2023,RLFDKIRQVIRK(C8),RLFDKIRQVIRK{conj:C8}{ct:Amid},retro-KR12-C8ε-NH2,Amidation,Free,Linear,L,C8 = C8,12,Antibacterial,5 % Hemolysis at 256 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,Low hemolytic,NA,NA
12750,36982579,2023,RLFDKIRQVIRK,RLFDKIRQVIRK{nt:C8}{ct:Amid},C8α-retro-KR12-NH2,Amidation,C8,Linear,L,C8 = C8,12,Antibacterial,5 % Hemolysis at ≥512 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,Non-hemolytic,CGGGTTCTTTTC,NA
12751,36982579,2023,KRIVQRIKDFLR,KRIVQRIKDFLR{nt:CH3-(CH2)5-CH(C4H9)-CO}{ct:Amid},2-Buthyloctanoic acid-KR12-NH2,Amidation,CH3-(CH2)5-CH(C4H9)-CO,Linear,L,CH3-(CH2)5-CH(C4H9)-CO,12,Antibacterial,5 % Hemolysis at 16 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,NA,CGGGTTCTTTTC,NA
12752,36982579,2023,KRIVQRIKDFLR,KRIVQRIKDFLR{nt:CH3-(CH2)3-CH(C2H5)-CO}{ct:Amid},2-Ethylhexanoic acid-KR12-NH2,Amidation,CH3-(CH2)3-CH(C2H5)-CO,Linear,L,CH3-(CH2)3-CH(C2H5)-CO,12,Antibacterial,5 % Hemolysis at 256 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,Low hemolytic,CGGGTTCTTTTC,NA
12753,36982579,2023,KRIVQRIKDFLR,KRIVQRIKDFLR{nt:C6H5-CO}{ct:Amid},Benzoic acid-KR12-NH2,Amidation,C6H5-CO,Linear,L,C6H5-CO,12,Antibacterial,5 % Hemolysis at ≥512 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,Non-hemolytic,CGGGTTCTTTTC,NA
12754,36982579,2023,KRIVQRIKDFLR,KRIVQRIKDFLR{nt:C6H5-CH2-CO}{ct:Amid},Phenylacetic acid-KR12-NH2,Amidation,C6H5-CH2-CO,Linear,L,C6H5-CH2-CO,12,Antibacterial,5 % Hemolysis at 256 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,Low hemolytic,CGGGTTCTTTTC,NA
12755,36982579,2023,KRIVQRIKDFLR,KRIVQRIKDFLR{nt:C6H5-CH2-CH2-CO}{ct:Amid},3-Phenylpropionic acid- KR12-NH2,Amidation,C6H5-CH2-CH2-CO,Linear,L,C6H5-CH2-CH2-CO,12,Antibacterial,5 % Hemolysis at 256 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,Low hemolytic,CGGGTTCTTTTC,NA
12756,36982579,2023,KRIVQRIKDFLR,KRIVQRIKDFLR{nt:C6H5-(CH2)3-CO}{ct:Amid},4-Phenylbutanoic acid-KR12-NH2,Amidation,C6H5-(CH2)3-CO,Linear,L,C6H5-(CH2)3-CO,12,Antibacterial,5 % Hemolysis at 128 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,NA,CCCTHHHHHTTC,NA
12757,36982579,2023,KRIVQRIKDFLR,KRIVQRIKDFLR{nt:C6H5-CH=CH-CO}{ct:Amid},trans-cinnamic acid-KR12-NH2,Amidation,C6H5-CH=CH-CO,Linear,L,C6H5-CH=CH-CO,12,Antibacterial,5 % Hemolysis at 128 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,NA,CCSCCCCCCC,NA
12758,36982579,2023,KRIVQRIKDFLR,KRIVQRIKDFLR{nt:C6H5-C≡C-CO}{ct:Amid},Phenylpropiolic acid-KR12-NH2,Amidation,C6H5-C≡C-CO,Linear,L,C6H5-C≡C-CO,12,Antibacterial,5 % Hemolysis at 256 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,Low hemolytic,CCSSSSTTC,NA
12759,36982579,2023,KRIVQRIKDFLR,KRIVQRIKDFLR{nt:C6H5-C6H4-CO}{ct:Amid},4-Phenylbenzoic acid- KR12-NH2,Amidation,C6H5-C6H4-CO,Linear,L,C6H5-C6H4-CO,12,Antibacterial,5 % Hemolysis at 32 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,NA,CHHHHHHHHIIIIITTSTTTGGGTSCCC,NA
12760,36982579,2023,KRIVQRIKDFLR,KRIVQRIKDFLR{nt:C24H39O3}{ct:Amid},Deoxycholic acid- KR12-NH2,Amidation,C24H39O3,Linear,L,C24H39O3,12,Antibacterial,5 % Hemolysis at 8 μg/ml,Human,Kr12-Nh2 Lipidated Analogs,POPG and POPC = α-Helical,NA,CHHHHHHHHHHHHTTTSTHHHHTTSSTTC,NA
12761,37007486,2023,VFRLKKWIQKVI,VFRLKKWIQKVI,FD10,Free,Free,Linear,L,None,12,"Antibacterial, Antifungal",0.31 % Hemolysis at 256 μg/ml,Mouse,Protaetia Brevitarsis Lewis Larvae,α-Helix,Non-hemolytic,CHHHHHHHHHTSGGGTCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O
12762,37007486,2023,KIYVLLRRQA,KIYVLLRRQA,FD12,Free,Free,Linear,L,None,10,Antibacterial,0.4 % Hemolysis at 256 μg/ml,Mouse,Protaetia Brevitarsis Lewis Larvae,α-Helix,Non-hemolytic,CTHHHHHHHTTCGGGGGCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C
12763,37007486,2023,STLHLVLRLR,STLHLVLRLR{ct:Amid},FD15,Amidation,Free,Linear,L,None,10,Antibacterial,0.55 % Hemolysis at 256 μg/ml,Mouse,Protaetia Brevitarsis Lewis Larvae,α-Helix,Non-hemolytic,CHHHHHHHHHTIIIIICCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12764,36979510,2023,AWLDKLKSIGKVVGKVAIGVAKNLLNPQ,AWLDKLKSIGKVVGKVAIGVAKNLLNPQ,Raniseptins-3,Free,Free,Linear,L,None,28,"Antibacterial, Antifungal",≤20 % Hemolysis at 128 µM,Human,Frog Boana Raniceps Skin Secretion,SDS = α-Helix,NA,CTHHHHHHHHHHHTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
12765,36979510,2023,ALLDKLKSLGKVVGKVALGVVQNYLNPRQ,ALLDKLKSLGKVVGKVALGVVQNYLNPRQ,Raniseptins-6,Free,Free,Linear,L,None,29,"Antibacterial, Antifungal",≤20 % Hemolysis at 128 µM,Human,Frog Boana Raniceps Skin Secretion,SDS = α-Helix,NA,CCCCCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
12766,36426386,2023,GIFDVLKNLAKGVITSLAS,GIFDVLKNLAKGVITSLAS{ct:Amid},OCN-3N,Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal",50 % Hemolysis at 56 ± 7 µM,Mouse,Caribbean Frog Leptodactylus Nesiotus,α-Helix,NA,CCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C
12767,36426386,2023,GIFKVLKNLAKGVITSLAS,GIFKVLKNLAKGVITSLAS{ct:Amid},[D4K]OCN-3N,Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal",50 % Hemolysis at 107 ± 8 µM,Mouse,Ocellatin-3N Analogs,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C
12768,36426386,2023,GIFDVLKNLAKGVITSLKS,GIFDVLKNLAKGVITSLKS{ct:Amid},[A18K]OCN-3N,Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal",50 % Hemolysis at >128 µM,Mouse,Ocellatin-3N Analogs,NA,NA,CBTTBCSTTCCCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C
12769,36426386,2023,GIFKVLKNLAKGVITSLKS,GIFKVLKNLAKGVITSLKS{ct:Amid},"[D4K,A18K]OCN-3N",Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal",50 % Hemolysis at >128 µM,Mouse,Ocellatin-3N Analogs,NA,NA,CBTTBCSTTCCCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C
12770,37242633,2023,VRLIVAVRIWRR,VRLIVAVRIWRR{ct:Amid},IDR1018,Amidation,Free,Linear,L,None,12,"Wound healing, Antibiofilm, Antibacterial",20 % Hemolysis at 128 μg/ml,Human,Cationic Host Defense Peptides,NA,NA,CBTTBCSTTCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12771,37242633,2023,VRLIVAVRIWRR,VRLIVAVRIWRR{nt:PEG6}{ct:Amid},PEG6-IDR1018,Amidation,PEG6,Linear,L,None,12,"Wound healing, Antibiofilm, Antibacterial",0 % Hemolysis at 128 μg/ml,Human,Cationic Host Defense Peptides,NA,Non-hemolytic,CCSSSSCSCSCTTTTSSSSCSCCSSCSSSSSSCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12772,37242633,2023,T(GlcNAc)VRLIVAVRIWRR,T{nnr:GlcNAc}VRLIVAVRIWRR{ct:Amid},Glc-IDR1018,Amidation,Free,Linear,L,GlcNAc = N-acetyl glucosamine,13,"Wound healing, Antibiofilm, Antibacterial",0 % Hemolysis at 128 μg/ml,Human,Cationic Host Defense Peptides,NA,Non-hemolytic,NA,NA
12773,36951612,2023,AKAFLPIIRWKKRW,AKAFLPIIRWKKRW{nt:C8H15O}{ct:C6H12NO5},GLP6,C6H12NO5,C8H15O,Linear,L,None,14,"Antibacterial, Antibiofilm",5.15 % Hemolysis at 8 µM,mouse,Synthetic Glycosylated Lp6 Lipopeptide,"SDS = 67.5% α-Helical, pure water =7 .38% α-Helical",NA,CCTTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12774,36951612,2023,AKAFLPIIRWKKRW,AKAFLPIIRWKKRW{nt:C8H15O}{ct:C6H12NO5},GLP6,C6H12NO5,C8H15O,Linear,L,None,14,"Antibacterial, Antibiofilm",15.6 % Hemolysis at 16 µM,mouse,Synthetic Glycosylated Lp6 Lipopeptide,"SDS = 67.5% α-Helical, pure water =7 .38% α-Helical",NA,CCTTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12775,36951612,2023,AKAFLPIIRWKKRW,AKAFLPIIRWKKRW{nt:C8H15O}{ct:C6H12NO5},GLP6,C6H12NO5,C8H15O,Linear,L,None,14,"Antibacterial, Antibiofilm",60.67 % Hemolysis at 64 µM,mouse,Synthetic Glycosylated Lp6 Lipopeptide,"SDS = 67.5% α-Helical, pure water =7 .38% α-Helical",NA,CCTTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12776,37107149,2023,FGFGCNGPWNEDDLRCHNHCKSIKGYKGGYCAKGGFVCKCY,FGFGCNGPWNEDDLRCHNHCKSIKGYKGGYCAKGGFVCKCY,FNZ,Free,Free,Linear,L,None,41,Antibacterial,0 % Hemolysis at 128 μg/ml,Mouse,"Analogs Of Nz2114, A Mutant Of Plectasin",SDS = β-Sheet,Non-hemolytic,CCTTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
12777,37093361,2023,WRLFRRILRVL,WRLFRRILRVL{nt:Amid}{ct:Amid},mCM11,Amidation,Amidation,Linear,L,None,11,"Antibacterial, Antibioflm",2.78 % Hemolysis at 4 μg/ml,Human,Modifed Cecropin–Melittin,SDS = α-Helix,Low hemolytic,CCTTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
12778,37093361,2023,WRLFRRILRVL,WRLFRRILRVL{nt:Amid}{ct:Amid},mCM11,Amidation,Amidation,Linear,L,None,11,"Antibacterial, Antibioflm",2.98 % Hemolysis at 8 μg/ml,Human,Modifed Cecropin–Melittin,SDS = α-Helix,Low hemolytic,CCTTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
12779,37093361,2023,WRLFRRILRVL,WRLFRRILRVL{nt:Amid}{ct:Amid},mCM11,Amidation,Amidation,Linear,L,None,11,"Antibacterial, Antibioflm",3.15 % Hemolysis at 16 μg/ml,Human,Modifed Cecropin–Melittin,SDS = α-Helix,Low hemolytic,CCTTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
12780,37093361,2023,WRLFRRILRVL,WRLFRRILRVL{nt:Amid}{ct:Amid},mCM11,Amidation,Amidation,Linear,L,None,11,"Antibacterial, Antibioflm",3.83 % Hemolysis at 32 μg/ml,Human,Modifed Cecropin–Melittin,SDS = α-Helix,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
12781,37093361,2023,WRLFRRILRVL,WRLFRRILRVL{nt:Amid}{ct:Amid},mCM11,Amidation,Amidation,Linear,L,None,11,"Antibacterial, Antibioflm",5.79 % Hemolysis at 64 μg/ml,Human,Modifed Cecropin–Melittin,SDS = α-Helix,Low hemolytic,CTHHHHHHHTTTHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
12782,37093361,2023,WRLFRRILRVL,WRLFRRILRVL{nt:Amid}{ct:Amid},mCM11,Amidation,Amidation,Linear,L,None,11,"Antibacterial, Antibioflm",6.64 % Hemolysis at 128 μg/ml,Human,Modifed Cecropin–Melittin,SDS = α-Helix,Low hemolytic,CCCCCSCCCCHHHHSCSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
12783,37093361,2023,WRLFRRILRVL,WRLFRRILRVL{nt:Amid}{ct:Amid},mCM11,Amidation,Amidation,Linear,L,None,11,"Antibacterial, Antibioflm",15.5 % Hemolysis at 256 μg/ml,Human,Modifed Cecropin–Melittin,SDS = α-Helix,Low hemolytic,CCCCSSSCCBTTBCCCSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
12784,37093361,2023,WRLFRRILRVL,WRLFRRILRVL{nt:Amid}{ct:Amid},mCM11,Amidation,Amidation,Linear,L,None,11,"Antibacterial, Antibioflm",24.53 % Hemolysis at 512 μg/ml,Human,Modifed Cecropin–Melittin,SDS = α-Helix,Low hemolytic,CCCBCCCSSHHHHHCCBCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
12785,37275897,2023,CDFIETHYLDEQVKSIKELADWVTNLRRMGAPQNGMAEYLFD-KHTLGKESS,CDFIETHYLDEQVKSIKELADWVTNLRRMGAPQNGMAEYLFDKHTLGKESS{ct:Ferritin H},Lc1687,Ferritin H,Free,Linear,L,None,51,"Antibacterial, Anti-parasitic",2.5 % Hemolysis at 1000 mg/L,Fish,Fish Large Yellow Croaker Larimichthys Crocea With Ferritin H,PBS solution = α-Helical,Non-hemolytic,CCCCCSCCCCHHHHSCSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CS)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C
12787,37251186,2023,KKKKKGIGFLAFGAFVILKKKK,KKKKKGIGFLAFGAFVILKKKK{ct:Amid},MSI-Seg,Amidation,Free,Linear,L,None,22,Antibacterial,16.6 ± 4.2 % Hemolysis at 100 µM,Pig,Msi-78 Analogues,LPC = α-Helical,NA,CCSSCCTTTCCTTCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C
12788,37251186,2023,KKKKKFIGLFAGGIVLAFKKKK,KKKKKFIGLFAGGIVLAFKKKK{ct:Amid},MSI-Seg-Scr,Amidation,Free,Linear,L,None,22,Antibacterial,3.9 ± 1.4 % Hemolysis at 100 µM,Pig,Msi-78 Analogues,LPC = α-Helical,NA,CCTHHHHTGGGTHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
12789,37251186,2023,KKKKKGIGGLAGGAFVILKKKK,KKKKKGIGGLAGGAFVILKKKK{ct:Amid},MSI-Seg-F2G,Amidation,Free,Linear,L,None,22,Antibacterial,1.2 ± 30.2 % Hemolysis at 100 µM,Pig,Msi-78 Analogues,LPC = Random coil,NA,CCTHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C
12790,37251186,2023,KKKKKGIGfLAfGAFVILKKKK,KKKKKGIGF{d}LAF{d}GAFVILKKKK{ct:Amid},MSI-Seg-F2F,Amidation,Free,Linear,Mix,None,22,Antibacterial,8.1 ± 3.2 % Hemolysis at 100 µM,Pig,Msi-78 Analogues,LPC and LPS = β-Sheet,NA,CCTHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C
12791,37251186,2023,KKKKKKKGIGFLAFGAFVKILK,KKKKKKKGIGFLAFGAFVKILK{ct:Amid},MSI-N7K,Amidation,Free,Linear,L,None,22,Antibacterial,10 ± 5.6 % Hemolysis at 100 µM,Pig,Msi-78 Analogues,LPC and LPS = Random coil,NA,CCSSCSSSSCCCCCCCHHHHTTSCSSSSSCCSSSSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C
12792,36868141,2023,FLPLIAGKIFCAISKKC,FLPLIAGKIFCAISKKC,Des(8–14)brevinin-1PMa,Free,Free,Linear,L,None,17,Antibacterial,50 % Hemolysis at >200 µM,Mouse,Amazon River Frog Lithobates Palmipes,NA,Low hemolytic,CCCSSSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
12793,36868141,2023,FLPLIAGVAAKVLPKIFCAISKKC,FLPLIAGVAAKVLPKIFCAISKKC,Brevinin-1PMa,Free,Free,Linear,L,None,24,Antibacterial,50 % Hemolysis at 4 µM,Mouse,Amazon River Frog Lithobates Palmipes,NA,NA,CCCSSSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
12794,36868141,2023,FLPFLGKLLSGIF,FLPFLGKLLSGIF{ct:Amid},Temporin-PMa,Amidation,Free,Linear,L,None,13,Antibacterial,50 % Hemolysis at 8 µM,Mouse,Amazon River Frog Lithobates Palmipes,NA,NA,CCCSSSCSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12795,36868141,2023,FLPFLGKLLSGIF,FLPFLGKLLSGIF,Temporin-PMa non-amidated,Free,Free,Linear,L,None,13,Antibacterial,50 % Hemolysis at 110 µM,Mouse,Amazon River Frog Lithobates Palmipes,NA,NA,CCCSCCSSSBSSSCCCSSCCCCBCCSSSCCSSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12797,37446618,2023,YaFGYPSGHFM,YA{d}FGYPSGHFM,LENART01,Free,Free,Linear,Mix,a = D-alanine,11,Antibacterial,4.8 % Hemolysis at 200 µM (1 hour),Human,Opioid–Ranatensin Hybrid Peptide,NA,Low hemolytic,CCCSTHHHHHHHHTTCTTSSCGGGCCSCCCCCC,NA
12798,37446618,2023,YaFGYPSGHFM,YA{d}FGYPSGHFM,LENART01,Free,Free,Linear,Mix,a = D-alanine,11,Antibacterial,8.3 % Hemolysis at 200 µM (2 hour),Human,Opioid–Ranatensin Hybrid Peptide,NA,Low hemolytic,CCHHHHHHHHTTTC,NA
12799,37446618,2023,YaFGYPSGHFM,YA{d}FGYPSGHFM,LENART01,Free,Free,Linear,Mix,a = D-alanine,11,Antibacterial,16.4 % Hemolysis at 200 µM (4 hour),Human,Opioid–Ranatensin Hybrid Peptide,NA,Low hemolytic,CCHHHHHHHHTTCC,NA
12803,37300579,2023,HIDWKKLLDAAKQIL,HIDWKKLLDAAKQIL{ct:Amid},MP1,Amidation,Free,Linear,L,None,15,"Antibacterial, Antibiofilm, Antifungal",50 % Hemolysis at 221.4 µM,Human,Mastoparan Family,α-Helix,Low hemolytic,CCCCCCCCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
12804,37300579,2023,HIDWKKLLDAAKKIL,HIDWKKLLDAAKKIL{ct:Amid},MP1-Q12K,Amidation,Free,Linear,L,None,15,"Antibacterial, Antibiofilm, Antifungal",50 % Hemolysis at 187.4 µM,Human,Mp1 Analog,α-Helix,Low hemolytic,CCCCCCCCTTCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
12805,37513276,2023,GPKTKAACKMACKLATCGKKPGGWKCKLCELGCDAV,GPKTKAACKMACKLATCGKKPGGWKCKLCELGCDAV,Turgencin A,Free,Free,Linear,L,None,36,Antibacterial,0 % Hemolysis at 10 μg/ml,Human,Fungi Pichia Pastoris,α-Helix and Random coil,Non-hemolytic,CCCCCSCCSSSSCCCTTC,CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)CN)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O
12806,37631261,2023,RGGRLCYCRRRFCVCVGR,RGGRLCYCRRRFCVCVGR,Protegrin-1 (PG-1),Free,Free,Linear,L,None,18,Antibacterial,2 % Hemolysis at 0.7 µM,Human,Porcine (Sus Scrofa) Leukocytes,β-Hairpin,NA,CCSCCCCCCCSCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
12807,37631261,2023,RGG-LCYCRGRFCVCVGR,RGG-LCYCRGRFCVCVGR,Iseganan,Free,Free,Linear,L,None,17,Antibacterial,2 % Hemolysis at 1 µM,Human,Protegrin-1 Analogs,NA,NA,CCTTCCCHHHHHTTSSCC,CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
12808,37631261,2023,RGGRRCYCRRRFCVCVGR,RGGRRCYCRRRFCVCVGR,[L5R],Free,Free,Linear,L,None,18,Antibacterial,2 % Hemolysis at 4.1 µM,Human,Protegrin-1 Analogs,NA,NA,CCCCCCCCTTTTSSSCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12809,37631261,2023,RGGRACYCRRRFCVCVGR,RGGRACYCRRRFCVCVGR,[L5A],Free,Free,Linear,L,None,18,Antibacterial,2 % Hemolysis at 4.1 µM,Human,Protegrin-1 Analogs,NA,NA,CCCCCCCCTTTSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12810,37631261,2023,RGGRLCYCRRRFCVCRGR,RGGRLCYCRRRFCVCRGR,[V16R],Free,Free,Linear,L,None,18,Antibacterial,2 % Hemolysis at 49.2 µM,Human,Protegrin-1 Analogs,β-Hairpin,Low hemolytic,CCCCCCCCTTTCCCCTTC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
12811,37631261,2023,RGGRLCYCRRRFCVCAGR,RGGRLCYCRRRFCVCAGR,[V16A],Free,Free,Linear,L,None,18,Antibacterial,2 % Hemolysis at 4.3 µM,Human,Protegrin-1 Analogs,NA,NA,CCCCCCCCTTTSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
12812,37631261,2023,RGGRLCYCRRRFCRCVGR,RGGRLCYCRRRFCRCVGR,[V14R],Free,Free,Linear,L,None,18,Antibacterial,2 % Hemolysis at >64 µM,Human,Protegrin-1 Analogs,NA,Low hemolytic,CCCCCCCCGGGGCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
12813,37631261,2023,RGGRLCYCRRRFCACVGR,RGGRLCYCRRRFCACVGR,[V14A],Free,Free,Linear,L,None,18,Antibacterial,2 % Hemolysis at 5.5 µM,Human,Protegrin-1 Analogs,NA,NA,CCCCCCCCSSCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
12814,37631261,2023,RGGRLCRCRRRFCVCVGR,RGGRLCRCRRRFCVCVGR,[Y7R],Free,Free,Linear,L,None,18,Antibacterial,2 % Hemolysis at 61.4 µM,Human,Protegrin-1 Analogs,NA,Low hemolytic,CCCCCSCCGGGGGGTSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
12815,37631261,2023,RGGRLCTCRRRFCVCVGR,RGGRLCTCRRRFCVCVGR,[Y7T],Free,Free,Linear,L,None,18,Antibacterial,2 % Hemolysis at 33.5 µM,Human,Protegrin-1 Analogs,NA,Low hemolytic,CCSSCCSCTTSCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
12816,37631261,2023,RGGRLCTCRRRFCVCRGR,RGGRLCTCRRRFCVCRGR,"[Y7T,V16R]",Free,Free,Linear,L,None,18,Antibacterial,2 % Hemolysis at >64 µM,Human,Protegrin-1 Analogs,NA,Low hemolytic,CCSTTTSCSSCCCCCCSSSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O
12817,37631261,2023,RGGRLCYCRRRFCACRGR,RGGRLCYCRRRFCACRGR,"[V14A,V16R]",Free,Free,Linear,L,None,18,Antibacterial,2 % Hemolysis at >64 µM,Human,Protegrin-1 Analogs,NA,Low hemolytic,CCCSSCCSSSCSCCSSCCSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12818,37631261,2023,RGGRACYCRRRFCVCRGR,RGGRACYCRRRFCVCRGR,"[L5A, V16R]",Free,Free,Linear,L,None,18,Antibacterial,2 % Hemolysis at >64 µM,Human,Protegrin-1 Analogs,NA,Low hemolytic,CTTHHHHHHHHHHHHTTTHHHHHHHHGGGGGGGGTCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12819,37631261,2023,RGGRACYCRRRFCACVGR,RGGRACYCRRRFCACVGR,"[L5A, V14A]",Free,Free,Linear,L,None,18,Antibacterial,2 % Hemolysis at 18.8 µM,Human,Protegrin-1 Analogs,NA,NA,CCCCCCCCCCSSTTTTCSSCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12820,37631261,2023,RGGRACYCRRRFCVCAGR,RGGRACYCRRRFCVCAGR,"[L5A,V16A]",Free,Free,Linear,L,None,18,Antibacterial,2 % Hemolysis at 11.9 µM,Human,Protegrin-1 Analogs,NA,NA,CCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12821,37310533,2023,RIIDLLWRVRRPQKPKFVTVWVR,RIIDLLWRVRRPQKPKFVTVWVR,PMAP-23,Free,Free,Linear,L,None,23,Antibacterial,<10 % Hemolysis at 100 µM,Human,Cathelicidin-Derived Amp,"aqueous bufer = unordered structure, membrane-mimetic environments = Helix–hinge–Helix",Low hemolytic,CCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C
12822,37310533,2023,RIIDRLWLVRRPQKPKFVLVWVL,RIIDRLWLVRRPQKPKFVLVWVL,PMAP-NC,Free,Free,Linear,L,None,23,"Antibacterial, Anticancer",20 % Hemolysis at 64 µM,Human,Pmap-23 Analogs,Helix–hinge–Helix,NA,CC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
12823,37635252,2023,GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSERFQS,GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSERFQS,PMAP-37(F34-R),Free,Free,Linear,L,None,37,Antibacterial,≤1.5 % Hemolysis at 0.36 μg/ml,Human,Pamp-37 (Pig Bone Marrow) Analogue,α-Helix,Low hemolytic,CCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC
12824,37686259,2023,RKYKEKKDKSQNKKKKRKCMIL,RKYKEKKDKSQNKKKKRKCMIL,RK22,Free,Free,Linear,L,None,22,"Antibacterial, Antibiofilm",0 % Hemolysis at 400 μg/ml,Mouse,Leech Hirudinaria Manillensis,NA,Non-hemolytic,CCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O
12826,36508953,2023,PFKLSLHL,PFKLSLHL{ct:Amid},Jelleine-I,Amidation,Free,Linear,L,None,8,"Antibacterial, Antibiofilm, Anti-Listeria monocytogenes",26.25 % Hemolysis at 1000 μg/ml,Rabbit,Honeybees Royal Jelly,NA,Low hemolytic,CGGGGTHHHHTTTCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)C(=O)O
12827,36736093,2023,KF,KF{nt:Fmoc = fluorenylmethyloxycarbonyl}{ct:Amid},Fmoc-KF,Amidation,Fmoc = fluorenylmethyloxycarbonyl,Linear,L,Fmoc = fluorenylmethyloxycarbonyl,2,Antibacterial,<5 % Hemolysis at 2.4 mM,Rabbit,Synthetic Peptide,NA,NA,CTHHHHHHHHTTTCC,NCCCC[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12828,36736093,2023,KKF,KKF{nt:Fmoc = fluorenylmethyloxycarbonyl}{ct:Amid},Fmoc-KKF,Amidation,Fmoc = fluorenylmethyloxycarbonyl,Linear,L,Fmoc = fluorenylmethyloxycarbonyl,3,Antibacterial,0 % Hemolysis at 2.4 mM,Rabbit,Synthetic Peptide,NA,Non-hemolytic,CTHHHHHHHHHHHTC,NCCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12829,36736093,2023,KKKF,KKKF{nt:Fmoc = fluorenylmethyloxycarbonyl}{ct:Amid},Fmoc-KKKF,Amidation,Fmoc = fluorenylmethyloxycarbonyl,Linear,L,Fmoc = fluorenylmethyloxycarbonyl,4,Antibacterial,0 % Hemolysis at 2.4 mM,Rabbit,Synthetic Peptide,NA,Non-hemolytic,CGGGGTHHHHTTTCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12842,36870201,2023,FVQWFSKFLGRIL,FVQWFSKFLGRIL{ct:Amid},Temporin L,Amidation,Free,Linear,L,None,13,"Antibacterial, Antibiofilm",50 % Hemolysis at 15 µM,Human,European Frog Rana Temporaria,"PC/PG (3:1 w/w) = 70.1% Helical, PC/Chol (8:1 w/w) vesicles = 61.7% Helical",NA,CCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
12843,36870201,2023,FVQWFSKF(βL)RIL,FVQWFSKF{nnr:βL}RIL{ct:Amid},L9βl-TL,Amidation,Free,Linear,L,βL = βL,12,"Antibacterial, Antibiofilm",50 % Hemolysis at 33.3 µM,Human,Tl-Analogue,"PC/PG (3:1 w/w) = 13.8% Helical, PC/Chol (8:1 w/w) vesicles = 7.2% Helical",NA,NA,NA
12847,37167720,2023,RRWQWR,RRWQWR{ct:Amid},LfcinB6 (Lf6),Amidation,Free,Linear,L,None,6,Antibacterial,10 % Hemolysis at >512 µM,Sheep,Lactoferrin Bovine Milk,NA,Low hemolytic,CCCHHHHHHHHHHHTCC,N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
12848,37167720,2023,RRWQWRpPRWQWRR,RRWQWRP{d}PRWQWRR{ct:Amid},Lf6-pP,Amidation,Free,Linear,L,p = D-Proline,14,"Antibacterial, Antibiofilm, Anti-inflammatory",10 % Hemolysis at >512 µM,Sheep,Synthetic Amps,"Phosphate buffer and 50% TFE = typical TrpZip Hairpin, 30 mM SDS = α-Helical",Low hemolytic,CHHHHHHHHHHTC,NA
12849,37167720,2023,RRWQWRGGRWQWRR,RRWQWRGGRWQWRR{ct:Amid},Lf6-GG,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiofilm",10 % Hemolysis at >512 µM,Sheep,Synthetic Amps,"Phosphate buffer and 50% TFE = typical TrpZip Hairpin, 30 mM SDS = α-Helical",Low hemolytic,CCHHHHHHHTC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
12882,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C2},PE-2C-C2-DH,Free,C2,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12883,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C3},PE-2C-C3-DH,Free,C3,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12884,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C4},PE-2C-C4-DH,Free,C4,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12885,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C5},PE-2C-C5-DH,Free,C5,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12886,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C6},PE-2C-C6-DH,Free,C6,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12887,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C7},PE-2C-C7-DH,Free,C7,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12888,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C8},PE-2C-C8-DH,Free,C8,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12889,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:6-MC7},PE-2C-6-MC7-DH,Free,6-MC7,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12890,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:6-MC8},PE-2C-6-MC8-DH,Free,6-MC8,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12891,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:LB-8},PE-2C-LB-8-DH),Free,LB-8,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at 1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12892,31608030,2019,FKRIVQRIKDFLRNLV,FKRIVQRIKDFLRNLV,FK16,Free,Free,Linear,L,None,16,Antibacterial,<10% (1 hr) % Hemolysis at 256 μg/ml,Human,Cathelicidin-Derived Peptides,NA,Low hemolytic,CHHHHHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C
12893,23409125,2013,RLLFRKIRRLKR,RLLFRKIRRLKR,EC5,Free,Free,Linear,L,None,12,Antibacterial,5 % Hemolysis at 500 μg/ml,Chicken,Peptide Synergists From Phage Display,NA,Low hemolytic,CCTTTCGGGGGGGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12894,19451300,2009,FFSLLPSLIGGLVSAIK,FFSLLPSLIGGLVSAIK,imcroporin,Free,Free,Linear,L,None,17,Antibacterial,<50 % Hemolysis at 50 μg/ml,Human,Scorpion Isometrus Maculates,α-Helix,NA,CBCSSCSSCCSSSCCCCBC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
12895,25626077,2015,FLFSLIPSVIAGLVSAIRN,FLFSLIPSVIAGLVSAIRN{ct:Amid},AaeAP1,Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal",100 % Hemolysis at 16 μg/ml,Horse,Scorpion Androctonus Aeneas,21.05 % α-Helix,NA,CCCTTGGGTTGGGCCCTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O
12896,25626077,2015,FLFSLIPSAIAGLVSAIRN,FLFSLIPSAIAGLVSAIRN{ct:Amid},AaeAP2,Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal",100 % Hemolysis at 64 μg/ml,Horse,Scorpion Androctonus Aeneas,21.05 % α-Helix,NA,CCCTTGGGTTGGGCCCTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)CC)C(C)C
12897,25626077,2015,FLFKLIPKVIKGLVKAIRK,FLFKLIPKVIKGLVKAIRK{ct:Amid},AaeAP1a,Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal. Anticancer, Antiproliferative",100 % Hemolysis at 32 μg/ml,Horse,Aaeap1 Analogues,31.58% α-Helix,NA,CTTTTTCTTGGGCCCHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
12898,25626077,2015,FLFKLIPKAIKGLVKAIRK,FLFKLIPKAIKGLVKAIRK{ct:Amid},AaeAP2a,Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal. Anticancer, Antiproliferative",100 % Hemolysis at 64 μg/ml,Horse,Aaeap2 Analogues,31.58% α-Helix,NA,CCCCCCSSCSSTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C
12899,25633390,2015,ARDGYIVDEKGCKFACFIN,ARDGYIVDEKGCKFACFIN,Cm38,Free,Free,Linear,L,None,19,Antibacterial,0 % Hemolysis at 64 µM,Human,Scorpion Centruroides Margaritatus,NA,Non-hemolytic,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O
12900,34971943,2022,FIHHIIGGLFSAGKAIHRLIRRRRR,FIHHIIGGLFSAGKAIHRLIRRRRR,Oreoch-2,Free,Free,Linear,L,None,25,Antibacterial,40.33 % Hemolysis at 64 μg/ml,Mouse,Synthetic,α-Helix,Low hemolytic,CCCCHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
12901,34971943,2022,FIHHIIGGLFSAGKAIHRLIRRRRR,FIHHIIGGLFSAGKAIHRLIRRRRR,Oreoch-2,Free,Free,Linear,L,None,25,Antibacterial,∼10 % Hemolysis at 32 μg/ml,Mouse,Synthetic,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
12902,34971943,2022,FIIGGLFSAGKAIHRLIRRRRR,FIIGGLFSAGKAIHRLIRRRRR,ZN-5,Free,Free,Linear,L,None,22,Antibacterial,4.84 % Hemolysis at 64 μg/ml,Mouse,Synthetic,α-Helix,Non-hemolytic,CCCCHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
12903,34971943,2022,FLFSAGKAIHRLIRRRRR,FLFSAGKAIHRLIRRRRR,ZN-6,Free,Free,Linear,L,None,18,Antibacterial,2.02 % Hemolysis at 64 μg/ml,Mouse,Synthetic,α-Helix,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
12904,35216177,2022,FVQWFSKFLGRIL,FVQWFSKFLGRIL,Temporin L,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",∼70 % Hemolysis at 100 µM,Human,Rana Temporaria (Red Frog),α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
12905,35216177,2022,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},"[Pro3 , DLeu9 ] TL",Amidation,Free,Linear,Mix,l = D-Leucine,13,"Antibacterial, Anti-biofilm",∼50 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCCCGGGTTTSCC,NA
12906,35216177,2022,FVQWFSKFLGRIL,FVQWFSKFLGRIL,Temporin L,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",∼43 % Hemolysis at 50 µM,Human,Rana Temporaria (Red Frog),α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
12907,35216177,2022,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},"[Pro3 , DLeu9 ] TL",Amidation,Free,Linear,Mix,l = D-Leucine,13,"Antibacterial, Anti-biofilm",∼25 % Hemolysis at 50 µM,Human,Synthetic,α-Helix,NA,CCCCHHHHHHHC,NA
12908,35216177,2022,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},"[Pro3,DLeu9] TL (TL1)",Amidation,Free,Linear,Mix,l=D-Leu,13,"Antibacterial, Anti-biofilm",60 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,NA,NA
12909,35216177,2022,FVPWFSKFlPRIL,FVPWFSKFL{d}PRIL{ct:Amid},"[Pro3,DLeu9,Pro10] TL (TL2)",Amidation,Free,Linear,Mix,l=D-Leu,14,"Antibacterial, Anti-biofilm",60 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCCCTHHHHTTTC,NA
12910,35216177,2022,FVPWFSKFlpRIL,FVPWFSKFL{d}P{d}RIL{ct:Amid},"[Pro3,DLeu9,DPro10] TL (TL3)",Amidation,Free,Linear,Mix,"l=D-Leu, p = D-Pro",14,"Antibacterial, Anti-biofilm",20 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,NA,NA
12911,35216177,2022,FVPWFSKFlORIL,FVPWFSKFL{d}{nnr:O}RIL{ct:Amid},"[Pro3,DLeu9,Hyp10] TL (TL4)",Amidation,Free,Linear,Mix,"l=D-Leu, O = Hyp = hydroxyproline",14,"Antibacterial, Anti-biofilm",80 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,NA,NA
12912,35216177,2022,FVPWFSKFloRIL,FVPWFSKFL{d}{nnr:o}RIL{ct:Amid},"[Pro3,DLeu9,DHyp10] TL (TL5)",Amidation,Free,Linear,Mix,"l=D-Leu, o = D-Hyp = hydroxyproline",14,"Antibacterial, Anti-biofilm",20 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,NA,NA
12913,35216177,2022,FVPWFSKFlNRIL,FVPWFSKFL{d}{nnr:N=Nle}RIL{ct:Amid},"[Pro3,DLeu9,Nle10] TL (TL6)",Amidation,Free,Linear,Mix,"l=D-Leu, N = Nle",14,"Antibacterial, Anti-biofilm",60 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCCCHHHHHTTTC,NA
12914,35216177,2022,FVPWFSKFlnRIL,FVPWFSKFL{d}{nnr:n=D-Nle}RIL{ct:Amid},"[Pro3,DLeu9,DNle10] TL (TL7)",Amidation,Free,Linear,Mix,"l=D-Leu, n = D-Nle",14,"Antibacterial, Anti-biofilm",40 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,NA,NA
12915,35216177,2022,FVPWFSKFlKRIL,FVPWFSKFL{d}KRIL{ct:Amid},"[Pro3,DLeu9,Lys10] TL (TL8)",Amidation,Free,Linear,Mix,l=D-Leu,14,"Antibacterial, Anti-biofilm",80 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCHHHHTTTCC,NA
12916,35216177,2022,FVPWFSKFlkRIL,FVPWFSKFL{d}K{d}RIL{ct:Amid},"[Pro3,DLeu9,DLys10] TL (TL9)",Amidation,Free,Linear,Mix,"l=D-Leu, k = D-Lys",14,"Antibacterial, Anti-biofilm",40 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCSGGGTGGGC,NA
12917,35216177,2022,FVPWFSKFlWRIL,FVPWFSKFL{d}WRIL{ct:Amid},"[Pro3,DLeu9,Trp10] TL (TL10)",Amidation,Free,Linear,Mix,l=D-Leu,14,"Antibacterial, Anti-biofilm",60 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCGGGTTCSCC,NA
12918,35216177,2022,FVPWFSKFlwRIL,FVPWFSKFL{d}W{d}RIL{ct:Amid},"[Pro3,DLeu9,DTrp10] TL (TL11)",Amidation,Free,Linear,Mix,"l=D-Leu, w = D-Trp",14,"Antibacterial, Anti-biofilm",80 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCHHHHTTTCC,NA
12919,35216177,2022,FVPWFSKFlAicRIL,FVPWFSKFl{nnr:Aic}RIL{ct:Amid},"[Pro3,DLeu9,Aic10] TL (TL12)",Amidation,Free,Linear,Mix,Aic = 2-aminoindane-2-carboxylic acid,14,"Antibacterial, Anti-biofilm",100 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,NA,NA
12920,35216297,2022,WFGKLYRGITK,WFGKLYRGITK,Pep-A,Free,Free,Linear,L,None,11,Antibacterial,∼3 % Hemolysis at 50 µM,Rabbit,Synthetic,α-Helix,Non-hemolytic,CCGGGTTCSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
12921,35216297,2022,WRGITKVVKKV,WRGITKVVKKV,Pep-B,Free,Free,Linear,L,None,11,Antibacterial,∼7 % Hemolysis at 50 µM,Rabbit,Synthetic,α-Helix,Non-hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12922,35216297,2022,WVVKKVKGLLK,WVVKKVKGLLK,Pep-C,Free,Free,Linear,L,None,11,Antibacterial,∼2 % Hemolysis at 50 µM,Rabbit,Synthetic,α-Helix,Non-hemolytic,NA,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
12923,35216297,2022,WFGKLYRGITK,WFGKLYRGITK{nt:myristic acid},Myr-A,Free,myristic acid,Linear,L,None,11,Antibacterial,∼5.5 % Hemolysis at 50 µM,Rabbit,Synthetic,α-Helix,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
12924,35216297,2022,WRGITKVVKKV,WRGITKVVKKV{nt:myristic acid},Myr-B,Free,myristic acid,Linear,L,None,11,Antibacterial,∼2.5 % Hemolysis at 50 µM,Rabbit,Synthetic,α-Helix,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
12925,35216297,2022,WVVKKVKGLLK,WVVKKVKGLLK{nt:myristic acid},Myr-C,Free,myristic acid,Linear,L,None,11,Antibacterial,28.5 % Hemolysis at 50 µM,Rabbit,Synthetic,α-Helix,NA,CTHHHHHHHHTC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
12926,35203875,2022,RRLFRRILRWL,RRLFRRILRWL,L6,Free,Free,Linear,L,None,11,Antibacterial,50 % Hemolysis at 50 µM,Sheep,Synthetic,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12927,35203875,2022,RR(S5)FRR(S5)LRWL,RR{nnr:S5}FRR{nnr:S5}LRWL,L6S1,Free,Free,Macrocyclized,L,"(R8) and (S5) indicate stapled using 8- and 5-atom linkers, respectively.",11,Antibacterial,∼5 % Hemolysis at 50 µM,Sheep,Synthetic,NA,Non-hemolytic,NA,NA
12928,35203875,2022,RRLFRR(S5)LRW(S5),RRLFRR{nnr:S5}LRW{nnr:S5},L6S2,Free,Free,Macrocyclized,L,"(S5) and (S5) indicate stapled using 5- and 5-atom linkers, respectively.",11,Antibacterial,∼55 % Hemolysis at 50 µM,Sheep,Synthetic,NA,NA,NA,NA
12929,35203875,2022,RRL(R8)RRILRW(S5),RRL{nnr:R8}RRILRW{nnr:S5},L6S3,Free,Free,Macrocyclized,L,"(R8) and (S5) indicate stapled using 8- and 5-atom linkers, respectively.",11,Antibacterial,<5 % Hemolysis at 50 µM,Sheep,Synthetic,NA,Non-hemolytic,NA,NA
12930,35203875,2022,KRIVQRIKKWLR,KRIVQRIKKWLR,L8,Free,Free,Linear,L,None,12,Antibacterial,∼1 % Hemolysis at 50 µM,Sheep,Synthetic,α-Helix,Non-hemolytic,CCSSCCHHHHSCCSCCCSSCC,NA
12931,35203875,2022,KR(S5)VQR(S5)KKWLR,KR{nnr:S5}VQR{nnr:S5}KKWLR,L8S1,Free,Free,Linear,L,"macrocyclized, (S5) and (S5) indicate stapled using 5- and 5-atom linkers, respectively",12,Antibacterial,0 % Hemolysis at 50 µM,Sheep,Synthetic,NA,Non-hemolytic,NA,NA
12932,35203875,2022,KRIVQR(S5)KKW(S5)R,KRIVQR{nnr:S5}KKW{nnr:S5}R,L8S2,Free,Free,Linear,L,"macrocyclized, (S5) and (S5) indicate stapled using 5- and 5-atom linkers, respectively",12,Antibacterial,0 % Hemolysis at 50 µM,Sheep,Synthetic,NA,Non-hemolytic,NA,NA
12933,35203875,2022,KRI(R8)QRIKKW(S5)R,KRI{nnr:R8}QRIKKW{nnr:S5}R,L8S3,Free,Free,Macrocyclized,L,"(R8) and (S5) indicate stapled using 8- and 5-atom linkers, respectively",12,Antibacterial,∼20 % Hemolysis at 50 µM,Sheep,Synthetic,NA,Non-hemolytic,NA,NA
12934,35323465,2022,SPRVCIRVCRNGVCYRRCWG,SPRVCIRVCRNGVCYRRCWG,Capitellacin,Free,Free,Linear,L,None,20,Antibacterial,50 % Hemolysis at 128 µM,Human,Capitella Teleta,NA,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O)C(C)C)C(C)C
12935,35323465,2022,RSPRVCIRVCRNGVCYRRCWG,RSPRVCIRVCRNGVCYRRCWG,CT2,Free,Free,Linear,L,None,21,Antibacterial,>5 % Hemolysis at 128 µM,Human,Synthetic,NA,Non-hemolytic,CCCCCCSSSSSCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O)C(C)C)C(C)C
12936,35323465,2022,SPRVCIRVCRNGVCYRRCW,SPRVCIRVCRNGVCYRRCW,CT3,Free,Free,Linear,L,None,19,Antibacterial,<5 % Hemolysis at 128 µM,Human,Synthetic,NA,Non-hemolytic,CCCHHHHTTCCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(C)C
12937,35323465,2022,RVCIRVCRNGVCYRRCW,RVCIRVCRNGVCYRRCW,CT4,Free,Free,Linear,L,None,17,Antibacterial,<5 % Hemolysis at 128 µM,Human,Synthetic,NA,Non-hemolytic,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(C)C
12938,35323465,2022,KWCI RVCRNGVCYRRCR,KWCI RVCRNGVCYRRCR,CT5,Free,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",<2.5 % Hemolysis at 128 µM,Human,Synthetic,NA,Non-hemolytic,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O.CC[C@H](C)[C@@H](C=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN
12939,35323465,2022,RVC FRVCRNGVCYRRCW,RVC FRVCRNGVCYRRCW,CT6,Free,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",<2.5 % Hemolysis at 128 µM,Human,Synthetic,NA,Non-hemolytic,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O.CC(C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C=O)CS
12940,35323465,2022,RVCIRVCYRGVCYRRCW,RVCIRVCYRGVCYRRCW,CT7,Free,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",50 % Hemolysis at 128 µM,Human,Synthetic,NA,Low hemolytic,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(C)C
12941,35323465,2022,KWCFRVCYRGICYRRCR,KWCFRVCYRGICYRRCR,Tachyplesin-1,Free,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",<5 % Hemolysis at 128 µM,Human,Synthetic,NA,Non-hemolytic,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12942,35123230,2022,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,26,"Antibacterial, Anti-biofilm",96 ± 2.1 % Hemolysis at 5 μg/ml,Human,Synthetic,NA,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
12943,35123230,2022,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,26,"Antibacterial, Anti-biofilm",80.5 ± 2.3 % Hemolysis at 2.5 μg/ml,Human,Synthetic,NA,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
12944,35123230,2022,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,26,"Antibacterial, Anti-biofilm",74.2 ± 2.2 % Hemolysis at 1.25 μg/ml,Human,Synthetic,NA,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
12945,35123230,2022,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,26,"Antibacterial, Anti-biofilm",59.5 ± 1.8 % Hemolysis at 0.625 μg/ml,Human,Synthetic,NA,NA,CCCCSSHHHHHHHTSSSTTSTHHHHTTSCCCSSSSSCSSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
12946,35123230,2022,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,26,"Antibacterial, Anti-biofilm",25 ± 1.2 % Hemolysis at 0.312 μg/ml,Human,Synthetic,NA,NA,CCCHHHHGGGTTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
12947,35123230,2022,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,26,"Antibacterial, Anti-biofilm",6 ± 0.8 % Hemolysis at 0.156 μg/ml,Human,Synthetic,NA,NA,CCCHHHHGGGTTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
12948,35123230,2022,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,26,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.078 μg/ml,Human,Synthetic,NA,Non-hemolytic,CCCTTTHHHHGGGTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
12949,35123230,2022,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,26,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.039 μg/ml,Human,Synthetic,NA,Non-hemolytic,CCCHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
12951,35335979,2022,FVDLKKIANILNSIF,FVDLKKIANILNSIF{ct:Amid},Temporin-1CEh,Amidation,Free,Linear,L,None,15,"Antibacterial, Anti-biofilm",50 % Hemolysis at 152.6 µM,Horse,Rana Chensinensis,α-Helix,NA,CTTCCHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
12952,35335979,2022,FVDLKKIANILNSIF,FVDLKKIANILNSIF{ct:Amid},Temporin-1CEh,Amidation,Free,Linear,L,None,15,"Antibacterial, Anti-biofilm",92.3 % Hemolysis at 256 µM,Horse,Rana Chensinensis,α-Helix,NA,CCCCTHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
12953,35335979,2022,FVDLKKIANIINSIF,FVDLKKIANIINSIF{ct:Amid},Temporin-1CEa,Amidation,Free,Linear,L,None,15,"Antibacterial, Anti-biofilm",50 % Hemolysis at 160 µM,Horse,Synthetic,α-Helix,NA,CCSCTTTTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
12954,35335979,2022,FVDLKKIANIL,FVDLKKIANIL{ct:Amid},T1CEh-t,Amidation,Free,Linear,L,None,11,"Antibacterial, Anti-biofilm",<5 % Hemolysis at 64 µM,Horse,Synthetic,α-Helix,NA,CCSCCGGGTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
12955,35335979,2022,FVDLKKIANII,FVDLKKIANII{ct:Amid},T1CEa-t,Amidation,Free,Linear,L,None,11,"Antibacterial, Anti-biofilm",0 % Hemolysis at 64 µM,Horse,Synthetic,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
12956,35335979,2022,KKFVDLKKIANIL,KKFVDLKKIANIL{ct:Amid},T1CEh-KK,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 64 µM,Horse,Synthetic,α-Helix,NA,CCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
12957,35335979,2022,KKFVPLKKIANIL,KKFVPLKKIANIL{ct:Amid},T1CEh-KKP,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",∼1 % Hemolysis at 64 µM,Horse,Synthetic,α-Helix,NA,CCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
12958,35335979,2022,KKWVPLKKIANIL,KKWVPLKKIANIL{ct:Amid},T1CEh-KKPW,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",<10 % Hemolysis at 256 µM,Horse,Synthetic,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
12959,35335979,2022,KKWVPWKKIANIL,KKWVPWKKIANIL{ct:Amid},T1CEh-KKPWW,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",6 % Hemolysis at 256 µM,Horse,Synthetic,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
12960,35335979,2022,KKWVPWKKKWVPWKKIANIL,KKWVPWKKKWVPWKKIANIL{ct:Amid},T1CEh-KKPWW2,Amidation,Free,Branched,L,None,20,"Antibacterial, Anti-biofilm",63 % Hemolysis at 256 µM,Horse,Synthetic,α-Helix,NA,NA,NA
12961,35326879,2022,RRRRWWWW,RRRRWWWW{cyc:N-C},[R4W4],Free,Free,Cyclic,L,None,8,"Antibacterial, Cytotoxic",80 % Hemolysis at 500 μg/ml,Human,Synthetic,NA,NA,NA,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12962,35326879,2022,RRRRWWWW,RRRRWWWW,(R4W4),Free,Free,Linear,L,None,8,"Antibacterial, Cytotoxic",38 % Hemolysis at 500 μg/ml,Human,Synthetic,NA,NA,CTTHHHHHGGGGGTC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12963,35326879,2022,(Levo-C10-KRRRWWWW),{conj:Levo}{conj:C10}KRRRWWWW,(Levo-C10-KR3W4),Free,Free,Linear,L,"Levo = Levofloxacin covalent conjugates, C10 = 10-hydroxy decanoic acid(linker)",8,"Antibacterial, Cytotoxic",∼9 % Hemolysis at 500 μg/ml,Human,Synthetic,NA,NA,NA,NA
12964,35326879,2022,[Levo-C10-KRRRWWWW],{conj:Levo}{conj:C10}KRRRWWWW{cyc:N-C},[Levo-C10-KR3W4],Free,Free,Cyclic,L,"Levo = Levofloxacin covalent conjugates, C10 = 10-hydroxy decanoic acid(linker)",8,"Antibacterial, Cytotoxic",∼30 % Hemolysis at 500 μg/ml,Human,Synthetic,NA,NA,NA,NA
12965,35326879,2022,Levo + (RRRRWWWW),{conj:Levo}(RRRRWWWW,Levo + (R4W4),Free,Free,Linear,L,"Levo = Levofloxacin, physical mixture of Levofloxacin and peptides (500 µg/mL (1:1; w/w))",8,"Antibacterial, Cytotoxic",∼10 % Hemolysis at 500 μg/ml,Human,Synthetic,NA,NA,NA,NA
12966,35326879,2022,Levo + [RRRRWWWW],{conj:Levo}[RRRRWWWW{cyc:N-C},Levo + [R4W4],Free,Free,Cyclic,L,"Levo = Levofloxacin, physical mixture of Levofloxacin and peptides (500 µg/mL (1:1; w/w))",8,"Antibacterial, Cytotoxic",∼22 % Hemolysis at 500 μg/ml,Human,Synthetic,NA,NA,NA,NA
12967,35290038,2022,LKLLKKLLKKLLKLL,LKLLKKLLKKLLKLL{ct:Amid},Amp1L,Amidation,Free,Linear,L,k = involved in isopeptide bond formation,15,Antibacterial,∼55 % Hemolysis at 10 µM,Human,Synthetic,α-Helix,NA,NA,NA
12968,35290038,2022,LkLLKKLLKKLLKLL,L{nnr:k}LLKKLLKKLLKLL{ct:Amid},Amp1EP2,Amidation,Free,Linear,L,k = involved in isopeptide bond formation,15,Antibacterial,∼35 % Hemolysis at 10 µM,Human,Synthetic,α-Helix,Low hemolytic,NA,NA
12969,35290038,2022,LKLLkKLLKKLLKLL,LKLL{nnr:k}KLLKKLLKLL{ct:Amid},Amp1EP5,Amidation,Free,Linear,L,k = involved in isopeptide bond formation,15,Antibacterial,<10 % Hemolysis at 10 µM,Human,Synthetic,α-Helix,Low hemolytic,CTTHHHHHGGGGGTC,NA
12970,35290038,2022,LKLLKkLLKKLLKLL,LKLLK{nnr:k}LLKKLLKLL{ct:Amid},Amp1EP6,Amidation,Free,Linear,L,k = involved in isopeptide bond formation,15,Antibacterial,<5 % Hemolysis at 10 µM,Human,Synthetic,α-Helix,Low hemolytic,NA,NA
12971,35290038,2022,LKLLKKLLkKLLKLL,LKLLKKLL{nnr:k}KLLKLL{ct:Amid},Amp1EP9,Amidation,Free,Linear,L,k = involved in isopeptide bond formation,15,Antibacterial,<5 % Hemolysis at 10 µM,Human,Synthetic,α-Helix,Non-hemolytic,NA,NA
12972,35290038,2022,LKLLKKLLKkLLKLL,LKLLKKLLK{nnr:k}LLKLL{ct:Amid},Amp1EP10,Amidation,Free,Linear,L,k = involved in isopeptide bond formation,15,Antibacterial,<5 % Hemolysis at 10 µM,Human,Synthetic,α-Helix,Non-hemolytic,NA,NA
12973,35290038,2022,LKLLKKLLKKLLkLL,LKLLKKLLKKLL{nnr:k}LL{ct:Amid},Amp1EP13,Amidation,Free,Linear,L,k = involved in isopeptide bond formation,15,Antibacterial,< 10 % Hemolysis at 10 µM,Human,Synthetic,α-Helix,Low hemolytic,NA,NA
12974,35290038,2022,LKLLKKLLKKLLKLL,LKLLKKLLKKLLKLL{ct:Amid},Amp1L,Amidation,Free,Linear,L,k = involved in isopeptide bond formation,15,Antibacterial,100 % Hemolysis at 50 µM,Human,Synthetic,α-Helix,NA,NA,NA
12975,35290038,2022,LkLLKKLLKKLLKLL,L{nnr:k}LLKKLLKKLLKLL{ct:Amid},Amp1EP2,Amidation,Free,Linear,L,k = involved in isopeptide bond formation,15,Antibacterial,100 % Hemolysis at 50 µM,Human,Synthetic,α-Helix,Low hemolytic,NA,NA
12976,35290038,2022,LKLLkKLLKKLLKLL,LKLL{nnr:k}KLLKKLLKLL{ct:Amid},Amp1EP5,Amidation,Free,Linear,L,k = involved in isopeptide bond formation,15,Antibacterial,∼85 % Hemolysis at 50 µM,Human,Synthetic,α-Helix,Low hemolytic,CCGGGGGTSSSCC,NA
12977,35290038,2022,LKLLKkLLKKLLKLL,LKLLK{nnr:k}LLKKLLKLL{ct:Amid},Amp1EP6,Amidation,Free,Linear,L,k = involved in isopeptide bond formation,15,Antibacterial,∼60 % Hemolysis at 50 µM,Human,Synthetic,α-Helix,Low hemolytic,CCGGGGGTSSSCC,NA
12978,35290038,2022,LKLLKKLLkKLLKLL,LKLLKKLL{nnr:k}KLLKLL{ct:Amid},Amp1EP9,Amidation,Free,Linear,L,k = involved in isopeptide bond formation,15,Antibacterial,>35 % Hemolysis at 50 µM,Human,Synthetic,α-Helix,Non-hemolytic,CCGGGGGTSSSCC,NA
12979,35290038,2022,LKLLKKLLKkLLKLL,LKLLKKLLK{nnr:k}LLKLL{ct:Amid},Amp1EP10,Amidation,Free,Linear,L,k = involved in isopeptide bond formation,15,Antibacterial,<10 % Hemolysis at 50 µM,Human,Synthetic,α-Helix,Non-hemolytic,CCGGGGGTSSSCC,NA
12980,35290038,2022,LKLLKKLLKKLLkLL,LKLLKKLLKKLL{nnr:k}LL{ct:Amid},Amp1EP13,Amidation,Free,Linear,L,k = involved in isopeptide bond formation,15,Antibacterial,< 10 % Hemolysis at 50 µM,Human,Synthetic,α-Helix,Low hemolytic,CCGGGGGTSSSCC,NA
12981,35538042,2022,FLQRIRGALGRLF,FLQRIRGALGRLF,GHaR6R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 3.1 µM,Human,Synthetic,α-Helix,Non-hemolytic,CCGGGGGTSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12982,35538042,2022,FLQRIRGALGRLF,FLQRIRGALGRLF,GHaR6R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 6.2 µM,Human,Synthetic,α-Helix,Non-hemolytic,CCGGGGGTSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12983,35538042,2022,FLQRIRGALGRLF,FLQRIRGALGRLF,GHaR6R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 12.5 µM,Human,Synthetic,α-Helix,Non-hemolytic,CTHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12984,35538042,2022,FLQRIRGALGRLF,FLQRIRGALGRLF,GHaR6R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 25 µM,Human,Synthetic,α-Helix,Non-hemolytic,CTHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12985,35538042,2022,FLQRIRGALGRLF,FLQRIRGALGRLF,GHaR6R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 50 µM,Human,Synthetic,α-Helix,Non-hemolytic,CTHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12986,35538042,2022,FLQRIRGALGRLF,FLQRIRGALGRLF,GHaR6R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Non-hemolytic,CHHHHHHHHSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12987,35538042,2022,FLQRIRGALGRLF,FLQRIRGALGRLF,GHaR6R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 200 µM,Human,Synthetic,α-Helix,Non-hemolytic,CHHHHHHHHSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12988,35538042,2022,FLQRIIRALGRLF,FLQRIIRALGRLF,GHaR7R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",>85 % Hemolysis at 50 µM,Human,Synthetic,α-Helix,NA,CHHHHHHHHSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12989,35538042,2022,FLQRIIRALGRLF,FLQRIIRALGRLF,GHaR7R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",50 % Hemolysis at 25 µM,Human,Synthetic,α-Helix,NA,CHHHHHHHHSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12990,35538042,2022,FLQRIIRALGRLF,FLQRIIRALGRLF,GHaR7R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",>100 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CGGGTGGGTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12991,35538042,2022,FLQRIIGRLGRLF,FLQRIIGRLGRLF,GHaR8R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",∼1 % Hemolysis at 25 µM,Human,Synthetic,α-Helix,Non-hemolytic,CGGGTGGGTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12992,35538042,2022,FLQRIIGRLGRLF,FLQRIIGRLGRLF,GHaR8R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",<10 % Hemolysis at 50 µM,Human,Synthetic,α-Helix,Low hemolytic,CGGGTGGGTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12993,35538042,2022,FLQRIIGRLGRLF,FLQRIIGRLGRLF,GHaR8R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",<25 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic,CGGGTGGGTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12994,35538042,2022,FLQRIIGRLGRLF,FLQRIIGRLGRLF,GHaR8R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",<50 % Hemolysis at 200 µM,Human,Synthetic,α-Helix,Low hemolytic,CCCCCCCGGGTTTTCSCCTTHHHHSTTTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12995,35538042,2022,FLQRIIGAWGRLF,FLQRIIGAWGRLF,GHaR9W,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 12.5 µM,Human,Synthetic,α-Helix,Non-hemolytic,CCCCCCCGGGTTTTCSCCTTHHHHSTTTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12996,35538042,2022,FLQRIIGAWGRLF,FLQRIIGAWGRLF,GHaR9W,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",∼10 % Hemolysis at 37.5 µM,Human,Synthetic,α-Helix,Low hemolytic,CCTHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12997,35538042,2022,FLQRIIGAWGRLF,FLQRIIGAWGRLF,GHaR9W,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",62.5 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12998,35538042,2022,FLQRIIGAWGRLF,FLQRIIGAWGRLF,GHaR9W,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",>100 % Hemolysis at 200 µM,Human,Synthetic,α-Helix,NA,CHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12999,35050481,2022,TTLRLNTLAYKVAWLVNVKAFWAAGRALKKVGR,TTLRLNTLAYKVAWLVNVKAFWAAGRALKKVGR,dendrocin-ZM1,Free,Free,Linear,L,None,34,Antibacterial,>5 % Hemolysis at 16 μg/ml,Human,Zataria Multifora,α-Helix,Low hemolytic,CCTTHIIIIITTC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
13000,35050481,2022,TTLRLNTLAYKVAWLVNVKAFWAAGRALKKVGR,TTLRLNTLAYKVAWLVNVKAFWAAGRALKKVGR,dendrocin-ZM1,Free,Free,Linear,L,None,34,Antibacterial,17 % Hemolysis at 128 μg/ml,Human,Zataria Multifora,α-Helix,Low hemolytic,CHHHHHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
13001,35092568,2022,FLSGIVGMLGKLF,FLSGIVGMLGKLF{ct:Amid},SHa,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",50 % Hemolysis at 25 µM,Human,Synthetic,α-Helix,NA,CHHHHIIIIITTC,NA
13002,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 2.812 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13003,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 2.812 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHTTTC,NA
13004,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 2.812 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHIIIIITTC,NA
13005,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",1±0.62 % Hemolysis at 5.625 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13006,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 5.625 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHTTTC,NA
13007,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 5.625 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHIIIIITTC,NA
13008,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",7±0.55 % Hemolysis at 11.25 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13009,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 11.25 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHTTTC,NA
13010,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",1.8±0.9 % Hemolysis at 11.25 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHIIIIITTC,NA
13011,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",52.74 ± 5.94 % Hemolysis at 22.5 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13012,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",2.88 ± 1.24 % Hemolysis at 22.5 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHTTTC,NA
13013,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",2 ± 0.94 % Hemolysis at 22.5 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHIIIIITTC,NA
13014,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",55.07 ± 5.23 % Hemolysis at 45 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13015,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",18.18 ± 7.65 % Hemolysis at 45 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHTTTC,NA
13016,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",7.49 ± 1.20 % Hemolysis at 45 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHIIIIITTC,NA
13017,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",58.93 ± 6.02 % Hemolysis at 90 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13018,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",42.93 ± 4.75 % Hemolysis at 90 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHTTTC,NA
13019,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",44.69 ± 3.73 % Hemolysis at 90 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHIIIIITTC,NA
13020,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",61.64 ± 13.83 % Hemolysis at 180 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13021,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",47.60 ± 7.88 % Hemolysis at 180 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHHHTTCC,NA
13022,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",57.01 ± 8.50 % Hemolysis at 180 µM,Human,Synthetic,α-Helix,Low hemolytic,CTTTHHHHHHHTTTC,NA
13023,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",64.71 ± 11.34 % Hemolysis at 360 µM,Human,Synthetic,α-Helix,NA,NA,NA
13024,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",51.15 ± 10.41 % Hemolysis at 360 µM,Human,Synthetic,α-Helix,Low hemolytic,NA,NA
13025,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",58.97 ± 5.51 % Hemolysis at 360 µM,Human,Synthetic,α-Helix,Low hemolytic,NA,NA
13026,35464194,2022,VKRFKKFFRKLKKSV,VKRFKKFFRKLKKSV{ct:Amid},B1,Amidation,Free,Linear,L,None,15,"Antibacterial, Cytotoxic",50 % Hemolysis at > 80 µM,Rabbit,Bungarus Fasciatus,NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C
13027,35464194,2022,VKRFKKFFRKLKKLV,VKRFKKFFRKLKKLV{ct:Amid},B1-Leu,Amidation,Free,Linear,L,None,15,"Antibacterial, Cytotoxic",50 % Hemolysis at > 80 µM,Rabbit,Bungarus Fasciatus,NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C
13028,35464194,2022,VS5RFKS5FFRKLKKLV,V{nnr:S5}RFK{nnr:S5}FFRKLKKLV{ct:Amid},B1-L-1,Amidation,Free,Linear,L,"S5 = (S)-2-(4-pentenyl) alanine, stapled b/w S5 and S5",15,"Antibacterial, Cytotoxic",50 % Hemolysis at > 80 µM,Rabbit,Bungarus Fasciatus,NA,Low hemolytic,NA,NA
13029,35464194,2022,VKRFS5KFFS5KLKKLV,VKRF{nnr:S5}KFF{nnr:S5}KLKKLV{ct:Amid},B1-L-2,Amidation,Free,Stapled,L,"S5 = (S)-2-(4-pentenyl) alanine, stapled b/w S5 and S5",15,"Antibacterial, Cytotoxic",50 % Hemolysis at > 80 µM,Rabbit,Bungarus Fasciatus,NA,Low hemolytic,NA,NA
13030,35464194,2022,VKRFKS5FFRS5LKKLV,VKRFK{nnr:S5}FFR{nnr:S5}LKKLV{ct:Amid},B1-L-3,Amidation,Free,Stapled,L,"S5 = (S)-2-(4-pentenyl) alanine, stapled b/w S5 and S5",15,"Antibacterial, Cytotoxic",50 % Hemolysis at > 80 µM,Rabbit,Bungarus Fasciatus,NA,Low hemolytic,NA,NA
13031,35464194,2022,VKRFKKFFS5KLKS5LV,VKRFKKFF{nnr:S5}KLK{nnr:S5}LV{ct:Amid},B1-L-4,Amidation,Free,Stapled,L,"S5 = (S)-2-(4-pentenyl) alanine, stapled b/w S5 and S5",15,"Antibacterial, Cytotoxic",50 % Hemolysis at > 80 µM,Rabbit,Bungarus Fasciatus,NA,Low hemolytic,NA,NA
13032,35464194,2022,VR8RFKKFFS5KLKKLV,V{nnr:R8}RFKKFF{nnr:S5}KLKKLV{ct:Amid},B1-L-5,Amidation,Free,Stapled,L,"S5 = (S)-2-(4-pentenyl) alanine, stapled b/w R8 and S5",15,"Antibacterial, Cytotoxic",50 % Hemolysis at > 80 µM,Rabbit,Bungarus Fasciatus,NA,Low hemolytic,NA,NA
13033,35464194,2022,VKRFR8KFFRKLS5KLV,VKRF{nnr:R8}KFFRKL{nnr:S5}KLV{ct:Amid},B1-L-6,Amidation,Free,Stapled,L,"R8 = (R)-2-(7-octenyl) alanine, S5 = (S)-2-(4-pentenyl) alanine, stapled b/w R8 and S5",15,"Antibacterial, Cytotoxic",50 % Hemolysis at > 80 µM,Rabbit,Bungarus Fasciatus,NA,Low hemolytic,NA,NA
13034,35464194,2022,VKRFKR8FFRKLKS5LV,VKRFK{nnr:R8}FFRKLK{nnr:S5}LV{ct:Amid},B1-L-7,Amidation,Free,Stapled,L,"R8 = (R)-2-(7-octenyl) alanine, S5 = (S)-2-(4-pentenyl) alanine, stapled b/w R8 and S5",15,"Antibacterial, Cytotoxic",50 % Hemolysis at > 80 µM,Rabbit,Bungarus Fasciatus,NA,Low hemolytic,NA,NA
13043,35563004,2022,LAVHHLHSIRGRHHSCTIAQTQANHRHNSYQPNNSSCLAKETDLPTTRSTPATTSSTAPARKSPPASPAPTRQRLCPSPPRGPVSSRHPRRRGQARGRTRAAGVRRTKGYGGKCV,LAVHHLHSIRGRHHSCTIAQTQANHRHNSYQPNNSSCLAKETDLPTTRSTPATTSSTAPARKSPPASPAPTRQRLCPSPPRGPVSSRHPRRRGQARGRTRAAGVRRTKGYGGKCV,CgR2150,Free,Free,Linear,L,None,115,Antibacterial,∼0 % Hemolysis at 10 μg/ml,Porcine,Bacillus Subtilis,α-Helix Random coil,Low hemolytic,CCSCCCCCSCCTTTTTTCCSCCCSSSTTTTSCCCCCSCCCCGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O
13044,35563004,2022,LAVHHLHSIRGRHHSCTIAQTQANHRHNSYQPNNSSCLAKETDLPTTRSTPATTSSTAPARKSPPASPAPTRQRLCPSPPRGPVSSRHPRRRGQARGRTRAAGVRRTKGYGGKCV,LAVHHLHSIRGRHHSCTIAQTQANHRHNSYQPNNSSCLAKETDLPTTRSTPATTSSTAPARKSPPASPAPTRQRLCPSPPRGPVSSRHPRRRGQARGRTRAAGVRRTKGYGGKCV,CgR2150,Free,Free,Linear,L,None,115,Antibacterial,∼0 % Hemolysis at 20 μg/ml,Porcine,Bacillus Subtilis,α-Helix Random coil,Low hemolytic,CCSCCCCCSCCTTTTTTCCSCCCSSSTTTTSCCCCCSCCCCGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O
13045,35563004,2022,LAVHHLHSIRGRHHSCTIAQTQANHRHNSYQPNNSSCLAKETDLPTTRSTPATTSSTAPARKSPPASPAPTRQRLCPSPPRGPVSSRHPRRRGQARGRTRAAGVRRTKGYGGKCV,LAVHHLHSIRGRHHSCTIAQTQANHRHNSYQPNNSSCLAKETDLPTTRSTPATTSSTAPARKSPPASPAPTRQRLCPSPPRGPVSSRHPRRRGQARGRTRAAGVRRTKGYGGKCV,CgR2150,Free,Free,Linear,L,None,115,Antibacterial,∼0 % Hemolysis at 30 μg/ml,Porcine,Bacillus Subtilis,α-Helix Random coil,Low hemolytic,CCSCCCCCSCCTTTTTTCCSCCCSSSTTTTSCCCCCSCCCCGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O
13046,35563004,2022,LAVHHLHSIRGRHHSCTIAQTQANHRHNSYQPNNSSCLAKETDLPTTRSTPATTSSTAPARKSPPASPAPTRQRLCPSPPRGPVSSRHPRRRGQARGRTRAAGVRRTKGYGGKCV,LAVHHLHSIRGRHHSCTIAQTQANHRHNSYQPNNSSCLAKETDLPTTRSTPATTSSTAPARKSPPASPAPTRQRLCPSPPRGPVSSRHPRRRGQARGRTRAAGVRRTKGYGGKCV,CgR2150,Free,Free,Linear,L,None,115,Antibacterial,∼0 % Hemolysis at 40 μg/ml,Porcine,Bacillus Subtilis,α-Helix Random coil,Low hemolytic,CCSCCCCCSCCTTTTTTCCSCCCSSSTTTTSCCCCCSCCCCGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O
13047,35563004,2022,LAVHHLHSIRGRHHSCTIAQTQANHRHNSYQPNNSSCLAKETDLPTTRSTPATTSSTAPARKSPPASPAPTRQRLCPSPPRGPVSSRHPRRRGQARGRTRAAGVRRTKGYGGKCV,LAVHHLHSIRGRHHSCTIAQTQANHRHNSYQPNNSSCLAKETDLPTTRSTPATTSSTAPARKSPPASPAPTRQRLCPSPPRGPVSSRHPRRRGQARGRTRAAGVRRTKGYGGKCV,CgR2150,Free,Free,Linear,L,None,115,Antibacterial,0.32 % Hemolysis at 50 μg/ml,Porcine,Bacillus Subtilis,α-Helix Random coil,Low hemolytic,CCSCCCCCSCCTTTTTTCCSCCCSSSTTTTSCCCCCSCCCCGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O
13048,35563004,2022,LAVPNFEPPTRTTCPAPTSPGNPCGPPPPASQTRRPPFHPTSPLRR,LAVPNFEPPTRTTCPAPTSPGNPCGPPPPASQTRRPPFHPTSPLRR,CgR3101,Free,Free,Linear,L,None,46,Antibacterial,∼0 % Hemolysis at 10 μg/ml,Porcine,Bacillus Subtilis,Random coil,Low hemolytic,CCSSSSSCCCSSSCSCCCTTTSSSTTCSCCSCCCCSCCCCCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13049,35563004,2022,LAVPNFEPPTRTTCPAPTSPGNPCGPPPPASQTRRPPFHPTSPLRR,LAVPNFEPPTRTTCPAPTSPGNPCGPPPPASQTRRPPFHPTSPLRR,CgR3101,Free,Free,Linear,L,None,46,Antibacterial,∼0 % Hemolysis at 20 μg/ml,Porcine,Bacillus Subtilis,Random coil,Low hemolytic,CCTTSCSCCCCCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13050,35563004,2022,LAVPNFEPPTRTTCPAPTSPGNPCGPPPPASQTRRPPFHPTSPLRR,LAVPNFEPPTRTTCPAPTSPGNPCGPPPPASQTRRPPFHPTSPLRR,CgR3101,Free,Free,Linear,L,None,46,Antibacterial,∼0 % Hemolysis at 30 μg/ml,Porcine,Bacillus Subtilis,Random coil,Low hemolytic,CCCCSCCCSSSSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13051,35563004,2022,LAVPNFEPPTRTTCPAPTSPGNPCGPPPPASQTRRPPFHPTSPLRR,LAVPNFEPPTRTTCPAPTSPGNPCGPPPPASQTRRPPFHPTSPLRR,CgR3101,Free,Free,Linear,L,None,46,Antibacterial,∼0 % Hemolysis at 40 μg/ml,Porcine,Bacillus Subtilis,Random coil,Low hemolytic,CCCCCSSTTTCSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13052,35563004,2022,LAVPNFEPPTRTTCPAPTSPGNPCGPPPPASQTRRPPFHPTSPLRR,LAVPNFEPPTRTTCPAPTSPGNPCGPPPPASQTRRPPFHPTSPLRR,CgR3101,Free,Free,Linear,L,None,46,Antibacterial,0.46 % Hemolysis at 50 μg/ml,Porcine,Bacillus Subtilis,Random coil,Low hemolytic,CCCCCCCCCSSSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13053,35563007,2022,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,Zophobas atratus defensin | P80033.1,Free,Free,Linear,L,None,43,"Antibacterial, Anti-biofilm",0 % Hemolysis at 1 mg/mL,Sheep,Zophobas Atratus,NA,Non-hemolytic,CCCCCCCBSSSSBC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
13054,35563007,2022,GGYCNSKSVCVCR,GGYCNSKSVCVCR{ct:Amid},Z-d13,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 1 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCSSSSSCCCSSSCSCCCTTTSSSTTCSCCSCCCCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13055,35563007,2022,RGCYCNSKSVCVCR,RGCYCNSKSVCVCR{ct:Amid},Z-d14C,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 1 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCTTSCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13056,35563007,2022,RGCYCNSKSFCVCR,RGCYCNSKSFCVCR{ct:Amid},Z-d14CF,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",<5 % Hemolysis at 1 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCSCCCSSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13057,35563007,2022,RGCRCNSKSVCVCR,RGCRCNSKSVCVCR{ct:Amid},Z-d14CR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",∼1 % Hemolysis at 1 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCCSSTTTCSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13058,35563007,2022,RGCRCNSKSFCVCR,RGCRCNSKSFCVCR{ct:Amid},Z-d14CFR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",<5 % Hemolysis at 1 mg/mL,Sheep,Synthetic,β-Hairpin,Low hemolytic,CCCCCCCCCSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13059,35563007,2022,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,Zophobas atratus defensin | P80033.1,Free,Free,Linear,L,None,43,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.5 mg/mL,Sheep,Zophobas Atratus,NA,Non-hemolytic,CCCCCCCBSSSSBC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
13060,35563007,2022,GGYCNSKSVCVCR,GGYCNSKSVCVCR{ct:Amid},Z-d13,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.5 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCSSSSSCCCSSSCSCCCTTTSSSTTCSCCSCCCCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13061,35563007,2022,RGCYCNSKSVCVCR,RGCYCNSKSVCVCR{ct:Amid},Z-d14C,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.5 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCTTSCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13062,35563007,2022,RGCYCNSKSFCVCR,RGCYCNSKSFCVCR{ct:Amid},Z-d14CF,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.5 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCSCCCSSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13063,35563007,2022,RGCRCNSKSVCVCR,RGCRCNSKSVCVCR{ct:Amid},Z-d14CR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.5 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCCSSTTTCSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13064,35563007,2022,RGCRCNSKSFCVCR,RGCRCNSKSFCVCR{ct:Amid},Z-d14CFR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 0.5 mg/mL,Sheep,Synthetic,β-Hairpin,Non-hemolytic,CCCCCCCCCSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13065,35563007,2022,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,Zophobas atratus defensin | P80033.1,Free,Free,Linear,L,None,43,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.1 mg/mL,Sheep,Zophobas Atratus,NA,Non-hemolytic,CCCCCCCBSSSSBC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
13066,35563007,2022,GGYCNSKSVCVCR,GGYCNSKSVCVCR{ct:Amid},Z-d13,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.1 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCSSSSSCCCSSSCSCCCTTTSSSTTCSCCSCCCCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13067,35563007,2022,RGCYCNSKSVCVCR,RGCYCNSKSVCVCR{ct:Amid},Z-d14C,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.1 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCTTSCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13068,35563007,2022,RGCYCNSKSFCVCR,RGCYCNSKSFCVCR{ct:Amid},Z-d14CF,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.1 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCSCCCSSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13069,35563007,2022,RGCRCNSKSVCVCR,RGCRCNSKSVCVCR{ct:Amid},Z-d14CR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.1 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCCSSTTTCSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13070,35563007,2022,RGCRCNSKSFCVCR,RGCRCNSKSFCVCR{ct:Amid},Z-d14CFR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 0.1 mg/mL,Sheep,Synthetic,β-Hairpin,Non-hemolytic,CCCCCCCCCSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13071,35563007,2022,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,Zophobas atratus defensin | P80033.1,Free,Free,Linear,L,None,43,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.05 mg/mL,Sheep,Zophobas Atratus,NA,Non-hemolytic,CCCCCCCBSSSSBC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
13072,35563007,2022,GGYCNSKSVCVCR,GGYCNSKSVCVCR{ct:Amid},Z-d13,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.05 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCSSSSSCCCSSSCSCCCTTTSSSTTCSCCSCCCCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13073,35563007,2022,RGCYCNSKSVCVCR,RGCYCNSKSVCVCR{ct:Amid},Z-d14C,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.05 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCTTSCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13074,35563007,2022,RGCYCNSKSFCVCR,RGCYCNSKSFCVCR{ct:Amid},Z-d14CF,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.05 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCSCCCSSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13075,35563007,2022,RGCRCNSKSVCVCR,RGCRCNSKSVCVCR{ct:Amid},Z-d14CR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.05 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCCSSTTTCSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13076,35563007,2022,RGCRCNSKSFCVCR,RGCRCNSKSFCVCR{ct:Amid},Z-d14CFR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.05 mg/mL,Sheep,Synthetic,β-Hairpin,Non-hemolytic,CCCCCCCCCSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13077,35563007,2022,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,Zophobas atratus defensin | P80033.1,Free,Free,Linear,L,None,43,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.01 mg/mL,Sheep,Zophobas Atratus,NA,Non-hemolytic,CCCCCCCBSSSSBC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
13078,35563007,2022,GGYCNSKSVCVCR,GGYCNSKSVCVCR{ct:Amid},Z-d13,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.01 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCSSSSSCCCSSSCSCCCTTTSSSTTCSCCSCCCCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13079,35563007,2022,RGCYCNSKSVCVCR,RGCYCNSKSVCVCR{ct:Amid},Z-d14C,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.01 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCTTSCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13080,35563007,2022,RGCYCNSKSFCVCR,RGCYCNSKSFCVCR{ct:Amid},Z-d14CF,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.01 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCSCCCSSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13081,35563007,2022,RGCRCNSKSVCVCR,RGCRCNSKSVCVCR{ct:Amid},Z-d14CR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.01 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCCSSTTTCSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13082,35563007,2022,RGCRCNSKSFCVCR,RGCRCNSKSFCVCR{ct:Amid},Z-d14CFR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.01 mg/mL,Sheep,Synthetic,β-Hairpin,Non-hemolytic,CCCCCCCCCSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13083,35563007,2022,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,Zophobas atratus defensin | P80033.1,Free,Free,Linear,L,None,43,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.005 mg/mL,Sheep,Zophobas Atratus,NA,Non-hemolytic,CCCCCCCBSSSSBC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
13084,35563007,2022,GGYCNSKSVCVCR,GGYCNSKSVCVCR{ct:Amid},Z-d13,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.005 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCSSSSSCCCSSSCSCCCTTTSSSTTCSCCSCCCCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13085,35563007,2022,RGCYCNSKSVCVCR,RGCYCNSKSVCVCR{ct:Amid},Z-d14C,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.005 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCTTSCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13086,35563007,2022,RGCYCNSKSFCVCR,RGCYCNSKSFCVCR{ct:Amid},Z-d14CF,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.005 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCSCCCSSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13087,35563007,2022,RGCRCNSKSVCVCR,RGCRCNSKSVCVCR{ct:Amid},Z-d14CR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.005 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCCSSTTTCSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13088,35563007,2022,RGCRCNSKSFCVCR,RGCRCNSKSFCVCR{ct:Amid},Z-d14CFR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.005 mg/mL,Sheep,Synthetic,β-Hairpin,Non-hemolytic,CCCCCCCCCSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13089,35563007,2022,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,Zophobas atratus defensin | P80033.1,Free,Free,Linear,L,None,43,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.001 mg/mL,Sheep,Zophobas Atratus,NA,Non-hemolytic,CCCCCCCBSSSSBC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
13090,35563007,2022,GGYCNSKSVCVCR,GGYCNSKSVCVCR{ct:Amid},Z-d13,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.001 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,NA,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13091,35563007,2022,RGCYCNSKSVCVCR,RGCYCNSKSVCVCR{ct:Amid},Z-d14C,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.001 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,NA,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13092,35563007,2022,RGCYCNSKSFCVCR,RGCYCNSKSFCVCR{ct:Amid},Z-d14CF,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.001 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,NA,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13093,35563007,2022,RGCRCNSKSVCVCR,RGCRCNSKSVCVCR{ct:Amid},Z-d14CR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.001 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,NA,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13094,35563007,2022,RGCRCNSKSFCVCR,RGCRCNSKSFCVCR{ct:Amid},Z-d14CFR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.001 mg/mL,Sheep,Synthetic,β-Hairpin,Non-hemolytic,NA,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13295,35616397,2022,GAIPKCCVGTSRNIPLSILMRVERYDVQHNHGACEIDAWLHANGRKYCADPRVKKVLGVAMQIRKAQLMREKLNSIMRR,GAIPKCCVGTSRNIPLSILMRVERYDVQHNHGACEIDAWLHANGRKYCADPRVKKVLGVAMQIRKAQLMREKLNSIMRR,omCK11,Free,Free,Linear,L,None,79,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 250 μg/ml,Human,Oncorhynchus Mykiss,α-Helix,NA,CCSSTTHHHHHHHHHHHTTGGGTSSCCCC,NA
13296,35616397,2022,AHPKVKRKLKRMQRKKDGKQKRH,AHPKVKRKLKRMQRKKDGKQKRH,omCCL28-like-23,Free,Free,Linear,L,None,23,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 250 μg/ml,Human,Synthetic; Omck11 Analogues,α-Helix,NA,CCSTTSSHHHHHHCSSCCCCSCC,CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
13297,35616397,2022,ATPKMEQFLQKLMKRMARLKASAV,ATPKMEQFLQKLMKRMARLKASAV,drCCL27b-24,Free,Free,Linear,L,None,24,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 250 μg/ml,Human,Synthetic; Omck11 Analogues,α-Helix,NA,CCHHHHTTGGGTC,CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C
13298,35616397,2022,AHPKWMEVRSRQRKKKHNKRRATY,AHPKWMEVRSRQRKKKHNKRRATY,IcCCL28-25,Free,Free,Linear,L,None,24,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 250 μg/ml,Human,Synthetic; Omck11 Analogues,α-Helix,NA,CTTHHHHHHHHHC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C
13299,35616397,2022,APLKMKAILEIVHRRMKQNKMKAAF,APLKMKAILEIVHRRMKQNKMKAAF,smCCL27b-25,Free,Free,Linear,L,None,25,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 250 μg/ml,Human,Synthetic; Omck11 Analogues,α-Helix,NA,CHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)CC
13300,35616397,2022,VDQTVFKDIWWRMKQWKQRVKKRAAKYNV,VDQTVFKDIWWRMKQWKQRVKKRAAKYNV,trCCL28-29,Free,Free,Linear,L,None,29,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 250 μg/ml,Human,Synthetic; Omck11 Analogues,α-Helix,NA,CCCCSTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
13301,35616397,2022,AHPRIKKHLDLLMKKKRHLAMKIAAP,AHPRIKKHLDLLMKKKRHLAMKIAAP,chCCL27a-26,Free,Free,Linear,L,None,26,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 250 μg/ml,Human,Synthetic; Omck11 Analogues,α-Helix,NA,CCCCSTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O
13302,35377553,2022,FFGSVLKLIPKIL,FFGSVLKLIPKIL,temporin-PTa,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",13 % Hemolysis at 87 µM,Mus musculus,Hylarana Picturata,α-Helix,NA,CTTSCTTCCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
13303,35377553,2022,AAGKVLKLLKKLL,AAGKVLKLLKKLL,Hp-MAP1,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",Hemolytic,Mus musculus,Synthetic; Temporin-Pta,α-Helix,NA,CCCSSCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)N)C(C)C)C(=O)O
13304,35377553,2022,AAKKVLKLLKKLL,AAKKVLKLLKKLL,Hp-MAP2,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",Hemolytic,Mus musculus,Synthetic; Temporin-Pta,α-Helix,NA,CCCCCCSCCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(C)C)C(=O)O
13327,35526666,2022,FFSLIPSLVGGLISAFK,FFSLIPSLVGGLISAFK{ct:Amid},Stig (stigmurin),Amidation,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",0 % Hemolysis at 150–1.17 µM,Human,Tityus Stigmurus,α-Helix,Non-hemolytic,CTTHHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
13328,35526666,2022,FFSLIPKLVGKLISAFK,FFSLIPKLVGKLISAFK{ct:Amid},StigA8,Amidation,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",11.5 % Hemolysis at 9.17 µM,Human,Synthetic; Analog Of Stigmurin,α-Helix,Non-hemolytic,CGGGTHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
13329,35526666,2022,FFSLIPKLVGKLIKAFK,FFSLIPKLVGKLIKAFK{ct:Amid},StigA18,Amidation,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",14 % Hemolysis at 9.17 µM,Human,Synthetic; Analog Of Stigmurin,α-Helix,Non-hemolytic,CCSSCTTTSSCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
13330,35526666,2022,FFSLIPKLVGKLISAFK,FFSLIPKLVGKLISAFK{ct:Amid},StigA8,Amidation,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",15 % Hemolysis at 150 µM,Human,Synthetic; Analog Of Stigmurin,α-Helix,Non-hemolytic,CTTSCHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
13331,35526666,2022,FFSLIPKLVGKLIKAFK,FFSLIPKLVGKLIKAFK{ct:Amid},StigA18,Amidation,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",22 % Hemolysis at 150 µM,Human,Synthetic; Analog Of Stigmurin,α-Helix,Non-hemolytic,CCTTTTTGGGCHHHHTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
13332,35526666,2022,FFSLIPSLVKKLIKAFK,FFSLIPSLVKKLIKAFK{ct:Amid},StigA25,Amidation,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",100 % Hemolysis at 150 µM,Human,Synthetic; Analog Of Stigmurin,NA,NA,CBTTBSCSCCTTTSSSCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
13333,35526666,2022,FFKLIPKLVKKLIKAFK,FFKLIPKLVKKLIKAFK{ct:Amid},StigA31,Amidation,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",80 % Hemolysis at 150 µM,Human,Synthetic; Analog Of Stigmurin,NA,NA,CCSHHHHHHHSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
13334,35526666,2022,FLSLIPSLVGGSISAFK,FLSLIPSLVGGSISAFK{ct:Amid},TsAP-1,Amidation,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",5 % Hemolysis at 160 µM,Human,T. Serrulatus Scorpion,NA,NA,CCSHHHHHHHSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
13335,35526666,2022,FLGMIPGLIGGLISAFK,FLGMIPGLIGGLISAFK{ct:Amid},TsAP-2,Amidation,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",86 % Hemolysis at 40 µM,Human,T. Serrulatus Scorpion,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
13346,35891269,2022,KLFGKVGNLLQKGWQKIKNIGRRIKDFFRNIRPMQEA,KLFGKVGNLLQKGWQKIKNIGRRIKDFFRNIRPMQEA{ct:Amid},To-KL37,Amidation,Free,Linear,L,None,37,"Antibacterial, Antifungal",16 % Hemolysis at 50 µM,Human,Cathelicidin-Derived,NA,Low hemolytic,CBTTBSCCCTTTSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
13408,35887160,2022,AGDKKIKIGINGFGRIGRL,AGDKKIKIGINGFGRIGRL,NP-6,Free,Free,Linear,L,None,19,Antibacterial,2.39 ± 0.13 % Hemolysis at 512 μg/ml,Mouse,Synthetic,NA,Non-hemolytic,CCCCHHHHHHHHGGGGTSSCCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13426,35966656,2022,KWKLFKKIHKVGQNIRKGIIKAGPAVAVVGQAAQIAK,KWKLFKKIHKVGQNIRKGIIKAGPAVAVVGQAAQIAK,PEW300,Free,Free,Linear,L,None,37,"Antibacterial, Anti-biofilm",0 % Hemolysis at 50 to 250 μg/ml,Mouse,Synthetic,α-Helix,Non-hemolytic,CCCCSHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)CC
13467,35978681,2022,KWKLFKKIGAVLKVL,KWKLFKKIGAVLKVL{ct:Amid},CAM (CA(1–7)M(2–9)),Amidation,Free,Linear,L,None,15,Antibacterial,50 % Hemolysis at 690 μg/ml,Sheep,Synthetic,NA,NA,CCCCGGGHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
13468,35978681,2022,RWKLFKKIGAVLKVL,RWKLFKKIGAVLKVL{ct:Amid},R1-CAM,Amidation,Free,Linear,L,None,15,Antibacterial,50 % Hemolysis at 450 μg/ml,Sheep,Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9),NA,NA,CCCCTTTTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
13469,35978681,2022,KWRLFKKIGAVLKVL,KWRLFKKIGAVLKVL{ct:Amid},R3-CAM,Amidation,Free,Linear,L,None,15,Antibacterial,50 % Hemolysis at 750 μg/ml,Sheep,Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9),NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
13470,35978681,2022,KWKLFRKIGAVLKVL,KWKLFRKIGAVLKVL{ct:Amid},R6-CAM,Amidation,Free,Linear,L,None,15,Antibacterial,50 % Hemolysis at 935 μg/ml,Sheep,Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9),NA,NA,CCSHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
13471,35978681,2022,KWKLFKRIGAVLKVL,KWKLFKRIGAVLKVL{ct:Amid},R7-CAM,Amidation,Free,Linear,L,None,15,Antibacterial,50 % Hemolysis at >1000 μg/ml,Sheep,Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9),NA,NA,CCSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
13472,35978681,2022,KWKLFKKIGAVLRVL,KWKLFKKIGAVLRVL{ct:Amid},R13-CAM,Amidation,Free,Linear,L,None,15,Antibacterial,50 % Hemolysis at 280 μg/ml,Sheep,Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9),NA,NA,CCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
13473,35978681,2022,RWRLFRRIGAVLRVL,RWRLFRRIGAVLRVL{ct:Amid},R-CAM,Amidation,Free,Linear,L,No subscript indicates that all Lys residues were replaced by either Arg or Orn,15,Antibacterial,50 % Hemolysis at 230 μg/ml,Sheep,Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9),NA,NA,CCCCCCTTC,NA
13474,35978681,2022,OWOLFOOIGAVLOVL,{nnr:O}W{nnr:O}LF{nnr:O}{nnr:O}IGAVL{nnr:O}VL{ct:Amid},O-CAM,Amidation,Free,Linear,L,"O = L-Ornithine, No subscript indicates that all Lys residues were replaced by either Arg or Orn",15,Antibacterial,50 % Hemolysis at >1000 μg/ml,Sheep,Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9),NA,NA,NA,NA
13475,35978681,2022,CKWKLFKKIGAVLKVL,CKWKLFKKIGAVLKVL{cyc:N-C}{ct:Amid},Cyc-CAM,Amidation,Free,Cyclic,L,None,16,Antibacterial,50 % Hemolysis at >1000 μg/ml,Sheep,Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9),NA,NA,CCCCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
13744,36145681,2022,GFLFKLIPKAIKKLISKFK,GFLFKLIPKAIKKLISKFK,GK-19,Free,Free,Linear,L,None,19,"Antibacterial, Antifungal",<5 % Hemolysis at 100 µM,Rat,Synthetic,NA,Low hemolytic,CCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
13745,36145681,2022,GFLFKLIPKAIKKLISKFK,GFLFKLIPKAIKKLISKFK,GK-19,Free,Free,Linear,L,None,19,"Antibacterial, Antifungal",15 % Hemolysis at 200 µM,Rat,Synthetic,NA,Low hemolytic,CCSSTTSCTTCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
13746,36145681,2022,GFLFKLIPKAIKKLISKFK,GFLFKLIPKAIKKLISKFK,GK-19,Free,Free,Linear,L,None,19,"Antibacterial, Antifungal",40 % Hemolysis at 400 µM,Rat,Synthetic,NA,Low hemolytic,CCTTHHHHHHHTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
13775,25561178,2015,xISqiIStAXI,{nnr:x}ISQ{d}I{d}IST{d}A{nnr:X}I,Teixobactin,Free,Free,Linear,Mix,"x = NmPhe(N-methylated phenylalanine), X = End (Enduracididine)",11,"Anticancer, Antibacterial",No Hemolysis,Human,Eleftheria Terrae,NA,Non-hemolytic,NA,NA
13776,25329706,2014,RFPGLMMKLLV,RFPGLMMKLLV,"LBP/BPI (324 334), ofLBP1N",Free,Free,Linear,L,None,11,"Antibacterial, Antifungal",45 % Hemolysis at 100 μg/ml,Human,Synthetic Construct,NA,NA,NA,CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C
13777,25329706,2014,RFPKLMMKLLV,RFPKLMMKLLV,"LBP/BPI (324 334)[G4K], ofLBP2A",Free,Free,Linear,L,None,11,"Antibacterial, Antifungal",30 % Hemolysis at 100 μg/ml,Human,Synthetic Construct,NA,NA,NA,CSCC[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C
13778,25329706,2014,KLVKTQLKVLK,KLVKTQLKVLK,"LBP/BPI (450 460), ofLBP4N",Free,Free,Linear,L,None,11,"Antibacterial, Antifungal",0 % Hemolysis at 100 μg/ml,Human,Synthetic Construct,NA,Non-hemolytic,CCTHHHHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
13779,25329706,2014,KLVKTWLKVLK,KLVKTWLKVLK,"LBP/BPI (450 460)[Q6W], ofLBP5A",Free,Free,Linear,L,None,11,"Antibacterial, Antifungal",0 % Hemolysis at 100 μg/ml,Human,Synthetic Construct,NA,Non-hemolytic,CCCTTHHHHHHHCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
13780,25329706,2014,MKLVKTWLKVLK,MKLVKTWLKVLK,"LBP/BPI (449 460)[Q7W], ofLBP6A",Free,Free,Linear,L,None,12,"Antibacterial, Antifungal",28 % Hemolysis at 100 μg/ml,Human,Synthetic Construct,NA,NA,CCCTTHHHHHHHCC,CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
13781,25485686,2015,TrSGxLrEqwIT,TR{d}SG{nnr:x}LR{d}EQ{d}W{d}IT,Lysocin E,Free,Free,Linear,Mix,x = D-N-Methylphenylalanine,12,"Antibacterial, Antifungal",<1 % Hemolysis at 100 μg/ml,Sheep,Lysobacter,NA,Non-hemolytic,NA,NA
13782,25485686,2015,TrSGxLrEqwIT,TR{d}SG{nnr:x}LR{d}EQ{d}W{d}IT,Lysocin E,Free,Free,Linear,Mix,x = D-N-Methylphenylalanine,12,"Antibacterial, Antifungal",<1 % Hemolysis at 100 μg/ml,Horse,Lysobacter,NA,Non-hemolytic,NA,NA
13783,21884742,2011,IKWKAILDAVKKVI,IKWKAILDAVKKVI{ct:Amid},Mastoparan-A,Amidation,Free,Linear,L,None,14,Antibacterial,4 % Hemolysis at 32 μg/ml,Sheep,Vespa Analis,40%TFE= α-Helix,NA,CCCCSSSSSSGGGTCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)CC
13784,21884742,2011,INLKAIAALAKKLL,INLKAIAALAKKLL{ct:Amid},Mastoparan M,Amidation,Free,Linear,L,None,14,Antibacterial,7 % Hemolysis at 64 μg/ml,Sheep,Vespa Mandarinia,40%TFE= α-Helix,NA,CCCSTHHHHHHHSSCSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13785,21884742,2011,INLKAIAALAKKLF,INLKAIAALAKKLF{ct:Amid},Mastoparan-AF,Amidation,Free,Linear,L,None,14,Antibacterial,2.5 % Hemolysis at 32 μg/ml,Sheep,Vespa Affinis,40%TFE= α-Helix,NA,CTTTHHHHHHHHTCSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
13786,28002968,2016,WGEAFSAGVHRLANGGNG,WGEAFSAGVHRLANGGNG{ct:Amid},Leucocin A (18-35)/ WG18,Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal",10 % Hemolysis at >71.15 µM,Human,Synthetic Construct,TFE = α-Helix,NA,CGGGHHHHTHHHHTTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)O
13787,28002968,2016,WGRAFSAGVHRLANGGNG,WGRAFSAGVHRLANGGNG{ct:Amid},WR1,Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal",10 % Hemolysis at >70.09 µM,Human,Synthetic Construct,TFE = Random coil,NA,CCCTHHHHHHHHHHHTTC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)O
13788,28002968,2016,WGRAFSAGVHRLARGGRG,WGRAFSAGVHRLARGGRG{ct:Amid},WR3,Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal",10 % Hemolysis at >67.01 µM,Human,Synthetic Construct,TFE = α-Helix,NA,CCCTHHHHTHHHHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
13789,28002968,2016,WGRAFSRGVRRLARGGRG,WGRAFSRGVRRLARGGRG{ct:Amid},WR5,Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal",10 % Hemolysis at >63.54 µM,Human,Synthetic Construct,TFE = Random coil,NA,CCGGGTGGGCSCGGGCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
13790,28002968,2016,WGRAFRRGVRRLARGGRR,WGRAFRRGVRRLARGGRR{ct:Amid},WR7,Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal",10 % Hemolysis at >58.64 µM,Human,Synthetic Construct,TFE = Random coil,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13791,28002968,2016,WGRAFRRLVRRLARGLRR,WGRAFRRLVRRLARGLRR{ct:Amid},WRL2,Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal",10 % Hemolysis at >55.78 µM,Human,Synthetic Construct,TFE = α-Helix,NA,CTHHHHHHHHHHGGGTTTC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13792,28002968,2016,WLRAFRRLVRRLARGLRR,WLRAFRRLVRRLARGLRR{ct:Amid},WRL3,Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal",10 % Hemolysis at 27.22 µM,Human,Synthetic Construct,TFE = α-Helix,NA,CCCSTTTTCSTTTSSCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13793,28002968,2016,WLRAFRRLVRRLARLLRR,WLRAFRRLVRRLARLLRR{ct:Amid},WRL4,Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal",10 % Hemolysis at 53.18 µM,Human,Synthetic Construct,TFE = α-Helix,NA,CHHHHHHHHHHHHHSTTTC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13794,11600395,2001,KNIRRIIRKIIHIIKKYG,KNIRRIIRKIIHIIKKYG,OV-5,Free,Free,Linear,L,None,18,Antibacterial,76 % Hemolysis at 100 µM,Human,Synthetic Construct,NA,NA,CCCCCSCCCCCCSSCCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
13795,28741926,2017,ZCRRLCYKQRCVTYCRGR,{nnr:Z}CRRLCYKQRCVTYCRGR{ct:Amid},Gomesin,Amidation,Free,Linear,L,Z = pyroglutamic acid,18,"Antibacterial, Antifungal",47.2±6 % Hemolysis at 64 µM,Human,Acanthoscurria Gomesiana [Tarantula Spider],NA,NA,NA,NA
13796,24269514,2014,GLLKKWLKKWKEFKRIVGY,GLLKKWLKKWKEFKRIVGY{ct:Amid},peptide2,Amidation,Free,Linear,L,None,19,Antibacterial,20 % Hemolysis at 160 μg/ml,Human,Synthetic Construct,α-Helix,NA,CCTTTCSSCSTTTSSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
13797,28433718,2017,FFFHIVKGLFHAGRMIHGLV,FFFHIVKGLFHAGRMIHGLV,"Piscidin-2 (1-20), ecPis-2 (1-20)",Free,Free,Linear,L,None,20,"Antibacterial, Antiparasitic, Antifungal",5.12±0.37 % Hemolysis at 2.5 µM,Rabbit,Synthetic Construct,α-Helix,NA,CCTTHHHHHHHHTTTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C
13798,15019209,2003,GIFSKLAGKKLKNLLISGL,GIFSKLAGKKLKNLLISGL{ct:Amid},Esculentin-1B (1-18),Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal",7 % Hemolysis at 15 µM,Human,Synthetic Construct,NA,NA,CCTTHHHHHHHHTTTTCCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13799,32828795,2020,WPKWWKWKRRWGRKKAKKRRG,WPKWWKWKRRWGRKKAKKRRG,Peptide 1,Free,Free,Linear,L,None,21,Antibacterial,3.4 % Hemolysis at 100 µM,Human,Synthetic Construct,NA,Low hemolytic,CCCCCCGGGSTHHHHHHHHSSSCCSSSCCCC,C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
13800,19113844,2009,GLWSKIKEVGKEAAKAAAKAAGK,GLWSKIKEVGKEAAKAAAKAAGK,Dermaseptin B2 (1-23),Free,Free,Linear,L,None,23,Antibacterial,0 % Hemolysis at 50 µM,Rat,Synthetic Construct,NA,Non-hemolytic,CCSHHHHHHHHHHHHTTCCCGGGTTSSSTHHHHSCCSSSCCCCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
13801,28433718,2017,IFGLLLHGAIHVGKLIHGLVRRH,IFGLLLHGAIHVGKLIHGLVRRH,"Piscidin-3 (1-23), ecPis-3 (1-23)",Free,Free,Linear,L,None,23,"Antibacterial, Antiparasitic, Antifungal",0.22±0.06 % Hemolysis at 1.25 µM,Rabbit,Synthetic Construct,α-Helix,NA,CCSSSCCBCSTTCCCTTCCCSSSCTTTCCCSSSSSCBSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
13802,24495783,2014,TQQAFQKFLAAVTSALGKQYH,TQQAFQKFLAAVTSALGKQYH{ct:Amid},SHbetaAP-NH2,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",0 % Hemolysis at 100 μg/ml,Human,C-Terminus Of Katsuwonus Pelamis Hemoglobin Beta Synthetic Construct,α-Helix Random coil,Non-hemolytic,CCGGGCSSCSTTTCCTTTSCTTTTTTTTTTTTTTCCCCTTCCCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
13803,24495783,2014,TQQAFQKFLAAVTSALGKQYH,TQQAFQKFLAAVTSALGKQYH{ct:OH},SHbetaAP-OH,OH,Free,Linear,L,None,21,"Antibacterial, Antifungal",0 % Hemolysis at 100 μg/ml,Human,Synthetic Construct,α-Helix Random coil,Non-hemolytic,CCSSTTGGGTTHHHHHHHTTGGGCCGGGGTSCCSSSSSCCCSCSSCCSSCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
13804,24412436,2014,VKVGINGFGRIGRLVTRAAFHGKKVEIVAIND,VKVGINGFGRIGRLVTRAAFHGKKVEIVAIND,SJGAP (Skipjack tuna GAPDH-related AMP),Free,Free,Linear,L,None,32,"Antibacterial, Antifungal",0 % Hemolysis at <100 μg/ml,Human,Fish Skipjack Tuna Katsuwonus Pelamis,"one Alphα-Helix Strand, two parallel Betα-Strands, and 2 Loop regions",Non-hemolytic,CCGGGTTTCCSCCSCCCCSSCCCCCTHHHHTTTCCSSSTTTTCCCCCCSCCCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)CC
13805,33179211,2021,QGWEAVAAAVASKIVGLWRNETTELLGHECKFTVKPYIKRFQLNYKGGRLWC,QGWEAVAAAVASKIVGLWRNETTELLGHECKFTVKPYIKRFQLNYKGGRLWC,Cf-ALF2,Free,Free,Linear,L,None,52,Antibacterial,0 % Hemolysis at 20 µM,Human,Charybdis Feriatus [Crucifix Crab],NA,Non-hemolytic,CTTHHHHHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
13806,28433718,2017,FFFHIVKGLFHAGRMIHGLVNRRRHRHGMEELDLDQRAFEREKAFA,FFFHIVKGLFHAGRMIHGLVNRRRHRHGMEELDLDQRAFEREKAFA,"Piscidin-2, ecPis-2",Free,Free,Linear,L,None,46,"Antibacterial, Antiparasitic, Antifungal",4.03±0.31 % Hemolysis at 2.5 µM,Rabbit,Epinephelus Coioides,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O)C(C)C
13807,28433718,2017,IFGLLLHGAIHVGKLIHGLVRRHGEEQLDDLEQLDKRALDYNPGRPGFD,IFGLLLHGAIHVGKLIHGLVRRHGEEQLDDLEQLDKRALDYNPGRPGFD,"Piscidin-3, ecPis-3",Free,Free,Linear,L,None,49,"Antibacterial, Antiparasitic, Antifungal",9.30±3.40% Hemolysis at 20 µM,Rabbit,Epinephelus Coioides,α-Helix,NA,CTTCCHHHHHHHHHHHHHHHHHHHHCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
13808,28433718,2017,FFRHIKSFWKGAKAIFRGARQGWREHRALSKQRKMDQGGGGNEVDNGTPPYWQK,FFRHIKSFWKGAKAIFRGARQGWREHRALSKQRKMDQGGGGNEVDNGTPPYWQK,"Piscidin-4, ecPis-4",Free,Free,Linear,L,None,54,"Antibacterial, Antiparasitic, Antifungal",9.29±1.06 % Hemolysis at 1.25 µM,Rabbit,Epinephelus Coioides,α-Helix,NA,CCCHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C
13809,23711469,2013,AATAKKGAKKADAPAKPKKATKPKSPKKAAKKAGAKKGVKRAGKKGAKKTTKAKK,AATAKKGAKKADAPAKPKKATKPKSPKKAAKKAGAKKGVKRAGKKGAKKTTKAKK,"Molluscidin-1, cgMolluscidin",Free,Free,Linear,L,None,55,"Antibacterial, Antifungal",0 % Hemolysis at 100 μg/ml,Human,Pacific Oyster Crassostrea Gigas,α-Helix and Random coil,Non-hemolytic,CCHHHHHHHHHHHHCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@@H](C)O
13810,8223491,1993,IIGPVLGMVGSALGGLLKKI,IIGPVLGMVGSALGGLLKKI{ct:Amid},Peptide B Bombinin H1,Amidation,Free,Linear,L,None,21,"Antibacterial, hemolytic",Hemolysis at 17 µM,Human,"Yellow-Bellied Toad, Bombina Variegata L, Europe",NA,NA,CTTHHHHHHHHTTTCC,CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)CC
13811,8223491,1993,IlGPVLGLVGSALGGLLKKI,I{nnr:l}GPVLGLVGSALGGLLKKI,Bombinin H4,Free,Free,Linear,Mix,l = D-aILe(D-alloisoleucine),20,"Antibacterial, hemolytic, Antifungal, candidacidal, Antiparasitic",Hemolysis at 14.6 µM,Human,"Yellow-Bellied Toad, Bombina Variegata L, Europe",Helix,NA,NA,NA
13812,11835991,2002,GIGTKILGGVKTALKGALKELASTYAN,GIGTKILGGVKTALKGALKELASTYAN{ct:Amid},Maximin 1,Amidation,Free,Linear,L,None,27,"Antibacterial, Antiviral, Antifungal, candidacidal, Spermicidal, Anti-HIV, Hemolytic, Anticancer",Low Hemolysis at 50 μg/ml,Rabbit,"Chinese Red Belly Toad, Bombina Maxima",Helix,Low hemolytic,CCCCHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O
13818,8163497,1994,GIFSKLAGKKLKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC,GIFSKLAGKKLKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC,Esculentin-1B,Free,Free,Linear,L,None,46,"Antibacterial, Anti-diabetes, Hemolytic",Hemolytic,Human,"Edible Frog, Rana Esculenta , Europe",Helix,NA,CCGGGHHHHHHHHTSSCCCCSSGGGGCSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)CC
13819,10931184,2000,GILDTIKSIASKVWNSKTVQDLKRKGINWVANKLGVSPQAA,GILDTIKSIASKVWNSKTVQDLKRKGINWVANKLGVSPQAA,Hadrurin,Free,Free,Linear,L,None,41,"Antibacterial, hemolytic",80 % Hemolysis at 20 µM,Human,"Venom, Hadrurus Aztecus, Mexico, North America",NA,NA,CCSSTHHHHSCHHHHHGGGSSCGGGGSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
13820,10931184,2000,GILDTIKSIASKVWNSKTVQDLKRKGINWVANKLGVSPQAA,GILDTIKSIASKVWNSKTVQDLKRKGINWVANKLGVSPQAA,Hadrurin,Free,Free,Linear,L,None,41,"Antibacterial, hemolytic",50 % Hemolysis at <10 µM,Human,"Venom, Hadrurus Aztecus, Mexico, North America",NA,NA,CGGGGGCIIIIIHHSSSCGGGCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
13821,10931184,2000,gildtiksiaskvwnsktvqdlkrkginwvanklgvspqaa,G{d}I{d}L{d}D{d}T{d}I{d}K{d}S{d}I{d}A{d}S{d}K{d}V{d}W{d}N{d}S{d}K{d}T{d}V{d}Q{d}D{d}L{d}K{d}R{d}K{d}G{d}I{d}N{d}W{d}V{d}A{d}N{d}K{d}L{d}G{d}V{d}S{d}P{d}Q{d}A{d}A{d},D-isomer Hadrurin,Free,Free,Linear,D,None,41,"Antibacterial, hemolytic",100 % Hemolysis at 5 µM,Human,"Venom, Hadrurus Aztecus, Mexico, North America",NA,NA,CCGGGHHHHHHHHHCSSCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
13822,9257708,1997,GWLRKAAKSVGKFYYKHKYYIKAAWQIGKHAL,GWLRKAAKSVGKFYYKHKYYIKAAWQIGKHAL,Styelin D,Free,Free,Linear,L,None,32,"Antibacterial, Anti-MRSA, Hemolytic",50 % Hemolysis at <10 μg/ml,Human,"Sea Squirt, Styela Clava",Helix,NA,CHHHHHHHHTTTTTCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O
13823,9257708,1997,GWLRKAAKSVGKFYYKHKYYIKAAWQIGKHAL,GWLRKAAKSVGKFYYKHKYYIKAAWQIGKHAL,Styelin D,Free,Free,Linear,L,None,32,"Antibacterial, Anti-MRSA, Hemolytic",50 % Hemolysis at 40 μg/ml,Sheep,"Sea Squirt, Styela Clava",Helix,NA,CCCCTHHHHHHSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O
13824,8353519,1993,SIGSAFKKALPVAKKIGKAALPIAKAALP,SIGSAFKKALPVAKKIGKAALPIAKAALP,Ceratotoxin B,Free,Free,Linear,L,None,29,"Antibacterial Gram-, Hemolytic",Hemolytic,Human,"Female Reproductive Accessory Glands, Medfly, Ceratitis Capitata",Helix,NA,CCCTTCCSCCTTTSSSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC
13825,15648972,2004,GVVDILKGAGKDLLAHLVGKISEKV,GVVDILKGAGKDLLAHLVGKISEKV{ct:Amid},Ocellatin-1,Amidation,Free,Linear,L,None,25,"Antibacterial Gram-, Hemolytic",Hemolytic,Human,Frog Skin South American Leptodactylus Ocellatus,NA,NA,CCCTTTHHHHHHHHHTHHHHHGGGTSTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C
13826,15648972,2004,GVLDIFKDAAKQILAHAAEKQI,GVLDIFKDAAKQILAHAAEKQI{ct:Amid},Ocellatin-2,Amidation,Free,Linear,L,None,22,"Antibacterial Gram-, Hemolytic",Hemolytic,Human,Frog Skin South American Leptodactylus Ocellatus,NA,NA,CCTHIIIIITTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
13827,15648972,2004,GVLDILKNAAKNILAHAAEQI,GVLDILKNAAKNILAHAAEQI{ct:Amid},Ocellatin-3,Amidation,Free,Linear,L,None,21,"Antibacterial Gram-, Hemolytic",Hemolytic,Human,South American Frog Leptodactylus Ocellatus,NA,NA,CCSSTTSCSSCCTTCTTBTCEETTEECCBCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
13828,17698251,2004,VWPLGLVICKALKIC,VWPLGLVICKALKIC,Dybowskin-4,Free,Free,Linear,L,None,15,"Antibacterial, Antifungal, candidacidal, Hemolytic",47.58 % Hemolysis,Human,"Frog Rana Dybowskii , Asia",NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)O
13829,17698251,2004,FLPLLLAGLPLKLCFLFKKC,FLPLLLAGLPLKLCFLFKKC,Dybowskin-6,Free,Free,Linear,L,None,20,"Antibacterial Gram+, Antifungal, candidacidal, Hemolytic",59.39 % Hemolysis,Human,"Frog Rana Dybowskii , Asia",NA,NA,CTHHHHGGGGTTTSCCCCCSSSSSSSSSCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
13830,14978112,2004,RKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,RKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,human RK-31,Free,Free,Linear,L,None,31,"Antibacterial, Antifungal, candidacidal, Hemolytic",6 % Hemolysis at 100 µM,Human,"Human Protease Truncation; Human Sweat, Homo Sapiens",NA,Low hemolytic,CTTHHHHHHHHTTSTTHHHHHHHCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
13833,9022710,1993,IlGPVLGMVGSALGGLLKKI,I{nnr:l}GPVLGMVGSALGGLLKKI,Bombinin H3,Free,Free,Linear,Mix,l = D-alloisoleucine,20,"Antibacterial, Hemolytic",Hemolytic at 15.7 µM,Human,"Toad, Bombina Variegata, Europe",NA,NA,NA,NA
13834,10477123,1999,ALWKTMLKKLGTMALHAGKAAFGAAADTISQ,ALWKTMLKKLGTMALHAGKAAFGAAADTISQ,Dermaseptin-DI3 (DD M),Free,Free,Linear,L,None,31,"Antibacterial, Hemolytic",Hemolytic at >33 µM,Human,"Brazilian Frog, Phyllomedusa Distincta, South America",NA,NA,CCCTTSSSHHHHHSSSSCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)O
13835,10477123,1999,ALWKTLLKNVGKAAGKAALNAVTDMVNQ,ALWKTLLKNVGKAAGKAALNAVTDMVNQ,"Dermaseptin-DI2 (Dermaseptin DI2, DRS-DI2, DD L)",Free,Free,Linear,L,None,28,"Antibacterial, Antiparasitic, Hemolytic",Hemolytic at 12.5 µM,Human,"Brazilian Frog, Phyllomedusa Distincta, South America",NA,NA,CCSSTTSTTCCCSSCCTTTSSCC,CSCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
13837,17272268,2007,GFMDTAKNVAKNVAVTLIDNLKCKITKAC,GFMDTAKNVAKNVAVTLIDNLKCKITKAC,Odorranain-F1,Free,Free,Linear,L,None,29,"Antibacterial, Antifungal, candidacidal, Hemolytic",15.4 % Hemolytic at 50 μg/ml,Rabbit,"Frog Skin, Odorrana Grahami, China, Asia",Helix,NA,CCSSGGGGSSSCCHHHHTTTGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC
13838,17272268,2007,GIFGKILGVGKKVLCGLSGWC,GIFGKILGVGKKVLCGLSGWC,Odorranain-H1,Free,Free,Linear,L,None,21,"Antibacterial, Antifungal, candidacidal, Hemolytic",21.6 % Hemolytic at 50 μg/ml,Rabbit,"Frog Skin, Odorrana Grahami, China, Asia",Helix,NA,CCCTHHHHHHHHSCCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C)[C@@H](C)CC
13839,17272268,2007,VIPFVASVAAEMMQHVYCAASKKC,VIPFVASVAAEMMQHVYCAASKKC,Odorranain-P1a (OdP1a),Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, candidacidal, Hemolytic",11.2 % Hemolytic at 50 μg/ml,Rabbit,"Frog Skin, Odorrana Grahami, China, Asia",NA,NA,CCCBTTTBCGGGTHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C)C(C)C
13840,17272268,2007,GLFGKSSVVGRKYYVDLAGCAKA,GLFGKSSVVGRKYYVDLAGCAKA,Odorranain-W1,Free,Free,Linear,L,None,23,"Antibacterial, Antifungal, candidacidal, Hemolytic",17.6 % Hemolytic at 50 μg/ml,Rabbit,"Frog Skin, Odorrana Grahami, China, Asia",NA,NA,CCCSSTHHHHHHTHIIIIIISCCC,CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C
13841,17272268,2007,GLLSGVLGVGKKVDCGLSGLC,GLLSGVLGVGKKVDCGLSGLC,Nigrocin-OG21,Free,Free,Linear,L,None,21,"Antibacterial, Antifungal, candidacidal, Hemolytic",100 % Hemolytic at 50 μg/ml,Rabbit,"Frog Skin, Odorrana Grahami, China, Asia",NA,NA,CCCSSHHHHHHHGGGTTSTTCSCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CS)C(=O)O
13842,19022312,2009,FFGTALKIAANVLPTAICKILKKC,FFGTALKIAANVLPTAICKILKKC,Brevinin-1LTa,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, candidacidal, Hemolytic",50 % Hemolytic at 1.5 μg/ml,Rabbit,"Chinese Broad-Folded Frog, Hylarana Latouchii (Anura:Ranidae), China, Asia",NA,NA,CCTTSHHHHHHHHHHHHHHHCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC
13843,19022312,2009,FFPLVLGALGSILPKIF,FFPLVLGALGSILPKIF{ct:Amid},Temporin-LTa,Amidation,Free,Linear,L,None,17,"Antibacterial Gram+, Hemolytic",50 % Hemolytic at 9 μg/ml,Rabbit,"Chinese Broad-Folded Frog, Hylarana Latouchii (Anura:Ranidae), China, Asia",NA,NA,CCCCCCSSSCTTTHHHHHHHCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
13844,19254736,2009,FLPAIVGAAAKFLPKIFCAISKKC,FLPAIVGAAAKFLPKIFCAISKKC,Brevinin-1BLa,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, candidacidal, Hemolytic, Anticancer",50 % Hemolytic at 14 µM,Human,"Leopard Frog, Lithobates Yavapaiensis, North America",NA,NA,CCCCTHHHHHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
13845,19254736,2009,FLPIIAGVAAKVLPKIFCAISKKC,FLPIIAGVAAKVLPKIFCAISKKC,Brevinin-1BLb,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, Hemolytic, Anticancer",Hemolytic,Human,"Leopard Frog, Lithobates Yavapaiensis, North America",NA,NA,CCTTCBCSSSSCSBSSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
13846,19254736,2009,FLPIIAGIAAKFLPKIFCTISKKC,FLPIIAGIAAKFLPKIFCTISKKC,Brevinin-1BLc,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, candidacidal, Hemolytic, Anticancer",50 % Hemolytic at 9 µM,Human,"Leopard Frog, Lithobates Yavapaiensis, North America",NA,NA,CCCCCSCSTTTTSSSCCSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC
13847,19254736,2009,FLPVIAGVAANFLPKLFCAISKKC,FLPVIAGVAANFLPKLFCAISKKC,Brevinin-1Ya,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, candidacidal, Hemolytic, Anticancer",50 % Hemolytic at 18 µM,Human,"Leopard Frog, Lithobates Yavapaiensis, North America",NA,NA,CCCSSCCHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
13848,19254736,2009,FLPIIAGAAAKVVEKIFCAISKKC,FLPIIAGAAAKVVEKIFCAISKKC,Brevinin-1Yc,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, candidacidal, Hemolytic, Anticancer",50 % Hemolytic at 13 µM,Human,"Leopard Frog, Lithobates Yavapaiensis, North America",NA,NA,CCHHHHHHHHHHHTTTGGGTTTTSSCCSCSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
13849,15556063,2004,FFPIIAGMAAKLIPSLFCKITKKC,FFPIIAGMAAKLIPSLFCKITKKC,Brevinin-1SPa,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, candidacidal, Hemolytic",50 % Hemolytic at 7 µM,Human,"Frog Rana Septentrionalis , North America",NA,NA,CCTTCCSSSTTTHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
13850,15556063,2004,FLPIIAGMAAKVICAITKKC,FLPIIAGMAAKVICAITKKC,Brevinin-1SPb,Free,Free,Linear,L,None,20,"Antibacterial, Antifungal, candidacidal, Hemolytic",50 % Hemolytic at 25 µM,Human,"Frog Rana Septentrionalis , North America",NA,NA,CCTTHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
13851,15556063,2004,FFPIIAGMAAKVICAITKKC,FFPIIAGMAAKVICAITKKC,Brevinin-1SPd,Free,Free,Linear,L,None,20,"Antibacterial, Antifungal, candidacidal, Hemolytic",50 % Hemolytic at 8 µM,Human,"Frog Rana Septentrionalis , North America",NA,NA,CCCCHHHHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
13852,20451254,2010,FLSLIPHIVSGVASIAKHF,FLSLIPHIVSGVASIAKHF{ct:Amid},Phylloseptin-1 (PSN-1),Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal, candidacidal, Antiparasitic, Hemolytic, Antibiofilm",6.7 % Hemolytic at 5 µM,Horse,"The Waxy Monkey Frog, Phyllomedusa Sauvagei, South America",Helix,NA,CCCCCCCSSCSCCSSSSSCBSSTTCBSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
13853,21295070,2011,GIFSALAAGVKLLGNTLFKMAGKAGAEHLACKATNQC,GIFSALAAGVKLLGNTLFKMAGKAGAEHLACKATNQC,Esculentin-2PRb,Free,Free,Linear,L,None,37,"Antibacterial, Antifungal, candidacidal, Hemolytic",50 % Hemolytic at 35 µM,Human,"Frog North America, The Oregon Spotted Rana Pretiosa",NA,NA,CCSSCCCSSCCCCCCCCCSTTCSCCCSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C
13854,21295070,2011,FLPVLTGLTPSIVPKLVCLLTKKC,FLPVLTGLTPSIVPKLVCLLTKKC,Brevinin-1PRa,Free,Free,Linear,L,None,24,"Antibacterial Gram+, Antifungal, candidacidal, Hemolytic",50 % Hemolytic at 7 µM,Human,"Frog North America, The Oregon Spotted Rana Pretiosa",NA,NA,CCSSSCCSCSCCSSSSSSCCEETTEECCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)C(C)C
13855,21295070,2011,FLPIITNLLGKLL,FLPIITNLLGKLL{ct:Amid},Temporin-PRb,Amidation,Free,Linear,L,None,13,"Antibacterial Gram+, Hemolytic",50 % Hemolytic at 35 µM,Human,"Frog North America, The Oregon Spotted Rana Pretiosa",NA,NA,CCCCCCCCCSSCCCCCSCSSCCCBTTBCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
13856,21338048,2011,ILGPVLGLVGNALGGLIKKL,ILGPVLGLVGNALGGLIKKL{ct:Amid},Maximin H39,Amidation,Free,Linear,L,None,20,"Antibacterial Gram+, Hemolytic",50 % Hemolytic at 100 μg/ml,Human,"Toad Brain, Bombina Maxima, China, Asia",NA,NA,CCCCCCCCCSSCCCCCSCSSCCCBTTBCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
13857,21596752,2011,GIPCGESCVFIPCITGAIGCSCKSKVCYRN,GIPCGESCVFIPCITGAIGCSCKSKVCYRN{cyc:N-C},Cliotide T1,Free,Free,Cyclic,L,None,30,"Antibacterial, Hemolytic, Anticancer",50 % Hemolytic at 7.1 µM,Human,Plant Clitoria Ternatea,NA,NA,CCHHHHTTTCTTCCTHHHHTCCCCCTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
13859,21596752,2011,GIPCGESCVFIPCITAAIGCSCKSKVCYRN,GIPCGESCVFIPCITAAIGCSCKSKVCYRN{cyc:N-C},Cliotide T4,Free,Free,Cyclic,L,None,30,"Antibacterial, Hemolytic, Anticancer",50 % Hemolytic at 8.4 µM,Human,Plant Clitoria Ternatea,NA,NA,CCCHHHHHHHSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
13862,21303203,2011,GLWDSIKNFGKTIALNVMDKIKCKIGGGCPP,GLWDSIKNFGKTIALNVMDKIKCKIGGGCPP,Palustrin-2CE,Free,Free,Linear,L,None,31,"Antibacterial, hemolytic",50 % Hemolytic at 64 µM,Human,"The Chinese Brown Frog, Rana Chensinensis, China, Asia",NA,NA,CCSSGGGSSSTTSGGGGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)O
13863,19778602,2010,FLPLVLGALSGILPKIL,FLPLVLGALSGILPKIL{ct:Amid},Temporin-RN1,Amidation,Free,Linear,L,None,17,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic",6.69±1.51 % Hemolytic at 100 μg/ml,Rabbit,"Frog Skin Secretions, Rana Nigrovittata , China, Asia",NA,NA,CCSSGGGSSSTTSGGGGGGCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13864,19778602,2010,FFPLLFGALSSHLPKLF,FFPLLFGALSSHLPKLF{ct:Amid},Temporin-RN3,Amidation,Free,Linear,L,None,17,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic",Hemolytic,Rabbit,"Frog Skin Secretions, Rana Nigrovittata , China, Asia",NA,NA,CCSSGGGTCSSSCCBCSSSSBCCSSCCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
13865,22306820,2012,FALGAVTKLLPSLLCMITRKC,FALGAVTKLLPSLLCMITRKC,Hainanenin 1,Free,Free,Linear,L,None,21,"Antibacterial, Antifungal, hemolytic, candidacidal",20.72 % Hemolytic at 25 μg/ml,Human,"Skin Secretions, Hainan Cascade-Frog, Amolops Hainanensis; China, Asia",NA,NA,CCCCCSHHHHHHCCCCSSSSCCCSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
13866,22306820,2012,FALGAVTKLLPSLLCMITRKC,FALGAVTKLLPSLLCMITRKC,Hainanenin 1,Free,Free,Linear,L,None,21,"Antibacterial, Antifungal, hemolytic, candidacidal",42.34 % Hemolytic at 50 μg/ml,Human,"Skin Secretions, Hainan Cascade-Frog, Amolops Hainanensis; China, Asia",NA,NA,CCCSCCSSCCGGGGGTSBSSSSSSSBCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
13867,22306820,2012,FALGAVTKRLPSLFCLITRKC,FALGAVTKRLPSLFCLITRKC,Hainanenin 5,Free,Free,Linear,L,None,21,"Antibacterial, Antifungal, hemolytic, candidacidal",23.31 % Hemolytic at 25 μg/ml,Human,"Skin Secretions, Hainan Cascade-Frog, Amolops Hainanensis; China, Asia",NA,NA,CBTTBGGGSCCCSSBTTBCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
13868,22306820,2012,FALGAVTKRLPSLFCLITRKC,FALGAVTKRLPSLFCLITRKC,Hainanenin 5,Free,Free,Linear,L,None,21,"Antibacterial, Antifungal, hemolytic, candidacidal",49.14 % Hemolytic at 50 μg/ml,Human,"Skin Secretions, Hainan Cascade-Frog, Amolops Hainanensis; China, Asia",NA,NA,CCCCCTTTTTTTTGGGTCBCSSCBTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
13871,22467870,2012,IPCGESCVWIPCITAIAGCSCKNKVCYT,IPCGESCVWIPCITAIAGCSCKNKVCYT,ChaC7 (chassatide C7),Free,Free,Linear,L,None,28,"Antibacterial, Hemolytic, Anticancer",50 % Hemolytic at 11.6 µM,Human,Plant Chassalia Chartacea (Or Chassalia Curviflora),Bridge,NA,CTTTTHHHHHHHHHHHSCGGGTCC,CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C
13872,22467870,2012,AIPCGESCVWIPCISTVIGCSCSNKVCYR,AIPCGESCVWIPCISTVIGCSCSNKVCYR,ChaC8 (chassatide C8),Free,Free,Linear,L,None,29,"Antibacterial, Hemolytic, Anticancer",50 % Hemolytic at 25.5 µM,Human,Plant Chassalia Chartacea (Or Chassalia Curviflora),Bridge,NA,CHHHHHHHHHHHHHHHHTTSSSCCCSTTSSCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O
13873,22467870,2012,IPCGESCVWIPCISGMFGCSCKDKVCYS,IPCGESCVWIPCISGMFGCSCKDKVCYS,ChaC11 (chassatide C11),Free,Free,Linear,L,None,28,"Antibacterial, Hemolytic, Anticancer",50 % Hemolytic at 13.3 µM,Human,Plant Chassalia Chartacea (Or Chassalia Curviflora),Bridge,NA,CCCBSSGGGGGGGGTTHHHHTTTTCCBCCCC,CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C
13874,22828809,2013,FLSTLLKVAFKVVPTLFCPITKKC,FLSTLLKVAFKVVPTLFCPITKKC,Brevinin-1-AJ1,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, hemolytic, candidacidal",50 % Hemolytic at 50-100 µM,Rabbit,"Skin, The Torrent Frog, Amolops Jingdongensis, South China, Asia",NA,NA,CCSCHHHHHHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
13875,22828809,2013,FLSTLLKVAFKVVPTLFCPITKKC,FLSTLLKVAFKVVPTLFCPITKKC,Brevinin-1-AJ1,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, hemolytic, candidacidal",83.05 % Hemolytic at 100 µM,Rabbit,"Skin, The Torrent Frog, Amolops Jingdongensis, South China, Asia",NA,NA,CCHHHHHHHHHHHHHHHHHHSCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
13876,22828809,2013,FLSTLLKVAFKVVPTLFCPITKKC,FLSTLLKVAFKVVPTLFCPITKKC,Brevinin-1-AJ1,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, hemolytic, candidacidal",24.58 % Hemolytic at 50 µM,Rabbit,"Skin, The Torrent Frog, Amolops Jingdongensis, South China, Asia",NA,NA,CCHHHHHHHHHCCTTCHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
13877,22951323,2012,SLFSIFKTAAKFVGKNLLKQAGKAGLETLACKAKNEC,SLFSIFKTAAKFVGKNLLKQAGKAGLETLACKAKNEC,Esculentin-2CG1,Free,Free,Linear,L,None,37,"Antibacterial, Antifungal, hemolytic",50 % Hemolytic at 75 µM,Human,"Frog Skin Secretions, Amolops Chunganensis, China, Asia",NA,NA,CCCCHHHHHHHHHHHHGGGTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O
13878,22951323,2012,GLWNTIKEAGKKFAINVLDKIRCGIAGGCKT,GLWNTIKEAGKKFAINVLDKIRCGIAGGCKT,Palustrin-2CG1,Free,Free,Linear,L,None,31,"Antibacterial, Antifungal, hemolytic",50 % Hemolytic at 75 µM,Human,"Frog Skin Secretions, Amolops Chunganensis, China, Asia",NA,NA,CHHHHTTTTTCCHHHHHHHHHHHTSCSCCSSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)O
13879,22951323,2012,FLPIVAGLAANFLPKIVCKITKKC,FLPIVAGLAANFLPKIVCKITKKC,Brevinin-1CG2,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, hemolytic",50 % Hemolytic at 19 µM,Human,"Frog Skin Secretions, Amolops Chunganensis, China, Asia",NA,NA,CCSSSSSSCSSSCHHHHHHHHTTSCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C
13880,22951323,2012,FLSTLLNVASNVVPTLICKITKKC,FLSTLLNVASNVVPTLICKITKKC,Brevinin-1CG3,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, hemolytic",50 % Hemolytic at 19 µM,Human,"Frog Skin Secretions, Amolops Chunganensis, China, Asia",NA,NA,CCSSSSSSCSSSCHHHHHHHHTTSCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC
13881,22951323,2012,FLSTLLNVASKVVPTLFCKITKKC,FLSTLLNVASKVVPTLFCKITKKC,Brevinin-1CG4,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, hemolytic",50 % Hemolytic at 37.5 µM,Human,"Frog Skin Secretions, Amolops Chunganensis, China, Asia",NA,NA,CCSSSSSSCSSSCHHHHHHHHTTSCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
13882,22951323,2012,FLPMLAGLAANFLPKIVCKITKKC,FLPMLAGLAANFLPKIVCKITKKC,Brevinin-1CG5,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, hemolytic, candidacidal",50 % Hemolytic at 19 µM,Human,"Frog Skin Secretions, Amolops Chunganensis, China, Asia",NA,NA,CCCCSIIIIIGGGGTHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C
13883,22951323,2012,GILDKLKEFGISAARGVAQSLLNTTASCKLAKTC,GILDKLKEFGISAARGVAQSLLNTTASCKLAKTC,Brevinin-2CG1,Free,Free,Linear,L,None,34,"Antibacterial, Antifungal, hemolytic",50 % Hemolytic at 75 µM,Human,"Frog Skin Secretions, Amolops Chunganensis, China, Asia",NA,NA,CCCSSTHHHHHHHHHHHHHTCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C
13884,23000095,2012,SGTSEKERESGRLLGVVKRLIVCFRSPFP,SGTSEKERESGRLLGVVKRLIVCFRSPFP{ct:Amid},HsAp1,Amidation,Free,Linear,L,None,29,"Antibacterial, Antifungal, hemolytic",95 % Hemolytic at 3.2 µM,Human,"Scorpions Venom, Heterometrus Spinifer, Asia",NA,NA,CCHHHHHHHTTTHHHHHHHHCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CO)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C
13885,23000095,2012,SGTSEKERESGRLLGVVKRLIVCFRSPFP,SGTSEKERESGRLLGVVKRLIVCFRSPFP{ct:Amid},HsAp1,Amidation,Free,Linear,L,None,29,"Antibacterial, Antifungal, hemolytic",100 % Hemolytic at 6.4 µM,Human,"Scorpions Venom, Heterometrus Spinifer, Asia",NA,NA,CCHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CO)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C
13886,23000095,2012,SGTSEKERESGRLLGVVKRLIVCFRSPFP,SGTSEKERESGRLLGVVKRLIVCFRSPFP{ct:Amid},HsAp1,Amidation,Free,Linear,L,None,29,"Antibacterial, Antifungal, hemolytic",35 % Hemolytic at 1.6 µM,Human,"Scorpions Venom, Heterometrus Spinifer, Asia",NA,NA,CCCSSHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CO)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C
13887,18339450,2008,MAADIISTIGDLVKLIINTVKKFQK,MAADIISTIGDLVKLIINTVKKFQK,delta-lysin I,Free,Free,Linear,L,None,25,"Antibacterial, hemolytic",50 % Hemolytic at ~12.5 µM,Human,Bacteria Staphylococcus Warneri Rk,NA,NA,CCSCSSCCSEETTEECSCCCCCCTTTTTTSBTTBC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)CC
13888,21262304,2011,FLPIIAGVAAKVLPKLFCAITKKC,FLPIIAGVAAKVLPKLFCAITKKC,Brevinin-1CHa,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, candidacidal, Hemolytic",50 % Hemolytic at 5 µM,Human,"Skin Secretions, Chiricahua Leopard Frog, Lithobates Chiricahuensis, Arizona, Usa, North America",NA,NA,CCCHHHHHHHHHCGGGTCSSSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
13889,21262304,2011,FLPVIAGLAAKVLPKLFCAITKKC,FLPVIAGLAAKVLPKLFCAITKKC,Brevinin-1CHb,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, candidacidal, Hemolytic",50 % Hemolytic at 5 µM,Human,"Skin Secretions, Chiricahua Leopard Frog, Lithobates Chiricahuensis, Arizona, Usa, North America",NA,NA,CCHHHHHHHHHHCGGGTCSSSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
13890,20308076,2010,FLPAALAGIGGILGKLF,FLPAALAGIGGILGKLF,Temporin-SHd (Temp-SHd),Free,Free,Linear,L,None,17,"Antibacterial, Antiparasitic, Anti-MRSA, Hemolytic",50 % Hemolytic at 44 µM,Human,"Skin, Pelophylax Saharica, Africa",Helix,NA,CCHHHHHHHHHHHHTCSCCTTCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
13891,22342498,2012,FLSTLWNAAKSIF,FLSTLWNAAKSIF{ct:Amid},VmCT2,Amidation,Free,Linear,L,None,13,"Antibacterial, Hemolytic",50 % Hemolytic at 35 µM,Human,Scorpions Vaejovis Mexicanus Smithi,Helix,NA,CTTHHHHHHHHHHTSCSGGGTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
13892,19633086,2009,NKGCAICSIGAACLVDGPIPDFEIAGATGLFGLWG,NKGCAICSIGAACLVDGPIPDFEIAGATGLFGLWG,Subtilosin A1,Free,Free,Linear,L,None,35,"Antibacterial Gram+, Hemolytic",Hemolytic at 16 µM,Rabbit,Bacteria Mutant Produced In B. Subtilis,NA,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC
13893,23935531,2013,SLFGTFAKMALKGASKLIPHLLPSRQQ,SLFGTFAKMALKGASKLIPHLLPSRQQ,CPF-St4,Free,Free,Linear,L,None,27,"Antibacterial, Antifungal, Antiparasitic, Hemolytic",50 % Hemolytic at 64 µM,Mouse,African Clawed Frog Silurana Tropicalis,NA,NA,CCGGGSHHHHHHHGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
13894,23935531,2013,GVFGLLAKAALKGASKLIPHLLPSRQQ,GVFGLLAKAALKGASKLIPHLLPSRQQ,CPF-St5,Free,Free,Linear,L,None,27,"Antibacterial, Antifungal, Antiparasitic, Hemolytic",50 % Hemolytic at 64 µM,Mouse,African Clawed Frog Silurana Tropicalis,NA,NA,CCHHHHHHHHHHSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
13895,23935531,2013,GVWSTILGGLKKFAKGGLDAIVNPK,GVWSTILGGLKKFAKGGLDAIVNPK,XPF-St6,Free,Free,Linear,L,None,25,"Antibacterial, Antifungal, Antiparasitic, Hemolytic",50 % Hemolytic at 64 µM,Mouse,African Clawed Frog Silurana Tropicalis,NA,NA,CCHHHHHHHHHHSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)CN)C(C)C)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
13896,23935531,2013,GFMSKVANFAKKFAKGGVNAIMNQK,GFMSKVANFAKKFAKGGVNAIMNQK,XPF-St8,Free,Free,Linear,L,None,25,"Antibacterial, Antifungal, Antiparasitic, Hemolytic",50 % Hemolytic at 64 µM,Mouse,African Clawed Frog Silurana Tropicalis,NA,NA,CCGGGGGGTTTTSBSSSSBSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
13897,22426384,2012,FLAGLIGGLAKML,FLAGLIGGLAKML,Temporin-LTe,Free,Free,Linear,L,None,13,"Antibacterial Gram+, Hemolytic",50 % Hemolytic at 40 µM,Human,"Broad-Folded Frog, Hylarana Latouchii, China, Asia",NA,NA,CCCGGGGGGGCCCCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)O
13898,22484288,2012,FLFSLIPSAISGLISAF,FLFSLIPSAISGLISAF{ct:Amid},AamAP2,Amidation,Free,Linear,L,None,17,"Antibacterial Gram+,Antifungal, candidacidal, Hemolytic",~50 % Hemolytic at 100 µM,Horse,"Scorpion Venom, The North African Scorpion, Androctonus Amoreuxi",NA,NA,CCSSSSCSSCSSSCCCSSCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
13899,25066917,2014,FLPLLVGAISSILPKIF,FLPLLVGAISSILPKIF{ct:Amid},Temporin-TP2,Amidation,Free,Linear,L,None,17,"Antibacterial Gram+, Hemolytic",50 % Hemolytic at 59.4 µM,Human,"Frog Skin Secretions, Hylarana Taipehensis, China, Asia",NA,NA,CCTTHHHHHTCSCCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
13900,25066917,2014,FLPLLFGALSTLLPKIF,FLPLLFGALSTLLPKIF{ct:Amid},Temporin-TP3,Amidation,Free,Linear,L,None,17,"Antibacterial Gram+, Hemolytic",50 % Hemolytic at 94.6 µM,Human,"Frog Skin Secretions, Hylarana Taipehensis, China, Asia",NA,NA,CTHHHHHHHCTTTTGGGHHHHGGGTHHHHCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
13901,25066917,2014,FLPGLIKAAVGVGSTILCKITKKC,FLPGLIKAAVGVGSTILCKITKKC,Brevinin-1TP1,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, Antioxidant, Hemolytic",50 % Hemolytic at 44.4 µM,Human,"Frog Skin Secretions, Hylarana Taipehensis, China, Asia",NA,NA,CCCCTTCGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
13902,25066917,2014,FLPGLIKAAVGIGSTIFCKISKKC,FLPGLIKAAVGIGSTIFCKISKKC,Brevinin-1TP2,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, candidacidal, Antioxidant, Hemolytic",50 % Hemolytic at 43.1 µM,Human,"Frog Skin Secretions, Hylarana Taipehensis, China, Asia",NA,NA,CCSCHHHHHHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O
13903,25066917,2014,FLPGLIKVAVGVGSTILCKITKKC,FLPGLIKVAVGVGSTILCKITKKC,Brevinin-1TP3,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, Antioxidant, Hemolytic",50 % Hemolytic at 65.4 µM,Human,"Frog Skin Secretions, Hylarana Taipehensis, China, Asia",NA,NA,CCCHHHHHHHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)C(C)C
13904,25066917,2014,FLPGLIKAAVGIGSTIFCKISRKC,FLPGLIKAAVGIGSTIFCKISRKC,Brevinin-1TP4,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, candidacidal, Hemolytic",50 % Hemolytic at 82 µM,Human,"Frog Skin Secretions, Hylarana Taipehensis, China, Asia",NA,NA,CCCHHHHHHHHHHHTHHHHHHTTSCCCCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O
13905,25066917,2014,SILSTLKDVGISAIKSAGSGVLSTLLCKLNKNC,SILSTLKDVGISAIKSAGSGVLSTLLCKLNKNC,Brevinin-2TP1,Free,Free,Linear,L,None,33,"Antibacterial, Hemolytic",50 % Hemolytic at 18.2 µM,Human,"Frog Skin Secretions, Hylarana Taipehensis, China, Asia",NA,NA,CTTHHHHHHHHHHHHHHHHHHHHHHSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC
13906,25066917,2014,FLPFVGKLLSGLL,FLPFVGKLLSGLL{ct:Amid},Temporin-LF1,Amidation,Free,Linear,L,None,13,"Antibacterial Gram+, Antifungal, Hemolytic",50 % Hemolytic at 34.2 µM,Human,"Frog Skin Secretions, Amolops Lifanensis, China, Asia",NA,NA,CCCCCCSSSGGGSSCSCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)O
13907,25066917,2014,FLPMLAGLAANFLPKIICKITKKC,FLPMLAGLAANFLPKIICKITKKC,Brevinin-1LF1,Free,Free,Linear,L,None,24,"Antibacterial Gram+, Antifungal, Antioxidant, Hemolytic",50 % Hemolytic at 100 µM,Human,"Frog Skin Secretions, Amolops Lifanensis, China, Asia",NA,NA,CCHHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
13908,25066917,2014,FLPIVASLAANFLPKIICKITKKC,FLPIVASLAANFLPKIICKITKKC,Brevinin-1LF2,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, candidacidal, Hemolytic",50 % Hemolytic at 68 µM,Human,"Frog Skin Secretions, Amolops Lifanensis, China, Asia",NA,NA,CHHHHHHHHHHHHGGGTHHHHSCCSCTTTTSTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
13909,25066917,2014,GLWNTIKEAGKKFALNLLDKIRCGIAGGCKG,GLWNTIKEAGKKFALNLLDKIRCGIAGGCKG,Palustrin-2GN1,Free,Free,Linear,L,None,31,"Antibacterial, Antioxidant, Hemolytic",50 % Hemolytic at 46.4 µM,Human,"Frog Skin Secretions, Amolops Granulosus, China, Asia",NA,NA,CHHHHHHHHTHHHHHHHHHHHCCCSSCCGGGGSCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
13910,25066917,2014,GILDTLKQLGKAAAQSLLSKAACKLAKTC,GILDTLKQLGKAAAQSLLSKAACKLAKTC,Palustrin-2GN3,Free,Free,Linear,L,None,29,"Antibacterial, Antifungal, Hemolytic",50 % Hemolytic at 52.2 µM,Human,"Frog Skin Secretions, Amolops Granulosus, China, Asia",NA,NA,CHHHHHHHHHHHHGGGTHHHHSCCSCTTTTSTTSCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)O
13911,30802593,2019,FIVPSIFLLKKAFCIALKKC,FIVPSIFLLKKAFCIALKKC,Japonicin-2LF,Free,Free,Linear,L,None,20,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic, Antibiofilm",>80 % Hemolytic at 64 µM,Horse,"Fujian Large-Headed Frog Skin Secretion, Limnonectes Fujianensis, China, Asia",Helix,NA,CHHHHHHHHTHHHHHHHHHHHCCCSSCCGGGGSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
13912,32933215,2020,FLPALAGIAGLLGKIF,FLPALAGIAGLLGKIF{ct:Amid},Temporin-SHe,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal, Antiparasitic, Hemolytic",84 % Hemolytic at 25 µM,Human,"Sahara Frog, Pelophylax Saharicus, Africa",Helix,NA,CCTHHHHHHHHHHHHHHHHHHTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
13913,31328553,2021,SIFSLFKMGAKALGKTLLKQAGKAGAEYAACKATNQC,SIFSLFKMGAKALGKTLLKQAGKAGAEYAACKATNQC{ct:Amid},Esculentin-2 HYba1,Amidation,Free,Linear,L,None,37,"Antibacterial, Anti-MRSA, Hemolytic, Anticancer",50 % Hemolytic at 15 µM,Human,"Frog Skin Secretion, Hydrophylax Bahuvistara, India, Asia",NA,NA,CCTHHHHHHHTTHHHHHHTTTTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)O
13914,31328553,2021,SILSLFKMGAKALGKTLIKQAGKAGAEYVACKATNQC,SILSLFKMGAKALGKTLIKQAGKAGAEYVACKATNQC{ct:Amid},Esculentin-2 HYba2,Amidation,Free,Linear,L,None,37,"Antibacterial, Anti-MRSA, Hemolytic, Anticancer",50 % Hemolytic at 12 µM,Human,"Frog Skin Secretion, Hydrophylax Bahuvistara, India, Asia",NA,NA,CCCCCCCCCCCCCCSCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C
13915,31328553,2021,SIFSLFKMGAKALGKTLLKQAGKAGAEYAACKATNQC,SIFSLFKMGAKALGKTLLKQAGKAGAEYAACKATNQC,Esculentin-2 HYba1,Free,Free,Linear,L,None,37,"Antibacterial, Anti-MRSA, Hemolytic, Anticancer",50 % Hemolytic at 10 µM,Human,"Frog Skin Secretion, Hydrophylax Bahuvistara, India, Asia",NA,NA,CCCCCCCCCGGGSSSCCSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)O
13916,31328553,2021,SILSLFKMGAKALGKTLIKQAGKAGAEYVACKATNQC,SILSLFKMGAKALGKTLIKQAGKAGAEYVACKATNQC,Esculentin-2 HYba2,Free,Free,Linear,L,None,37,"Antibacterial, Anti-MRSA, Hemolytic, Anticancer",50 % Hemolytic at 10 µM,Human,"Frog Skin Secretion, Hydrophylax Bahuvistara, India, Asia",NA,NA,CCCGGGCSSHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C
13917,37228702,2023,FLPLLAGLAANFLPQIICKIARKC,FLPLLAGLAANFLPQIICKIARKC,Brevinin-1-AW,Free,Free,Linear,L,None,24,"Antibacterial, Anti-MRSA, Hemolytic, Antibiofilm, Anticance",50 % Hemolytic at 23.96 µM,Horse,"Skin Secretion, The Wuyi Torrent Frog, Amolops Wuyiensis, China, Asia",Helix,NA,CCGGGGHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
13918,37228702,2023,FLPLLAGLAANFLPKIICKIARKC,FLPLLAGLAANFLPKIICKIARKC,B1AW-K,Free,Free,Linear,L,None,24,"Antibacterial, Anti-MRSA, Hemolytic, Antibiofilm, Anticance",50 % Hemolytic at 10.6 µM,Horse,Synthetic Peptide,Helix,NA,CGGGSCTTHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
13919,33508505,2021,RIRIRIWRIRIRICTKSIPPIC,RIRIRIWRIRIRICTKSIPPIC,RI3,Free,Free,Linear,L,None,22,"Antibacterial, Anti-MRSA, Hemolytic",10 % Hemolytic at 8 µM,Human,Synthetic Peptide,NA,NA,CCCCSSTTHHHHGGGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
13920,37516110,2023,GSKPWWWSYFTSLSTHRPRWLLKY,GSKPWWWSYFTSLSTHRPRWLLKY,CBPZ-GSK24,Free,Free,Linear,L,None,24,"Antibacterial Gram-, Hemolytic",50 % Hemolytic at 19.42 µM,Human,Synthetic Peptide,NA,NA,CCSSCCCSGGGGHHHHSSGGGHHHHTTHHHHHHCCCHHHHHHHHTTCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
13921,31386688,2019,LKMLGMLFHNIRNILKTV,LKMLGMLFHNIRNILKTV{ct:Amid},Hs01,Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal, candidacidal, Hemolytic",50 % Hemolytic at >128 µM,Human,Human Prame Family Member 20,Helix,NA,CCTHHHHHHHHHHTTTSGGGGGHHHHHHHHHHHHHHHHHHSCBTTBCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)CC
13922,31386688,2019,KWAVRIIRKFIKGFIS,KWAVRIIRKFIKGFIS{ct:Amid},Hs02,Amidation,Free,Linear,L,None,16,"Antibacterial, Antifungal, candidacidal, Hemolytic",50 % Hemolytic at >128 µM,Human,Human Unconventional Myosin-Ih,Helix,NA,CCTTCCBSSSSSBSCSTTHHHHHHHTCCTHHHHHHHSSCCCTTTCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)O
13923,31386688,2019,FLREFHKWIERVVGWLGKVF,FLREFHKWIERVVGWLGKVF{ct:Amid},Hs03,Amidation,Free,Linear,L,None,20,"Antibacterial, Antifungal, candidacidal, Hemolytic",50 % Hemolytic at >128 µM,Human,Human Anaphase-Promoting Complex Subunit 2,Helix,NA,CCCTTTSCCCSCCCCTTHHHHTTGGGTTTCTHHHHHHTTCHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C
13924,31386688,2019,LFNNYITAALKLLEKLYKV,LFNNYITAALKLLEKLYKV{ct:Amid},Hs04,Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal, candidacidal, Hemolytic",50 % Hemolytic at 64 µM,Human,"Human Unconventional Myosin 1H Protein, Intragenic Antimicrobial Peptide, Homo Sapiens (Probable E3 Ubiquitin-Protein Ligase Herc3 Isoform 1)",Helix,NA,CTTSSCCCCCSBCSSSBCSSCTTTCCCCCCCSSSCTTGGGSSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O
13925,37938588,2023,MRRKTPVKWKTFFKALKHKKKIFKKTFEKFKFLAKGPAFLKGFDQKLKS,MRRKTPVKWKTFFKALKHKKKIFKKTFEKFKFLAKGPAFLKGFDQKLKS,CFPS_AMP_5,Free,Free,Linear,L,None,49,"Antibacterial, Hemolytic",50 % Hemolytic at 82.9 µM,Human,Synthetic Peptide,NA,NA,CCSSSHHHHHHHHHHHHHHHHHHGGGGSHHHHSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
13926,37938588,2023,MYLKKFLALKNSLKKLSPFKCAVKSWLKKCAEVTFYSKLLGRRGKKDGN,MYLKKFLALKNSLKKLSPFKCAVKSWLKKCAEVTFYSKLLGRRGKKDGN,CFPS_AMP_6,Free,Free,Linear,L,None,49,"Antibacterial, Hemolytic",50 % Hemolytic at 73.8 µM,Human,Synthetic Peptide,NA,NA,CCCTTSCTGGGCCCCCSCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC,CSCC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)C(C)C
13927,37938588,2023,MWFDRKKFFWPGVCLFLLFFPKRFYKKGPEKVFSFRKKYKFARKCKCKL,MWFDRKKFFWPGVCLFLLFFPKRFYKKGPEKVFSFRKKYKFARKCKCKL,CFPS_AMP_12,Free,Free,Linear,L,None,49,"Antibacterial, Hemolytic",50 % Hemolytic at 17.1 µM,Human,Synthetic Peptide,NA,NA,CCHHHHHHHHHCC,CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
13928,37938588,2023,MEAFKKKPRLPLFKVKLTRFLERARGLGSYRIFEFFKKFGVKKFVSSLR,MEAFKKKPRLPLFKVKLTRFLERARGLGSYRIFEFFKKFGVKKFVSSLR,CFPS_AMP_15,Free,Free,Linear,L,None,49,"Antibacterial, Hemolytic",50 % Hemolytic at 24.8 µM,Human,Synthetic Peptide,NA,NA,CCTTHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
13929,37938588,2023,MCFFPRRKSKVKVKGGLCRLLFIFFKTTFCFKAKTKKEIKKGTGKKIVR,MCFFPRRKSKVKVKGGLCRLLFIFFKTTFCFKAKTKKEIKKGTGKKIVR,CFPS_AMP_18,Free,Free,Linear,L,None,49,"Antibacterial, Hemolytic",50 % Hemolytic at 4.7 µM,Human,Synthetic Peptide,NA,NA,CCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)O
13930,37938588,2023,MSTRSSSIRRLVEAVRTRFRAALRTVLFFALRTTKRRPRR,MSTRSSSIRRLVEAVRTRFRAALRTVLFFALRTTKRRPRR,CFPS_AMP_23,Free,Free,Linear,L,None,40,"Antibacterial, Hemolytic",50 % Hemolytic at 11.5 µM,Human,Synthetic Peptide,NA,NA,CCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
13931,37938588,2023,MKKKKKGILKQNNKKKKYTLFNRMVVFLFLGFIMIIFVQKYKKVIYHK,MKKKKKGILKQNNKKKKYTLFNRMVVFLFLGFIMIIFVQKYKKVIYHK,CFPS_AMP_29,Free,Free,Linear,L,None,48,"Antibacterial, Hemolytic",50 % Hemolytic at 50.6 µM,Human,Synthetic Peptide,NA,NA,CCCTTSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)O
13932,28161291,2017,FWRIVRWIKRWLR,FWRIVRWIKRWLR{ct:Amid},FK13-a2,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-inflammatory, Hemolytic",50 % Hemolytic at 14 µM,Human,Human Cathelicidin Analog,Helix,NA,CCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13933,28161291,2017,FWRIVRRIWRWLR,FWRIVRRIWRWLR{ct:Amid},FK13-a3,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-inflammatory, Hemolytic",50 % Hemolytic at 12.5 µM,Human,Human Cathelicidin Analog,Helix,NA,CCSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13934,37812567,2023,RRWWRWWL,RRWWRWWL,W544,Free,Free,Linear,L,None,8,"Antibacterial, Hemolytic",50 % Hemolytic at 80 µM,Human,Human Cathelicidin Analog,NA,NA,CCSSSCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
13935,27915018,2017,WWWLKRIW,WWWLKRIW{ct:Amid},TetraF2W-KR,Amidation,Free,Linear,L,None,8,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic",50 % Hemolytic at 30 µM,Human,Synthetic Peptide,Rich,NA,CCSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
13936,27915018,2017,WWWLKRIW,WWWLKRIW{ct:Amid},TetraF2W-KR,Amidation,Free,Linear,L,None,8,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic",50 % Hemolytic at 50 µM,Porcine,Synthetic Peptide,Rich,NA,CCCTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
13937,27915018,2017,WWWLKRIW,WWWLKRIW{ct:Amid},TetraF2W-KR,Amidation,Free,Linear,L,None,8,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic",50 % Hemolytic at 35 µM,Chicken,Synthetic Peptide,Rich,NA,CCCTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
13938,27915018,2017,WWWLRKIW,WWWLRKIW{ct:Amid},TetraF2W-RK,Amidation,Free,Linear,L,None,8,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic",50 % Hemolytic at 30 µM,Human,Synthetic Peptide,Helix,NA,CCCTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
13939,27915018,2017,WWWLRKIW,WWWLRKIW{ct:Amid},TetraF2W-RK,Amidation,Free,Linear,L,None,8,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic",50 % Hemolytic at 40 µM,Porcine,Synthetic Peptide,Helix,NA,CCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
13940,27915018,2017,WWWLRKIW,WWWLRKIW{ct:Amid},TetraF2W-RK,Amidation,Free,Linear,L,None,8,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic",50 % Hemolytic at 35 µM,Chicken,Synthetic Peptide,Helix,NA,CCTHHHHHHTSCCGGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
13941,27915018,2017,WWWLKKIW,WWWLKKIW{ct:Amid},TetraF2W-KK,Amidation,Free,Linear,L,None,8,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic",50 % Hemolytic at 40 µM,Human,Synthetic Peptide,Rich,NA,CCCTTHHHHTTTHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
13942,27915018,2017,WWWLKKIW,WWWLKKIW{ct:Amid},TetraF2W-KK,Amidation,Free,Linear,L,None,8,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic",50 % Hemolytic at 55 µM,Porcine,Synthetic Peptide,Rich,NA,CGGGTIIIIITTTTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
13943,27915018,2017,WWWLKKIW,WWWLKKIW{ct:Amid},TetraF2W-KK,Amidation,Free,Linear,L,None,8,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic",50 % Hemolytic at 50 µM,Chicken,Synthetic Peptide,Rich,NA,CCHHHHHHHHHHGGGGGSTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
13944,32723829,2020,RRRWWWWL,RRRWWWWL,WW306 (Horine-L),Free,Free,Linear,L,None,8,"Antibacterial, Anti-MRSA, Hemolytic",50 % Hemolytic at 60 µM,Human,Synthetic Peptide,Rich,NA,CHHHHGGGTSTTC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
13945,9010936,1996,GFFALIAKTISSPLFKTL,GFFALIAKTISSPLFKTL{ct:Amid},18A,Amidation,Free,Linear,L,None,18,"Antibacterial Gram+, Hemolytic",100 % Hemolytic at 33 μg/ml,Human,Synthetic Peptide,NA,NA,CHHHHTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O
13946,38074470,2023,FLGTVLKVAAKVLPAALCQIFKKC,FLGTVLKVAAKVLPAALCQIFKKC,Brevinin-1LTe,Free,Free,Linear,L,None,24,"Antibacterial, Anti-MRSA, Hemolytic, Antibiofilm",50 % Hemolytic at 6.4 µM,Human,"Skin Secretion, The Broad-Folded Frog, Hylarana Latouchii",NA,NA,CHHHHHHHGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
13948,38611812,2024,FLPLLAGLAASFLPTIFCKISRKC,FLPLLAGLAASFLPTIFCKISRKC{cyc:18-24},Brevinin-1BW,C-terminus contains a Rana box: one disulfide bond.,Free,Linear,L,None,24,"Antibacterial, Anti-inflammatory, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer",50 % Hemolytic at 35.8 μg/ml,Sheep,"Skin, Pelophylax Nigromaculatus, East Asia",NA,NA,CCCCTHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
13949,36249542,2022,FLSKILSTLRILL,FLSKILSTLRILL,YZ106,Free,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",50 % Hemolytic at 50 µM,Human,Synthetic Peptide,NA,NA,CHHHHHHHHHHHHHHHGGGGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
13950,36249542,2022,FLSKILSTLRILF,FLSKILSTLRILF,YZ107,Free,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",50 % Hemolytic at 25 µM,Human,Synthetic Peptide,NA,NA,CGGGGTTHHHHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
13951,36138742,2022,FLKIIGKLLSGLL,FLKIIGKLLSGLL,VM-3K,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic, Antibiofilm",50 % Hemolytic at 11.2 µM,Horse,Synthetic Peptide,Helix,NA,CCTHHHHHHHHHHHHHHHHHSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13952,36138742,2022,FLGIIGKLLSGLL,FLGIIGKLLSGLL,VM-3G,Free,Free,Linear,L,None,13,"Antibacterial Gram+, Anti-MRSA, Hemolytic, Antibiofilm",50 % Hemolytic at 9.7 µM,Horse,Synthetic Peptide,Helix,NA,CCCCHHHHHHHHHHHHHTTTSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13953,36138742,2022,FLWIIGKLLSGLL,FLWIIGKLLSGLL,VM-3W,Free,Free,Linear,L,None,13,"Antibacterial Gram+, Anti-MRSA, Hemolytic, Antibiofilm",50 % Hemolytic at 9.7 µM,Horse,Synthetic Peptide,Helix,NA,CTHHHHHHHHGGGGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13954,38988311,2024,HLLSLLKKAAKKLLKKLLKKLAKKL,HLLSLLKKAAKKLLKKLLKKLAKKL,DeNo1011,Free,Free,Linear,L,None,25,"Antibacterial Gram-, Hemolytic",50 % Hemolytic at 32 μg/ml,Porcine,Synthetic Peptide,NA,NA,CTHHHHHHHHGGGGGGTC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)O
13955,38988311,2024,KIFGKILKKLLKKLLKKLLKKL,KIFGKILKKLLKKLLKKLLKKL,DeNo1013,Free,Free,Linear,L,None,22,"Antibacterial Gram-, Hemolytic",50 % Hemolytic at 64 μg/ml,Porcine,Synthetic Peptide,NA,NA,CTHHHHHHHHHHHGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
13956,38988311,2024,FLPIIAGLAAKLLPKLFCKITKKC,FLPIIAGLAAKLLPKLFCKITKKC,DeNo1017,Free,Free,Linear,L,None,24,"Antibacterial, Hemolytic",50 % Hemolytic at 16 μg/ml,Porcine,Synthetic Peptide,NA,NA,CTHHHHHHHHHHHGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
13957,38988311,2024,FLPIIAGLAAKFLPKIFCKITKKC,FLPIIAGLAAKFLPKIFCKITKKC,DeNo1016,Free,Free,Linear,L,None,24,"Antibacterial, Hemolytic",50 % Hemolytic at 4-8 μg/ml,Porcine,Synthetic Peptide,NA,NA,CCGGGSHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC
13958,39141008,2024,GLLKKLLKKLLKKLLKKI,GLLKKLLKKLLKKLLKKI,LK4,Free,Free,Linear,L,None,18,"Antibacterial, Hemolytic",50 % Hemolytic at 64 µM,Human,Synthetic Peptide,Helix,NA,CCGGGSHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
13959,39141008,2024,GLLKKLLKKLLKKLLKKI,GLLKKLLKKLLKKLLKKI,LK4,Free,Free,Linear,L,None,18,"Antibacterial, Hemolytic",10 % Hemolytic at 5.42 µM,Human,Synthetic Peptide,Helix,NA,CCTHHHHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
13960,39141008,2024,GFFKKFFKKFFKKFFKKI,GFFKKFFKKFFKKFFKKI,FK4,Free,Free,Linear,L,None,18,"Antibacterial, Hemolytic",50 % Hemolytic at 32-64 µM,Human,Synthetic Peptide,Helix,NA,CCCSSSSHHHHHSTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)O
13961,39141008,2024,GFFKKFFKKFFKKFFKKI,GFFKKFFKKFFKKFFKKI,FK4,Free,Free,Linear,L,None,18,"Antibacterial, Hemolytic",10 % Hemolytic at 4.02 µM,Human,Synthetic Peptide,Helix,NA,CCSSSTTSHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)O
13962,39141008,2024,GWWKKWWKKWWKKI,GWWKKWWKKWWKKI,WK3,Free,Free,Linear,L,None,14,"Antibacterial, Hemolytic",50 % Hemolytic at 32-64 µM,Human,Synthetic Peptide,Helix,NA,CCSSSCHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(=O)O
13963,39141008,2024,GWWKKWWKKWWKKI,GWWKKWWKKWWKKI,WK3,Free,Free,Linear,L,None,14,"Antibacterial, Hemolytic",10 % Hemolytic at 55.52 µM,Human,Synthetic Peptide,Helix,NA,CCCCCHHHHTTHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(=O)O
13964,39141008,2024,GWWKKWWKKWWKKWWKKI,GWWKKWWKKWWKKWWKKI,WK4,Free,Free,Linear,L,None,18,"Antibacterial, Hemolytic",10 % Hemolytic at 4.38 µM,Human,Synthetic Peptide,Helix,NA,CCSCSHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(=O)O
13965,39204443,2024,FLSLIPHAISAVSALAKHL,FLSLIPHAISAVSALAKHL,Phylloseptin-TO2,Free,Free,Linear,L,None,19,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer",50 % Hemolytic at 64 µM,Horse,"Skin Secretion, Super Tiger Leg Monkey Tree Frog, Phyllomedusa Tomopterna, Central America, South America",Helix,NA,CCCCGGGGTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13966,39204443,2024,FLSLIPKAISAVSALAKHL,FLSLIPKAISAVSALAKHL,PSTO2 7K,Free,Free,Linear,L,None,19,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer",50 % Hemolytic at 32-64 µM,Horse,Synthetic Peptide,Helix,NA,CCHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13967,39204443,2024,FLSLIPKAISAVSALAKKL,FLSLIPKAISAVSALAKKL,PSTO2 18K,Free,Free,Linear,L,None,19,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer",50 % Hemolytic at 64 µM,Horse,Synthetic Peptide,Helix,NA,CCCCCSCHHHHHHHHCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13968,39204443,2024,FLSLIPKAIKAVSALAKKL,FLSLIPKAIKAVSALAKKL,PSTO2 SR (Phylloseptin-TO2 analog),Free,Free,Linear,L,None,19,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer",50 % Hemolytic at 64 µM,Horse,Synthetic Peptide,Helix,NA,CCCGGGGHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13969,39204443,2024,FLSLIPKAIKAVKALAKKL,FLSLIPKAIKAVKALAKKL,PSTO2 SR2 (Phylloseptin-TO2 analog),Free,Free,Linear,L,None,19,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer",50 % Hemolytic at 32 µM,Horse,Synthetic Peptide,Helix,NA,CCCSSTHHHHHHHHHHTSSSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13970,39138237,2024,FLPFLASLALKIL,FLPFLASLALKIL{ct:Amid},"Temporin-WY2 (Natural AMPs, Leu-rich, frog, amphibians, animals, XXA, UCLL1c)",Amidation,Free,Linear,L,None,13,"Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic",50 % Hemolytic at 32-64 µM,Horse,"Cutaneous Secretion, The Ranidae Frog, Amolops Wuyiensis, China, Asia",Helix,NA,CCCCCCSTTHHHHHHHTSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
13971,39138237,2024,FLPKLLSALAKIL,FLPKLLSALAKIL{ct:Amid},"QUB-1426 (Synthetic AMPs, Temporin-WY2 analog, Leu-rich, XXA, UCLL1c",Amidation,Free,Linear,L,None,13,"Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic",50 % Hemolytic at 16-32 µM,Horse,Synthetic Peptide,Helix,NA,CCCCCCGGGGGGTTTCSSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
13972,39138237,2024,KKKKKKFLPFLASLALKIL,KKKKKKFLPFLASLALKIL{ct:Amid},"6K-WY2 (Synthetic AMPs, Temporin-WY2 analog, Lys-rich, Leu-rich, XXA, UCLL1c",Amidation,Free,Linear,L,None,19,"Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic",50 % Hemolytic at 32 µM,Horse,Synthetic Peptide,Helix,NA,CCSSCCCHIIIIIHHHHSCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
13973,39138237,2024,KKKKKKFLPKLLSALAKIL,KKKKKKFLPKLLSALAKIL{ct:Amid},"6K-1426 (Synthetic AMPs, Temporin-WY2 analog, Lys-rich, Leu-rich, XXA, UCLL1c)",Amidation,Free,Linear,L,None,19,"Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic",50 % Hemolytic at 32 µM,Horse,Synthetic Peptide,Helix,NA,CCCCGGGGGGCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
13974,39345903,2024,FFPIVAGVAAKVLKKIFCTISKKC,FFPIVAGVAAKVLKKIFCTISKKC,"Brevinin-1pl (natural AMPs; frog, amphibians, animals; XXU; 1S=S, UCSS1a; BBL)",Free,Free,Linear,L,None,24,"Antibacterial, Anticancer, Anti-MRSA, Hemolytic",50 % Hemolytic at 37.64 µM,Horse,"Skin Secretions, The Northern Leopard Frog, Rana Pipiens, North America",Helix,NA,CHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC)[C@@H](C)O
13975,39345903,2024,FFPKVAGVAAKVLKKIFCTISKKC,FFPKVAGVAAKVLKKIFCTISKKC,"[Lys4] brevinine-1pl (brevinine-1pl I4K analog, Synthetic AMPs, XXU; 1S=S, UCSS1a)",Free,Free,Linear,L,None,24,"Antibacterial, Anti-MRSA, Hemolytic",50 % Hemolytic at 80.77 µM,Horse,Synthetic Peptide,Helix,NA,CHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC)[C@@H](C)O
13976,39345903,2024,FFPKVAGVAAKVAKKIFCTISKKC,FFPKVAGVAAKVAKKIFCTISKKC,"[Lys4, Ala13] brevinine-1pl (brevinine-1pl I4K,L13A analog, Synthetic AMPs, XXU; 1S=S, UCSS1a)",Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic",50 % Hemolytic at 41.34 µM,Horse,Synthetic Peptide,Helix,NA,CCHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC)[C@@H](C)O
13977,39345903,2024,FFPKVAGVAAKVLKKAFCTISKKC,FFPKVAGVAAKVLKKAFCTISKKC,"[Lys4, Ala16] brevinine-1pl (brevinine-1pl I4K,I16A analog, Synthetic AMPs, XXU; 1S=S, UCSS1a",Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic",50 % Hemolytic at 84.86 µM,Horse,Synthetic Peptide,Helix,NA,CCSTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
13978,39427973,2025,FLPFLGKLFSGIF,FLPFLGKLFSGIF{ct:Amid},Temporin-PMb,Amidation,Free,Linear,L,None,13,"Antibacterial, Hemolytic, Anticancer",50 % Hemolytic at 32-64 µM,Human,"Skin Secretion, The Amazon River Frog, Lithobates Palmipes (Ranidae), Brazil, South America",NA,NA,CCHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
13979,39357847,2025,FLKLIGKVLSGIL,FLKLIGKVLSGIL{ct:Amid},Temporin F P3K analog,Amidation,Free,Linear,L,None,13,"Antibacterial, Hemolytic",50 % Hemolytic at 70 µM,Human,Synthetic Peptide,Helix,NA,CCSTTTHHHHTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
13980,39357847,2025,FLKLIGKVLSKIL,FLKLIGKVLSKIL{ct:Amid},"Temporin F P3K,G11K analog",Amidation,Free,Linear,L,None,13,"Antibacterial, Hemolytic",50 % Hemolytic at 30 µM,Human,Synthetic Peptide,Helix,NA,CHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C
13981,34953322,2022,IILLLLKKFLKKL,IILLLLKKFLKKL{ct:Amid},2K4L,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",50 % Hemolytic at 62.5 µM,Human,Synthetic Peptide,Helix,NA,CCSTTTHHHHTTC,CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13982,34953322,2022,WILLLLKKFLKKL,WILLLLKKFLKKL{ct:Amid},2K4L_W1,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",50 % Hemolytic at 12.5 µM,Human,Synthetic Peptide,Helix,NA,CCHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
13983,34953322,2022,IWLLLLKKFLKKL,IWLLLLKKFLKKL{ct:Amid},2K4L_W2,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",50 % Hemolytic at 50 µM,Human,Synthetic Peptide,Helix,NA,CTTSSSCSSCCCSCCTTSCCSSCCSCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
13984,34953322,2022,IILLLLKKFWKKL,IILLLLKKFWKKL{ct:Amid},2K4L_W10,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",50 % Hemolytic at 12.5 µM,Human,Synthetic Peptide,Helix,NA,CCCCCGGGGGGGSHHHHSSTTTGGGCCCCCCSSSBTTBCSSSSCCCCSSCCTTHHHHTTSCCCSSSSCHHHHTTCCCCCCTTCCSSSSCCCTTCCCCCCCCCCCCCCSSTTCBTTBCCSSCSTTTCTTTTCSSTTSCSCCCSCBHHHHSBCCCSSCSSCCSSGGGTTTTTTTTSCCSSTTSCSSTTTTCSSCCCSSSSCCCCTTCSTTCCSCGGGSCCSSSCSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13985,34953322,2022,IILLLLKKFLKKW,IILLLLKKFLKKW{ct:Amid},2K4L_W13,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",50 % Hemolytic at 12.5 µM,Human,Synthetic Peptide,Helix,NA,NA,CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC
13986,34953322,2022,IILLLLKKFWKKW,IILLLLKKFWKKW{ct:Amid},2K4L_2W,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",50 % Hemolytic at 25 µM,Human,Synthetic Peptide,Helix,NA,NA,CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC
13987,34953322,2022,IWLLLLKKFWKKW,IWLLLLKKFWKKW{ct:Amid},2K4L_3W (Temporin-1CEc analog),Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",50 % Hemolytic at 6.25 µM,Human,Synthetic Peptide,Helix,NA,CCCCCCCCTHHHHHHHHHTSCCSCCCCCSSCSSSTTSBSCSSSSCBCCCTTSCHHHHHHHHHHHHHTHHHHSCCCSSSSTTTSCCCCSSGGGSSSSCCCCSSCSSSCSSSCCTTTSCCCCCCCSSTHHHHGGGTSCSSSCCCCCCCSCCCSSCCSCTTCSSSSCCCCCCTTSSCTTTSSCCCCSSCCSSCSSSSTTTSSSCSSSCCCCCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
14088,19944711,2010,AHDGNPLEECFREDDEEFFLEIAKNGLTATSNPKRVVIV,AHDGNPLEECFREDDEEFFLEIAKNGLTATSNPKRVVIV{ct:Amid},L-amino-acid oxidase (BmarLAAO) (LAO) (EC 1.4.3.2),Amidation,Free,Linear,L,None,39,Antibacterial and Antiparasitic,Hemolytic,NA,Bothrops Marajoensis (Marajo Lancehead),NA,NA,CCCCCCSSGGGGGGGTCTTHHHHTCCCCCCSSTTCCCSSSCCCCCCCBSCGGGCBCGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O
14089,15142548,2004,ADVRNPLEEFRETDYEVL,ADVRNPLEEFRETDYEVL,L-amino-acid oxidase (Balt-LAAO-I) (LAO) (EC 1.4.3.2),Free,Free,Linear,L,None,18,Antibacterial,Hemolytic,NA,Bothrops Alternatus (Urutu) (Rhinocerophis Alternatus),NA,NA,NA,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(C)C)C(=O)O
14128,31671555,2019,MAFLKKSLFLVLFLGLVSLSMCEEEKRENEVEEEQEDDEQSELRRSLRSSIKDMAAAAGRAALNAVNGIVNPGEQ,MAFLKKSLFLVLFLGLVSLSMCEEEKRENEVEEEQEDDEQSELRRSLRSSIKDMAAAAGRAALNAVNGIVNPGEQ{ct:Amid},Dermaseptin-SP5 (DRS-SP5),Amidation,Free,Linear,L,None,75,"Antibacterial, Antifungal",<20 % Hemolytic at 256mg/L,Human,Agalychnis Spurrelli (Gliding Leaf Frog) (Agalychnis Litodryas),Alpha Helix,Non-hemolytic,CCCSSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
14129,31671555,2019,MAFLKKSLFLVLFLGLVSLSMCEEEKRENEVEEEQEDDEQSELRRSLWSSIKDMAAAAGRAALNAVNGILNPGEQ,MAFLKKSLFLVLFLGLVSLSMCEEEKRENEVEEEQEDDEQSELRRSLWSSIKDMAAAAGRAALNAVNGILNPGEQ{ct:Amid},Dermaseptin-SP4 (DRS-SP4),Amidation,Free,Linear,L,None,75,"Antibacterial, Antifungal",<20 % Hemolytic at 256mg/L,Human,Agalychnis Spurrelli (Gliding Leaf Frog) (Agalychnis Litodryas),Alpha Helix,Low hemolytic,CCCSSCSCTTTTTCSSCCCCTTCCCCCCSTTTTTCCCTTTTTTTTTTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
14130,31671555,2019,MAFLKKSLFLVLFLGLVSLSMCEEEKRENEVEEEQEDDEQSELRRSLWSSIKDMAAAAGRAALNAVNGIVNPGEQ,MAFLKKSLFLVLFLGLVSLSMCEEEKRENEVEEEQEDDEQSELRRSLWSSIKDMAAAAGRAALNAVNGIVNPGEQ{ct:Amid},Dermaseptin-SP3 (DRS-SP3),Amidation,Free,Linear,L,None,75,"Antibacterial, Antifungal",<20 % Hemolytic at 256mg/L,Human,Agalychnis Spurrelli (Gliding Leaf Frog) (Agalychnis Litodryas),Alpha Helix,Low hemolytic,CTTHHHHHHHHHHHSSHHHHHSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
14131,17000029,2006,MFTLKKSLLLLFFLGTINLSLCEQERNAEEERRDEPDERNAEVEKRFLPIVGKLLSGLSGLLGK,MFTLKKSLLLLFFLGTINLSLCEQERNAEEERRDEPDERNAEVEKRFLPIVGKLLSGLSGLLGK{ct:Amid},Temporin-ALa (Amolopin-2a),Amidation,Free,Linear,L,None,64,"Antibacterial, Antifungal",Hemolytic,Rabbit,Amolops Loloensis (Lolokou Sucker Frog) (Staurois Loloensis),NA,Low hemolytic,CCCCSSCCSCCCCCSSSSCSSCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C
14132,22438972,2012,IKFEPPLPPKKAHKKFWEDDGIYYPPNHNFP,IKFEPPLPPKKAHKKFWEDDGIYYPPNHNFP,L-amino-acid oxidase (Bm-LAO) (LAAO) (EC 1.4.3.2),Free,Free,Linear,L,None,31,Antibacterial Antiparasitic,12.5+-5.3 % Hemolytic at 512 μg/ml,Human,Bothrops Mattogrossensis (Pitviper) (Bothrops Neuwiedi Mattogrossensis),NA,NA,CCSSEECSSCEECCSSSSSSSCSCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC
14135,19946788,2010,IWLTALKFLGKNLGKHLAKQQLAKL,IWLTALKFLGKNLGKHLAKQQLAKL{nt:H}{ct:Amid},Toxin LyeTx 1,Amidation,H,Linear,L,None,25,Antibacterial,50 % Hemolytic at 1.3*10^-4M,Rabbit,Lycosa Erythrognatha (Wolf Spider) (Scaptocosa Raptoria),α-Helix,Low hemolytic,CCCSSCCCSCGGGGCCSCCSSCCCSSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
14136,26322745,2015,GKYTCGETCFKGKCYTPGCTCSYPICKKD,GKYTCGETCFKGKCYTPGCTCSYPICKKD{cyc:N-C},Cyclotide mela-1,Free,Free,Cyclic,L,None,29,Antibacterial,50 % Hemolytic at >64 µM,Human,Melicytus Latifolius (Norfolk Island Mahoe) (Hymenanthera Latifolia),NA,Non-hemolytic,CCCCCSSSSSSTTSSCSBCCSSSCBCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O
14137,26322745,2015,GKPTCGETCFKGKCYTPGCTCSYPLCKKD,GKPTCGETCFKGKCYTPGCTCSYPLCKKD{cyc:N-C},Cyclotide mela-2,Free,Free,Cyclic,L,None,29,Antibacterial,50 % Hemolytic at >64 µM,Human,Melicytus Latifolius (Norfolk Island Mahoe) (Hymenanthera Latifolia),NA,Non-hemolytic,CCHHHHHHHTTCSCCCCHHHHHHCCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O
14138,26322745,2015,GLPTCGETCFKGKCYTPGCSCSYPICKKD,GLPTCGETCFKGKCYTPGCSCSYPICKKD{cyc:N-C},Cyclotide mela-6,Free,Free,Cyclic,L,None,29,Antibacterial,50 % Hemolytic at >64 µM,Human,Melicytus Latifolius (Norfolk Island Mahoe) (Hymenanthera Latifolia),NA,Non-hemolytic,CCTTTSCCCCCCSSSSSCCSSCTTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O
14139,26322745,2015,GLPTCGETCFKGKCYTPGCSCSYPICKKN,GLPTCGETCFKGKCYTPGCSCSYPICKKN{cyc:N-C},Cyclotide mela-7,Free,Free,Cyclic,L,None,29,Antibacterial,50 % Hemolytic at >64 µM,Human,Melicytus Latifolius (Norfolk Island Mahoe) (Hymenanthera Latifolia),NA,Non-hemolytic,CCCCCCSSCSTHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O
14142,25220871,2014,FWGAVWKILSKVLPHIPGTVKWLQEKV,FWGAVWKILSKVLPHIPGTVKWLQEKV,M-ectatotoxin-Eb2a (M-ECTX-Eb2a) (Ponericin-Q42),Free,Free,Linear,L,None,27,Antibacterial,50 % Hemolytic at 2.5+-0.1 µM,Human,Ectatomma Brunneum (Ant) (Ectatomma Quadridens),NA,NA,CTTTSCTHHHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)CC)C(C)C
14144,30734396,2019,FLSLIPKIAGGIASLVKNL,FLSLIPKIAGGIASLVKNL{ct:Amid},Phylloseptin-1.1TR (PLS-1.1TR),Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal",50 % Hemolytic at 28 µM,Mouse,Phyllomedusa Trinitatis (Trinidad Leaf Frog),Helical,NA,CCSSCGGGHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
14145,30734396,2019,FLSLIPKIAGGIASLVKDL,FLSLIPKIAGGIASLVKDL{ct:Amid},Phylloseptin-1.2TR (PLS-1.2TR) (Phylloseptin-1.3TR),Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal",50 % Hemolytic at 75 µM,Mouse,Phyllomedusa Trinitatis (Trinidad Leaf Frog),NA,NA,CCTTSSCCCCCCCSSSCCCCCSCCCCCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
14146,30734396,2019,FLSLIPHIATGIAALAKHL,FLSLIPHIATGIAALAKHL{ct:Amid},Phylloseptin-2.1TR (PLS-2.1TR) (Phylloseptin-2.2TR),Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal",50 % Hemolytic at 41 µM,Mouse,Phyllomedusa Trinitatis (Trinidad Leaf Frog),Helical,NA,CCSSCCCSSSCSCTTTTTSCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O
14147,30734396,2019,FFSMIPKIATGIASLVKDL,FFSMIPKIATGIASLVKDL{ct:Amid},Phylloseptin-3.2TR (PLS-3.2TR),Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal, Anti-inflammatory",50 % Hemolytic at 110 µM,Mouse,Phyllomedusa Trinitatis (Trinidad Leaf Frog),NA,NA,CTHHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
14149,30734396,2019,LLGMIPVAITAISALSKL,LLGMIPVAITAISALSKL{ct:Amid},Medusin-TR1 (MDS-TR1) (Phylloseptin-4TR) (PLS-4TR),Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal, Anti-inflammatory, Antibiofilm",50 % Hemolytic at 65 µM,Mouse,Phyllomedusa Trinitatis (Trinidad Leaf Frog),Helical,NA,CCTTTHHHHTCSHHHHHHHHCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
14152,18312859,2008,NILSSIVNGINRALSFFG,NILSSIVNGINRALSFFG,Amolopin-P1,Free,Free,Linear,L,None,18,"Antibacterial, Antifungal",3 % Hemolytic at 200 μg/ml,Rabbit,Amolops Loloensis (Lolokou Sucker Frog) (Staurois Loloensis),β-Sheet,Non-hemolytic,CTTTCSHHHHTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O
14153,19843479,2009,MFTLKKSLLLLFFLGTINLSLCEQERNAEEERRDDLGERQAEVEKRFFPIVGKLLSG,MFTLKKSLLLLFFLGTINLSLCEQERNAEEERRDDLGERQAEVEKRFFPIVGKLLSG,Temporin-ALk (Amolopin-n1),Free,Free,Linear,L,None,57,"Antibacterial, Antifungal",25 % Hemolytic at 100 μg/ml,Rabbit,Amolops Loloensis (Lolokou Sucker Frog) (Staurois Loloensis),NA,Low hemolytic,CHHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)C(C)C
14154,22450466,2012,FLPLIASVAANLVPKIFCKITKKC,FLPLIASVAANLVPKIFCKITKKC,Brevinin-1V,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal",50 % Hemolytic at 75 µM,Human,Odorrana Hainanensis (Odor Frog) (Rana Hainanensis),Helical,NA,CCCCCSCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C
14155,22450466,2012,FLPLIASLAANFVPKIFCKITKKC,FLPLIASLAANFVPKIFCKITKKC,Brevinin-1HN1,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal",50 % Hemolytic at 75 µM,Human,Odorrana Hainanensis (Odor Frog) (Rana Hainanensis),Helical,NA,CCGGGGGGHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C
14156,22450466,2012,SLLGTVKDLLIGAGKSAAQSVLKGLSCKLSKDC,SLLGTVKDLLIGAGKSAAQSVLKGLSCKLSKDC,Brevinin-2HS2,Free,Free,Linear,L,None,33,"Antibacterial, Antifungal",50 % Hemolytic at 300 µM,Human,Odorrana Hainanensis (Odor Frog) (Rana Hainanensis),Helical,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O)C(C)C
14157,22450466,2012,AILTTLANWARKFL,AILTTLANWARKFL{ct:Amid},temporin-HN1,Amidation,Free,Linear,L,None,14,"Antibacterial, Antifungal",50 % Hemolytic at 75 µM,Human,Odorrana Hainanensis (Odor Frog) (Rana Hainanensis),Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@@H](C)O
14158,22450466,2012,NILNTIINLAKKIL,NILNTIINLAKKIL{ct:Amid},temporin-HN2:,Amidation,Free,Linear,L,None,14,"Antibacterial, Antifungal",50 % Hemolytic at 300 µM,Human,Odorrana Hainanensis (Odor Frog) (Rana Hainanensis),Helical,Low hemolytic,CCCHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
14162,15274631,2004,MSSRAGIAEGYEQIEVDVVAVWKEGYVYENRGSTSVEQKIKITKGMRNLNSETKTLTASHSIGSTISTGDLFEIATVDVSYSYSHEESQVSMTETEVYESKEIEHTITIPPTSKFTRWQLNADVGGADIEYMYLIDEVTPIGGTLSIPQVIKSRAKILVGREIYLGETEIRIKHADRKEYMTVVSRKSWPAATLGHSKLYKFVLYEDMYGFRIKTLNTMYSGYEYAYSSDQGGIYFDQGSDNPKQRWAINKSLPLRHGDVVTFMNKYFTRSGLCYYDGPATDVYCLDKREDKWILEVVKP,MSSRAGIAEGYEQIEVDVVAVWKEGYVYENRGSTSVEQKIKITKGMRNLNSETKTLTASHSIGSTISTGDLFEIATVDVSYSYSHEESQVSMTETEVYESKEIEHTITIPPTSKFTRWQLNADVGGADIEYMYLIDEVTPIGGTLSIPQVIKSRAKILVGREIYLGETEIRIKHADRKEYMTVVSRKSWPAATLGHSKLYKFVLYEDMYGFRIKTLNTMYSGYEYAYSSDQGGIYFDQGSDNPKQRWAINKSLPLRHGDVVTFMNKYFTRSGLCYYDGPATDVYCLDKREDKWILEVVKP,Lysenin-related protein 2 (LRP-2) (Fetidin) (Hemolysin) (Lysenin-3) (efL3),Free,Free,Linear,L,None,300,Antibacterial,Hemolytic,Sheep,Eisenia Fetida (Red Wiggler Worm),NA,NA,CHHHHHHSSSCCSCCCCCSSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)CC
14163,16330062,2006,FLPIIAKLLGGLL,FLPIIAKLLGGLL,Vespid chemotactic peptide 5e (VCP 5e),Free,Free,Linear,L,None,13,"Antibacterial, Antifungal",Hemolytic at 50 μg/ml,Rabbit,Vespa Magnifica (Hornet),NA,NA,CCCCCSSSCCCCCSSCSSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
14166,19716842,2010,FLPKMSTKLRVPYRRGTKDYH,FLPKMSTKLRVPYRRGTKDYH,Antimicrobial peptide scolopin-1,Free,Free,Linear,L,None,21,"Antibacterial, Antiyeast",25±2 % Hemolytic at 50 μg/ml,Human,Scolopendra Mutilans (Chinese Red-Headed Centipede) (Scolopendra Subspinipes Mutilans),NA,NA,CHHHHHHHHHHHHHHHHTCSCC,CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O
14167,19716842,2010,GILKKFMLHRGTKVYKMRTLSKRSH,GILKKFMLHRGTKVYKMRTLSKRSH,Antimicrobial peptide scolopin-2,Free,Free,Linear,L,None,25,"Antibacterial, Antiyeast",32±7 % Hemolytic at 50 μg/ml,Human,Scolopendra Mutilans (Chinese Red-Headed Centipede) (Scolopendra Subspinipes Mutilans),NA,NA,CHHHHHHHHHHHHTTTTTSSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O
14168,19716842,2010,FLPKMSTKLRVPYRRGTKDYH,FLPKMSTKLRVPYRRGTKDYH,Antimicrobial peptide scolopin-1,Free,Free,Linear,L,None,21,"Antibacterial, Antiyeast",21±5 % Hemolytic at 50 μg/ml,Rabbit,Scolopendra Mutilans (Chinese Red-Headed Centipede) (Scolopendra Subspinipes Mutilans),NA,NA,CHHHHIIIIIHHHGGGTCSSSCC,CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O
14169,19716842,2010,GILKKFMLHRGTKVYKMRTLSKRSH,GILKKFMLHRGTKVYKMRTLSKRSH,Antimicrobial peptide scolopin-2,Free,Free,Linear,L,None,25,"Antibacterial, Antiyeast",37±6 % Hemolytic at 50 μg/ml,Rabbit,Scolopendra Mutilans (Chinese Red-Headed Centipede) (Scolopendra Subspinipes Mutilans),NA,NA,CCGGGHHHHHHHHHHHHHTTTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O
14171,15207717,2004,GFRDVLKGAAKAFVKTVAGHIAN,GFRDVLKGAAKAFVKTVAGHIAN{ct:Amid},Ascaphin-1,Amidation,Free,Linear,L,None,23,Antibacterial,50 % Hemolytic at >200 µM,Human,Ascaphus Truei (Coastal Tailed Frog),NA,NA,CTTHHHHHHTTTSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O
14172,15207717,2004,GFRDVLKGAAKAFVKTVAGHIANI,GFRDVLKGAAKAFVKTVAGHIANI,Ascaphin-3,Free,Free,Linear,L,None,24,Antibacterial,50 % Hemolytic at >200 µM,Human,Ascaphus Truei (Coastal Tailed Frog),NA,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(=O)O
14173,15207717,2004,GIKDWIKGAAKKLIKTVASHIANQ,GIKDWIKGAAKKLIKTVASHIANQ,Ascaphin-5,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal",50 % Hemolytic at >200 µM,Human,Ascaphus Truei (Coastal Tailed Frog),NA,NA,CCTHHHHHHHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC
14174,15207717,2004,GFKDWIKGAAKKLIKTVASAIANQ,GFKDWIKGAAKKLIKTVASAIANQ,Ascaphin-7,Free,Free,Linear,L,None,24,Antibacterial,50 % Hemolytic at >200 µM,Human,Ascaphus Truei (Coastal Tailed Frog),NA,NA,CCGGGHHHHHHHHHHHHTSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
14175,21549739,2011,FDVMGIIKKIAGAL,FDVMGIIKKIAGAL{ct:Amid},Eumenine mastoparan-EF (EMP-EF),Amidation,Free,Linear,L,None,14,"Antibacterial, Antifungal",50 % Hemolytic at 181.1 µM,Mouse,Eumenes Fraterculus (Solitary Wasp),Alphα-Helical,Low hemolytic,CHHHHHHHHHHHHHHHHTSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
14177,15556063,2004,FLSAITSLLGKLL,FLSAITSLLGKLL{ct:Amid},Temporin-1SPb,Amidation,Free,Linear,L,None,13,Antibacterial,50 % Hemolytic at 60 µM,Human,Lithobates Septentrionalis (Mink Frog) (Rana Septentrionalis),NA,NA,CHHHHTTTHHHHHHHHHSTHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
14178,15556063,2004,GIWDTIKSMGKVFAGKILQNL,GIWDTIKSMGKVFAGKILQNL{ct:Amid},Brevinin-2-related peptide,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal, Anti-HIV",50 % Hemolytic at 70 µM,Human,Lithobates Septentrionalis (Mink Frog) (Rana Septentrionalis),NA,NA,CHHHHHGGGTTSCCCCBHHHHSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)O
14179,19463738,2009,GLKDIFKAGLGSLVKGIAAHVAN,GLKDIFKAGLGSLVKGIAAHVAN{ct:Amid},Alyteserin-1a,Amidation,Free,Linear,L,None,23,Antibacterial Gram-,50 % Hemolytic at >100 µM,Human,Alytes Obstetricans (Common Midwife Toad) (Bufo Obstetricans),Alphα-Helical,NA,CCTTGGGGTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
14180,19463738,2009,GLKEIFKAGLGSLVKGIAAHVAN,GLKEIFKAGLGSLVKGIAAHVAN{ct:Amid},Alyteserin-1b,Amidation,Free,Linear,L,None,23,Antibacterial Gram-,50 % Hemolytic at 210 µM,Human,Alytes Obstetricans (Common Midwife Toad) (Bufo Obstetricans),Alphα-Helical,NA,CCCCGGGGGGGTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
14181,19463738,2009,ILGKLLSTAAGLLSNL,ILGKLLSTAAGLLSNL{ct:Amid},Alyteserin-2a,Amidation,Free,Linear,L,None,16,Antibacterial,50 % Hemolytic at 135 µM,Human,Alytes Obstetricans (Common Midwife Toad) (Bufo Obstetricans),NA,NA,NA,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
14191,15809084,2005,DICTNCCAGTKGCNTTSANGAFICEGQSDPKKPKACPLNCDPHIAYA,DICTNCCAGTKGCNTTSANGAFICEGQSDPKKPKACPLNCDPHIAYA{nt:Amid},Potamin-1 (PT-1),Free,Amidation,Linear,L,None,47,"Antibacterial, Antifungal",0 % Hemolytic at 40 µM,Human,Solanum Tuberosum (Potato),NA,Non-hemolytic,CCCCCCCCSSCCCCCCSSCSSSSSCCCCCSSCSSSCSGGGTCCCCSSCCCCCCSSSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O
14192,18976634,2008,MAFLKKSLFLVLFLGIVSLSICEEEKREGEEEEKQEEENEELSEEELRERRAWLDKLKSLGKVVGKVALGVAQNYLNPQQ,MAFLKKSLFLVLFLGIVSLSICEEEKREGEEEEKQEEENEELSEEELRERRAWLDKLKSLGKVVGKVALGVAQNYLNPQQ,Raniseptin-1 (Rsp-1),Free,Free,Linear,L,None,80,Antibacterial,20 % Hemolytic at 80 µM,Human,Boana Raniceps (Chaco Tree Frog) (Hyla Roeschmanni),NA,NA,CCCSSCCSSSCCSCHHHHHHHHCSSCCCCSSCCCCSCSSSSCCCCSSSTTSSSSSTTSSCSSCCCCCSSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)C(C)C
14197,21539875,2011,MLLTISDFLFLSLTFSRYARMRDSRPWSDRKNNYSGPQFTYPPEKAPPEKLIKWNNEGSPIFEMPAEGGHIEP,MLLTISDFLFLSLTFSRYARMRDSRPWSDRKNNYSGPQFTYPPEKAPPEKLIKWNNEGSPIFEMPAEGGHIEP,Antimicrobial peptide lumbricin-PG (Lumbricin-PG),Free,Free,Linear,L,None,73,"Antibacterial, Antifungal",1.5 % Hemolytic at 200 μg/ml,Human,Metaphire Guillelmi (Earthworm) (Pheretima Guillelmi),NA,Low hemolytic,CCCSCCSSSSSCCCTTTTTSSCSCCCCCCSSCHHHHTTTTTTTHHHHSSCSCCCSCCSSCHHHHSSTTTSCCCTTCCSSSHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC)[C@@H](C)CC
14198,21539875,2011,MLLTISDFLFLSLTFSRYARMRDSRPWSDRKNNYSGPQFTYPPEKAPPEKLIKWNNEGSPIFEMPAEGGHIEP,MLLTISDFLFLSLTFSRYARMRDSRPWSDRKNNYSGPQFTYPPEKAPPEKLIKWNNEGSPIFEMPAEGGHIEP,Antimicrobial peptide lumbricin-PG (Lumbricin-PG),Free,Free,Linear,L,None,73,"Antibacterial, Antifungal",2.1 % Hemolytic at 200 μg/ml,Rabbit,Metaphire Guillelmi (Earthworm) (Pheretima Guillelmi),NA,Low hemolytic,CCCSSSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC)[C@@H](C)CC
14199,16087274,2006,GLHKVMREVLGYERNSYKKFFLR,GLHKVMREVLGYERNSYKKFFLR,Ixosin,Free,Free,Linear,L,None,23,"Antibacterial, Antifungal",Hemolytic at 50 μg/ml,Rabbit,Ixodes Sinensis (Hard Tick),NA,Non-hemolytic,CHHHHHHHHHHHHHHHHC,CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
14204,18312859,2008,NVLSSVANGINRALSFFG,NVLSSVANGINRALSFFG,Amolopin-P2,Free,Free,Linear,L,None,18,Antibacterial,3 % Hemolytic at 200 μg/ml,Rabbit,Amolops Loloensis (Lolokou Sucker Frog) (Staurois Loloensis),NA,Non-hemolytic,CCHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O
14205,11682065,2001,GLLDSIKGMAISAGKGALQNLLKVASCKLDKTC,GLLDSIKGMAISAGKGALQNLLKVASCKLDKTC,Nigrocin-1,Free,Free,Linear,L,None,33,"Antibacterial, Antifungal",1.1 % Hemolytic at 100 μg/ml,Human,Pelophylax Nigromaculatus (Black-Spotted Frog) (Rana Nigromaculata),α-Helical,Non-hemolytic,CTTHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C
14206,11682065,2001,GLLSKVLGVGKKVLCGVSGLC,GLLSKVLGVGKKVLCGVSGLC,Nigrocin-2,Free,Free,Linear,L,None,21,"Antibacterial, Antifungal",0.9 % Hemolytic at 100 μg/ml,Human,Pelophylax Nigromaculatus (Black-Spotted Frog) (Rana Nigromaculata),α-Helical,Non-hemolytic,CHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CS)C(=O)O
14208,26930596,2016,AVAGEKLWLLPHLLKMLLTPTP,AVAGEKLWLLPHLLKMLLTPTP,Polydim-I,Free,Free,Linear,L,None,22,Antibacterial,<2.6 % Hemolytic at 121.6 μg/ml,Human,Polybia Dimorpha (Neotropical Wasp),NA,Non-hemolytic,CTHHHHHHHHHHHHHHHHHHHHHCCC,CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)[C@@H](C)O
14209,15777955,2005,IGGIISFFKRLF,IGGIISFFKRLF,Grammistin Gs B,Free,Free,Linear,L,None,12,Antibacterial,Hemolytic at <10HU/mg,Horse,Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata),NA,Non-hemolytic,CTHHHHTTTTTSSSTTTTTSCCSCC,CC[C@H](C)[C@H](N)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
14210,15777955,2005,FIGGIISFFKRLF,FIGGIISFFKRLF,Grammistin Gs D,Free,Free,Linear,L,None,13,Antibacterial,Hemolytic at 79HU/mg,Horse,Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata),NA,NA,CCCSSSSSSSHHHHTSCSSCCCCSTTCCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
14211,15777955,2005,FIGGIISFIKKLF,FIGGIISFIKKLF,Grammistin Gs E,Free,Free,Linear,L,None,13,Antibacterial,Hemolytic at 63HU/mg,Horse,Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata),NA,NA,CCTHHIIIIIHHHHSCTTGGGCSSSSCCSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
14212,15777955,2005,WWRELLKKLAFTAAGHLGSVLAAKQSGW,WWRELLKKLAFTAAGHLGSVLAAKQSGW,Grammistin Gs A,Free,Free,Linear,L,None,28,Antibacterial,Hemolytic at <10HU/mg,Horse,Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata),NA,Non-hemolytic,CCGGGHHHHHHHHHHHHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
14213,15777955,2005,NWRKILGKIAKVAAGLLGSMLAGYQV,NWRKILGKIAKVAAGLLGSMLAGYQV,Grammistin Gs C,Free,Free,Linear,L,None,26,Antibacterial,Hemolytic at <10HU/mg,Horse,Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata),NA,Non-hemolytic,CCTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
14214,9784389,1998,SMLSVLKNLGKVGLGFVACKINKQC,SMLSVLKNLGKVGLGFVACKINKQC,Ranatuerin-1,Free,Free,Linear,L,None,25,Antibacterial,0 % Hemolytic at 20 μg/ml,Human,Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana),NA,Non-hemolytic,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CO)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)O
14215,9784389,1998,GLFLDTLKGAAKDVAGKLEGLKCKITGCKLP,GLFLDTLKGAAKDVAGKLEGLKCKITGCKLP,Ranatuerin-2,Free,Free,Linear,L,None,31,Antibacterial,0 % Hemolytic at 20 μg/ml,Human,Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana),NA,Non-hemolytic,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O
14216,9784389,1998,GFLDIINKLGKTFAGHMLDKIKCTIGTCPPSP,GFLDIINKLGKTFAGHMLDKIKCTIGTCPPSP,Ranatuerin-3,Free,Free,Linear,L,None,32,Antibacterial,0 % Hemolytic at 20 μg/ml,Human,Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana),NA,Non-hemolytic,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O
14217,9784389,1998,FLPFIARLAAKVFPSIICSVTKKC,FLPFIARLAAKVFPSIICSVTKKC,Ranatuerin-4,Free,Free,Linear,L,None,24,Antibacterial,0 % Hemolytic at 20 μg/ml,Human,Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana),NA,Non-hemolytic,CHHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C
14218,9784389,1998,FLPIASLLGKYL,FLPIASLLGKYL,Ranatuerin-5 (Temporin),Free,Free,Linear,L,None,12,Antibacterial,0 % Hemolytic at 20 μg/ml,Human,Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana),NA,Non-hemolytic,CCCHHHHHHHHHTCCBSSSSBC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
14219,9784389,1998,FISAIASMLGKFL,FISAIASMLGKFL,Ranatuerin-6 (Temporin),Free,Free,Linear,L,None,13,Antibacterial,0 % Hemolytic at 20 μg/ml,Human,Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana),NA,Non-hemolytic,CCSSSSCSSGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
14220,9784389,1998,FLSAIASMLGKFL,FLSAIASMLGKFL,Ranatuerin-7 (Temporin),Free,Free,Linear,L,None,13,Antibacterial,0 % Hemolytic at 20 μg/ml,Human,Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana),NA,Non-hemolytic,CCCCSSCCSTTTTTSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
14221,9784389,1998,FISAIASFLGKFL,FISAIASFLGKFL,Ranatuerin-8 (Temporin),Free,Free,Linear,L,None,13,Antibacterial,0 % Hemolytic at 20 μg/ml,Human,Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana),NA,Non-hemolytic,CCCSSSCSSSCCCCCCCCCCCCCCCCCCTTSCCCSCSSCSSSCSSCCSCSCCCSSSSCSSCSSCCCSSSCCCCCCCSCSCCCCCSSSSCSSCSCCSCCSSCCSSCCCSSSCSSCCTTSCCSCTTSSSCCSCSSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
14222,9784389,1998,FLFPLITSFLSKVL,FLFPLITSFLSKVL,Ranatuerin-9 (Temporin),Free,Free,Linear,L,None,14,Antibacterial,0 % Hemolytic at 20 μg/ml,Human,Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana),NA,Non-hemolytic,CCCCCCCHHHHHHHTTCCCSCSSCCCCSSSTTSSTTCCCCGGGGCCTTSSCTTCHHHHHHHHHHHHTTSCCSSCCSCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O
14223,19298834,2009,GLLGGLLGPLLGGGGGGGGGLL,GLLGGLLGPLLGGGGGGGGGLL,Leptoglycin,Free,Free,Linear,L,None,22,Antibacterial,0 % Hemolytic at 2-200 µM,Human,Leptodactylus Pentadactylus (Smokey Jungle Frog) (Rana Pentadactyla),NA,Non-hemolytic,CHHHHIIIIITTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14225,21520894,2011,PVVDTTGNNPLQQQEEYYV,PVVDTTGNNPLQQQEEYYV,Kunitz-type serine protease inhibitor 1 (Xb-KTI),Free,Free,Linear,L,None,19,"Antibacterial, trypsin inhibitor",0 % Hemolytic at 250 μg/ml,Human,Xanthosoma Sagittifolium (Arrowleaf Elephant'S Ear) (Arum Sagittifolium),NA,Non-hemolytic,CHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)C(C)C
14227,15246874,2004,MKLSCLLLTLAIIFVLTIVHAPNVKAKALADPESDAVGFADAVGEADPFDITKLNIKKLTKATCKVISKGASMCKVLFDKKKQE,MKLSCLLLTLAIIFVLTIVHAPNVKAKALADPESDAVGFADAVGEADPFDITKLNIKKLTKATCKVISKGASMCKVLFDKKKQE,M-myrmeciitoxin-Mb2a (M-MIITX-Mb2a) (M-myrmeciitoxin-Mp3a) (M-MIITX-Mp3a) (Pilosulin-4),Free,Free,Linear,L,None,84,Antibacterial,0 % Hemolysis at 50 µM,Human,Myrmecia Banksi (Jack Jumper Ant) (Australian Jumper Ant),NA,Non-hemolytic,CCHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)CC
14228,31209048,2019,GLLSLLSLLGKLL,GLLSLLSLLGKLL{ct:Amid},DFTamP1,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at <3.1 µM,Human,Synthetic Peptide,NA,NA,CHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14229,31209048,2019,GALSLLSLLGKLL,GALSLLSLLGKLL{ct:Amid},DFT506,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at 4 µM,Human,Synthetic Peptide,NA,NA,CCTHHHHHHSTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CN)C(=O)O
14230,31209048,2019,GLASLLSLLGKLL,GLASLLSLLGKLL{ct:Amid},DFT507,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at <3.1 µM,Human,Synthetic Peptide,NA,NA,CHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14231,31209048,2019,GLLSALSLLGKLL,GLLSALSLLGKLL{ct:Amid},DFT508,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at 6 µM,Human,Synthetic Peptide,NA,NA,CHHHHHHHHHSCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14232,31209048,2019,GLLSLASLLGKLL,GLLSLASLLGKLL{ct:Amid},DFT509,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at 4 µM,Human,Synthetic Peptide,NA,NA,CHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14233,31209048,2019,GLLSLLSALGKLL,GLLSLLSALGKLL{ct:Amid},DFT510,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at 19 µM,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14234,31209048,2019,GLLSLLSLAGKLL,GLLSLLSLAGKLL{ct:Amid},DFT511,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at 14 µM,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14235,31209048,2019,GLLSLLSLLGKAL,GLLSLLSLLGKAL{ct:Amid},DFT512,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at 4 µM,Human,Synthetic Peptide,NA,NA,CHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14236,31209048,2019,GLLSLLSLLGKLA,GLLSLLSLLGKLA{ct:Amid},DFT513,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at <3.1 µM,Human,Synthetic Peptide,NA,NA,CHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
14237,31209048,2019,GLLSALKALGKLL,GLLSALKALGKLL{ct:Amid},DFT514,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at 36 µM,Human,Synthetic Peptide,NA,NA,CHHHHHHHHHTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14238,31209048,2019,GLLSALOALGKLL,GLLSAL{nnr:O}ALGKLL{ct:Amid},DFT515,Amidation,Free,Linear,L,O = L-Ornithine,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at 36 µM,Human,Synthetic Peptide,NA,NA,NA,NA
14239,31209048,2019,GLLSALOALGOLL,GLLSAL{nnr:O}ALG{nnr:O}LL{ct:Amid},DFT516,Amidation,Free,Linear,L,O = L-Ornithine,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at 36 µM,Human,Synthetic Peptide,NA,NA,NA,NA
14240,31209048,2019,GLLSALKAAGKLL,GLLSALKAAGKLL{ct:Amid},DFT521,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at > 50 µM,Human,Synthetic Peptide,NA,NA,CCSSHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14241,31209048,2019,GALSALKALGKLL,GALSALKALGKLL{ct:Amid},DFT528,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at > 50 µM,Human,Synthetic Peptide,NA,NA,CCCCCCSSTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CN)C(=O)O
14242,31209048,2019,GLLSALKALGKAL,GLLSALKALGKAL{ct:Amid},DFT529,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at > 50 µM,Human,Synthetic Peptide,NA,NA,CTTSSCCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14243,31209048,2019,GLLSAAKAAGKLL,GLLSAAKAAGKLL{ct:Amid},DFT522,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at 50 µM,Human,Synthetic Peptide,NA,NA,CCSSSTTCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14244,31209048,2019,GALSALKALGKAL,GALSALKALGKAL{ct:Amid},DFT530,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at >100 µM,Human,Synthetic Peptide,NA,NA,CHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CN)C(=O)O
14245,31209048,2019,GLLSLSLLGKLL,GLLSLSLLGKLL{ct:Amid},DFT523,Amidation,Free,Linear,L,None,12,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at >50 µM,Human,Synthetic Peptide,NA,NA,CCCSGGGTTSCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14246,31209048,2019,GLLSLSLGKLL,GLLSLSLGKLL{ct:Amid},DFT524,Amidation,Free,Linear,L,None,11,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at >300 µM,Human,Synthetic Peptide,NA,NA,CHHHHHHHHTCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14247,31209048,2019,GLLSLGKLL,GLLSLGKLL{ct:Amid},DFT525,Amidation,Free,Linear,L,None,9,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at >300 µM,Human,Synthetic Peptide,NA,NA,CHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14248,31209048,2019,GLSSLGKLL,GLSSLGKLL{ct:Amid},DFT526,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at >300 µM,Human,Synthetic Peptide,NA,NA,CHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14249,31209048,2019,GLSLLLSLLGKLL,GLSLLLSLLGKLL{ct:Amid},DFT502,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at 3.1 µM,Human,Synthetic Peptide,NA,NA,CHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14250,31209048,2019,GLSLLLSLGLKLL,GLSLLLSLGLKLL{ct:Amid},DFT503,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at >300 µM,Human,Synthetic Peptide,NA,NA,CCHHHHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14251,31209048,2019,GLSLLLSLLLGKL,GLSLLLSLLLGKL{ct:Amid},DFT504,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at 8 µM,Human,Synthetic Peptide,NA,NA,CCCSGGGTTSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14252,31209048,2019,GLLSSLLLLGKLL,GLLSSLLLLGKLL{ct:Amid},DFT505,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at 20 µM,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14253,31209048,2019,GKLLSLLSLLGLL,GKLLSLLSLLGLL{ct:Amid},DFT527,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at 20 µM,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)O
14254,31209048,2019,GLLSLLSLGLKLL,GLLSLLSLGLKLL{ct:Amid},DFT531,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at 7 µM,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O
14255,31209048,2019,LLGSLLSLGLKLL,LLGSLLSLGLKLL{ct:Amid},DFT532,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at 13 µM,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)O
14256,31209048,2019,glslllslglkll,G{d}L{d}S{d}L{d}L{d}L{d}S{d}L{d}G{d}L{d}K{d}L{d}L{d}{ct:Amid},DFT503d,Amidation,Free,Linear,D,None,13,"Antibacterial, Anti-MRSA, Hemolytic",HL50 % Hemolysis at >300 µM,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O